Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,embryonic skeletal system development (GO:0048706),-0.7187819645560473,-2.171372077015808,0.0,0.0019606171681868555,0.002,14/35,5.68%,SULF1;COL1A1;PDGFRA;HOXC4;OSR1;HOXB3;PCSK5;HOXA3;HOXB4;SULF2;RBP4;DYNC2I1;WNT9A;SIX1
prerank,collagen fibril organization (GO:0030199),-0.595565175780619,-2.133854290292691,0.0,0.002450771460233569,0.005,41/88,8.48%,COL1A2;COL3A1;COL5A2;COL4A5;ADAMTS2;COL1A1;COL5A1;COL4A6;COL8A1;COL12A1;COL22A1;COL25A1;COL4A3;LOXL1;COL6A2;COL4A4;PLOD2;COL6A3;COL26A1;COL6A1;COL8A2;COL18A1;COL13A1;COL23A1;COL11A1;COL15A1;LOXL3;TGFBR1;P4HA1;SERPINH1;CYP1B1;COL20A1;COL27A1;TLL1;COL16A1;LOX;ATP7A;COL9A2;LUM;COL5A3;DPT
prerank,dermatan sulfate metabolic process (GO:0030205),-0.8850666182736342,-2.1202499948020863,0.0,0.0019606171681868555,0.006,5/13,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.8916527693568707,-2.0636393937941224,0.0,0.0066170829426306366,0.026,5/12,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.8001923051937119,-2.0330151287617118,0.0,0.010195209274571649,0.047,10/17,12.08%,ATP1A2;CACNA1C;ANK2;CACNA2D1;KCNJ2;CACNA1G;SLC8A1;CACNA1D;TRPM4;CACNB2
prerank,ureteric bud development (GO:0001657),-0.792635118951589,-2.0325067439714735,0.0,0.008496007728809707,0.047,14/17,14.39%,BMP7;FGFR2;GPC3;BMP4;OSR1;SLIT2;SALL1;FOXC1;PKD2;SIX1;ROBO2;BMP2;NPNT;WNT11
prerank,mesonephric tubule development (GO:0072164),-0.8207265983042255,-2.0318205358651324,0.0,0.007282292338979749,0.047,13/15,14.39%,BMP7;FGFR2;BMP4;OSR1;SLIT2;PKD1;SALL1;FOXC1;PKD2;SIX1;ROBO2;NPNT;WNT11
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.6312919319509183,-2.0307664877579112,0.0,0.00637200579660728,0.047,20/50,10.29%,ZIC1;GLI3;FGFR2;GPC3;DCDC2;TULP3;GAS1;SMO;FBXL17;IFT81;SUFU;RORA;GLIS2;GLI1;MGRN1;IFT122;EVC;FUZ;ARMC9;BTRC
prerank,retinoid metabolic process (GO:0001523),-0.5773155216783808,-2.0010928307485334,0.0,0.012090472537152275,0.098,17/71,8.01%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;GPC3;RBP1;CYP26B1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;CYP1B1;SCPEP1;SDC4;APOE
prerank,skeletal system development (GO:0001501),-0.5205315726350093,-1.9980521071345192,0.0,0.011469610433893104,0.102,51/148,14.60%,BMP6;COL1A2;SULF1;IGF1;SOX5;FBN1;COL1A1;GLI2;BMP5;BMP7;EXT1;CDH11;FGFR2;ITGB8;PCSK5;PKD1;MMP14;NPR3;COL13A1;MMP16;GJA1;SULF2;WWOX;CREB3L2;RBP4;SH3PXD2B;TGFBR1;SUFU;TNFRSF11B;PRELP;PAPSS2;AKAP13;IGF2;TLL1;GNAS;ATP7A;COL9A2;PTH1R;MYOC;SOX6;EVC;PAPSS1;CHRD;PTHLH;PKDCC;BMP2;CMKLR1;P3H1;COMP;WNT11;DDRGK1
prerank,establishment of endothelial barrier (GO:0061028),0.7994196101643725,1.9847608940415236,0.0,0.08706808489235834,0.071,15/29,8.79%,PECAM1;TJP1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;TJP2;F11R;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;SOX18;RAP1B;MSN
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.8410248445900089,1.9457039078798042,0.0,0.09668607101418862,0.149,5/19,6.45%,SLCO1C1;PDGFB;APP;KLF2;KLF4
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.7707857941967714,-1.9400377835437943,0.0,0.030122209220325324,0.252,7/16,8.16%,IGF1;IGFBP2;IGFBP5;BMP5;IGFBP6;IGFBP4;IGFBP3
prerank,eye development (GO:0001654),-0.5848404777946532,-1.9262667393867465,0.0,0.03635310999346461,0.313,14/54,6.51%,CACNA1C;PBX1;FBN1;COL5A2;SMOC1;COL5A1;EFEMP1;LAMA1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,ceramide biosynthetic process (GO:0046513),0.7112748247052759,1.9242433674624178,0.0,0.10866636951681932,0.231,7/40,2.43%,SGMS1;ST8SIA4;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4
prerank,hemopoiesis (GO:0030097),0.6311138951305593,1.9209217907155243,0.0,0.08605566530058673,0.241,18/87,5.83%,FLT1;MECOM;KITLG;TEK;PDGFB;KDR;CD34;TGFB2;NOTCH4;RASGRP4;TIRAP;FLT4;SNRK;ZFPM1;ZBTB16;TAL1;PLD4;ETV6
prerank,monocyte chemotaxis (GO:0002548),0.7280445830456503,1.919599352991041,0.0,0.07127433926072124,0.248,4/32,2.32%,FLT1;PDGFB;IL6R;TNFRSF11A
prerank,glycerolipid catabolic process (GO:0046503),0.8209587107204376,1.9174307482842587,0.0,0.06395117088023994,0.266,5/19,5.89%,GPCPD1;ABHD2;PLA2G4B;PNPLA6;GDPD1
prerank,positive regulation of developmental growth (GO:0048639),0.6923698467332488,1.9097716050163391,0.0,0.06609653620566074,0.309,15/49,12.62%,PLCB1;SEMA7A;INSR;MACF1;NTN1;NEDD4L;AGRN;ITSN2;DBNL;RASAL1;TWF2;SMURF1;CPNE5;SYT4;CPNE6
prerank,angiogenesis involved in wound healing (GO:0060055),0.8987451685230938,1.9040903218961451,0.0,0.06580727346515455,0.343,6/11,4.52%,NDNF;KDR;ADIPOR2;CD34;PRCP;GATA2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.7040357786851976,-1.893021377916014,0.0,0.06236270761886652,0.499,12/22,20.69%,TIMP2;TIMP3;PTPN3;ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;TIMP4;ADAM8
prerank,membrane lipid biosynthetic process (GO:0046467),0.6641843588674746,1.8909571896363273,0.0014858841010401188,0.07829378176367106,0.428,15/58,5.12%,SGMS1;CERT1;SGPP2;ELOVL7;ST8SIA6;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1
prerank,bile acid and bile salt transport (GO:0015721),0.7819460918872617,1.8869854917715316,0.001718213058419244,0.0765389211379336,0.453,6/24,7.18%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;ABCB11;NCOA2
prerank,sphingolipid metabolic process (GO:0006665),0.6023238413589237,1.885857427865069,0.0,0.07169771472637118,0.461,34/108,13.93%,SGMS1;ST6GALNAC3;CERT1;SGPP2;ELOVL7;ESYT2;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1;NEU4;ESYT1;GAL3ST1;SPTLC2;CERKL;ELOVL5;ENPP2;GLB1;ORMDL1;GLTP;ORMDL3;ELOVL6;B4GALNT1;CERK;HACD2;DEGS1;SPTLC1;NEU2
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.5672882096900278,-1.8851468636740927,0.0,0.06470036655016623,0.536,20/55,12.23%,GPC6;DCN;SDC2;OGN;CEMIP;FMOD;GPC3;BGN;CEMIP2;GPC4;FGF2;PRELP;CSPG4;SDC4;LUM;OMD;ARSB;SLC9A1;HEXA;GNS
prerank,regulation of cell junction assembly (GO:1901888),0.7565046505442815,1.8806597563114695,0.0,0.0716286861178413,0.493,11/27,7.23%,PRKCH;OCLN;TJP1;CLDN5;RAPGEF2;F11R;MEF2C;RAPGEF1;APLNR;SNAI2;RAP1B
prerank,organic hydroxy compound transport (GO:0015850),0.7023268412393844,1.863488696401298,0.0016207455429497568,0.09353199459366936,0.618,7/36,7.18%,SLCO1C1;ABCC4;SLCO2B1;NCOA1;OSBP;ABCB11;NCOA2
prerank,extracellular structure organization (GO:0043062),-0.46414484988750243,-1.863208371958764,0.0,0.08580967806097804,0.669,78/204,8.12%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;COL8A1;ADAMTS10;COL22A1;NID1;VTN;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;COL6A3;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;COL15A1;DDR1;CDH1;DAG1;TGFBR1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;FGF2;ADAMTSL4;ST7;TNC;SPP1;COL27A1;ADAMTS15;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19
prerank,external encapsulating structure organization (GO:0045229),-0.4609603807831827,-1.8614972624666728,0.0,0.08216211320433041,0.677,77/205,8.12%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;COL8A1;ADAMTS10;COL22A1;NID1;VTN;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;COL6A3;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;COL15A1;DDR1;CDH1;DAG1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;FGF2;ADAMTSL4;ST7;TNC;SPP1;COL27A1;ADAMTS15;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.7044941349128413,-1.8597925179457926,0.002386634844868735,0.08003931263068692,0.694,8/20,10.27%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA;SLC9A1
prerank,extracellular matrix organization (GO:0030198),-0.44990279478373507,-1.8541624029211081,0.0,0.08207361312382197,0.724,99/276,9.27%,COL1A2;LAMA2;COL3A1;FBN1;COL5A2;COL4A5;SMOC1;THSD4;ADAMTS2;COL1A1;ADAMTS12;ADAMTSL3;DCN;ITGA9;COL5A1;COL4A6;GSN;COL8A1;COL12A1;TIMP2;ADAMTS10;COL22A1;NID1;VTN;COL25A1;COL4A3;LOXL1;ADAMTS6;COL6A2;COL4A4;BGN;PLOD2;COL6A3;COL26A1;ELN;ADAMTSL5;LAMA1;COL6A1;ITGB5;COL8A2;ITGB8;VIT;MFAP5;MMP14;ITGA10;COL18A1;LAMC3;SMOC2;COL13A1;MMP16;COL23A1;COL11A1;FBLN5;THBS1;SH3PXD2B;COL15A1;DDR1;CDH1;LOXL3;DAG1;TGFBR1;P4HA1;SH3PXD2A;ECM2;ADAMTS5;NID2;ADAMTS17;ITGA11;SERPINH1;FGF2;ADAMTSL4;SCUBE1;CYP1B1;ST7;TNC;SPP1;COL20A1;CTSL;COL27A1;ADAMTS15;TLL1;ADAMTSL1;COL16A1;MMP2;SPARC;LOX;ATP7A;TGFBI;ITGA5;ADAMTS16;COL9A2;LUM;ADAM19;COL5A3;DPT;KLK2;LAMB1;CREB3L1;ITGB4
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.7632960464422692,-1.8478995714941113,0.0,0.08477089492976324,0.755,9/16,12.61%,FOXD1;BMP4;FGF1;SALL1;PKD2;FGF2;SIX1;BMP2;NPNT
prerank,maintenance of blood-brain barrier (GO:0035633),0.7310293038243069,1.8462320120456157,0.003215434083601286,0.12105645690183375,0.73,12/30,3.99%,OCLN;SLC1A1;MFSD2A;PECAM1;ESAM;TJP1;CLDN5;JAM2;TJP2;F11R;ACTB;LSR
prerank,cellular response to interleukin-4 (GO:0071353),0.8810215435792159,1.8426890262555604,0.0,0.12095039389698149,0.751,3/10,5.83%,LEF1;JAK3;TCF7
prerank,heme catabolic process (GO:0042167),0.837538268987579,1.8425274044317124,0.0019193857965451055,0.10749513900869137,0.754,2/14,1.07%,ABCG2;SLCO2B1
prerank,porphyrin-containing compound catabolic process (GO:0006787),0.837538268987579,1.8425274044317124,0.0019193857965451055,0.10749513900869137,0.754,2/14,1.07%,ABCG2;SLCO2B1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.7033284188472374,1.8405243928808621,0.0031847133757961785,0.10501040987986629,0.764,11/34,5.18%,FLT1;SEMA6A;KDR;DAB2IP;FLT4;PRKD1;NOTCH1;PRKD2;RAMP2;DLL4;GAB1
prerank,organic anion transport (GO:0015711),0.6256107592317843,1.8383743836908013,0.0014084507042253522,0.10385293601909816,0.779,9/76,2.53%,SLCO1C1;ABCC4;ABCG2;CA4;ABCC6;SLCO2B1;SLC39A8;SLC16A2;LRRC8C
prerank,neutral amino acid transport (GO:0015804),0.7273052194430809,1.82777878614099,0.001652892561983471,0.11971861672699269,0.835,5/28,2.87%,SLC6A6;SLC7A5;SLC1A1;SLC38A5;SLC43A2
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.7331189568532311,-1.8275898144608522,0.006818181818181818,0.10626545051572756,0.837,7/16,10.12%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1;PRKACA
prerank,cardiac muscle cell action potential (GO:0086001),-0.6276379522035026,-1.8260110373631244,0.005263157894736842,0.10321248949669375,0.84,9/30,7.86%,ATP1A2;CACNA1C;ANK2;DMD;CACNA2D1;KCNJ2;CACNA1G;SLC8A1;CACNA1D
prerank,activation of adenylate cyclase activity (GO:0007190),-0.5982240351725007,-1.8242553687577558,0.0027100271002710027,0.10146193845366977,0.846,7/35,4.82%,LGR4;ADCY5;ADCY1;ADCY9;EDNRA;ADCY2;ADCY7
prerank,regulation of interleukin-4 production (GO:0032673),0.7735684658803004,1.8213197019157954,0.0017452006980802793,0.12727560582271652,0.869,5/21,8.41%,LEF1;SLC7A5;ZFPM1;LGALS9;FOXP3
prerank,response to interleukin-4 (GO:0070670),0.8795068932388017,1.8196729946021737,0.0019083969465648854,0.12558604845203272,0.874,3/10,5.83%,LEF1;JAK3;TCF7
prerank,relaxation of cardiac muscle (GO:0055119),-0.7686954949973678,-1.819671505846481,0.0,0.10284715710510613,0.862,6/13,7.24%,ATP1A2;GSN;CAMK2D;KCNJ2;P2RX4;SLC8A1
prerank,sulfur compound catabolic process (GO:0044273),-0.6017110550626807,-1.8196240748512338,0.002570694087403599,0.09868439746540505,0.862,12/38,12.23%,DCN;OGN;FMOD;BGN;PRELP;CSPG4;GGT5;LUM;OMD;ARSB;HEXA;GNS
prerank,diterpenoid metabolic process (GO:0016101),-0.5487840047632552,-1.8158427557649335,0.0,0.10010911260762083,0.881,13/55,8.01%,GPC6;ALDH1A1;LRP1;SDC2;GPC3;RBP1;ABCA4;RBP4;DHRS3;GPC4;AKR1B1;SDC4;APOE
prerank,positive regulation of neuron migration (GO:2001224),0.8527545637451523,1.8134580585648883,0.0035149384885764497,0.13447573273314192,0.899,4/11,2.67%,SEMA6A;DAB2IP;RAPGEF2;ARHGEF2
prerank,relaxation of muscle (GO:0090075),-0.7575556050806035,-1.8101009472407965,0.0,0.10410123079545976,0.902,6/13,7.24%,ATP1A2;GSN;CAMK2D;KCNJ2;P2RX4;SLC8A1
prerank,cellular component maintenance (GO:0043954),0.8278186063655326,1.8020649790596228,0.0019455252918287938,0.15654537937768498,0.932,3/12,6.12%,IGF1R;INSR;FYN
prerank,vascular transport (GO:0010232),0.5986191876587729,1.8020069697525944,0.0,0.1503645577699193,0.932,16/81,3.10%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,kidney development (GO:0001822),-0.531071379693805,-1.8006740925767657,0.0,0.11291702579742814,0.922,19/65,8.22%,SULF1;GLI2;WNT4;BMP7;BMP4;KANK2;OSR1;PCSK5;PKD1;GREB1L;SULF2;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;ACE;AGTR1
prerank,sphingolipid biosynthetic process (GO:0030148),0.6084830103628345,1.8004092703222738,0.0,0.1500717348726069,0.938,17/71,7.79%,SGMS1;CERT1;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;CERS4;PPM1L;PRKD1;PRKD2;PRKD3;ACER1;TLCD3B;SPTLC2;ELOVL5
prerank,cardiac muscle cell contraction (GO:0086003),-0.6841609204040974,-1.795286099062235,0.007009345794392523,0.11662171048625741,0.937,7/19,7.86%,CACNA1C;GSN;CAMK2D;CACNA2D1;KCNJ2;CACNA1G;CACNA1D
prerank,amide transport (GO:0042886),0.723125804091905,1.7945608920454752,0.0017271157167530224,0.15981230741224428,0.952,5/26,1.98%,CERT1;ABCG2;PLTP;AQP11;SLC38A5
prerank,transport across blood-brain barrier (GO:0150104),0.5945039584442419,1.7945519380564117,0.0,0.15410472500466413,0.952,16/83,3.10%,SLCO1C1;SLC6A6;SLC7A5;TFRC;ABCC4;SLC7A1;ABCG2;SLC1A1;SLC2A1;MFSD2A;ATP8A1;INSR;SLCO2B1;SLC16A2;SLC38A5;SLC22A8
prerank,regulation of JNK cascade (GO:0046328),0.5861847832529686,1.7942937563284134,0.0,0.14938425631692115,0.953,19/101,5.25%,IGF1R;MECOM;PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;TIRAP;SH3RF1;FLT4;PHLPP1;TPD52L1;NOD2;MEN1;DUSP3;WNT7A;CCR7
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7607627399481952,-1.7902455114637124,0.0,0.12047654461065437,0.946,6/13,9.50%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2;TGFB3
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.5466203455005835,-1.7857548744598826,0.003076923076923077,0.12253857301167845,0.952,13/53,12.85%,EYA2;EYA1;EGFR;EYA4;DDX5;PLA2R1;PRKCD;FBH1;ATM;FXR2;SPRED1;TMEM161A;FMR1
prerank,glycerophospholipid catabolic process (GO:0046475),0.7126405170228082,1.7844135822399674,0.004991680532445923,0.16883784058777856,0.969,9/27,14.91%,GPCPD1;PLA2G4B;PNPLA6;INPP5F;GDPD1;ENPP2;LIPC;PNPLA8;PRDX6
prerank,ganglioside biosynthetic process (GO:0001574),0.8049900706254718,1.7843600105786892,0.001876172607879925,0.16355475211587794,0.969,5/15,2.10%,ST8SIA4;ST6GALNAC3;ST8SIA6;ST3GAL1;B4GALT5
prerank,dendritic spine organization (GO:0097061),0.7210496267002885,1.7814572650011882,0.0016863406408094434,0.1657204319281152,0.974,6/26,6.12%,IGF1R;SHANK3;INSR;WNT7A;DIP2A;FYN
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.7556405758034895,-1.7705531175024634,0.0042643923240938165,0.1447694418703133,0.976,5/13,11.96%,DCN;BGN;CSPG4;ARSB;HEXA
prerank,protein targeting to ER (GO:0045047),0.5789012116500374,1.7682512917390614,0.0,0.19696162967193115,0.992,70/99,32.26%,SEC62;RPL38;RPL13;RPS29;RPL36A;ZFAND2A;RPL3;RPL27;RPSA;SRP14;SGTB;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;GET3;RPS9;SPCS2;RPL11;EDEM1;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;SPCS1;RPL18A;RPS21;RPL10A;RPL24;SRPRA;RPL7A;ZFAND2B;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,regulation of epithelial cell migration (GO:0010632),0.6397207136077938,1.7658156626070194,0.0,0.19882134159585382,0.993,17/51,8.63%,PTPRG;DAB2IP;MACF1;BMPR2;TGFB2;DOCK1;MCC;PTK2;EVL;VIL1;PLCG1;RREB1;INSL3;RAB11A;PTPRR;PTN;ENPP2
prerank,blood vessel morphogenesis (GO:0048514),0.6244915345041839,1.7618120571207734,0.0,0.2054922508555859,0.996,20/54,9.09%,FLT1;SLC1A1;EGFL7;KDR;ENG;RASIP1;CAV1;TBX1;SOX17;FLT4;ID1;APLNR;CDH2;RAMP2;SMAD7;COL4A1;SOX18;TGFB1;LRP5;CCM2
prerank,myeloid cell differentiation (GO:0030099),0.6408212230564684,1.760769266054866,0.0,0.202849514318017,0.996,13/47,7.67%,MFHAS1;RASGRP4;TIRAP;SNRK;JAK3;ZFPM1;LYN;ZBTB16;KLF1;SLC25A5;TAL1;CDKN2B;KAT6A
prerank,endodermal cell differentiation (GO:0035987),-0.616000049523292,-1.760729162463578,0.004705882352941176,0.1591469716989174,0.983,12/31,10.36%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;CTR9;MMP2;ITGA5;LAMB1;ITGAV
prerank,embryonic eye morphogenesis (GO:0048048),-0.774450721908349,-1.7606282599514942,0.0,0.15441345515507993,0.983,10/11,22.61%,FBN1;EFEMP1;MFAP5;KDM2B;FBN2;LRP6;MFAP2;TBX2;RARG;ALDH1A3
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.7610148126406654,1.7585688513054922,0.005042016806722689,0.20319534833772876,0.996,7/19,5.99%,PRKCH;OCLN;TJP1;CLDN5;F11R;IKBKB;SNAI2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5998205697431848,1.7574628311278244,0.0,0.20117842993335303,0.996,39/70,21.62%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.7044677359728234,-1.7524367977599795,0.0044943820224719105,0.16506666599808453,0.989,4/14,7.08%,ANK2;ACTN2;ATP1B3;ATP1B2
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.6458417488649167,-1.7514560013022535,0.007263922518159807,0.1621990574424297,0.99,11/23,15.15%,GLI3;ENPP1;GPC3;TULP3;SUFU;GLIS2;MGRN1;IFT122;BTRC;KIF7;PTCH2
prerank,purine ribonucleotide transport (GO:0015868),0.7759230265846403,1.7501354549321821,0.010398613518197574,0.2182153612418498,0.998,3/16,2.53%,ABCC4;ABCC6;LRRC8C
prerank,regulation of calcium ion transmembrane transport (GO:1903169),-0.6406589595055716,-1.7485009073043787,0.002331002331002331,0.16330307163356347,0.99,7/23,13.29%,ATP1A2;ANK2;CAMK2D;CACNA2D1;DIAPH1;PTK2B;CACNB1
prerank,positive regulation of lymphocyte migration (GO:2000403),0.8112479870882181,1.7471722792180955,0.00375234521575985,0.22270699969995958,0.999,3/12,1.57%,CXCL12;JAM2;APP
prerank,negative regulation of reproductive process (GO:2000242),-0.6779909048012822,-1.743678700321647,0.0069767441860465115,0.16877204542365226,0.993,3/17,3.09%,SULF1;IGF1;GJA1
prerank,renal system development (GO:0072001),-0.5359903131116487,-1.7398572728144108,0.0,0.1726632987720345,0.993,18/52,8.22%,SULF1;GLI2;WNT4;BMP4;PCSK5;PKD1;GREB1L;SULF2;RBP4;SALL1;FOXC1;TGFBR1;ARL3;PYGO1;SIX1;TBX18;ACE;AGTR1
prerank,ureteric bud morphogenesis (GO:0060675),-0.702221525682749,-1.73898508524611,0.002320185614849188,0.16989501845865326,0.993,9/16,17.87%,BMP4;SALL1;PKD2;FGF2;SIX1;BMP2;NPNT;WNT11;PAX2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5934635746718393,1.7376656474193453,0.0,0.24987009388138798,0.999,39/71,21.62%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,lipid transport (GO:0006869),0.5687894894101748,1.7376422513865017,0.0,0.24401722684533314,0.999,20/97,7.36%,SLCO1C1;ABCC4;CERT1;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;PPARD;NCOA1;SCARB1;OSBP;ABCG1;PITPNC1;PRELID2;PITPNA;ABCA3;ABCB11;NCOA2;CHKA
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.726226904508191,1.7369415349841841,0.005190311418685121,0.24064978249994443,0.999,7/21,11.53%,SLC39A10;PRKCH;LYN;CD19;ELF2;CBFB;PRKCB
prerank,T-helper cell differentiation (GO:0042093),0.7818399908921853,1.736328728193346,0.009208103130755065,0.2370672512277928,0.999,2/14,3.19%,LEF1;ZFPM1
prerank,phospholipid catabolic process (GO:0009395),0.7149311395183852,1.7362373321274207,0.00505902192242833,0.23211406507350413,0.999,5/24,8.63%,GPCPD1;PLA2G4B;PNPLA6;GDPD1;ENPP2
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.866577048783204,1.735824934080042,0.0018450184501845018,0.22834463618761822,0.999,3/10,3.20%,NAMPT;KDR;NOD2
prerank,amino acid import (GO:0043090),0.7352808954056115,1.7354382771150936,0.006920415224913495,0.224735608530919,0.999,6/21,1.67%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SH3BP4;SLC16A2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7350207083607848,1.7351755642134938,0.005226480836236934,0.22096057590415358,0.999,3/21,3.43%,SLC39A10;PRKCH;PRKD2
prerank,negative regulation of blood pressure (GO:0045776),0.8071887324730667,1.7333078344546105,0.008944543828264758,0.22198849171416657,0.999,5/13,4.86%,BMPR2;NOS3;PRCP;NOS2;NPPA
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.7365901973163077,-1.7331480647012867,0.002304147465437788,0.17643103742221466,0.993,6/14,10.18%,SULF1;SULF2;THBS1;FGF2;CREB3L1;FUZ
prerank,regulation of protein import into nucleus (GO:0042306),-0.5860349415306888,-1.7327506435711908,0.005235602094240838,0.17284514035149728,0.993,13/36,14.12%,ZIC1;SMAD3;BMP4;MDFIC;APOD;CDH1;PRKCD;SUFU;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6694122586026375,1.7327334636915044,0.0,0.21896610930836352,0.999,12/33,10.12%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;FBXW7;TGFA;SHKBP1;ADAM17;CNOT9;PTK6
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.7170026609004603,1.731734053480183,0.003552397868561279,0.21717392811728234,1.0,5/23,7.37%,PIK3R6;CADM1;LGALS9;PVR;CD160
prerank,adenine nucleotide transport (GO:0051503),0.764526199446826,1.7303053931933539,0.010327022375215147,0.2167162014617264,1.0,4/17,5.07%,ABCC4;ABCC6;LRRC8C;SLC25A5
prerank,cell junction assembly (GO:0034329),0.5648479781393541,1.7277344408407318,0.0,0.22122323193032073,1.0,25/100,9.63%,SPOCK2;DNM3;ITGA6;SHANK3;TJP1;CLDN5;LIMS2;ADGRL3;GJC1;PLXND1;CDH2;ACTB;CDH20;CTNND1;CDH8;DBNL;DCHS1;CDH19;PKP4;SLITRK1;GPM6A;OPHN1;NRXN1;DNER;ACTG1
prerank,ceramide transport (GO:0035627),0.8058057235361131,1.7264225988197397,0.0036900369003690036,0.22155115399935366,1.0,2/12,0.53%,CERT1;PLTP
prerank,positive regulation of axon extension (GO:0045773),0.7227077227314357,1.7256378844606715,0.009057971014492754,0.21980549718808684,1.0,5/22,8.14%,SEMA7A;MACF1;NTN1;DBNL;TWF2
prerank,positive regulation of JNK cascade (GO:0046330),0.5933351070379707,1.7249177630236354,0.0014124293785310734,0.21788715928627547,1.0,14/70,5.25%,PLCB1;MFHAS1;DAB2IP;MAP4K2;TNFRSF19;APP;ANKRD6;TIRAP;SH3RF1;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.797303181506781,1.7244129092054221,0.005494505494505495,0.21555656431123232,1.0,4/12,8.62%,IGF1R;INSR;IRGM;FYCO1
prerank,cardiac conduction system development (GO:0003161),-0.6265907090998919,-1.7233449131060434,0.007125890736342043,0.18782245657618604,0.995,7/24,5.68%,NOTCH2;BMPR1A;GJB6;BMP4;GJA1;CACNA1G;TBX18
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.6474468498922987,1.720690576321824,0.012903225806451613,0.22290686529178344,1.0,6/36,4.52%,LEF1;PLCB1;FZD6;FZD4;CALM1;CTNNB1
prerank,regulation of angiogenesis (GO:0045765),0.5155731105029758,1.7204933184405733,0.0,0.21960925314394994,1.0,40/192,7.37%,FLT1;TEK;PTPRM;ETS1;SEMA6A;CLDN5;PIK3R6;KDR;PPP1R16B;TIE1;DAB2IP;CD34;TGFB2;NOS3;STAB1;RGCC;COL4A2;PLXND1;SP100;CD40;AMOT;APLNR;PRKD1;PRKD2;RAMP2;VASH1;RAPGEF3;PLCG1;HHEX;SARS1;CTNNB1;GATA2;TSPAN12;FGF16;GAB1;RHOB;KLF4;STAT1;GTF2I;CD160
prerank,positive regulation of vasculature development (GO:1904018),0.5612639319705065,1.7187424619744127,0.0,0.22075809198579927,1.0,18/94,5.30%,FLT1;TEK;ETS1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD1;PRKD2;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB
prerank,hematopoietic stem cell proliferation (GO:0071425),0.8240139344061876,1.7183382708732307,0.0036900369003690036,0.21821791463300177,1.0,3/11,5.83%,MECOM;CD34;ETV6
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5857233942140596,1.7153895469894693,0.0,0.22253635801070132,1.0,39/73,21.62%,MYO10;WASF2;DOCK1;ELMO1;PTK2;ARPC4;ACTB;LYN;ELMO2;PLCG1;GRB2;HSP90AB1;BAIAP2;FYN;MAPK3;YES1;NCKAP1;WIPF2;HCK;ARPC3;PAK1;ACTG1;CYFIP1;RAC1;SYK;PIK3CB;NCKAP1L;MAPK1;NCK1;ACTR2;PRKCE;CRK;MYO1C;FCGR3A;PLCG2;ARPC1B;VAV1;WIPF1;ARPC2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.654051598694673,1.71508966693759,0.009615384615384616,0.2199361036981942,1.0,11/34,5.25%,FLT1;TEK;PDGFB;DAB2IP;PTK2;PIK3R3;NOD2;PIK3IP1;PRKD1;CD19;CCR7
prerank,skeletal system morphogenesis (GO:0048705),-0.5507518833186764,-1.7140500324873937,0.0028169014084507044,0.20278708966304743,0.998,18/42,16.73%,PDGFRA;HOXC4;FGFR2;HOXB3;CYP26B1;HOXA3;HOXB4;WWOX;DYNC2I1;TGFBR1;SIX1;SFRP4;FUZ;FBN2;SKI;HOXA9;LRP6;RFLNA
prerank,regulation of acrosome reaction (GO:0060046),0.8344358374768897,1.7134016849118736,0.009157509157509158,0.22111876646536788,1.0,1/10,0.22%,PLCB1
prerank,organic acid transport (GO:0015849),0.5584150449231899,1.711200720264082,0.0,0.22394721369987983,1.0,11/94,2.87%,SLCO1C1;SLC6A6;ABCC4;SLC7A1;ABCG2;MFSD2A;SLCO2B1;PPARD;SLC38A5;NCOA1;SLC43A2
prerank,tight junction assembly (GO:0120192),0.6156808623955258,1.7109660461212557,0.0046875,0.2211676617297432,1.0,10/49,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;LSR;MARVELD2;CLDN14
prerank,membrane depolarization during action potential (GO:0086010),-0.6227910141094162,-1.7037235384222296,0.01256281407035176,0.22244092962701775,1.0,7/26,7.86%,ATP1A2;CACNA1C;SCN7A;KCNJ2;CACNA1G;SLC8A1;CACNA1D
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.5336627529746003,1.7024832809024637,0.0,0.24326780608852425,1.0,33/138,9.30%,PTPRG;FLT1;IGF1R;TEK;MPZL1;KDR;INSR;TIE1;BMPR2;RASGRP4;FES;FLT4;NEDD9;PTK2;MTSS1;JAK3;RAPGEF1;ZAP70;MERTK;LYN;NPPA;CD4;EPHA4;FYN;RET;YES1;EPHB4;HCK;PTN;SHC3;CD8B;NPR1;LIFR
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5829504109597261,1.701271882117719,0.00436046511627907,0.24293603645496084,1.0,17/67,6.86%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;FYN;MAPK3;AATK;HCK
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.6029277055586589,1.6994954469773187,0.0015337423312883436,0.24488815922707458,1.0,25/54,14.67%,ETS1;PDGFB;KDR;NOS3;RGCC;MEF2C;CD40;ACVRL1;PRKD1;PRKD2;VASH1;TMSB4X;PLCG1;PRCP;GATA2;TGFB1;ADAM17;AGTR2;HSPB1;HIF1A;ATP5F1A;PPARG;CSNK2B;SP1;NUS1
prerank,ceramide metabolic process (GO:0006672),0.6089798086871604,1.6977650991561775,0.0014792899408284023,0.24643739177423482,1.0,16/49,15.01%,SGMS1;ST6GALNAC3;SGMS2;DEGS2;ACER2;CERS4;ACER1;TLCD3B;SPTLC2;ORMDL1;ORMDL3;CERK;DEGS1;SPTLC1;CLN8;FA2H
prerank,bicellular tight junction assembly (GO:0070830),0.6178855408779147,1.6963905450189107,0.009478672985781991,0.2470303803922725,1.0,9/46,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;CLDN14
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6458115384421332,-1.6956535245777042,0.011737089201877934,0.23675541537616382,1.0,10/19,9.61%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBP4;TGFBR1;RBPJ;FGF2;GLI1;VGLL4
prerank,peptide catabolic process (GO:0043171),-0.6153428295223,-1.695048193147015,0.011682242990654205,0.23310033245247636,1.0,8/23,13.44%,CPQ;ANPEP;GGT5;ACE;ENPEP;NPEPPS;IDE;CTSH
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.648001868207795,-1.6946662731984585,0.011363636363636364,0.22920449001282292,1.0,10/20,9.01%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2;ACE;IGFBP3;CCN4
prerank,lung development (GO:0030324),-0.5642851272788639,-1.693174050961251,0.0026041666666666665,0.22765624556019662,1.0,11/33,6.14%,GLI2;ERRFI1;PDPN;FGFR2;BMP4;FGF1;PKD1;RBP4;LOXL3;FGF2;RCN3
prerank,phospholipid transport (GO:0015914),0.6049776119560929,1.6924437547969875,0.007633587786259542,0.25553751723979784,1.0,15/52,9.75%,ATP10A;MFSD2A;PLTP;ATP8A1;ATP11B;SCARB1;ABCG1;PITPNC1;ATP11A;PRELID2;PITPNA;ABCA3;ABCA7;ATP11C;ATP10B
prerank,embryonic hemopoiesis (GO:0035162),0.7704581652466773,1.6917549421493896,0.02095238095238095,0.2540618424885493,1.0,4/12,5.20%,KITLG;KDR;ZFPM1;TAL1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.5597068548387073,1.6907394248619916,0.002793296089385475,0.2534469315887709,1.0,16/93,5.25%,PLCB1;MFHAS1;DAB2IP;TGFB2;MAP4K2;TNFRSF19;APP;XDH;ANKRD6;TIRAP;SH3RF1;FLT4;TPD52L1;NOD2;WNT7A;CCR7
prerank,digestive tract development (GO:0048565),-0.5760859109410343,-1.6897793724683148,0.0,0.2309727061909923,1.0,13/33,7.73%,GLI3;CLMP;RARB;GLI2;FGFR2;PCSK5;COBL;PKD1;SMO;SALL1;KIT;GLI1;CHD8
prerank,chordate embryonic development (GO:0043009),-0.514639658846002,-1.6889609144153646,0.008746355685131196,0.2285491432955417,1.0,16/55,6.93%,SULF1;ALDH1A2;COL1A1;BMP5;BMP7;FGFR2;ARNT2;PCSK5;PKD1;SULF2;RBP4;TGFBR1;PKD2;IGF2;DACT1;ZNF568
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.6912878408614855,-1.6885020236384,0.009070294784580499,0.22510576133957122,1.0,6/15,10.98%,IGF1;ROCK2;CAMK2D;PRKCA;SLC9A1;PARP1
prerank,carboxylic acid transport (GO:0046942),0.5972767462452998,1.687028711671191,0.007385524372230428,0.2614472353791002,1.0,7/55,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A4;SLC16A2;SLC38A5
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5165537134615686,1.6848469064041474,0.0,0.26497418552538243,1.0,36/151,13.84%,SGMS1;CERT1;MFSD2A;SGPP2;ELOVL7;SGMS2;DEGS2;ACER2;SPNS2;B4GALT5;GCH1;CERS4;ALAS1;PPM1L;PRKD1;PRKD2;PRKD3;SLC44A5;MGST2;ACER1;GSTA4;SPTLC2;GPHN;CHKA;ELOVL5;HPGDS;LPCAT3;GSTK1;SLC25A15;ELOVL6;CEPT1;CSNK2B;LPIN3;HACD2;DEGS1;SPTLC1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.43545761127674065,-1.6831912478170123,0.0,0.23331344301423582,1.0,36/152,12.99%,RNF220;WLS;SULF1;ZEB2;EGFR;LGR4;COL1A1;PTK7;FGFR2;GPC3;WNT5B;RSPO3;LRRK1;KANK1;SULF2;SALL1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;RSPO2;SFRP4;DACT1;TNKS2;PSME4;UBR5;SMURF2;AXIN1;PPM1B;TRPM4;PSME3;LRRK2;CAPRIN2;BMP2;SCEL;SKI
prerank,neurotransmitter uptake (GO:0001504),-0.7298267292468645,-1.6808260088416305,0.015555555555555555,0.23427525520995013,1.0,2/12,0.90%,ATP1A2;SLC1A3
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7759182201740367,1.6802117293188528,0.005535055350553505,0.2753123874299443,1.0,6/13,7.04%,KDR;ENG;NOTCH4;CTNNB1;DLL4;COL4A1
prerank,smooth muscle contraction (GO:0006939),-0.7045622591775559,-1.6796843088107518,0.02288329519450801,0.23287775031019425,1.0,7/14,9.85%,ROCK2;MYLK;EDNRA;SLC8A1;MYH11;BDKRB2;ACTA2
prerank,nuclear migration (GO:0007097),-0.7161615268869781,-1.6755901520580543,0.015217391304347827,0.23835757627420742,1.0,7/13,17.32%,DOCK7;SYNE2;CLMN;SYNE3;PCM1;FBXW11;SUN2
prerank,positive regulation of cellular component movement (GO:0051272),0.6896502818483358,1.673360540499223,0.014010507880910683,0.29476985806581063,1.0,6/24,6.03%,SPOCK2;ETS1;NTN1;LYN;CCR7;ACTN4
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.6654459608074131,-1.6727051341629802,0.013793103448275862,0.2409283400513901,1.0,8/16,6.56%,IGF1;TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,apical junction assembly (GO:0043297),0.5919976734746834,1.668562075899582,0.012403100775193798,0.3071732303186543,1.0,10/53,6.92%,OCLN;PECAM1;ESAM;CLDN5;F11R;PARD3;RAMP2;MARVELD2;PKN2;CLDN14
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.6601372641935813,1.6667663960580983,0.014563106796116505,0.3097118083678322,1.0,9/30,12.47%,DACH1;BMPR2;ACVRL1;MEN1;TERF2;HNRNPC;ACD;DCP2;TERF1
prerank,cardiac muscle contraction (GO:0060048),-0.5449374877339808,-1.6659655874054284,0.005376344086021506,0.25365914573322745,1.0,7/34,10.13%,ATP1A2;GSN;TPM1;DMD;CAMK2D;SLC8A1;GAA
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6714677971727796,-1.6632986244101502,0.007058823529411765,0.2562323816354546,1.0,7/16,10.98%,IGF1;ROCK2;CAMK2D;TRPC3;PRKCA;SLC9A1;PARP1
prerank,positive regulation of angiogenesis (GO:0045766),0.5320011033684654,1.663010714169963,0.0027624309392265192,0.3190871575103382,1.0,19/108,5.30%,FLT1;TEK;ETS1;TJP1;PIK3R6;KDR;TIE1;CD34;NOS3;CD40;APLNR;PRKD1;PRKD2;RAMP2;RAPGEF3;PLCG1;GATA2;GAB1;RHOB
prerank,embryonic organ morphogenesis (GO:0048562),-0.5273117181797081,-1.6629862594660432,0.008379888268156424,0.25285315309718276,1.0,13/42,5.68%,FBN1;PDGFRA;EFEMP1;HOXC4;FGFR2;HOXB3;HOXA3;MFAP5;HOXB4;RBP4;DYNC2I1;RBPMS2;SIX1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.694604585498791,-1.6629465244738013,0.008988764044943821,0.24872062626090416,1.0,5/13,3.44%,FSTL1;FBN1;NBL1;LTBP1;GREM2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7081446389604789,1.6610946462890808,0.017482517482517484,0.32199881650492135,1.0,6/20,12.40%,PLCB1;AGRN;GNAQ;LYPD1;CHRM3;GNB1
prerank,regulation of interleukin-13 production (GO:0032656),0.7540089198988569,1.659370792703508,0.028409090909090908,0.32380349979721834,1.0,3/13,6.44%,LEF1;TNFRSF21;LGALS9
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.7490111660251252,1.6589307561868398,0.01048951048951049,0.3213829573165469,1.0,2/16,0.95%,IGF1R;INSR
prerank,protein localization to cilium (GO:0061512),-0.5584492144599563,-1.6585430214842642,0.01832460732984293,0.25542663337017935,1.0,12/32,17.78%,TULP3;WDR35;INVS;ARL3;ZNF423;IFT122;EHD1;BBS9;RAB29;WDR19;SNX10;TULP1
prerank,insulin receptor signaling pathway (GO:0008286),0.5591585795273035,1.6577210876312216,0.0043541364296081275,0.3214849082530293,1.0,17/69,10.31%,IGF1R;GRB14;NAMPT;INSR;BCAR3;FOXO1;PIK3R3;ATP6V0A1;GRB2;GAB1;BAIAP2;SOS1;SORBS1;AP3S1;CAV2;PIK3C2A;GRB7
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.8050732429791341,1.6567172675910102,0.016885553470919325,0.32078397042075074,1.0,4/11,2.47%,TJP1;RAPGEF2;TJP2;F11R
prerank,alanine transport (GO:0032328),0.8115251033520213,1.6559521662069476,0.011214953271028037,0.3199129539930264,1.0,1/10,0.07%,SLC6A6
prerank,regulation of gastrulation (GO:0010470),-0.6712730325625975,-1.6558395601165028,0.01327433628318584,0.25805832904820697,1.0,4/14,7.49%,PHLDB2;OSR1;DAG1;PHLDB1
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.5574231062028381,1.6555955228798478,0.004335260115606936,0.31737053248422264,1.0,13/75,4.52%,TEK;EGFL7;JCAD;PDGFB;KDR;PPP1R16B;BMPR2;FLT4;APLNR;PRKD1;PRKD2;PLCG1;GATA2
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5529945277543132,1.654754187042215,0.001402524544179523,0.31676220171317093,1.0,62/87,32.26%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;SRP14;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;RPL7A;ZFAND2B;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.5676687711881964,1.654399564723327,0.004651162790697674,0.3144462760976864,1.0,9/63,6.19%,TFRC;SLC7A1;TIRAP;MEF2C;JAK3;CD40;CD6;CD38;CCDC88B
prerank,positive regulation of cell motility (GO:2000147),0.49698156410642724,1.6526265562883633,0.0,0.31664257144408514,1.0,33/205,6.46%,LEF1;SPOCK2;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;CXCL12;PDGFD;CAV1;NTN1;NEDD9;SEMA6B;PTK2;PIK3R3;TIAM1;NOTCH1;VIL1;RIPOR1;SEMA4F;CCR7;SNAI2;ACTN4;FAM107A;ADAM10;RET
prerank,cAMP biosynthetic process (GO:0006171),-0.7404566672553006,-1.6525373625111792,0.013422818791946308,0.26216252420327096,1.0,5/10,4.82%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7
prerank,mesoderm development (GO:0007498),0.706864299242352,1.6506788696078707,0.022968197879858657,0.319550435933304,1.0,5/18,6.86%,TIE1;TBX1;TBX3;MESD;HCK
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.6225567357133204,-1.6495110586072055,0.018140589569160998,0.26563299164606596,1.0,6/21,7.24%,ATP1A2;CACNA1C;ANK2;DMD;CAMK2D;SLC8A1
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.746612597229795,-1.649031218461957,0.016771488469601678,0.26266237385494057,1.0,7/10,18.62%,HOXB4;ACE;MLLT3;LMBR1L;SFRP1;BATF;SP7
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5342578801748087,-1.6466560233039385,0.002717391304347826,0.2644308139790196,1.0,17/40,12.42%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;WNT6;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;CEBPB;FBN2;PKDCC;BMP2
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.7027931392103256,-1.6444520521125765,0.022222222222222223,0.2656636262893189,1.0,7/11,16.33%,PARP8;PARP3;PARP4;PARP11;PARP6;PARP12;TIPARP
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.704167588114729,-1.643202715773783,0.013363028953229399,0.26466890140251825,1.0,8/12,16.33%,PARP8;PARP3;TNKS2;PARP11;PARP6;PARP1;PARP12;TIPARP
prerank,negative regulation of cell junction assembly (GO:1901889),-0.6030412116604067,-1.6430673832690719,0.01694915254237288,0.26128775608785837,1.0,11/25,13.57%,PHLDB2;ARHGAP6;ROCK2;APOD;THBS1;ACE;ITGB1BP1;ROBO2;DMTN;BCAS3;PTEN
prerank,endothelial cell development (GO:0001885),0.6845153933444041,1.6414245148602802,0.0180623973727422,0.34842474681980756,1.0,12/25,8.79%,PECAM1;PPP1R16B;ROBO4;PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;PDE4D;MARVELD2;SOX18;RAP1B;MSN
prerank,ameboidal-type cell migration (GO:0001667),0.5865712941742696,1.6409236474615438,0.009259259259259259,0.3464952200732385,1.0,15/51,9.47%,SEMA3C;SEMA7A;SEMA6A;SRGAP2;TBX1;SEMA6B;PKN3;AMOT;SEMA4F;PKN1;NANOS1;PKN2;SEMA6D;SEMA4C;PHACTR4
prerank,cellular response to fatty acid (GO:0071398),-0.6979248753048926,-1.6405708050129684,0.01939655172413793,0.2635909738543785,1.0,2/12,2.42%,PID1;IRS1
prerank,cartilage development (GO:0051216),-0.5083271788828253,-1.638236398406129,0.017191977077363897,0.26592596238928756,1.0,15/49,9.47%,SULF1;SOX5;WNT5B;BMP4;OSR1;ITGB8;PKD1;SULF2;CREB3L2;SLC39A14;FGF2;RUNX2;ATP7A;CCN3;SOX6
prerank,regulation of neuron projection arborization (GO:0150011),0.7360748043445928,1.6382191425234947,0.02,0.35292946969158273,1.0,4/15,3.39%,MFSD2A;MACF1;FZD4;NTNG2
prerank,modified amino acid transport (GO:0072337),-0.668396372799374,-1.638094204536144,0.0228310502283105,0.2623823156120062,1.0,4/15,6.32%,SLC6A13;SLC16A12;PDPN;SLC5A6
prerank,positive regulation of cell adhesion (GO:0045785),0.5541871763378056,1.6339501977144908,0.009395973154362415,0.3644710530377791,1.0,16/74,6.46%,NDNF;FRMD5;PDGFB;TGFB2;CXCL12;MAGI1;STX3;ADGRG1;PTPRJ;PRKD2;TGM2;SMAD7;CCR7;EPHA4;RSU1;RET
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.7053557509033812,-1.6330378067412596,0.021739130434782608,0.27091432021233985,1.0,4/12,11.13%,ANK2;ANXA6;DIAPH1;PTK2B
prerank,negative regulation of epithelial cell migration (GO:0010633),0.6253349232704005,1.6326112872926586,0.012578616352201259,0.3654625979987925,1.0,9/33,5.01%,PTPRG;PTPRM;DAB2IP;MCC;SP100;ACVRL1;VASH1;EVL;DLL4
prerank,epithelial cell morphogenesis (GO:0003382),-0.6495229488799773,-1.63246828508829,0.01152073732718894,0.268670789108092,1.0,6/17,13.59%,COL22A1;COL18A1;COL15A1;MET;DACT2;RILPL2
prerank,carbohydrate derivative transport (GO:1901264),0.7004583831864482,1.6321824402094747,0.025044722719141325,0.3633966485730419,1.0,5/18,6.51%,MFSD2A;PLTP;SCARB1;ABCG1;SLC10A7
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.583046994874324,-1.6319106902043619,0.009501187648456057,0.2665262978433211,1.0,6/24,10.91%,PID1;LEPR;PPARGC1A;GFPT1;GFPT2;COQ10A
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.766973194424624,1.6313963103674243,0.02464788732394366,0.36224168464377693,1.0,3/13,3.20%,NAMPT;KDR;NOD2
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.7029977430353498,-1.6313664587937076,0.011848341232227487,0.2641802646160196,1.0,2/12,3.28%,NUPR1;IL18
prerank,positive regulation of interferon-gamma production (GO:0032729),0.5861116530040662,1.6312372046215917,0.017001545595054096,0.359196346964649,1.0,11/48,12.52%,SLC7A5;IL1R1;ZFPM1;PDE4D;TLR3;LGALS9;TLR7;PDE4B;EBI3;TLR8;CYRIB
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6172316889771444,-1.6307303916065363,0.018867924528301886,0.26217525548358384,1.0,7/21,9.50%,BMP6;BMPR1A;BMP4;TGFBR1;DAB2;CCN3;TGFB3
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6699893898460639,1.630150688422383,0.01485148514851485,0.3594690988170461,1.0,7/26,11.43%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1
prerank,eye morphogenesis (GO:0048592),-0.6319990586085322,-1.6289709651329003,0.013986013986013986,0.2628483811247429,1.0,9/19,13.29%,FBN1;COL5A2;COL5A1;EFEMP1;MFAP5;IFT122;FBN2;SKI;NF1
prerank,regulation of transmembrane transport (GO:0034762),0.6324456464065189,1.6286674425936132,0.006633499170812604,0.3613345374397416,1.0,5/31,3.87%,OCLN;SLC2A1;CTTNBP2NL;NEDD4L;ACTB
prerank,positive regulation of T cell activation (GO:0050870),0.5625404699991853,1.6278417406135348,0.007763975155279503,0.3608243766441163,1.0,17/62,17.12%,TFRC;SLC7A1;JAK3;NOD2;ZAP70;CD6;CCR7;CCDC88B;LGALS9;PNP;TNFSF11;CYRIB;IL15;NCKAP1L;VCAM1;NCK1;CCR2
prerank,regulation of endothelial cell proliferation (GO:0001936),0.538005079670993,1.6277510861768718,0.004166666666666667,0.35770536441969,1.0,16/88,3.62%,TEK;PTPRM;EGFL7;PDGFB;KDR;PPP1R16B;TIE1;BMPR2;XDH;CAV1;FLT4;RGCC;ACVRL1;PRKD1;PRKD2;VASH1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5863628016896187,1.6267107433247248,0.008038585209003215,0.35811691483799346,1.0,20/48,11.99%,ETS1;JCAD;PDGFB;KDR;NOS3;CD40;PRKD1;PRKD2;HDAC9;HDAC7;TMSB4X;PLCG1;GATA2;TGFB1;MAP3K3;ADAM17;PIK3C2A;HSPB1;HIF1A;ATP5F1A
prerank,aminoglycan biosynthetic process (GO:0006023),-0.5187816890474263,-1.6256193313815879,0.008152173913043478,0.2671899295278441,1.0,14/49,9.24%,GPC6;SDC2;B3GALT1;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;SDC4;HS6ST2;NDST2
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.6770198507214782,-1.6248306520559601,0.016241299303944315,0.26583518029153524,1.0,4/14,13.98%,MOXD1;DAGLA;SLC5A7;SLC22A2
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.43311994389097425,-1.6247135653098537,0.004484304932735426,0.2628558288632735,1.0,27/129,11.53%,RNF220;WLS;ZEB2;EGFR;LGR4;COL1A1;PTK7;FGFR2;GPC3;LRRK1;KANK1;LYPD6;TBL1XR1;DAAM2;PLEKHA4;SFRP4;DACT1;TNKS2;PSME4;UBR5;SMURF2;AXIN1;PPM1B;TRPM4;PSME3;LRRK2;CAPRIN2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.7587425265921521,1.6243554090266672,0.031078610603290677,0.3631625484710554,1.0,3/12,0.97%,PROM1;MYO1E;PODXL
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.6638263347649912,-1.6238029185269653,0.017777777777777778,0.26186194178027367,1.0,8/15,20.69%,ADAM9;APOE;SNX9;SNX33;NRDC;PACSIN3;ADRA2A;ADAM8
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.7296720657117306,1.6229812883006736,0.013816925734024179,0.36444266744174814,1.0,3/15,4.02%,PLTP;SCARB1;ABCG1
prerank,regulation of cell projection organization (GO:0031344),0.7534300201701893,1.6229344347996109,0.01845018450184502,0.36122756064191813,1.0,3/13,3.39%,MFSD2A;MACF1;NTNG2
prerank,regulation of vasculogenesis (GO:2001212),0.7485530114233921,1.6227947370585731,0.025,0.3584151119934205,1.0,4/14,1.74%,KDR;CD34;RAPGEF2;XDH
prerank,histone H3 acetylation (GO:0043966),0.6020009244114072,1.6222386728382596,0.006379585326953748,0.35731968919408325,1.0,12/40,14.76%,LEF1;TRIM16;YEATS2;BRCA2;KAT6A;JADE2;NAA60;BRD1;BRPF1;PHF14;BRPF3;POLE3
prerank,oligosaccharide metabolic process (GO:0009311),0.5923754447562323,1.62219606220289,0.01984732824427481,0.35425564814783134,1.0,14/46,14.38%,ST8SIA4;ST6GALNAC3;ST3GAL6;ST8SIA6;FUT8;NEU4;FUT9;B3GALT4;ST6GALNAC4;MAN1B1;B3GALT2;MANBA;NEU2;MAN2B1
prerank,response to axon injury (GO:0048678),-0.6288801748429673,-1.6219449774947419,0.017977528089887642,0.263124272728113,1.0,6/18,22.37%,DPYSL3;APOD;P2RX4;SARM1;GAP43;TYROBP
prerank,regulation of cardiac conduction (GO:1903779),-0.4950137411593041,-1.6210693012560262,0.0061162079510703364,0.26198746909896853,1.0,14/54,10.47%,ATP1A2;ANK2;ITPR1;STIM1;SLC8A3;DMPK;ASPH;ABCC9;ATP1B3;TMEM65;ATP1B2;SLC8A1;PRKACA;ITPR2
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5968535983027609,1.6209839179180447,0.009077155824508321,0.3552869610267081,1.0,22/47,16.29%,IGF1R;DAB2IP;TGFB2;FAS;PHLPP1;FOXO1;NOD2;PPIA;MAPK3;LGALS9;GREM1;SEMA4C;AGER;PDCD10;ARL6IP5;MID1;MAP4K4;EPHB1;INAVA;MAPK1;KLHDC10;COPS5
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.7450302893349288,-1.6187175703892291,0.024742268041237112,0.2646602516208939,1.0,5/10,8.53%,PID1;APPL2;ENPP1;SELENOS;GRB10
prerank,amino acid import across plasma membrane (GO:0089718),0.6518761900545909,1.6182431715413315,0.02413793103448276,0.3621774298918186,1.0,6/24,1.94%,SLC6A6;SLC7A5;SLC7A1;SLC1A1;SLC16A2;SLC6A5
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6809139303857603,-1.6181392353041744,0.023454157782515993,0.2629848760885985,1.0,9/13,21.30%,ADHFE1;IDH2;D2HGDH;GOT1;PHYH;GPT2;L2HGDH;IDH1;GOT2
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.8055087269501771,1.6173198770225896,0.018214936247723135,0.36201105104724635,1.0,2/10,1.56%,PRKCH;TRIM16
prerank,regulation of plasminogen activation (GO:0010755),-0.6938538528094348,-1.6168542973376632,0.022964509394572025,0.262891719258434,1.0,6/12,19.05%,THBS1;CLEC3B;SERPINE2;CTSZ;RUNX1;SERPINE1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6296185179480377,-1.616559955325502,0.016867469879518072,0.2605170062228284,1.0,4/18,6.13%,IGF1;IGFBP2;IL18;IGF2
prerank,heart morphogenesis (GO:0003007),0.5807155959701582,1.6152763844242832,0.02034428794992175,0.36577399303414604,1.0,11/50,3.41%,INSR;ENG;TGFB2;NOS3;TBX1;SOX17;TBX3;PTK2;ACVRL1;ZFPM1;NOTCH1
prerank,receptor internalization (GO:0031623),0.5959100035247198,1.613838516499491,0.01557632398753894,0.36780505548654424,1.0,12/44,8.20%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;GTF2H2;DNM2;AP2M1;CXCR2
prerank,positive regulation of isotype switching (GO:0045830),0.7411034225779407,1.613602406893413,0.01763668430335097,0.36561327001311117,1.0,4/15,8.09%,TFRC;CD40;SHLD1;TGFB1
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.6581217810132531,-1.6130174477433898,0.020134228187919462,0.26608218501061726,1.0,5/15,8.93%,LRP1;PDPN;DDR1;FAP;DPP4
prerank,regulation of GTPase activity (GO:0043087),0.494580240584965,1.6112427845914319,0.0012610340479192938,0.37061420920480004,1.0,45/177,11.61%,CHN2;ITGA6;DOCK9;FGD5;LRCH1;SRGAP2;DAB2IP;RASIP1;RAPGEF2;SH3BP4;ARHGAP27;NET1;BCAR3;F11R;AGRN;PTK2;PLXND1;RAPGEF1;CD40;SNX13;RAPGEF3;PRKG1;TGM2;TBC1D2;USP6NL;MAPRE2;EPHA4;OCRL;RSU1;RAP1GDS1;RASGRP2;STMN3;PKP4;FICD;ARHGEF5;PIN1;CAV2;ARHGEF7;FGD6;FERMT2;TBC1D10B;CCL1;PLXNB3;HRAS;TBC1D30
prerank,regulation of T cell proliferation (GO:0042129),0.5576460020037071,1.6096833864041844,0.0077279752704791345,0.37268101023155725,1.0,12/61,16.17%,TFRC;SLC7A1;JAK3;TNFRSF21;CD6;CCDC88B;FOXP3;PNP;IL15;NCKAP1L;VCAM1;NCK1
prerank,respiratory tube development (GO:0030323),-0.5583324233554129,-1.6086299317695194,0.012594458438287154,0.27362591045567775,1.0,9/28,4.69%,GLI2;PDPN;FGFR2;BMP4;FGF1;PCSK5;RBP4;LOXL3;FGF2
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6438472762700882,1.6066741876398043,0.01951219512195122,0.37980920985311895,1.0,9/25,10.12%,HIP1;HIP1R;BCAR3;PLAUR;AFAP1L2;CCDC88A;SHKBP1;CNOT9;PTK6
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.614764752385855,1.6053608855351529,0.014218009478672985,0.3816487176816395,1.0,7/36,6.54%,SGMS1;DAB2IP;FAS;TPD52L1;PTPMT1;PPIA;CRADD
prerank,monocarboxylic acid transport (GO:0015718),0.5842303712415224,1.6051010848895269,0.007861635220125786,0.3794830779682286,1.0,7/51,2.80%,SLCO1C1;ABCC4;ABCG2;SLCO2B1;SLC16A4;SLC16A2;NCOA1
prerank,cytoplasmic translation (GO:0002181),0.5223997277331064,1.6049542147728701,0.008185538881309686,0.376834095532421,1.0,63/91,32.26%,RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;RPS7;RPL9;RPL18;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPL22L1;RPS15;RPL37;RPS28;RPS10;EIF3M;RPS25;RPL37A;EIF4A1;RPL15;RWDD1;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;RPL7A;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;DRG1;RPL36;RPS3;RPS26;RPL27A
prerank,cellular transition metal ion homeostasis (GO:0046916),0.525255741783336,1.6047529325276129,0.0028328611898017,0.37452993156247766,1.0,9/91,4.15%,SLC39A10;TFRC;SLC40A1;ABCG2;SLC39A8;APP;ATOX1;SLC30A1;SLC31A1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5535449121945083,1.603967659225681,0.010479041916167664,0.37441706310734335,1.0,24/67,12.15%,FLT1;KDR;DAB2IP;WASF2;DOCK1;ELMO1;FLT4;PTK2;PRKD1;PRKD2;PXN;ELMO2;BAIAP2;FYN;NCKAP1;PGF;CYFIP1;HSPB1;SHB;CYBB;CLEC14A;RAC1;NCF4;PIK3CB
prerank,cotranslational protein targeting to membrane (GO:0006613),0.5276408698205489,1.6031413327435342,0.0027247956403269754,0.37433812651948967,1.0,64/91,32.26%,SEC62;RPL38;RPL13;RPS29;RPL36A;RPL3;RPL27;RPSA;SRP14;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;RPL11;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RPS18;RPL21;RPS4X;RPL18A;RPS21;RPL10A;RPL24;SRPRA;RPL7A;RPL32;RPL4;RPS2;RPS20;RPL6;RPS13;RPS19;SEC63;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;SSR1;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.7087585615298241,1.6028816681201636,0.030249110320284697,0.3723631427689121,1.0,9/17,16.13%,TGFB2;NOD2;LYN;SEMA4C;PDCD10;ARL6IP5;MID1;INAVA;KLHDC10
prerank,peptidyl-tyrosine modification (GO:0018212),0.5635783899610803,1.6024256528195726,0.013313609467455622,0.3709173184072624,1.0,15/56,6.86%,FLT1;TEK;PDGFB;KDR;INSR;FES;FLT4;PTK2;JAK3;ZAP70;LYN;EPHA4;TPST2;FYN;HCK
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.5701222866585779,-1.6021906173860665,0.015544041450777202,0.28663792094019697,1.0,11/27,24.43%,EGFR;BMP4;DDX5;AGO2;TNRC6B;FMR1;LIMD1;EIF4G1;MAP2K1;AJUBA;STAT3
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7231308326818706,-1.6014012166026614,0.03303964757709251,0.2853763532520672,1.0,3/11,2.31%,EGFR;BMP4;DDX5
prerank,calcium ion transmembrane transport (GO:0070588),-0.4526458751094226,-1.6000436223883407,0.003355704697986577,0.28567035416683856,1.0,25/86,12.34%,SLC24A3;TRPM3;CACNA1C;NALCN;MCU;PKD1;SLC8A3;ANO6;CACNA2D1;PKD2;TRPC3;CACNA1G;TRPM6;SLC35G1;SLC8B1;P2RX4;SLC8A1;CACNA1D;TRPC6;ITGAV;TRPM4;SLC24A5;AFG3L2;TRPC4;TRPC4AP
prerank,neural crest cell development (GO:0014032),0.5907717596459058,1.5996605593876623,0.016975308641975308,0.37756187380580264,1.0,15/44,14.27%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;CDH2;SEMA4F;SNAI2;SEMA6D;SEMA4C;PHACTR4;SOX10;SOX11;PDCD6;SEMA3G
prerank,cellular response to drug (GO:0035690),0.6512258901847128,1.5996268167070622,0.024179620034542316,0.37477436934480857,1.0,7/25,8.10%,TFRC;ACER2;MEF2C;KCNQ1;AIM2;KCNH2;PDE4B
prerank,positive regulation of cell migration (GO:0030335),0.46969746304862275,1.5995099805033786,0.0,0.37229991598789086,1.0,53/253,10.41%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;PECAM1;SEMA6A;TJP1;PDGFB;KDR;INSR;PODXL;DAB2IP;BMPR2;TGFB2;CXCL12;RAPGEF2;PDGFD;DOCK1;CAV1;NEDD9;SEMA6B;ARHGEF2;PTK2;PIK3R3;TIAM1;NOTCH1;VIL1;RIPOR1;PLCG1;RREB1;SEMA4F;GAB1;SNAI2;ACTN4;FAM107A;INSL3;ADAM10;RET;SEMA6D;RAB11A;SPAG9;TGFB1;ARHGEF7;ENPP2;PAK1;SEMA4C;ACTG1;ADAM17;CBLL1;GRB7;PDCD10
prerank,vesicle transport along actin filament (GO:0030050),0.694816727696413,1.599323400452818,0.01444043321299639,0.3702004275457593,1.0,6/19,10.03%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4;MYO1F
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.546102933466337,-1.5988398849016827,0.0175,0.28581209633685617,1.0,10/31,5.68%,PDGFRA;HOXC4;FGFR2;OSR1;HOXB3;HOXA3;HOXB4;DYNC2I1;TGFBR1;SIX1
prerank,sulfation (GO:0051923),-0.711765169996889,-1.5985475575474728,0.022321428571428572,0.2834639663689101,1.0,1/11,0.06%,UST
prerank,retinoic acid metabolic process (GO:0042573),-0.6738213472817265,-1.5978468381180195,0.017977528089887642,0.28233908376665817,1.0,3/14,6.81%,ALDH1A2;CYP26B1;SCPEP1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.649525459524397,1.5966395162567426,0.0297029702970297,0.37682561692834543,1.0,5/24,4.52%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,regulation of protein neddylation (GO:2000434),0.7848581361376294,1.5963854354388025,0.029684601113172542,0.3748596869085698,1.0,6/10,13.34%,EPAS1;DCUN1D3;COPS9;HIF1A;DCUN1D1;RPL11
prerank,positive regulation of locomotion (GO:0040017),0.6440923522877654,1.5960073320086767,0.029801324503311258,0.3734028436585197,1.0,6/27,8.09%,SPOCK2;PDGFB;NTN1;STX3;CCR7;TGFB1
prerank,innate immune response (GO:0045087),0.4785520843075506,1.5953756076870638,0.0,0.3727714048379654,1.0,45/217,13.36%,MFHAS1;PGLYRP1;APP;FES;GCH1;TRIM25;TRIM14;B2M;PTK2;SERINC3;SP100;ADAM15;CD40;DEFA6;NOD2;IFIH1;NLRC5;ZAP70;LYN;SERINC5;IKBKB;ADAR;NOS2;CFD;TLR3;NRROS;FYN;YES1;HCK;IRF5;BST2;SHMT2;IRGM;MALT1;PTK6;AGER;CYBB;TLR8;SYK;TNK2;RNF187;SLPI;PPARG;CYLD;TRIM39
prerank,metanephros development (GO:0001656),-0.5683536119206721,-1.594273475625567,0.009685230024213076,0.2887261437006715,1.0,12/26,17.87%,FOXD1;BMP7;BMP4;OSR1;PKD1;PKD2;SIX1;ROBO2;NF1;CTSH;SIX4;PAX2
prerank,regulation of muscle contraction (GO:0006937),-0.5658350401860823,-1.5925995940206723,0.018648018648018648,0.28990125587358806,1.0,7/26,8.95%,ATP1A2;PLCE1;TPM1;PPP1R12B;ANXA6;KCNB2;MYL9
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.6928676231462997,1.5924285410719867,0.022530329289428077,0.38041111916516124,1.0,5/18,12.40%,PLCB1;AGRN;GNAQ;CHRM3;GNB1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.544034831361637,1.5923988880867266,0.010385756676557863,0.3777718988340249,1.0,11/72,5.18%,FLT1;IGF1R;TEK;PDGFB;KDR;INSR;TGFB2;PDGFD;PTK2;LYN;GAB1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.6077754953996904,1.5923047992189625,0.015600624024960999,0.37538916072170453,1.0,13/36,12.15%,NOSTRIN;NOS3;CAV1;DDAH1;GCH1;SCARB1;CALM1;DNM2;TERF2;LYPLA1;AGTR2;HIF1A;PIK3CB
prerank,receptor metabolic process (GO:0043112),0.5706485918099845,1.590968275876056,0.0075528700906344415,0.3771190663664115,1.0,16/53,11.87%,TFRC;DNM3;CAV1;RAB31;RAMP2;CALCRL;GRB2;RAMP3;REP15;DNM2;AP2M1;TGFB1;CXCR2;SMURF1;SYK;SH3GLB1
prerank,keratan sulfate catabolic process (GO:0042340),-0.698965128269699,-1.5905242060241982,0.024719101123595506,0.29210225173911136,1.0,7/11,12.23%,OGN;FMOD;PRELP;LUM;OMD;HEXA;GNS
prerank,synapse assembly (GO:0007416),0.5483401957535544,1.5888839140273787,0.012893982808022923,0.3814524171125298,1.0,14/67,9.29%,SPOCK2;DNM3;SHANK3;ADGRL3;PLXND1;FGF13;CDH2;WNT7A;GRID2;DBNL;SLITRK1;GPM6A;NRXN1;DNER
prerank,cellular response to increased oxygen levels (GO:0036295),0.746739297584718,1.587258656669066,0.04119850187265917,0.3846410180034261,1.0,3/11,2.99%,CAV1;FAS;FOXO1
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7077504282327995,1.5862454266066155,0.032490974729241874,0.3855194687464294,1.0,5/16,5.21%,NDNF;NOS3;DDAH1;NOS2;KCNC2
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.7577781025419394,1.5860322601040744,0.040697674418604654,0.38336252139257293,1.0,2/10,1.57%,SHANK3;APP
prerank,mesonephros development (GO:0001823),-0.7062249250366212,-1.585674661335722,0.03171247357293869,0.30184681612820735,1.0,4/11,2.26%,BMP7;BMP4;OSR1;FGF1
prerank,positive regulation of vasculogenesis (GO:2001214),0.7722957457903576,1.5849793001146903,0.04562043795620438,0.3843354236487462,1.0,3/10,1.44%,KDR;CD34;RAPGEF2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.6743536759561665,1.5840052494459484,0.04666666666666667,0.3851355077191448,1.0,6/20,16.94%,FAR2;FASN;ACSL3;SLC25A1;HSD17B8;DGAT1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.6322106877862081,1.5831260355096701,0.028380634390651086,0.38558723309472975,1.0,8/27,5.25%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,clathrin coat assembly (GO:0048268),0.7236238127074907,1.5827834922413409,0.030852994555353903,0.38401485556272147,1.0,5/15,12.19%,HIP1;HIP1R;FCHO2;PIK3C2A;EPS15
prerank,positive regulation of tissue remodeling (GO:0034105),-0.7229997346502498,-1.5827743988391465,0.02702702702702703,0.306157165030287,1.0,2/10,3.28%,ROCK2;IL18
prerank,ganglioside metabolic process (GO:0001573),0.681546967153106,1.581782677304202,0.017361111111111112,0.38477380297209834,1.0,3/20,1.09%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,neuron remodeling (GO:0016322),0.7545119401965534,1.5814162307086974,0.031189083820662766,0.3836192822501528,1.0,3/10,2.06%,APP;SCARF1;ANKS1A
prerank,regulation of vasculature development (GO:1901342),0.6399946450044913,1.5811305150433284,0.02533783783783784,0.38210458632492694,1.0,6/26,4.57%,ETS1;PLXND1;SP100;VASH1;CTNNB1;TSPAN12
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.48993884001966215,1.5798567560467933,0.0063371356147021544,0.3837270072470667,1.0,31/149,11.71%,TFRC;PRKCH;APP;CAV1;TIRAP;NFKBIA;TRIM25;TNFRSF11A;TRIM14;ARHGEF2;NOD1;CD40;NOD2;PRKD1;PRKD2;IKBKB;PPIA;RPS6KA5;LGALS9;AIM2;CRNN;PIDD1;IRAK2;MALT1;UBE2V1;AGER;LAMTOR5;S100A8;TNFSF11;PRKCB;ZBTB7A
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6272952524564296,1.5796432022269893,0.02622950819672131,0.3818873168648567,1.0,9/31,11.86%,PLCB1;TIRAP;CD40;CCR7;TLR3;LGALS9;IRF5;AGER;SYK
prerank,odontogenesis (GO:0042476),-0.5288174533510355,-1.579430948281564,0.01675977653631285,0.3118726819003111,1.0,9/35,3.85%,COL1A2;GLI2;EDA;FGFR2;BMP4;OSR1;WNT6;FOXC1;BCOR
prerank,sodium-independent organic anion transport (GO:0043252),0.763844143602283,1.5793336162792961,0.030592734225621414,0.3804265228379719,1.0,3/10,1.67%,SLCO1C1;SLCO2B1;SLC16A2
prerank,cellular zinc ion homeostasis (GO:0006882),0.6532933948476154,1.5792697194605572,0.024013722126929673,0.37814851513564846,1.0,11/26,13.52%,SLC39A10;SLC39A8;SLC30A1;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,filopodium assembly (GO:0046847),0.6996161182247524,1.5792663804172227,0.0410958904109589,0.3757374659308272,1.0,5/16,3.96%,DNM3;FGD5;SRGAP2;SPATA13;PPP1R9B
prerank,positive regulation of microtubule polymerization (GO:0031116),0.6429084970140824,1.578579241740669,0.029411764705882353,0.37545290376890683,1.0,12/28,21.14%,OCLN;FES;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;GIT1;CKAP5;DCTN1;MECP2;CLASP1
prerank,regulation of B cell proliferation (GO:0030888),0.5826245064057357,1.5781219949762133,0.01386748844375963,0.3745888412365599,1.0,7/44,5.65%,TFRC;TIRAP;MEF2C;CD40;LYN;TNFRSF21;CD38
prerank,regulation of neuron migration (GO:2001222),0.6417288519494104,1.577517239824105,0.03150912106135987,0.3743469196216644,1.0,7/26,3.39%,SEMA6A;SRGAP2;DAB2IP;RAPGEF2;ADGRG1;ARHGEF2;NTNG2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.6591887194760374,-1.57724952875797,0.021834061135371178,0.3143554584856488,1.0,7/13,6.56%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1
prerank,L-amino acid transport (GO:0015807),0.6312329955013192,1.575968785526158,0.03125,0.37698076261860697,1.0,5/28,5.02%,SLC7A5;SLC7A1;SLC1A1;SLC38A5;SLC1A2
prerank,phospholipid biosynthetic process (GO:0008654),0.5945089151679049,1.5753026651685536,0.03395585738539898,0.37681502607285783,1.0,3/36,1.83%,SGMS1;SGMS2;MBOAT1
prerank,positive regulation of B cell proliferation (GO:0030890),0.623825559228816,1.5740027404169272,0.02702702702702703,0.3787449193810282,1.0,5/29,5.65%,TFRC;TIRAP;MEF2C;CD40;CD38
prerank,negative regulation of wound healing (GO:0061045),-0.5475485840475774,-1.5727871535789142,0.03617571059431524,0.32341699835413074,1.0,9/28,8.01%,PHLDB2;TFPI;VTN;CASK;SLC12A2;FGF2;THBD;CD109;APOE
prerank,camera-type eye morphogenesis (GO:0048593),-0.7079731501217075,-1.5723678944432675,0.035555555555555556,0.32154121558264426,1.0,6/10,19.43%,KDM2B;IFT122;SKI;NF1;LRP6;TBX2
prerank,positive regulation of bone mineralization (GO:0030501),-0.5197509166179946,-1.5720616764782083,0.020618556701030927,0.319358641753908,1.0,15/35,12.42%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;FBN2;PKDCC;BMP2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.567597176312368,-1.5715381733837146,0.019704433497536946,0.3177115988709522,1.0,8/25,8.56%,ANK2;ACTN2;SLC6A9;DMD;WNK4;ATP1B3;ATP1B2;TRPC6
prerank,regulation of interleukin-2 production (GO:0032663),0.569893844763004,1.5704149002382528,0.02147239263803681,0.38791198272701866,1.0,11/43,11.08%,SPTBN1;CD34;PRKD2;HDAC7;HOMER2;PDE4D;CD4;PDE4B;FOXP3;MALT1;PNP
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.5031081963165392,1.5702886510355873,0.006720430107526882,0.38598496936292576,1.0,72/110,32.26%,RPL38;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPL27;RPSA;EIF3E;RPS7;RPL9;RPL18;RPLP2;MAGOHB;RPL13A;HELZ2;RPS11;RPL8;NCBP2;RPS27;RPL19;RPS9;RPL11;PNRC2;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;RPL17;RPL23;RPL34;RBM8A;RPS18;UPF2;RPL21;RPS4X;RPL18A;NCBP1;RPS21;RPL10A;PABPC1;RPL24;RPL7A;RPL32;RPL4;UPF3B;UPF1;RPS2;RPS20;RPL6;RPS13;RPS19;PPP2R1A;RPL14;RPL26;RPS6;RPS15A;RPS14;RPS23;RPS24;RPS12;RPL41;RPS16;RPL10;RPL12;RPL36;RPS3;RPS26;RPL27A
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7363771414688032,1.5686381394386568,0.028846153846153848,0.3890820529322998,1.0,5/12,7.16%,CAV1;GJD3;CALM1;PDE4D;SRI
prerank,vasculogenesis (GO:0001570),0.6123165888308657,1.5681389410673214,0.023734177215189875,0.38831780366324287,1.0,12/32,9.09%,EGFL7;KDR;ENG;RASIP1;CAV1;SOX17;APLNR;NOTCH1;RAMP2;SOX18;TGFB1;CCM2
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.48593730441240335,-1.5681230583990782,0.011834319526627219,0.3238104484161939,1.0,19/54,15.37%,GPC6;SDC2;EXT1;GPC3;HS3ST3A1;HS2ST1;GPC4;PXYLP1;HS3ST3B1;HS6ST1;SDC4;HS6ST2;NDST2;HEXA;GNS;NDST1;HGSNAT;B3GAT1;HPSE2
prerank,regulation of T cell migration (GO:2000404),0.6751916791194156,1.5667668329469444,0.04251700680272109,0.3908424615659617,1.0,4/18,2.13%,LRCH1;CXCL12;APP;CD200
prerank,zinc ion transmembrane transport (GO:0071577),0.6668621323087414,1.5667378327019692,0.043859649122807015,0.38860038664166907,1.0,3/22,3.02%,SLC39A10;SLC39A8;SLC30A1
prerank,positive regulation of hydrolase activity (GO:0051345),0.48742140509048304,1.5657042684959501,0.003740648379052369,0.3895958327294366,1.0,26/137,8.52%,ITGA6;DOCK9;SRGAP2;RAPGEF2;ARHGAP27;NET1;CD200;BCAR3;F11R;AGRN;RAPGEF1;CD40;SNX13;RAPGEF3;TGM2;TBC1D2;CALM1;USP6NL;MAPRE2;RSU1;RAP1GDS1;RASGRP2;PKP4;PIN1;CAV2;ARHGEF7
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.4460679928050467,1.5650612411846443,0.0,0.38953141563880805,1.0,94/390,12.50%,PTPRG;FLT1;IGF1R;GRB14;TEK;PLCB1;MPZL1;NAMPT;PDGFB;KDR;INSR;TIE1;WASF2;RAPGEF2;PDGFD;DOCK1;RASGRP4;FES;ELMO1;ANKS1A;FLT4;BCAR3;NEDD9;PTPRJ;PTK2;MTSS1;COL4A2;KALRN;ARPC4;FOXO1;RAPGEF1;PIK3R3;TIAM1;PRKD1;PRKD2;ATP6V0A1;ZAP70;MERTK;PXN;ACTB;LYN;ELMO2;STMN1;SOCS2;GRB2;FGF16;SORT1;GAB1;CD4;EPHA4;BAIAP2;FYN;SOS1;MAPK3;RET;YES1;NCKAP1;EPHB4;HCK;SORBS1;ANKS1B;EFNA1;TIAL1;AP2M1;AP3S1;CAV2;ARHGEF7;SHC3;CD8B;ARPC3;PAK1;PGF;PLAT;ACTG1;PTK6;DDIT4;CYFIP1;PIK3C2A;GRB7;SHB;CYBB;APH1A;GRIN2B;RAC1;NCBP2;HRAS;GSK3A;SYK;NCF4;PIK3CB;TNK2;AP2B1;GDF15;EPHB1
prerank,regulation of leukocyte activation (GO:0002694),0.7143225881118477,1.5645328778575842,0.04528985507246377,0.38891713780049825,1.0,3/14,3.88%,MFHAS1;CD200;LYN
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.5051326277609249,-1.5642839110668616,0.016901408450704224,0.33084065664642964,1.0,16/43,12.03%,IGF1;BMPR1A;PDGFRB;IGFBP5;BMP4;GJA1;IL18;THBS1;FGF2;RBPMS2;MMP2;FOXJ2;CCN4;CDH13;ADAMTS1;MFN2
prerank,eye photoreceptor cell differentiation (GO:0001754),0.7275836892514238,1.5631016588970075,0.061420345489443376,0.3911765628509639,1.0,2/12,2.21%,PROM1;NKD1
prerank,respiratory system development (GO:0060541),-0.5296343074543058,-1.56208647754561,0.021108179419525065,0.33376833719515503,1.0,8/32,4.69%,GLI2;PDPN;FGFR2;BMP4;FGF1;RBP4;LOXL3;FGF2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.7241506424526186,1.5614487967573158,0.03148148148148148,0.3942350186085906,1.0,4/12,6.98%,CAV1;IFIH1;ZCCHC3;RALB
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.6611159776888781,1.5614337941082295,0.029310344827586206,0.392015848138048,1.0,7/20,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,positive regulation of DNA repair (GO:0045739),-0.48797402240538695,-1.5611709357553027,0.01729106628242075,0.3332254341119741,1.0,4/46,2.10%,EYA2;EYA1;EGFR;EYA4
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.6345846193104163,1.5608025638620275,0.029259896729776247,0.3918353082896632,1.0,7/24,9.32%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;SEMA4F;SEMA6D;SEMA4C
prerank,neural crest cell migration (GO:0001755),0.5981989010053897,1.560322514449475,0.04065040650406504,0.39120238169097604,1.0,9/36,9.47%,SEMA3C;SEMA7A;SEMA6A;TBX1;SEMA6B;SEMA4F;SEMA6D;SEMA4C;PHACTR4
prerank,glucose transmembrane transport (GO:1904659),0.6902570027639611,1.5594114330772455,0.044293015332197615,0.3918235416697103,1.0,3/18,5.10%,SLC2A1;PPARD;SORT1
prerank,early endosome to Golgi transport (GO:0034498),-0.6840012888672595,-1.559220833287063,0.03837953091684435,0.33568566801027805,1.0,7/11,23.00%,STX5;SNX8;RAB6A;LMAN1;TRAPPC10;SURF4;TMED9
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5784618028444095,1.55827611704297,0.0382262996941896,0.3931543788878028,1.0,8/39,4.52%,TEK;NDNF;KDR;RGCC;CD40;RAMP2;PLCG1;GATA2
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.6963262009197093,1.5560996516430756,0.039783001808318265,0.39843518515279874,1.0,3/16,1.09%,ST8SIA4;ST6GALNAC3;ST8SIA6
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.6450285449196159,1.5552307489674597,0.033444816053511704,0.3992082941421205,1.0,3/22,5.61%,SLC7A5;NOD2;TRIL
prerank,embryonic digestive tract development (GO:0048566),-0.6074102763272514,-1.553258363256865,0.03631961259079903,0.3492414395561869,1.0,8/18,5.56%,GLI3;RARB;GLI2;PDGFRA;FGFR2;PCSK5;SALL1;RBPMS2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.6138635815150753,1.5526813598380584,0.03636363636363636,0.40526429106424505,1.0,8/29,5.25%,FLT1;TEK;PDGFB;PTK2;NOD2;PRKD1;CD19;CCR7
prerank,regulation of actomyosin structure organization (GO:0110020),-0.6650837422303598,-1.5525465185640137,0.03686635944700461,0.3481213369285459,1.0,6/13,10.27%,ROCK2;ASAP3;ALMS1;AKAP13;FHOD1;SLC9A1
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.7045531364612734,-1.5523327321821623,0.02608695652173913,0.34565680675134264,1.0,7/10,25.66%,SETD7;SETD4;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.565187440831783,1.5515743044779982,0.024096385542168676,0.40678685432682643,1.0,12/45,11.01%,TRIM16;APP;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6269897229497268,1.5515191086339577,0.03511705685618729,0.40475760750379475,1.0,7/27,3.77%,DACH1;PDGFB;BMPR2;RGCC;ACVRL1;PRKD2;HMBOX1
prerank,intraciliary retrograde transport (GO:0035721),-0.6703329062954887,-1.548571142691031,0.027149321266968326,0.35340969550175044,1.0,6/12,14.69%,WDR35;DYNC2I1;DYNC2H1;IFT122;WDR19;DYNC2I2
prerank,regulation of trophoblast cell migration (GO:1901163),-0.6400720870811692,-1.5482070396979049,0.04772234273318872,0.35137778710364165,1.0,7/14,20.08%,GJA1;SYDE1;AGO2;SMURF2;ACVR1B;C1QBP;ARHGDIB
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.5328750347483989,1.5478904605989778,0.013062409288824383,0.41441525213838176,1.0,21/65,12.42%,HIP1;DAB2IP;ITGA1;HIP1R;BCAR3;PLAUR;AFAP1L2;PTPRJ;RHBDF2;PTPN12;DUSP3;GRB2;CCDC88A;TGFA;ARHGEF7;SHKBP1;CNOT9;PTK6;CEACAM1;EPS15;HGS
prerank,cellular response to sterol (GO:0036315),-0.6589399674224428,-1.5476327300022268,0.03556485355648536,0.3497790874244541,1.0,8/13,20.36%,INSIG2;SMO;RORA;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1
prerank,amino acid transport (GO:0006865),0.5512452614725641,1.5472050141543319,0.022556390977443608,0.4145995041763084,1.0,6/49,2.87%,SLC6A6;SLC7A5;SLC7A1;SH3BP4;SLC38A5;SLC43A2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7090610267440242,1.5470147809654347,0.06545454545454546,0.4130399778623923,1.0,4/13,4.35%,DAB2IP;EPN2;MMRN2;HHEX
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.6960105571408436,-1.5461911489241726,0.03829787234042553,0.35105756563984386,1.0,1/10,0.02%,ATP1A2
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.7145106189911228,1.5461023353596512,0.048736462093862815,0.41375477252385906,1.0,2/14,6.58%,TFRC;SHLD1
prerank,synaptic membrane adhesion (GO:0099560),-0.6503298979789223,-1.5454052347605702,0.044543429844097995,0.3503786264313926,1.0,4/14,4.60%,GPC6;PTPRF;PTPRS;GPC4
prerank,regulation of cell communication (GO:0010646),-0.5184751383345267,-1.5442266644659048,0.024630541871921183,0.3506750144950407,1.0,9/35,8.25%,ANK2;CXADR;GRK5;GRK3;CAMK2D;ANXA1;TBX18;SLC8A1;TSPYL2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5614497061455812,-1.542544412259819,0.04047619047619048,0.3524530772466395,1.0,6/23,5.68%,WNT5B;BMP4;GJA1;SMO;FGF2;SIX1
prerank,sulfate transport (GO:0008272),-0.6398427312944251,-1.542012084349304,0.033707865168539325,0.35100626302486704,1.0,3/14,2.84%,SLC13A4;SLC26A7;SLC26A2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.5014518285626834,1.541148473170561,0.011142061281337047,0.4280811605803655,1.0,17/100,6.20%,FLT1;IGF1R;TEK;PDGFB;KDR;PPP1R16B;INSR;DAB2IP;TGFB2;PDGFD;PTK2;PIK3IP1;LYN;GAB1;PIP5K1C;MAPK3;ENTPD5
prerank,modulation by symbiont of entry into host (GO:0052372),0.6874907118925437,1.5410878640346377,0.045454545454545456,0.42600366600434236,1.0,3/16,2.37%,CAV1;TRIM25;TRIM14
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.6421459727389623,-1.5404668929493102,0.043668122270742356,0.3523655959808723,1.0,8/13,22.68%,DDO;ASPA;ACOT8;GOT1;GLUL;QPRT;GOT2;MTHFS
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.6241539453865009,-1.5398937863896403,0.04357798165137615,0.3512563293836843,1.0,6/16,14.60%,ANK2;GBF1;SEC16B;LRRK2;SEC16A;DDRGK1
prerank,regulation of striated muscle contraction (GO:0006942),-0.5469638557320802,-1.5396294720967356,0.04092071611253197,0.3490832186595549,1.0,6/27,10.12%,ATP1A2;ANK2;SLC8A3;DMD;P2RX4;PRKACA
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.5971286130804577,1.5395864927240324,0.04262295081967213,0.4290634229928077,1.0,5/29,3.73%,KANK3;SHANK3;TJP1;HIP1R;SSH2
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6621050753895068,-1.5389938786010933,0.042826552462526764,0.3480095473531668,1.0,4/13,12.42%,BMP5;DKK3;APOE;BMP2
prerank,negative regulation of interleukin-10 production (GO:0032693),0.680811602870338,1.5389883570230605,0.04529616724738676,0.42885775869877235,1.0,6/16,11.81%,JAK3;TNFRSF21;FOXP3;TRIB2;AGER;VSIR
prerank,cellular response to copper ion (GO:0071280),0.6836118254883383,1.5357611892848695,0.037300177619893425,0.437697463823885,1.0,11/16,25.24%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;DAXX;SNCA;AOC1
prerank,N-glycan processing (GO:0006491),0.6664762033603773,1.534819944923877,0.03859649122807018,0.43861373961860767,1.0,3/18,1.96%,ST8SIA4;ST8SIA6;FUT8
prerank,cAMP metabolic process (GO:0046058),-0.6279483647166303,-1.534271531071104,0.04932735426008968,0.357376089527747,1.0,7/13,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PTHLH;ADCY6
prerank,bone development (GO:0060348),-0.49711431534285483,-1.5342306704179407,0.0332409972299169,0.35477291665427657,1.0,10/39,6.60%,RANBP3L;SULF1;FGFR2;CYP26B1;GJA1;SULF2;SH3PXD2B;AKAP13;SFRP4;GNAS
prerank,regulation of monooxygenase activity (GO:0032768),0.6447034050605691,1.5331516055823389,0.050761421319796954,0.44187418388910116,1.0,7/23,8.87%,NOSTRIN;NOS3;CAV1;DDAH1;CALM1;DNM2;LYPLA1
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5883187265329017,-1.5330215846071669,0.021791767554479417,0.3553392392280808,1.0,6/20,9.03%,SULF1;SMOC2;SULF2;THBS1;FGF2;CREB3L1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5969236143774372,-1.5326731748673457,0.0425,0.3536294843505269,1.0,6/17,6.33%,FSTL1;SULF1;SLIT2;CASK;TWSG1;SFRP4
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.6336373336255606,1.532467288253945,0.06354515050167224,0.44189778827926623,1.0,8/23,13.46%,FAR2;ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,adherens junction organization (GO:0034332),0.5655451258722027,1.5320050903136087,0.03162650602409638,0.44123415279960504,1.0,15/48,7.00%,TJP1;CADM1;CDH2;RAMP2;ACTB;NECTIN4;CDH20;SMAD7;CTNND1;CTNNB1;CDH8;PIP5K1C;PVR;DCHS1;CDH19
prerank,limb development (GO:0060173),-0.5394020381687905,-1.5307772147635827,0.025380710659898477,0.3560748134313901,1.0,11/28,20.36%,SMOC1;GLI3;PCSK5;SALL1;RSPO2;IFT122;IQCE;COMP;INTU;KREMEN1;PTCH1
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),0.7199903292034091,1.5304852446351183,0.05426356589147287,0.4442466333579348,1.0,2/11,0.22%,IGF1R;PLCB1
prerank,negative regulation of angiogenesis (GO:0016525),0.5146862555555011,1.529550208430506,0.016643550624133148,0.4449993164257138,1.0,20/84,7.37%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;EPN2;TGFB2;STAB1;RGCC;COL4A2;AMOT;VASH1;KLF2;HHEX;SARS1;CTNNB1;KLF4;STAT1;GTF2I;CD160
prerank,positive regulation of interleukin-4 production (GO:0032753),0.6726379888209448,1.5294532285979334,0.061946902654867256,0.44308874123700853,1.0,2/17,6.44%,SLC7A5;LGALS9
prerank,myelination (GO:0042552),0.5576979537144157,1.5293104498206243,0.018691588785046728,0.4413187621512031,1.0,20/46,19.06%,MPZ;CMTM8;MAL;B4GALT5;PLLP;PARD3;TNFRSF21;BCAS1;GAL3ST1;NFASC;EIF2B2;ABCD1;SOX10;DEGS1;MBP;PMP22;ARHGEF10;MAL2;TPPP;ABCD2
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.6215266218276484,-1.5292261302384653,0.03736263736263736,0.35493754906314057,1.0,8/16,13.57%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.6215266218276484,-1.5292261302384653,0.03736263736263736,0.35493754906314057,1.0,8/16,13.57%,PHLDB2;ARHGAP6;APOD;THBS1;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,zinc ion homeostasis (GO:0055069),0.6255507479630354,1.5290356989324314,0.035897435897435895,0.4400801599635682,1.0,11/28,13.52%,SLC39A10;SLC39A8;SLC30A1;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,granulocyte differentiation (GO:0030851),0.6619219510824901,1.528944360805438,0.0429553264604811,0.43821729993543973,1.0,2/18,5.20%,LEF1;TAL1
prerank,skin development (GO:0043588),-0.45319473356366696,-1.5281470425133319,0.015822784810126583,0.35517669233464993,1.0,22/65,14.74%,COL1A2;COL3A1;COL5A2;COL1A1;COL5A1;ERRFI1;PKD1;ADAM9;ANXA1;ATP7A;TXNIP;JAG1;MET;COL5A3;ITGB4;CLDN1;GATA6;SCEL;DACT2;BCR;SLC2A10;CASP3
prerank,L-serine metabolic process (GO:0006563),0.7437358308840136,1.5274107971522648,0.05989110707803993,0.44111071740602686,1.0,4/10,9.59%,SERINC3;SERINC5;SHMT2;CBS
prerank,glycolipid metabolic process (GO:0006664),0.5605778241806004,1.5260884474867258,0.023622047244094488,0.4434397811959646,1.0,12/47,13.93%,ST6GALNAC3;ST3GAL6;ST8SIA6;ESYT2;NEU4;ESYT1;GLB1;GLTP;ST6GALNAC4;B4GALNT1;CERK;NEU2
prerank,amino acid transmembrane transport (GO:0003333),0.556050234168611,1.5258426210436669,0.019908116385911178,0.4420964732498091,1.0,5/45,1.98%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;SLC38A5
prerank,intestinal absorption (GO:0050892),0.709772804794474,1.5245187142781482,0.05615942028985507,0.44475199493869766,1.0,3/13,5.16%,TJP2;F11R;KCNQ1
prerank,negative regulation of axon extension (GO:0030517),0.597568131334254,1.5221400278949846,0.04501607717041801,0.4511087373307369,1.0,7/30,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;DIP2B;SEMA4F;SEMA6D
prerank,negative regulation of anoikis (GO:2000811),0.6945962508415839,1.5221342060620866,0.045627376425855515,0.4489545475299897,1.0,7/14,11.88%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,amino sugar metabolic process (GO:0006040),0.7260411659135204,1.521930548221884,0.06130268199233716,0.44747977133729244,1.0,3/10,8.00%,CSGALNACT1;ST3GAL1;ST6GAL1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.6805161664625077,-1.5215893106428902,0.04415011037527594,0.37009532310068344,1.0,6/10,24.38%,EMC8;EMC7;EMC1;EMC2;EMC3;EMC4
prerank,lung epithelium development (GO:0060428),-0.6876690737468353,-1.5214301404442325,0.034,0.3678303851483405,1.0,4/10,6.14%,ERRFI1;BMP4;PKD1;RCN3
prerank,cardiac muscle tissue development (GO:0048738),-0.4764799752814892,-1.520962035375582,0.00872093023255814,0.36651464779927834,1.0,13/50,6.00%,NOTCH2;BMPR1A;GJB6;BMP5;SGCD;BMP7;BMP4;GJA1;RBP4;CACNA1G;NDUFV2;TBX18;AKAP13
prerank,positive regulation of integrin activation (GO:0033625),0.7244285641694019,1.5207683357540493,0.05628517823639775,0.4493262779652652,1.0,4/11,10.91%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,cellular response to dsRNA (GO:0071359),0.6785569572781966,1.5205011561544033,0.06386861313868614,0.4480844360056087,1.0,5/15,10.56%,CAV1;IFIH1;ZCCHC3;RALB;PDE12
prerank,glycerophospholipid metabolic process (GO:0006650),0.510272234960346,1.5204731065560677,0.020028612303290415,0.4460711170217483,1.0,10/75,6.36%,GPCPD1;PLCB1;DGKH;PLA2G4B;PLCG1;SERINC5;PNPLA6;GDPD1;ABCA3;PIGM
prerank,secondary palate development (GO:0062009),0.6820441597967781,1.5180326898050884,0.05789473684210526,0.4521950717501585,1.0,3/14,4.25%,LEF1;TGFB2;WNT7A
prerank,regulation of cell migration (GO:0030334),0.4356638081209396,1.5178331932464242,0.0,0.4507679959046291,1.0,58/382,6.48%,LEF1;FLT1;IGF1R;SEMA3C;ITGA6;SEMA7A;LIMCH1;DACH1;PECAM1;FRMD5;SEMA6A;TJP1;CLDN5;PDGFB;KDR;SRGAP3;SRGAP2;INSR;PODXL;MACF1;ROBO4;SRGAP1;ENG;CXCL12;PDGFD;PRR5L;CAV1;NKD1;NEDD9;SEMA6B;SPATA13;PTPRJ;PTK2;PLXND1;ADAM15;PIK3R3;AMOT;ACVRL1;TIAM1;NTNG2;NOTCH1;DUSP3;VIL1;RIPOR1;TMSB4X;SMAD7;GNA12;FGF16;SEMA4F;RHOB;EPHA4;SNAI2;ACTN4;FAM107A;KIF2A;ADAM10;RET;RFFL
prerank,cellular potassium ion homeostasis (GO:0030007),-0.6431524765261434,-1.5163138144406711,0.056155507559395246,0.3766571262638683,1.0,5/13,7.08%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;ATP1B2
prerank,spinal cord development (GO:0021510),-0.6439186734765473,-1.5163032104899994,0.04740406320541761,0.37398072262747056,1.0,5/12,4.66%,GLI2;PKD1;VIT;LOXL3;PKD2
prerank,cellular response to peptide (GO:1901653),0.534260774666412,1.5153939794182707,0.02009273570324575,0.4568413912340204,1.0,12/56,6.25%,IGF1R;CACNA1A;APP;CAV1;ARHGEF2;NOD1;NOD2;CYP11B1;CYP11A1;EPHA4;FYN;ATP1A3
prerank,regulation of establishment of cell polarity (GO:2000114),-0.6023635527848642,-1.5148688873503766,0.045662100456621,0.3749228418852637,1.0,6/16,12.46%,ROCK2;GSN;KANK1;RIPOR2;PTK2B;BCAS3
prerank,regulation of chemokine production (GO:0032642),0.588489867332233,1.5145931706485927,0.03542673107890499,0.45738867334926225,1.0,10/36,11.82%,APP;IL6R;SIGIRR;TLR3;SNAI2;LGALS9;TLR7;ADAM17;AGER;HIF1A
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.4229709539707259,-1.51452605079709,0.0036363636363636364,0.37327665592909604,1.0,27/95,9.29%,GPC6;UST;DSE;DCN;ANGPT1;SDC2;OGN;CEMIP;EXT1;FMOD;GPC3;BGN;HS3ST3A1;ST3GAL4;HS2ST1;CHST15;GPC4;PRELP;PXYLP1;CSPG4;HS3ST3B1;HS6ST1;SDC4;LUM;HS6ST2;NDST2;OMD
prerank,glycoprotein metabolic process (GO:0009100),0.5486601153384845,1.5143667442687359,0.03587443946188341,0.45612535202558213,1.0,8/53,5.56%,ST8SIA4;ST6GALNAC3;ST8SIA6;FUT8;B4GALT5;OGA;NEU4;STT3B
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),-0.40076171651688,-1.5140032383214634,0.0,0.37198254818236065,1.0,27/142,12.11%,ATP1A2;CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;SMAD3;CD55;CCR9;EDNRA;ADRA1B;TRPC3;SLC35G1;SLC8B1;DLG4;SLC8A1;BDKRB2;AGTR1;PTGDR;TRPC6;PTGFR;PRKACA;TRPM4;CLN3;TRPC4;ABL1;ESR1
prerank,regulation of blood circulation (GO:1903522),-0.5173763600511035,-1.5136751530517512,0.027989821882951654,0.37029795224429096,1.0,10/34,10.36%,CELF2;TPM1;DMPK;CAMK2D;KCNMB2;PER2;ACE;BDKRB2;AGTR1;DES
prerank,striated muscle cell development (GO:0055002),0.6893585424082291,1.5134887404308048,0.05956678700361011,0.45695418950814515,1.0,2/14,1.54%,FLII;PGM5
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.5777752942554082,1.5120301506305838,0.046822742474916385,0.459684723869414,1.0,14/32,10.41%,JCAD;KDR;MMRN2;NOTCH1;HDAC9;HDAC7;STARD13;GATA2;DLL4;CARD10;KLF4;MAP3K3;PIK3C2A;PDCD10
prerank,mesenchymal to epithelial transition (GO:0060231),-0.6903551447288071,-1.5119871460571888,0.026476578411405296,0.3721386600195768,1.0,3/10,6.35%,BMP4;SALL1;FZD7
prerank,positive regulation of lipid localization (GO:1905954),-0.6707239508027947,-1.5114487477992464,0.05485232067510549,0.3707782213850902,1.0,2/11,3.91%,LRP1;IKBKE
prerank,positive regulation of ruffle assembly (GO:1900029),0.6999356111697876,1.5114487086896766,0.05486725663716814,0.4595234469834271,1.0,6/13,15.74%,EPS8;EPS8L2;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,neuron maturation (GO:0042551),0.6521998064578842,1.510273009245027,0.051001821493624776,0.4615029959034552,1.0,4/18,2.10%,APP;SCARF1;ANKS1A;B4GALT5
prerank,phospholipid translocation (GO:0045332),0.6026312048904455,1.5100722091206675,0.047377326565143825,0.46011734176852664,1.0,9/28,9.75%,ATP10A;MFSD2A;ATP8A1;ATP11B;ATP11A;ABCA7;P2RX7;ATP11C;ATP10B
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),0.6082030082702038,1.5087968641014886,0.04923599320882852,0.46230347358973595,1.0,5/27,1.98%,SLC7A5;SLC7A1;SLC1A1;SLC6A5;SLC38A5
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.6321739565169099,-1.5087654645451427,0.054945054945054944,0.3758983262557431,1.0,5/14,10.23%,IRS1;PPARGC1A;IRS2;NNMT;SLC45A3
prerank,regulation of phospholipase activity (GO:0010517),-0.6917119826811616,-1.5085249848697209,0.04563492063492063,0.37402746707153833,1.0,3/10,9.06%,LRP1;FGFR2;PDPK1
prerank,neutrophil migration (GO:1990266),0.5233406260054847,1.5060575422717288,0.022288261515601784,0.4696587367846569,1.0,11/58,11.86%,BSG;PECAM1;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,Rap protein signal transduction (GO:0032486),0.739917240129546,1.5052881798397877,0.06282722513089005,0.47014965984821455,1.0,4/10,7.23%,RAPGEF2;RAPGEF1;RAPGEF3;RAP1B
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4649054349939054,1.5046878006828508,0.018018018018018018,0.47028681930874,1.0,32/140,8.85%,CHN2;MCF2L;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;SRGAP1;ARAP2;RASGRF2;NET1;PLEKHG5;ARHGEF2;KALRN;FAM13A;TIAM1;ABR;CD2AP;STARD13;TGM2;RHOB;OCRL;DEPDC7;ARHGAP23;SOS1;ARHGAP25;ARHGEF12;ARHGEF5;PREX1;ARHGEF7;OPHN1;ARHGAP4
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.7325539547431159,1.5037526238866394,0.07604562737642585,0.4715779098500926,1.0,3/10,4.03%,DGKH;PARD3;PRKD3
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5886452896601531,-1.5031039884057082,0.05707762557077625,0.38653106923146896,1.0,4/17,5.34%,PID1;NUPR1;HDAC4;PPARA
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.6184901667730468,-1.5030884349062825,0.04728132387706856,0.383980336998835,1.0,5/14,9.96%,SEC24D;SEC24A;SAR1A;SEC31A;SEC23A
prerank,fat cell differentiation (GO:0045444),-0.4542702009903132,-1.5030601085648179,0.0182370820668693,0.38151532617771106,1.0,17/57,14.76%,PID1;WNT5B;SMAD6;OSBPL8;PPARGC1A;FAM120B;PER2;ATF5;C1QTNF3;CLIP3;BBS9;MKKS;MAFB;NR4A1;EP300;METRNL;TMEM120A
prerank,actin filament organization (GO:0007015),0.46454399724899403,1.5020206548699733,0.011688311688311689,0.4754952944985928,1.0,27/151,7.03%,FLII;HIP1;MYO1D;MYO1E;RHOBTB1;SHROOM4;NEBL;SHROOM1;ELMO1;HIP1R;NEDD9;ARHGEF2;ARPC4;CD2AP;EVL;PLS3;ELMO2;VIL1;PPP1R9B;MYO6;RFLNB;EPS8;RHOB;TPM3;BAIAP2;ARHGAP25;ACTN1
prerank,regulation of anoikis (GO:2000209),0.6399639748911331,1.5018520114377159,0.06304728546409807,0.4739892107992039,1.0,7/19,11.88%,CAV1;PTK2;NOTCH1;SNAI2;MCL1;PTRH2;TLE1
prerank,anterior/posterior pattern specification (GO:0009952),-0.45981417098155625,-1.4993291581511665,0.022988505747126436,0.38934374284957984,1.0,23/53,20.29%,WLS;HOXC4;HOXC6;HOXB3;PCSK5;HOXA3;HOXA5;HOXB4;HOXB6;TGFBR1;HOXA7;HEYL;BMP2;HOXB5;SKI;HOXC5;HOXA9;HOXA6;DDIT3;HEY2;ATP6AP2;HOXD3;HES6
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.47408646623280715,-1.499120607292305,0.025,0.38735644287550497,1.0,18/46,15.48%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;RBPJ;ZNF423;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4;NRDC
prerank,glycoprotein biosynthetic process (GO:0009101),0.5064055753096094,1.4983959594137495,0.018387553041018388,0.4836636517594818,1.0,11/79,7.12%,ST8SIA4;CSGALNACT1;ST3GAL6;ST8SIA6;BMPR2;B4GALT5;ST6GALNAC2;CHST11;B3GNT2;FUT9;COG3
prerank,diol metabolic process (GO:0034311),0.6592557815350567,1.497980102491364,0.07636363636363637,0.48292852804385283,1.0,5/19,4.35%,SGPP2;DEGS2;NOS3;GCH1;CALM1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.6221528610145161,1.4971275798314148,0.05733558178752108,0.48373146262194416,1.0,9/24,12.23%,TEK;KDR;PTPRJ;DUSP3;MAPRE2;IQSEC1;FERMT2;RAC1;MAP4K4
prerank,regulation of potassium ion transport (GO:0043266),-0.515750542554382,-1.4965153308885857,0.0327455919395466,0.3919133675122082,1.0,8/31,11.13%,ANK2;ACTN2;FHL1;KCNIP3;CD63;DLG1;CACNA1D;PTK2B
prerank,positive regulation of MAPK cascade (GO:0043410),0.43920335099938124,1.4962281351326567,0.007177033492822967,0.48476214307471127,1.0,34/245,6.46%,FLT1;IGF1R;TEK;SEMA7A;MFHAS1;PIK3R6;JCAD;PDGFB;KDR;INSR;DAB2IP;TGFB2;RAPGEF2;PDGFD;APP;TBX1;TIRAP;PDE8A;FLT4;BCAR3;TPD52L1;PTPRJ;CD40;NOD2;NOTCH1;PRKD2;RAMP3;CCR7;CD4;MAPK3;ADRA2B;FBXW7;LGALS9;RET
prerank,catecholamine biosynthetic process (GO:0042423),0.7326391188164179,1.4955425122723163,0.0705244122965642,0.48489706550517636,1.0,4/11,7.04%,DDC;TGFB2;GCH1;INSM1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5442656456499297,-1.4948857882508648,0.04205607476635514,0.3938500416596776,1.0,7/23,15.28%,PLCE1;AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.529829930621498,-1.494618453441424,0.037783375314861464,0.3919914690202816,1.0,9/28,14.12%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,cell-cell junction organization (GO:0045216),0.5021144451108431,1.4935521427848462,0.04435483870967742,0.48984306384690923,1.0,19/79,8.09%,OCLN;TJP1;CLDN5;CADM1;LIMS2;TGFB2;GJC1;TJP2;CDH2;NECTIN4;CDH20;CTNND1;CDH8;MARVELD2;PVR;DCHS1;CDH19;PKP4;TGFB1
prerank,protein glycosylation (GO:0006486),0.4766544772604579,1.4930860369318693,0.013123359580052493,0.4893976247834613,1.0,36/125,17.29%,ST8SIA4;ST3GAL6;EOGT;AQP11;ST8SIA6;SLC39A8;ST3GAL1;GALNT18;FUT8;B4GALT5;ST6GALNAC2;B3GNT2;OGA;STT3B;FUT9;ENTPD5;GAL3ST1;COG3;PLOD3;NPC1;B3GALT4;MGAT4B;B3GALT2;PLOD1;DPAGT1;SERP2;NUS1;POFUT1;DAD1;GCNT2;DPM3;MGAT2;B3GNT3;POGLUT1;DOLPP1;POMGNT1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.6081812468982607,-1.492455573879476,0.06712962962962964,0.39575119979888884,1.0,7/15,21.30%,GGT5;ALDH4A1;PRODH;GGACT;SARDH;ABHD16A;GOT2
prerank,protein secretion (GO:0009306),-0.45112710695380714,-1.492083433766728,0.033950617283950615,0.3942329584385848,1.0,10/56,9.51%,WLS;PCSK5;STEAP3;ABCA1;TANGO2;ANXA1;RCN3;ARFGAP3;TANGO6;CANX
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.6237650988991683,-1.4919392766364625,0.05434782608695652,0.39209260632340587,1.0,5/14,2.27%,LRP1;BMPR1A;IGFBP5;TPM1;SLIT2
prerank,copper ion homeostasis (GO:0055070),0.6532357296876936,1.4917458715294012,0.08976660682226212,0.49187359272130843,1.0,4/17,5.15%,APP;ATOX1;SLC31A1;XIAP
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.609010703091866,1.489427318938918,0.05647840531561462,0.49771908367918183,1.0,8/26,13.79%,NOD1;NOD2;IFIH1;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3
prerank,regulation of interleukin-17 production (GO:0032660),0.5898164677131087,1.4884082928485423,0.05737704918032787,0.4992753570919544,1.0,9/31,14.70%,SLC7A5;NOD2;TGFB1;FOXP3;CCL1;VSIR;IL15;RFTN1;NCKAP1L
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.5071323353587637,1.4883237313598676,0.02575107296137339,0.4974397111720827,1.0,18/75,7.37%,TEK;PTPRM;SEMA6A;CLDN5;DAB2IP;TGFB2;STAB1;RGCC;COL4A2;AMOT;VASH1;HHEX;SARS1;CTNNB1;KLF4;STAT1;GTF2I;CD160
prerank,peptide metabolic process (GO:0006518),-0.4282859489690619,-1.487789746195474,0.021052631578947368,0.40067049910493563,1.0,18/75,15.68%,CPQ;AEBP1;MGAT3;PCSK5;DMD;ANPEP;GSTT1;BACE2;ACE;ENPEP;NPEPPS;CPXM1;CPXM2;IDE;PSEN1;GSTA3;GSTM2;HM13
prerank,inorganic ion transmembrane transport (GO:0098660),-0.6286191509829353,-1.4876656915231128,0.0757238307349666,0.39853501710973366,1.0,4/12,15.14%,PKD2;ABCC9;TRPM4;KCNJ8
prerank,positive regulation by host of viral transcription (GO:0043923),0.6686129670531741,1.4876335721861424,0.0625,0.49786678630381914,1.0,3/15,8.95%,LEF1;JUN;CHD1
prerank,smoothened signaling pathway (GO:0007224),-0.5038409762367706,-1.4875714233007316,0.043010752688172046,0.39633512977643914,1.0,13/32,23.61%,GLI3;GLI2;CC2D2A;SMO;EVC2;GLI1;DYRK2;PTCH2;STIL;TMEM231;PTCH1;TMEM17;STK36
prerank,regulation of interleukin-10 production (GO:0032653),0.5527615540105266,1.4871245881946176,0.051036682615629984,0.49752892541916754,1.0,10/44,11.86%,CD34;JAK3;NOD2;TNFRSF21;LGALS9;FOXP3;TRIB2;AGER;VSIR;SYK
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.663180100130924,1.486934102363822,0.06756756756756757,0.49622308904845225,1.0,5/15,8.41%,TGFB2;JAK3;SMAD7;TGFB1;FOXP3
prerank,receptor-mediated endocytosis (GO:0006898),0.4718713745403368,1.4858305219053372,0.010596026490066225,0.49826811105526797,1.0,31/132,12.31%,TFRC;DNM3;INSR;STAB1;ARHGAP27;CAV1;SCARF1;FNBP1L;HIP1R;RAB31;SCARB1;RAMP2;CALCRL;DNAJC13;GRB2;PIKFYVE;RAMP3;PIP5K1C;INPP5F;LRP1B;DNM2;FCHO2;AP2M1;CXCR2;CAV2;LRP2;AMN;CD163;SYK;EPS15;AP2B1
prerank,hemidesmosome assembly (GO:0031581),0.7236157468836043,1.485030703683445,0.05850091407678245,0.49892863947477745,1.0,1/11,0.31%,ITGA6
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5956826556754741,1.4849741915534076,0.05601317957166392,0.4970815574526765,1.0,8/30,10.45%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;RFFL;FAIM;CASP8
prerank,protein localization to cell-cell junction (GO:0150105),0.6631923493918207,1.4847431121355512,0.06764168190127971,0.4958560635424234,1.0,5/15,3.99%,TJP1;TJP2;F11R;ACTB;LSR
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.5389411004285419,-1.4842915967894479,0.033854166666666664,0.4025279357875651,1.0,7/26,7.86%,ANK2;ACTN2;FHL1;DLG1;ATP1B3;ATP1B2;CACNA1D
prerank,regulation of protein localization to nucleus (GO:1900180),0.5452981731417853,1.4833716488508177,0.044189852700491,0.49874320139648864,1.0,10/43,12.05%,TFRC;MFHAS1;WWTR1;CARD10;LIMK2;PIN1;TGFB1;LAMTOR5;FERMT2;ORMDL3
prerank,regulation of integrin activation (GO:0033623),0.6652500696776358,1.4832413781900415,0.0763765541740675,0.49718340434470804,1.0,4/15,10.91%,RASIP1;PIEZO1;RAP1B;FERMT2
prerank,regulation of glucose transmembrane transport (GO:0010827),0.6276190420162263,1.4830024130668145,0.06338028169014084,0.49614229546522737,1.0,2/18,0.45%,OCLN;SLC2A1
prerank,transition metal ion transport (GO:0000041),0.5621148920965076,1.482852994722608,0.054365733113673806,0.49465369178052276,1.0,6/35,4.15%,TFRC;SLC39A8;ATOX1;SLC30A1;ATP2C1;SLC31A1
prerank,regulation of macrophage cytokine production (GO:0010935),0.6704724725618488,1.4813966138965209,0.062146892655367235,0.49762431704605853,1.0,2/13,1.32%,SEMA7A;TGFB2
prerank,regulation of glucose import (GO:0046324),-0.5172542123226062,-1.481368565157421,0.042821158690176324,0.40791596582746154,1.0,12/30,8.53%,PID1;IGF1;PRKAG2;APPL2;ENPP1;IRS1;RHOQ;OSBPL8;PRKCI;IRS2;SELENOS;GRB10
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6107245486746237,-1.481242336254131,0.0625,0.4057764586449268,1.0,7/15,16.37%,PIEZO2;ADGRV1;COL11A1;KIT;MKKS;TMEM120A;PDZD7
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4858826699983217,1.4808590044882228,0.034578146611341634,0.4974901820894788,1.0,20/94,11.35%,PLCB1;IL1R1;NFKBIA;NOD1;NOD2;PELI1;MAP3K8;IKBKB;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;PSMD8
prerank,positive regulation of cellular metabolic process (GO:0031325),0.48235779833852355,1.4805945692479046,0.02200825309491059,0.4965041198780725,1.0,19/98,8.89%,SLCO1C1;PDGFB;INSR;XDH;FASN;PPARD;NFKBIA;IFNAR1;IL10RB;WNT7A;GRB2;RAMP3;INPP5F;TBC1D5;KLF4;ACACB;NR1H2;TGFB1;GREM1
prerank,calcium ion transport (GO:0006816),-0.4024247673346065,-1.4805039607848725,0.0038910505836575876,0.4055288582511788,1.0,30/113,13.69%,SLC24A3;TRPM3;CACNA1C;ANK2;NALCN;ITPR1;PKD1;STIM1;SLC8A3;ANO6;CACNA2D1;RAMP1;PKD2;TRPC3;CACNA1G;TRPM6;P2RX4;SLC8A1;CACNA1D;TRPC6;ITGAV;TRPM4;SLC24A5;TRPC4;CACNB2;TRPC4AP;PSEN1;PANX1;ORAI2;CRACR2A
prerank,muscle cell differentiation (GO:0042692),0.5794523045756643,1.4802398212806216,0.049679487179487176,0.4956488699481082,1.0,7/32,2.75%,SYNE1;NEBL;TMEM204;MRTFB;TBX1;MRTFA;MEF2C
prerank,positive regulation of cell junction assembly (GO:1901890),0.5343071163915145,1.4791811137786888,0.03265940902021773,0.4971850243685277,1.0,15/56,13.19%,TEK;CLDN5;KDR;CAV1;PTPRJ;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;FERMT2;RAC1;MAP4K4;EPHB1;CNTNAP2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.429831102677698,-1.4790228602531206,0.012422360248447204,0.4072154897433843,1.0,17/73,6.76%,FSTL1;SULF1;BMPR1A;FOXD1;NBL1;CRIM1;BMP4;BMPER;SMAD6;HTRA3;TWSG1;RBPJ;ZNF423;RBPMS2;SFRP4;CCN1;SMAD9
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5162438621193174,1.4778798867454463,0.038922155688622756,0.4998319463952275,1.0,11/59,6.91%,HMCN1;PTPRM;BSG;PECAM1;CADM1;ROBO4;CDH2;DSCAML1;NECTIN4;PVR;CNTN2
prerank,negative regulation of DNA binding (GO:0043392),0.594149558536702,1.4777724228926068,0.05823627287853577,0.49826740342942544,1.0,10/28,17.92%,LEF1;NFKBIA;SP100;JUN;SOX11;HEY1;HMGA2;SUMO1;SIN3A;CPNE1
prerank,membrane organization (GO:0061024),0.43829107789198474,1.4777128994131492,0.005868544600938967,0.496472586607414,1.0,59/227,16.46%,TFRC;DNM3;CERT1;HIP1;SPTBN1;EPN2;REEP1;FNBP1L;HIP1R;AGFG1;DYSF;FZD4;ARPC4;ATP2C1;ACTB;SNX3;GRB2;CD4;PIP5K1C;OCRL;CCDC88A;CNTN2;DNM2;CHRNB1;GRIN3B;FCHO2;CHMP1B;AP2M1;TGFA;RTP4;ARPC3;NPC1;ACTG1;ATP10B;LPCAT3;PIK3C2A;LEMD3;HSPA8;LRP2;SH3GLB1;GLTP;EPS15;SNAP29;AP2B1;HGS;MITD1;IL7R;SUN1;SGCZ;M6PR;AMPH;RTP3;PLEKHA3;SH3KBP1;SYNJ1;REEP3;PDCD6IP;ANK3;SPAST
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.5975325808146746,1.4771677300593107,0.060810810810810814,0.4963075534939766,1.0,7/29,11.88%,LEF1;MEN1;CTNNB1;TCF7;TLE4;AXIN2;TLE1
prerank,negative regulation of metabolic process (GO:0009892),-0.44994297123293436,-1.476777516085704,0.030985915492957747,0.4110177145617432,1.0,18/54,15.48%,ALDH1A1;LGR4;DOCK7;PLCL1;NPR3;FOXC2;ADAMTS5;RBPJ;ZNF423;ACOT11;TLE3;NOVA1;PLCL2;STK11;RHEB;PCTP;TLR4;NRDC
prerank,regulation of dendrite extension (GO:1903859),0.6353089655732972,1.4765612770250245,0.05154639175257732,0.49624463906104854,1.0,10/18,20.26%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,cellular response to BMP stimulus (GO:0071773),-0.44305063879447343,-1.4765178063948448,0.021021021021021023,0.4092759335377513,1.0,15/66,6.76%,BMP6;TGFBR3;BMPR1A;ADAMTS12;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,defense response to symbiont (GO:0140546),0.4899610871635168,1.4761052910067969,0.03496503496503497,0.49581897038094225,1.0,23/92,11.42%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;BST2;TLR7;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;TLR8;RNASE1
prerank,cellular response to type I interferon (GO:0071357),0.553198267512947,1.4759937682869566,0.06125574272588055,0.49250761709262264,1.0,12/41,10.15%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;XAF1;IRF9;STAT1;IRF5;BST2;OASL
prerank,type I interferon signaling pathway (GO:0060337),0.553198267512947,1.4759937682869566,0.06125574272588055,0.49250761709262264,1.0,12/41,10.15%,IFNAR1;SP100;IFNAR2;IRF2;ADAR;SAMHD1;XAF1;IRF9;STAT1;IRF5;BST2;OASL
prerank,regulation of cell-cell adhesion (GO:0022407),0.5610308155660327,1.4757915752879567,0.04754358161648178,0.4913520608201447,1.0,8/39,8.09%,PTPRG;PODXL;MAGI1;PTK2;SMAD7;FUT9;PTPRR;TGFB1
prerank,lipid modification (GO:0030258),0.5541144941116322,1.4756596488740004,0.0492845786963434,0.48991973628887764,1.0,9/37,11.93%,SGPP2;DGKH;MBOAT1;CYP2E1;PLPP6;DGKI;DGKE;LPCAT3;DGKZ
prerank,response to exogenous dsRNA (GO:0043330),0.6407228230314259,1.474699110747589,0.0757314974182444,0.49125101202985294,1.0,6/18,8.98%,CAV1;IFIH1;TLR3;ZCCHC3;RALB;SLC3A2
prerank,ATP transport (GO:0015867),0.729714552363012,1.4744904898470215,0.07526881720430108,0.4900790807482492,1.0,2/10,5.07%,ABCC6;SLC25A5
prerank,axon extension (GO:0048675),-0.5378706376225901,-1.4743270104241595,0.049868766404199474,0.41314240298455074,1.0,11/23,21.59%,ALCAM;AUTS2;SLIT2;ULK2;SPG11;PPP3CB;USP9X;MAP1B;SEMA5A;SEMA3F;CDK5
prerank,cardiac atrium morphogenesis (GO:0003209),0.6513621230203513,1.4741568371365499,0.07317073170731707,0.4893524451365662,1.0,6/16,5.01%,ENG;BMPR2;TGFB2;ZFPM1;NOTCH1;DLL4
prerank,positive regulation of cellular component organization (GO:0051130),0.4770852945794775,1.47385804056173,0.02510460251046025,0.48854494886048555,1.0,13/107,5.96%,IGF1R;ATP10A;TFRC;SHANK3;INSR;DAB2IP;TGFB2;TIRAP;NEDD4L;RAPGEF3;FNIP2;TAL1;BIK
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.5549785705764968,-1.4738284053656523,0.07476635514018691,0.41222835880939246,1.0,9/19,21.62%,DDO;ASPA;ALDH7A1;GOT1;PHYKPL;HYKK;PIPOX;GOT2;AASS
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.5908830437172561,1.473768067680581,0.06687898089171974,0.48704106922388496,1.0,10/29,14.32%,ELOVL7;FASN;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;SLC25A1;HACD2;HSD17B8
prerank,camera-type eye development (GO:0043010),-0.5349747143578905,-1.473550991168045,0.0399002493765586,0.41052701746317155,1.0,9/25,13.29%,CACNA1C;FBN1;EFEMP1;LAMA1;CYP1B1;IFT122;FBN2;SKI;NF1
prerank,acylglycerol metabolic process (GO:0006639),0.558772340042641,1.4733814354259271,0.04830917874396135,0.48647133597710995,1.0,6/37,7.90%,ABHD2;DGKH;CAV1;DGKI;DGKE;AWAT2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7199569373983765,1.472475148553085,0.07289719626168224,0.4875931425865608,1.0,3/11,3.88%,MFHAS1;TIRAP;LYN
prerank,very-low-density lipoprotein particle assembly (GO:0034379),0.7064461199082785,1.472299544490459,0.07393715341959335,0.48641957934007896,1.0,4/12,11.60%,MFSD2A;ACSL3;LPCAT3;MTTP
prerank,regulation of developmental growth (GO:0048638),0.5904146322425059,1.4720293741704096,0.04690117252931323,0.48559693299733436,1.0,4/29,1.57%,PLCB1;MFSD2A;INSR;APP
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6692517909458365,1.4720012898390584,0.07806691449814127,0.48393656486682884,1.0,4/15,6.88%,MFSD2A;SCARB1;FBXW7;NR1H2
prerank,microtubule depolymerization (GO:0007019),0.657710251297288,1.471758321565688,0.06770833333333333,0.4830922727162902,1.0,7/17,15.68%,STMN1;NCKAP5;KIF2A;STMN3;STMN4;NCKAP5L;CKAP5
prerank,glucose import (GO:0046323),0.6876386919375718,1.4716843153202726,0.06994328922495274,0.48156939675657157,1.0,2/13,5.10%,SLC2A1;SORT1
prerank,positive regulation of dendrite extension (GO:1903861),0.6424056906355778,1.4712045881109679,0.05410122164048865,0.48145813267621956,1.0,10/17,20.26%,NEDD4L;ITSN2;RASAL1;SMURF1;CPNE5;SYT4;CPNE6;RIMS2;UNC13A;PLAA
prerank,endocrine system development (GO:0035270),-0.5492968958069009,-1.4707309047933383,0.05752212389380531,0.41605316283174415,1.0,11/21,19.52%,GLI2;WNT4;DKK3;SALL1;TGFBR1;SIX1;FOXE1;NF1;WNT11;MDK;HOXD3
prerank,nitrogen compound transport (GO:0071705),0.46162602910551154,1.4703290848062276,0.013440860215053764,0.4824070881264025,1.0,24/141,10.98%,SLC6A6;SLC7A5;SLC7A1;CERT1;ABCG2;SLC6A2;SLC38A5;ATP11B;SLC43A2;RAMP2;CALCRL;RAMP3;SLC52A2;CMTM6;SEC14L1;LRP1B;SCAMP1;CHMP1B;SLC3A2;SLC52A3;SLC18A1;ARL6IP5;LRP2;AMN
prerank,glutamate receptor signaling pathway (GO:0007215),0.5516502519420313,1.469309495316381,0.04918032786885246,0.4841022990348769,1.0,12/37,14.47%,PLCB1;APP;GNAQ;HOMER2;GRID2;HOMER1;GRIN3B;GRIA4;GRIN2B;GRIK2;GRIK1;GRM7
prerank,endothelial cell proliferation (GO:0001935),0.6462556780921753,1.4692350378305665,0.08163265306122448,0.4826441143241418,1.0,4/17,3.18%,TEK;CD34;BMPR2;ACVRL1
prerank,heart contraction (GO:0060047),-0.46936651443394883,-1.4692176224210136,0.02997275204359673,0.4177241359713971,1.0,7/41,10.13%,ATP1A2;SGCD;TPM1;DMD;SLC8A1;ACE;GAA
prerank,chondrocyte differentiation (GO:0002062),-0.4994858190931765,-1.4691856184532865,0.03787878787878788,0.415432370885444,1.0,11/32,9.47%,SULF1;SOX5;WNT5B;BMP4;OSR1;SULF2;CREB3L2;SLC39A14;RUNX2;CCN3;SOX6
prerank,positive regulation of GTPase activity (GO:0043547),0.4435404343717381,1.4690401519775826,0.008728179551122194,0.48160406460592753,1.0,38/188,8.52%,ITGA6;DOCK9;TBC1D4;SRGAP2;RAPGEF2;ARHGAP27;ARHGEF15;NET1;BCAR3;F11R;TBC1D14;AGRN;TBC1D22A;RAPGEF1;SIPA1L2;CD40;SIPA1;TIAM1;ABR;RALGAPA1;TBC1D12;SNX13;RAPGEF3;TGM2;TBC1D2;CCR7;USP6NL;MAPRE2;RSU1;TBC1D5;RAP1GDS1;RASGRP2;ARHGAP25;PKP4;ARHGEF5;PIN1;CAV2;ARHGEF7
prerank,JNK cascade (GO:0007254),0.5583511295051724,1.468816971752675,0.05825242718446602,0.48054995003519846,1.0,6/40,3.20%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5718304467464002,1.4686816898253878,0.05057096247960848,0.4793966622763583,1.0,4/33,5.26%,LEF1;FES;CTNNBIP1;CD4
prerank,energy reserve metabolic process (GO:0006112),-0.560098613300208,-1.4664754115959147,0.05811138014527845,0.42097569764648446,1.0,8/19,10.73%,PID1;PRKAG2;LEPR;PHKB;PYGM;GFPT1;GFPT2;PPP1R3C
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),-0.5529057889250337,-1.465282237975427,0.07125890736342043,0.422136384017045,1.0,8/20,10.27%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;LACC1;ATP1B2;SLC8A1;SLC9A1
prerank,oogenesis (GO:0048477),0.6532342876837117,1.4650757180770082,0.08703703703703704,0.48956505140849627,1.0,4/15,8.49%,NANOS3;NANOS2;NANOS1;PTN
prerank,dendrite self-avoidance (GO:0070593),0.6387686759935306,1.4648777514455786,0.0947176684881603,0.4885471307429456,1.0,4/16,6.91%,BSG;ROBO4;DSCAML1;CNTN2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5289349793048654,1.4647929936283042,0.050445103857566766,0.4871249835117485,1.0,5/49,2.65%,SGMS1;BCL2L1;CAV1;PLAUR;PTPMT1
prerank,growth hormone receptor signaling pathway (GO:0060396),0.6664835648622975,1.4647849803793176,0.10153256704980843,0.48544643629954015,1.0,5/14,4.17%,PTK2;JAK3;PXN;LYN;SOCS2
prerank,negative regulation of defense response to virus (GO:0050687),-0.6670364082516077,-1.464459936087165,0.07743362831858407,0.42224864686765784,1.0,5/10,20.58%,PPM1B;PCBP2;C1QBP;MUL1;TARBP2
prerank,regulation of heart contraction (GO:0008016),-0.4056232285424809,-1.463878739140531,0.017482517482517484,0.42146697214894974,1.0,16/90,7.24%,ATP1A2;CELF2;ANK2;ITPR1;TPM1;STIM1;SLC8A3;DMPK;ASPH;CAMK2D;ABCC9;ATP1B3;TMEM65;ATP1B2;P2RX4;SLC8A1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7215433940052055,1.4635777873137386,0.06486486486486487,0.4876860084584244,1.0,3/10,1.74%,SEMA6A;DAB2IP;XDH
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.6003778819147069,-1.46357775143088,0.05411255411255411,0.41997508974322545,1.0,4/16,5.34%,APPL2;APOD;ADCY7;PPARA
prerank,response to progesterone (GO:0032570),0.649526606872937,1.4624758783194471,0.07692307692307693,0.4895414032253996,1.0,3/18,1.75%,ABHD2;TGFB2;CAV1
prerank,regulation of calcium ion import (GO:0090279),0.6054819923678137,1.4622097690311295,0.0657672849915683,0.4888634424007585,1.0,5/21,6.12%,PDGFB;CXCL12;SLC30A1;CTNNB1;FYN
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.44761399731464535,-1.4621324626602283,0.03581267217630854,0.42155435543827535,1.0,11/51,6.76%,FSTL1;FBN1;BMPR1A;NBL1;CRIM1;BMPER;SMAD6;HTRA3;GREM2;RBPMS2;SMAD9
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.607285065592042,-1.4599081884114034,0.07029478458049887,0.42524385937138476,1.0,7/13,15.12%,LARGE1;MGAT3;RENBP;PGM3;CHST3;CHST1;NAGK
prerank,regulation of Notch signaling pathway (GO:0008593),0.4922830696432097,1.4593406733737597,0.031746031746031744,0.49634475174072595,1.0,16/76,6.44%,EGFL7;EPN2;TGFB2;NOS3;NOTCH4;JAG2;TSPAN5;NOD2;PRAG1;TSPAN14;NOTCH1;MFNG;GATA2;DLL4;MAML2;FBXW7
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5584057088778496,1.4581161908816236,0.05511811023622047,0.49867174661237545,1.0,15/33,12.99%,MMRN2;RGCC;MEF2C;ACVRL1;NOTCH1;VASH1;STARD13;DLL4;CARD10;KLF4;TGFB1;AGTR2;PDCD10;PPARG;CSNK2B
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5572108194124664,1.4577963871483985,0.044444444444444446,0.4979525703339314,1.0,11/39,6.17%,EPN2;TGFB2;NOS3;NOTCH4;JAG2;TSPAN5;NOD2;TSPAN14;NOTCH1;DLL4;MAML2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.7117892551833218,1.4565779231414144,0.08365758754863813,0.5003268171768611,1.0,3/11,4.35%,NOS3;GCH1;CALM1
prerank,response to molecule of bacterial origin (GO:0002237),0.4981302988568452,1.4563119805405225,0.04231311706629055,0.4994978289625778,1.0,19/69,15.03%,NOS3;TIRAP;GCH1;IFNAR1;TNFRSF11A;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;IRF5;ADAM17;S100A8;CYRIB;SLPI;HMGB2;TNFAIP3;INAVA
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.47031103912476335,-1.4543591357561567,0.04419889502762431,0.4385032791077585,1.0,12/37,14.69%,WDR35;IFT80;DYNC2I1;IFT81;IFT74;DYNC2H1;IFT122;IFT57;CLUAP1;PCM1;WDR19;DYNC2I2
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.5445845574614809,-1.4542206897446377,0.04009433962264151,0.43652501917995057,1.0,7/22,10.98%,IGF1;ROCK2;CAMK2D;P2RX4;PRKCA;SLC9A1;PARP1
prerank,B cell activation (GO:0042113),0.497646805914047,1.4540743332775319,0.03735632183908046,0.5052177605811153,1.0,22/68,16.54%,TPD52;PTPRJ;MEF2C;JAK3;CD40;HDAC9;ZAP70;HHEX;SLC25A5;CD79A;KLF6;MALT1;ADAM17;CASP8;PRKCB;ZBTB7A;VCAM1;HDAC5;DNAJB9;MSH2;LAT2;ITGA4
prerank,stabilization of membrane potential (GO:0030322),-0.5844253858280177,-1.45398749359086,0.08375634517766498,0.4348489910078862,1.0,2/16,3.08%,KCNK2;KCNK5
prerank,organic substance transport (GO:0071702),0.4641898745406599,1.4529822159268226,0.02540106951871658,0.5071443370474397,1.0,24/121,10.98%,ABCG2;MFSD2A;PLTP;ATP8A1;SLCO2B1;SPNS2;SLC6A2;RAMP2;CALCRL;ABCG1;RAMP3;CMTM6;ABCA3;LRP1B;CHKA;SCAMP1;CHMP1B;ABCA7;TAP2;SLC18A1;ARL6IP5;LRP2;ABCD1;AMN
prerank,heart looping (GO:0001947),0.5533489050906539,1.452933573595277,0.055299539170506916,0.5055989693987688,1.0,7/40,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,lipid translocation (GO:0034204),0.6174898317706916,1.4529141681343187,0.06451612903225806,0.5039764184474775,1.0,7/21,9.75%,ATP10A;ATP8A1;ATP11B;ATP11A;ABCA7;ATP11C;ATP10B
prerank,prostanoid biosynthetic process (GO:0046457),-0.6046682159368673,-1.4505683958657989,0.07352941176470588,0.44236161333402996,1.0,4/15,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,MAPK cascade (GO:0000165),0.4195470845474783,1.4505286347002055,0.00683371298405467,0.5099711693360286,1.0,50/295,9.52%,KITLG;TEK;RASGRP3;SHANK3;RASAL2;SPTBN1;PDGFB;KDR;BCL2L1;DAB2IP;RAPGEF2;RASGRF2;RASGRP4;PTK2;MEF2C;DUSP7;JAK3;FGF13;MEN1;MAP3K8;IKBKB;CALM1;GRB2;FGF16;CAMKK2;ZDHHC9;IL17RD;FYN;SOS1;MAPK3;ABHD17A;LGALS9;RET;PSMB3;LRRC7;RGL2;RASAL1;PSMD11;TGFB1;TGFA;SPTAN1;MARK3;SHC3;PSMC6;LYPLA1;CCM2;PAK1;MAP3K3;PPP1CB;PSME2
prerank,lamellipodium assembly (GO:0030032),0.5883285833007335,1.4500693146805252,0.0734094616639478,0.5097716417103209,1.0,9/26,11.43%,PARVB;ABLIM1;SRGAP2;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,negative regulation of protein processing (GO:0010955),-0.6192817858138395,-1.4499850319202363,0.08108108108108109,0.4414638849394424,1.0,7/12,19.05%,GAS1;THBS1;SNX12;LRRK2;SERPINE2;CTSZ;SERPINE1
prerank,positive regulation of interleukin-17 production (GO:0032740),0.6144726113140289,1.4496052884144297,0.07758620689655173,0.5096233816804289,1.0,6/22,14.30%,SLC7A5;NOD2;TGFB1;CCL1;IL15;RFTN1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.44588860081424836,1.4486452960337632,0.009198423127463863,0.5110760487433033,1.0,19/150,6.46%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;GAB1;CCR7;FYN;RET
prerank,regulation of endothelial cell migration (GO:0010594),0.48101970272735306,1.4480927780406665,0.03719599427753934,0.5111726370219396,1.0,17/85,5.30%,TEK;PTPRM;ETS1;KDR;DAB2IP;BMPR2;FLT4;PTK2;SP100;SCARB1;ACVRL1;PRKD1;PRKD2;VASH1;PRCP;DLL4;RHOB
prerank,Rac protein signal transduction (GO:0016601),0.6319723768451763,1.448053077041113,0.08732876712328767,0.5096394909198189,1.0,7/18,11.43%,ELMO1;TIAM1;EPS8;DBNL;NCKAP1;CYFIP1;RAC1
prerank,cellular response to insulin stimulus (GO:0032869),0.4531766255092278,1.4450474086139853,0.018396846254927726,0.5177572959698746,1.0,30/124,14.06%,IGF1R;GRB14;TBC1D4;NAMPT;INSR;BCAR3;RAB31;FOXO1;PIK3R3;HDAC9;ATP6V0A1;GRB2;GAB1;BAIAP2;DENND4C;SOS1;SLC25A33;SORBS1;PKM;AP3S1;CAV2;PIK3C2A;GRB7;GSK3A;CEACAM1;ZFP36L1;PPARG;LPIN3;SH2B2;PDE3B
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6426949650542808,1.4423417670089784,0.07581227436823104,0.5247937568066087,1.0,5/16,5.01%,JCAD;PPP1R16B;APLNR;GATA2;DLL4
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.6297083687474979,-1.4423198068391991,0.05747126436781609,0.46136554900001275,1.0,7/13,18.21%,NUPR1;TMEM39A;LRRK2;SCFD1;PHF23;FEZ1;SMCR8
prerank,fatty acid biosynthetic process (GO:0006633),0.5016932753241872,1.4422506278793976,0.039764359351988215,0.5234045995976673,1.0,12/63,14.32%,ABHD2;ELOVL7;TECRL;CYP2E1;ELOVL5;LIPC;ABCD1;ELOVL6;LTA4H;HACD2;DEGS1;HSD17B8
prerank,regulation of axon extension (GO:0030516),0.5513577694354954,1.442177304886541,0.046031746031746035,0.521956013137892,1.0,7/37,8.14%,SEMA7A;MACF1;NTN1;DIP2B;DBNL;DNM2;TWF2
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6707858876136987,1.4415943226409618,0.09665427509293681,0.5221099753719609,1.0,3/13,4.35%,NOS3;GCH1;CALM1
prerank,amide biosynthetic process (GO:0043604),0.5245768099822576,1.4412151529616555,0.0502283105022831,0.5217001390966485,1.0,11/47,15.01%,SGMS1;SGMS2;DEGS2;CERS4;TLCD3B;SPTLC2;SLC25A15;DEGS1;SPTLC1;CLN8;FA2H
prerank,anion transmembrane transport (GO:0098656),0.4898617061432823,1.4411987753333066,0.04354136429608128,0.5200870376787502,1.0,10/67,5.07%,SLC7A5;SLC7A1;SLC1A1;SLC39A8;SLC6A5;SLC38A5;LRRC8B;LRRC8C;SLC1A2;SLC25A5
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.4605814242850321,-1.4407555959167575,0.03581267217630854,0.46357703710018083,1.0,15/46,12.49%,IGF1;PDGFRB;OGN;IGFBP5;BMP4;ELN;APOD;IL18;THBS1;RBPMS2;IGFBP3;CCN4;CDH13;MFN2;XRCC5
prerank,positive regulation of cytokine production (GO:0001819),0.42068731315036406,1.4407071545529406,0.006896551724137931,0.5199690602425481,1.0,52/292,13.02%,SLC7A5;PLCB1;SPTBN1;CADM1;CD34;APP;IL1R1;TIRAP;IL6R;FLT4;CD200;AFAP1L2;ARHGEF2;RGCC;NOD1;LRRFIP1;CD40;ZFPM1;NOD2;PRKD2;IFIH1;GBP5;NOS2;CTNNB1;PDE4D;POU2AF1;CD6;HYAL2;CCR7;CD4;TLR3;MRE11;CCDC88B;LGALS9;IRF5;TLR7;TGFB1;PDE4B;MALT1;EBI3;ADAM17;AGER;LAMTOR5;CCL1;TLR8;PNP;HIF1A;SYK;C1QTNF4;CYRIB;IL15;RAB1A
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.557961347965882,1.4405594438327562,0.07087827426810478,0.5187977597341291,1.0,5/33,4.52%,TEK;NDNF;KDR;RAMP2;GATA2
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.6032941353681636,1.4403276721897837,0.08131487889273356,0.517857411820161,1.0,4/22,3.88%,MFHAS1;DAB2IP;TIRAP;LYN
prerank,divalent inorganic cation homeostasis (GO:0072507),0.6038878173543597,1.4390585408449315,0.07755775577557755,0.520243586956651,1.0,2/25,1.75%,TMTC2;CAV1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5690948654527672,-1.4373714342338153,0.09647058823529411,0.47112082695871044,1.0,4/16,5.34%,PRKAG2;APPL2;PPARGC1A;PPARA
prerank,embryonic heart tube morphogenesis (GO:0003143),0.532230759024567,1.4372894101408555,0.05714285714285714,0.5244174798920541,1.0,7/44,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,smooth muscle cell differentiation (GO:0051145),0.6878634064846756,1.4369295720389805,0.10196779964221825,0.5239429577979289,1.0,5/12,3.28%,TMEM204;MRTFB;MRTFA;MEF2C;APLNR
prerank,response to lipid (GO:0033993),0.4635219970148295,1.4366557001787015,0.036241610738255034,0.5232506153697357,1.0,26/105,13.76%,NOS3;ACER2;TRIM16;PPARD;TIRAP;GCH1;IFNAR1;TNFRSF11A;FOXO1;PELI1;ABCG1;SOCS2;NOS2;CTNNB1;NOCT;PALM3;CD6;LGALS9;TGFB1;ADAM17;S100A8;PAQR7;SLPI;PPARG;SOX9;HMGB2
prerank,response to muramyl dipeptide (GO:0032495),0.6790430633174278,1.4364546717594469,0.10567514677103718,0.522263877983897,1.0,4/12,7.15%,ARHGEF2;NOD1;NOD2;IRF5
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.6102134189826531,-1.43633996662352,0.07543103448275862,0.4717953192440845,1.0,2/12,6.03%,INSIG2;KDELR3
prerank,iron ion transmembrane transport (GO:0034755),0.7039634628896356,1.4363081413791499,0.09498207885304659,0.5211077225721524,1.0,2/10,1.24%,SLC40A1;SLC39A8
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.6681951097946426,1.436216531768229,0.10110294117647059,0.5198399633528035,1.0,4/15,10.08%,ENTPD1;AK4;ENTPD5;CMPK1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6428563856185061,1.4343668514260397,0.09608540925266904,0.524417772851666,1.0,3/16,6.88%,MFSD2A;SCARB1;NR1H2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.43884593195602195,1.434321002301853,0.028314028314028315,0.5229457749657344,1.0,26/159,7.00%,MPZ;HMCN1;PTPRM;BSG;PECAM1;CLDN5;CADM1;ROBO4;TGFB2;ADGRL3;CDH2;DSCAML1;ATP2C1;NECTIN4;CDH20;PCDHGB4;CD6;CDH8;GRID2;PVR;SLITRK3;FAT4;CNTN2;CLDN14;DCHS1;CDH19
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.6154825024798034,-1.4328815046842767,0.1031390134529148,0.47980999417497794,1.0,7/12,19.35%,DMD;WNK4;ATP1B3;ATP1B2;FXYD1;WNK1;WNK3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6712050026590757,1.4322172258463974,0.09497206703910614,0.5280898241887093,1.0,2/12,0.85%,DDC;MAOA
prerank,positive regulation of B cell activation (GO:0050871),0.51682731150618,1.4306695761039645,0.058383233532934134,0.5315665853565474,1.0,7/50,6.58%,TFRC;TIRAP;MEF2C;CD40;NOD2;CD38;SHLD1
prerank,regulation of cellular component biogenesis (GO:0044087),0.5376368717711122,1.4294552114862493,0.05873261205564142,0.533954400868822,1.0,11/39,10.71%,TJP1;TIE1;DAB2IP;RAPGEF2;RAPGEF1;NOTCH1;INSM1;RAP1B;IRGM;MSN;HSPA8
prerank,lipid phosphorylation (GO:0046834),0.6938208790776182,1.4282429352994548,0.10305343511450382,0.5364443264218927,1.0,4/10,11.93%,DGKH;DGKI;DGKE;DGKZ
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5529745878302966,1.4278138332425727,0.08527131782945736,0.536209225964644,1.0,9/35,6.71%,FLT1;PTPRM;XDH;CAV1;RGCC;MEF2C;VASH1;DLL4;STAT1
prerank,regulation of DNA repair (GO:0006282),-0.45577570160023084,-1.4268826250868811,0.04885057471264368,0.4953402768361407,1.0,4/44,2.10%,EYA2;EYA1;EGFR;EYA4
prerank,modulation by host of symbiont process (GO:0051851),0.5504907545939685,1.4267818016263853,0.08585055643879173,0.5381040624832117,1.0,1/31,0.03%,LEF1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.5953119053155695,-1.4265987372771696,0.08482142857142858,0.4936207440502607,1.0,7/13,24.90%,DDX5;PLA2R1;ATM;SPRED1;HIC1;ATR;MSX1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6964400205800017,1.4262434999623024,0.1062618595825427,0.538297112316908,1.0,5/10,6.44%,CXCL12;RAPGEF2;LYN;CCR7;LGALS9
prerank,determination of heart left/right asymmetry (GO:0061371),0.5352002951441234,1.425970399660167,0.0715372907153729,0.5375735848560462,1.0,7/43,3.41%,ENG;ZIC3;SOX17;TBX3;MEF2C;APLNR;NOTCH1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5142763619405065,-1.425965912041051,0.06930693069306931,0.49296450998778163,1.0,7/26,15.91%,IGF1;FHL2;EFHB;SLC9A1;STIMATE;DYRK2;HOMER3
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6419424487363032,-1.4254869904710374,0.08298755186721991,0.491944855685007,1.0,2/10,1.89%,GLI3;BMP4
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.39038938101848564,-1.42470839873044,0.011029411764705883,0.49184619518677347,1.0,37/108,13.22%,TRABD2B;WLS;SULF1;LRP1;PTK7;FGFR2;GPC3;RNF43;DCDC2;MDFIC;RSPO3;KANK1;SULF2;WWOX;SALL1;DAAM2;RSPO2;SFRP4;FZD7;DACT1;CTNND2;PRKN;FOXL1;GRB10;NXN;AXIN1;VGLL4;CDK14;BTRC;LRRK2;CXXC4;ESR1;PSEN1;BMP2;EMD;SKI;NKD2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.6338671111331835,-1.4244783106933063,0.09843400447427293,0.4900552709776135,1.0,5/11,19.16%,WNT4;BMP5;BMP2;NR1H4;STAR
prerank,cellular response to glucagon stimulus (GO:0071377),-0.5461504220945395,-1.4238284485995947,0.07177033492822966,0.4895089632803005,1.0,8/17,13.39%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,Golgi to plasma membrane transport (GO:0006893),0.5206930181984294,1.4233784443140305,0.060092449922958396,0.5440168678053948,1.0,10/47,11.22%,SPTBN1;MACF1;EXOC6B;EXOC6;RAB31;STXBP6;RAB34;AMN;EXOC4;EXOC2
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.5193780844854257,-1.4233720123164806,0.06372549019607843,0.48838483505242525,1.0,11/25,15.71%,ERRFI1;SLC6A9;CBLB;SNX6;PPARA;TSG101;EPHB2;CNRIP1;ZFYVE28;ACE2;GPRC5A
prerank,negative regulation of GTPase activity (GO:0034260),0.5964451066573433,1.4231308622815015,0.0946843853820598,0.5431721504461088,1.0,7/22,11.49%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;PLXNB3;HRAS
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5782851432896856,1.4225635780400883,0.07899159663865546,0.5434800553977288,1.0,3/24,3.18%,DACH1;BMPR2;ACVRL1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5644339482179904,-1.4222938464808783,0.08533916849015317,0.48919349209115953,1.0,2/17,1.85%,BMP6;CD55
prerank,cellular response to mechanical stimulus (GO:0071260),0.5242962996342316,1.4215301430884333,0.05674846625766871,0.5452208987356073,1.0,14/46,14.07%,PDE2A;FAS;F11R;CD40;MAP3K1;PIEZO1;TLR3;MAPK3;CRADD;TLR7;CASP8;TLR8;SOX9;BCL10
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.6401487168114881,-1.4214167617298326,0.07234042553191489,0.4891982485265831,1.0,3/10,3.85%,ATP1A2;OSR1;CAMK2D
prerank,cellular copper ion homeostasis (GO:0006878),0.6460515032592942,1.420786307287638,0.1141804788213628,0.5460614980468672,1.0,3/14,4.15%,APP;ATOX1;SLC31A1
prerank,negative regulation of immune effector process (GO:0002698),-0.6005699161125673,-1.4203421227079738,0.10212765957446808,0.4899514695810393,1.0,4/13,16.97%,CD55;ENPP3;CD300A;GRN
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.6231023098571673,1.4200272869705166,0.1,0.5471859900104192,1.0,3/16,7.37%,CADM1;PVR;CD160
prerank,response to copper ion (GO:0046688),0.6071286292235253,1.4199327110050657,0.09743589743589744,0.5458841741991298,1.0,12/20,25.24%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;LOXL2;DAXX;SNCA;AOC1
prerank,hippo signaling (GO:0035329),0.5727686430161866,1.4197522395585522,0.1045531197301855,0.5449244842518542,1.0,7/26,6.99%,TJP1;TEAD4;TJP2;AMOT;WWTR1;FAT4;DCHS1
prerank,defense response to virus (GO:0051607),0.46472130920604177,1.4196362450525137,0.03872752420470263,0.5437106440299976,1.0,23/100,11.42%,BCL2L1;SERINC3;IFNAR2;CD40;IFIH1;NLRC5;IRF2;SERINC5;SAMHD1;NT5C3A;TLR3;STAT1;BST2;TLR7;RTP4;AGBL5;BNIP3L;ZMYND11;OASL;DDIT4;PDE12;TLR8;RNASE1
prerank,stress-activated MAPK cascade (GO:0051403),0.4960710839106856,1.4186672759797692,0.07309941520467836,0.5453351041794431,1.0,13/61,9.77%,SH2D3C;MAP4K2;TNFRSF19;MAP4K3;NOD1;NOD2;MAP3K8;IKBKB;MAPK3;LGALS9;IRAK2;CCM2;UBE2V1
prerank,positive regulation of transferase activity (GO:0051347),0.4454628807220233,1.4178252342083786,0.03354838709677419,0.5466038703227207,1.0,24/142,8.09%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;CD200;DCUN1D3;HMBOX1;MERTK;SERINC5;CTNNB1;HSP90AB1;CD4;EPHA4;MRE11;MAPK3;FBXW7;KLF4;RET;EPHB4;PIN1;TGFB1
prerank,carboxylic acid metabolic process (GO:0019752),0.5525084171743776,1.4167275739239398,0.08387096774193549,0.548573411058259,1.0,6/33,9.51%,CSGALNACT1;SLC2A1;ST3GAL1;GLYAT;ST6GAL1;TBXAS1
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.6608039998639417,1.416612631660338,0.1054481546572935,0.5474476590273025,1.0,5/13,13.46%,ELOVL7;TECRL;ELOVL5;ELOVL6;HACD2
prerank,positive regulation of interleukin-1 production (GO:0032732),0.5113078604962582,1.415810086925067,0.06360946745562131,0.5485568636381823,1.0,12/51,11.01%,TRIM16;APP;NOD2;GBP5;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.5378973844365688,-1.4152869114454514,0.07908163265306123,0.5027541406128558,1.0,9/21,12.03%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2;FOXJ2;ADAMTS1;MFN2
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5595168500450938,-1.4145993851301077,0.11221945137157108,0.5023053364963791,1.0,6/15,6.43%,GPC3;WNT5B;RSPO3;DAAM2;SFRP4;DACT1
prerank,regulation of microtubule polymerization (GO:0031113),0.5329782002454073,1.4145664631290291,0.0873634945397816,0.5509970339298211,1.0,10/40,13.45%,OCLN;FES;STMN1;CLIP1;CDK5RAP2;PAK1;AKAP9;RAC1;MAPRE3;CDH5
prerank,defense response to protozoan (GO:0042832),0.6575162774163117,1.4138902722250697,0.1198501872659176,0.5516298314000837,1.0,3/12,3.22%,CD40;GBP7;GBP4
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.5642039721547749,-1.4135167957975754,0.09113924050632911,0.50317907163246,1.0,3/18,2.31%,EGFR;BMP4;DDX5
prerank,regulation of MAPK cascade (GO:0043408),0.43790499678277056,1.413230538623477,0.017587939698492462,0.5521580696662081,1.0,37/157,12.68%,FLT1;IGF1R;TEK;JCAD;PDGFB;KDR;INSR;DAB2IP;CAV1;FAS;TBX1;FLT4;BCAR3;PHLPP1;PTPRJ;DUSP3;LYN;CD4;PAK5;MAPK3;ADRA2B;RET;ARHGEF5;ABCA7;IQGAP1;CAV2;P2RX7;GREM1;PAK1;DUSP1;HRAS;SYK;CEACAM1;MAP4K4;GDF15;EPHB1;WWC1
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.6432960372527602,1.4131380765111785,0.08787346221441125,0.5508856865647486,1.0,2/15,1.56%,PRKCH;TRIM16
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.6815097278665322,1.4130871518086567,0.127134724857685,0.5495086587100988,1.0,5/11,12.15%,RAPGEF2;MEF2C;LYN;LGALS9;PIK3CB
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6385599904359982,1.412596379358181,0.12089810017271158,0.5495436423675087,1.0,3/14,1.75%,NOTCH4;XDH;CAV1
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.6129737149033404,1.411721227368008,0.09272727272727273,0.5510414465411555,1.0,3/17,7.37%,CADM1;PVR;CD160
prerank,positive regulation of macrophage activation (GO:0043032),-0.5643535510646006,-1.411618475306269,0.09466019417475728,0.5063080726280794,1.0,4/17,14.74%,LBP;THBS1;TNIP2;TLR4
prerank,B cell proliferation (GO:0042100),0.6253713074323374,1.4113144967838391,0.10369068541300527,0.5507989160526218,1.0,4/17,8.21%,MEF2C;CD40;CD19;CD79A
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),-0.6175692106391025,-1.4107501728000325,0.0915032679738562,0.5065037654996951,1.0,5/11,24.43%,XPO5;FMR1;LIMD1;AJUBA;STAT3
prerank,regulation of interferon-gamma production (GO:0032649),0.4814121616980702,1.4106068064901105,0.05803571428571429,0.5515134456856683,1.0,14/71,12.52%,SLC7A5;IL1R1;ZFPM1;PDE4D;CCR7;TLR3;LGALS9;TLR7;PDE4B;FOXP3;EBI3;TLR8;VSIR;CYRIB
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),-0.6192949180583673,-1.410532045096085,0.11506276150627615,0.5046806828837346,1.0,5/11,8.27%,PDK1;MAP3K5;PRKCD;CYP1B1;PRODH
prerank,cellular response to growth factor stimulus (GO:0071363),0.43610343525083456,1.4101330445894047,0.04183006535947712,0.5516442460573202,1.0,28/151,5.07%,FLT1;NDNF;SEMA6A;PDGFB;KDR;DAB2IP;BMPR2;PDE2A;RAPGEF2;TBX1;PDE8A;FLT4;MEF2C;RAPGEF1;PTPN12;ACVRL1;PRKD1;NOTCH1;PRKD2;RAMP2;DUSP3;VIL1;PLCG1;WNT7A;SMAD7;CTNNB1;DLL4;HYAL2
prerank,actin filament-based transport (GO:0099515),0.6021484802239825,1.4098459855438457,0.09734513274336283,0.5510044276287018,1.0,5/21,6.03%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.5177029151133832,-1.4098280933919163,0.08716707021791767,0.5043874390605275,1.0,8/21,13.67%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;GUCY1A1;ADCY6;GUCY1B1
prerank,regulation of osteoblast differentiation (GO:0045667),-0.3929468005276864,-1.4094160823033746,0.02786377708978328,0.5031584803257542,1.0,29/82,13.13%,BMP6;RANBP3L;IGF1;BMPR1A;SMOC1;WNT4;CRIM1;BMP7;FGFR2;BMP4;DDX5;SMAD6;SUFU;RUNX2;CCN1;TMEM64;YAP1;CCN4;LRP3;TWIST2;PRKACA;TRPM4;FBN2;CHRD;IFITM1;BMP2;NPNT;SKI;TWIST1
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.524815100124414,1.4090546985761072,0.06771653543307087,0.5520105333068944,1.0,9/39,12.15%,EFR3B;ITPKB;PIK3R3;SOCS2;SOCS5;PIK3C3;PIK3C2A;PIP4K2A;PIK3CB
prerank,phosphatidylcholine metabolic process (GO:0046470),0.48678293614359414,1.4076681395272386,0.05701754385964912,0.5548199587228605,1.0,14/70,13.32%,MFSD2A;MBOAT1;PLA2G4B;SLC44A5;ABCA3;NR1H2;CHKA;ENPP2;LPCAT3;LIPC;CEPT1;PNPLA8;CSNK2B;LPIN3
prerank,positive regulation of ion transport (GO:0043270),-0.4331411855025786,-1.4076079160633967,0.050793650793650794,0.5064773547912883,1.0,12/48,13.69%,ANK2;ACTN2;FHL1;MYLK;ANO6;DLG1;P2RX4;CACNA1D;TRPC6;GPD1L;CACNB2;CRACR2A
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.5321648121624077,1.4071985589024654,0.09190031152647975,0.5547304243323391,1.0,11/35,11.43%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;PLXND1;SEMA4F;SEMA6D;SEMA4C;ARHGDIA;PLXNB3;RAC1
prerank,regulation of glucose metabolic process (GO:0010906),-0.4908287297624132,-1.4064552293574135,0.07213930348258707,0.5075467152358643,1.0,8/34,10.23%,PDK1;IRS1;OGT;RORA;IRS2;PRKN;SELENOS;SLC45A3
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.5527908338483077,-1.4060508126035292,0.07239819004524888,0.5065446851022573,1.0,3/17,4.57%,ANK2;SNTA1;CACNA2D1
prerank,metanephric mesenchyme development (GO:0072075),-0.6262164435498399,-1.4058193033190294,0.08714596949891068,0.5048771591073542,1.0,4/10,5.68%,WNT4;OSR1;PKD2;SIX1
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.5493008492983185,1.4051377922578059,0.10588235294117647,0.5598596671456353,1.0,11/31,17.11%,PPP1R13B;HIP1R;PPP3CC;YWHAH;YWHAQ;CASP8;ZNF205;GSK3A;PPP3R1;YWHAZ;YWHAB
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.6280216405493741,1.404643743087819,0.10873440285204991,0.5598068440545924,1.0,6/16,11.66%,BMPR2;DDAH1;PRCP;NPPA;KLK1;GSK3A
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.3949063176162872,1.4041355795951835,0.0010626992561105207,0.5598430704789435,1.0,87/509,12.33%,FLT1;IGF1R;TFRC;KITLG;TEK;HIP1;MFHAS1;JCAD;PDGFB;KDR;INSR;BCL2L1;DAB2IP;ENG;TGFB2;RAPGEF2;TNFRSF19;PDGFD;APP;CAV1;TBX1;TIRAP;FLT4;PLEKHG5;TRIM25;BCAR3;TNFSF10;TRIM14;PTPRJ;PTK2;NOD1;CD40;NOD2;PELI1;PRKD1;PRKD2;ATP2C1;VWF;LYN;TGM2;IKBKB;GRB2;CD19;FGF16;RAMP3;HSP90AB1;GAB1;CCR7;CD4;WDR59;TLR3;ACTN4;FYN;ZCCHC3;ADRA2B;LGALS9;RET;BST2;TLR7;BIRC3;TGFB1;TGFA;IQGAP1;CAV2;MALT1;MAP3K3;NDFIP2;SCHIP1;UBE2V1;OASL;SHARPIN;AGER;CASP8;BRD4;LRP2;LAMTOR5;FERMT2;S100A8;RAC1;TNFSF11;HRAS;PRKCB;GPR89A;C1QTNF4;PIK3CB;RPTOR;GDF15
prerank,regulation of metal ion transport (GO:0010959),-0.558474152034345,-1.4039757214417783,0.10538116591928251,0.5080857698974228,1.0,7/16,7.38%,ANK2;SLC30A10;STIM1;IL16;CACNA2D1;DLG1;BCL2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.6077490758685347,1.4037211826937537,0.10260869565217391,0.5595969492223946,1.0,6/19,12.23%,TEK;KDR;PTPRJ;FERMT2;RAC1;MAP4K4
prerank,acylglycerol catabolic process (GO:0046464),0.5546872547725923,1.4033388122414985,0.09369676320272573,0.5592749274043838,1.0,4/30,10.76%,ABHD2;LIPE;FABP5;LIPC
prerank,cell-cell junction assembly (GO:0007043),0.4898473278832845,1.4031778295423638,0.07234042553191489,0.5582641195159962,1.0,17/63,7.09%,TJP1;CLDN5;GJD3;GJC1;CDH2;RAMP2;ACTB;CDH20;SMAD7;CTNND1;CTNNB1;CDH8;PIP5K1C;PKN2;DCHS1;CDH19;PKP4
prerank,endoderm formation (GO:0001706),-0.47632179672456343,-1.4020988454911858,0.052884615384615384,0.5117391511010843,1.0,11/35,10.36%,COL8A1;COL12A1;VTN;COL6A1;ITGB5;MMP14;COL11A1;MMP2;ITGA5;LAMB1;ITGAV
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.6805502138250118,1.4018552226863215,0.12407407407407407,0.5609572770083264,1.0,3/11,6.88%,MFSD2A;SCARB1;NR1H2
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5255607325211403,1.4016097402119758,0.07476635514018691,0.560286683432243,1.0,12/42,13.54%,NDNF;PDGFB;FZD4;CORO2B;PTK2;NOTCH1;RSU1;ATXN3;SPOCK1;RAC1;PIK3CB;MINK1
prerank,negative regulation of neuron projection development (GO:0010977),-0.4235600429974952,-1.401541021581071,0.04804804804804805,0.5112174361196203,1.0,13/56,13.57%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;MYLIP;RAB29;ADCY6;PTEN
prerank,negative regulation of chemotaxis (GO:0050922),0.5409880201346198,1.4013103466525596,0.09838709677419355,0.5597588784985651,1.0,8/31,6.97%,SEMA3C;SEMA7A;SEMA6A;SEMA6B;NOTCH1;DUSP3;SEMA4F;SEMA6D
prerank,positive regulation of proteolysis (GO:0045862),-0.43783534262897006,-1.4012090239406605,0.05621301775147929,0.5098231318572458,1.0,21/55,20.69%,CCBE1;CYFIP2;ASPH;OGT;ADAM9;RCN3;APOE;SNX9;PERP;BTRC;TBC1D10A;NKD2;CTSH;FBXW11;ATP5IF1;SNX33;NRDC;PACSIN3;CLN6;ADRA2A;ADAM8
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5435924484097844,1.400065873386255,0.07580645161290323,0.5622493975367967,1.0,9/38,10.45%,BCL2L1;NOS3;FAS;TNFSF10;ARHGEF2;SP100;RFFL;FAIM;CASP8
prerank,xenobiotic transport (GO:0042908),0.627670330889341,1.3999002056249985,0.10810810810810811,0.5612767360409313,1.0,2/17,0.38%,SLC7A5;ABCG2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.5491941536066567,-1.3997520978292408,0.0761904761904762,0.5119082307173689,1.0,7/21,8.16%,SULF1;EXT1;SULF2;HS2ST1;HS3ST3B1;HS6ST1;HS6ST2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.548943811845732,1.3989146380693036,0.07512520868113523,0.562926949059063,1.0,5/30,8.09%,FLT1;KDR;FLT4;PLD4;TGFB1
prerank,positive regulation of T cell migration (GO:2000406),0.6034089405116911,1.3983297770970011,0.1009009009009009,0.5632292672943814,1.0,4/20,9.89%,CXCL12;APP;ADAM10;ADAM17
prerank,membrane repolarization (GO:0086009),-0.5649396746088908,-1.3973189851174883,0.09153318077803203,0.5170883812893169,1.0,4/15,7.08%,ATP1A2;KCNJ2;ATP1B3;ATP1B2
prerank,neuron migration (GO:0001764),0.5116437475385586,1.396904311269998,0.07836990595611286,0.5663760612531888,1.0,15/48,11.43%,NDNF;RAPGEF2;ADGRL3;SH3RF1;NAV1;MEF2C;FGF13;GPM6A;SPOCK1;DNER;DISC1;DDIT4;DCX;CEP85L;RAC1
prerank,spliceosomal complex assembly (GO:0000245),-0.43724509016356883,-1.396745330059727,0.05232558139534884,0.5164150810088923,1.0,9/46,12.48%,CELF2;SRSF5;LUC7L3;DDX1;SRSF6;GCFC2;RBM5;LUC7L2;PRPF19
prerank,negative regulation of binding (GO:0051100),0.46635984393232327,1.3962414226028714,0.0502092050209205,0.566995253338723,1.0,12/81,8.04%,LEF1;PDGFB;CAV1;NFKBIA;CTNNBIP1;NES;SP100;ZFPM1;ACTB;RALB;JUN;PIN1
prerank,cell junction organization (GO:0034330),0.47752279303207057,1.3955821105040929,0.05627705627705628,0.5676808066020747,1.0,17/71,10.91%,OCLN;TJP1;APBB2;LIMS2;TGFB2;APP;TJP2;AGRN;PPFIBP1;ACTB;MARVELD2;PIN1;TGFB1;OPHN1;ACTG1;ELFN1;FERMT2
prerank,membrane lipid metabolic process (GO:0006643),0.5833169036194318,1.3953864131778866,0.11054421768707483,0.5668107216349618,1.0,9/22,13.84%,ST3GAL6;B4GALT4;MGST2;ACER1;GAL3ST1;CERKL;ST6GALNAC4;CERK;SPTLC1
prerank,positive regulation of chromatin organization (GO:1905269),0.6568522723464089,1.3950775213432163,0.14154411764705882,0.5663182127541181,1.0,6/12,21.77%,TAL1;TERF2;ACD;TERF1;SIN3A;DAXX
prerank,sodium ion transport (GO:0006814),-0.3981856582919093,-1.3950051661971543,0.035842293906810034,0.5195239855459434,1.0,17/85,7.24%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;PKD2;ATP1B3;SLC5A5;SLC6A1;SLC5A6;SLC9B2;SLC8A1
prerank,cellular response to interleukin-15 (GO:0071350),0.638282976600587,1.394717643161629,0.12093862815884476,0.5644875299262908,1.0,4/13,5.26%,PLCB1;JAK3;GRB2;CD4
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.638282976600587,1.394717643161629,0.12093862815884476,0.5644875299262908,1.0,4/13,5.26%,PLCB1;JAK3;GRB2;CD4
prerank,positive regulation of blood coagulation (GO:0030194),-0.5578912871714405,-1.3943422201697613,0.10444444444444445,0.519143417319191,1.0,6/17,12.29%,ST3GAL4;THBS1;F3;ANO6;THBD;DMTN
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6120984451646764,1.394340890550444,0.11805555555555555,0.5642534235519165,1.0,3/16,5.99%,BCL2L1;CXCL12;SNAI2
prerank,regulation of isotype switching (GO:0045191),0.6481797300167625,1.3942945655023924,0.10782608695652174,0.5629263850998429,1.0,2/14,6.58%,TFRC;SHLD1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.524080445847972,1.3937535757650672,0.06875,0.5633155201842777,1.0,11/39,13.02%,MYO1D;MYO1E;FNBP1L;MYO6;ACTN4;KIF1A;MYO1F;BICDL1;SYT4;F8A1;RAB1A
prerank,activation of phospholipase C activity (GO:0007202),-0.48312315250333443,-1.393499124811377,0.07329842931937172,0.5194633402475871,1.0,4/29,2.82%,ARHGAP6;LPAR1;EGFR;EDNRA
prerank,positive regulation of cell differentiation (GO:0045597),0.4107211979885078,1.3926017928048628,0.02155688622754491,0.5655071589188937,1.0,30/237,5.03%,LEF1;SLC6A6;PRKCH;KITLG;PLCB1;KDR;CD34;BMPR2;TGFB2;RAPGEF2;ZHX3;FES;PPARD;IL6R;CTNNBIP1;ARHGEF2;RGCC;MEF2C;RPS6KA1;ACVRL1;TIAM1;CDH2;PRKD1;MMD;ZBTB16;CTNNB1;NOCT;CREB1;WWTR1;HSP90AB1
prerank,protein autophosphorylation (GO:0046777),0.4300487855310042,1.3922482056582688,0.024203821656050957,0.5651865071956211,1.0,25/157,10.12%,FLT1;IGF1R;TEK;KDR;INSR;FES;FLT4;PTK2;PRKD1;STK10;PRKD2;LYN;PIKFYVE;CAMKK2;EPHA4;MAPK3;AATK;EPHB4;HCK;MARK3;PAK1;MAP3K3;EIF2AK4;STK33;PTK6
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.507009857131253,1.3922449605250373,0.07026143790849673,0.5637298409399624,1.0,8/46,7.63%,TEK;PARVB;SRGAP2;LAMA5;NTNG2;PXN;PARVG;EFNA1
prerank,positive regulation of secretion (GO:0051047),0.6661757032097939,1.391637927119514,0.132486388384755,0.564256053354396,1.0,4/11,17.41%,ABCB11;ACSL3;NPR1;TRH
prerank,BMP signaling pathway (GO:0030509),-0.42555061178265335,-1.391162099053488,0.04985337243401759,0.5241267558990135,1.0,14/62,6.76%,BMP6;TGFBR3;BMPR1A;SMAD3;BMP5;BMP7;BMP4;DDX5;SMAD6;RGMA;RGMB;RUNX2;TMEM100;SMAD9
prerank,endocardial cushion development (GO:0003197),0.5909499713750456,1.3909047492984414,0.1206896551724138,0.5652104945570482,1.0,7/21,4.36%,ENG;BMPR2;TGFB2;NOS3;ACVRL1;NOTCH1;FOXF1
prerank,defense response to bacterium (GO:0042742),0.45515987649878653,1.3906058169161228,0.06275579809004093,0.5647048623761174,1.0,20/105,13.76%,PGLYRP1;STAB1;TIRAP;IL6R;NOD1;DEFA6;NOD2;GBP7;GBP4;NOS2;TLR3;IRGM;PPP1R11;ADAM17;S100A8;SYK;LPO;SLPI;RAB1A;HMGB2
prerank,triglyceride biosynthetic process (GO:0019432),-0.540855233634632,-1.3902412915087172,0.10904872389791183,0.5246076043105788,1.0,6/18,15.28%,AGMO;MOGAT3;GK;LPGAT1;GPAT3;PNPLA3
prerank,protein modification process (GO:0036211),0.4689884921383604,1.3896707450747101,0.05857142857142857,0.5663816113171689,1.0,23/76,19.23%,ST8SIA4;ST3GAL6;ST3GAL1;STK38;YES1;LCMT1;PLAT;FBXL2;CHRM3;DUSP12;UBA3;MANBA;FBXW2;MAN2B1;UBE2D3;LOXL2;MMP15;MCRS1;SEPHS1;FBXO2;ERO1A;CPE;USP25
prerank,protein O-linked glycosylation (GO:0006493),0.4614303147755588,1.389503858604127,0.05080213903743316,0.5655174901396618,1.0,11/96,4.42%,TMTC2;EOGT;ST8SIA6;ST3GAL1;GALNT18;B4GALT5;ST6GALNAC2;MUC3B;MUC3A;B3GNT2;OGA
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.481539294668797,1.3894143769034537,0.06179775280898876,0.5643596825908589,1.0,17/73,10.41%,TFRC;SH2D3C;APP;CAV1;BCAR3;PRKD1;PRKD2;RAPGEF3;FNIP2;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;CNOT9;AKAP9;PDCD10
prerank,wound healing (GO:0042060),-0.4094868609763409,-1.389409857557477,0.0436046511627907,0.5248520564047576,1.0,13/62,6.35%,IGF1;COL3A1;PDGFRA;SMAD3;TPM1;FGF1;DCBLD2;MYOF;TGFBR1;AHNAK2;FGF2;ANXA6;FZD7
prerank,positive regulation of MAP kinase activity (GO:0043406),0.48118031783031545,1.3891880263813698,0.06743185078909612,0.5636383360712085,1.0,9/66,3.20%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TPD52L1;TNFRSF11A;CD40;NOD2
prerank,cellular response to fluid shear stress (GO:0071498),0.6527414032837131,1.3888191581897809,0.13194444444444445,0.563296455140017,1.0,4/12,6.45%,MTSS1;MEF2C;KLF2;KLF4
prerank,positive regulation of endothelial cell migration (GO:0010595),0.4610595854309216,1.3888166304038905,0.04335260115606936,0.5618903232579485,1.0,15/84,5.30%,TEK;ETS1;PDGFB;KDR;BMPR2;NOS3;FLT4;SCARB1;CD40;PRKD1;PRKD2;TMSB4X;PLCG1;GATA2;RHOB
prerank,regulation of kinase activity (GO:0043549),0.461336481648354,1.3877105912506063,0.05196629213483146,0.5638820998673266,1.0,15/89,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;FLT4;NLRC5;MERTK;CD4;CAMKK2;EPHA4;MRE11;RET;EPHB4
prerank,regulation of p38MAPK cascade (GO:1900744),0.5230437121426921,1.3876530183945819,0.09744408945686901,0.5626211050694293,1.0,9/35,13.54%,MFHAS1;DAB2IP;XDH;PHLPP1;LGALS9;AGER;DUSP1;CYLD;MINK1
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.541253486577086,-1.387628680265801,0.08027522935779817,0.5280310184749175,1.0,10/18,22.94%,ASPA;NAALAD2;ASPG;MTHFR;MTHFD1;GOT1;SLC25A12;NIT2;GOT2;NAT8L
prerank,base conversion or substitution editing (GO:0016553),0.661945141667033,1.3875968680156812,0.12897196261682242,0.5613714773434804,1.0,5/11,23.34%,ADAR;ADAD1;NUDT16;METTL3;ADARB2
prerank,positive regulation of interleukin-6 production (GO:0032755),0.4853443902145858,1.3870860826890636,0.06531204644412192,0.5616025286625352,1.0,16/68,12.10%,APP;TIRAP;IL6R;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;AGER;TLR8;SYK;C1QTNF4
prerank,regulation of lymphocyte migration (GO:2000401),0.6712790008292193,1.3867260912162083,0.1357142857142857,0.5612783699994311,1.0,3/10,8.79%,JAM2;STK10;MSN
prerank,renal water homeostasis (GO:0003091),-0.5031689603631724,-1.3866977822905775,0.07611548556430446,0.5286036995993522,1.0,8/23,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;RAB11FIP2;ADCY7;PRKACA;ADCY6
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6280184596170882,1.3857189793568332,0.11170212765957446,0.5630309033962019,1.0,4/14,10.06%,RAPGEF2;PKIG;PRKAR2B;PRKAR2A
prerank,positive regulation of histone deacetylation (GO:0031065),0.6327687217497111,1.385633830182602,0.12571428571428572,0.5619329692586594,1.0,3/12,3.43%,APLNR;PRKD1;PRKD2
prerank,T cell homeostasis (GO:0043029),0.6811695459526194,1.3855479683198282,0.13446969696969696,0.5608354574151702,1.0,4/10,14.70%,FAS;JAK3;FOXP3;NCKAP1L
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5763048729574385,1.3844609481207542,0.12048192771084337,0.5627506870775024,1.0,10/24,14.18%,DAB2IP;EPN2;TMEM204;MMRN2;PRKD2;HHEX;PRKCB;HIF1A;HGS;PDCD6
prerank,regulation of cardiac muscle cell action potential (GO:0098901),-0.4916539976040549,-1.3844056571626724,0.08801955990220049,0.5332878697468246,1.0,6/25,5.68%,CACNA1C;ANK2;CXADR;CAMK2D;DLG1;TBX18
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5655512623174821,1.384232640813864,0.10508474576271186,0.5620943623446273,1.0,7/25,11.08%,SPTBN1;PRKD2;PDE4D;CD4;PDE4B;MALT1;PNP
prerank,hepaticobiliary system development (GO:0061008),-0.5357304363370152,-1.3835835741810751,0.10141509433962265,0.5333216734911038,1.0,5/20,8.05%,TGFBR3;WNT4;COBL;PKD2;MET
prerank,regulation of histone methylation (GO:0031060),-0.582845188175655,-1.3834541353855572,0.13507625272331156,0.5314450579020481,1.0,10/13,33.37%,CTR9;MTHFR;NNMT;PAF1;NSD1;AASS;TET1;TTLL12;PIH1D1;JARID2
prerank,regulation of cellular component organization (GO:0051128),0.4300935853962828,1.3832751383085962,0.028460543337645538,0.5637589017004296,1.0,21/135,9.03%,TFRC;HIP1;TJP1;DAB2IP;LTBP4;RAPGEF2;NET1;HIP1R;RAPGEF1;SOCS2;PAK5;WFDC1;FAM107A;RASGRP2;INSM1;EGLN2;RAP1B;MARK4;IRGM;OPHN1;SPOCK1
prerank,organophosphate ester transport (GO:0015748),0.568792961271734,1.3829398515329747,0.11438474870017332,0.563331053831334,1.0,6/24,6.01%,PLTP;SCARB1;PITPNC1;PRELID2;PITPNA;ABCA3
prerank,positive regulation of kinase activity (GO:0033674),0.4444773196678321,1.382713354744168,0.046008119079837616,0.5626287296243353,1.0,17/107,6.79%,FLT1;IGF1R;TEK;KDR;INSR;TIE1;RAPGEF2;FLT4;PTK2;MMD;MERTK;CCR7;CD4;EPHA4;MRE11;RET;EPHB4
prerank,regulation of protein dephosphorylation (GO:0035304),0.5285372621005731,1.3824745620105616,0.07868852459016394,0.5619815525215731,1.0,11/37,13.64%,MFHAS1;PPP1R16B;CALM1;PPIA;PPP1R2;PPP2R5A;PIN1;TGFB1;NSMF;CDH5;PPP1R8
prerank,regulation of inflammatory response (GO:0050727),0.41833874991364844,1.3823700356151298,0.033210332103321034,0.5608976551452148,1.0,35/190,13.79%,TEK;ETS1;SEMA7A;MFHAS1;PDE2A;APP;IL1R1;PPARD;NFKBIA;CD200;BCL6B;NOD2;TMSB4X;HYAL2;MGST2;XIAP;TLR3;KLF4;HCK;TLR7;BIRC3;NLRP6;CD200R1;LPCAT3;SHARPIN;BRD4;CCL1;S100A8;USP18;IL15;DDT;PPARG;CYLD;CDH5;TNFAIP3
prerank,negative regulation of complement activation (GO:0045916),-0.6423588042575937,-1.3822205492913697,0.1059322033898305,0.5330113724538752,1.0,2/10,1.85%,SERPING1;CD55
prerank,regulation of interleukin-12 production (GO:0032655),0.5063366362480849,1.3821705443127053,0.09188361408882083,0.5601621997485193,1.0,11/47,11.86%,PLCB1;TIRAP;JAK3;CD40;CCR7;TLR3;LGALS9;IRF5;AGER;TLR8;SYK
prerank,melanocyte differentiation (GO:0030318),-0.6081089015125395,-1.3820664673374672,0.12601626016260162,0.5312146213796143,1.0,5/11,11.17%,LRMDA;ENPP1;KIT;MITF;SLC24A5
prerank,positive regulation of signaling receptor activity (GO:2000273),0.5374016602162656,1.3819701590867932,0.0921875,0.5594645336877615,1.0,11/36,19.12%,SHANK3;ADRA2B;FBXW7;BUD31;TGFA;GREM1;ADAM17;HIF1A;EDN1;CCR2;NRP1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.5845185584735684,-1.3818978384703526,0.1282051282051282,0.5272529742860976,1.0,5/12,12.29%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.5845185584735684,-1.3818978384703526,0.1282051282051282,0.5272529742860976,1.0,5/12,12.29%,FBLN1;EFNA5;KANK1;ITGB1BP1;DMTN
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.5761456606917605,1.381038860940404,0.10314685314685315,0.561190278632206,1.0,5/25,9.05%,SLC7A5;B2M;NOD2;CD160;MALT1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.5418454520288014,-1.3808676796354271,0.1111111111111111,0.5282298069683931,1.0,4/16,11.52%,AUTS2;BCOR;CTR9;KDM1A
prerank,cellular response to ketone (GO:1901655),-0.46015547409867125,-1.3801708722672463,0.09762532981530343,0.5280910037382623,1.0,7/35,8.86%,ROCK2;ADCY5;ADCY1;ADCY2;AR;SPP1;PTGFR
prerank,positive regulation of protein import (GO:1904591),-0.4784819750888598,-1.3799226617837168,0.08333333333333333,0.5265359943738812,1.0,9/30,14.12%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;BAG3;PIK3R1
prerank,endoderm development (GO:0007492),0.6364656660712741,1.3793228849396062,0.14128440366972478,0.5650712868631795,1.0,4/13,16.13%,SOX17;SOX7;DUSP1;LHX1
prerank,positive regulation of potassium ion transport (GO:0043268),-0.4585073435560306,-1.379202544550652,0.06,0.5264826570447985,1.0,7/38,6.15%,ANK2;ACTN2;FHL1;KCNMB2;KCNJ2;DLG1;FLNA
prerank,somite development (GO:0061053),-0.6107863357058554,-1.3790029390111194,0.10256410256410256,0.5248742295436757,1.0,4/11,8.73%,MEOX2;SMO;LOXL3;MTHFD1
prerank,C4-dicarboxylate transport (GO:0015740),0.6189506931907063,1.378239098044283,0.15283018867924528,0.5670545138459681,1.0,2/14,5.02%,SLC1A1;SLC1A2
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.5300125839019177,1.3780291674077703,0.10747663551401869,0.5663058602662759,1.0,7/33,8.09%,ETS1;PDGFB;TGFB2;GATA2;KLF4;JUN;TGFB1
prerank,positive regulation of cellular process (GO:0048522),0.38480077692711157,1.3769491739904836,0.0031914893617021275,0.5684385647795657,1.0,90/565,12.69%,LEF1;FLT1;IGF1R;SLC6A6;KITLG;ETS1;MFSD2A;FRMD5;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;TGFB2;CXCL12;ACER2;PDGFD;CAV1;FASN;TBX1;IL6R;FLT4;CNOT6L;TBX3;TNFRSF11A;STX3;ADGRG1;GNAI2;PTPRJ;PTK2;RPS6KA1;TIAM1;PARD3;NOTCH1;PRKD2;MERTK;LYN;TGM2;GATA2;OSMR;FGF16;RAMP3;WWTR1;HSP90AB1;SLC25A5;TAL1;CCR7;EPHA4;ACTN4;SLC25A33;ADAM10;ACACB;HCK;INSM1;TGFB1;TGFA;CXCR2;CST7;ABCA7;PTN;P2RX7;LRP5;COPS9;GREM1;PAK1;PGF;LIFR;ADAM17;PTK6;AXIN2;CDCA7L;PDCD10;CNTF;CDC6;S100A8;PPP3CA;RAC1;HRAS;BRAT1;CNOT6;RNF187;RPTOR;TGFBR2;RPS9;ZFP36L1;SOX11;IL15;DERL2
prerank,positive regulation of phosphorylation (GO:0042327),0.41068643130344545,1.3767703878969435,0.02303030303030303,0.5676877703347164,1.0,47/240,10.36%,FLT1;IGF1R;TFRC;TEK;ITGA6;LIMCH1;PECAM1;KDR;INSR;TIE1;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MERTK;LYN;FGF16;CD4;CAMKK2;EPHA4;MRE11;LIMK2;PPIA;MAPK3;ENTPD5;RET;EPHB4;RALB;EFNA1;PIN1;TGFB1;IRGM;P2RX7;PAK1;PGF;PFKFB3;CCND3;ADAM17;AXIN2;AGER
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5163364158334873,1.3761127272900417,0.08482142857142858,0.5684050640615504,1.0,15/49,14.07%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;NOS2;HYAL2;TLR3;LGALS9;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,positive regulation of protein modification process (GO:0031401),0.414423694218347,1.3759337810777021,0.03117206982543641,0.5676483108755652,1.0,40/203,10.36%,TFRC;TEK;LIMCH1;PECAM1;KDR;PPP1R16B;INSR;ENG;APP;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;RAPGEF3;LYN;CALM1;FGF16;CD4;CAMKK2;LIMK2;PPIA;MAPK3;PPP2R5A;RALB;EFNA1;PIN1;TGFB1;IRGM;ASPSCR1;PAK1;PGF;CCND3;ADAM17;AXIN2;AGER
prerank,positive regulation of developmental process (GO:0051094),0.4217823436509869,1.3755907075963456,0.026785714285714284,0.5673570671164924,1.0,25/164,9.33%,SLC6A6;TFRC;PLCB1;SHANK3;PDGFB;KDR;INSR;DAB2IP;BMPR2;B4GALT5;LRP8;FZD4;RPS6KA1;RAPGEF3;VIL1;ZBTB16;RREB1;HSP90AB1;SHLD1;INSM1;PTN;ARHGEF7;ENPP2;NRXN1;RBM19
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3947574288620826,1.3752476877368942,0.017937219730941704,0.5670552582384555,1.0,65/348,10.41%,TFRC;TEK;LIMCH1;PECAM1;PDGFB;SH2D3C;KDR;INSR;ENG;BMPR2;TGFB2;RAPGEF2;PDGFD;APP;CAV1;FAS;TBX1;PDE8A;IL6R;FLT4;BCAR3;LRP8;PLAUR;PTPRJ;ARHGEF2;PTK2;NIBAN1;CD40;PIK3R3;ACVRL1;APLNR;PRKD1;PRKD2;MMD;RAPGEF3;LYN;FNIP2;CALM1;FGF16;RAMP3;HSP90AB1;CCR7;CD4;CAMKK2;MRE11;LIMK2;PPIA;MAPK3;RPS6KA5;RALB;EFNA1;PIN1;TGFB1;IRGM;IQGAP1;ENPP2;PAK1;PGF;CCND3;ADAM17;CNOT9;AKAP9;AXIN2;AGER;PDCD10
prerank,negative regulation of cytokine production (GO:0001818),0.42627958151293455,1.3747765576797764,0.028314028314028315,0.5671860412753993,1.0,35/163,12.03%,LEF1;CD34;CD200;TRIM25;RGCC;SRGN;JAK3;ZFPM1;IFIH1;SIGIRR;HDAC9;HDAC7;NLRC5;RNF125;TMSB4X;SARS1;HOMER2;TNFRSF21;CCR7;RPS6KA5;ATP2B1;LGALS9;KLF4;N4BP1;PIN1;CD200R1;FOXP3;PPP1R11;TRIB2;AGER;ABCD1;TLR8;RAC1;VSIR;CEACAM1
prerank,neuron projection organization (GO:0106027),0.6224903803610662,1.37370118148689,0.1308411214953271,0.5692055848977527,1.0,4/15,10.97%,INSR;APP;ATP1A3;ABCD1
prerank,amino sugar biosynthetic process (GO:0046349),-0.5841243542867223,-1.373231991424848,0.1301518438177874,0.5403113975036421,1.0,8/12,28.37%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.5880375640846481,1.3726770349141273,0.12637362637362637,0.5709501166195836,1.0,7/18,10.26%,JCAD;KDR;HDAC9;HDAC7;GATA2;MAP3K3;PIK3C2A
prerank,iron ion homeostasis (GO:0055072),0.4752570782625833,1.372665848693594,0.07555555555555556,0.5696634303467234,1.0,4/58,2.47%,TFRC;SLC40A1;ABCG2;B2M
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4434618063730345,1.3722046563113366,0.0546448087431694,0.5697444351624366,1.0,23/101,12.53%,FLT1;PIK3R6;PDGFB;DAB2IP;RAPGEF2;PDGFD;CCNY;TPD52L1;RGCC;CD40;NOD2;CALM1;RALB;TGFB1;IRGM;CCND3;ADAM17;PDCD10;FERMT2;TNFSF11;HRAS;RPTOR;MAPRE3
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4769495904674359,-1.372186891741958,0.0810126582278481,0.5412428328472549,1.0,4/30,6.13%,IGF1;IGFBP2;IL18;IGF2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.33716006160289624,-1.3715645221226396,0.02127659574468085,0.5407342137264077,1.0,62/248,14.39%,RNF220;BICC1;RBMS3;WLS;ZEB2;EGFR;LGR4;GLI3;COL1A1;IGFBP2;PTK7;DKK3;FGFR2;GPC3;IGFBP6;LRRK1;KANK1;INVS;AMFR;LYPD6;DAB2;IGFBP4;TBL1XR1;DAAM2;PLEKHA4;SFRP4;FZD7;DACT1;GLI1;CTNND2;PFDN5;TNKS2;TMEM64;CHD8;PRKN;TLE3;APOE;PSME4;UBR5;SMURF2;MLLT3;AXIN1;CUL3;CDK14;STK11;PPM1B;FUZ;BTRC;TRPM4;PSME3;LRRK2;CAPRIN2;PSEN1;BMP2;SCEL;EMD;NKD2;DVL2;WNK1;DDX3X;LMBR1L;WNT11
prerank,cell-matrix adhesion (GO:0007160),-0.38131022202219234,-1.3714058808150904,0.03460207612456748,0.5389864115161483,1.0,21/95,7.16%,ITGBL1;COL3A1;ADAMTS12;VTN;ACTN2;ITGB5;ITGB8;PKD1;ITGA10;COL13A1;FBLN5;DDR1;VCL;ECM2;CD63;ADAM9;NID2;ITGA11;THBS3;EMILIN1;MSLN
prerank,carnitine shuttle (GO:0006853),-0.5982504645862592,-1.3705408057950124,0.14157303370786517,0.5393403822599521,1.0,2/11,1.34%,PRKAG2;PRKAA2
prerank,calcium-mediated signaling (GO:0019722),-0.37308095570731864,-1.3703456917757457,0.026217228464419477,0.5377111169468269,1.0,23/93,12.29%,CACNA1C;ANK2;EGFR;PLCE1;MCU;NUDT4;CCR9;ADGRL1;DMPK;P2RX4;SLC8A1;AGTR1;PTGFR;PDPK1;PRKACA;SLC9A1;TRPM4;STIMATE;LRRK2;PPP3CB;SPHK1;RCAN3;DMTN
prerank,epithelial tube morphogenesis (GO:0060562),0.5326825129208368,1.3690801701578852,0.09983361064891846,0.5781692842190965,1.0,12/32,9.22%,PODXL;RASIP1;SOX17;MTSS1;MEF2C;ACVRL1;PRKD2;CTNNB1;RHOB;COL4A1;CCM2;PAK1
prerank,development of primary male sexual characteristics (GO:0046546),0.5211525506407012,1.3690364511097532,0.10876623376623376,0.5769617172411659,1.0,7/34,10.83%,KITLG;TGFB2;LHFPL2;BIK;COL9A3;NCOA4;LRP2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.6047614168286329,1.3689202520418455,0.13752122241086587,0.5760292506961278,1.0,4/15,6.75%,IGF1R;KDR;MAPK3;AATK
prerank,cyclooxygenase pathway (GO:0019371),-0.627754998649497,-1.3687021824075112,0.12527964205816555,0.5402996351615652,1.0,4/10,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,regulation of interleukin-6 production (GO:0032675),0.45083489626195483,1.3686857674029143,0.05142083897158322,0.5754939006049181,1.0,24/96,15.03%,APP;TIRAP;IL6R;CD200;AFAP1L2;ARHGEF2;NOD2;IFIH1;NOS2;POU2AF1;HYAL2;TLR3;LGALS9;TLR7;CD200R1;AGER;TLR8;SYK;C1QTNF4;TNFAIP3;FOXJ1;BCL10;NCKAP1L;INAVA
prerank,regulation of protein kinase B signaling (GO:0051896),0.4111780867175748,1.3686072571430732,0.01893939393939394,0.5743964886680258,1.0,23/193,6.46%,IGF1R;KITLG;TEK;HIP1;MFHAS1;PDGFB;INSR;ENG;XDH;PHLPP1;PTPRJ;PTK2;GRB2;CD19;FGF16;RAMP3;HSP90AB1;HYAL2;GAB1;CCR7;FYN;PLEKHA1;RET
prerank,heart development (GO:0007507),-0.3533962397948929,-1.368462997498247,0.02304147465437788,0.5387736765834115,1.0,38/150,8.99%,CACNA1C;COL3A1;TGFBR3;FBN1;NTRK3;PLCE1;GLI2;CXADR;BMP5;SGCD;MICAL2;BMP7;ADAP2;GPC3;BMP4;ZFPM2;OSR1;PCSK5;PKD1;PDLIM7;RBP4;SH3PXD2B;SALL1;FOXC2;FOXC1;BCOR;TGFBR1;PKD2;SCUBE1;NDUFV2;PDLIM2;AKAP13;PDLIM4;FOXL1;KDM6B;POU6F1;MTHFD1;IFT122
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.524226236225283,-1.3671827067111513,0.11739130434782609,0.5406616649929139,1.0,6/19,17.85%,IRS1;PRKCD;PPARA;IRS2;TWIST1;ANGPTL3
prerank,cellular defense response (GO:0006968),-0.4384000222034736,-1.3666984837950389,0.08284023668639054,0.5399438538237447,1.0,7/40,11.13%,DCDC2;LBP;CCR9;LSP1;ADORA2A;ZNF148;PTK2B
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5752970371468928,-1.366382986472548,0.12814645308924486,0.5387938717151913,1.0,2/12,0.75%,NOTCH2;DOCK11
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),-0.4832935980300831,-1.3662319183908518,0.07474226804123711,0.537120335983064,1.0,12/27,19.83%,ANK2;DMD;CAMK2D;CACNB4;PRKACA;CACNB2;JPH1;CACNB1;AHNAK;JPH2;ADRA2A;CACNB3
prerank,regulation of ossification (GO:0030278),0.5188736388033967,1.3654584479011975,0.0963302752293578,0.5830512792005892,1.0,8/36,4.55%,SGMS2;BMPR2;TGFB2;S1PR1;MEF2C;NOTCH1;ZBTB16;NOTUM
prerank,carbohydrate transport (GO:0008643),0.6780611218519841,1.3653109200611937,0.13688212927756654,0.5821691300280815,1.0,2/11,4.59%,AQP11;AQP7
prerank,heterochromatin organization (GO:0070828),0.6123830170518435,1.3651962827744315,0.1336996336996337,0.5811635969214721,1.0,1/14,0.11%,MECOM
prerank,dephosphorylation (GO:0016311),0.4171533385526175,1.36494688220065,0.03841229193341869,0.5806295702617831,1.0,15/147,4.61%,PTPRG;PTPRM;PTPRB;SGPP2;CTTNBP2NL;PTPRJ;DUSP23;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PLPP6;PPP3CC;PPP4R1
prerank,positive regulation of epithelial cell migration (GO:0010634),0.44824796774142717,1.3642861410917484,0.0787292817679558,0.5812579925952159,1.0,27/92,14.37%,TEK;ETS1;KDR;BMPR2;TGFB2;DOCK1;FLT4;SCARB1;PRKD1;PRKD2;VIL1;PLCG1;RREB1;RHOB;MAPRE2;INSL3;RAB11A;IQSEC1;ENPP2;RAC1;HIF1A;PIK3CB;MAP4K4;RIN2;SOX9;PDCD6;NRP2
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.5032255726662705,-1.364076582429336,0.08056872037914692,0.5417185235700281,1.0,7/22,15.64%,AEBP1;MAP1S;AKAP13;APOE;EFEMP2;ABL1;MAP2
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4621374792878556,1.3638595838394885,0.07507507507507508,0.5812623009867277,1.0,11/70,8.64%,TEK;PARVB;SRGAP2;MEF2C;LAMA5;NTNG2;PXN;PARVG;ACTN1;EFNA1;OPHN1
prerank,muscle organ development (GO:0007517),-0.40804896735591295,-1.3634776304284462,0.06451612903225806,0.5413983915480352,1.0,16/54,9.60%,LAMA2;IGF1;LARGE1;SGCD;COL6A3;FHL1;DMD;SPEG;ITGA11;MKX;MRAS;CHD2;VAMP5;POU6F1;SOX6;EVC
prerank,lipid oxidation (GO:0034440),0.6424629681810354,1.3633094610929164,0.15045871559633028,0.5817463986705236,1.0,3/12,11.57%,ADIPOR2;ACOX1;ADIPOR1
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.4023538304668036,-1.3624347338000715,0.06,0.5424043581358646,1.0,21/65,14.36%,FBN1;LDLRAD4;LTBP1;SMAD3;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;SMURF2;PDPK1;SPRED1;FBN2;VASN;SKI;HTRA4;SLC2A10
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.631902037959184,1.3624107038272177,0.1282952548330404,0.5833186038889704,1.0,6/14,19.50%,DAB2IP;FICD;DNAJB9;COPS5;BFAR;BAK1
prerank,positive regulation of cholesterol transport (GO:0032376),0.5537023081853223,1.361962267309823,0.11414790996784566,0.5834165025874302,1.0,7/27,10.01%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;LPCAT3
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.547480664513766,1.3611962179454422,0.12935323383084577,0.5844739347335001,1.0,6/26,6.96%,NOS3;ACER2;GCH1;NOS2;ACER1;SPTLC2
prerank,cellular iron ion homeostasis (GO:0006879),0.4782714002484856,1.3603056999774656,0.09692307692307692,0.5859975601182319,1.0,3/55,0.38%,TFRC;SLC40A1;ABCG2
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.5280372970082278,1.3602402399973401,0.1206896551724138,0.584912934151081,1.0,11/35,11.49%,TEK;ESAM;TJP1;FES;F11R;RAPGEF3;BAIAP2;HCK;ARHGDIA;ABI3;HRAS
prerank,nitric oxide metabolic process (GO:0046209),0.624836537173743,1.3598148689291514,0.13533834586466165,0.5849407073613588,1.0,3/14,4.51%,NOS3;GCH1;NOS2
prerank,activation of protein kinase A activity (GO:0034199),-0.5319660653318131,-1.359174939836612,0.10926365795724466,0.5500785039836807,1.0,7/16,12.33%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5629910989546266,1.3590683887404829,0.1296928327645051,0.5860530918609889,1.0,9/23,15.05%,MYO10;CCDC88A;CCDC88B;KIF1A;MAP6D1;TUBB;HOOK1;F8A1;TUBA1A
prerank,sister chromatid segregation (GO:0000819),-0.4663655798666405,-1.3586791184175455,0.10050251256281408,0.5495670482031405,1.0,15/31,27.21%,TOP2B;KLHL22;ZWINT;SMC4;CENPK;TUBG1;LATS1;KIF18A;NUSAP1;TOP2A;KNSTRN;KIFC1;NSL1;SGO1;CDCA8
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4154294441092638,1.3583828394918467,0.05739795918367347,0.5868967060683327,1.0,24/151,8.30%,TEK;SEMA7A;MFHAS1;PDGFB;KDR;RAPGEF2;PDGFD;APP;TIRAP;PDE8A;FLT4;TNFRSF11A;NOD2;NOTCH1;PRKD2;RAMP3;CCR7;CD4;MAPK3;FBXW7;LGALS9;HTR2A;TGFB1;ABCA7
prerank,nitric oxide biosynthetic process (GO:0006809),0.6306459877244688,1.3578165470835748,0.15925925925925927,0.5873383525064358,1.0,3/13,4.51%,NOS3;GCH1;NOS2
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.5043565765810227,1.3577986552376031,0.10584518167456557,0.5861011503238526,1.0,5/42,5.25%,TEK;UTRN;KDR;PTPRJ;CCR7
prerank,regulation of cellular protein metabolic process (GO:0032268),0.4954530803086769,1.3575774791829691,0.09034267912772585,0.5854361086746397,1.0,11/47,13.85%,NANOS3;APP;NFKBIA;WNT7A;KLF4;NR1H2;TGFB1;CYFIP1;EIF4E;PUM3;SSH1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),-0.4672679135143712,-1.3574078028634995,0.07769423558897243,0.5511558789007429,1.0,7/30,4.91%,CACNA1C;ANK2;SNTA1;GJA1;CACNA2D1;KCNJ2;CACNA1G
prerank,positive regulation of cholesterol efflux (GO:0010875),0.577233565912857,1.357237757902456,0.12751677852348994,0.585245571699074,1.0,6/21,8.30%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.6218183949098849,1.356891010716602,0.14031971580817051,0.5850581040925456,1.0,2/15,1.32%,STOX2;TGFB2
prerank,embryonic limb morphogenesis (GO:0030326),-0.4599544442219219,-1.3563087056248138,0.11734693877551021,0.5523081098611891,1.0,7/34,4.36%,CACNA1C;GLI3;AFF3;OSR1;CYP26B1;SALL1;WDPCP
prerank,cell-substrate junction assembly (GO:0007044),0.522339803260362,1.356213916654393,0.09870550161812297,0.5858927805032397,1.0,6/33,10.91%,ITGA6;THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,innate immune response in mucosa (GO:0002227),0.6724868847856197,1.3551547589875965,0.1503623188405797,0.5878871904956594,1.0,2/10,4.51%,DEFA6;NOS2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5931480771929525,1.3549533189869194,0.14235500878734622,0.5872365936298887,1.0,6/17,12.03%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4496662580150111,1.3545512624188976,0.07356948228882834,0.5872895736294523,1.0,21/93,10.41%,TFRC;SH2D3C;APP;CAV1;CNKSR3;BCAR3;PRKD1;PRKD2;RAPGEF3;FNIP2;SMAD7;PDE4D;RAMP3;HSP90AB1;TGFB1;IRGM;PAK1;CNOT9;AKAP9;DDIT4;PDCD10
prerank,regulation of cholesterol efflux (GO:0010874),0.5366094125089733,1.3545054581933451,0.1282051282051282,0.5861490351995006,1.0,8/30,12.84%,PLTP;CAV1;NFKBIA;ABCA3;NR1H2;ABCA7;NAXE;PPARG
prerank,cellular response to alcohol (GO:0097306),-0.43285869080164996,-1.3539524439610626,0.07407407407407407,0.5572605304273078,1.0,19/42,25.64%,ADCY5;ADCY1;SMO;CDH1;ADCY2;ADCY7;GRAMD1B;PTGFR;GRAMD1C;ADCY6;LRP6;SFRP1;GRAMD1A;BRCA1;PTCH1;KLF9;MLC1;SPIDR;AHR
prerank,positive regulation of calcium ion import (GO:0090280),0.6394851582148315,1.3537163422043679,0.15342960288808663,0.5873376188690506,1.0,3/12,4.91%,PDGFB;CXCL12;RAMP3
prerank,import into cell (GO:0098657),0.5078478178736884,1.3531104964701488,0.10492845786963434,0.5880181304044251,1.0,5/41,2.53%,SLC6A6;SLC7A5;SLC7A1;SLC16A2;LRRC8C
prerank,regulation of hydrolase activity (GO:0051336),0.4680195647320545,1.3530959825711226,0.07352941176470588,0.5867935743451492,1.0,17/71,11.16%,CHN2;FGD5;DAB2IP;RASIP1;ARHGAP27;CAV1;PTK2;PLXND1;PRKG1;EPHA4;OCRL;STMN3;CFAP100;ARHGEF5;FGD6;TBC1D10B;PLXNB3
prerank,regulation of intracellular signal transduction (GO:1902531),0.3842856861756993,1.352513412296533,0.01193058568329718,0.5873520555217888,1.0,88/420,13.66%,SGMS1;CHN2;MCF2L;TEK;ARHGAP31;ARHGEF3;ARAP3;SRGAP3;SRGAP2;PPP1R16B;DAB2IP;SRGAP1;PPP1R13B;PDE2A;ARAP2;RASGRF2;NET1;NFKBIA;PLEKHG5;PHLPP1;PTPMT1;ARHGEF2;KALRN;FAM13A;TIAM1;ABR;PRKD2;VWF;STARD13;MOB3B;LYN;TMSB4X;PEX5L;GNA12;XIAP;RHOB;PIP5K1C;PHF20;OCRL;DEPDC7;MRE11;ARHGAP23;PAK5;SOS1;MAPK3;ENTPD5;ARHGAP25;RFFL;ARHGEF12;JMY;PRKAR2B;KAT6A;BIRC3;CRNN;ARHGEF5;PIN1;PIDD1;PREX1;ARHGEF7;OPHN1;ARHGAP4;PAK1;ARHGDIA;DNA2;PRKAR2A;DDIT4;ARHGAP17;AGER;PRKAB1;FBXL2;HSPB1;IER3;RAC1;TNFSF11;PIP4K2A;CEACAM1;MAP4K4;WWC1;TMEM127;HIPK2;CSNK2B;FGD2;CYLD;BRPF1;RPL11;STK3;MINK1;AKAP6
prerank,cell chemotaxis (GO:0060326),0.47096093909865644,1.352406342781271,0.09422492401215805,0.5864418665949288,1.0,7/60,5.25%,LEF1;DOCK4;PDGFB;CXCL12;PLEKHG5;ELMO2;CCR7
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.579700976546331,-1.3518729751458967,0.125,0.5613068036883847,1.0,6/13,15.71%,ERRFI1;CBLB;SNX6;TSG101;ZFYVE28;GPRC5A
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.6116193500944582,-1.3517384569047595,0.13530655391120508,0.5574367544146054,1.0,3/10,5.34%,NUPR1;HDAC4;PPARA
prerank,negative regulation of glycolytic process (GO:0045820),-0.6116193500944582,-1.3517384569047595,0.13530655391120508,0.5574367544146054,1.0,3/10,5.34%,NUPR1;HDAC4;PPARA
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.5873320943529188,1.3515908077264833,0.1349911190053286,0.5876671167179573,1.0,13/18,26.47%,UNC13B;CDH8;GRID2;GRIK5;GRIK2;GRIK1;SLC17A6;UNC13A;GRIA2;GRIK3;GRID1;SLC17A8;NAPB
prerank,visual system development (GO:0150063),-0.44669652128421256,-1.3511387291736074,0.0855614973262032,0.5571801274561393,1.0,8/37,6.51%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.5579873159283376,1.3509684578531782,0.1320754716981132,0.5882570617296987,1.0,7/24,10.06%,PDE2A;RAPGEF2;APLNR;PEX5L;PDE4D;PRKAR2B;PRKAR2A
prerank,anterograde trans-synaptic signaling (GO:0098916),0.39730281275530954,1.350926744456263,0.03841536614645858,0.5871253180341629,1.0,53/224,17.53%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A2;SLC6A5;UNC13B;RPS6KA1;CALM1;PDE7B;SLC1A2;CAMKK2;SYPL1;SLC12A6;PRKACB;ATXN3;HOMER1;CHRNB1;GABRB1;HTR2A;PRKAR2B;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;PRKAR2A;NPY5R;CHRM3;EXOC4;GRIN2B;GABRQ;PCDHB14;CPNE6;GRIK2;CPLX1;SDCBP;MINK1;GRIK1;MYCBPAP;SYNJ2BP;GABRG1;HTR4;GRM7;AMPH;NLGN1;MAPK1;GABRG3;MBP;PMP22;GABRA1;SST
prerank,neutrophil chemotaxis (GO:0030593),0.4756462308523927,1.3507017881985521,0.0889894419306184,0.5866041319734289,1.0,10/53,11.86%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.4645698519981708,1.3506651568421222,0.09090909090909091,0.5854267719183047,1.0,18/66,8.51%,PTPRM;AQP11;DAB2IP;TGFB2;XDH;CAV1;MCC;B2M;RGCC;MTSS1;VASH1;SNAI2;FBXW7;CDKN2B;STAT1;BRCA2;TGFB1;CAV2
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5841315380352023,-1.3499860344516663,0.15732758620689655,0.5586070008176421,1.0,5/11,8.15%,ITGB5;KIT;VCL;PLEKHA7;CCN3
prerank,actin filament depolymerization (GO:0030042),-0.6020864949525595,-1.3494309821434671,0.1337579617834395,0.5582674493019516,1.0,3/11,1.66%,MICAL3;GSN;MICAL2
prerank,regulation of MAP kinase activity (GO:0043405),0.43939422559066466,1.3490299323587012,0.061898211829436035,0.5893057494436374,1.0,14/92,5.07%,FLT1;PIK3R6;PDGFB;DAB2IP;PDGFD;TPD52L1;STK38;PTPRJ;DUSP7;CD40;NOD2;LYN;FGF16;HYAL2
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.5891277524973848,1.3481735707890252,0.1546218487394958,0.5906683746541483,1.0,7/18,13.46%,ELOVL7;ACSL5;ACSL6;ELOVL5;ACSL3;ELOVL6;HACD2
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5792127583227602,-1.3479043300552744,0.1292517006802721,0.5588630314740621,1.0,3/12,10.68%,IGF1;SLC9A1;STIMATE
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5792127583227602,-1.3479043300552744,0.1292517006802721,0.5588630314740621,1.0,3/12,10.68%,IGF1;SLC9A1;STIMATE
prerank,cellular response to interleukin-1 (GO:0071347),0.42108499341099254,1.3477071204766549,0.06684141546526867,0.5909377329505718,1.0,25/143,11.82%,PLCB1;DAB2IP;IL1R1;NFKBIA;NOD1;CD40;NOD2;PELI1;MAP3K8;IKBKB;HYAL2;ST18;MAPK3;RPS6KA5;PSMB3;PSMD11;PSMC6;IRAK2;MAP3K3;PSME2;UBE2V1;TOLLIP;CCL1;PSMD8;HIF1A
prerank,regulation of bone mineralization (GO:0030500),-0.4128971134786385,-1.3472063671342616,0.05901639344262295,0.5589784659248007,1.0,21/55,13.13%,BMP6;BMPR1A;WNT4;BMP7;ENPP1;BMP4;OSR1;ADGRV1;ANO6;BCOR;KL;ECM1;CCN1;SLC8A1;TGFB3;TRPM4;FBN2;PTK2B;PKDCC;BMP2;TWIST1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.6145290923346346,1.3471890596890317,0.14548802946593,0.5912551820165893,1.0,1/15,0.16%,PRKCH
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.600768333674621,1.3471636745957938,0.1518987341772152,0.5900825649357779,1.0,7/14,19.69%,KDR;FLT4;GAB1;PGF;NUS1;NRP1;MYO1C
prerank,negative regulation of cell-matrix adhesion (GO:0001953),-0.4623377967150398,-1.3464304052774445,0.09203980099502487,0.5591543208793193,1.0,13/32,13.57%,PHLDB2;ARHGAP6;APOD;CASK;THBS1;HOXA7;JAG1;MYOC;SEMA3E;ITGB1BP1;DMTN;BCAS3;PTEN
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),0.6274675704939753,1.3461231581764772,0.1618181818181818,0.591922304230022,1.0,2/13,5.93%,ETS1;FUT9
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5805731126014424,1.3456573037276913,0.14136125654450263,0.5922037801608419,1.0,4/18,8.41%,CD34;HDAC7;HOMER2;FOXP3
prerank,cellular response to lipid (GO:0071396),-0.34141759662142834,-1.3454458632276576,0.022099447513812154,0.5600865619193127,1.0,27/191,8.17%,ATP1A2;PID1;EGFR;ROCK2;ADCY5;EPHA3;TFPI;PTK7;AXL;ADCY1;WNT5B;IRS1;LBP;WNT6;ADCY2;WNT9A;ADAM9;RORA;AR;CTR9;SPP1;FZD7;PABPN1;LCOR;SELENOS;ATM;TNIP2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5126262387658654,1.3449628527407784,0.1309148264984227,0.5931335526183293,1.0,15/36,14.21%,PTPRM;DAB2IP;RGCC;MEF2C;SP100;ACVRL1;NOTCH1;VASH1;DLL4;TGFB1;AGTR2;PPARG;CSNK2B;DNAJA4;SYNJ2BP
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5555600255465913,-1.344869237599621,0.11830357142857142,0.5598528012683346,1.0,5/15,5.48%,UST;DSE;DCN;BGN;CSPG4
prerank,cytosolic calcium ion transport (GO:0060401),-0.4700305672024957,-1.3446203294140904,0.11704834605597965,0.5585762664579474,1.0,13/28,20.43%,CACNA1C;MCU;CACNA2D1;SLC35G1;SLC8A1;AFG3L2;JPH1;ATP2A3;ATP2B3;JPH2;ATP2A2;CACNB3;MICU1
prerank,alpha-amino acid catabolic process (GO:1901606),-0.4705597107066415,-1.3431407557843231,0.10230179028132992,0.5611059017418236,1.0,11/29,21.30%,DDO;ACADSB;ALDH4A1;PRODH;THNSL2;KYAT1;SARDH;FAH;KMO;KYNU;GOT2
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.4363637661360378,1.3429816074972447,0.056865464632454926,0.5979672049961173,1.0,39/113,22.16%,TFRC;DAB2IP;RASIP1;UNC13B;TIRAP;GBP5;FNIP2;PIEZO1;TAL1;BIK;GTF2H2;RAP1B;TGFB1;PSMC6;CAPG;MMP1;FERMT2;GTF2H4;SYK;SH3GLB1;TERF1;CDH5;FSCN1;RBX1;MPP7;SUMO1;IL5;SLF1;RPA1;TPPP;SKAP1;BAK1;GTF2H3;DDB1;ERCC4;PSMC3;HRK;RACK1;SNCA
prerank,purine nucleotide catabolic process (GO:0006195),0.6185149387198039,1.342171270624625,0.16724137931034483,0.5992234680676273,1.0,4/13,11.08%,XDH;HINT1;NT5C2;PNP
prerank,negative regulation of lipid catabolic process (GO:0050995),0.6037874875470018,1.3417021921823011,0.13392857142857142,0.5994093469308294,1.0,1/17,0.46%,MFSD2A
prerank,regulation of cytokine production (GO:0001817),0.41827235619302344,1.3407480845860198,0.06476683937823834,0.6009773212494735,1.0,23/126,10.63%,CADM1;AFAP1L2;BCL6B;RGCC;SRGN;IFIH1;HDAC9;LYN;NOS2;MOG;CCR7;PLD4;TRIL;SNAI2;CCDC88B;RPS6KA5;ATP2B1;LGALS9;N4BP1;FOXP3;PPP1R11;CASP8;NLRP4
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.4629831648599547,1.3407002770232186,0.09052333804809053,0.5998670099470164,1.0,15/70,12.48%,BCL2L1;DAB2IP;TGFB2;FAS;IL6R;SORT1;TLR3;CRADD;MCL1;TGFB1;P2RX7;DEDD2;CASP8;GSK3A;TNFSF12
prerank,negative chemotaxis (GO:0050919),0.5167196683847259,1.340697613994494,0.1270096463022508,0.5986292414775267,1.0,7/33,6.97%,SEMA3C;SEMA7A;SEMA6A;NTN1;SEMA6B;SEMA4F;SEMA6D
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.42439415875552583,1.340446726571377,0.06322580645161291,0.5982040132959768,1.0,26/124,12.16%,PTPRM;FRY;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;CCR7;TBC1D24;PLEKHA1;STMN3;RAB11A;STMN4;MARK4;GPM6A;OPHN1;TBC1D23;BICDL1;CYFIP1;AGER;CEP78;RAC1;BTG2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.39330309197619,-1.3402962388360111,0.05389221556886228,0.5678180894399638,1.0,19/63,12.31%,AUTS2;PARVA;GSN;CXADR;PTK7;MCU;SIPA1L1;NRK;KIT;DTNBP1;ANXA1;FLNA;SYDE1;PHACTR1;PDLIM4;EZR;EFS;DMTN;S1PR2
prerank,artery development (GO:0060840),0.5595675163387345,1.3396473572892147,0.12520593080724876,0.5993356986241857,1.0,7/23,4.31%,ENG;BMPR2;PDE2A;TBX1;ACVRL1;APLNR;SMAD7
prerank,hexose transmembrane transport (GO:0008645),0.570254395194969,1.3396311746685572,0.1404399323181049,0.5981462441237804,1.0,2/21,1.88%,SLC2A1;PPARD
prerank,cilium-dependent cell motility (GO:0060285),0.5486778308693872,1.3393281659466092,0.14950166112956811,0.5978431239476296,1.0,6/22,12.40%,EFHC2;DNAH3;DRC1;CFAP54;DNAAF2;DNAH8
prerank,negative regulation of cartilage development (GO:0061037),-0.5659506215452705,-1.3392674156986082,0.145933014354067,0.568734135528505,1.0,4/13,4.34%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,potassium ion homeostasis (GO:0055075),-0.49103987755244627,-1.339229140303774,0.12679425837320574,0.566762421290402,1.0,6/23,7.08%,ATP1A2;SLC12A2;KCNJ2;ATP1B3;SLC12A7;ATP1B2
prerank,adipose tissue development (GO:0060612),0.6483907878230607,1.3384585215509608,0.1539961013645224,0.5992963833103951,1.0,3/11,8.59%,NAMPT;SPTLC2;LRP5
prerank,regulation of cell motility (GO:2000145),0.42805426675226205,1.3365994518710818,0.05698778833107191,0.6037002125265845,1.0,28/121,12.52%,SPOCK2;FRMD5;MACF1;ROBO4;FES;NTN1;SPATA13;PLXND1;AMOT;PRAG1;TMSB4X;FGF16;CCR7;RHOB;PKN1;INPP5F;KIF2A;PKN2;TMSB10;PIN1;TGFB1;ENPP2;ABI3;PLXNB3;RAC1;SLK;CEACAM1;CYRIB
prerank,axon guidance (GO:0007411),0.3960632212154942,1.3365028713685219,0.03308823529411765,0.6027656986667651,1.0,39/201,9.32%,SEMA3C;PTPRM;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;NTN1;SEMA6B;KLF7;PTK2;LAMA5;PLXND1;TMEFF1;NOTCH1;DSCAML1;EVL;PLCG1;GRB2;SEMA4F;GAB1;EPHA4;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;EPHB4;CNTN2;SEMA6D;EFNA1;SPTAN1;SHC3;OPHN1;NRXN1;SEMA4C
prerank,negative regulation of dephosphorylation (GO:0035305),0.5792936598406542,1.3361182716649849,0.1265597147950089,0.6026886404866058,1.0,2/18,0.95%,MFHAS1;PPP1R16B
prerank,positive regulation of defense response (GO:0031349),0.4389541398126759,1.3360181726078642,0.0796221322537112,0.6018052522991006,1.0,15/89,12.73%,ETS1;PDE2A;APP;NFKBIA;MEF2C;GBP5;HYAL2;MGST2;TLR3;TLR7;CCL1;TLR8;S100A8;IL15;DDT
prerank,positive regulation of ossification (GO:0045778),-0.43307562340433625,-1.3355900296421968,0.09577464788732394,0.575952299767405,1.0,15/39,12.42%,BMP6;BMPR1A;WNT4;BMP7;BMP4;OSR1;ADGRV1;ANO6;KL;CCN1;SLC8A1;TGFB3;FBN2;PKDCC;BMP2
prerank,retinol metabolic process (GO:0042572),-0.564889357927477,-1.3355120835083114,0.13836477987421383,0.5741538297257229,1.0,3/14,5.39%,RBP4;DHRS3;CYP1B1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.4194567649105754,1.3352191671368674,0.07197943444730077,0.603032430597463,1.0,20/124,12.40%,LEF1;PLCB1;FZD6;FZD4;TIAM1;WNT7A;CALM1;CTNNB1;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;PPP3CA;RAC1;PPP3R1;AP2B1;GNB1
prerank,cellular macromolecule catabolic process (GO:0044265),0.4888922979917535,1.33510215685691,0.10236220472440945,0.6021888127316504,1.0,18/49,21.62%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;DFFB;FBXO6;MANBA;PPP1R8;NEU2;SND1;UBE2G2;FBXO2;RNASEH2C;XRN2;NCBP1;RNASE6
prerank,histone H4 acetylation (GO:0043967),0.4917978716091158,1.3348544144406942,0.1224188790560472,0.6017208465859065,1.0,10/47,16.39%,LEF1;TRIM16;PHF20;BRCA2;JADE2;NAA60;TRRAP;MCRS1;HCFC1;MSL2
prerank,positive regulation of immune system process (GO:0002684),0.5945669720878588,1.3345650096922193,0.15300546448087432,0.6014201020515032,1.0,5/16,14.70%,TGFB2;LGALS9;PIK3CB;IL15;NCKAP1L
prerank,negative regulation of vascular permeability (GO:0043116),0.6148265099582024,1.334401603583499,0.15837937384898712,0.6007396372462902,1.0,5/12,3.52%,CLDN5;PDE2A;DDAH1;PTPRJ;RAMP2
prerank,arachidonate transport (GO:1903963),-0.5950934077749856,-1.3335541910804876,0.13876651982378854,0.5762136081711559,1.0,3/10,8.12%,ANXA1;ACE;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),-0.5950934077749856,-1.3335541910804876,0.13876651982378854,0.5762136081711559,1.0,3/10,8.12%,ANXA1;ACE;BDKRB2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5369924716867209,1.333229897803099,0.1505016722408027,0.6032699335764707,1.0,11/26,13.39%,DAB2IP;PDE8A;PTPN12;DUSP3;VIL1;PLCG1;SNAI2;IQGAP1;ZPR1;ZFP36L1;SOX9
prerank,positive regulation of chemokine production (GO:0032722),0.5006377413955151,1.3328204261673047,0.10015649452269171,0.6032925162590937,1.0,10/44,11.86%,APP;TIRAP;IL6R;TLR3;LGALS9;TLR7;ADAM17;AGER;HIF1A;SYK
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5788153203078656,1.332708020912056,0.15265866209262435,0.6024301538877779,1.0,2/18,1.49%,SLC39A8;JAM2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),-0.4983636491783774,-1.33265690670776,0.10071942446043165,0.5770393179981774,1.0,5/21,7.86%,ANK2;SNTA1;CACNA2D1;FLNA;CACNA1D
prerank,transferrin transport (GO:0033572),0.5185656473938915,1.3325306646072255,0.1256198347107438,0.601783417827597,1.0,5/33,7.03%,TFRC;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5517742122283352,1.3324926307970895,0.15141430948419302,0.6006996020883608,1.0,7/24,13.79%,NOD1;NOD2;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5227884135066329,1.3322097535717117,0.1349206349206349,0.6003728689709955,1.0,12/33,15.74%,CACNA1A;LRP8;ABR;BTBD9;GRID2;PXK;FABP5;GRIK5;GRIK2;GRIK1;LRRC4C;NLGN1
prerank,transepithelial transport (GO:0070633),0.5923310901846819,1.332122998344106,0.15810276679841898,0.5994608718564821,1.0,3/15,5.02%,ABCG2;SLC1A1;SLC1A2
prerank,regulation of protein phosphorylation (GO:0001932),0.39089734462880676,1.3320077011038842,0.03546099290780142,0.5986186447236668,1.0,48/256,10.75%,TFRC;TEK;OCLN;LIMCH1;PECAM1;KDR;INSR;DAB2IP;ENG;APP;PRR5L;XDH;FAS;TBX1;PDE8A;FLT4;PLAUR;PTK2;NIBAN1;CD40;PIK3R3;MEN1;LYN;FNIP2;FGF16;WWTR1;CD4;CAMKK2;CCDC88A;LIMK2;PPIA;FYN;MAPK3;PPP2R5A;RALB;INSM1;EFNA1;PIN1;TGFB1;IRGM;PAK1;PGF;CCND3;ADAM17;AXIN2;AGER;BRD4;HSPB1
prerank,heme biosynthetic process (GO:0006783),0.558451429825507,1.3316998310752304,0.14956521739130435,0.5983199704446932,1.0,3/22,8.34%,ABCG2;ALAS1;CPOX
prerank,protein localization to cell junction (GO:1902414),0.5521652910384234,1.3316155399419651,0.15889464594127806,0.5973874656299692,1.0,3/22,1.89%,TJP1;HEG1;TJP2
prerank,positive regulation of cell growth (GO:0030307),0.4361972783252073,1.3312872853566429,0.08575380359612725,0.5971860595566353,1.0,24/96,13.66%,SEMA7A;MFSD2A;MACF1;TGFB2;NTN1;NEDD4L;ITSN2;RPS6KA1;SLC25A33;DBNL;ADAM10;RASAL1;TWF2;SMURF1;ADAM17;CPNE5;S100A8;SYT4;BRAT1;RPTOR;CPNE6;DERL2;SDCBP;AKAP6
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.591170119398033,-1.3312745477531083,0.14757709251101322,0.5791491130861849,1.0,8/11,28.37%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,polyol metabolic process (GO:0019751),0.488984158950334,1.330998110743756,0.11026033690658499,0.5969098614747735,1.0,13/46,12.48%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;IPMK;PLCH1;INPP1
prerank,sodium ion transmembrane transport (GO:0035725),-0.37938914829847203,-1.3309566228744578,0.05574912891986063,0.5780701482474563,1.0,16/84,7.24%,ATP1A2;SLC24A3;NALCN;SLC6A13;SCN7A;SLC6A12;SLC8A3;SLC6A9;SLC12A2;ANO6;PKD2;SLC9A2;ATP1B3;SLC6A1;ATP1B2;SLC8A1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5234246915629535,-1.3306641522570892,0.13695652173913042,0.5769406352684762,1.0,7/17,17.62%,FGFR2;NPR3;CCN1;MN1;BMP2;SFRP1;TMEM119
prerank,sulfur compound transport (GO:0072348),0.5306551705892794,1.3298488352467512,0.12186978297161936,0.5992313050050705,1.0,2/27,0.38%,SLC6A6;ABCG2
prerank,retinal metabolic process (GO:0042574),-0.5822383866369499,-1.329846088419617,0.1431578947368421,0.5774323906742819,1.0,7/12,34.21%,ABCA4;CYP1B1;RDH10;ALDH1A3;RDH13;ALDH8A1;DHRS13
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.6239846643360403,1.3297350512141186,0.17333333333333334,0.5983479037436099,1.0,1/12,1.02%,DAB2IP
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),-0.4508618325813681,-1.3281469904912124,0.11653116531165311,0.5808311400397432,1.0,14/33,19.26%,APPL2;PKD1;STXBP4;GLI1;PSME3;MN1;PTEN;PAF1;TCIM;PLK5;DDRGK1;ID2;PTPN6;EZH2
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.47349358891945653,1.3280939398231095,0.09558823529411764,0.6020811855097392,1.0,15/55,14.07%,BCL2L1;DAB2IP;CAV1;FAS;TPD52L1;TNFSF10;HYAL2;CRADD;DEDD2;AGTR2;S100A8;TNFSF12;CYLD;TRIM39;BCL10
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.4149808932597154,-1.3279731196699005,0.09411764705882353,0.579429980687774,1.0,15/48,15.28%,ADCY5;AMPD3;ADCY1;ADCY9;SLC26A2;ADCY2;ADCY7;PAPSS2;GUCY1A1;DCAKD;PAPSS1;ADCY6;GUCY1B1;IMPDH2;GMPS
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.46402156330345545,1.327899287704132,0.11711711711711711,0.6014956491604959,1.0,14/54,17.70%,IVNS1ABP;CAV1;DCUN1D3;SMAD7;CTNNB1;N4BP1;COPS9;UBXN1;RPL11;TNFAIP3;DNAJA1;BAG2;SIRT7;PRKCG
prerank,nucleoside catabolic process (GO:0009164),-0.5988716985127693,-1.3276757479088501,0.13588110403397027,0.5784460710175201,1.0,6/11,15.12%,DPYD;NT5E;UPB1;UPP2;DERA;NT5C1A
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5518328931102011,1.3273802729731201,0.14748784440842788,0.6018893563719865,1.0,11/25,18.49%,FGF13;STMN1;NCKAP5;KIF2A;STMN3;STMN4;PIN1;NCKAP5L;CKAP5;TRPV4;TPPP
prerank,defense response to Gram-positive bacterium (GO:0050830),0.5039370596399904,1.3272996600468518,0.10819165378670788,0.6009172255036471,1.0,7/40,9.89%,PGLYRP1;TIRAP;DEFA6;GBP7;GBP4;PPP1R11;ADAM17
prerank,regulation of heart rate by cardiac conduction (GO:0086091),-0.43186648656040905,-1.3271961760267892,0.10555555555555556,0.577828123120686,1.0,9/38,12.08%,CACNA1C;ANK2;CAMK2D;CACNA2D1;KCNJ2;CACNA1G;CACNA1D;TRPM4;CACNB2
prerank,myotube cell development (GO:0014904),-0.6029310767744929,-1.3264110112106375,0.15145228215767634,0.5782415425655253,1.0,3/10,12.99%,IGF1;SIX1;SKI
prerank,protein oxidation (GO:0018158),-0.5959167973116115,-1.3264022486636677,0.1550925925925926,0.5763080784270064,1.0,3/11,6.71%,LOXL1;LOXL3;LOX
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6665993307532444,1.3260556689526481,0.16856060606060605,0.60356492713409,1.0,4/10,8.89%,FAS;LYN;MAPK3;GREM1
prerank,carbohydrate biosynthetic process (GO:0016051),0.5536776176533535,1.3260181054684534,0.16370106761565836,0.6025012778327936,1.0,4/21,5.93%,ST3GAL6;ST8SIA6;FUT8;FUT9
prerank,positive regulation of T cell proliferation (GO:0042102),0.4626522940987484,1.3259055381458487,0.1122754491017964,0.6016899539885583,1.0,15/55,17.12%,TFRC;SLC7A1;JAK3;CD6;CCDC88B;EBI3;AGER;PNP;SYK;IL27RA;IL15;NCKAP1L;VCAM1;NCK1;CCR2
prerank,negative regulation of JNK cascade (GO:0046329),0.519806461210192,1.3258273753996912,0.13322368421052633,0.6007881224512275,1.0,8/31,15.14%,MECOM;MEN1;DUSP3;NPPA;ZMYND11;CYLD;DNAJA1;HIPK3
prerank,protein ADP-ribosylation (GO:0006471),-0.46487979403440133,-1.3247041888576014,0.1164021164021164,0.5795185579566815,1.0,11/28,16.33%,PARP8;PARP3;SIRT3;TNKS2;PARP4;PARP11;PARP6;PARP1;SIRT2;PARP12;TIPARP
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5376872401713116,-1.32389006733229,0.13968957871396895,0.5799154527044306,1.0,6/16,15.12%,DPYSL3;DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,sodium ion export across plasma membrane (GO:0036376),-0.5578293314249234,-1.3237158636014752,0.16241299303944315,0.5784777849819193,1.0,4/13,10.27%,ATP1A2;ATP1B3;ATP1B2;SLC9A1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.6356468014308506,1.3233314415918356,0.18045112781954886,0.6074147628086504,1.0,4/11,9.66%,JAK3;SMAD7;FOXP3;SOCS5
prerank,positive regulation of protein sumoylation (GO:0033235),-0.6036008772328312,-1.3230760178718477,0.14432989690721648,0.5785958903129951,1.0,5/10,24.79%,HDAC4;PIAS1;MUL1;UBA2;RWDD3
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.49565096862179214,1.3227947847286952,0.11682242990654206,0.6078540023863753,1.0,8/38,7.63%,PDGFB;APP;CAV1;LRP8;NEDD9;HYAL2;EPHA4;EFNA1
prerank,protein localization to cell surface (GO:0034394),-0.47020870420222566,-1.3227293511238063,0.10353535353535354,0.5777165039376274,1.0,7/26,10.34%,ANK2;ANGPT1;FBLN5;VCL;FLNA;GGA2;PRRT1
prerank,maintenance of protein location in nucleus (GO:0051457),0.5605314826601298,1.3222141437494415,0.12412587412587413,0.6083962921150585,1.0,3/20,2.92%,SYNE1;ARL2BP;SP100
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.6045909607444517,1.321753213629476,0.1750465549348231,0.6085299916071655,1.0,2/13,1.57%,SHANK3;APP
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6080981037793589,-1.3216872452352626,0.1693548387096774,0.5787839911346007,1.0,4/10,10.23%,IRS1;IRS2;PTH1R;SLC45A3
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.442671921664578,-1.3207693720357252,0.11695906432748537,0.579772734932092,1.0,14/37,13.57%,IGF1;BMPR1A;IGFBP5;TPM1;GJA1;FGF2;MMP2;FOXJ2;SOD2;EFEMP2;TGFB3;ADAMTS1;MFN2;PTEN
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3734890095613033,-1.320250560212914,0.06206896551724138,0.5793883416385295,1.0,14/86,4.67%,BMP6;SULF1;ZEB2;BMPR1A;FOXD1;BMP5;BMP7;BMP4;THBS1;TGFBR1;TWSG1;RBPJ;ZNF423;DAB2
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.4061839712557539,-1.3202186273018206,0.07964601769911504,0.5775732291496987,1.0,11/56,4.67%,BMP6;BMPR1A;LDLRAD4;BMP5;BMP7;BMP4;BMPER;SMAD6;TGFBR1;TWSG1;DAB2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5484668674619317,1.3198069247996058,0.16835016835016836,0.6130161986207938,1.0,4/26,5.43%,MFHAS1;CAV1;TIRAP;TLR3
prerank,protein hydroxylation (GO:0018126),-0.531965069540571,-1.3192220955298644,0.16359447004608296,0.5786916357469414,1.0,7/15,13.27%,PLOD2;ASPH;P3H3;EGLN3;P3H2;OGFOD1;P3H1
prerank,atrioventricular valve development (GO:0003171),0.5896086074492841,1.318973211868336,0.15889464594127806,0.6143381367052821,1.0,5/14,3.41%,BMPR2;TGFB2;ZFPM1;APLNR;NOTCH1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.3916364518665823,-1.318730144691474,0.0749185667752443,0.5782984973259865,1.0,8/61,6.27%,EYA2;EYA1;EGFR;PDGFRB;EYA4;SMOC2;FGF2;PARP3
prerank,metal ion homeostasis (GO:0055065),0.49839449422274495,1.3177631263616139,0.14082278481012658,0.6166982640342024,1.0,6/40,9.14%,TMTC2;CAV1;SLC12A6;SLC12A9;KCNH2;LETM1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5289583235663339,-1.3176996801939564,0.15575620767494355,0.5796667173674801,1.0,4/15,3.80%,GLI2;EDA;WNT6;FOXC1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.6471618085316327,1.316935555324656,0.20517560073937152,0.6179505654406345,1.0,3/11,3.96%,SEMA6A;EPN2;KLF2
prerank,aminoglycan catabolic process (GO:0006026),-0.46379459140663193,-1.3168616527444759,0.12378640776699029,0.5801095790906746,1.0,5/28,7.96%,GPC6;SDC2;GPC3;GPC4;SDC4
prerank,iron ion transport (GO:0006826),0.4750705960321316,1.3167432739484544,0.1109375,0.6173190111600423,1.0,6/47,7.03%,TFRC;SLC40A1;ATP6V0A1;MCOLN1;REP15;DNM2
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.4766611106780592,-1.3164077792068054,0.13471502590673576,0.5795533424039093,1.0,11/23,25.22%,SELENOS;HSP90B1;SEC16A;SYVN1;AUP1;LMAN1;SURF4;SEC61B;DERL1;TMED9;UFD1
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.42900657967698824,-1.3162460797955406,0.10674157303370786,0.5781504706777798,1.0,9/40,4.69%,ARHGAP6;LPAR1;NTRK3;EGFR;PDGFRB;PDGFRA;EDNRA;KIT;FGF2
prerank,positive regulation of vascular permeability (GO:0043117),0.6050713322768706,1.3159408504868642,0.177007299270073,0.6185022479228692,1.0,4/12,1.89%,OCLN;TJP1;PDE2A;TJP2
prerank,regulation of sprouting angiogenesis (GO:1903670),0.5118589455635645,1.315869277419222,0.143317230273752,0.6175358362421393,1.0,11/33,12.15%,SEMA6A;TJP1;PPP1R16B;EPN2;KLF2;FGF16;KLF4;PKM;SMAD1;CEACAM1;PIK3CB
prerank,telomere maintenance via recombination (GO:0000722),-0.5866313293519236,-1.3157355595972247,0.14772727272727273,0.5779172086091168,1.0,6/11,19.24%,SMC6;TEP1;ERCC1;RAD50;NSMCE2;TPRKB
prerank,inositol phosphate metabolic process (GO:0043647),0.48339940768361933,1.3157076878177585,0.125,0.6168685919062042,1.0,13/46,12.48%,PLCB1;PLCB4;ITPKB;INPP5D;PLCG1;CALM1;PLD4;OCRL;PLCH2;NUDT3;IPMK;PLCH1;INPP1
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.4466898098390507,1.315702138065707,0.11730205278592376,0.615729997965609,1.0,11/73,11.35%,KITLG;LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,sodium ion homeostasis (GO:0055078),-0.49823859609663174,-1.3155725630425543,0.13012048192771083,0.5765160109759477,1.0,6/21,10.27%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1;SLC9A1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.5205008223805716,1.3149574594851914,0.14429530201342283,0.6167724735185435,1.0,7/32,13.32%,MFSD2A;SLC44A5;CHKA;LPCAT3;CEPT1;CSNK2B;LPIN3
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.590458388272823,1.3146888972943447,0.17164179104477612,0.6164156498755048,1.0,2/16,6.92%,CLDN5;CLDN14
prerank,negative regulation of calcium ion transport (GO:0051926),-0.533833000559488,-1.3146183065687058,0.1471861471861472,0.5775839928832002,1.0,1/15,0.02%,ATP1A2
prerank,histone lysine demethylation (GO:0070076),-0.47501262758194407,-1.3144449693851898,0.1393643031784841,0.5762993003709622,1.0,12/25,23.80%,KDM7A;KDM2A;KDM3B;KDM5B;KDM6B;KDM2B;KDM1A;PHF8;RIOX2;PHF2;KDM4D;HR
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6043418452134356,-1.3139927584076956,0.1623931623931624,0.5739971287580187,1.0,5/10,18.78%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6043418452134356,-1.3139927584076956,0.1623931623931624,0.5739971287580187,1.0,5/10,18.78%,PRKCD;SMPD3;SIRT3;NSMAF;PLA2G6
prerank,neuron projection development (GO:0031175),0.40390354167485776,1.3123391424318367,0.059332509270704575,0.6221176463456379,1.0,31/168,10.36%,PTPRM;FRY;SHANK3;SRGAP2;DAB2IP;RAPGEF2;APP;FRYL;STX3;MAP4;LYN;PPP1R9B;STMN1;WNT7A;TBC1D24;EPHA4;DIP2A;DBNL;NCKAP1;STMN3;DNM2;RAB11A;STMN4;GPM6A;OPHN1;PAK1;SLC9A6;ZPR1;TBC1D23;BICDL1;AGER
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.5187070683360817,-1.3122253578727965,0.13443396226415094,0.5773738358498364,1.0,7/17,14.67%,BMP4;FGF2;TMEM100;SFRP4;ATOH8;NKX6-1;AHI1
prerank,mitochondrion morphogenesis (GO:0070584),-0.5808523236532757,-1.3121599017397259,0.15766738660907129,0.575722552368055,1.0,1/11,0.14%,PID1
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.49589714035200044,-1.3115462575057089,0.1342925659472422,0.5756630955233916,1.0,6/20,14.60%,IGF1;FOXC1;NIBAN2;TWIST1;EP300;DDRGK1
prerank,regulation of protein localization to membrane (GO:1905475),-0.46836752099618795,-1.311471227097045,0.12561576354679804,0.574119719768296,1.0,9/28,11.08%,GPC6;GSN;GPC3;MMP14;GPC4;AR;PRKN;SLC5A3;CLN3
prerank,erythrocyte differentiation (GO:0030218),0.48314714064896624,1.3112942011030662,0.1298904538341158,0.6242095659178115,1.0,8/44,5.20%,MFHAS1;ALAS1;JAK3;ZFPM1;LYN;KLF1;SLC25A5;TAL1
prerank,actin filament polymerization (GO:0030041),-0.45747322323505607,-1.3112622026545626,0.12121212121212122,0.5729566692950303,1.0,4/29,2.45%,ARHGAP6;GAS7;GSN;COBL
prerank,regulated exocytosis (GO:0045055),0.4011075103617376,1.3107120751132526,0.05742821473158552,0.6248514206355167,1.0,28/173,10.33%,ABCC4;PECAM1;RAB11FIP1;PDGFB;TGFB2;APP;LHFPL2;RAB31;STX1A;SRGN;SELENOP;VWF;LYN;TMSB4X;CALM1;CFD;PIP5K1C;SYT7;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;SCG3;CDC37L1;DNAJC5;ARHGAP17
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5010533260704073,1.3103611617847215,0.13968253968253969,0.624890588440191,1.0,8/36,13.09%,MECOM;FOXO1;MEN1;DUSP3;PPIA;ZMYND11;DUSP1;CYLD
prerank,positive regulation of protein secretion (GO:0050714),-0.38072439640421935,-1.3103338829622262,0.07861635220125786,0.5737339971229409,1.0,13/69,9.52%,BMP6;WLS;IGF1;MCU;FRMD4A;NLGN2;RBP4;ADAM9;IRS2;NNAT;C1QTNF3;TGFB3;EZR
prerank,regulation of synapse maturation (GO:0090128),0.6413408094782133,1.3102699726375677,0.1785063752276867,0.6240223777691045,1.0,7/10,19.95%,DAB2IP;ARHGEF15;NRXN1;CAMK2B;YWHAZ;NEUROD2;ANAPC2
prerank,microtubule bundle formation (GO:0001578),0.4949048449238726,1.3100982769393847,0.12322274881516587,0.6233579917603547,1.0,15/42,18.49%,NAV1;CLIP1;RP1;NCKAP5;MARK4;TTLL3;CDK5RAP2;RSPH4A;DCX;RSPH1;FOXJ1;NCKAP5L;SPAST;CCDC66;TPPP
prerank,mesenchyme morphogenesis (GO:0072132),0.5785068048383272,1.3100179427218308,0.16225749559082892,0.6224789811663404,1.0,5/17,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,mRNA splice site selection (GO:0006376),-0.4482877325339747,-1.309802472612597,0.1096938775510204,0.573571854792552,1.0,6/30,13.96%,CELF2;SRSF5;LUC7L3;SRSF6;LUC7L2;PSIP1
prerank,icosanoid secretion (GO:0032309),0.6355358717997357,1.3097992346794742,0.16201117318435754,0.6219469137938648,1.0,2/12,4.51%,ABCC4;NOS2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.6455129621924902,1.3092770922448222,0.2003780718336484,0.6223490525551477,1.0,2/10,3.94%,PODXL;PIEZO1
prerank,nucleotide catabolic process (GO:0009166),0.5891544671448904,1.3092592640078002,0.19469026548672566,0.6212645826551138,1.0,5/16,11.08%,XDH;SAMHD1;NT5C2;NUDT3;PNP
prerank,vasodilation (GO:0042311),0.6105127785185059,1.3090098122585987,0.17383177570093458,0.6208045477705877,1.0,3/13,10.36%,NOS3;KLF2;AGTR2
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5703611800372665,-1.3089694822175038,0.1406926406926407,0.5741755392356998,1.0,5/12,13.13%,IRS1;PPARGC1A;PPARA;IRS2;TWIST1
prerank,negative regulation of cell adhesion (GO:0007162),0.44404271100240067,1.308920898074827,0.1184407796101949,0.619923429374789,1.0,20/72,11.99%,SEMA6A;PODXL;ACER2;FZD4;CORO2B;PTK2;PLXND1;SIPA1;ACVRL1;NOTCH1;SNAI2;ADAM10;NEXMIF;TGFB1;SPOCK1;ARHGDIA;CBLL1;DUSP1;PLXNB3;RND1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5381187136166895,1.3088695723348227,0.1576271186440678,0.6189363319677966,1.0,7/27,11.66%,EFHC2;MBOAT1;NTNG2;CCDC88A;HOMER1;DISC1;GSK3A
prerank,positive regulation of protein processing (GO:0010954),-0.5072064586160605,-1.3086632010232855,0.14253897550111358,0.5731809829606266,1.0,3/19,3.29%,GSN;CCBE1;CLEC3B
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5158384239262686,-1.3081653669884834,0.13838120104438642,0.5728983692124089,1.0,4/19,5.22%,IGF1;NUPR1;IL18;DAGLA
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.5763550189501683,1.3077274298772263,0.16576576576576577,0.6211970137541709,1.0,5/18,10.15%,RNF125;SEC14L1;ZCCHC3;BIRC3;OASL
prerank,positive regulation of cell population proliferation (GO:0008284),0.3696003246574635,1.3073722076175955,0.026172300981461286,0.621157223926438,1.0,52/423,9.30%,LEF1;FLT1;IGF1R;PRKCH;KITLG;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;TGFB2;ACER2;PDGFD;TBX1;IL6R;FLT4;CNOT6L;TBX3;TNFRSF11A;STX3;GNAI2;PTK2;NES;MEF2C;NOD2;TIAM1;NOTCH1;LYN;OSMR;FGF16;DLL4;WWTR1;SLC25A5;SLC25A33;ADAM10;STAT1;HCK;INSM1;BST2;TGFB1;TGFA;CXCR2;PTN;LRP5;COPS9;GREM1;PAK1;PGF;MAP3K3;LIFR
prerank,regulation of macrophage migration (GO:1905521),0.6457104973069807,1.3073122228647958,0.18947368421052632,0.6201824712387696,1.0,3/10,8.06%,MTUS1;CD200;CD200R1
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.554666391842294,-1.3067405829125247,0.15789473684210525,0.5753930255581012,1.0,8/13,28.37%,GFPT1;RENBP;GFPT2;PGM3;NAGK;UAP1;UAP1L1;GNPDA1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5871876458424469,-1.3061358028176142,0.16806722689075632,0.5755070923455639,1.0,6/10,30.54%,ADGRV1;PDZD7;TSKU;PLS1;IFT88;WHRN
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5868579351210059,1.3057682155900854,0.16283185840707964,0.6237643887031618,1.0,4/17,6.46%,PODXL;TGFB2;PIEZO1;RET
prerank,axonogenesis (GO:0007409),0.3833674937188511,1.3045436606871754,0.047044632086851626,0.626218199380007,1.0,46/237,9.42%,SEMA3C;SEMA7A;BSG;SHANK3;SEMA6A;SPTBN1;ROBO4;CXCL12;APP;B4GALT5;SEMA6B;KLF7;PTK2;LAMA5;PARD3;NTNG2;NOTCH1;DSCAML1;EVL;ACTB;PLCG1;WNT7A;GRB2;HSP90AB1;SEMA4F;GAB1;EPHA4;BAIAP2;DOK4;FYN;SOS1;MAPK3;RPS6KA5;RET;EPHB4;SLITRK3;CNTN2;SEMA6D;EFNA1;SLITRK1;SPTAN1;SHC3;OPHN1;NRXN1;SEMA4C;SLC9A6
prerank,neuron development (GO:0048666),0.4076914581905094,1.304459430582508,0.07711757269279393,0.6253695679828001,1.0,25/141,10.39%,PTPRM;FRY;TGFB2;RAPGEF2;APP;FRYL;B4GALT5;STX3;MEF2C;MAP4;LYN;PPP1R9B;STMN1;TBC1D24;RP1;STMN3;INSM1;RAB11A;STMN4;GPM6A;OPHN1;TBC1D23;BICDL1;AGER;DCX
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.35200708023905364,-1.3042614798719547,0.03501945525291829,0.5793862831646814,1.0,23/128,7.28%,BMP6;COL1A2;COL3A1;TGFBR3;BMPR1A;APPL2;SMAD3;BMP5;BMP7;BMP4;ITGB5;DDX5;SMAD6;RGMA;RGMB;TGFBR1;TWSG1;ADAM9;RUNX2;TMEM100;ARHGEF18;SMAD9;TGFB1I1
prerank,connective tissue development (GO:0061448),-0.4384619222811511,-1.3042004889472107,0.0967741935483871,0.5778487052335031,1.0,10/35,10.20%,SULF1;SOX5;ITGB8;PKD1;SULF2;CREB3L2;SH3PXD2B;ATP7A;SOX6;SLC39A13
prerank,regulation of cell population proliferation (GO:0042127),0.3607960574021588,1.3040213042205475,0.007306889352818371,0.6256369307989206,1.0,85/691,9.30%,LEF1;FLT1;IGF1R;TFRC;KITLG;ETS1;TJP1;CLDN5;NAMPT;PDGFB;KDR;INSR;AQP11;DAB2IP;ENG;BMPR2;TGFB2;NOS3;RAPGEF2;ACER2;PDGFD;SH3BP4;APP;JAG2;FES;TBX1;DDAH1;ITGA1;IL6R;FLT4;CNOT6L;CD200;TBX3;TNFRSF11A;STX3;ADGRG1;GNAI2;BCL6B;PTPRJ;ARHGEF2;RGCC;PTK2;SMARCA2;ACVRL1;TIAM1;NOTCH1;MEN1;LYN;PPP1R9B;HHEX;CTNNB1;SOX7;OSMR;FGF16;DLL4;WWTR1;SLC25A5;XIAP;IGFBP7;BTG4;ST18;CCDC88A;SLC25A33;ADAM10;KLF4;CDKN2B;STAT1;HCK;INSM1;JUN;TGFB1;TGFA;CXCR2;TMEM115;CDCA7;FOXP3;PTN;LRP5;ADAMTS8;COPS9;GREM1;HMGA1;PAK1;PGF;LIFR
prerank,chemical synaptic transmission (GO:0007268),0.37768762572561715,1.3037147971053868,0.03760282021151586,0.6254491094637196,1.0,66/284,17.53%,MPZ;SLC1A1;CACNA1A;HCRTR1;SLC6A2;SLC6A5;UNC13B;STX1A;RPS6KA1;CALM1;PDE7B;SLC1A2;CDH8;CAMKK2;TBC1D24;SYPL1;SLC12A6;PRKACB;GRID2;ATXN3;HOMER1;STXBP1;CHRNB1;GABRB1;HTR2A;PRKAR2B;HCRTR2;GRIA4;KCNQ3;APBA2;NRXN1;AKAP9;PRKAR2A;DNAJC5;HSPA8;NPY5R;CHRM3;EXOC4;GRIN2B;SHISA6;GABRQ;PCDHB14;CPNE6;GRIK5;GRIK2;CPLX1;SDCBP;MINK1;GRIK1;MYCBPAP;SLC17A6;SYNJ2BP;GABRG1;HTR4;GRM7;ERC1;AMPH;NLGN1;FCHSD1;MAPK1;GABRG3;CRHBP;MBP;PMP22;GABRA1;SST
prerank,vesicle organization (GO:0016050),0.4803990281209023,1.3036635320767838,0.11538461538461539,0.6244826191669937,1.0,10/46,12.19%,CD34;CAV1;FNBP1L;ALS2CL;SRGN;DNAJC13;SORT1;CAV2;HOOK1;EPS15
prerank,neural tube development (GO:0021915),-0.5346702778527501,-1.3035881033791716,0.15124153498871332,0.5778859690589295,1.0,4/15,6.43%,ALDH1A2;PKD1;PKD2;DACT1
prerank,negative regulation of cell activation (GO:0050866),0.5911905955998034,1.3032787806204784,0.18115942028985507,0.624537471692504,1.0,3/14,2.13%,PDGFB;NOS3;CD200
prerank,negative regulation of hormone secretion (GO:0046888),0.6336051123117556,1.3025737713504564,0.20618556701030927,0.6255011280001407,1.0,1/10,0.73%,RAB11FIP1
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5176715869727915,-1.3019685732532436,0.1662921348314607,0.580709927295175,1.0,3/16,4.19%,AUTS2;ARHGAP24;OGT
prerank,synaptic vesicle endocytosis (GO:0048488),0.5064944180141401,1.3010605357643905,0.13754045307443366,0.6289154126337797,1.0,7/33,8.64%,DNM3;STX1A;ITSN2;PIP5K1C;DNM2;FCHO2;OPHN1
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),-0.34487872974199696,-1.301035511680358,0.020080321285140562,0.5817422789786716,1.0,24/140,13.00%,CACNA1C;LPAR1;PLCE1;ADCY5;PDGFRA;CD55;CCR9;EDNRA;ADRA1B;CACNA2D1;TRPC3;DLG4;P2RX4;SLC8A1;BDKRB2;AGTR1;PTGDR;PTGFR;TRPM4;ABL1;ESR1;JPH1;LPAR4;CMKLR1
prerank,regulation of cell growth (GO:0001558),0.390370516086797,1.3004014885354622,0.06781750924784218,0.6296852124551209,1.0,40/204,12.23%,TFRC;MFSD2A;APBB2;LTBP4;BMPR2;TGFB2;SH3BP4;NET1;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;RPS6KA1;ACVRL1;CCDC85B;PPP1R9B;SOCS2;KIF26A;HYAL2;PAK5;WFDC1;FAM107A;SLC25A33;ADAM10;RASGRP2;EGLN2;BST2;TGFB1;NPR1;SPOCK1;ADAM17;BTG1;AGTR2;S100A8;BRAT1;NAIF1;CEACAM1;RPTOR
prerank,negative regulation of developmental process (GO:0051093),0.44579445273787577,1.3002241432427804,0.11654676258992806,0.6290789143994908,1.0,9/69,3.85%,TFRC;NOS3;NOTCH4;ARHGEF15;TBX1;KLF7;NOTCH1;VASH1;RAPGEF3
prerank,I-kappaB phosphorylation (GO:0007252),0.6435729570735209,1.3000883448463447,0.2054794520547945,0.6283847010707695,1.0,3/10,7.62%,DAB2IP;TLR3;TLR7
prerank,muscle contraction (GO:0006936),-0.3446770244185376,-1.2997450926626735,0.06172839506172839,0.5836780860649243,1.0,30/126,13.20%,CALD1;ROCK2;ACTN2;MYLK;TPM1;SNTA1;ITGB5;SNTB1;EDNRA;MYOF;DMD;VCL;ASPH;PABPN1;GNAO1;SLC8A1;MYH11;BDKRB2;MYL9;LMOD1;ACTA2;TPM2;TMOD3;DES;ARHGEF11;DTNA;TLN1;MYOM1;EMD;FXYD1
prerank,apoptotic DNA fragmentation (GO:0006309),0.5801093664623477,1.2990254224048294,0.17869415807560138,0.6305054303143186,1.0,8/16,19.18%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.3963558501270173,-1.2986477946507375,0.08708708708708708,0.5851737833683923,1.0,22/52,22.68%,ME1;ADHFE1;ME2;ACOT8;IDH2;MTHFR;MTHFD1;MDH2;ALDH18A1;D2HGDH;GOT1;PHYH;GCLC;GPT2;MTHFD1L;L2HGDH;MTHFD2;NIT2;IDH1;GOT2;FPGS;MTHFS
prerank,response to glucagon (GO:0033762),-0.4889929333487089,-1.298556854616898,0.12378640776699029,0.58371962538344,1.0,8/19,13.39%,ADCY5;ADCY1;ADCY9;ADCY2;ADCY7;PRKACA;ADCY6;CYSLTR2
prerank,positive regulation of growth (GO:0045927),0.4571341244201604,1.2983443103635346,0.1188707280832095,0.6314823598059555,1.0,16/64,14.30%,PLCB1;MFSD2A;INSR;TGFB2;RPS6KA1;SLC25A33;ADAM10;ZPR1;ADAM17;S100A8;BRAT1;RPTOR;DERL2;SDCBP;AKAP6;RFTN1
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.5343473288588606,1.2974892023112294,0.16306156405990016,0.6328823016938018,1.0,11/25,18.88%,HSP90AB1;EPHA4;EFNA1;RPS7;OPHN1;HIPK2;F8A1;RPL11;TRIM39;PRKCG;RPL23
prerank,cell part morphogenesis (GO:0032990),-0.5455746926706136,-1.297332572404467,0.15938864628820962,0.5857372965808947,1.0,1/13,0.14%,PID1
prerank,histone acetylation (GO:0016573),0.4478339961354905,1.2967746399856552,0.12536443148688048,0.6338748331718878,1.0,13/69,15.65%,LEF1;TRIM16;PHF20;YEATS2;BRCA2;KAT6A;JADE2;NAA60;BRD1;BRPF1;BRPF3;POLE3;TRRAP
prerank,fatty acid elongation (GO:0030497),0.5978354741027949,1.296713905589308,0.20035460992907803,0.6329354453870646,1.0,5/13,13.46%,ELOVL7;ELOVL5;ABCD1;ELOVL6;HACD2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.6098896237852788,1.29666844888457,0.17907801418439717,0.6319583694419578,1.0,6/11,13.39%,TBX1;CTNNBIP1;STAT1;LRP5;TGFBR2;SOX9
prerank,positive regulation of histone methylation (GO:0031062),-0.4678302942264352,-1.2966216537414772,0.16166281755196305,0.5860441797798169,1.0,3/24,5.56%,AUTS2;OGT;CTR9
prerank,mitochondrial fission (GO:0000266),0.5820407560094553,1.2964381545917136,0.18213660245183888,0.6315594405619344,1.0,2/16,7.03%,DNM3;DNM2
prerank,regulation of phospholipid metabolic process (GO:1903725),0.6484517479797448,1.2964097040475728,0.20156555772994128,0.6305331455806354,1.0,4/10,15.12%,MFSD2A;ABCA3;DNAJC19;MTMR2
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.5738311549577338,-1.2963199372529015,0.17872340425531916,0.5851601153873897,1.0,2/12,2.85%,DPYSL3;DPYD
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.512310964923715,-1.2952006180658615,0.15991471215351813,0.5867132416970491,1.0,6/17,1.46%,IGF1;DOCK5;PDGFRB;DOCK7;IGFBP5;VTN
prerank,retina homeostasis (GO:0001895),0.5408225860229956,1.2949848748738053,0.16749585406301823,0.6336487768990868,1.0,6/23,10.75%,B2M;POTEF;ACTB;POC1B;ACTG1;HSPB1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.5791350296504183,1.294556786704085,0.19117647058823528,0.6338118336997738,1.0,5/15,4.91%,KDR;PRKD1;PRKD2;TMSB4X;FGF16
prerank,prostaglandin biosynthetic process (GO:0001516),-0.5131373493843309,-1.294376366631716,0.1556122448979592,0.5874037868493234,1.0,4/18,5.75%,PTGDS;PTGIS;PTGS1;PTGES
prerank,potassium ion transport (GO:0006813),-0.34146140385800944,-1.293925291750835,0.038461538461538464,0.5870438527789742,1.0,13/120,5.51%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNK5;KCNMB2;PKD2;SLC9A2;KCNJ2;ABCC9;ATP1B3;KCNQ4
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.4337217626417238,1.2937606319205917,0.125,0.6350238453414921,1.0,9/75,6.22%,PLCB1;RGS12;RGS3;RASGRP4;GIT2;PPP1R9B;CALM1;RAMP3;GNG7
prerank,natural killer cell activation (GO:0030101),-0.48278368958651496,-1.293266428381448,0.17718446601941748,0.5871245826896397,1.0,3/23,7.34%,PBX1;AXL;ELF4
prerank,glycine transport (GO:0015816),0.6159052050340559,1.2928828319848467,0.17307692307692307,0.636475037959484,1.0,2/10,1.98%,SLC6A5;SLC38A5
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.5182555954944937,1.2925503621590793,0.14935064935064934,0.6362960294149694,1.0,8/28,12.58%,SHANK3;APP;EPHA4;FAM107A;PTN;EIF2AK4;AGER;CALB2
prerank,regulation of stress fiber assembly (GO:0051492),-0.37687094765422735,-1.292523709603624,0.08099688473520249,0.5876821349726734,1.0,24/74,10.27%,PHLDB2;ARHGAP6;LPAR1;ROCK2;ARHGAP28;PPM1E;CCN2;ARHGEF10L;ASAP3;ARAP1;TPM1;CARMIL1;TGFBR1;S100A10;ALMS1;CGNL1;ARHGEF18;FHOD1;MET;PFN2;MYOC;TGFB3;ITGB1BP1;SLC9A1
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5677674648842337,1.292370478629321,0.18198198198198198,0.6357731385390345,1.0,3/18,4.11%,FLT1;MEF2C;PLCG1
prerank,potassium ion transmembrane transport (GO:0071805),-0.3362256074700188,-1.2919503491315583,0.03508771929824561,0.5876380014788881,1.0,17/135,7.22%,ATP1A2;SLC24A3;KCNK2;NALCN;SLC1A3;KCNT2;KCNK5;SLC12A2;PKD2;SLC9A2;KCNJ2;ABCC9;ATP1B3;KCNQ4;SLC12A7;ATP1B2;KCNB2
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.538330272854618,1.291413247080165,0.16336633663366337,0.6374786813610371,1.0,5/22,8.89%,PDGFB;PDGFD;CALM1;MRE11;GREM1
prerank,cellular sodium ion homeostasis (GO:0006883),-0.5303750296080963,-1.2904261526487024,0.15704387990762125,0.5902565851163584,1.0,6/15,10.27%,ATP1A2;SLC12A2;ATP1B3;ATP1B2;SLC8A1;SLC9A1
prerank,peptidyl-lysine methylation (GO:0018022),-0.4580894906026439,-1.2903322326920432,0.11948051948051948,0.588873633074365,1.0,13/26,28.73%,EHMT2;SMYD3;SETD7;SETD4;EEF2KMT;TRMT112;SETD2;KMT5A;SETD6;EEF1AKMT2;SMYD2;ANTKMT;METTL21C
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.39884250737864085,1.2903146037864757,0.0743073047858942,0.6396670165367773,1.0,48/163,20.06%,INPP5D;PTPRJ;MEF2C;PRKD2;ZAP70;PLCG1;IKBKB;PDE4D;TNFRSF21;MOG;CD19;CD4;CD38;FYN;PLEKHA1;PSMB3;PSMD11;PDE4B;CD79A;PSMC6;MALT1;PAK1;PSME2;EIF2B1;EIF2B2;DENND1B;PSMD8;PRKCB;SYK;PIK3CB;SH2B2;PSMB10;BCL10;RFTN1;LCP2;NCKAP1L;CARD11;PSMA8;NCK1;LAT2;PAK2;SKP1;PSMD9;SPPL3;SKAP1;RBCK1;FYB2;PLCG2
prerank,lamellipodium organization (GO:0097581),0.5177351711400422,1.290276473898146,0.15830721003134796,0.6386881343158287,1.0,8/29,11.43%,PARVB;ABLIM1;S1PR1;SPATA13;CCDC88A;ARHGEF7;CYFIP1;RAC1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.394353502712329,1.289581421638891,0.06768837803320563,0.639768886652723,1.0,82/168,27.88%,CNOT6L;RPL38;MTPAP;RPL13;RPS29;RPL36A;RPL3;RNPS1;RPL27;RPSA;PAN3;EIF3E;RPS7;RPL9;RPL18;RPLP2;MAGOHB;RPL13A;CNOT9;PDE12;PAN2;HELZ2;RPS11;RPL8;DCP2;NCBP2;RPS27;RPL19;CNOT6;DXO;RPS9;ZFP36L1;DCP1B;RPL11;PNRC2;RPS15;RPL37;RPS28;RPS10;RPS25;RPL37A;RPL15;EXOSC10;NBAS;RPL17;RPL23;CNOT11;XRN1;RPL34;RBM8A;RPS18;EXOSC9;UPF2;XRN2;RPL21;PELO;RPS4X;RPL18A;NCBP1;RPS21;DCPS;RPL10A;EXOSC8;CNOT4;PABPC1;RPL24;RPL7A;RPL32;RPL4;UPF3B;UPF1;RPS2;ZC3H12A;RPS20;RPL6;RPS13;AGO1;RPS19;PPP2R1A;NBDY;RPL14;RPL26
prerank,alpha-amino acid metabolic process (GO:1901605),-0.4092690370702429,-1.2894433855118903,0.13709677419354838,0.5897954556230112,1.0,22/45,22.94%,ASPA;ATP7A;NAALAD2;ASPG;NOX4;MTHFR;MTHFD1;OAT;ALDH18A1;GOT1;GLUL;SLC25A12;GLS;GLS2;KYAT3;DDAH2;GPT2;KYAT1;KMO;GOT2;PYCR3;NAT8L
prerank,rRNA catabolic process (GO:0016075),0.5635253350715855,1.2886400358025103,0.20623916811091855,0.6415185416707706,1.0,8/16,22.45%,DEDD2;TRIR;DIS3L;EXOSC10;XRN1;EXOSC9;PELO;EXOSC8
prerank,regulation of programmed cell death (GO:0043067),0.39699757127459434,1.2885478927612626,0.07721518987341772,0.6406824276774205,1.0,22/161,9.05%,MECOM;HIP1;PPP1R13B;ACER2;FAS;TNFRSF25;LRP8;PHLPP1;JAK3;TGM2;ACTN4;TOX3;CRADD;STAT1;ACTN1;LCMT1;MARK4;BIRC3;PIDD1;TRIM24;BNIP3L;MALT1
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.49095399990618005,1.2883639030536531,0.1377245508982036,0.6401687106529773,1.0,6/41,4.31%,TJP1;PODXL;MAGI1;PLAUR;PIEZO1;SMAD7
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.5853213383372968,-1.2881011307843715,0.18162839248434237,0.5917317266266705,1.0,1/10,2.79%,TUT4
prerank,response to interferon-gamma (GO:0034341),0.4450632809979601,1.2878028636070602,0.13193403298350825,0.6408598679962368,1.0,12/67,11.00%,GCH1;SP100;CD40;GBP7;GBP4;GBP5;LGALS9;STAT1;BST2;RPL13A;PDE12;CCL1
prerank,response to lipopolysaccharide (GO:0032496),0.4073135286886899,1.2871626987662197,0.08047493403693931,0.6416819210555303,1.0,25/138,14.07%,DAB2IP;NOS3;TIRAP;GCH1;IFNAR1;TNFRSF11A;MEF2C;SCARB1;DEFA6;NOD2;PELI1;NOS2;NOCT;PALM3;CD6;LGALS9;PDE4B;IRGM;ADAM17;S100A8;SLPI;HMGB2;TNFAIP3;GIT1;BCL10
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.5427672089803044,1.2857811009493294,0.18600682593856654,0.6448836371027666,1.0,2/21,0.95%,MFHAS1;PPP1R16B
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3911809174448195,1.285460029147206,0.08066581306017925,0.6447008622580102,1.0,17/152,6.60%,ADGRL4;ADGRE5;WASF2;ADGRL2;PDE2A;ADGRL3;S1PR1;ADGRG1;GNAI2;RAMP2;GNAQ;CALCRL;GNA12;RAMP3;PRKACB;INSL3;ADCY4
prerank,phagosome-lysosome fusion (GO:0090385),0.6329614382832665,1.2851268157618314,0.22,0.6446840020909741,1.0,4/10,7.82%,PIKFYVE;SYT7;RAB34;RAB39A
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.6035347714352187,1.2848414893343745,0.19858156028368795,0.644426556147174,1.0,3/12,1.74%,SEMA6A;DAB2IP;XDH
prerank,negative regulation of response to stimulus (GO:0048585),0.4433493066724182,1.2847589909350583,0.14772727272727273,0.6435573832501963,1.0,15/60,10.12%,AQP11;CD34;DDAH1;KLF7;YBX1;LYN;KIF26A;KLF4;NR1H2;TERF2;FOXP3;MAP3K3;SOCS5;LPCAT3;PTK6
prerank,synapse organization (GO:0050808),0.40752066912672613,1.2846215686753955,0.08465608465608465,0.6428607448462462,1.0,23/125,10.23%,SPOCK2;DNM3;SHANK3;APBB2;APP;ADGRL3;UNC13B;AGRN;PLXND1;CDH2;PPFIBP1;DBNL;SLITRK3;CNTN2;GPHN;PIN1;SLITRK1;GPM6A;NRXN1;DNER;LRRC4B;ELFN1;CYFIP1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5198496406280231,1.2844357159073185,0.16965742251223492,0.6423237954275173,1.0,9/28,15.03%,NOD1;NOD2;IRGM;IRAK2;UBE2V1;CASP8;CYLD;TNFAIP3;INAVA
prerank,regulation of transport (GO:0051049),0.487216168241243,1.2842296376363673,0.16612377850162866,0.6418245099384083,1.0,12/36,14.79%,ICA1;FES;EPB41;ACTB;MYO6;RAB11A;ACTG1;REEP5;ARL6IP5;WWC1;DISP3;DNAJA1
prerank,cellular response to oxidative stress (GO:0034599),-0.3480230303370617,-1.2840538777677346,0.05508474576271186,0.6021454188312553,1.0,26/118,11.95%,EGFR;PDGFRA;PRKAA2;MGAT3;CPEB2;TPM1;PLA2R1;PRKCD;PPARGC1A;PKD2;STX2;SOD3;GPX8;SOD2;NOX4;SELENOS;SLC25A24;FOXO3;ARNT;CYBA;PARP1;LRRK2;TMEM161A;CHUK;MPV17;ABL1
prerank,replicative senescence (GO:0090399),-0.5482459985369642,-1.283867811197882,0.18018018018018017,0.600915157640927,1.0,5/12,23.64%,PLA2R1;ATM;SERPINE1;WNT16;ATR
prerank,regulation of endocytic recycling (GO:2001135),-0.5643741170399683,-1.2830826499242989,0.16806722689075632,0.6015771153014354,1.0,5/11,16.13%,ACTN2;ATP9A;EHD1;RAB11B;EHD2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.37925039727564963,1.282356854440568,0.07272727272727272,0.6464128652453006,1.0,31/214,8.30%,TEK;SEMA7A;SEMA6A;MFHAS1;PDGFB;KDR;DAB2IP;RAPGEF2;PDGFD;APP;CNKSR3;TIRAP;PDE8A;FLT4;NOD2;NOTCH1;PRKD2;DUSP3;LYN;RAMP3;CCR7;CD4;MAPK3;FBXW7;LGALS9;PTPRR;HTR2A;ARHGEF5;PIN1;TGFB1;ABCA7
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.46884673218148,-1.2820877589251949,0.1569620253164557,0.6028535746390682,1.0,8/24,12.27%,SOX5;ADAMTS12;EFEMP1;TGFBR1;WNT9A;SOX6;PTHLH;PKDCC
prerank,cellular response to hexose stimulus (GO:0071331),0.5381222610419246,1.2820253606089513,0.18016528925619835,0.646350787478916,1.0,2/23,2.00%,IGF1R;UNC13B
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.4711669945532958,-1.2819288359028393,0.15258215962441316,0.601656756522451,1.0,8/24,10.73%,IGF1;ENPP1;IRS1;IRS2;IGF2;SELENOS;PPP1R3B;PPP1R3C
prerank,response to X-ray (GO:0010165),-0.5412676035681314,-1.2815681498087113,0.18876404494382024,0.6010094698146348,1.0,5/14,12.49%,ANXA1;IKBIP;ATM;NUCKS1;XRCC5
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.4442715515009092,1.2814212833840137,0.11287988422575977,0.6470329445057005,1.0,9/67,5.88%,NDNF;UTRN;PDGFB;LIMS2;DOCK1;NEDD9;RREB1;CCR7;RSU1
prerank,regulation of protein metabolic process (GO:0051246),0.4705687042232089,1.2813203560682807,0.16055045871559634,0.6462611727475435,1.0,8/44,8.30%,LTBP4;APP;PLAUR;NEDD4L;KLF2;HSP90AB1;KLF4;ABCA7
prerank,regulation of DNA binding (GO:0051101),0.4665938167661924,1.2812678999397094,0.16930379746835442,0.6453548484084213,1.0,11/44,13.76%,LEF1;NFKBIA;PLAUR;SP100;JUN;TGFB1;ZBTB7A;PPARG;CSNK2B;EDF1;HMGB2
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5065738876413021,1.2811590963080397,0.15384615384615385,0.6445985961113063,1.0,6/29,16.15%,CADM1;NOS2;PVR;CD160;CYRIB;AP1G1
prerank,negative regulation of cell migration (GO:0030336),0.40180991928177573,1.2806658968286913,0.09974424552429667,0.6450057724537467,1.0,23/137,7.36%,PTPRG;LIMCH1;DACH1;CLDN5;SRGAP3;SRGAP2;DAB2IP;SRGAP1;ENG;MCC;ADGRG1;PTPRJ;ADAM15;ACVRL1;EVL;DUSP3;SMAD7;HYAL2;RHOB;EPHA4;NEXMIF;PTPRR;BST2
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.5075227027406095,-1.2804392046929387,0.15492957746478872,0.6026302045501205,1.0,8/17,13.03%,NOTCH2;BMPR1A;BMP4;RBPJ;HEYL;JAG1;BMP2;SNAI1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.35855460385766585,1.280404974090875,0.017932489451476793,0.6446737572256698,1.0,106/532,14.05%,PLCB1;PDGFB;MAOA;BCL2L1;ADIPOR2;CXCL12;IL1R1;NFKBIA;IL6R;TNFRSF25;IFNAR1;TRIM25;LRP8;S1PR1;TNFRSF11A;INPP5D;STX3;B2M;PTPRJ;STX1A;NOD1;LAMA5;SP100;IFNAR2;FOXO1;JAK3;RAPGEF1;CD40;NOD2;PELI1;IL10RB;MAP3K8;TMSB4X;SOCS2;IRF2;IKBKB;ADAR;SAMHD1;GRB2;NOS2;OSMR;PITPNA;CD4;ST18;XAF1;PPIA;IRF9;ACTN4;FYN;SOS1;MAPK3;RPS6KA5;AIM2;MCL1;STAT1;PSMB3;HCK;IL13RA2;IRF5;RAP1B;BST2;IL4R;PSMD11;BIRC3;TGFB1;CXCR2;PSMC6;MSN;IRAK2;MAP3K3;LIFR;PSME2;CEBPD;SOCS5;EBI3;UBE2V1;ADAM17;MMP1;OASL;EIF5A;TALDO1;CNTF;TOLLIP;HSPA8;CCL1;PSMD8;TNFSF11;ADIPOR1;IL20RB;TNFRSF4;HIF1A;SYK;MID1;CEACAM1;PIK3CB;IL27RA;TNFSF12;IL15;IL7R;CSNK2B;POU2F1;FSCN1;CFL1;PLVAP;GPR75;PSMB10
prerank,regulation of neuron projection development (GO:0010975),0.3945368256536055,1.2803814597636436,0.09701492537313433,0.6436735045107673,1.0,35/163,11.66%,ITGA6;NDNF;MFSD2A;SHANK3;DAB2IP;EFHC2;RAPGEF2;SCARF1;FES;MBOAT1;RAPGEF1;PRAG1;CDH2;PRKD1;NTNG2;LYN;SNX3;EPHA4;CCDC88A;FUT9;CSMD3;RET;KIF1A;LRRC7;TWF2;PTN;SPOCK1;PAK1;SERPINI1;DISC1;PTK6;ACP4;ABI3;PLXNB3;GSK3A
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.5947510384242234,1.2802665323626872,0.20517560073937152,0.642938488880021,1.0,3/13,15.81%,PRR5L;GTPBP1;ZC3HAV1
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.5310161246173443,-1.2802015070872512,0.1875,0.601628595701967,1.0,3/13,3.09%,CACNA1C;ANK2;GJA1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.5568646514749214,-1.279664101006127,0.1630695443645084,0.6016788097900485,1.0,7/12,29.97%,ANO1;TRPM4;PPP3CB;STX4;PLA2G6;BAIAP3;GPLD1
prerank,response to cAMP (GO:0051591),0.4889331056258778,1.2796482349382252,0.15512048192771086,0.6436289935550291,1.0,11/37,13.66%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;STAT1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6
prerank,positive regulation of cellular senescence (GO:2000774),0.6281551082100415,1.279220792919271,0.20107719928186715,0.643724824602207,1.0,4/10,16.58%,B2M;HMGA1;ABI3;HMGA2
prerank,positive regulation of lipid transport (GO:0032370),-0.5490408281047272,-1.2791221800109582,0.17982456140350878,0.6015781372851096,1.0,3/12,8.01%,LRP1;SPP1;APOE
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5356338435466951,-1.2790040947836097,0.18969555035128804,0.6002164585939832,1.0,6/14,22.70%,CPEB1;CPEB2;YBX3;FMR1;RBM24;CPEB4
prerank,regulation of fibrinolysis (GO:0051917),-0.5523825075040594,-1.2783525273565481,0.17701149425287357,0.6004607923924266,1.0,3/13,7.12%,THBS1;FAP;THBD
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.5594478417965264,1.278277949149724,0.19202898550724637,0.6455745317372824,1.0,6/18,6.20%,CD200;LRP8;PRKD1;PRKD2;CRTC1;RPS6KA5
prerank,endothelial tube morphogenesis (GO:0061154),0.6231374667053875,1.2779405965224055,0.23517786561264822,0.6455250697604453,1.0,7/10,12.99%,ACVRL1;PRKD2;STARD13;CTNNB1;RHOB;CCM2;CSNK2B
prerank,positive regulation of protein kinase activity (GO:0045860),0.3909746330839002,1.2778681469145943,0.089058524173028,0.6446964738280236,1.0,29/148,13.54%,PDGFB;INSR;DAB2IP;TGFB2;RAPGEF2;IL6R;LRP8;NEDD9;PTK2;MMD;CALM1;HSP90AB1;CCR7;CD4;EPHA4;CCDC88A;PAK5;RALB;EFNA1;IRGM;IQGAP1;PAK1;PDCD10;RPTOR;MAP4K4;TGFBR2;MAPRE3;STK3;MINK1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),0.5157268686622197,1.2777464770607545,0.178752107925801,0.6440035934279608,1.0,4/27,6.88%,PRKCH;NFKBIA;ABCG1;NR1H2
prerank,cellular response to cytokine stimulus (GO:0071345),0.3614071748599211,1.2777198399314607,0.04600219058050383,0.6430291753403687,1.0,81/416,13.66%,LEF1;ST3GAL6;MAOA;LRCH1;BCL2L1;DAB2IP;PDE2A;CXCL12;IL1R1;IL6R;IFNAR1;LRP8;S1PR1;INPP5D;STX3;PTPRJ;ARHGEF2;STX1A;LAMA5;IFNAR2;FOXO1;JAK3;RAPGEF1;CD40;PTPN12;GBP7;GBP4;SIGIRR;GBP5;IL10RB;SOCS2;IKBKB;GRB2;NOS2;TNFRSF21;OSMR;HYAL2;CCR7;CD4;TCF7;FYN;SOS1;LGALS9;AIM2;MCL1;STAT1;HCK;IL13RA2;IRF5;IL4R;CRNN;TGFB1;IRGM;IRAK2;PTPN5;LIFR;CEBPD;SOCS5;EBI3;RPL13A;MMP1;PDE12;CNTF;HSPA8;CCL1;DUSP1;TNFSF11;GSK3A;IL20RB;HIF1A;SYK;PIK3CB;IL27RA;ZFP36L1;RO60;POU2F1;NPR2;SOX9;MT1X;FSCN1;AKAP6
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4359752576152411,-1.2777160142431552,0.1694915254237288,0.60061144430872,1.0,7/32,5.34%,PID1;IGF1;ZBTB20;PRKAA2;NUPR1;PPARGC1A;PPARA
prerank,gland development (GO:0048732),-0.38342503486527246,-1.2771216153959168,0.10249307479224377,0.6006231541210872,1.0,15/59,9.52%,TGFBR3;GLI2;WNT4;DKK3;FGFR2;COBL;SALL1;TGFBR1;PKD2;ANXA1;SIX1;IGSF3;MET;TGFB3;EZR
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4775810683239907,-1.2770755373784357,0.15724815724815724,0.5974496052068297,1.0,3/21,2.10%,EYA2;EYA1;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4775810683239907,-1.2770755373784357,0.15724815724815724,0.5974496052068297,1.0,3/21,2.10%,EYA2;EYA1;EYA4
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.49942271734598653,1.2770186088224056,0.16013071895424835,0.6440877569845205,1.0,2/34,3.20%,SLC7A5;NOD2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.48963233663077904,1.2763829541012577,0.16556291390728478,0.6449708340521483,1.0,8/37,6.99%,HMCN1;CADM1;NECTIN4;CD6;GRID2;PVR;FAT4;DCHS1
prerank,photoreceptor cell development (GO:0042461),0.5852754453068849,1.2763465725259433,0.2199630314232902,0.6440095163417001,1.0,3/14,10.39%,MFSD2A;RP1;DCX
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.4119683107045792,-1.2761792748459622,0.12044817927170869,0.5984018459461701,1.0,9/44,7.08%,ANK2;ACTN2;ANO6;WNK4;KCNMB2;KCNJ2;ATP1B3;FLNA;ATP1B2
prerank,cellular response to zinc ion (GO:0071294),0.573726178507567,1.2759326270220552,0.21223021582733814,0.6441758741964134,1.0,9/15,19.26%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;GLRA2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.4430381046020716,-1.2756599013429422,0.15308641975308643,0.5982962567537415,1.0,14/27,25.66%,DDX5;PLA2R1;ATM;SPRED1;KDM1A;SNAI1;TWIST1;CD44;HIC1;KMT5A;ATR;YJU2;MSX1;SMYD2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.4978887816627883,1.2755403847953786,0.16666666666666666,0.6442955971498601,1.0,11/33,14.70%,TGFB2;ACER2;PTK2;LYN;SNAI2;RET;NEXMIF;EFNA1;SYK;PDE3B;NCKAP1L
prerank,cellular biogenic amine biosynthetic process (GO:0042401),0.5739887227742071,1.275184084427153,0.19301470588235295,0.6443278238626073,1.0,2/15,3.26%,DDC;SMOX
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5562031658128554,-1.2750798614258987,0.19607843137254902,0.5983995919426324,1.0,3/12,8.01%,ROCK2;FLOT2;APOE
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.40383801906130984,1.2744120065782483,0.09749670619235837,0.6455659889003572,1.0,13/110,6.60%,ADGRL4;ADGRE5;ADGRL2;RAPGEF2;ADGRL3;S1PR1;ADGRG1;RAMP2;GNAQ;CALCRL;RAMP3;ADRA2B;ADCY4
prerank,anion transport (GO:0006820),0.4871667066952152,1.2743499431763037,0.15728476821192053,0.6446966732165695,1.0,4/33,2.53%,ABCG2;SLCO2B1;LRRC8B;LRRC8C
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.4533903395437971,-1.2743107609332367,0.14953271028037382,0.5989445699428864,1.0,6/26,14.96%,ATP1A2;PKD2;THADA;GNB5;FMR1;GSTM2
prerank,water transport (GO:0006833),0.6035379055805462,1.2738993508990466,0.21100917431192662,0.6449488981339763,1.0,2/12,4.59%,AQP11;AQP7
prerank,error-prone translesion synthesis (GO:0042276),0.5540261329887721,1.273843431269332,0.16974789915966387,0.6440866478716685,1.0,1/21,0.28%,POLK
prerank,blood circulation (GO:0008015),-0.40030075147941846,-1.2736369674018908,0.10028653295128939,0.5992607777923317,1.0,18/49,13.67%,ROCK2;SERPING1;COL4A3;SGCD;ELN;MEOX2;MYOF;SCPEP1;GUCY1A1;ACE;BDKRB2;AGTR1;ADORA2A;ITGB1BP1;ADCY6;GCLC;HTR7;GUCY1B1
prerank,acidic amino acid transport (GO:0015800),0.5601934111823732,1.2734350666226326,0.20257826887661143,0.6443031760813314,1.0,2/17,0.40%,SLC6A6;SLC1A1
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4724521068333941,-1.2732444587212184,0.14646464646464646,0.5987300914417102,1.0,3/23,2.20%,TGFBR3;FGFR2;TPM1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.4841076442964875,-1.272854640733817,0.1780821917808219,0.5983264559702091,1.0,5/21,6.33%,ROCK2;ERRFI1;BMP4;CTSL;SFRP4
prerank,central nervous system neuron development (GO:0021954),0.5727248121430393,1.2727090539713128,0.19818181818181818,0.6453930744909333,1.0,3/15,5.03%,RAPGEF2;B4GALT5;HSP90AB1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.49613986840215657,1.2727027805520759,0.15091210613598674,0.6443782564816268,1.0,2/32,3.16%,PGLYRP1;DEFA6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.6179056384732672,1.2724491162943035,0.21651376146788992,0.6441032912458508,1.0,3/11,4.69%,SLC19A3;NT5C3A;TPK1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.3664672412673906,1.2723971428390302,0.05736782902137233,0.6432282336291535,1.0,31/308,8.78%,LEF1;IGF1R;TFRC;PRKCH;PLCB1;EPAS1;PDGFB;CADM1;ADIPOR2;GATM;BMPR2;TGFB2;TRIM16;CAV1;B4GALT5;RGCC;UCP2;TIAM1;ZBTB16;RREB1;CTNNB1;WWTR1;OXTR;CCDC88B;SHLD1;YBX2;IL4R;TGFB1;ABCA7;PTN;NPR1
prerank,positive regulation of DNA recombination (GO:0045911),0.5148906519787154,1.2720764568236318,0.15577889447236182,0.6431371197473749,1.0,6/27,17.43%,TFRC;SHLD1;PRDM9;WDR48;ACTR2;FANCB
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5917861488548423,1.2714467127515816,0.21794871794871795,0.6439779808771049,1.0,3/13,4.51%,NOS3;DDAH1;NOS2
prerank,regulation of membrane repolarization (GO:0060306),0.5867686583344526,1.2713979869994012,0.2209737827715356,0.6431185879425114,1.0,6/13,13.66%,CAV1;NEDD4L;KCNQ1;KCNH2;AKAP9;AKAP6
prerank,miRNA metabolic process (GO:0010586),-0.48381268811431755,-1.2704726832569295,0.16129032258064516,0.6033562163663412,1.0,8/20,25.59%,TUT4;AGO2;XPO5;DDX17;BCDIN3D;TARBP2;PARN;DROSHA
prerank,positive regulation of cellular protein localization (GO:1903829),0.43805896051240606,1.270433664277441,0.11824817518248175,0.6448340205938008,1.0,14/69,12.05%,TFRC;STX3;WWTR1;HSP90AB1;CARD10;CCDC88A;LIMK2;FYN;MARK4;TGFB1;ABCA7;LAMTOR5;FERMT2;ORMDL3
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5614221860470763,1.2702880178112745,0.21891418563922943,0.6442395475944503,1.0,5/16,15.66%,FASN;DIP2A;SLC25A1;HSD17B8;ACAT1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.529702491814822,1.2699904876489352,0.18319327731092436,0.6440304267796199,1.0,5/24,10.01%,AQP11;BCL2L1;NR1H2;UBXN1;LPCAT3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.4360467234698027,-1.2699499430490988,0.14473684210526316,0.6032156726877732,1.0,10/33,13.57%,OGN;IGFBP5;TPM1;APOD;SOD2;IGFBP3;EFEMP2;TGFB3;MFN2;PTEN
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.5171532500087958,-1.2693176508755528,0.18632075471698112,0.6034402198662804,1.0,6/15,15.12%,LARGE1;MGAT3;RENBP;CHST3;CHST1;NAGK
prerank,regulation of stem cell proliferation (GO:0072091),-0.5081826632275057,-1.2689903125934983,0.182648401826484,0.6026963316568635,1.0,5/17,11.52%,FBLN1;GJA1;ACE;YAP1;KDM1A
prerank,granulocyte chemotaxis (GO:0071621),0.44613333263664573,1.268836909046974,0.16187594553706505,0.6462408816375819,1.0,10/55,11.86%,BSG;TGFB2;PIKFYVE;PIP5K1C;PPIA;PDE4B;CXCR2;CCL1;S100A8;SYK
prerank,regulation of cell adhesion (GO:0030155),0.39857037354948815,1.2684159437711158,0.12449799196787148,0.646363534286048,1.0,30/129,11.99%,FRMD5;PODXL;CXCL12;FES;STX3;CYTH1;ADGRG1;PTPRJ;PTK2;PLXND1;SIPA1;ACVRL1;PRKD2;LYN;TGM2;CCR7;EPHA4;RSU1;ATXN3;ADAM10;RET;PKP4;EFNA1;PPP1CB;ARHGDIA;CBLL1;DUSP1;PLXNB3;PPP3CA;RND1
prerank,brain morphogenesis (GO:0048854),0.5952831960506658,1.268140173476413,0.22309197651663404,0.6461504559888219,1.0,1/12,0.50%,SHANK3
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.499103750135124,1.2681365423950726,0.18312101910828024,0.6451456511081058,1.0,3/30,2.34%,SPTBN1;MACF1;RAB31
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3484008944277041,-1.267836599885136,0.07251908396946564,0.6044541014261178,1.0,28/104,14.36%,BMPR1A;LDLRAD4;NBL1;SMAD3;CRIM1;BMPER;MAGI2;SMAD6;HTRA3;SNX6;TGFBR1;PPARA;RBPMS2;ASPN;SMAD9;EMILIN1;TGFB1I1;CD109;CCN3;SMURF2;PDPK1;SPRED1;VASN;CHRD;BMP2;SKI;HTRA4;SLC2A10
prerank,negative regulation of cell differentiation (GO:0045596),-0.3190117573594353,-1.2674506145704665,0.05128205128205128,0.6039819001864746,1.0,41/181,11.18%,RANBP3L;COL5A2;EGFR;LDLRAD4;ADAMTS12;COL5A1;EFEMP1;SMAD3;CRIM1;BMP5;BMP7;ENPP1;BMP4;ZFPM2;OSR1;SMAD6;ADGRV1;ABCA1;TGFBR1;SUFU;WNT9A;RORA;PPARA;CTR9;IGF2;DTX1;MEIS1;RUNX1T1;TMEM64;JAG1;YAP1;LRP3;SPRED1;TWIST2;ANKRD26;ITGAV;TRPM4;VASN;PTK2B;CHRD;PTHLH
prerank,platelet degranulation (GO:0002576),0.4074794450208987,1.2673053126091933,0.10540184453227931,0.6465174613548945,1.0,21/118,9.65%,ABCC4;PECAM1;PDGFB;TGFB2;APP;LHFPL2;SRGN;SELENOP;VWF;LYN;TMSB4X;CALM1;CFD;ACTN4;CTSW;STXBP1;ACTN1;TGFB1;QSOX1;SCG3;CDC37L1
prerank,sphingoid metabolic process (GO:0046519),0.5958712595894526,1.2670799697511426,0.21731123388581952,0.6461048861020319,1.0,2/12,1.18%,SGPP2;DEGS2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6246187459903492,1.2668484379329077,0.2222222222222222,0.6457729474167152,1.0,3/10,9.05%,SMAD7;FOXP3;MALT1
prerank,Ras protein signal transduction (GO:0007265),0.3976976479521081,1.2667615027983146,0.10533159947984395,0.6450206022618514,1.0,33/137,10.23%,RASGRP3;ARHGEF3;RAPGEF2;NTN1;ELMO1;GRAP;PLEKHG5;ADGRG1;RAPGEF1;TIAM1;PRKD1;RAPGEF3;RIPOR1;GRB2;RREB1;EPS8;GNA12;RHOB;EPS8L2;CDC42EP3;SOS1;DBNL;RASGRP2;NCKAP1;RALB;RAP1B;RGL2;JUN;SHC3;ARHGAP4;PHACTR4;ARHGDIA;CYFIP1
prerank,regulation of myelination (GO:0031641),0.515744716429208,1.2655891938588002,0.19120135363790186,0.6475277518409993,1.0,6/25,9.55%,JAM2;PARD3;TNFRSF21;CST7;PTN;ZPR1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.46264369781096853,-1.2655524645133553,0.16784869976359337,0.6079469266750828,1.0,5/24,5.39%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,regulation of exosomal secretion (GO:1903541),-0.49270563526107436,-1.265256219476882,0.18052256532066507,0.6071834790844636,1.0,5/19,7.96%,ATP9A;SMPD3;TSG101;PRKN;SDC4
prerank,response to amyloid-beta (GO:1904645),0.466278704351361,1.2652344942042917,0.1767515923566879,0.6475678942383271,1.0,7/44,6.25%,IGF1R;CACNA1A;APP;RAMP3;EPHA4;FYN;ATP1A3
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.3772942555315085,1.2652002413951065,0.07407407407407407,0.6466412243388471,1.0,40/234,11.71%,TFRC;PRKCH;APP;CAV1;TIRAP;NFKBIA;CD200;TRIM25;LRP8;TNFRSF11A;TRIM14;FZD4;ARHGEF2;RGCC;NOD1;CD40;NOD2;PRKD1;PRKD2;IKBKB;CTNNB1;PPIA;CRTC1;RPS6KA5;LGALS9;AIM2;BUD31;JMY;CRNN;ARHGEF5;PIDD1;IRAK2;MALT1;UBE2V1;AGER;LAMTOR5;S100A8;TNFSF11;PRKCB;ZBTB7A
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.5304946674929754,1.2651899629976524,0.19145299145299147,0.6456591793459041,1.0,2/22,1.74%,MFHAS1;XDH
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5777794547450327,-1.263985318301625,0.1910828025477707,0.6091534351179286,1.0,5/10,15.12%,DPYD;NT5E;UPB1;UPP2;NT5C1A
prerank,response to nitric oxide (GO:0071731),0.5870493386807681,1.2630068577704805,0.21636363636363637,0.6511571542412921,1.0,4/13,12.80%,FOXO1;KCNC2;CCR7;EGLN1
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.4700684441411589,-1.2623774773609524,0.15544041450777202,0.6121216616314402,1.0,2/22,1.81%,ALDH1A2;RBP1
prerank,regulation of actin filament-based movement (GO:1903115),-0.582540285414886,-1.2620140368068007,0.20861678004535147,0.6116355688891606,1.0,2/10,1.60%,ANK2;PDPN
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6021129963466909,1.2617402102363482,0.23827392120075047,0.6538503955788857,1.0,4/11,5.25%,CXCL12;NOD2;MERTK;CCR7
prerank,regulation of cellular respiration (GO:0043457),0.5577340482181669,1.2611560478982493,0.2065972222222222,0.6545057578854896,1.0,4/17,8.05%,IFNAR1;IL10RB;NOS2;SHMT2
prerank,regulation of interleukin-1 beta production (GO:0032651),0.432230638851789,1.2609068578406135,0.15295815295815296,0.6542264790772417,1.0,16/66,15.03%,TRIM16;APP;NOD2;GBP5;CCR7;LGALS9;AIM2;P2RX7;MALT1;AGER;CASP8;HSPB1;TLR8;TNFAIP3;GIT1;INAVA
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.5331984170502789,1.2608019914922268,0.1854419410745234,0.6535199712403997,1.0,1/24,0.28%,POLK
prerank,vasculature development (GO:0001944),0.563431174139832,1.2605633737980042,0.2,0.6531869131393289,1.0,9/16,10.09%,BMPR2;NOTCH4;FLT4;ACVRL1;APLNR;FOXF1;FBXW7;SOX18;STRA6
prerank,protein trimerization (GO:0070206),-0.5310115312519053,-1.2603686706967885,0.20652173913043478,0.6132391828630693,1.0,3/14,5.18%,SCARA5;SLC1A5;CLYBL
prerank,protein homotrimerization (GO:0070207),-0.5310115312519053,-1.2603686706967885,0.20652173913043478,0.6132391828630693,1.0,3/14,5.18%,SCARA5;SLC1A5;CLYBL
prerank,synaptic vesicle cycle (GO:0099504),0.49888201604214133,1.2603508607608112,0.18344155844155843,0.6528190557545522,1.0,8/30,15.74%,STX1A;WNT7A;PIP5K1C;SYT7;DNAJC5;CPLX1;SLC17A6;NLGN1
prerank,positive regulation of biosynthetic process (GO:0009891),-0.40369711215662607,-1.2602096980957274,0.13505747126436782,0.6120741248351852,1.0,13/40,16.84%,ZBTB20;WNT4;BMP4;PPARA;APOE;CREB3L1;TGFB3;SLC5A3;CYBA;TLR4;LARP6;RUNX1;SUCO
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5687166960804395,1.2600420289750893,0.2130281690140845,0.6527027118398906,1.0,4/17,6.86%,TEK;FES;BAIAP2;HCK
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6170379565457311,1.2599168961015892,0.22882882882882882,0.6520494591968184,1.0,4/10,16.69%,CAV1;ANK3;KCNRG;SUMO1
prerank,nucleotide-sugar metabolic process (GO:0009225),0.5825547369401894,1.259896992177249,0.21032504780114722,0.6511206834271904,1.0,2/12,1.96%,CSGALNACT1;FUT8
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.5875066807371242,1.2597391449915198,0.2413793103448276,0.6505430574430179,1.0,5/11,24.10%,NPPA;AKAP6;KCNIP2;ALG10B;LRRC55
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.523127221436998,-1.2592790767576052,0.18614718614718614,0.6132185745840589,1.0,7/14,21.12%,DPYD;NT5E;UPB1;UPP2;NT5C1A;UMPS;ERH
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5622265682070177,1.2590876278363774,0.20471014492753623,0.6513382122678067,1.0,1/15,0.28%,TENT4A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5220387306206176,1.2580126336800515,0.19120135363790186,0.653487523360153,1.0,12/23,25.14%,NLRC5;HSP90AB1;STAT1;NR1H2;IRGM;PPARG;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2;PARP14
prerank,protein phosphorylation (GO:0006468),0.35399472715125596,1.2578561919351172,0.032362459546925564,0.6529967679311564,1.0,101/479,15.41%,FLT1;IGF1R;PRKCH;TEK;ERG;PDGFB;KDR;INSR;DAB2IP;BMPR2;TGFB2;MAP4K2;APP;CDK17;FES;MAP4K3;FLT4;STK38;PKN3;PTK2;LIPE;SNRK;JAK3;RPS6KA1;ACVRL1;PRAG1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;SMAD7;PPP4R1;CREB1;MAST4;CAMKK2;PKN1;TLR3;STK19;EPHA4;LIMK2;PRKACB;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;RET;AATK;EPHB4;PKN2;HCK;PXK;MARK4;TLR7;TGFB1;MARK3;MAP3K6;PAK1;MAP3K3;EIF2AK4;STK33;PTK6;TRIB2;PRKAB1;ABI3;STK32C;SLK;PRKCB;GTF2H4;GSK3A;SYK;MAP4K4;TGFBR2;EPHB1;HIPK2;CSNK2B;STK24;STK3;MINK1;PIM2;VRK1;SGK1;TBCK;CAMK2B;STK26;CTBP1;GRK6;NEK3;HIPK3;SRMS;ERC1;PLK2;SGK3;SGK2
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.45803765065762625,-1.2572248518292237,0.1607565011820331,0.6172701715479448,1.0,7/22,13.74%,MDFIC;APOD;SUFU;ITGB1BP1;LRRK2;DMTN;LMAN1
prerank,negative regulation of cell projection organization (GO:0031345),-0.39227186395572583,-1.2570276787620844,0.1,0.6163184908784286,1.0,13/48,13.57%,DPYSL3;LPAR1;PTPN9;EFNB2;KANK1;PTPRS;APOE;CBFA2T2;STX1B;MYLIP;RAB29;ADCY6;PTEN
prerank,regulation of apoptotic process (GO:0042981),0.34905031889249494,1.2556937563037995,0.02931937172774869,0.6584343130771783,1.0,82/676,9.05%,LEF1;IGF1R;TFRC;MCF2L;TEK;ITGA6;HIP1;RNF144B;ARHGEF3;TJP1;KDR;BCL2L1;DAB2IP;PPP1R13B;RASGRF2;ACER2;FAS;NET1;UNC13B;NFKBIA;SH3RF1;FLT4;TBX3;HIP1R;TNFRSF25;PLEKHG5;LRP8;PHLPP1;PLAUR;DCUN1D3;TNFSF10;ARHGEF2;PTK2;MEF2C;RYBP;KALRN;FOXO1;JAK3;FOXL2;RPS6KA1;TIAM1;ABR;TGM2;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;RHOB;CAT;CD38;MRE11;PPIA;ACTN4;GRID2;SOS1;ADAM10;TOX3;CRADD;MCL1;STAT1;HCK;RNPS1;ARHGEF12;DNM2;ACTN1;EGLN2;IRF5;LCMT1;JMY;JUN;BIRC3;ARHGEF5;RHBDD1;PIDD1;PRDM9;PREX1;ARHGEF7;TRIM24;GREM1;BNIP3L;MALT1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.43282727754704203,1.2555912460118366,0.17058823529411765,0.6577577938073677,1.0,11/67,5.98%,MYO10;PPP1R16B;PODXL;CAV1;TBC1D14;TBC1D22A;TBC1D2;CCR7;USP6NL;TBC1D24;TBC1D5
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5404257546573947,-1.2552981493202933,0.21656050955414013,0.6197112697028658,1.0,6/11,14.52%,P4HA1;EGLN3;P4HTM;P3H2;OGFOD1;P4HB
prerank,T cell proliferation (GO:0042098),0.5773695256589921,1.2552855814899064,0.22916666666666666,0.657703048103641,1.0,3/13,11.80%,CADM1;MSN;TNFRSF4
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.4986453685266426,1.2550053145642706,0.18016528925619835,0.6575075563922963,1.0,10/30,13.46%,ELOVL7;TECRL;ABCD4;ACOX1;ACSL6;ELOVL5;ABCD1;ELOVL6;SLC27A2;HACD2
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.5271771773876155,1.2547388295911264,0.1950354609929078,0.6572392472232744,1.0,10/21,17.33%,NES;CTNNB1;DLL4;DCT;INSM1;DISC1;LRP2;DISP3;TOX;PROX1
prerank,potassium ion import across plasma membrane (GO:1990573),-0.40188382811970935,-1.2545909331702148,0.11956521739130435,0.620133155850486,1.0,11/41,15.78%,ATP1A2;SLC12A2;KCNJ2;ABCC9;ATP1B3;SLC12A7;ATP1B2;KCNJ13;SLC12A4;KCNJ8;KCNJ15
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.4643753816177206,1.2545251857658255,0.1616,0.6568587473582448,1.0,9/41,9.89%,PDGFB;LRP8;NEDD9;EPHA4;FYN;FBXW7;EFNA1;TGFA;ADAM17
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5641981344808266,1.2536191886284958,0.20404411764705882,0.6585423509682108,1.0,7/14,10.41%,MMRN2;NOTCH1;STARD13;DLL4;CARD10;KLF4;PDCD10
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5476214598014532,1.2536031395257095,0.20207253886010362,0.6576007796538776,1.0,5/19,7.11%,TJP1;NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,carboxylic acid catabolic process (GO:0046395),-0.5426802272520911,-1.2534136263437317,0.2281449893390192,0.6220271076634558,1.0,8/12,29.12%,ACOT8;PON3;RENBP;NAGK;BCKDK;NPL;GNPDA1;IL4I1
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5056443212447554,-1.253052558203088,0.19162995594713655,0.6214331163374907,1.0,2/15,1.85%,GLI3;CD55
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5941114973153095,1.2527935675974524,0.22306238185255198,0.6589012161493167,1.0,5/11,22.25%,CAV1;ADIPOR1;HGS;SH2B3;SOCS1
prerank,inhibitory synapse assembly (GO:1904862),0.5945662298622718,1.2526591218343672,0.2196969696969697,0.6582913079966957,1.0,6/11,25.86%,FGF13;GABRA1;GABRB2;GABRA2;CBLN4;GABRG2
prerank,stem cell development (GO:0048864),0.5524215323972874,1.252425713535852,0.21428571428571427,0.6579560335908174,1.0,6/16,17.63%,CDH2;WNT7A;SNAI2;SOX11;PDCD6;KBTBD8
prerank,thyroid hormone generation (GO:0006590),-0.573467043538507,-1.2521596408648874,0.20359281437125748,0.6225109174425952,1.0,3/10,13.00%,CPQ;SLC5A5;FOXE1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.5793739718576435,1.2521538922680147,0.2322695035460993,0.6578003347613829,1.0,4/13,16.98%,JAK3;PIGU;IL7R;CRLF2
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4394328793792164,-1.2520173031119624,0.16393442622950818,0.6212867377727544,1.0,11/26,19.78%,ADCY5;EFNA5;STXBP4;ANO1;CDK16;TRPM4;PPP3CB;STX4;NR1H4;PLA2G6;ADRA2A
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.4651288850626647,1.2518668566257432,0.18952234206471494,0.6575997684840462,1.0,10/39,9.22%,KDR;TIE1;ENG;RASIP1;NOTCH4;CTNNB1;DLL4;COL4A1;LRP5;PAK1
prerank,male gonad development (GO:0008584),0.47800664663799614,1.2515921763588684,0.1781701444622793,0.6574420470369993,1.0,6/34,10.83%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.5635699514503341,1.2514037329372059,0.20284697508896798,0.6570362098313984,1.0,8/15,26.08%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;ARPC5;WHAMM
prerank,negative regulation of heart contraction (GO:0045822),-0.5572284867363799,-1.2512401114446776,0.208067940552017,0.6219747741837327,1.0,1/11,0.02%,ATP1A2
prerank,positive regulation of protein binding (GO:0032092),0.44386131224607067,1.2512162855381417,0.17091454272863568,0.6565939702255255,1.0,12/56,8.28%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;B2M;EPB41;TIAM1;MEN1;RALB;PIN1;MARK3
prerank,dendritic spine morphogenesis (GO:0060997),0.5736663885376888,1.2512027887671555,0.22279792746113988,0.6556558457447792,1.0,3/15,5.82%,SHANK3;WNT7A;DIP2A
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.48534841494422387,-1.250128576287929,0.16666666666666666,0.6236445953008907,1.0,1/19,0.34%,IGF1
prerank,rRNA metabolic process (GO:0016072),0.38273765491098277,1.2499783043907673,0.11504424778761062,0.6583502126137348,1.0,69/160,28.18%,RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;DEDD2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;MRM2;RPL11;RPS15;TRIR;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;DIS3L;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;XRN1;RPL34;WDR75;EXOSC9;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;RPL24;RPL7A;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS
prerank,neuromuscular process controlling balance (GO:0050885),0.5901479744109519,1.249574466254638,0.23595505617977527,0.6585639678262513,1.0,4/12,11.93%,PCDH15;NRXN1;CLRN1;CDH23
prerank,regulation of axon regeneration (GO:0048679),0.5911022619568569,1.2494927868942585,0.21910112359550563,0.6578364535651351,1.0,6/12,13.36%,SCARF1;EPHA4;INPP5F;PTN;CNTF;STK24
prerank,actin polymerization or depolymerization (GO:0008154),-0.38702318623923526,-1.2482262618224023,0.12941176470588237,0.6274888575921147,1.0,10/50,7.33%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;SVIL;VILL;DIAPH1;ABI2
prerank,cellular metal ion homeostasis (GO:0006875),-0.3388575729111099,-1.2477468161948053,0.09090909090909091,0.6273309904736365,1.0,16/102,8.19%,ATP1A2;SLC24A3;ANK2;ATP13A5;SLC41A1;STIM1;SLC8A3;SLC12A2;DMPK;ATP13A3;KCNJ2;ATP1B3;SLC8B1;ATP1B2;SLC8A1;PTH1R
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.4772358496035647,-1.2474354576634736,0.18439716312056736,0.6266825319201166,1.0,4/19,11.34%,IGF1;FLOT2;APOE;RTN1
prerank,cellular response to amyloid-beta (GO:1904646),0.4785609769213963,1.247204772416583,0.18845500848896435,0.6635320355770868,1.0,6/35,6.25%,IGF1R;CACNA1A;APP;EPHA4;FYN;ATP1A3
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.5237995643546386,1.2471835758020324,0.22033898305084745,0.6626263862469366,1.0,6/20,13.17%,EPAS1;DCUN1D3;HSP90AB1;UBQLN1;HIF1A;DCUN1D1
prerank,protein localization to cell periphery (GO:1990778),0.3911525899746956,1.246420693616335,0.11424903722721438,0.6638688368144381,1.0,25/133,10.90%,EFR3B;BSG;SPTBN1;RAPGEF2;CAV1;TSPAN5;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C
prerank,apoptotic process (GO:0006915),0.37488419145552343,1.2461213305666003,0.11887254901960784,0.6637696390211033,1.0,23/203,6.76%,HIP1;SEMA6A;BCL2L1;TNFRSF19;APP;FAS;TBX1;PPARD;MAL;ELMO1;NFKBIA;TNFRSF25;MAGI3;FOXO1;ADAM15;ZBTB16;TNFRSF21;RHOB;PPIA;BIK;PAK5;CASP7;NCKAP1
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.5647697683504627,1.2455606408084436,0.2423076923076923,0.6643625027018921,1.0,1/14,0.33%,SEMA7A
prerank,regulation of cholesterol storage (GO:0010885),0.5649987914759755,1.2453346226950375,0.21554770318021202,0.6640998181949473,1.0,6/15,14.14%,PPARD;SCARB1;ABCG1;NR1H2;PPARG;MSR1
prerank,regulation of immune effector process (GO:0002697),-0.4081644430244755,-1.2450035131728707,0.15281501340482573,0.6321225811951241,1.0,4/41,2.01%,SERPING1;VTN;CD55;CFH
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.35587900562996966,-1.2445073519023395,0.09698996655518395,0.6319518950471404,1.0,18/79,9.03%,SULF1;BMPR1A;ADAMTS12;NBL1;CRIM1;BMPER;SLIT2;SMAD6;HTRA3;SULF2;CASK;THBS1;FGF2;RBPMS2;SMAD9;EMILIN1;SMURF2;CREB3L1
prerank,regulation of embryonic development (GO:0045995),0.4818723586989822,1.2443436283961213,0.18425460636515914,0.6659397085262037,1.0,4/34,2.11%,PLCB1;INSR;B4GALT5;SOX17
prerank,protein targeting (GO:0006605),0.39494090328286163,1.2443102554148142,0.14435695538057744,0.6650443889791173,1.0,39/118,21.23%,AQP11;RASSF9;ZDHHC14;PARD3;PIKFYVE;TOMM22;ZDHHC9;ZDHHC20;ZFAND2A;ZDHHC19;SRP14;TIMM13;RTP4;AP1S3;ZDHHC18;ZDHHC22;TIMM10;AP4S1;DNAJC19;SPCS2;RPL11;SDCBP;NACAD;EDEM1;AKAP6;HACL1;MFF;NLGN1;RTP3;ZDHHC21;PEX16;TOMM7;VPS37A;MYO1C;LONP2;VPS37B;TOMM5;SPCS1;GABARAP
prerank,positive regulation of dendritic spine development (GO:0060999),0.525128203050157,1.2441155436828897,0.20623916811091855,0.6646283728828131,1.0,3/20,6.37%,SHANK3;LRP8;DBNL
prerank,"base-excision repair, AP site formation (GO:0006285)",0.5449324189938087,1.2439876435242097,0.2120689655172414,0.6640205155429433,1.0,6/17,12.47%,NTHL1;TERF2;SMUG1;ACD;MPG;TERF1
prerank,positive regulation of protein polymerization (GO:0032273),0.4318265804797952,1.2437356182264008,0.17604617604617603,0.6637881964167213,1.0,24/65,21.32%,OCLN;FES;EVL;CLIP1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;FCHSD1;NCK1;PRKCE;TENM1;BIN1;TPPP;DCTN1;CDC42EP1;CLASP1;BAIAP2L1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.4157580885130466,1.2430703711083022,0.15027322404371585,0.6647129728739198,1.0,26/86,18.12%,OCLN;APP;FES;EVL;VIL1;CLIP1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;CDK5RAP2;PAK1;AKAP9;RAC1;NCKAP1L;FCHSD1;EDN1;NCK1;TRPV4;PROX1;PRKCE;TENM1;BIN1;WDR1;COLGALT1
prerank,negative regulation of cell motility (GO:2000146),0.4008264107043617,1.2429846387466386,0.14,0.6639653101306104,1.0,15/108,5.52%,LIMCH1;DACH1;FRMD5;CLDN5;SRGAP3;SRGAP2;SRGAP1;ENG;PTPRJ;ADAM15;ACVRL1;DUSP3;SMAD7;RHOB;EPHA4
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5812398743098474,1.2420706044388612,0.23118279569892472,0.6657237550686675,1.0,3/14,10.15%,TLR3;ZCCHC3;OASL
prerank,diol biosynthetic process (GO:0034312),0.552529569285995,1.2417091195555667,0.2218370883882149,0.665876558499103,1.0,6/15,14.82%,ACER2;GCH1;ACER1;SPTLC2;SPTLC1;QDPR
prerank,regulation of complement activation (GO:0030449),-0.40946449966610515,-1.2416330418824797,0.14285714285714285,0.638732007001053,1.0,4/40,2.01%,SERPING1;VTN;CD55;CFH
prerank,regulation of defense response (GO:0031347),0.416094932493445,1.2414436324001696,0.17372881355932204,0.6657265098915043,1.0,16/76,11.38%,SEMA7A;IL1R1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4;USP18
prerank,positive regulation of dephosphorylation (GO:0035306),0.49639615571605505,1.2413604808828533,0.21357615894039736,0.6649568961120212,1.0,8/27,13.45%,PPP1R16B;CALM1;PPIA;PPP2R5A;PIN1;TGFB1;NSMF;CDH5
prerank,negative regulation of locomotion (GO:0040013),0.5954614902852164,1.241207582613977,0.24074074074074073,0.6644546198767993,1.0,3/12,8.04%,FRMD5;DUSP3;PIN1
prerank,positive regulation of insulin secretion (GO:0032024),-0.4089357469853543,-1.2406742478979302,0.15363881401617252,0.6400223115653145,1.0,9/36,11.27%,MCU;NLGN2;RBP4;IRS2;NNAT;ANO1;TRPM4;AACS;PPP3CB
prerank,sensory organ development (GO:0007423),-0.38750539858997524,-1.240451033093877,0.1518624641833811,0.639117519713782,1.0,8/51,6.51%,PBX1;SMOC1;RBP4;SH3PXD2B;FOXC1;PBX4;MEIS1;PBX3
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.509042382897009,1.2404391301985722,0.20751633986928106,0.6656542445830308,1.0,7/25,14.70%,ETS1;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,neuron projection extension (GO:1990138),-0.42361445633565054,-1.2400724820814524,0.1544943820224719,0.6385754321934812,1.0,9/32,13.78%,ALCAM;AUTS2;IMPACT;ULK2;FLRT1;SPG11;PPP3CB;CDKL3;USP9X
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.5183518643936377,1.2397986258628422,0.21739130434782608,0.6655716018284212,1.0,8/23,17.11%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.5183518643936377,1.2397986258628422,0.21739130434782608,0.6655716018284212,1.0,8/23,17.11%,PPP1R13B;PPP3CC;YWHAH;YWHAQ;CASP8;PPP3R1;YWHAZ;YWHAB
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.533872667895506,1.239726836545738,0.2233502538071066,0.6648308888936147,1.0,5/19,4.57%,SEMA6A;JCAD;DAB2IP;XDH;TSPAN12
prerank,neuropeptide signaling pathway (GO:0007218),0.4356723521478994,1.2385891299123997,0.18456883509833585,0.667042772234642,1.0,14/58,19.26%,RAPGEF2;HCRTR1;NPPA;SORT1;SORCS1;HCRTR2;CYSLTR1;PPY;RXFP3;OPRD1;SSTR1;NTS;CPE;GLRA2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.47133211387540824,1.2380738477699509,0.20754716981132076,0.6675369080964519,1.0,7/38,6.45%,INSR;CD34;CAV1;DDAH1;KLF2;HSP90AB1;KLF4
prerank,cobalamin metabolic process (GO:0009235),0.5351531103500788,1.237982171049142,0.22916666666666666,0.6668268470761234,1.0,8/17,24.20%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,positive regulation of response to external stimulus (GO:0032103),0.39260860183726504,1.2374252812375197,0.13730569948186527,0.6674106132191802,1.0,22/128,12.73%,ETS1;PDGFB;PDE2A;APP;SCARF1;NFKBIA;STX3;GBP5;HYAL2;MGST2;TLR3;ZCCHC3;TLR7;TGFB1;PTN;OASL;CNTF;CCL1;TLR8;S100A8;IL15;DDT
prerank,establishment of epithelial cell polarity (GO:0090162),0.534406720214154,1.2370558797404074,0.21616871704745166,0.6674836349477862,1.0,5/19,8.79%,CYTH1;PARD3;CYTH3;OPHN1;MSN
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.5092155565217148,1.236691054246322,0.21428571428571427,0.6675894788141986,1.0,2/24,2.72%,ABCG2;ALAS1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.47152849992610446,1.2363541384878542,0.22870662460567823,0.6676061134703808,1.0,12/39,21.63%,POLK;NTHL1;GTF2H2;GTF2H4;FAN1;RBX1;RPA1;POLD1;GTF2H3;RFC2;DDB1;ERCC4
prerank,negative regulation of viral genome replication (GO:0045071),0.4547376067845753,1.2363071942602213,0.20222929936305734,0.6668021686422665,1.0,13/40,18.09%,IFIH1;BTBD17;N4BP1;BST2;BANF1;OASL;TASOR;SLPI;SETDB1;ZC3HAV1;HMGA2;PROX1;TNIP1
prerank,epithelial cell differentiation (GO:0030855),-0.35434138779983193,-1.2353883235329162,0.10294117647058823,0.6509852636671057,1.0,17/88,11.03%,FSTL1;MAF;FGFR2;BMP4;DAB2;SCUBE1;ANXA1;ANXA4;SIX1;FZD7;CNN3;GLI1;JAG1;KDM6B;BDH2;GATA6;TAGLN
prerank,endothelial cell differentiation (GO:0045446),0.5805170512522001,1.23502346922645,0.24738675958188153,0.6695239438194933,1.0,5/12,7.20%,KDR;TIE1;BMPR2;ACVRL1;SOX18
prerank,histone modification (GO:0016570),-0.3362656459557264,-1.234959684846232,0.08540925266903915,0.6506310481248679,1.0,22/109,15.82%,EYA2;EYA1;EYA4;HDAC4;PRKCD;BAZ1B;EHMT2;TBL1XR1;MIER3;MAP3K12;KAT6B;SGF29;MORF4L2;HUWE1;USP3;SIRT2;PRMT8;BRD8;EP300;MRGBP;UBE2B;MTA3
prerank,negative regulation of protein catabolic process (GO:0042177),-0.4046778920917272,-1.2349395143436526,0.16230366492146597,0.6491012375455681,1.0,10/40,11.30%,EGFR;TIMP2;TIMP3;PTPN3;MDM4;SNX12;FLNA;SNRNP70;AZIN1;IRAK3
prerank,response to peptide (GO:1901652),0.48529117602955407,1.2348325741805006,0.20327868852459016,0.6691308126750707,1.0,9/33,10.81%,CACNA1A;NOD2;RAMP3;FYN;STAT1;IRF5;EIF2B1;AGER;EIF2B2
prerank,entry into host (GO:0044409),0.566924677538539,1.2348075131954421,0.22794117647058823,0.6682625239512637,1.0,6/13,10.31%,GRB2;CTNND1;CTNNB1;CD4;PPIA;CBLL1
prerank,negative regulation of growth (GO:0045926),0.39049868337789495,1.2335125080797977,0.12630208333333334,0.6709095315851897,1.0,30/121,13.52%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;ACVRL1;CCDC85B;NOTCH1;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2;NAIF1;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,positive regulation of leukocyte activation (GO:0002696),-0.49100577170065496,-1.2333663614092167,0.20714285714285716,0.6521161305624722,1.0,4/18,14.74%,LBP;THBS1;TNIP2;TLR4
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5405121364910983,-1.2330581826608031,0.21961620469083157,0.6515489499366905,1.0,4/10,10.30%,GFPT1;PFKP;HK2;GFPT2
prerank,purine ribonucleotide catabolic process (GO:0009154),0.5164638212039202,1.2328509848199514,0.24057450628366248,0.6719551117224251,1.0,8/21,11.08%,PDE2A;XDH;HPRT1;PDE4D;HINT1;NT5C2;NUDT3;PNP
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5297946121184242,1.2326522327150862,0.23076923076923078,0.6715494167630524,1.0,9/18,20.23%,SAMHD1;OGA;NEU4;STT3B;FBXO6;MANBA;NEU2;FBXO2;AOAH
prerank,regulation of immune response (GO:0050776),0.3864268091535666,1.2325651459625941,0.13324873096446702,0.6708258184168031,1.0,26/135,12.67%,CD34;TGFB2;CLEC2D;TIRAP;CD200;LRP8;B2M;CD40;LYN;ICAM2;SAMHD1;CD19;PILRA;XIAP;PVR;N4BP1;CD160;BIRC3;CD200R1;FOXP3;CD8B;CASP8;DENND1B;KIR3DL2;SYK;IL15
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.579277318585174,1.2319498425702993,0.23809523809523808,0.6716943800681091,1.0,4/14,9.05%,TIRAP;CARD10;TLR3;MALT1
prerank,regulation of protein processing (GO:0070613),-0.45596271223655604,-1.231831167885168,0.17798594847775176,0.6535700633897625,1.0,8/21,16.02%,CCBE1;GAS1;SNX12;CLN3;LRRK2;NKD2;SERPINE2;RUNX1
prerank,sterol transport (GO:0015918),0.5245017170231008,1.2318150395957024,0.24113475177304963,0.6711281398063323,1.0,4/19,14.14%,CAV1;OSBP;NPC1;MSR1
prerank,mitotic chromosome condensation (GO:0007076),0.4968411525082756,1.2315368761178738,0.224283305227656,0.6710308582131747,1.0,8/26,18.75%,TENT4A;NCAPH;MCPH1;NCAPG;CSNK2B;TTN;NCAPH2;SET
prerank,regulation of calcium ion transport (GO:0051924),-0.3814106478331429,-1.2314883792768045,0.16025641025641027,0.6529402429708688,1.0,13/54,8.87%,ANK2;MYLK;STIM1;IL16;CACNA2D1;PKD2;EFHB;SLC8B1;P2RX4;BCL2;CACNA1D;TRPC6;SARAF
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.37237863177382985,1.2314806828111728,0.11206896551724138,0.6702894523996085,1.0,26/182,6.45%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;APP;XDH;MEF2C;ANKRD13A;ACVRL1;APLNR;RIN3;NOTCH1;NOS2;GATA2;NOCT;DLL4;HSP90AB1;DIP2A;ADAM10;FBXW7;LGALS9;KLF4
prerank,regulation of multicellular organism growth (GO:0040014),0.5387811489843319,1.231153194302858,0.21880650994575046,0.6702457073509414,1.0,2/15,1.57%,MFSD2A;APP
prerank,regulation of sister chromatid cohesion (GO:0007063),0.5890717704165138,1.2307432830593177,0.2423146473779385,0.6704523764375973,1.0,6/12,21.73%,CTNNB1;AXIN2;CTCF;RAD21;DDX11;WAPL
prerank,epithelial to mesenchymal transition (GO:0001837),0.45263369471106085,1.2304901470189042,0.17620481927710843,0.6702779372752332,1.0,8/47,5.99%,LEF1;ENG;TGFB2;NOTCH4;TBX3;NOTCH1;CTNNB1;SNAI2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4859336688701146,-1.229992811674111,0.22249388753056235,0.6558857834718259,1.0,6/17,10.12%,ATP1A2;CACNA1C;GJA1;ATP1B2;SLC8A1;PRKACA
prerank,protein localization to plasma membrane (GO:0072659),0.3876467344740849,1.2295546141181726,0.13298565840938723,0.6719942051600062,1.0,25/129,10.90%,EFR3B;BSG;SPTBN1;RAPGEF2;TSPAN5;F11R;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;CCDC88A;DENND4C;MAP7;STXBP1;RAB11A;FCHO2;RAB34;TMEM88;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C
prerank,response to cytokine (GO:0034097),0.3826955888207874,1.2291208804803662,0.12403100775193798,0.6723306271597316,1.0,30/141,10.45%,LEF1;BCL2L1;APP;IL1R1;MAP4K3;IL6R;GCH1;TNFRSF11A;SP100;IFNAR2;JAK3;CD40;PTPN12;SIGIRR;ADAR;OSMR;CCR7;XAF1;ADAM10;LGALS9;MCL1;STAT1;BST2;CRNN;SHMT2;IRAK2;PTPN5;LIFR;KLHL20;CASP8
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5165258837737756,-1.2288877655065882,0.23863636363636365,0.6575502704136239,1.0,2/13,1.89%,GLI2;BMP4
prerank,gluconeogenesis (GO:0006094),-0.3998268679914349,-1.2286675870344246,0.19289340101522842,0.6566319493300112,1.0,12/39,22.43%,RBP4;SLC39A14;PPARGC1A;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;ENO3;PGK1
prerank,regulation of multicellular organismal development (GO:2000026),0.4957793318396513,1.2283675184473988,0.218213058419244,0.6735345073396929,1.0,4/25,10.17%,INSR;SOX17;PTN;MYSM1
prerank,cardiac ventricle development (GO:0003231),0.5145382755808451,1.2274130846547937,0.21934369602763384,0.6752475602504407,1.0,6/20,10.09%,ENG;PDE2A;NOTCH1;DLL4;HECTD1;STRA6
prerank,cellular response to cAMP (GO:0071320),0.48887947245840285,1.227215808399846,0.2049306625577812,0.6748766686472037,1.0,10/30,13.66%,PDE2A;RAPGEF2;RAPGEF1;RAPGEF3;KCNQ1;RAP1B;AKAP9;ZFP36L1;HCN2;AKAP6
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.46714272590025646,-1.227068592546419,0.21395348837209302,0.6597571031389546,1.0,9/18,30.18%,EHMT2;SETD7;SETD4;SETD2;EEF1AKMT2;SMYD2;SETMAR;KMT2A;SETD1B
prerank,leukocyte cell-cell adhesion (GO:0007159),0.5062268005241426,1.2265047151839623,0.23305785123966943,0.6759634561033886,1.0,8/24,19.97%,PECAM1;F11R;MSN;SYK;VCAM1;ITGA4;TNIP1;SEMA4D
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.3516291344780293,-1.2263344305519213,0.11724137931034483,0.6603142343341251,1.0,17/80,15.70%,SAMD4A;PLD1;ROCK2;SLC2A13;THBS1;PRKCD;SMPD3;PLXNB2;SIRT3;FXR2;NSMAF;EIF3C;FMR1;DDX3X;CASP3;LARP6;YTHDF1
prerank,urogenital system development (GO:0001655),-0.5404389158291226,-1.2257253771014274,0.22746781115879827,0.6604817359150233,1.0,3/11,7.23%,OSR1;ANXA1;EPHB2
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.5301282611206963,1.225474647107839,0.2265193370165746,0.6778788882587038,1.0,5/20,15.22%,BCL2L1;FAS;MCL1;GSK3A;DCC
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.5555696382183791,1.2246944015842194,0.23304347826086957,0.6791752253195422,1.0,1/16,0.25%,ETS1
prerank,cellular component assembly (GO:0022607),0.35583022517400964,1.2243354543972138,0.10477299185098952,0.6793002610510748,1.0,60/253,17.36%,OCLN;SLC2A1;PARVB;SPTBN1;LIMS2;SHROOM1;FAS;MAGI1;NEDD9;CD40;PARD3;CD2AP;PLS3;ACTB;VIL1;WNT7A;EPS8;CARD10;RP1;BAIAP2;ABCA3;FAM107A;PARVG;NCKAP1;CLDN14;TTLL3;TGFB1;OPHN1;QSOX1;CAPG;ACTG1;RSPH4A;CYFIP1;DCX;PDCD10;FERMT2;ACD;PEX14;RAC1;FSCN3;CHAF1A;RANBP9;RSPH1;SOX9;FSCN1;FOXJ1;RHOV;SH3BGR;NCKAP1L;ELOB;NLGN1;APC;HAS3;CHAF1B;ANK3;GAS6;IL1RAP;YWHAZ;RAD21;BAG6
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.44553527290290024,-1.2240958607748242,0.2044334975369458,0.6637578176990204,1.0,5/22,8.92%,NOTCH2;FGFR2;CASK;STXBP4;SRSF6
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.4949161521766432,-1.2238640292819527,0.21700223713646533,0.6629150074487216,1.0,2/14,5.56%,AUTS2;CTR9
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.5620163446769698,1.223764173864049,0.26022304832713755,0.6800689698861786,1.0,4/13,7.16%,CAV1;CALM1;PDE4D;SRI
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4529583063901073,-1.2236506224509882,0.21153846153846154,0.661959774849957,1.0,13/21,30.58%,DCDC2;SMO;GLI1;EVC;ARMC9;KIF7;SFRP1;TTC23;STK36;PDCL;TXNDC15;SHH;ULK3
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.5141830330848196,-1.2236130322189431,0.22444444444444445,0.6604840700360085,1.0,3/13,8.74%,TNRC6A;AGO2;TNRC6B
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.5850910889875938,1.2235375415971794,0.23783783783783785,0.679783049312801,1.0,4/11,8.89%,TGFB2;MEF2C;TGFB1;GREM1
prerank,positive regulation of embryonic development (GO:0040019),0.5191344429808151,1.2231645689023785,0.24179620034542315,0.6799827100734733,1.0,2/19,2.10%,PLCB1;B4GALT5
prerank,negative regulation of lymphocyte migration (GO:2000402),0.6057737862826171,1.2225701137759204,0.2737030411449016,0.6807473472797928,1.0,3/10,8.06%,LRCH1;CD200;CD200R1
prerank,nucleotide metabolic process (GO:0009117),-0.44914290594494055,-1.2223771206118874,0.18461538461538463,0.6625333293834827,1.0,4/23,5.27%,FHIT;NMNAT2;ME1;ENPP3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3901149359301494,-1.2223498796222125,0.13714285714285715,0.6610447363299627,1.0,11/46,16.03%,ZIC1;SMAD3;CDH1;PRKCD;FLNA;UBR5;PSEN1;EMD;BAG3;PIK3R1;CAMK1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.5314023795585788,1.2221763497646772,0.25573192239858905,0.6809465302174766,1.0,3/17,2.51%,CAV1;APOLD1;KLF7
prerank,positive regulation of protein depolymerization (GO:1901881),0.5955495217211296,1.222147293246457,0.2572992700729927,0.6800942363426756,1.0,4/11,18.01%,NES;VIL1;TRPV4;WDR1
prerank,inorganic cation transmembrane transport (GO:0098662),-0.2932397864941676,-1.221711054644548,0.03289473684210526,0.6614960862872128,1.0,31/268,5.61%,ATP1A2;SLC24A3;TRPM3;CACNA1C;KCNK2;NALCN;SLC6A13;SLC1A3;SLC41A1;SCN7A;SCARA5;SLC6A12;PKD1;SLC30A10;KCNK5;SLC8A3;SLC6A9;SLC12A2;ANO6;SLC39A14;PKD2;SLC9A2;KCNJ2;TRPC3;CACNA1G;ABCC9;ATP6V0A4;TRPM6;ATP1B3;KCNQ4;SLC6A1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.46893459801065074,1.2214631224957924,0.19334389857369255,0.6811207345304384,1.0,6/35,6.89%,DAB2IP;RASIP1;TGFB2;HEG1;STMN1;STMN3
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.4775234499742064,1.221114240423421,0.2315112540192926,0.6812376631429485,1.0,6/29,11.00%,CXCL12;JAM2;CCR7;LGALS9;AGER;CCL1
prerank,B cell differentiation (GO:0030183),0.4470796971773369,1.2211114562192722,0.2018348623853211,0.6803281558536156,1.0,16/46,17.84%,TPD52;PTPRJ;JAK3;HDAC9;HHEX;SLC25A5;CD79A;KLF6;ADAM17;ZBTB7A;VCAM1;HDAC5;DNAJB9;MSH2;ITGA4;ADGRG3
prerank,activin receptor signaling pathway (GO:0032924),-0.4968574477383112,-1.2205187408083742,0.22170900692840648,0.6635032254733755,1.0,7/15,30.22%,SMAD3;TGFBR1;ACVR1B;INHBB;INHBA;SMAD2;AMHR2
prerank,positive regulation of lamellipodium organization (GO:1902745),0.4748007616123115,1.2203358528878245,0.2181208053691275,0.6816073857564849,1.0,11/32,11.43%,OCLN;WASF2;VIL1;RREB1;NCKAP1;TWF2;ARHGEF7;ENPP2;CYFIP1;CLRN1;RAC1
prerank,proteoglycan biosynthetic process (GO:0030166),0.4819803378877533,1.2201199408248637,0.21371610845295055,0.6813105651736123,1.0,4/31,2.89%,CSGALNACT1;BMPR2;EXTL3;CHST11
prerank,phagolysosome assembly (GO:0001845),0.5688935161430442,1.2200554780924466,0.2682926829268293,0.680543810469452,1.0,4/12,7.82%,PIKFYVE;SYT7;RAB34;RAB39A
prerank,negative regulation of neurogenesis (GO:0050768),0.47475100297168404,1.2200129539647588,0.1942675159235669,0.6797477796667689,1.0,7/34,9.68%,RAPGEF2;B2M;NOTCH1;WNT7A;YWHAH;PTN;ARHGDIA
prerank,carbohydrate homeostasis (GO:0033500),0.4249539509105774,1.2184124430270742,0.17862371888726208,0.683309742378691,1.0,5/67,4.99%,IGF1R;INSR;ADIPOR2;KLF7;CYP11B1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5873532689430282,1.218294893080379,0.26095238095238094,0.6827091840196361,1.0,3/10,7.63%,DAB2IP;EPHA4;EFNA1
prerank,negative regulation of apoptotic process (GO:0043066),0.34598494621836134,1.2178337910505495,0.08424507658643327,0.683132155244123,1.0,59/444,10.86%,LEF1;IGF1R;TFRC;PRKCH;TEK;NDNF;RNF144B;TJP1;KDR;BCL2L1;CAV1;FAS;TBX1;NFKBIA;SH3RF1;FLT4;TBX3;PLAUR;PTK2;MEF2C;FOXO1;RPS6KA1;NOTCH1;MERTK;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;CAT;CD38;MRE11;SNAI2;MAPK3;ADAM10;KLF4;TOX3;RETREG1;MCL1;HCK;POU3F4;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;FOXQ1;ARHGDIA;PTRH2;KLHL20;PDCD10;MGMT;CNTF;THOC6;HSPB1;LRP2;LAMTOR5
prerank,autonomic nervous system development (GO:0048483),0.5410884524540983,1.2176503295326482,0.23156089193825044,0.6827340290181804,1.0,5/17,12.63%,KIF26A;PHOX2A;PHACTR4;SOX10;SOX11
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5019299747679971,-1.217562793257398,0.21951219512195122,0.6706297911197079,1.0,5/15,17.87%,BMP4;SMO;SIX1;SIX4;PAX2
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4525120876744338,1.2168902559419985,0.222052067381317,0.6840193704460131,1.0,7/40,5.02%,LEF1;TGFB2;RGCC;TIAM1;NOTCH1;CTNNB1;WWTR1
prerank,cellular response to interferon-gamma (GO:0071346),0.4007612106813428,1.2166687970316774,0.18723994452149792,0.683730610073453,1.0,17/88,11.89%,TRIM25;B2M;SP100;GBP7;GBP4;GBP5;IRF2;IRF9;LGALS9;STAT1;HCK;IRF5;RPL13A;OASL;PDE12;CCL1;MID1
prerank,canonical Wnt signaling pathway (GO:0060070),0.42418638517009316,1.2161139261436722,0.2134502923976608,0.6844631386770589,1.0,8/68,5.83%,LEF1;FZD6;CAV1;FZD4;WNT7A;CTNNB1;FRAT2;TCF7
prerank,cellular response to reactive oxygen species (GO:0034614),-0.36302843276960395,-1.2160996276715716,0.15669515669515668,0.6732658576166511,1.0,13/59,11.95%,EGFR;PDGFRA;TPM1;MAP3K5;IMPACT;PRKCD;PKD2;ANXA1;CYP1B1;FXN;CHUK;MPV17;ABL1
prerank,protein polyglutamylation (GO:0018095),0.5864193921866854,1.2158031225705253,0.26703499079189685,0.6844441754694367,1.0,2/11,5.28%,TTLL7;TTLL5
prerank,regulation of histone modification (GO:0031056),-0.49778073631391806,-1.2157142677793766,0.24203821656050956,0.6729098622799075,1.0,7/13,18.57%,IGF2;AKAP8L;MTHFR;NNMT;SETD5;MYOCD;FLCN
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5016862312501058,-1.2155525364578421,0.24285714285714285,0.6718123120414405,1.0,4/14,4.34%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.4844678909816981,-1.2154662706732797,0.24305555555555555,0.6705196990305299,1.0,4/16,10.98%,PID1;PPARGC1A;PPARA;PARP1
prerank,regulation of ERAD pathway (GO:1904292),0.5889155248313719,1.2153671865575688,0.25788497217068646,0.6847483753315491,1.0,5/11,19.23%,AQP11;ATXN3;UBXN1;BAG6;USP25
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5388687928278153,-1.2151286890737159,0.24480369515011546,0.6699819171741855,1.0,5/11,9.05%,WNT5B;RSPO3;DAB2;PLEKHA4;MLLT3
prerank,negative regulation of proteolysis (GO:0045861),-0.4106734868784683,-1.2149513645048198,0.19289340101522842,0.6689643889790439,1.0,9/34,13.65%,TIMP2;TIMP3;PTPN3;GAS1;SNX12;ECM1;CLN3;LRRK2;SERPINE2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5724857287486771,1.214787162772499,0.2593320235756385,0.6854147862030295,1.0,4/11,6.44%,FAS;PLAUR;ST18;LGALS9
prerank,positive regulation of metabolic process (GO:0009893),0.39143242252008376,1.2140075841708455,0.16895604395604397,0.6866769449479787,1.0,12/103,7.53%,IGF1R;EPAS1;INSR;ADIPOR2;GATM;CAV1;FASN;UCP2;OXTR;ACACB;YBX2;IL4R
prerank,protein localization to membrane (GO:0072657),0.36571471363423314,1.2135912721987236,0.1292270531400966,0.6869662511335362,1.0,35/187,11.87%,EFR3B;BSG;SHANK3;SPTBN1;RAPGEF2;CAV1;TSPAN5;F11R;AGRN;FGF13;TSPAN14;RAMP2;IKBKB;RAMP3;DENND4C;ABHD17A;MAP7;STXBP1;LRRC7;RAB11A;FCHO2;RAB34;TMEM88;PTN;NRXN1;NPC1;ZDHHC22;SMURF1;RAB3B;PACS1;EHD4;RAB40C;FERMT2;NUP54;SH3GLB1
prerank,erythrocyte development (GO:0048821),0.609231655992727,1.2127249553273205,0.2681992337164751,0.6884573750188815,1.0,5/10,18.52%,ALAS1;ZBTB7A;NCKAP1L;LYAR;SH2B3
prerank,Golgi organization (GO:0007030),-0.3290388777931017,-1.212485329285241,0.13478260869565217,0.6747120650433075,1.0,43/112,24.15%,RAB30;GBF1;OBSL1;TANGO2;ARHGAP21;GOLGB1;FBXW8;FAM174B;DYNC2H1;GOLGA2;SEC16B;PI4K2B;STX5;COG4;CUL7;ARL1;HUWE1;LRRK2;GORASP2;PRMT5;ATP8B2;RAB29;ATP8B1;BCAS3;PLEKHM2;SEC16A;LMAN1;STX16;PLK5;SURF4;OPTN;BLZF1;GOLGA5;GOLGA8B;ATL3;TMED4;LMAN2L;SEC23IP;TMED9;MYO18A;UBXN2A;HTT;TJAP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.49703076230673254,1.2119407085871436,0.2512,0.6897653463638465,1.0,6/25,10.36%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.45781913405606556,-1.2119286748975406,0.2136150234741784,0.6746709034026164,1.0,8/19,16.84%,WNT4;BMP4;EMILIN1;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,negative regulation of mitochondrion organization (GO:0010823),0.47261489628447634,1.2116589937310465,0.22617124394184168,0.6896701096944755,1.0,5/33,10.14%,TFRC;BCL2L1;SLC25A5;VAT1;GHITM
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.47241209160048475,-1.211429414417783,0.2267818574514039,0.6745265035243404,1.0,5/17,5.02%,ATP1A2;TFPI;BMP7;BMP4;AR
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3738510697829277,1.2109566253758997,0.14846625766871166,0.690926350653304,1.0,29/158,11.70%,TFRC;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TNFSF10;TRIM14;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;LGALS9;BST2;BIRC3;MALT1;MAP3K3;NDFIP2;UBE2V1;SHARPIN;CASP8;BRD4;LAMTOR5;PRKCB;GPR89A
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5223276293656082,1.2109052761879677,0.24534686971235195,0.6901531144002875,1.0,8/19,21.66%,TERF2;HNRNPC;ACD;DCP2;TERF1;EXOSC10;XRN1;PINX1
prerank,regulation of erythrocyte differentiation (GO:0045646),0.4653345591714871,1.210805950785504,0.2304075235109718,0.6895402255900132,1.0,10/35,14.70%,ETS1;ZFPM1;LYN;TAL1;STAT1;HIF1A;ZFP36L1;BRD1;HMGB2;NCKAP1L
prerank,negative regulation of MAPK cascade (GO:0043409),0.4023641365189985,1.2105306564324643,0.18398876404494383,0.6894590706311002,1.0,16/87,8.58%,SEMA6A;DAB2IP;CAV1;CNKSR3;STK38;PTPRJ;DUSP7;FOXO1;DUSP3;LYN;HYAL2;PPIA;PTPRR;PIN1;ABCA7;P2RX7
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.5747441748225006,1.210456060538922,0.24538745387453875,0.6887730650510471,1.0,5/14,19.74%,ENTPD1;ENTPD5;NUDT9;NUDT1;NUDT16
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5021918700240511,1.2101148559482917,0.24108658743633277,0.6878881607731437,1.0,6/22,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5021918700240511,1.2101148559482917,0.24108658743633277,0.6878881607731437,1.0,6/22,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,fatty acid transport (GO:0015908),0.5407552268296122,1.2097544359076522,0.27079646017699116,0.6879866936862281,1.0,2/17,1.88%,MFSD2A;PPARD
prerank,negative regulation of actin filament polymerization (GO:0030837),0.49381018061322524,1.2091916874257416,0.2538860103626943,0.6886670779345734,1.0,7/22,8.14%,KANK3;HIP1R;SSH2;VIL1;TMSB4X;TMSB10;TWF2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.4492614337000392,1.2090390890886384,0.22376543209876543,0.6882238556189938,1.0,8/43,8.09%,ETS1;PDGFB;TGFB2;PPARD;GATA2;KLF4;JUN;TGFB1
prerank,regulation of protein binding (GO:0043393),0.3867855410637813,1.2085047907603952,0.16733067729083664,0.6888034214020434,1.0,14/114,3.87%,CLDN5;PDGFB;RAPGEF2;APP;CAV1;HIP1R;CTNNBIP1;B2M;NES;EPB41;ZFPM1;TIAM1;MEN1;ACTB
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.47965932773648906,1.208151430921714,0.22585669781931464,0.6889475877086636,1.0,4/29,5.03%,IFNAR2;NLRC5;SAMHD1;HSP90AB1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.38255581568830505,-1.2079103618043652,0.20304568527918782,0.6835734378995822,1.0,15/43,12.61%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;RUNX2;CCN1;YAP1;CCN4;LRP3;FBN2;IFITM1;BMP2;NPNT
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.43400095755282325,-1.2078795823827284,0.19444444444444445,0.6821179608802964,1.0,3/26,2.10%,EYA2;EYA1;EYA4
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.49035430245455736,1.2074094770053334,0.2464,0.6900946077578264,1.0,6/26,10.36%,INSR;DDAH1;KLF2;HSP90AB1;KLF4;AGTR2
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.531306637987496,1.207176717184837,0.2602739726027397,0.6898590378450173,1.0,7/16,14.67%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,protein polymerization (GO:0051258),-0.3653406358900699,-1.2067493775067382,0.14461538461538462,0.6839159682239047,1.0,9/56,9.18%,ARHGAP6;GAS7;GSN;COBL;HDGFL3;DIAPH1;PRKN;RNF135;MAP7D3
prerank,positive regulation of immunoglobulin production (GO:0002639),0.479698583410457,1.20669367654227,0.21855345911949686,0.6902881094236105,1.0,1/31,0.15%,TFRC
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.38099274383248727,1.2063860284926833,0.1657754010695187,0.6902477955280287,1.0,32/119,17.20%,EFR3B;PIK3R6;ITPKB;INPP5D;PIK3R3;SOCS2;PIKFYVE;PIGU;PIP5K1C;OCRL;INPP5F;PLEKHA1;PIGM;MTMR6;PGAP4;PIGF;SOCS5;PIK3C3;PIK3C2A;RAB4A;PIP4K2A;PIK3CB;MTMR12;CDIPT;MTMR2;PIK3R5;DPM3;PLEKHA3;SYNJ1;TTC7B;INPP5E;INPPL1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.4577295436370638,-1.206075634282961,0.2119815668202765,0.6843110910485815,1.0,5/20,18.64%,WNT4;C1QTNF3;EP300;BCKDK;NCOR1
prerank,atrial septum morphogenesis (GO:0060413),0.5905561448870249,1.2057589613270885,0.28884826325411334,0.691059324473255,1.0,3/10,3.19%,BMPR2;TGFB2;ZFPM1
prerank,negative regulation of viral process (GO:0048525),0.431994689242527,1.2053155841775907,0.20684523809523808,0.6913964733281311,1.0,16/57,18.45%,TRIM14;IFIH1;BTBD17;PPIA;STAT1;N4BP1;BST2;BANF1;OASL;SLPI;ZC3HAV1;MBL2;TRIM26;PROX1;TNIP1;TRIM11
prerank,striated muscle contraction (GO:0006941),-0.36448233169607225,-1.2050729512879184,0.1590909090909091,0.6858136599907487,1.0,10/53,16.45%,ATP1A2;TPM1;DMD;SLC8A1;GAA;ARHGEF11;DTNA;STAC3;TNNT3;ALDOA
prerank,negative regulation of cell growth (GO:0030308),0.38087161173536926,1.2050580215064086,0.168848167539267,0.6912519527787943,1.0,22/121,10.36%,APBB2;BMPR2;TGFB2;SH3BP4;SOX17;DCUN1D3;PTPRJ;SMARCA2;ADAM15;SIPA1;ACVRL1;FGF13;CCDC85B;DIP2B;PPP1R9B;HYAL2;WFDC1;BST2;TGFB1;NPR1;BTG1;AGTR2
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.4227735843181025,1.2046898583353267,0.20906432748538012,0.6913966946850768,1.0,23/59,23.35%,DAB2IP;NFKBIA;IKBKB;TLR3;TLR7;BIRC3;FAIM;IRAK2;SHARPIN;TLR8;BCL10;ERC1;CARD11;NKIRAS1;RELB;TBK1;RBCK1;AZI2;TICAM2;TBKBP1;PRDX4;TRAF6;RIPK1
prerank,axoneme assembly (GO:0035082),0.46752120104642986,1.204461702211227,0.24881141045958796,0.691171967210261,1.0,10/31,17.66%,RP1;TTLL3;DRC1;RSPH4A;DCX;DNAAF2;RSPH1;FOXJ1;DNAAF3;TTC12
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.4295129918665297,-1.2038826391852342,0.18,0.6877352653814717,1.0,5/25,13.00%,ITPR1;P2RX4;CDH13;LRRK2;CMKLR1
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),-0.5125075286501057,-1.2036657517573628,0.23427331887201736,0.6868134881378717,1.0,4/13,11.42%,CYFIP2;ASPH;PERP;TBC1D10A
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.5913555867910196,1.2036214955482194,0.28313253012048195,0.692679313056436,1.0,3/11,7.93%,CAV1;NEDD4L;KCNH2
prerank,protein O-linked mannosylation (GO:0035269),0.5246626978507332,1.2033041800580941,0.2722602739726027,0.6927011143634468,1.0,1/18,0.08%,TMTC2
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.4510644143930468,1.2032882621676888,0.2324159021406728,0.6918709774428367,1.0,8/39,8.09%,PODXL;NOTCH4;RGCC;PTK2;NOTCH1;KLF4;NEXMIF;TGFB1
prerank,liver development (GO:0001889),-0.41334582856494556,-1.2029367823772406,0.21621621621621623,0.687372949626807,1.0,7/32,10.02%,TGFBR3;WNT4;COBL;PKD2;ANXA1;MET;CEBPB
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.5766701332691185,1.2028233690281365,0.26846846846846845,0.6922415726236485,1.0,6/11,20.96%,PLAUR;LYN;TNFSF11;SYK;ANK3;RDX
prerank,membrane fusion (GO:0061025),0.46826215561469264,1.202729922753635,0.2282958199356913,0.6916388347139428,1.0,2/33,2.16%,DNM3;DYSF
prerank,response to interferon-alpha (GO:0035455),0.534769634887469,1.202218389242545,0.26119402985074625,0.692176443269656,1.0,8/16,16.47%,IFNAR1;IFNAR2;ADAR;BST2;KLHL20;PDE12;RO60;GAS6
prerank,positive regulation of inflammatory response (GO:0050729),0.3998370577584346,1.2019980183191434,0.1829608938547486,0.6919578774005731,1.0,13/86,12.73%,ETS1;PDE2A;APP;NFKBIA;OSMR;HYAL2;MGST2;TLR3;TLR7;CCL1;S100A8;IL15;DDT
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4100275555867064,1.2019337888099233,0.2019914651493599,0.6912651746857147,1.0,19/72,11.43%,ARHGEF3;RASIP1;HEG1;NET1;F11R;ADGRG1;ARHGEF2;LPAR6;PRAG1;STARD13;STMN1;EPS8;EPS8L2;GPR17;OPHN1;ARHGDIA;KCTD10;PDCD10;RAC1
prerank,response to ketone (GO:1901654),0.5052110315337239,1.2018549762697448,0.2396551724137931,0.6906461787000044,1.0,5/24,8.09%,ABHD2;TGFB2;CAV1;CCR7;TGFB1
prerank,T cell receptor signaling pathway (GO:0050852),0.3777020116386147,1.2014677155289701,0.16219667943805874,0.6908332981465024,1.0,45/138,23.35%,INPP5D;PTPRJ;PRKD2;ZAP70;PLCG1;IKBKB;PDE4D;TNFRSF21;MOG;CD4;FYN;PSMB3;PSMD11;PDE4B;PSMC6;MALT1;PAK1;PSME2;EIF2B1;EIF2B2;DENND1B;PSMD8;PIK3CB;PSMB10;BCL10;RFTN1;LCP2;CARD11;PSMA8;NCK1;PAK2;SKP1;PSMD9;SPPL3;SKAP1;RBCK1;FYB2;PLCG2;CUL1;PSMC3;PSMD1;TRAT1;PSMD10;TRAF6;NFKBID
prerank,ncRNA 3'-end processing (GO:0043628),-0.5078187942615874,-1.2010394901014878,0.23127753303964757,0.6915845752012099,1.0,9/14,37.22%,INTS8;INTS2;ERI1;TOE1;PTCD1;INTS6L;INTS5;SSB;ELAC2
prerank,glycogen catabolic process (GO:0005980),-0.4790232713906589,-1.2008353389610114,0.25,0.6906098134833427,1.0,10/15,23.03%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,phosphorylation (GO:0016310),0.3418939351736262,1.2002907019169928,0.10607734806629834,0.6931819082416405,1.0,87/385,15.41%,PRKCH;ERG;PDGFB;INSR;BMPR2;TGFB2;MAP4K2;DGKH;APP;CDK17;MAP4K3;STK38;PKN3;LIPE;SNRK;JAK3;ACVRL1;PRAG1;MAP3K1;PRKD1;STK10;PRKD2;CDK19;ZAP70;MERTK;LYN;FNIP2;PRKG1;IKBKB;PPP4R1;CREB1;CAMKK2;DGKI;PKN1;STK19;LIMK2;PRKACB;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;RET;AATK;DGKE;PKN2;HCK;PXK;MARK4;CERKL;TGFB1;MARK3;MAP3K6;PAK1;EIF2AK4;PTK6;TRIB2;PRKAB1;TOLLIP;HK1;PRKCB;GSK3A;SYK;DGKZ;PIK3CB;TNK2;MAP4K4;TGFBR2;PANK3;HIPK2;CERK;STK24;STK3;MINK1;PIM2;VRK1;SGK1;TBCK;CAMK2B;STK26;CTBP1;GRK6;NEK3;HIPK3;PLK2;SGK3;SGK2
prerank,glucan biosynthetic process (GO:0009250),0.5588951257430922,1.2002655547348524,0.274582560296846,0.6914928076405316,1.0,4/12,16.05%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.5588951257430922,1.2002655547348524,0.274582560296846,0.6914928076405316,1.0,4/12,16.05%,GBE1;PGM2L1;NHLRC1;UGP2
prerank,protein catabolic process (GO:0030163),0.42670824650141165,1.2002264500053947,0.21936459909228442,0.690745927832654,1.0,20/59,18.29%,DAB2IP;DENND3;OGA;NEU4;STT3B;UBE2G1;TRIM24;HSPA8;CEACAM1;FBXO6;MANBA;NEU2;CLN8;PSMA8;ATE1;UBE2G2;BAG6;USE1;FBXO2;SIAH1
prerank,organelle fusion (GO:0048284),-0.4395799717803516,-1.2000753908391442,0.23134328358208955,0.6913237016894567,1.0,7/22,16.25%,MIGA2;EEA1;MIEF1;AFG3L2;MFN2;MIEF2;STX4
prerank,negative regulation of nuclear division (GO:0051784),-0.5318548845021477,-1.200074104122529,0.2579957356076759,0.6897849448043646,1.0,6/11,22.73%,BMP7;BMP4;TOM1L2;NME6;AURKAIP1;TOM1L1
prerank,fluid transport (GO:0042044),0.5683467599856014,1.1996661408912843,0.2759259259259259,0.6914596296023614,1.0,2/12,4.59%,AQP11;AQP7
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.4668476795806284,1.199472154678269,0.2524271844660194,0.6911247322425397,1.0,11/37,21.63%,POLK;NTHL1;GTF2H2;GTF2H4;RBX1;RPA1;POLD1;GTF2H3;RFC2;DDB1;ERCC4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.4540260691499854,1.199457317291722,0.22685185185185186,0.6902933697248498,1.0,3/35,2.84%,FAR2;FASN;HMGCS2
prerank,endocardial cushion morphogenesis (GO:0003203),0.5249962361868686,1.1989414672034895,0.26173285198555957,0.6907877336057312,1.0,5/18,3.41%,ENG;TGFB2;NOS3;ACVRL1;NOTCH1
prerank,regulation of axonogenesis (GO:0050770),-0.3681117554085547,-1.198246526794835,0.18404907975460122,0.6935453984351135,1.0,13/51,14.09%,ROBO1;PLXNA2;TIAM2;SLIT2;SIPA1L1;KIF13B;NGF;PLXNB2;ROBO2;MAP6;CHN1;PTEN;BRSK1
prerank,regulation of myoblast fusion (GO:1901739),-0.5157069808317556,-1.1978742419570263,0.2767857142857143,0.6930803474175735,1.0,4/11,16.13%,RIPOR2;EHD1;MAPK14;EHD2
prerank,regulation of glycolytic process (GO:0006110),-0.35242362979683256,-1.1969025259624575,0.14950166112956811,0.6943932170546666,1.0,9/68,5.34%,IGF1;PRKAG2;ZBTB20;PRKAA2;NUPR1;HDAC4;OGT;SEH1L;PPARA
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),-0.30162916144065793,-1.196834023913586,0.06451612903225806,0.693043467765236,1.0,35/173,15.16%,ANK2;CD55;SEC24D;CAPZB;SEC24A;GBF1;USO1;GOLGB1;COPA;NRBP2;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;GOLGA2;ERGIC3;SAR1A;SEC31A;TRAPPC3;SEC16B;STX5;COG4;CUL3;SEC23A;DYNC1I1;GOLT1A;ERGIC1;RAB29;SCFD1;SEC16A;LMAN1;CTSZ;COPB2;DCTN6
prerank,cardiac right ventricle morphogenesis (GO:0003215),-0.5237634951025997,-1.1966768464313446,0.2554585152838428,0.692039431381504,1.0,4/11,7.70%,BMPR1A;BMP4;ZFPM2;JAG1
prerank,regulation of AMPA receptor activity (GO:2000311),0.4802844933384986,1.19594036215212,0.24373956594323873,0.6984134686860841,1.0,6/25,15.74%,SHANK3;MEF2C;SHISA6;CNIH3;MINK1;NLGN1
prerank,protein targeting to membrane (GO:0006612),0.39803254369077395,1.195571965126334,0.19919246298788695,0.6985986618150392,1.0,25/83,19.69%,AQP11;ZDHHC14;PARD3;SEC62;PIKFYVE;ZDHHC9;ZDHHC20;ZDHHC19;SRP14;SGTB;RTP4;ZDHHC18;ZDHHC22;ABCD1;PEX14;GET3;SDCBP;NACAD;RTP3;ZDHHC21;PEX16;VPS37A;ABCD2;ACBD5;MYO1C
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5404935723828153,1.1954129945417389,0.28421052631578947,0.6981417710448865,1.0,9/15,24.76%,ZFAND2A;SRP14;SPCS2;EDEM1;SPCS1;RAB3GAP1;RYR2;SRPRA;ZFAND2B
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.36487677145823694,-1.1952007270042408,0.17325227963525835,0.6949005928416632,1.0,8/57,6.15%,LPAR1;ADCY5;ADCY1;ADCY9;AKAP12;ADCY2;ADCY7;FLNA
prerank,response to fatty acid (GO:0070542),-0.4760151448973589,-1.1947293624468025,0.23370786516853934,0.6947802431989628,1.0,2/17,2.42%,PID1;IRS1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.3883826211495293,1.1946068126352025,0.1741424802110818,0.6995225325199078,1.0,25/114,15.92%,NFKBIA;TNFRSF25;TNFRSF11A;CD40;TMSB4X;IKBKB;ST18;ACTN4;AIM2;STAT1;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;ADAM17;EIF5A;PSMD8;TNFSF11;TNFRSF4;TNFSF12;PLVAP;PSMB10;EDARADD;PSMA8
prerank,lymphocyte mediated immunity (GO:0002449),-0.5191806923406825,-1.1943930567617418,0.25333333333333335,0.6942068137054768,1.0,2/12,7.70%,CD55;JAG1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.5176708286576053,1.1939472526119475,0.24833333333333332,0.7004491851205994,1.0,6/19,11.01%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,regulation of cellular protein localization (GO:1903827),-0.38271816261459984,-1.193597214082822,0.19480519480519481,0.6951910878935107,1.0,5/45,4.60%,GPC6;PRKAA2;GPC3;GBF1;GPC4
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.26969993566538514,-1.1932308468104607,0.0,0.6947455497117144,1.0,126/572,16.56%,BMP6;FOXP2;PRDM6;FHL2;ZEB2;NR2F2;AEBP1;GLI3;RARB;GLI2;ZFHX3;GLIS3;SMAD3;FOXP4;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;FNIP1;NR6A1;THRB;FRK;HDAC4;CUX1;MXI1;PER3;WWOX;SALL1;IMPACT;NR1D2;ZHX2;FOXC2;DNMT3A;FOXC1;BCOR;KCNIP3;SUFU;RBPJ;HOXA7;DAB2;EHMT2;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;PPARA;CTR9;ZNF25;ZMYM5;BCL6;CBX7;IGF2;DACT1;ZEB1;ZNF568;LCOR;NFATC4;ATN1;CHD3;CHD8;PRKN;CBX5;MITF;YAP1;KDM2B;MED25;POU6F1;SMURF2;USP2;FOXO3;CXXC5;PCGF2;EZR;CEBPB;EZH1;GATA6;NR2F1;URI1;PARP1;ZNF148;CRY2;WWP2;KDM1A;RXRA;NFX1;ESR1;PSEN1;BMP2;ZNF219;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;ZNF3;ZBTB4;BAG3;SIRT2;USP9X;PAF1;PEX2;GZF1;IFI27;ZBTB1;EP300;CBX6;ZBTB7B;PHF12;MAP2K5;NFIB;MTA3;NFIL3;RUNX1;LDB1;LDB2;MDFI;ZFP37;NR1H4;JDP2
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.5389043115756902,-1.1930899592494537,0.24772727272727274,0.6921127781092832,1.0,4/10,25.19%,TULP1;CEP250;CNGB1;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.5389043115756902,-1.1930899592494537,0.24772727272727274,0.6921127781092832,1.0,4/10,25.19%,TULP1;CEP250;CNGB1;CACNA2D4
prerank,negative regulation of protein metabolic process (GO:0051248),-0.36758875894373294,-1.1925569630492783,0.21098265895953758,0.6921659078204827,1.0,16/48,18.49%,EGFR;MDM4;SNX12;FLOT2;FLNA;PFDN5;APOE;LDLR;ITGAV;AZIN1;IRAK3;SIRT2;CRYAB;INHBB;ITGB3;MAD2L1
prerank,positive regulation of programmed cell death (GO:0043068),0.3489850128718994,1.1925075226055633,0.14102564102564102,0.703646745839302,1.0,37/272,8.96%,MCF2L;ITGA6;ARHGEF3;DAB2IP;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;NOS2;CTNNB1;RHOB;SOS1;CRADD;RNPS1;ARHGEF12;DNM2;IRF5;JMY;MARK4;JUN;ARHGEF5;PIDD1;PREX1;ARHGEF7;BNIP3L
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.4016818498898941,1.1924212143875454,0.20229555236728838,0.702985632138757,1.0,17/72,15.84%,KANK3;SHANK3;HIP1R;ARHGEF2;FGF13;SSH2;STMN1;TWF2;PFDN4;PFDN2;HSPA8;CYRIB;ATXN7;CDH5;SSH1;PFDN1;APC
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.3824775291565478,-1.1923073454220225,0.19338422391857507,0.6914294681535326,1.0,6/44,5.81%,PRKAG2;CYP7B1;INSIG2;CYP27A1;PER2;ACOT8
prerank,negative regulation of catabolic process (GO:0009895),-0.37952162062990924,-1.1922149362107057,0.19553072625698323,0.6901965275221935,1.0,10/47,13.66%,EGFR;NUPR1;HDAC4;MDM4;SNX12;PPARA;FLNA;AZIN1;IRAK3;SIRT2
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.4481236591699067,-1.1921010333073918,0.23284313725490197,0.689015381438511,1.0,6/20,6.33%,GSN;PLA2R1;THBS1;ANO6;PRKCI;SFRP4
prerank,negative regulation of phosphorylation (GO:0042326),-0.33860999442013323,-1.192026255144539,0.14469453376205788,0.6877317978373632,1.0,16/85,8.16%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;BMP4;NUPR1;SLIT2;HDAC4;IMPACT;PPARA;IRS2;EPHB2;PRKN;IGFBP3
prerank,negative regulation of programmed cell death (GO:0043069),0.3437235302692848,1.1918278615404674,0.12950450450450451,0.7037787629796994,1.0,43/355,10.83%,LEF1;IGF1R;MECOM;TFRC;TEK;RNF144B;TJP1;KDR;BCL2L1;FAS;NFKBIA;SH3RF1;FLT4;TBX3;PLAUR;PTK2;FOXO1;RPS6KA1;SOCS2;IKBKB;PTMA;CTNNB1;XIAP;CAT;CD38;MRE11;ADAM10;MCL1;HCK;BIRC3;RHBDD1;PIDD1;PRDM9;GREM1;BNIP3L;MALT1;ARHGDIA;KLHL20;PDCD10;MGMT;THOC6;HSPB1;LRP2
prerank,protein neddylation (GO:0045116),0.5545393575751302,1.1917293989846578,0.2835820895522388,0.7031982605006709,1.0,4/13,14.26%,DCUN1D3;UBA3;DCUN1D1;RBX1
prerank,cGMP metabolic process (GO:0046068),0.5485836198197649,1.191657102558387,0.27580071174377224,0.7025464329517978,1.0,4/12,13.27%,PDE2A;NPPA;NPR1;NPR2
prerank,positive regulation of behavior (GO:0048520),0.5745736045253254,1.1915770945498207,0.3126177024482109,0.7018887008701858,1.0,3/10,15.74%,MEF2C;STRA6;NLGN1
prerank,response to alcohol (GO:0097305),-0.4230807824055244,-1.1914828687010734,0.20681265206812652,0.6878358320622918,1.0,3/27,3.86%,TGFBR3;SLIT2;TGFBR1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.49702609051530067,1.191327779130128,0.24573378839590443,0.7017169043215515,1.0,4/23,12.55%,MBOAT1;PLA2G4B;LPCAT3;PNPLA8
prerank,inorganic anion transport (GO:0015698),-0.36106299365578143,-1.1912116258704148,0.18208955223880596,0.6871543342124866,1.0,9/53,6.46%,SLC13A4;SLC4A10;ENPP1;SLC26A7;ANO6;CLCN2;ENPP3;SLC5A5;ANO1
prerank,cognition (GO:0050890),0.43767879432777285,1.191156185395745,0.25306748466257667,0.7013380484406495,1.0,7/42,10.23%,MFSD2A;SHROOM4;APP;GPR155;FAM107A;STRA6;CYFIP1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.5848768751679735,1.1910979520040155,0.28884462151394424,0.7006442918877914,1.0,5/10,22.40%,SVIP;DERL2;UBAC2;UBE2G2;UBE2J1
prerank,negative regulation of signal transduction (GO:0009968),-0.2895367846284495,-1.189993533436669,0.07142857142857142,0.6893915383813943,1.0,53/249,11.50%,PID1;TRABD2B;SULF1;LRP1;EGFR;LGR4;GLI3;ADAMTS12;DCN;IGFBP5;BMP5;DKK3;ENPP1;GPC3;KANK2;RNF43;CYP26B1;IRS1;TULP3;MMP14;APOD;KANK1;NOTCH3;SULF2;WWOX;THBS1;PRKCD;ARRB1;SUFU;FGF2;GLIS2;SFRP4;DACT1;MGRN1;EMILIN1;BCL2;IGFBP3;GRB10;TNS2;NXN;IFT122;CREB3L1;BEND6;VGLL4;PIP4K2C;QARS1;BTRC;NIBAN2;RPGRIP1L;LRRK2;IRAK3;CXXC4;WWP2
prerank,ventricular septum morphogenesis (GO:0060412),-0.41884374586877404,-1.1899318253582714,0.21739130434782608,0.6880930176255612,1.0,8/27,6.34%,ROBO1;TGFBR3;BMPR1A;BMP4;ZFPM2;SLIT2;TGFBR1;HEYL
prerank,vasoconstriction (GO:0042310),-0.5297533509749486,-1.1898993923570649,0.25733634311512416,0.6867332780757295,1.0,3/11,9.85%,EDNRA;SLC8A1;ACTA2
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4925298429279944,1.1897487277206065,0.25795644891122277,0.7035954584387046,1.0,5/26,4.22%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,negative regulation of hydrolase activity (GO:0051346),0.43682429224566,1.1889868736918632,0.22239031770045387,0.7048918482946417,1.0,11/49,13.04%,LRCH1;DAB2IP;SH3BP4;F11R;FICD;CST7;TERF2;PLXNB3;HRAS;EGLN1;PPP1R35
prerank,regulation of peptide hormone secretion (GO:0090276),0.40677177094190053,1.1888841969182524,0.2158273381294964,0.7043293649188402,1.0,9/67,6.34%,SLC2A1;CACNA1A;STX1A;RAPGEF3;NOS2;KCNC2;SYT7;RAPGEF4;KCNG2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4997770102910709,1.1887309826473416,0.27017543859649124,0.7039260254140899,1.0,6/22,12.03%,PTPRJ;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1
prerank,glutamate metabolic process (GO:0006536),-0.45260075673825706,-1.1886284653188117,0.2846715328467153,0.6888572224391033,1.0,11/19,22.68%,PRODH;OAT;ALDH18A1;GOT1;GCLC;GLUL;GLS;GLS2;GOT2;FPGS;MTHFS
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.4577784381473176,1.1882384674865654,0.23974763406940064,0.7044095416293572,1.0,12/37,21.62%,ENTPD1;ENTPD5;DFFB;NUDT9;PPP1R8;SND1;NUDT1;RNASEH2C;NUDT16;XRN2;NCBP1;RNASE6
prerank,positive regulation of interleukin-10 production (GO:0032733),0.47467477500642524,1.1881667896672183,0.24914089347079038,0.7037369475729456,1.0,5/30,15.03%,CD34;NOD2;LGALS9;SYK;INAVA
prerank,chondroitin sulfate metabolic process (GO:0030204),0.46704848571362456,1.1877944646593872,0.2706270627062706,0.7040016816332726,1.0,3/30,2.89%,CSGALNACT1;NDNF;CHST11
prerank,regulation of dendritic spine development (GO:0060998),0.49991656605200996,1.1876180614379483,0.26108374384236455,0.7036526310957492,1.0,3/19,6.88%,SHANK3;MEF2C;KIF1A
prerank,positive regulation of cell cycle phase transition (GO:1901989),-0.48519689131848903,-1.1875474082865232,0.26014319809069214,0.6905692435947635,1.0,7/15,19.26%,STXBP4;GLI1;KLHL18;CUL3;PAF1;DDRGK1;EZH2
prerank,positive regulation of axonogenesis (GO:0050772),0.4375434392059954,1.18675060950709,0.23510971786833856,0.7051946933583202,1.0,11/43,11.16%,SEMA7A;MACF1;NTN1;PLXND1;TIAM1;DBNL;SLITRK1;TWF2;ARHGDIA;METRN;PLXNB3
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.46394446412274554,1.186710929901509,0.2300163132137031,0.7044380991229472,1.0,8/33,14.70%,ETS1;FES;TAL1;STAT1;HIF1A;BRD1;HMGB2;NCKAP1L
prerank,tetrapyrrole metabolic process (GO:0033013),0.5112942718756506,1.1865443533319135,0.28733459357277885,0.7040614635288693,1.0,8/18,24.20%,ABCD4;AMN;MMAA;LMBRD1;TCN2;MMACHC;MMADHC;CD320
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.5654082766418802,1.1865414135062295,0.2792452830188679,0.7032133627439625,1.0,3/11,15.78%,RTP4;LPO;RTP3
prerank,synaptic vesicle recycling (GO:0036465),0.46956200284068306,1.186066002335218,0.2550335570469799,0.7036095003193117,1.0,10/31,15.89%,STX1A;WNT7A;PIP5K1C;TBC1D24;SYT7;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5325069618678576,1.186054793108998,0.2695035460992908,0.7027750479478659,1.0,8/15,18.73%,KCNQ1;ATP1A1;KCNH2;KCNN2;KCNJ3;KCNJ5;KCNA5;KCNIP2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.5825716705060764,1.1859499243348097,0.29174311926605506,0.7021902053370507,1.0,2/10,5.97%,RNF125;SEC14L1
prerank,heterocycle biosynthetic process (GO:0018130),0.542073895623848,1.1859411111494158,0.2883959044368601,0.7013656082227803,1.0,2/14,7.20%,GCH1;GPHN
prerank,lymphocyte differentiation (GO:0030098),0.4091653244892562,1.1857720978821964,0.21068249258160238,0.7010051944417445,1.0,25/68,17.84%,JAG2;TPD52;PTPRJ;JAK3;HDAC9;ZAP70;HHEX;DLL4;SLC25A5;CD4;CD79A;KLF6;ADAM17;GPR89A;GPR89B;ZBTB7A;TOX;VCAM1;HDAC5;IKZF1;DNAJB9;MSH2;ITGA4;RELB;ADGRG3
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),-0.5134928232026009,-1.1853823622609425,0.2703296703296703,0.6953973345050058,1.0,6/12,33.08%,UCK2;UPP2;UMPS;UCK1;UCKL1;DCK
prerank,regulation of biomineral tissue development (GO:0070167),0.4811549766908402,1.1843633460468992,0.24086378737541528,0.7039515848374129,1.0,6/26,8.09%,SGMS2;NOS3;S1PR1;NOTCH1;NOTUM;TGFB1
prerank,small GTPase mediated signal transduction (GO:0007264),0.38182840967990966,1.1842817630806157,0.2026315789473684,0.7033071540988447,1.0,24/103,13.29%,RASGRP3;ARHGAP31;RAPGEF2;NTN1;GRAP;TIAM1;PRKD1;ABR;GRB2;RREB1;CCDC88A;SOS1;RASGRP2;RALB;RGL2;JUN;SHC3;RAC1;HRAS;RAPGEF5;TNK2;GNB1;RIN2;SETDB1
prerank,protein export from nucleus (GO:0006611),-0.4229332438196908,-1.1842305302120433,0.2193211488250653,0.6972910140717713,1.0,7/27,16.48%,RANBP3L;PKD1;RANBP17;XPO5;XPO6;STRADA;XPO1
prerank,positive regulation of response to wounding (GO:1903036),0.49638856813104765,1.1840564512641663,0.2667814113597246,0.7030760647363247,1.0,8/24,11.49%,OCLN;SCARF1;PTK2;INSL3;PTN;ACTG1;CNTF;HRAS
prerank,ear morphogenesis (GO:0042471),-0.46091189073090016,-1.1838600605413077,0.24087591240875914,0.6969189147961542,1.0,5/20,7.23%,ZIC1;FGFR2;OSR1;SIX1;EPHB2
prerank,cellular response to glucose stimulus (GO:0071333),0.4746830717223158,1.1837155680443092,0.2413793103448276,0.7031631288499793,1.0,2/30,2.00%,IGF1R;UNC13B
prerank,protein autoubiquitination (GO:0051865),-0.3513374377020716,-1.1835508071214174,0.18456375838926176,0.6963053612886635,1.0,12/61,11.83%,RNF220;SH3RF3;AMFR;SH3RF2;PRKN;LRSAM1;DDB2;CUL3;RNF10;WWP2;RNF181;NFX1
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.5336748011809562,1.1835204082108643,0.26666666666666666,0.7028683515710248,1.0,8/16,27.43%,CAV1;INPP5F;ADIPOR1;HGS;SH2B3;SOCS1;PARP14;PPP2R1A
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.461870247967887,-1.1833937051464036,0.2426470588235294,0.6953018458680765,1.0,6/18,11.95%,POR;ATP7A;SIRT3;AGTR1;FXN;ABL1
prerank,translation (GO:0006412),0.35440386493908205,1.1830960078089914,0.13990267639902676,0.7031715359152231,1.0,96/208,28.91%,SARS2;SARS1;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPL27;RPSA;RPS7;RPL9;RPL18;RPLP2;GTPBP1;RPL13A;GARS1;RPS11;RPL8;RPS27;RPL19;MRPL57;RPS9;MRPL28;RPL11;EEFSEC;RPL22L1;RPS15;SRBD1;RPL37;GATC;RPS28;RPS10;EEF1D;RPS25;RPL37A;MRPS2;MRPL9;COPS5;RPL15;TNIP1;MRPL16;RWDD1;MRPL23;RPL17;RPL23;RPL34;FARSB;RPS18;APEH;RPL21;RPS4X;MRPS18A;RPL18A;DHPS;RPS21;RPL10A;GTPBP2;EEF1B2;CARS1;ABCE1;RSL24D1;RPL24;PTCD3;RPL7A;MRPL41;MRPL27;NARS1;IARS2;MRPL51;HARS1;RPL32;RPL4;RPS2;MRPS33;MRPL37;MRPL2;NDUFA7;RPS20;RPL6;RPS13;MRPS18C;RPS19;QRSL1;RPL14;VARS1;EEF1G;RPL26;MARS2;LARS2;MRPS34;MRPS12;RPS6
prerank,protein localization to organelle (GO:0033365),-0.3124241408290162,-1.1822318246537389,0.12442396313364056,0.6972824212498514,1.0,37/133,17.83%,ANK2;COL1A1;BMP7;BMP4;TULP3;LMNA;LAMP2;WDR35;GBF1;OBSL1;ARL3;ZNF423;SIX1;DCP1A;DDX1;IFT122;BICD1;STX5;EHD1;BBS9;ARL1;LRRK2;TOR1AIP1;RAB6A;EMD;TRAM2;AUP1;PAF1;DDX3X;DDRGK1;OPTN;SNX10;SEC61B;SIX4;VAMP2;TULP1;GET1
prerank,microvillus organization (GO:0032528),0.5562016490536777,1.182169407314962,0.29818181818181816,0.7048877440621966,1.0,5/13,14.59%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.4049685242025703,-1.1818079897388702,0.23391812865497075,0.697026008742605,1.0,15/35,22.38%,DDX5;PPARGC1B;AR;NR3C2;YAP1;UBR5;DDX17;ESR1;PGR;CALCOCO1;RNF14;ZMIZ1;ESR2;NEDD4;GPER1
prerank,muscle cell migration (GO:0014812),-0.5273533446425782,-1.1814377307963013,0.25681818181818183,0.6966767183814963,1.0,4/10,10.01%,DDR1;SIX1;CCN3;ITGB1BP1
prerank,regulation of viral entry into host cell (GO:0046596),0.466059803235149,1.1808868423817522,0.2743221690590112,0.7076183211809236,1.0,6/30,6.44%,LY6E;TRIM25;TRIM14;SNX3;CD4;LGALS9
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.48574529815908013,1.1806114867272084,0.2826797385620915,0.7075748514893629,1.0,3/24,5.99%,BCL2L1;CXCL12;SNAI2
prerank,neuron apoptotic process (GO:0051402),0.508838563000495,1.1797474800172612,0.27287853577371046,0.7091044811389354,1.0,3/19,4.54%,APP;FAS;TNFRSF21
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4192432158156601,-1.1794502996985603,0.23809523809523808,0.7009104473088787,1.0,7/24,7.47%,COL5A1;PDPN;ARHGAP24;DDR1;FLNA;CCN1;ITGA5
prerank,regulation of epithelial cell proliferation (GO:0050678),0.39114355725844085,1.1793154175972131,0.21793103448275863,0.7094696210309592,1.0,16/85,8.18%,SGPP2;TIE1;AQP11;DAB2IP;TGFB2;TBX1;MCC;B2M;MTSS1;ACVRL1;NOD2;PRKD1;FGF16;CDKN2B;TGFB1;TGFA
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.45700251367989064,1.1791133684943722,0.24440894568690097,0.7091697925005425,1.0,12/32,14.34%,PPP1R16B;ITGA1;CALM1;HSP90AB1;PPIA;PPP2R5A;PIN1;TGFB1;AGTR2;NSMF;CDH5;PPP1R15B
prerank,positive regulation of neuron projection development (GO:0010976),0.3931337949544954,1.1791082603786287,0.20254957507082152,0.7083373810663276,1.0,19/85,10.12%,ITGA6;NDNF;DAB2IP;RAPGEF2;SCARF1;FES;LRP8;RAPGEF1;PRKD1;LYN;SNX3;FUT9;DBNL;RET;LRRC7;TWF2;PTN;SERPINI1;PTK6
prerank,protein mannosylation (GO:0035268),0.4994650442121683,1.178808357007407,0.27677100494233936,0.7082981251122248,1.0,1/22,0.08%,TMTC2
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3770964641980786,-1.1787856967930064,0.1940700808625337,0.7014250287655045,1.0,8/45,4.67%,BMP6;BMPR1A;BMP5;BMP7;BMP4;TGFBR1;TWSG1;DAB2
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4513121617227289,-1.1777666363488006,0.2511013215859031,0.7029847656392708,1.0,8/20,16.18%,HOXA5;CTR9;MEIS1;PTK2B;MAFB;PAF1;HOXA9;LDB1
prerank,regulation of humoral immune response (GO:0002920),-0.3806473282079429,-1.1775918065972735,0.19148936170212766,0.7020953875829459,1.0,12/44,21.20%,SERPING1;VTN;CD55;CFH;GATA6;C2;C1QB;CD81;C1QBP;C4B;C3AR1;C6
prerank,regulation of mast cell degranulation (GO:0043304),0.5266049214984553,1.177138546612801,0.29484902309058614,0.71203722093466,1.0,5/14,11.86%,FES;LYN;LGALS9;UNC13D;SYK
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.44815659415724984,-1.1768103099883787,0.2655086848635236,0.7029358286749269,1.0,4/22,7.13%,UGGT2;MAN1C1;AMFR;MAN1A2
prerank,cell proliferation in forebrain (GO:0021846),-0.5323399914896271,-1.176577370022738,0.3,0.7021732541509201,1.0,4/10,13.87%,DOCK7;NUMBL;PCM1;AKNA
prerank,pulmonary valve morphogenesis (GO:0003184),-0.4679910300546345,-1.1762881344390135,0.27880184331797236,0.7016573787803495,1.0,7/17,7.70%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,heart trabecula morphogenesis (GO:0061384),0.5157252051508209,1.1757606200698072,0.27882960413080893,0.7149505632812169,1.0,6/18,5.01%,TEK;ENG;TGFB2;S1PR1;NOTCH1;DLL4
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5109505214889521,1.1757555918185811,0.27806563039723664,0.7141224398854716,1.0,6/19,17.88%,CORO2B;CCT3;CCT5;CEP135;PTP4A3;CCT7
prerank,dorsal/ventral pattern formation (GO:0009953),-0.45373982465009566,-1.1757208195082378,0.27,0.7018848755783681,1.0,3/20,1.29%,BMPR1A;GLI2;NBL1
prerank,COPII-coated vesicle budding (GO:0090114),-0.34354097522877974,-1.175685876230239,0.17275747508305647,0.7005337264678436,1.0,16/68,14.55%,SEC24D;SEC24A;USO1;GOLGA2;SAR1A;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,O-glycan processing (GO:0016266),0.42455225427715126,1.1756852119995103,0.2364963503649635,0.713476977961534,1.0,6/54,4.22%,ST3GAL1;B4GALT5;ST6GALNAC2;MUC3B;MUC3A;B3GNT2
prerank,positive regulation of translation (GO:0045727),-0.32797842863661314,-1.1754442700000725,0.1494661921708185,0.699864305111696,1.0,39/94,29.50%,SAMD4A;PLD1;THBS1;PLXNB2;AGO2;YBX3;FXR2;MRPS27;RMND1;EIF3C;FMR1;HABP4;DDX3X;LARP6;YTHDF1;JMJD4;RPUSD4;C1QBP;RCC1L;USP16;RPS6KB1;FASTKD3;CIRBP;PIWIL2;FASTKD2;EIF4A3;BCL3;RPS27L;POLDIP3;ERBB2;CDC123;HNRNPD;LARP4;MPV17L2;RPUSD3;VIM;BOLL;DHX36;EIF5A2
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.45460253129165773,1.1753731763771984,0.2507987220447284,0.7135179473834439,1.0,10/31,15.74%,SHANK3;LRP8;EPHA4;DBNL;KIF1A;EFNA1;ABI3;CFL1;CAMK2B;NLGN1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.44682756773884913,-1.1752169231748726,0.25,0.6976708748205886,1.0,7/20,12.03%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.44682756773884913,-1.1752169231748726,0.25,0.6976708748205886,1.0,7/20,12.03%,ACADSB;IVD;MCCC2;AUH;HIBADH;BCKDHB;HIBCH
prerank,negative regulation of receptor internalization (GO:0002091),0.5492556762043976,1.1749235249049383,0.2811881188118812,0.7139623553468336,1.0,5/12,19.35%,ANKRD13A;RIN3;SDCBP;MTMR2;LRPAP1
prerank,pancreas development (GO:0031016),0.550162635567433,1.1742749274873592,0.2958801498127341,0.7149482969949459,1.0,2/12,4.36%,ZIC3;FOXF1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.5238264584566507,1.1740336200297967,0.2859778597785978,0.7139711446856006,1.0,3/15,5.88%,NANOS3;NANOS2;NANOS1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.5238264584566507,1.1740336200297967,0.2859778597785978,0.7139711446856006,1.0,3/15,5.88%,NANOS3;NANOS2;NANOS1
prerank,organelle disassembly (GO:1903008),-0.39217542292385743,-1.1732375622791884,0.2297650130548303,0.7018373156334277,1.0,10/33,14.77%,GBF1;ULK2;ATG2B;MCTS1;GOLGA2;TEX264;STX5;PLK5;DDRGK1;UFC1
prerank,regulation of cell differentiation (GO:0045595),0.36920199402621084,1.1726443715154224,0.1974025974025974,0.7169059581353532,1.0,20/148,9.60%,SPOCK2;SLC6A6;LTBP4;NOTCH4;FES;TBX1;BCL6B;PTK2;RPS6KA1;TIAM1;SMAD7;HSP90AB1;SNAI2;KLF4;INSM1;TGFB1;YWHAH;CDK5RAP2;GREM1;CEBPD
prerank,neuromuscular process (GO:0050905),0.5295864219728689,1.1717807958789948,0.302491103202847,0.7184772719130139,1.0,3/16,10.09%,GCH1;NRXN1;STRA6
prerank,dopamine metabolic process (GO:0042417),0.5172721151191175,1.1713745746547712,0.28055077452667815,0.7187681190303779,1.0,3/18,2.19%,MAOA;TGFB2;GCH1
prerank,negative regulation of gene expression (GO:0010629),0.34020303371820076,1.1709393804770782,0.15295480880648898,0.7191340692584304,1.0,58/302,13.44%,SLC7A5;OCLN;CLDN5;PDGFB;KDR;CD34;ENG;TGFB2;NANOS3;APP;XDH;RGCC;MEF2C;SRGN;ACVRL1;APLNR;NOTCH1;YBX1;HDAC9;NANOS2;NOS2;GATA2;NOCT;DLL4;ENC1;MRPL13;DIP2A;NANOS1;RPS6KA5;ATP2B1;ADAM10;FBXW7;LGALS9;KLF4;PTBP3;N4BP1;HINFP;TGFB1;TERF2;FOXP3;NDFIP2;KDM4A;PPP1R11;RPL13A;CNOT9;GRB7;PTRH2;PDCD10;TASOR;DCP2;HRAS;HIF1A;BTG2;DXO;SOX11;HELLS;SETDB1;PAIP2
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.49683182172436674,-1.170777214108418,0.2817204301075269,0.7076855606291783,1.0,2/13,3.28%,AXL;IL18
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.3803847372971123,-1.1706643315842848,0.22465753424657534,0.7065806819365766,1.0,7/39,9.51%,STEAP3;ABCA1;TANGO2;RCN3;ARFGAP3;TANGO6;CANX
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.5064665691786963,-1.169663965079821,0.2727272727272727,0.708035780575866,1.0,2/12,7.33%,IL18;IL17D
prerank,regulation of microtubule-based process (GO:0032886),-0.3917947478452065,-1.1693587975455264,0.2388451443569554,0.7075717453643522,1.0,11/36,14.86%,PHLDB2;EPHA3;PRKAA2;EFNA5;DIAPH1;ATF5;PHLDB1;BICD1;MAP6;MEMO1;KLHL42
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.44791431470275994,1.1690929549887652,0.25732899022801303,0.7233170271287523,1.0,10/33,16.30%,PTPRJ;PRKD2;DUSP3;UBASH3A;CD160;DGKZ;CEACAM1;BCL10;CARD11;TESPA1
prerank,regulation of viral genome replication (GO:0045069),0.41462602943927135,1.1690697799227858,0.26119402985074625,0.7225285401902279,1.0,17/56,18.09%,IFIH1;FKBP6;ADAR;BTBD17;PPIA;PKN2;N4BP1;BST2;BANF1;OASL;PDE12;NR5A2;SLPI;ZC3HAV1;RAD23A;PROX1;TNIP1
prerank,mesenchyme development (GO:0060485),-0.46219404883449544,-1.1688373506176204,0.28874734607218683,0.707690278632217,1.0,5/15,4.66%,BMP7;FGFR2;BMP4;TGFBR1;PKD2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.32088097623759004,-1.1674288024487316,0.17110266159695817,0.7103642115020256,1.0,26/95,14.57%,TGFBR3;ZEB2;LDLRAD4;SMAD3;DKK3;SMAD6;HTRA3;THBS1;SNX6;TGFBR1;DAB2;PPARA;ASPN;EMILIN1;TGFB1I1;CD109;SMURF2;PDPK1;SPRED1;STK11;VASN;SKI;GIPC1;HTRA4;SLC2A10;EP300
prerank,organelle transport along microtubule (GO:0072384),-0.39683536565974054,-1.16596769198562,0.22865013774104684,0.7131490069047822,1.0,13/31,24.75%,TRAK1;ARHGAP21;MAP1S;BICD1;DYNC1I1;CLN3;RAB6A;FBXW11;RHOT1;BORCS5;COPG1;HTT;HAP1
prerank,regulation of interleukin-8 production (GO:0032677),0.4092425370299047,1.1658745040790077,0.23055555555555557,0.7306613314196271,1.0,17/69,14.07%,TIRAP;AFAP1L2;NOD1;NOD2;PRKD2;TMSB4X;NOS2;HYAL2;TLR3;LGALS9;KLF4;TLR7;LAMTOR5;TLR8;SYK;RAB1A;BCL10
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.5713054451272257,1.1656575673753387,0.3230769230769231,0.7304082876496721,1.0,3/10,7.45%,CD40;LYN;BTLA
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3503209633612785,1.1655422969715532,0.18883610451306412,0.7298791828139886,1.0,36/208,11.88%,TFRC;DAB2IP;TNFRSF19;TIRAP;PLEKHG5;TRIM25;TNFSF10;TRIM14;NOD1;CD40;NOD2;PELI1;PRKD1;ATP2C1;IKBKB;CCR7;CD4;LGALS9;STAT1;BST2;BIRC3;PIDD1;MALT1;MAP3K3;NDFIP2;ZMYND11;UBE2V1;OTUD7A;SHARPIN;CASP8;BRD4;HSPB1;LAMTOR5;PRKCB;GPR89A;TLE1
prerank,cation transmembrane transport (GO:0098655),0.4324530608477231,1.1651627383980638,0.26625386996904027,0.7301367847111446,1.0,4/44,1.98%,SLC7A5;SLC7A1;SLC6A5;SLC38A5
prerank,ion homeostasis (GO:0050801),-0.40252635607873843,-1.1650307058733047,0.26184538653366585,0.7144805946882129,1.0,8/30,15.36%,SLC4A10;FHL1;WNK4;CAMK2D;SLC4A7;SLC4A2;WNK1;SLC4A3
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.4463347573546752,-1.1645675744879531,0.27790432801822323,0.7144184323145573,1.0,11/19,33.47%,GFPT1;RENBP;GFPT2;SLC35D1;PGM3;NAGK;UAP1;UAP1L1;GNPDA1;PMM1;GMPPB
prerank,integrin-mediated signaling pathway (GO:0007229),-0.3375720901901563,-1.1645467752717304,0.16778523489932887,0.7130604828958227,1.0,21/73,11.95%,ITGBL1;COL3A1;PLPP3;FBLN1;ITGB5;ITGB8;ITGA10;TEC;ADAM9;ITGA11;DAB2;COL16A1;ITGA5;FYB1;ITGB4;CUL3;ITGB1BP1;ITGAV;PTK2B;ADAMTS1;ABL1
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3935367287002295,1.164387475161627,0.23665223665223664,0.7313979870110505,1.0,16/75,12.15%,DAB2IP;RASIP1;HEG1;STK38;PTPRJ;DUSP7;MEN1;PKIG;LYN;HHEX;HYAL2;PRKAR2B;LRP5;PRKAR2A;DUSP1;PIK3CB
prerank,gliogenesis (GO:0042063),0.5323052591526196,1.164241586692761,0.30141843971631205,0.7309716378180434,1.0,4/15,10.01%,TGFB2;CDH2;MMP24;METRN
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.4230605413280267,1.1635640142509984,0.25152439024390244,0.732007487617311,1.0,11/45,17.80%,NANOS3;APP;NANOS1;TDRD7;CYFIP1;EIF4E;PUM3;ZC3H7A;GCNT2;ATG14;TRIM71
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.4270516090889376,1.1634011758290592,0.25987841945288753,0.7316364296596717,1.0,15/45,18.79%,TRIM25;B2M;SP100;IRF2;IRF9;STAT1;HCK;IRF5;OASL;MID1;CAMK2B;VCAM1;TRIM26;TRIM68;CAMK2G
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.3948622739605702,1.1632931912172706,0.23665223665223664,0.7310908672876554,1.0,13/75,8.64%,MFSD2A;APP;KLF7;MEF2C;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;SLITRK1;OPHN1
prerank,response to cholesterol (GO:0070723),-0.45459219330400913,-1.1632754790267479,0.26540284360189575,0.7154288156600406,1.0,10/17,26.79%,SMO;TGFBR1;GRAMD1B;GRAMD1C;LRP6;GRAMD1A;PTCH1;MLC1;PMVK;SMAD2
prerank,regulation of gluconeogenesis (GO:0006111),-0.41064988736452696,-1.163050463391533,0.2396088019559902,0.7146663110603959,1.0,5/27,8.85%,OGT;PPARGC1A;C1QTNF3;SELENOS;NNMT
prerank,mitochondrion localization (GO:0051646),-0.4532139795031425,-1.162980942050644,0.2753623188405797,0.7134282902333368,1.0,10/19,28.49%,TRAK1;MARK1;LRRK2;MFN2;MUL1;TLE6;HAP1;MFN1;MARK2;ATCAY
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.5048243839032653,-1.1627964252410539,0.27901785714285715,0.712508387813136,1.0,4/11,9.52%,DAB2;RAB21;PRKN;EZR
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4151124827716193,-1.1625398292855196,0.24876847290640394,0.711842973425952,1.0,12/26,30.18%,OGT;CTR9;SETD4;KMT5C;EEF2KMT;SETD5;KMT5B;SETD2;ANTKMT;METTL21C;KMT2A;SETD1B
prerank,regulation of protein modification process (GO:0031399),0.41883550035530176,1.162481401145671,0.2411674347158218,0.7325200226028802,1.0,12/50,13.45%,PPP1R16B;PTK2;LYN;FNIP2;CCDC88A;PIN1;ASPSCR1;HPF1;PARG;HSPB1;PUM3;CDH5
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.346484548943655,-1.1621890511210669,0.19682539682539682,0.7086978802880821,1.0,15/61,14.55%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,vesicle coating (GO:0006901),-0.346484548943655,-1.1621890511210669,0.19682539682539682,0.7086978802880821,1.0,15/61,14.55%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,COPII vesicle coating (GO:0048208),-0.346484548943655,-1.1621890511210669,0.19682539682539682,0.7086978802880821,1.0,15/61,14.55%,SEC24D;SEC24A;USO1;GOLGA2;SEC31A;TRAPPC3;SEC16B;STX5;CUL3;SEC23A;SCFD1;SEC16A;LMAN1;TRAPPC10;CTSZ
prerank,peptide biosynthetic process (GO:0043043),0.3616810747437251,1.1619339519759022,0.1997439180537772,0.7331994004418788,1.0,64/153,26.76%,SARS1;ZAR1L;RPL38;MRPL13;RPL13;RPS29;MRPL10;RPL36A;RPL3;YARS2;RPL27;RPSA;RPS7;RPL9;RPL18;RPLP2;RPL13A;RPS11;RPL8;RPS27;RPL19;RPS9;MRPL28;RPL11;RPS15;SRBD1;RPL37;RPS28;RPS10;RPS25;RPL37A;MRPL9;COPS5;RPL15;TNIP1;MRPL23;RPL17;RPL23;RPL34;FARSB;RPS18;RPL21;RPS4X;MRPS18A;RPL18A;DHPS;RPS21;RPL10A;RSL24D1;RPL24;RPL7A;MRPL41;MRPL27;MRPL51;HARS1;RPL32;RPL4;RPS2;MRPS33;MRPL37;RPS20;RPL6;RPS13;MRPS18C
prerank,L-glutamate transmembrane transport (GO:0015813),0.5570440985262197,1.159919938649871,0.3058823529411765,0.7379781548140858,1.0,3/10,10.83%,SLC1A1;SLC1A2;ARL6IP5
prerank,regulation of actin filament polymerization (GO:0030833),0.39310159116795645,1.1594499624924606,0.2453900709219858,0.7384309214218866,1.0,13/69,8.14%,KANK3;ESAM;HIP1R;EVL;SSH2;VIL1;CCR7;CDC42EP3;BAIAP2;DBNL;NCKAP1;HCK;TWF2
prerank,determination of bilateral symmetry (GO:0009855),0.4801938522740569,1.1592072146209782,0.27697262479871176,0.7382665951285913,1.0,6/25,15.28%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DNAH5
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.4136937448037,-1.159174687107617,0.23300970873786409,0.7159565034683744,1.0,5/26,5.39%,SULF1;CCBE1;SULF2;RORA;CYP1B1
prerank,negative regulation of histone methylation (GO:0031061),-0.5228664997966406,-1.158309182352299,0.30257510729613735,0.7170852191333239,1.0,6/10,33.37%,BCOR;KDM1A;BRCA1;AASS;MTF2;JARID2
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.4930495416312029,-1.1579910853630535,0.2748917748917749,0.7165559873785478,1.0,7/13,24.32%,IRS1;IGF2;SNX5;ECHDC3;ZBTB7B;PRKCZ;C1QTNF12
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.4081511276147867,-1.1577114330585305,0.2576832151300236,0.715922214231151,1.0,9/28,9.88%,PID1;APPL2;ENPP1;IRS1;KANK1;PRKCD;GRB10;TNS2;PIP4K2C
prerank,B cell receptor signaling pathway (GO:0050853),0.4665396326529994,1.1572331719118425,0.2720970537261698,0.742992911006315,1.0,11/32,16.40%,MEF2C;CD19;CD38;PLEKHA1;CD79A;PRKCB;SYK;SH2B2;RFTN1;NCKAP1L;LAT2
prerank,tryptophan metabolic process (GO:0006568),-0.5041643551097864,-1.1571274909421898,0.31625835189309576,0.7160432274124281,1.0,6/11,30.36%,ATP7A;KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,nervous system development (GO:0007399),0.3250392195079169,1.1569442895364521,0.16083150984682712,0.7429269489818283,1.0,68/429,12.79%,SPOCK2;ST8SIA4;MPZ;DNM3;SLC2A1;SHANK3;SEMA6A;ZIC3;ADGRL3;MAL;PCDH1;TBX3;SEMA6B;NAV1;NES;MEF2C;PLXND1;KALRN;FGF13;CDH2;DSCAML1;EVL;MERTK;ZBTB16;PCDHA11;MOG;PCDHAC1;WWTR1;SEMA4F;ATXN3;DBNL;NCKAP1;STMN3;FAT4;DCHS1;PCDHA1;NAV2;MARK4;NFASC;DPYSL2;TGFB1;SLITRK1;GPM6A;PTN;CDK5RAP2;OPHN1;APBA2;NRXN1;SPOCK1;CAPG;DNER;SERPINI1;RITA1;DCX;THOC6;EIF2B2;VXN;CHRM3;MOBP;PCDHB12;RAPGEF5;RBM45;HMGCR;SOX10;EPHB1;PCDHB14;CPNE6;FEZ2
prerank,lymphocyte migration (GO:0072676),0.4545263228804758,1.1566581878823743,0.28407224958949095,0.7428657713994652,1.0,5/32,11.00%,S1PR1;ZAP70;RET;MSN;CCL1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3999623192044717,-1.1563154314444817,0.2602739726027397,0.7170018699318228,1.0,7/31,4.56%,TGFBR3;BMPR1A;FGFR2;ZFPM2;TPM1;TGFBR1;RBPJ
prerank,phosphate ion homeostasis (GO:0055062),-0.5279456974269678,-1.1562239387507245,0.27293064876957496,0.7158902146541735,1.0,2/10,6.33%,ENPP1;SFRP4
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.4277173608061491,-1.1560502937143988,0.2559241706161137,0.7150435032978346,1.0,4/23,7.57%,NUPR1;HDAC4;PPARA;C1QTNF3
prerank,regulation of postsynapse organization (GO:0099175),0.45906522764366164,1.1550161027916406,0.28802588996763756,0.7466183736224095,1.0,5/28,6.88%,SHANK3;EPHA4;ABHD17A;HOMER1;KIF1A
prerank,epidermis development (GO:0008544),-0.352729738307925,-1.1548453222496495,0.1930379746835443,0.7170825328026335,1.0,11/56,13.22%,SVEP1;CCN2;FGFR2;EMP1;FLOT2;CRABP2;GLI1;GATA6;PTHLH;SCEL;LAMC2
prerank,positive regulation of neurogenesis (GO:0050769),-0.33486571514665814,-1.1548380847930595,0.21646341463414634,0.7157249906779468,1.0,18/68,11.66%,ROBO1;PLXNA2;TIAM2;SLIT2;CUX1;OBSL1;NGF;FBXW8;SERPINF1;PLXNB2;FZD3;SMARCD3;CUL7;NUMBL;ROBO2;KDM1A;CAPRIN2;MAP6
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.35510023148354053,-1.1545959863136916,0.20489296636085627,0.715105064323463,1.0,18/52,24.25%,CELF2;DDX5;FXR2;SRRM4;NOVA1;SRSF6;DDX17;RBM5;FMR1;NSRP1;RBFOX1;SAP18;TRA2B;MBNL2;ZC3H10;RBM24;KHDRBS3;CELF6
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.5693398738337163,1.154560474810241,0.31954887218045114,0.7469530043839699,1.0,3/10,9.89%,FBXW7;TGFA;ADAM17
prerank,monosaccharide transmembrane transport (GO:0015749),-0.47300022231453975,-1.1545292799011169,0.29128440366972475,0.7138820790398143,1.0,4/16,14.36%,SLC2A12;SLC5A3;SLC45A3;SLC2A10
prerank,ketone body metabolic process (GO:1902224),-0.5101619758945102,-1.1539457653921101,0.2774327122153209,0.7140780999778106,1.0,6/10,15.67%,OXCT1;ACSS3;BDH2;AACS;BDH1;HMGCLL1
prerank,epithelial structure maintenance (GO:0010669),-0.5104643591329998,-1.1537190086648692,0.30885529157667385,0.713392030070915,1.0,2/11,3.27%,CXADR;RBP4
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.34972979170751883,1.153509841681702,0.19757575757575757,0.7490681302066257,1.0,46/190,14.19%,BCL2L1;DAB2IP;PDE2A;SH3BP4;XDH;CAV1;PHLPP1;PLAUR;PTPRJ;TNFAIP8L1;APLNR;PIK3IP1;CD2AP;HDAC7;DUSP3;LYN;TMSB4X;PDE4D;HYAL2;PLEKHA1;ARHGAP25;RFFL;MCL1;STAT1;MARK3;ABCA7;P2RX7;ZMYND11;OTUD7A;DEPDC5;DDIT4;CASP8;DUSP1;ADIPOR1;GSK3A;TLE1;PIK3CB;CYRIB;WWC1;TMEM127;CYLD;TRIM39;TNFAIP3;PDE3B;PDCD6;EPM2A
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),-0.3880818064524353,-1.153277461889043,0.24225352112676057,0.7133198638815034,1.0,8/37,11.86%,PHLDB2;EPHA3;PRKAA2;EFNA5;PHLDB1;BICD1;MAP6;SKA2
prerank,cardiac cell development (GO:0055006),-0.5143574639956761,-1.1531524703508065,0.27912087912087913,0.7123383493709478,1.0,4/11,7.89%,CXADR;SLC8A1;JAG1;MYH11
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.46927297415327157,-1.152632350722273,0.28602620087336245,0.7125135292917238,1.0,3/16,7.73%,PDK1;RORA;PRKN
prerank,B cell mediated immunity (GO:0019724),0.5613011373170411,1.1525283666250612,0.3333333333333333,0.7510896494686757,1.0,3/10,15.56%,CD19;TLR8;MSH2
prerank,synaptic vesicle exocytosis (GO:0016079),0.43654302669091305,1.1525046084657264,0.2682170542635659,0.7503100335687855,1.0,9/40,13.19%,UNC13B;STX3;STX1A;PIP5K1C;SYT7;DNAJC5;STX19;SNAP29;CPLX1
prerank,regulation of innate immune response (GO:0045088),0.413322336823106,1.1519575729867715,0.2559880239520958,0.7509645331502083,1.0,12/57,11.38%,TIRAP;LRP8;IFNAR2;GBP5;SAMHD1;HSP90AB1;XIAP;N4BP1;BIRC3;CASP8;TLR8;USP18
prerank,histone H3-K36 demethylation (GO:0070544),-0.5227827219481219,-1.1516019597535974,0.29130434782608694,0.7140741921256574,1.0,5/10,16.92%,KDM7A;KDM2A;KDM2B;PHF8;RIOX2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.362807819690359,1.1514652513298416,0.2258485639686684,0.7514991823149281,1.0,28/118,13.84%,ETS1;SHANK3;TBX1;FLT4;NEDD4L;MEF2C;PLXND1;SP100;CDH2;VASH1;LZTS1;CTNNB1;TSPAN12;EPHA4;KIF1A;INF2;TGFB1;PAK1;STRIP1;FERMT2;ABI3;PDZD8;CEACAM1;CYRIB;EGLN1;NSMF;TNFAIP3;CFL1
prerank,negative regulation of protein binding (GO:0032091),0.3925052650478723,1.151106695217675,0.25105189340813466,0.7516423439971855,1.0,14/71,12.78%,PDGFB;CAV1;CTNNBIP1;B2M;NES;ADAM15;ZFPM1;ACTB;RALB;PIN1;DISC1;PEX14;MITD1;SLPI
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.4399944491718213,-1.1509948922576403,0.30210772833723654,0.71457282188943,1.0,7/17,16.49%,ARRB1;ANXA1;ANXA4;SSC5D;PTPN22;MAP2K5;MAPKBP1
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4372833540216719,1.150915101409254,0.2671875,0.7513196747874566,1.0,5/36,5.17%,CAV1;JAK3;NOTCH1;IL10RB;PIGU
prerank,regulation of cell morphogenesis (GO:0022604),0.4550268110473254,1.1508878500319346,0.2912,0.7505419177280609,1.0,7/30,11.20%,MFSD2A;MACF1;NTNG2;VIL1;STRIP1;FERMT2;PDZD8
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5652883910910441,1.1507245626830498,0.3302752293577982,0.750156014448228,1.0,6/10,17.33%,CORO2B;SNX3;NDFIP2;TERF1;DNAJA1;PPM1F
prerank,ion transport (GO:0006811),-0.3150129234383621,-1.1504735263675823,0.16342412451361868,0.7147446502024911,1.0,21/111,9.09%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC26A7;SLC26A2;SLC8A3;SLC12A2;ANO6;WNK4;SLC9A2;SLC5A5;SLC8B1;SLC12A7;ANO1;SLC8A1;SLC20A2;TRPC6;SLC4A2;SLC9A9;GLRB
prerank,postreplication repair (GO:0006301),0.4229525945416223,1.1504606793107823,0.27191679049034173,0.7500566537242667,1.0,5/45,9.77%,POLK;TRIM25;UBE2V2;USP43;UBE2V1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.4317219011749393,1.1503678933028447,0.27936507936507937,0.7494735644935827,1.0,2/42,2.24%,POLK;TRIM25
prerank,protein localization to vacuole (GO:0072665),0.5390080982430152,1.1497831033629018,0.3116883116883117,0.7501926564933858,1.0,5/13,15.55%,SH3BP4;LAMTOR5;SH3GLB1;LMBRD1;LAMTOR4
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.5527619730304201,1.1494397293436425,0.3026315789473684,0.7502849132402283,1.0,2/11,8.30%,ITM2A;ABCA7
prerank,long-chain fatty acid import into cell (GO:0044539),0.5570237743171961,1.1492214268845986,0.30330882352941174,0.7500482106887385,1.0,3/10,12.91%,SLC2A1;ACSL3;SLC27A2
prerank,sodium ion import across plasma membrane (GO:0098719),-0.4477157151146014,-1.1491565879481203,0.2789598108747045,0.7171104707468099,1.0,7/17,10.60%,SLC12A2;SLC9A2;SLC6A1;SLC8A1;SLC9A9;SLC9A1;TRPM4
prerank,lymphocyte chemotaxis (GO:0048247),-0.38757777284105965,-1.1487559381693373,0.25316455696202533,0.7170341151225654,1.0,15/34,33.65%,CYP7B1;SLC12A2;CXCL16;CCL13;CKLF;ADAM8;PIK3CD;CCL19;CCL2;CXCL10;CCL15;CX3CL1;CCL5;GPR183;CCL11
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.52818400931437,1.1487313088092597,0.3255395683453237,0.7505744789017622,1.0,7/13,22.40%,SVIP;DERL2;EDEM1;UBAC2;UBE2G2;BRSK2;UBE2J1
prerank,cellular response to organic substance (GO:0071310),0.3667097941149635,1.148624401653098,0.24592391304347827,0.7499929425874281,1.0,19/116,8.14%,LEF1;SLC1A1;PDGFB;BMPR2;NCOA1;PTPN12;ACVRL1;SIGIRR;RAMP2;SOCS2;CTNNB1;RAMP3;CYP11B1;CCR7;KLF4;NCOA2;CRNN;TGFB1;TWF2
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.52148942740351,1.148361956744837,0.3079584775086505,0.7498956770667372,1.0,3/15,11.38%,NLRC5;SAMHD1;USP18
prerank,sphingosine metabolic process (GO:0006670),0.5052904164087696,1.1481794233712503,0.30319148936170215,0.7495585475388715,1.0,4/17,6.96%,SGPP2;ACER2;ACER1;SPTLC2
prerank,dicarboxylic acid transport (GO:0006835),-0.4068383293464841,-1.1476992273305933,0.28502415458937197,0.7186671602530763,1.0,6/28,4.51%,SLC1A3;SLC13A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,response to interferon-beta (GO:0035456),0.47770193653454723,1.147494042036419,0.3205574912891986,0.7506361652163357,1.0,6/22,8.17%,IFNAR2;XAF1;AIM2;STAT1;BST2;IRGM
prerank,regulation of leukocyte chemotaxis (GO:0002688),0.504088154665839,1.147125855073978,0.3069139966273187,0.7508130810960171,1.0,5/18,9.89%,MTUS1;IL6R;LYN;PTN;ADAM17
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.4484706656527403,1.1469057210692588,0.28548644338118023,0.7505911809805428,1.0,7/35,12.18%,HIP1;HIP1R;B2M;MKLN1;RAC1;PIK3CB;TNK2
prerank,negative regulation of cilium assembly (GO:1902018),0.5312367461101682,1.14641271242297,0.3185328185328185,0.7510631359309599,1.0,5/12,11.61%,MAP4;LIMK2;CCP110;ODF2L;TBC1D30
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.54576792866847,1.1462885214659495,0.3259668508287293,0.7505869387272269,1.0,6/11,18.73%,KCNQ1;ATP1A1;KCNH2;KCNJ3;KCNJ5;KCNIP2
prerank,organelle fission (GO:0048285),0.4700143653364373,1.146178838044488,0.30392156862745096,0.7500836769730643,1.0,1/24,0.16%,DNM3
prerank,fibrinolysis (GO:0042730),0.5294847266026801,1.1461032930530262,0.3416370106761566,0.7494287142855248,1.0,2/13,9.25%,PLAUR;PLAT
prerank,phosphate-containing compound metabolic process (GO:0006796),0.34344998025113965,1.1458486397640313,0.2105911330049261,0.749329677544449,1.0,51/198,18.95%,PLCB1;PTPRB;PLCB4;ITPKB;GPD2;INPP5D;DUSP23;PLA2G4B;DUSP3;PLCG1;CALM1;PLD4;OCRL;LIMK2;MAPK3;CERKL;PGM2L1;TGFB1;PLCH2;PAK1;PFKFB3;NUDT3;ACP4;TOLLIP;HK1;DUSP12;PPP3CA;IPMK;PLCH1;PIP4K2A;PIK3CB;TNK2;PANK3;DUSP16;INPP1;CERK;G6PC3;PFKL;DUSP8;CLN8;PLPPR4;SYNJ1;ALK;PLPP2;INPPL1;MINPP1;PRKCG;PAK2;NUDT10;GPX4;PGP
prerank,positive regulation of chemotaxis (GO:0050921),0.42843355480137435,1.1447568200402356,0.2732919254658385,0.7515191750894064,1.0,11/43,10.75%,PDGFB;KDR;IL6R;STX3;PRKD1;PRKD2;TMSB4X;TGFB1;PTN;ADAM17;HSPB1
prerank,positive regulation of nuclear division (GO:0051785),0.4747482322664794,1.1447396142038784,0.30103806228373703,0.7507259262962989,1.0,6/25,8.59%,PDGFB;INSR;RGCC;NPM2;TGFA;LRP5
prerank,circulatory system development (GO:0072359),0.3627702341099415,1.14465152840073,0.22626788036410922,0.7501548135884567,1.0,17/118,4.36%,TEK;RBM20;PDGFB;TGFB2;NOTCH4;HEG1;TBX1;SOX17;FLT4;MEF2C;ACVRL1;ZFPM1;APLNR;NOTCH1;HDAC9;RAMP2;FOXF1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.5375311916666277,1.1443415116667948,0.33270676691729323,0.7501582190660392,1.0,7/13,22.01%,ATF6B;ABCA7;PPP1R15B;DNAJB9;NCK1;BFAR;RACK1
prerank,regulation of insulin secretion (GO:0050796),-0.3118049750334221,-1.1442340624338632,0.22088353413654618,0.7274292811521833,1.0,22/101,11.27%,CACNA1C;ADCY5;ITPR1;MCU;IRS1;EFNA5;NLGN2;RBP4;PER2;STXBP4;IRS2;SLC8B1;NNAT;PRKN;CACNA1D;CCN3;DPP4;CDK16;PRKCA;ITPR2;AACS;PPP3CB
prerank,regulation of focal adhesion assembly (GO:0051893),0.40815813859437156,1.1442095212325616,0.26952526799387444,0.7497061956523338,1.0,8/54,3.74%,TEK;LIMCH1;KDR;MACF1;PTPRJ;PTK2;ACVRL1;DUSP3
prerank,mitochondrial fusion (GO:0008053),-0.4316089632468251,-1.144123624374245,0.2699530516431925,0.7263739110686445,1.0,5/18,14.16%,MIGA2;MIEF1;AFG3L2;MFN2;MIEF2
prerank,postsynaptic membrane organization (GO:0001941),0.5007119663421636,1.1435925712124158,0.29381443298969073,0.7505898223467539,1.0,4/17,8.93%,SHANK3;CHRNB1;GPHN;NRXN1
prerank,establishment of protein localization to plasma membrane (GO:0061951),0.44000327197084066,1.1435915993334484,0.28322784810126583,0.7497674322878195,1.0,3/36,2.34%,SPTBN1;MACF1;RAB31
prerank,negative regulation of cellular component organization (GO:0051129),-0.33197714526345684,-1.1435861161552123,0.1786833855799373,0.726582085981738,1.0,19/74,17.67%,BMP6;EPHA3;CARMIL1;IMPACT;AR;FAP;LRSAM1;RTEL1;IRAK3;TMEFF2;XRCC5;SCAMP5;DDX3X;SNX33;EP300;CRYAB;NR1H4;DNAJB2;PACSIN3
prerank,inner ear morphogenesis (GO:0042472),-0.4314118779408747,-1.1423914602143295,0.29854368932038833,0.7287264164246924,1.0,6/22,7.23%,ZIC1;FGFR2;SIX1;TBX18;TTC39C;EPHB2
prerank,regulation of ruffle assembly (GO:1900027),0.47902410728741046,1.1418827803583738,0.30677966101694915,0.7536740703888359,1.0,9/23,15.74%,CAV1;EVL;EPS8;EPS8L2;ABI3;PLEKHM1;HRAS;FAM98A;NLGN1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.45508835607366865,-1.1418344082188459,0.2822966507177033,0.72890944801755,1.0,5/16,12.11%,DDX5;PPARGC1B;AR;DDX17;ESR1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.3336243840759944,1.1417882502973726,0.205607476635514,0.7531157075686602,1.0,47/260,13.59%,DNM3;ABCC4;FGD5;PARVB;ABLIM1;SRGAP2;RAPGEF2;FNBP1L;NTN1;EXOC6;S1PR1;SPATA13;MTSS1;NOTCH1;CD2AP;CNGA2;CEP83;PPP1R9B;POC1B;CDC14A;CFAP52;OCRL;CCDC88A;DYNLL1;RAB11A;RAP1B;TTLL3;ARHGEF7;P2RX7;OPHN1;FGD6;DISC1;CYFIP1;KIF3B;EHD4;CFAP54;EXOC4;EXOC2;RAC1;MAP4K4;SNAP29;RAB1A;FGD2;BBIP1;SDCBP;MINK1;FSCN1
prerank,transcription preinitiation complex assembly (GO:0070897),0.5434022696889711,1.141742813646488,0.33157894736842103,0.7524164752505608,1.0,9/12,34.02%,TAF1B;TAF7L;GTF2B;BDP1;GTF2A2;TAF7;DR1;TAF11;TAF12
prerank,regulation of phagocytosis (GO:0050764),0.40600804977848964,1.141730646380535,0.2781954887218045,0.7516311720856773,1.0,14/53,17.30%,DYSF;SCARB1;MERTK;TGM2;SNX3;GATA2;SYT7;HCK;ABCA7;SYK;IL15;GAS6;DOCK2;LYAR
prerank,mammary gland development (GO:0030879),0.4904884527259038,1.1415892342205314,0.32669983416252074,0.7511920758128845,1.0,4/21,5.76%,NOTCH4;CAV1;TBX3;OXTR
prerank,regulation of lamellipodium organization (GO:1902743),-0.4667711207275868,-1.1409763271094158,0.27510917030567683,0.7300321718018419,1.0,3/14,2.69%,PDPN;CARMIL1;CAPZB
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),-0.3113822022452426,-1.1408525835269347,0.19615384615384615,0.729005300741152,1.0,16/112,4.40%,COL1A2;COL3A1;SOX5;TGFBR3;BMPR1A;APPL2;WNT4;SMAD3;PDE3A;ITGB5;SMAD6;WWOX;CLEC3B;TGFBR1;TWSG1;ADAM9
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5522043031078258,1.1408216915397302,0.33396946564885494,0.7525231840425926,1.0,3/11,14.90%,PXDN;CAT;PRDX5
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5516288912101606,1.1405511657502954,0.3235294117647059,0.7524366511217252,1.0,3/10,6.45%,SIGIRR;PALM3;KLF4
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.4885399976396724,1.140070737971572,0.32105263157894737,0.752886878274405,1.0,4/21,6.47%,DAB2IP;TGFB2;CD2AP;ARHGAP25
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5603742747931124,1.1399322551442368,0.33396946564885494,0.7516504902378958,1.0,4/10,12.65%,ALKBH2;MGMT;MPG;ASCC3
prerank,DNA dealkylation (GO:0035510),0.5603742747931124,1.1399322551442368,0.33396946564885494,0.7516504902378958,1.0,4/10,12.65%,ALKBH2;MGMT;MPG;ASCC3
prerank,negative regulation of potassium ion transport (GO:0043267),0.5301972722406223,1.1392679796383165,0.3416506717850288,0.7526525327324181,1.0,3/13,7.93%,CAV1;NEDD4L;KCNH2
prerank,mucosal immune response (GO:0002385),0.528370015025944,1.13882033090924,0.34330985915492956,0.7531478383348533,1.0,2/15,4.51%,DEFA6;NOS2
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.36770547341119897,1.1386415104490932,0.2537313432835821,0.7528327926896308,1.0,13/113,4.45%,TEK;EGFL7;PDGFB;KDR;PPP1R16B;BMPR2;TBX1;FLT4;NOD2;PRKD1;PRKD2;WNT7A;RREB1
prerank,establishment of protein localization to membrane (GO:0090150),0.39884882351151846,1.1385190466603414,0.2886297376093295,0.7523495102883492,1.0,19/66,16.37%,AQP11;REEP1;ZDHHC14;PARD3;PIKFYVE;ZDHHC9;ZDHHC20;RAB11A;GRIN3B;ZDHHC19;RTP4;NPC1;ZDHHC18;ZDHHC22;SDCBP;NACAD;RFTN1;RTP3;ZDHHC21
prerank,RNA destabilization (GO:0050779),-0.44179679462420496,-1.1379928162916508,0.2817258883248731,0.7357071228627212,1.0,5/18,24.65%,ROCK2;YTHDF1;RBM24;ZC3H18;MEX3D
prerank,serine family amino acid biosynthetic process (GO:0009070),0.538126560160961,1.1375981794739507,0.34946236559139787,0.754091529116612,1.0,3/12,9.59%,SERINC3;SERINC5;CBS
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3886990158415295,-1.1373273801651078,0.28535353535353536,0.736309235905621,1.0,7/30,8.91%,FSTL1;TGFBR3;SMAD3;DKK3;TWSG1;SFRP4;SMURF2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.48982171973133015,-1.137278840402012,0.33059548254620125,0.7337294973953588,1.0,3/12,15.91%,FHL2;DYRK2;HOMER3
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.48982171973133015,-1.137278840402012,0.33059548254620125,0.7337294973953588,1.0,3/12,15.91%,FHL2;DYRK2;HOMER3
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.47228279126855527,-1.1372395880755615,0.32175925925925924,0.7324790331993469,1.0,7/14,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.4232572781162341,1.1370753114390357,0.2982998454404946,0.754628011999554,1.0,12/46,18.70%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,negative regulation of mRNA processing (GO:0050686),-0.4671487656957921,-1.1370490111272413,0.30120481927710846,0.731727775763119,1.0,7/15,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;SRSF10
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.3962680558337169,1.1370210597805457,0.2671532846715328,0.7539727044924256,1.0,13/69,12.73%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;C1QTNF4;DDT
prerank,positive regulation of binding (GO:0051099),0.37997282205492144,1.1367437091956951,0.27363896848137537,0.7539708221323327,1.0,12/84,4.05%,CLDN5;RAPGEF2;APP;CAV1;HIP1R;PLAUR;B2M;EPB41;TIAM1;MEN1;HMBOX1;STMN1
prerank,negative regulation of secretion by cell (GO:1903531),0.43024940155718266,1.1363944717812458,0.2836767036450079,0.754059494288228,1.0,8/38,14.47%,RHBDF2;SLC30A1;NOTCH1;STXBP6;PNKD;SYT4;HMGCR;GRM7
prerank,negative regulation of lipid storage (GO:0010888),0.4947712827586344,1.1363928577816593,0.30122591943957966,0.7532521640235121,1.0,4/19,6.88%,PPARD;NFKBIA;ABCG1;NR1H2
prerank,rRNA transcription (GO:0009303),0.49754881667315176,1.1361312763416183,0.30329289428076256,0.7531128073616925,1.0,6/17,22.62%,TAF1B;GTF3A;GTF3C5;SIRT7;SPIN1;GTF3C1
prerank,transcription by RNA polymerase III (GO:0006383),0.454520994697418,1.1358425006769277,0.30505709624796085,0.7530400847583281,1.0,6/27,15.25%,IVNS1ABP;GTF3A;GTF3C5;RO60;SNAPC1;CRCP
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4548394172450434,1.1357631499620553,0.2971246006389776,0.7524634809903978,1.0,6/29,7.79%,MFSD2A;SCARB1;CREB1;NR1H2;SORBS1;ELOVL5
prerank,positive regulation of response to stimulus (GO:0048584),0.42727592014158855,1.1357010097866398,0.2954898911353033,0.7518457934533966,1.0,10/40,16.60%,TGFB2;B2M;IFIH1;HOMER1;HMGA1;ABI3;IL15;NSMCE4A;HMGA2;CDKN2AIP
prerank,negative regulation of cellular process (GO:0048523),0.3164501748605156,1.135657841341096,0.17127659574468085,0.7511719786537724,1.0,78/521,11.25%,ETS1;SRGAP2;PODXL;AQP11;DAB2IP;CD34;APBB2;BMPR2;PPP1R13B;TGFB2;NOS3;NOTCH4;RAPGEF2;JAM2;SH3BP4;APP;TBX1;DDAH1;PDE8A;ITGA1;SOX17;CD200;DYSF;CTTNBP2NL;DCUN1D3;ADGRG1;PTPRJ;RGCC;SMARCA2;PLXND1;SP100;ADAM15;SIPA1;ACVRL1;CCDC85B;PRKD1;NOTCH1;MEN1;LYN;PPP1R9B;SNX3;CTNNB1;TNFRSF21;SOX7;PIWIL1;DLL4;HYAL2;IGFBP7;BTG4;RHOB;ST18;WFDC1;ADAM10;KLF4;CDKN2B;NR1H2;ACTN1;INSM1;BST2;TGFB1;TMEM115;FOXP3;ADAMTS8;NPR1;BNIP3L;HMGA1;ARHGDIA;LPCAT3;AXIN2;BTG1;CBLL1;AGTR2;PDE12;CDC6;FERMT2;DUSP1;PLXNB3;CTCF
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.5625892728725541,1.1354279532022478,0.3492647058823529,0.7510388404170375,1.0,4/10,14.06%,ACER2;SNAI2;NEXMIF;PDE3B
prerank,positive regulation of leukocyte migration (GO:0002687),0.4613618075415852,1.135293336478613,0.31189710610932475,0.7505620235972793,1.0,5/27,14.70%,IL6R;PTN;ADAM17;PLVAP;NCKAP1L
prerank,substrate-dependent cell migration (GO:0006929),0.5138684541694606,1.1352599926346085,0.30892857142857144,0.749856080054567,1.0,4/14,8.64%,NTN1;ANKS1A;CD2AP;OPHN1
prerank,negative regulation of macroautophagy (GO:0016242),-0.41123880444689087,-1.1350406056665276,0.30484988452655887,0.7361384023987849,1.0,11/26,20.39%,NUPR1;NRBP2;TMEM39A;LRRK2;CLEC16A;SCFD1;PHF23;FEZ1;SMG1;SMCR8;TSC1
prerank,microvillus assembly (GO:0030033),0.529612321783093,1.1350151821943828,0.34229390681003585,0.7496481374705971,1.0,5/14,14.59%,RAPGEF2;RAP1B;MAP4K4;MINK1;STK26
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5339009065345222,1.134740642696964,0.33269961977186313,0.749664901127582,1.0,4/12,19.71%,UNC13B;SYT7;RIMS2;UNC13A
prerank,myeloid leukocyte differentiation (GO:0002573),0.39301366024858064,1.1345225349704875,0.27611940298507465,0.74944683393529,1.0,12/65,13.51%,LEF1;TNFRSF11A;CCR7;CD4;PIR;LGALS9;CASP8;TNFSF11;TGFBR2;IL15;PPARG;MT1G
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5200649462475673,1.1343847238459945,0.3610586011342155,0.7490355686642155,1.0,5/13,12.34%,NOTCH1;FOXF1;NPY5R;GSK3A;TGFBR2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.40972105213188226,1.1337462897583361,0.28483920367534454,0.7500760963649392,1.0,7/46,8.04%,SEMA6A;DAB2IP;CNKSR3;DUSP3;LYN;PTPRR;PIN1
prerank,positive regulation of JUN kinase activity (GO:0043507),0.4793865844774504,1.1337415770918524,0.31727574750830567,0.7492978594795769,1.0,4/23,9.22%,DAB2IP;TNFRSF11A;ARHGEF5;PAK1
prerank,regulation of dephosphorylation (GO:0035303),0.5107770695593185,1.1325995832807094,0.3159851301115242,0.7515263558250566,1.0,1/15,0.95%,PPP1R16B
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.4383435615447263,1.1325735720505106,0.2986798679867987,0.7507867997011911,1.0,9/33,16.12%,IGF1R;PLEKHA1;CD160;HTR2A;PIK3C2A;PIK3CB;ZFP36L1;PIK3R5;EDN1
prerank,negative regulation of cell development (GO:0010721),-0.40405817601136956,-1.1324120321431705,0.28391959798994976,0.7424328670676096,1.0,3/25,1.30%,IGF1;FBN1;APPL2
prerank,oligosaccharide biosynthetic process (GO:0009312),0.47926950890663034,1.1323461429481236,0.33634719710669075,0.7506213699978811,1.0,3/20,5.93%,ST3GAL6;FUT8;FUT9
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5228816449176751,1.13176891001898,0.3271186440677966,0.7514483967260078,1.0,3/13,10.01%,AQP11;NR1H2;LPCAT3
prerank,chromosome condensation (GO:0030261),0.4352029249007661,1.131694768426068,0.3016393442622951,0.7508447573494441,1.0,10/36,18.75%,TENT4A;NCAPH;MCPH1;DFFB;NCAPG;BANF1;CSNK2B;TTN;NCAPH2;SET
prerank,neurotrophin signaling pathway (GO:0038179),0.48392841428819167,1.1315853354656493,0.32482993197278914,0.750339471462453,1.0,6/21,10.22%,RAPGEF2;RAPGEF1;GRB2;SORT1;SOS1;DDIT4
prerank,focal adhesion assembly (GO:0048041),0.46731439131199837,1.1310903709090647,0.31186440677966104,0.75089242853,1.0,5/21,10.91%,THSD1;ACTN1;SORBS1;ARHGEF7;FERMT2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4783442121800351,1.131086583425693,0.32142857142857145,0.7501145570126282,1.0,4/21,3.74%,LIMCH1;MACF1;PTK2;DUSP3
prerank,glucose homeostasis (GO:0042593),0.38088500980517714,1.130951526275204,0.27399165507649514,0.7497413732771013,1.0,6/83,4.99%,IGF1R;INSR;ADIPOR2;KLF7;FOXO1;CYP11B1
prerank,cholesterol transport (GO:0030301),0.4105750692252196,1.1307160776024858,0.3167883211678832,0.7495761309769012,1.0,9/45,14.49%,CAV1;SCARB1;OSBP;ABCG1;ABCA7;NPC1;LIPC;MSR1;STARD4
prerank,vitamin transport (GO:0051180),0.4496983149209566,1.130686356962169,0.31239935587761675,0.7488657595513655,1.0,5/29,10.98%,ABCG2;SLC52A2;SLC25A32;SLC52A3;AMN
prerank,cellular response to interleukin-12 (GO:0071349),0.4150338485703695,1.1306617623886823,0.2978723404255319,0.7481367334353664,1.0,12/48,18.70%,PLCB1;PITPNA;PPIA;RAP1B;MSN;PSME2;TALDO1;CFL1;RALA;HSPA9;PAK2;BOLA2
prerank,positive regulation of apoptotic process (GO:0043065),0.328665638457305,1.130644022289774,0.21764032073310424,0.7474124095275337,1.0,36/293,8.52%,MCF2L;ITGA6;ARHGEF3;DAB2IP;TGFB2;RASGRF2;FAS;NET1;UNC13B;HIP1R;PLEKHG5;TPD52L1;DCUN1D3;TNFSF10;ARHGEF2;RYBP;KALRN;FOXO1;FOXL2;TIAM1;ABR;TGM2;CTNNB1;RHOB;SOS1;CRADD;RNPS1;ARHGEF12;DNM2;IRF5;JMY;JUN;ARHGEF5;PIDD1;PREX1;ARHGEF7
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.5484035121145999,1.1306250858382747,0.33911368015414256,0.7466800781708921,1.0,4/10,25.65%,LGALS9;FOXP3;SCRIB;PRKAR1A
prerank,peptidyl-glutamic acid modification (GO:0018200),0.461683548833946,1.1305937894782978,0.31699346405228757,0.7459894342956707,1.0,5/24,8.66%,TTLL7;TTLL5;TTLL10;TTLL3;AGBL5
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.42175598815099374,-1.1301969215851102,0.29210526315789476,0.747554808161747,1.0,7/25,6.63%,SULF1;BMPR1A;FOXD1;BMP4;RBPJ;ZNF423;CCN1
prerank,lipoprotein transport (GO:0042953),-0.5277415613598794,-1.1293514145714987,0.3225152129817444,0.7487031197375036,1.0,1/10,0.53%,LRP1
prerank,cellular glucose homeostasis (GO:0001678),0.4318560508090522,1.1291690874486198,0.30495356037151705,0.7489276277562967,1.0,3/41,2.99%,IGF1R;UNC13B;FOXO1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.37525583951478236,1.1284836916266265,0.2764456981664316,0.7499076284551618,1.0,30/80,17.99%,OCLN;WASF2;FNBP1L;PALM;AGRN;EPS8;CCR7;EPS8L2;CCDC88A;CDC42EP3;CCP110;NCKAP1;MARK4;GPM6A;TWF2;P2RX7;CYFIP1;CLRN1;PLEKHM1;RAC1;HRAS;FSCN1;FAM98A;ANLN;NLGN1;APC;RALA;ACTR2;TENM1;KCTD17
prerank,response to iron ion (GO:0010039),-0.4862819068530766,-1.1283197358112163,0.3295711060948081,0.7502841474156793,1.0,4/12,11.49%,BMP6;BCL2;FXN;ACO1
prerank,megakaryocyte differentiation (GO:0030219),0.5389870314535254,1.1283079488136256,0.35663082437275984,0.7496055794085533,1.0,3/11,6.68%,ZFPM1;TAL1;CDKN2B
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.44370272276876893,-1.1277307478956788,0.3069306930693069,0.7506575597676857,1.0,8/19,24.07%,ENPP1;SLC26A2;PAPSS2;PAPSS1;TPST1;ABHD14B;SLC35B2;SULT1A1
prerank,amyloid-beta metabolic process (GO:0050435),-0.44992500273160424,-1.127140827275609,0.30317848410757947,0.7510066204296247,1.0,5/16,12.41%,MGAT3;BACE2;ACE;IDE;PSEN1
prerank,epithelium development (GO:0060429),-0.30586249044709485,-1.1269613550481798,0.21673003802281368,0.7501815855579389,1.0,22/107,8.99%,ALDH1A2;ERRFI1;WNT4;FGFR2;KANK2;OSR1;PKD1;MEOX2;SMO;SALL1;VCL;LOXL3;DAG1;PKD2;ANXA4;SIX1;RCN3;DACT1;CNN3;BDH2;MTHFD1;IFT122
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.48785920465650734,1.1259326888760082,0.3440134907251265,0.7552555437606575,1.0,6/20,5.99%,ENG;TGFB2;TBX3;ACVRL1;NOTCH1;SNAI2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.4558306458217345,1.1258883835011881,0.3087248322147651,0.7545963769773347,1.0,6/25,15.12%,APP;ANKRD13A;RIN3;RAC1;SDCBP;MTMR2
prerank,protein dephosphorylation (GO:0006470),0.3500237179294388,1.1257880905609194,0.24769433465085638,0.7540971621565887,1.0,21/135,11.40%,PTPRG;PTPRM;PTPRB;CTTNBP2NL;PTPRJ;PPM1L;DUSP7;PTPN12;SSH2;DUSP3;PPP3CC;PPP4R1;PPP2R5A;PTPRR;MTMR6;PTPN5;PPP1CB;SSU72;DUSP12;DUSP1;PPP3CA
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.43320614475464436,-1.1252265221788464,0.3092105263157895,0.7539225375304565,1.0,7/19,17.09%,IL34;CAMK1D;THBS1;CMKLR1;MPP1;RARRES2;MDK
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3197281882879694,-1.125072833484599,0.21785714285714286,0.7530054710875923,1.0,30/80,23.65%,PLPP3;ATP9A;GBF1;COPA;KDELR3;COPZ2;COPB1;ARFGAP1;ARFGAP3;ERGIC3;COG4;ERGIC1;RAB6A;STX18;SCFD1;COPB2;SURF4;RACGAP1;ATP9B;ERGIC2;KIF18A;KIF15;CENPE;SCYL1;COPZ1;TMED9;KIF3C;COPG1;RER1;HTT
prerank,cellular component disassembly (GO:0022411),-0.34493002032736836,-1.1249921723038123,0.24096385542168675,0.7518808725708833,1.0,12/53,8.63%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;CTSL;ADAMTS15;TLL1;MMP2;KLK2
prerank,negative regulation of synaptic transmission (GO:0050805),0.4644535217126636,1.1249773592418657,0.3304195804195804,0.7555419882825813,1.0,7/23,15.36%,SLC30A1;SLC24A2;STXBP1;PNKD;TMEM25;MTMR2;PLK2
prerank,positive regulation of DNA replication (GO:0045740),-0.44908759582264357,-1.1248453931397118,0.319634703196347,0.7509146217329465,1.0,3/16,6.56%,EGFR;GLI2;GLI1
prerank,organic cation transport (GO:0015695),-0.4322401620586662,-1.124838230705261,0.312807881773399,0.7495947093780825,1.0,6/20,18.07%,SLC47A1;SLC22A4;SLC22A18;SLC5A7;SLC22A2;SLC25A29
prerank,positive regulation of endopeptidase activity (GO:0010950),0.45291535307806985,1.124720354826365,0.32167832167832167,0.7554547131284012,1.0,10/26,11.81%,LYN;EPHA4;FYN;AIM2;EFNA1;PSME2;AGER;APH1A;GRIN2B;VSIR
prerank,exit from mitosis (GO:0010458),0.5286034014516799,1.1242982482149109,0.3302752293577982,0.7557811714685935,1.0,5/12,25.98%,EPS8;SIRT7;SPAST;CLASP1;CLASP2
prerank,ethanol metabolic process (GO:0006067),-0.48612008231166864,-1.1242122458048907,0.33259911894273125,0.7501055676026969,1.0,1/12,0.31%,ALDH1A1
prerank,calcium ion transport into cytosol (GO:0060402),-0.42781008497276396,-1.1238861278959205,0.296551724137931,0.7497023277740548,1.0,4/21,12.15%,CACNA1C;CACNA2D1;SLC8A1;JPH1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.36562014477028265,1.12377788169311,0.26438356164383564,0.7564113087184192,1.0,24/107,13.52%,SLC39A10;SLC39A8;CXCL12;CAV1;SLC30A1;CD40;ATP2C1;SLC24A2;SLC24A4;ATP2B1;SLC10A7;HTR2A;CALCB;CCL1;CSRP3;CDH5;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B
prerank,regulation of response to cytokine stimulus (GO:0060759),0.48047176216337645,1.1236220195155022,0.34851138353765326,0.7560277257835945,1.0,5/19,10.94%,IFIH1;KLF4;IRAK2;LIFR;CBFB
prerank,positive regulation of telomerase activity (GO:0051973),0.4402585227975654,1.1234928111392057,0.3511326860841424,0.7556136217952815,1.0,15/33,27.17%,HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;MAPK1;NAF1;MAP2K7;NVL;PTGES3;MYC;PNKP;NEK7
prerank,keratan sulfate metabolic process (GO:0042339),0.4476216850094067,1.1233583170884993,0.31942215088282505,0.7552493756121076,1.0,5/31,4.22%,ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;B3GNT2
prerank,extracellular matrix disassembly (GO:0022617),-0.34559005408035565,-1.1229125414642682,0.25,0.7511253221830456,1.0,12/53,8.63%,GSN;TIMP2;MMP14;MMP16;SH3PXD2B;ADAMTS5;SCUBE1;CTSL;ADAMTS15;TLL1;MMP2;KLK2
prerank,positive regulation of T cell differentiation (GO:0045582),0.43178987295680926,1.1228715480876337,0.30194805194805197,0.7557868490166382,1.0,5/36,11.81%,LEF1;ZAP70;SOX12;PNP;VSIR
prerank,hydrogen peroxide metabolic process (GO:0042743),0.4836744324745985,1.1225614331378475,0.3239929947460595,0.7558830804539246,1.0,5/19,14.90%,PXDN;CAT;ACOX1;MAOB;PRDX5
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4535393460345501,1.1223747147637586,0.31569965870307165,0.7556277818245853,1.0,8/24,13.59%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;RAC1;FSCN1
prerank,negative regulation of protein modification process (GO:0031400),0.3804662817160182,1.122291469724968,0.2781740370898716,0.7550594164060602,1.0,13/79,8.09%,OCLN;MFHAS1;PPP1R16B;DAB2IP;PRR5L;XDH;NIBAN1;MEN1;LYN;WWTR1;PPIA;INSM1;TGFB1
prerank,arachidonic acid metabolic process (GO:0019369),-0.37258972391739276,-1.122286664869538,0.27296587926509186,0.7516237966810372,1.0,6/35,5.75%,PTGDS;PTGIS;PTGS1;DAGLA;CYP1B1;PTGES
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.4002304525018749,-1.1221391041606699,0.30612244897959184,0.7507758356008548,1.0,7/24,10.21%,SEC24D;SEC24A;ACE;SEC31A;CANX;SEC23A;IDE
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.4521705881389453,1.1220595524095989,0.32682926829268294,0.7548884700601721,1.0,4/27,12.52%,ETS1;CCDC88B;TNFSF11;CYRIB
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.42458688812252066,1.1219450709946557,0.29559748427672955,0.7543821275474036,1.0,11/39,12.42%,DAB2IP;ITGA1;PTPRJ;PTPN12;DUSP3;GRB2;TGFA;ARHGEF7;ACP4;EPS15;HGS
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.44625640656994137,-1.1208173485086779,0.30444444444444446,0.7533255790206432,1.0,7/16,16.84%,WNT4;BMP4;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,ribosomal small subunit assembly (GO:0000028),0.5045337442377822,1.1208075143500609,0.3368055555555556,0.7565993803427995,1.0,6/16,14.11%,ABT1;RPSA;RPS27;PWP2;RPS15;RPS28
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.48221617281126705,1.1207713656256508,0.37132987910189985,0.7559320334766279,1.0,5/20,8.58%,ENTPD1;APP;HSP90AB1;ENTPD5;P2RX7
prerank,negative regulation of MAP kinase activity (GO:0043407),0.4134626188871743,1.120547241395932,0.3130016051364366,0.7557722583387219,1.0,7/44,5.07%,DAB2IP;STK38;PTPRJ;DUSP7;LYN;NPPA;HYAL2
prerank,positive regulation of wound healing (GO:0090303),-0.37056620966327464,-1.1204510178276694,0.2813299232736573,0.7529772710632541,1.0,9/36,5.24%,PLPP3;VTN;MYLK;ST3GAL4;KANK1;SMOC2;THBS1;FOXC2;ANXA1
prerank,long-chain fatty acid metabolic process (GO:0001676),0.385542356909878,1.120431416155441,0.28125,0.7553310652616948,1.0,15/64,13.75%,CYP2E1;PLA2G4B;ACSL5;CPT1A;ACOX1;ACSL6;ELOVL5;ACSL3;AIG1;ABCD1;ELOVL6;PNPLA8;SLC27A2;LTA4H;HACL1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3778844008261992,1.120393489320455,0.2796610169491525,0.7546639557650793,1.0,13/75,9.42%,SLC39A10;SLC39A8;SLC24A2;SLC9A5;SLC12A6;ATP1A4;ATP1A1;ATP1A3;SLC9A3;SLC12A9;KCNH2;SLC9A7;SLC9A6
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.5424244105367977,1.1203803565876687,0.35251798561151076,0.7539415575008604,1.0,3/10,4.54%,PDE2A;APLNR;PDE4D
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.4251151374034027,-1.1198320149267726,0.302158273381295,0.7533844058297445,1.0,6/20,11.06%,GRK3;MGRN1;MET;BICD1;GPRASP1;RPGRIP1L
prerank,potassium ion export across plasma membrane (GO:0097623),-0.46483445394357625,-1.119563907272664,0.32842105263157895,0.7528098009584807,1.0,2/13,3.08%,KCNT2;KCNK5
prerank,embryonic digit morphogenesis (GO:0042733),-0.4389490781480053,-1.1188261402948385,0.3231850117096019,0.7535924458661785,1.0,4/18,4.36%,GLI3;OSR1;SALL1;WDPCP
prerank,positive regulation of ERAD pathway (GO:1904294),0.5297228397193657,1.1188204460247837,0.3430127041742287,0.7573032301072495,1.0,4/13,17.36%,CAV1;ATXN3;UBQLN1;BAG6
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.40251610732054066,-1.118598360758153,0.30676328502415456,0.7516104750249325,1.0,11/23,18.57%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;SLC2A10;EP300;CDKN1C;CITED2;FLCN
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.40251610732054066,-1.118598360758153,0.30676328502415456,0.7516104750249325,1.0,11/23,18.57%,ZEB2;THBS1;DAB2;TGFB1I1;STK11;GIPC1;SLC2A10;EP300;CDKN1C;CITED2;FLCN
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.3649884962545042,1.118439511855901,0.2861150070126227,0.7575098117950506,1.0,14/90,12.19%,IGF1R;EPAS1;ADIPOR2;GATM;CAV1;UCP2;OXTR;YBX2;IL4R;FABP5;PRKAB1;ADIPOR1;SYK;ELOVL6
prerank,neural tube closure (GO:0001843),-0.372631615230555,-1.1175354836852,0.2743589743589744,0.7533851106456647,1.0,15/34,17.87%,LMO4;COBL;PLXNB2;KDM2B;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,outflow tract septum morphogenesis (GO:0003148),0.4605590144224394,1.117264425046408,0.3440134907251265,0.7597367064577308,1.0,5/24,1.88%,SEMA3C;ENG;BMPR2;TGFB2;TBX1
prerank,activation of protein kinase activity (GO:0032147),-0.30165883978237523,-1.117013364463174,0.20242914979757085,0.7536335722052739,1.0,26/106,13.69%,IGF1;NTRK3;ADCY5;ANGPT1;ADCY1;FGF1;ADCY9;NRK;IL18;PRKCD;ADCY2;OSBPL8;ADCY7;CARD14;PDPK1;AXIN1;ITGB1BP1;STK11;PRKACA;PTK2B;ABL1;ADCY6;PRLR;PIBF1;GHR;STRADA
prerank,positive regulation of reproductive process (GO:2000243),0.44218386165260937,1.1169935498132806,0.34210526315789475,0.759639857973176,1.0,2/31,1.70%,PLCB1;LHFPL2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.42875357302809913,1.1168832511151718,0.31627906976744186,0.759169184130294,1.0,11/35,15.74%,ATP2C1;CDH20;PCDHGB4;CDH8;DCHS1;CDH19;CDH10;CDH23;PCDHB14;CDH5;NLGN1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.49394260993499495,1.1167963582965716,0.3426086956521739,0.7586329229003749,1.0,5/16,10.26%,PDGFB;PDGFD;PTPRJ;PLAT;PIK3C2A
prerank,blood vessel diameter maintenance (GO:0097746),-0.3795673768698159,-1.1164751192852338,0.29736842105263156,0.7538197937089762,1.0,12/34,15.39%,ROCK2;EDNRA;KCNMB2;PER2;SCPEP1;ACE;BDKRB2;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.34916730955100367,-1.1159900101618896,0.2737752161383285,0.7539270800774776,1.0,9/49,16.16%,LDLRAD4;SMAD6;IMPACT;DACT1;ANKRD27;DDX3X;EP300;NLRP2B;CRYAB
prerank,oligodendrocyte development (GO:0014003),0.49954612883655913,1.1159817957851728,0.3399638336347197,0.7599835043469071,1.0,9/15,28.62%,B4GALT5;EIF2B1;EIF2B2;SOX10;TPPP;EIF2B4;PLP1;MYRF;HES5
prerank,rRNA processing (GO:0006364),0.3404467190456255,1.115837762762399,0.27854454203262236,0.7595946160972689,1.0,79/172,29.84%,RPL38;RPL13;RPL36A;MAK16;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;RIOK1;MRM2;RPL11;RPS15;RRP15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;NHP2;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;RPL34;WDR75;EXOSC9;THUMPD1;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;RIOK3;RPL24;MRPL1;RPL7A;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS;DCAF13;RPS6;LSM6;POP5;TFB1M;DDX27;RPS14
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3323792545694356,1.1156328462201022,0.2738537794299876,0.7593371466825563,1.0,35/199,12.68%,PTPRG;RAB11FIP1;DAB2IP;BMPR2;NOS3;NOVA2;MCC;ID1;KLF7;RGCC;MEF2C;SRGN;NOTCH1;HDAC9;EVL;SMAD7;IL17RD;RPS6KA5;ATP2B1;NR1H2;N4BP1;PTPRR;BRCA2;EFNA1;TGFB1;FOXP3;PPP1R11;ADAM17;AGER;ADIPOR1;GSK3A;HMGCR;GDF15;IL15;WWC1
prerank,Golgi ribbon formation (GO:0090161),-0.4695688276972569,-1.115506222239683,0.34965034965034963,0.7541206422952886,1.0,6/13,29.07%,GOLGA2;PRMT5;STX16;OPTN;MYO18A;TRIP11
prerank,mRNA metabolic process (GO:0016071),-0.3117732893385829,-1.114872838047704,0.20802919708029197,0.7546764863687405,1.0,27/90,22.90%,DDX5;PPARGC1A;SON;SRSF5;SRSF11;PCF11;AKAP8L;SRRM4;CPSF3;PRKACA;SRSF4;RNASE4;HNRNPR;NONO;HNRNPA2B1;PRMT9;PCBP2;PRPF18;LSM10;PRPF3;U2AF2;U2AF1;LSM3;TCERG1;CSTF3;AURKAIP1;TBRG4
prerank,response to chemokine (GO:1990868),0.5326310779930892,1.1145203894203748,0.34896810506566606,0.7615862656821477,1.0,2/13,1.41%,LRCH1;CXCL12
prerank,homeostasis of number of cells (GO:0048872),0.5290444225383875,1.1145171427873273,0.3405511811023622,0.7608241564393761,1.0,3/12,10.01%,NOS3;NOTCH1;LPCAT3
prerank,negative regulation of inflammatory response (GO:0050728),0.3402569244381959,1.1144746471692197,0.26616915422885573,0.7601622772658378,1.0,36/182,14.39%,TEK;MFHAS1;PPARD;CD200;RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;KLF4;ADCY4;YES1;HCK;PRKAR2B;CD200R1;NPS;CALCB;ADAM17;LPCAT3;PRKAR2A;SHARPIN;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1;PPARG;CDH5;TNFAIP3;GIT1;HTR4
prerank,positive regulation of autophagy (GO:0010508),0.3753438753064194,1.1142027016012288,0.2969613259668508,0.7601675251916545,1.0,21/81,15.36%,KDR;SH3BP4;TRIM14;FOXO1;PRKD1;CAMKK2;SESN3;IRGM;BNIP3L;EIF2AK4;PIK3C2A;GSK3A;SH3GLB1;ORMDL3;PIK3CB;SVIP;TFEB;EPM2A;PIM2;TMEM59;PLK2
prerank,positive regulation of DNA binding (GO:0043388),-0.383185075644461,-1.1140923845852484,0.2963917525773196,0.7556604594442872,1.0,8/31,13.66%,IGF1;FOXC1;NGF;PRKN;NIBAN2;SKI;TWIST1;SIRT2
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.4288852117213674,1.1140812563224136,0.3174846625766871,0.7597320503504899,1.0,4/34,5.43%,MFHAS1;DAB2IP;LYN;TLR3
prerank,cellular response to glucose starvation (GO:0042149),-0.3630773677589686,-1.1139844259716398,0.28316326530612246,0.7546601400944741,1.0,7/41,10.34%,PRKAG2;PRKAA2;IMPACT;FOXO3;NUAK1;MTMR3;PRKAG3
prerank,contractile actin filament bundle assembly (GO:0030038),-0.45902535904328,-1.1138159291878578,0.34216335540838855,0.7525367480236376,1.0,5/15,15.60%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,stress fiber assembly (GO:0043149),-0.45902535904328,-1.1138159291878578,0.34216335540838855,0.7525367480236376,1.0,5/15,15.60%,ITGB5;ARRB1;PHACTR1;CUL3;ZYX
prerank,regulation of fibroblast migration (GO:0010762),0.4682815016461717,1.113748064198272,0.3397212543554007,0.7598898861218272,1.0,8/20,11.43%,PRR5L;PTK2;GNA12;HYAL2;RFFL;TGFB1;ARHGEF7;RAC1
prerank,neural crest cell differentiation (GO:0014033),0.47929903140708524,1.1135152013976148,0.33559322033898303,0.7597707386898648,1.0,6/18,17.63%,MEF2C;CDH2;SNAI2;SOX11;PDCD6;KBTBD8
prerank,negative regulation of protein polymerization (GO:0032272),0.438580968460014,1.113299029106961,0.33003300330033003,0.7595718484050163,1.0,8/27,13.85%,KANK3;HIP1R;SSH2;STMN1;TWF2;CYRIB;CDH5;SSH1
prerank,cardiac myofibril assembly (GO:0055003),-0.4470192248974518,-1.1132485038070195,0.35266821345707655,0.752831592357731,1.0,3/15,3.88%,PDGFRB;PDGFRA;OBSL1
prerank,cellular response to radiation (GO:0071478),0.4200067297002863,1.1130553106992107,0.3175355450236967,0.7594633708316938,1.0,13/40,22.80%,NET1;GRB2;RHOB;OPN5;GPR52;OPN3;EEF1D;HUS1;RRH;NSMCE3;RAD9B;RAD1;INO80
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.41366403542065444,1.112722889006854,0.32978723404255317,0.7596370110440508,1.0,13/36,19.23%,AQP11;RYBP;HSP90AB1;N4BP1;OPHN1;UBXN1;F8A1;RPL11;TRIM39;SDCBP;BAG6;PRKCG;USP25
prerank,regulation of cell cycle process (GO:0010564),0.3595937401948339,1.1127108775508179,0.26766304347826086,0.7589038715217762,1.0,26/104,17.15%,BCL2L1;DCUN1D3;CALM1;CTNNB1;CDKN2B;CCP110;INSM1;RAB11A;MARK4;PIN1;CETN2;CAV2;RAB11FIP4;PIK3C3;SH3GLB1;SOX9;GIT1;TTL;SPAG5;PLK2;SND1;RPRD1B;APC;PRPF40A;HMGA2;CEP85
prerank,regulation of cell-matrix adhesion (GO:0001952),0.3868934571937021,1.1124742616692893,0.2981651376146789,0.7587731905211552,1.0,13/64,12.23%,LIMCH1;UTRN;MACF1;ACER2;PTK2;ADAM15;DUSP3;CCR7;NEXMIF;ACTG1;SLK;PIK3CB;MAP4K4
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.48263044507897884,1.1121954841186654,0.34513274336283184,0.7587646628863111,1.0,4/18,11.66%,HIP1R;SLC25A5;ZNF205;GSK3A
prerank,regulation of transforming growth factor beta production (GO:0071634),0.48192213480895485,1.112078649938866,0.34525939177101966,0.7583173699564941,1.0,4/18,6.44%,CD34;TGFB2;CD200;LGALS9
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.44483964626045325,1.1118556448952979,0.335,0.7581253270193063,1.0,8/26,16.18%,SHANK3;APP;WNT7A;NRXN1;TMEM25;MTMR2;NLGN1;RIMS2
prerank,regulation of B cell activation (GO:0050864),0.46089521831777436,1.1117097353063679,0.3441226575809199,0.7577689460591266,1.0,8/25,19.85%,NOD2;CD19;ZFP36L1;TNFAIP3;FOXJ1;SH3KBP1;SAMSN1;ZFP36L2
prerank,cellular protein modification process (GO:0006464),0.3043426526302937,1.1116629891580567,0.14893617021276595,0.7571513869507484,1.0,222/983,18.28%,PTPRG;ST8SIA4;PRKCH;PTPRM;ST3GAL6;PTPRB;ERG;EPAS1;PDGFB;INSR;ST8SIA6;BMPR2;TGFB2;LMO7;MAP4K2;KLHL5;KLHL2;APP;CDK17;ST3GAL1;MAP4K3;B4GALT5;CTTNBP2NL;DCUN1D3;ST6GALNAC2;STK38;PKN3;SPARCL1;PTPRJ;VWA1;PPM1L;LIPE;SNRK;DUSP7;JAK3;PTPN12;ACVRL1;PRAG1;MAP3K1;CDH2;PRKD1;STK10;PRKD2;MEN1;CDK19;ZAP70;SSH2;MERTK;LYN;FNIP2;PRKG1;ZBTB16;TGM2;SOCS2;B3GNT2;PPP3CC;IKBKB;OGA;NOTUM;PPP4R1;CREB1;PIGU;IGFBP7;CAMKK2;PKN1;STK19;STT3B;LIMK2;PRKACB;FUT9;KLHL25;PAK5;FYN;MAPK3;RPS6KA5;ADAM10;FBXW7;RET;PPP2R5A;YES1;AATK;PSMB3;GOLM1;PKN2;HCK;RAB11A;COG3;LCMT1;PTPRR;PXK;MARK4;FBXO41;PDIA6;MTMR6;PSMD11;TGFB1;RHBDD1;MARK3;ABCA7;MAP3K6;QSOX1;PIGK;PSMC6;FEM1C;NPC1;PTPN5;KLHL3;PAK1;PGGT1B;PLAT;PPP1CB;PSME2;SCG3;EIF2AK4;SOCS5;PIK3C3;PTK6;TRIB2;KLHL20;PRKAB1;FBXL2;JMJD7;CHRM3;DUSP12;DUSP1;PSMD8;PPP3CA;PRKCB;GSK3A;WSB1;UBA3;HIF1A;SYK;B3GALT4;FBXO6;MAP4K4;TGFBR2;DUSP16;HIPK2;ASB13;RAB1A;EVA1A;DCUN1D1;B3GALT2;MANBA;STK24;STK3;MINK1;FBXW2;SSH1;METAP2;ASB5;PSMB10;FBXO21;SERP2;RBX1;PIM2;MAN2B1;DUSP8;VRK1;SGK1;TBCK;CAMK2B;STK26;SERPINC1;NUS1;FBXL8;CTBP1;DAD1;UBE2D3;GRK6;FBXL15;MTMR2;NEK3;HIPK3;ELOB;ASB15;LOXL2;LORICRIN;PLK2;SGK3;SGK2;GCNT2;MMP15;MCRS1;ZC3HAV1;PROC;DCAF5;PSMA8;ASB7;MAPK1;B3GNT3;ATE1;COPS5;ACVR1;SIRT7;GAS6;SEPHS1;YWHAZ;PTPRZ1;TMEM132A;SIK2;GPS1;FN3K;PPM1F;MAP3K11;SCG2;PRKG2;KBTBD8;WDR45;FBXO2;PRKCG;PRKCE;RCE1;TBK1;PAK2;SKP1;WNK2;PTPRK;RSKR;CDK11B;PSMD9
prerank,negative regulation of cell death (GO:0060548),0.3679158180868783,1.1111378935802687,0.3049645390070922,0.7578231291232053,1.0,12/88,11.17%,MECOM;SRGAP2;CD34;PDE8A;CD200;PRKD1;FYN;CD200R1;BNIP3L;PDE12;FERMT2;KIR3DL2
prerank,defense response to tumor cell (GO:0002357),-0.49701095169640747,-1.111085866359484,0.3411764705882353,0.7577029980277055,1.0,1/10,0.11%,RBMS3
prerank,hyaluronan metabolic process (GO:0030212),-0.40073800330038906,-1.1110027604022155,0.32592592592592595,0.7567211428263342,1.0,12/23,27.44%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;ABCC5;CD44;LYVE1;HAS1;HMMR;GUSB;HYAL3
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.38587012433345835,-1.1104315391444362,0.29797979797979796,0.7570976727162911,1.0,10/29,23.27%,COPA;COPZ2;COPB1;TRAPPC3;RAB6A;TRAPPC10;COPB2;GOLGA5;COPZ1;COPG1
prerank,regulation of platelet activation (GO:0010543),0.4653417836461263,1.1102710993064542,0.36593591905564926,0.7593667668443069,1.0,3/21,3.88%,PDGFB;NOS3;LYN
prerank,SNARE complex assembly (GO:0035493),0.5471598566571022,1.109775724136752,0.365234375,0.7599819703778286,1.0,5/10,22.16%,STXBP6;STXBP1;UVRAG;VAMP8;SNCA
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.501380780636478,1.1092850133264,0.35431654676258995,0.7604790263305957,1.0,4/15,11.82%,NOD2;GBP5;CD6;HIF1A
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.3874291386930435,-1.1091183599663237,0.3246753246753247,0.7595721495064621,1.0,4/27,7.09%,IGF1;PDGFRA;S100A6;PDGFC
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3597092226523747,-1.1088497134111008,0.3016759776536313,0.7590539369784228,1.0,15/40,27.39%,FBH1;RTEL1;NUCKS1;TIPIN;ZRANB3;TRAIP;PRIMPOL;DONSON;WRN;ATR;BOD1L1;THOC1;CDK9;MCM9;SETMAR
prerank,artery morphogenesis (GO:0048844),0.43357970617789277,1.1087608237231712,0.3312302839116719,0.7611458353783209,1.0,7/30,4.36%,ENG;BMPR2;TGFB2;TBX1;NOTCH1;SMAD7;FOXF1
prerank,translesion synthesis (GO:0019985),0.4214519437505645,1.1084097349247333,0.3258785942492013,0.7613335482658944,1.0,2/42,2.24%,POLK;TRIM25
prerank,negative regulation of receptor binding (GO:1900121),0.5425088023040829,1.1074255687980572,0.3452830188679245,0.7631331897693252,1.0,2/10,3.06%,B2M;ADAM15
prerank,negative regulation of platelet activation (GO:0010544),0.48716790693559053,1.1066302958189218,0.3502626970227671,0.7645261162111296,1.0,3/16,3.95%,PDGFB;NOS3;PRKG1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.47465973108764126,-1.1059427423270796,0.34945054945054943,0.7661069975667044,1.0,5/12,21.67%,NINL;BICD1;PCM1;CEP19;BBS4
prerank,macrophage activation (GO:0042116),0.4328248646883896,1.1058824108656655,0.3371900826446281,0.7657283421070317,1.0,11/34,22.16%,APP;DYSF;CD93;AGER;SYK;NMI;SBNO2;PLCG2;FOXP1;IFNGR1;SNCA
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.35943224620253456,-1.1058552610199552,0.2997275204359673,0.7650677113659448,1.0,12/43,11.72%,PID1;ENPP1;IRS1;KANK1;PRKCD;OGT;IGF2;GRB10;TNS2;PIP4K2C;NUCKS1;SNX5
prerank,positive regulation of cellular biosynthetic process (GO:0031328),-0.2840811001449269,-1.1055682051927993,0.21,0.7645876162786758,1.0,26/166,8.85%,SAMD4A;IGF1;ZEB2;EGFR;PLD1;PDGFRB;GLI2;SMAD3;IRS1;SMOC2;THBS1;SLC6A9;PPARGC1A;PKD2;FGF2;IRS2;IGF2;GLI1;PLXNB2;ATP7A;P2RX4;PTH1R;LPGAT1;FXR2;LDLR;NNMT
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3790917601900126,1.1054930794058984,0.3151862464183381,0.7660201107324027,1.0,14/73,14.07%,APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;SYK;C1QTNF4;DDT;BCL10
prerank,RNA catabolic process (GO:0006401),0.3977750682323401,1.1048508165079978,0.3215926493108729,0.7669812908158082,1.0,16/46,24.13%,NANOS2;ZPR1;DNA2;DCP2;DXO;PPP1R8;SND1;RNASEH2C;NUDT16;ZFP36L2;XRN2;METTL3;NCBP1;RNASE6;RIDA;NUDT12
prerank,excitatory postsynaptic potential (GO:0060079),0.4716008909026023,1.1046979176604659,0.35578583765112265,0.7666376308367704,1.0,4/19,11.66%,MEF2C;GRID2;GRIN2B;GSK3A
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.3573072357064556,-1.1040956029539402,0.2861111111111111,0.7675004809387003,1.0,10/45,8.19%,SMAD3;BMP7;BMP4;PTPN3;GAS1;FOXC1;BCL6;FZD3;PRCC;ZWINT
prerank,positive regulation of endocytosis (GO:0045807),-0.3536696459941197,-1.104075729458599,0.2958904109589041,0.7662624202488527,1.0,11/45,9.19%,LRP1;APPL2;VTN;AXL;GPC3;ANO6;DAB2;RAB21;APOE;CLIP3;BICD1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.38001000880063934,-1.104035663107742,0.29770992366412213,0.7650813393503701,1.0,12/30,21.83%,DDX5;DAB2;AR;HEYL;KLK2;KDM1A;PIAS2;EP300;SFRP1;NCOR1;RNF14;SAFB2
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.2370775518402217,-1.1039563766830105,0.0,0.7640113210061111,1.0,342/1667,16.32%,BMP6;AUTS2;PID1;FOXP2;PBX1;PRDM6;IGF1;SOX5;MAF;FHL2;ZIC1;NFIA;ZEB2;EGFR;NR2F2;ZIC4;AEBP1;BMPR1A;GLI3;ZBTB7C;DCN;PRRX1;RARB;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;GLIS3;FOXD1;HLF;SMAD3;PKNOX2;FOXP4;SSBP2;BMP5;HOXC4;FGFR2;HOXC6;ZNF462;BMP4;KANK2;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;FGF1;DDX5;PPARGC1B;FNIP1;SMAD6;NR6A1;RGMA;HOXA3;HOXA5;NFAT5;PKD1;MEOX2;THRB;TNRC6A;FRK;HDAC4;GABPB2;CUX1;TRAK1;MXI1;PER3;IKZF2;HOXB4;WWOX;PRRX2;CREB3L2;TEF;IL18;SALL1;RHOQ;IMPACT;NR1D2;HOXB6;ZHX2;CCNT2;KIT;FOXC2;DNMT3A;FOXC1;CAMK2D;BCOR;ARRB1;TBX15;KCNIP3;HIVEP2;MLXIP;OGT;SUFU;VGLL3;PLAGL1;CDK8;PPARGC1A;RBPJ;HOXA7;BAZ1B;PKD2;DAB2;FGF2;PIAS1;MKX;ZNF367;KDM7A;EHMT2;RORA;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;ANXA4;HDGFL3;PPARA;KAT6B;PBX4;HIF3A;RUNX2;KLF3;PURG;MED23;CTR9;SIX1;TBX18;EBF4;ZNF25;CRTC3;ZMYM5;IKZF4;BCL6;TEAD3;CBX7;IGF2;TSHZ1;SSBP3;CHD2;HEYL;HOXC8;NR3C2;PAXBP1;DACT1;MEIS1;PBX3;SMARCC2;GLI1;CCN1;ZEB1;SMAD9;KDM2A;CCNL1;ZNF568;KDM3B;LCOR;FOXJ2;NFATC4;ATF5;EBF2;AGO2;ELF4;ZSCAN29;SOD2;KLF15;ATN1;CHD3;JAG1;CHD8;PRKN;CBX5;RFX7;SMARCD3;FHOD1;MITF;FBXL19;KDM5B;APOE;FOXL1;MET;KDM6B;ATM;AKAP8L;TNIP2;YAP1;SMARCB1;RBBP8;KDM2B;MED25;POU6F1;RBAK;CHD4;TNRC6B;HSF2;ATOH8;SMURF2;CREB3L1;USP2;STAT5A;ZNF23;FOXO3;CXXC5;SOX6;PCGF2;MGA;TGFB3;EZR;SLC30A9;PPM1D;BRD9;TWIST2;DDX17;ZNF483;ZKSCAN7;ARNT;ELP3;CDH13;ITGB1BP1;CEBPB;ELK1;SLC9A1;CCNC;SP140;ZNF507;NOP2;EZH1;GATA6;SMARCA1;ZNF182;RNF10;ZBTB38;CCNH;NR2F1;URI1;ARID3A;PARP1;ZNF148;CRY2;PPP3CB;NUCKS1;CHUK;ETV1;MED14;WWP2;KDM1A;CAPRIN2;CREBRF;TFCP2L1;RXRA;PHF8;NFX1;RFXAP;ABL1;CDK7;ESR1;PIAS2;PGR;PSEN1;BMP2;BCAS3;ZNF219;HOXB5;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5;MED15;ZNF3;DVL2;SP3;PTEN;ZBTB4;SIRT2;MAFB;CAMTA2;USP9X;PAF1;PEX2;AKNA;SMARCA5;PSIP1;BRD8;MTF1;PIK3R1;GZF1;HOXA9;MAPK14;DDX3X;ATF2;IFI27;NR4A1;ZBTB1;EP300;DDRGK1;AHI1;MRGBP;CBX6;TSHZ3;TLR4;LAGE3;ZBTB7B;PHF12;ZFP64;E2F3;RFX5;ZSCAN20;CD81;LRP6;ELP4;MAP2K5;SAP18;SREBF1;GTF2F1;NFIB;IKBKG;MYBL2;ZSCAN2;PROX2;MTA3;NFIL3;RUNX1;CAMK1;HIVEP3;FOXJ3;ATMIN;LDB1;LDB2;MDFI;ZSCAN21;ATAD2B;MED30;ZBTB26;ZFP37
prerank,primary neural tube formation (GO:0014020),-0.3780828056411727,-1.1035574563696358,0.2623762376237624,0.7639054641548035,1.0,14/30,17.87%,LMO4;COBL;PLXNB2;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),-0.3875817446838939,-1.1029418138350882,0.3168831168831169,0.7644584271626652,1.0,4/27,5.09%,CACNA1C;ANK2;CAMK2D;DLG1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.3532782810966023,1.1026540613823066,0.2953020134228188,0.7715489227507997,1.0,25/110,16.69%,TFRC;DAB2IP;TIRAP;FNIP2;TAL1;BIK;HCK;STXBP1;RALB;INSM1;LCMT1;TGFB1;IRGM;MMP1;HSPA8;SYK;SH3GLB1;SVIP;CDH5;BBS10;GFAP;MPP7;OPRD1;HCFC1;SUMO1
prerank,sphingosine biosynthetic process (GO:0046512),0.5157970311213418,1.1025223027528466,0.3392857142857143,0.7703949539507615,1.0,3/11,6.96%,ACER2;ACER1;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),0.5157970311213418,1.1025223027528466,0.3392857142857143,0.7703949539507615,1.0,3/11,6.96%,ACER2;ACER1;SPTLC2
prerank,glycosphingolipid metabolic process (GO:0006687),0.4079683985646078,1.1021629923494458,0.3410493827160494,0.7705431678962769,1.0,9/42,13.93%,ST6GALNAC3;ESYT2;NEU4;ESYT1;GLB1;GLTP;B4GALNT1;CERK;NEU2
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3808656808944348,1.101975672379303,0.32848837209302323,0.7702904668494429,1.0,7/73,2.77%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.45819029496839037,-1.1019614351138949,0.34468937875751504,0.7659144410273897,1.0,4/14,23.09%,IL18;IL17D;CD84;CD80
prerank,regulation of small molecule metabolic process (GO:0062012),-0.3929668328954821,-1.1018408499677865,0.32304038004750596,0.7649794666728524,1.0,5/28,8.01%,PDK1;RORA;PPARA;PRKN;APOE
prerank,cellular response to lectin (GO:1990858),0.3612470250192923,1.1012494597518538,0.3081081081081081,0.7706709295414675,1.0,25/104,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3612470250192923,1.1012494597518538,0.3081081081081081,0.7706709295414675,1.0,25/104,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,cardiac muscle cell differentiation (GO:0055007),-0.40897350111451314,-1.100971394257147,0.30162412993039445,0.7662533032137073,1.0,6/21,12.42%,CXADR;AKAP13;SLC8A1;MYH11;KDM6B;BMP2
prerank,negative regulation of protein phosphorylation (GO:0001933),-0.28562699847070255,-1.1008336248999722,0.16593886462882096,0.7653747036841249,1.0,35/150,13.66%,PID1;PTPN13;PRKAG2;NTRK3;LDLRAD4;PLPP3;ERRFI1;PPM1E;FBLN1;ENPP1;SLIT2;SMAD6;DEPTOR;IMPACT;DMD;RASSF2;PRKCD;DTNBP1;EMILIN1;EPHB2;PRKN;IGFBP3;PDPK1;SPRED1;QARS1;ITGB1BP1;PPEF2;LRRK2;IBTK;GPD1L;DMTN;TWIST1;NF1;PTEN;SIRT2
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.44440881581384506,1.1002826069098486,0.36507936507936506,0.7724574546711603,1.0,6/30,3.23%,ARHGEF3;NET1;F11R;ADGRG1;LPAR6;PRAG1
prerank,positive regulation of coagulation (GO:0050820),-0.49774175633695306,-1.1001501003035628,0.3796095444685466,0.7647967646211871,1.0,5/10,22.31%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,positive regulation of hemostasis (GO:1900048),-0.49774175633695306,-1.1001501003035628,0.3796095444685466,0.7647967646211871,1.0,5/10,22.31%,ST3GAL4;THBS1;DMTN;SERPINE1;HPSE
prerank,regulation of protein secretion (GO:0050708),0.3509466931247513,1.0999344013101557,0.30533333333333335,0.7726098272251168,1.0,15/119,6.34%,SLC2A1;CACNA1A;TGFB2;UNC13B;STX1A;RHBDF2;CD2AP;RAPGEF3;ABCG1;NOS2;KCNC2;SYT7;PPIA;RAPGEF4;KCNG2
prerank,actomyosin structure organization (GO:0031032),0.3748234404820417,1.0998104504487096,0.3163265306122449,0.7721697713028889,1.0,6/75,3.01%,FLII;FRMD5;TJP1;PGM5;F11R;EPB41
prerank,regulation of cellular amide metabolic process (GO:0034248),0.42567845412959193,1.099564371150434,0.3563218390804598,0.7720788326935711,1.0,6/32,14.00%,NANOS3;APP;CYFIP1;EIF4E;PUM3;PGAM1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.4785420561031393,-1.0994646003625907,0.36043956043956044,0.7654181257448285,1.0,8/11,36.45%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.34091562887239285,-1.0994010036617679,0.26975476839237056,0.7643474131900291,1.0,15/51,10.01%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;SYNPO;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,regulation of macrophage differentiation (GO:0045649),-0.4386783461564673,-1.0991638816321239,0.34334763948497854,0.7637768593158011,1.0,9/15,36.35%,IL34;PRKCA;INHA;ID2;INHBA;FADD;LIF;HSF1;PF4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4716981089001902,1.0990711621729714,0.374113475177305,0.772631000695503,1.0,7/20,12.53%,PDGFB;CCNY;RGCC;HSP90AB1;CCND3;ADAM17;MAPRE3
prerank,calcium ion import (GO:0070509),-0.3843151275552843,-1.0984872643328185,0.32722513089005234,0.7644840400201272,1.0,8/28,12.08%,CACNA1C;MCU;CACNA1G;SLC8A1;CACNA1D;AFG3L2;TRPC4;CACNB2
prerank,histone methylation (GO:0016571),-0.3859506527768704,-1.0984132589180786,0.3239795918367347,0.7634265963102711,1.0,17/26,39.44%,EHMT2;SMYD3;PRMT5;PRMT8;EZH2;TRMT112;NSD1;SETD6;SMYD2;CREBBP;PRMT2;CARM1;PRMT1;NTMT1;PRMT6;FBLL1;NSD3
prerank,negative regulation of cholesterol transport (GO:0032375),-0.4923733601154981,-1.0983799909732894,0.36147186147186144,0.7622647752806866,1.0,8/10,50.79%,APOC1;SHH;NFKB1;ABCA2;SREBF2;ABCG5;APOA2;PLA2G10
prerank,prostaglandin metabolic process (GO:0006693),-0.40097463354919793,-1.0982299270602953,0.340153452685422,0.7614603174159541,1.0,5/26,9.44%,PTGDS;PTGIS;PTGS1;PTGES;PTGR2
prerank,positive regulation of cellular respiration (GO:1901857),0.5362197281888798,1.098071464621158,0.36312849162011174,0.7745127372556686,1.0,2/11,3.56%,IFNAR1;IL10RB
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.4917398555752449,-1.0979233303384692,0.3644067796610169,0.7610772498231985,1.0,2/10,2.33%,ACTN2;CARMIL1
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3597806715770605,1.097713950297272,0.30987821380243574,0.7746956461581912,1.0,25/105,18.28%,MUC3B;MUC3A;LYN;ICAM2;IKBKB;PRKACB;FYN;RPS6KA5;PSMB3;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;HRAS;SYK;PSMB10;BCL10;CARD11;PSMA8;RELB;PAK2;SKP1;PSMD9
prerank,cell-cell junction maintenance (GO:0045217),0.5248991337405641,1.0969122682654981,0.3690909090909091,0.7759863909673392,1.0,5/11,19.90%,TJP1;FERMT2;INAVA;CSF1R;F2R
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5305110928482257,1.096875972428951,0.375,0.7753298635330664,1.0,6/11,21.34%,UQCRB;CYC1;UQCRC1;CYCS;UQCRQ;UQCR11
prerank,microtubule anchoring at centrosome (GO:0034454),-0.4992570192486564,-1.0965796505121155,0.36225596529284165,0.763742079390788,1.0,4/10,21.67%,NINL;PCM1;CEP19;BBS4
prerank,myoblast differentiation (GO:0045445),-0.44820658718487416,-1.096343143408788,0.3317972350230415,0.7631550403324775,1.0,5/14,9.76%,IGF1;DDX5;JAG1;PLEKHM3;DDX17
prerank,positive regulation of stress fiber assembly (GO:0051496),-0.35256390119084,-1.0963189699830111,0.30327868852459017,0.7619759805654275,1.0,14/44,10.01%,LPAR1;ROCK2;PPM1E;CCN2;ARHGEF10L;TPM1;CARMIL1;TGFBR1;S100A10;FHOD1;PFN2;MYOC;TGFB3;ITGB1BP1
prerank,peptidyl-methionine modification (GO:0018206),0.5130325451398717,1.0962163972222054,0.37962962962962965,0.7763151499795533,1.0,3/12,13.95%,NAA60;NAA16;METAP2
prerank,acute inflammatory response (GO:0002526),0.4578618733664245,1.0961053355201547,0.3502454991816694,0.7758252208383101,1.0,4/23,4.95%,IL6R;CTNNBIP1;SIGIRR;CD6
prerank,aerobic respiration (GO:0009060),-0.4200004414490484,-1.096028381374414,0.3227990970654628,0.7614973321329838,1.0,9/20,20.26%,SIRT3;SDHC;MDH2;SDHB;MTFR1;SLC25A14;SURF1;MTFR2;UQCRC2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.48321782565255966,1.0952956521878072,0.38188277087033745,0.7772870885434059,1.0,3/17,4.26%,CLDN5;F11R;IKBKB
prerank,lymphocyte proliferation (GO:0046651),0.4626738118171755,1.0952826188095894,0.371900826446281,0.7765763992411505,1.0,6/22,12.86%,MEF2C;CD40;CD79A;MSN;TNFRSF4;HELLS
prerank,glucan catabolic process (GO:0009251),-0.442199284977302,-1.0952312127114257,0.3644251626898048,0.7623474737265122,1.0,10/15,23.03%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,membrane depolarization (GO:0051899),0.4234541066088637,1.0952098650620508,0.3504,0.7760011564669844,1.0,6/32,8.58%,CACNA1A;CAV1;SCN1A;KCNH2;YWHAH;P2RX7
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5316563617532971,1.094800800026441,0.3857677902621723,0.7763074238129383,1.0,4/12,3.95%,DOCK4;PDGFB;MEF2C;PRKG1
prerank,protein-containing complex subunit organization (GO:0043933),0.3498083578261304,1.0946416954776874,0.30364372469635625,0.7759691900634628,1.0,10/109,6.92%,OCLN;SLC2A1;FAS;MAGI1;CD40;PARD3;CD2AP;VIL1;CARD10;CLDN14
prerank,hexose biosynthetic process (GO:0019319),-0.35214267241364616,-1.094620719865225,0.3324538258575198,0.7627769971015581,1.0,14/42,22.43%,RBP4;SLC39A14;CHST15;PPARGC1A;AKR1B1;PER2;MDH2;GOT1;SLC25A12;ALDOA;ENO2;GOT2;ENO3;PGK1
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.5239651026809425,1.0945888952469387,0.38198198198198197,0.7753554892171873,1.0,5/10,13.39%,TBX1;STAT1;LRP5;TGFBR2;SOX9
prerank,proteolysis (GO:0006508),-0.2659409555446046,-1.094208581145862,0.15862068965517243,0.7627213211806518,1.0,46/252,15.76%,TRABD2B;CPQ;AEBP1;ADAMTS12;PCSK5;MMP14;HTRA3;ADGRV1;MMP16;F3;ANPEP;OGT;SUFU;FAP;GGT5;BACE2;CTSL;MMP2;NAALAD2;ACE;ENPEP;ADAM19;NPEPPS;CPXM1;DPP4;CPXM2;ADAM33;CUL7;IDE;ATG4A;CLN3;MMP19;AFG3L2;SENP6;PSEN1;HTRA1;CTSH;HTRA4;HTRA2;CTSZ;CAPN1;CASP3;SDE2;ADAMTS9;HM13;ZMPSTE24
prerank,transition metal ion homeostasis (GO:0055076),0.43143878804793334,1.0940926386064107,0.3449419568822554,0.7758995979443915,1.0,3/28,5.15%,SLC40A1;B2M;XIAP
prerank,phosphatidylcholine catabolic process (GO:0034638),0.5242474959821473,1.093793858051359,0.375,0.7759330731068218,1.0,3/10,12.55%,ENPP2;LIPC;PNPLA8
prerank,modulation by symbiont of host process (GO:0044003),0.5376644862522023,1.0932868178653794,0.38593155893536124,0.776538385528798,1.0,2/10,12.42%,B2M;HGS
prerank,regulation of Ras protein signal transduction (GO:0046578),0.3575448033158343,1.0932206516584282,0.3084370677731674,0.77596412221541,1.0,18/86,10.41%,DAB2IP;TGFB2;DENND3;RASGRP4;ARHGEF2;RAPGEF1;NOTCH1;STARD13;LYN;GRB2;EPS8;STK19;EPS8L2;DENND4C;OPHN1;ARHGDIA;ARHGAP17;PDCD10
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.5133190256297335,1.0931869754224264,0.3706293706293706,0.7753282791431282,1.0,6/13,23.90%,ARID1A;SMARCD1;SPI1;ZMIZ2;SERTAD2;PADI2
prerank,ventricular cardiac muscle cell action potential (GO:0086005),-0.42159967366255413,-1.0931266553728929,0.36465324384787473,0.7644617378061166,1.0,2/17,2.25%,ANK2;SNTA1
prerank,lytic vacuole organization (GO:0080171),-0.37440536680894415,-1.0923829567719454,0.329923273657289,0.7653696024594334,1.0,12/32,18.25%,ABCA1;HOOK2;ARSB;GAA;CLN3;LRRK2;AKTIP;ACP2;GNPTAB;GRN;CLN6;MBTPS1
prerank,glutathione biosynthetic process (GO:0006750),0.5152844971876068,1.0922786918775398,0.37592592592592594,0.7769872436199927,1.0,2/11,5.09%,GCLM;MGST2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.45954380805896844,-1.0922538078458224,0.3287981859410431,0.7644986218850339,1.0,7/15,19.98%,PRKCD;SMPD3;SIRT3;NSMAF;SPHK1;PLA2G6;ORMDL2
prerank,peptidyl-lysine modification (GO:0018205),-0.30798419260110294,-1.0917270942548558,0.29914529914529914,0.7647289548866184,1.0,20/99,14.57%,EYA1;LOXL1;PLOD2;HDAC4;LOXL3;PIAS1;SEH1L;P3H3;NNAT;LOX;ATP7A;SIRT3;NUP205;TRPM4;SENP3;SENP6;PIAS2;SENP7;SIRT2;EP300
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.42834127110691467,1.091405228819345,0.35657686212361334,0.7785660640889719,1.0,3/30,5.99%,BCL2L1;CXCL12;SNAI2
prerank,response to glucocorticoid (GO:0051384),-0.387163540718409,-1.0911076913311581,0.3238341968911917,0.7651646807590102,1.0,4/26,11.70%,SLIT2;ADAM9;ANXA1;GOT1
prerank,negative regulation of blood coagulation (GO:0030195),0.4122869546194753,1.0908364767915737,0.3426791277258567,0.7792736855719037,1.0,4/38,2.28%,PDGFB;CD34;NOS3;PLAUR
prerank,renal filtration (GO:0097205),0.5319371812977266,1.0899804183464867,0.3817829457364341,0.780775299634552,1.0,2/10,1.05%,MYO1E;CD34
prerank,negative regulation of phagocytosis (GO:0050765),0.48042054592373606,1.0898092574743126,0.3520140105078809,0.7804296400635411,1.0,2/17,4.37%,DYSF;SNX3
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.30853299625764546,1.0896729384342239,0.25862068965517243,0.7800683367293504,1.0,83/476,14.38%,LEF1;MECOM;PLCB1;ETS1;FLI1;PDGFB;NOTCH4;TRIM16;ZIC3;TBX1;PPARD;SOX17;AFAP1L2;FZD4;MEF2C;RYBP;NCOA1;SMARCA2;SP100;FOXO1;FOXL2;RPS6KA1;ACVRL1;NOTCH1;KLF2;ZBTB16;WNT7A;IKBKB;HHEX;FOXF1;RREB1;CTNNB1;CREB1;MRPL12;KLF1;TAL1;CD4;CAMKK2;CD38;KLF4;RET;STAT1;NR1H2;DNM2;SOX18;BRCA2;HINFP;KAT6A;JUN;KCNH2;TGFB1;YWHAH;KLF6;FOXP3;LRP5;CDK5RAP2;ARID1A;HMGA1;UBE2V1;ELF2;SMAD5;BRD4;NR5A2;CTCF;HIF1A;SOX10;RNF187;RAI1;TFEB;MAPRE3;SOX11;NAA16;PPARG;HIPK2;EDF1;BRPF1;SOX9;HMGB2;NAT14;BCL10;SP1;PIM2;BICRA
prerank,tryptophan catabolic process (GO:0006569),-0.479846232101493,-1.0896629748319382,0.3598130841121495,0.7679523790788816,1.0,6/11,30.36%,AFMID;KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,lipoprotein localization (GO:0044872),-0.5008735098071984,-1.0892053760269627,0.37267080745341613,0.7680380530219078,1.0,1/11,0.53%,LRP1
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.4568313362879899,1.0890577448991763,0.37217391304347824,0.7809710864209071,1.0,10/22,17.80%,SLC16A2;NES;GATA2;DLL4;INSM1;DISP3;TOX;PTPRZ1;PROX1;TRIM71
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.43110054879288245,1.089008677911556,0.34959349593495936,0.780354457121979,1.0,8/28,15.10%,DAB2IP;PTK2;CTSC;FBXW7;PSMC6;SMURF1;RNF139;BAG2
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3712514273575713,1.0889658745849067,0.33048433048433046,0.779716048019836,1.0,23/76,18.01%,TEK;FES;NES;EVL;VIL1;CCR7;CDC42EP3;BAIAP2;NCKAP1;HCK;P2RX7;PFDN2;HRAS;NCKAP1L;SPAG5;FCHSD1;EDN1;NCK1;PROX1;PRKCE;TENM1;BIN1;WDR1
prerank,ribosome biogenesis (GO:0042254),0.3321513101948377,1.0889277284499523,0.3075,0.7790855292529256,1.0,78/187,28.91%,RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;NOP16;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;PDCD11;RPL13A;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;GTF3A;NOL9;RIOK1;MRM2;RPL11;RPS15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;RPL37A;NOL8;LYAR;RPL15;NAF1;RRP12;EXOSC10;RPL17;RPL23;RPL34;WDR75;EXOSC9;NOC2L;PAK1IP1;XRN2;NVL;RPL21;DDX54;RPL18A;RPL10A;EXOSC8;SURF6;ABCE1;RPL24;RPL7A;MRPL22;RPL32;RPL4;RPS2;TBL3;BYSL;RPL6;RPS19;HEATR1;RPL14;RPL26;DDX10;UTP4;SBDS;DHX29;RAN;DCAF13;RPS6
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.5171446905511778,1.0886784406817207,0.376599634369287,0.7790249097454212,1.0,6/12,24.79%,PCGF3;RBM15;RLIM;METTL3;CDYL;PCGF5
prerank,negative regulation of protein kinase activity (GO:0006469),0.3635867668800029,1.0885740050283208,0.3323943661971831,0.7785544793288331,1.0,17/88,12.35%,PTPRB;DAB2IP;CAV1;GNAQ;DUSP3;ADAR;WWTR1;HYAL2;PPIA;LRP5;PTK6;TRIB2;ACP4;HSPB1;CEACAM1;PTPRQ;DBNDD1
prerank,tube closure (GO:0060606),-0.37398337611083365,-1.0883833380350956,0.28607594936708863,0.769064612126522,1.0,14/31,17.87%,LMO4;COBL;PLXNB2;MTHFR;MTHFD1;IFT122;FUZ;SKI;CELSR1;DVL2;LRP6;STIL;MTHFD1L;PAX2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),-0.40033201692661347,-1.0880003902355335,0.3564102564102564,0.7689043343629259,1.0,6/24,11.45%,ITPR1;PKD2;FGF2;ANXA6;ITPR2;IBTK
prerank,inositol phosphate-mediated signaling (GO:0048016),-0.41963488294709134,-1.0878970192106487,0.3446601941747573,0.767985920586046,1.0,8/19,20.56%,PLCE1;NFAT5;NFATC4;PPP3CB;INPP5A;NFATC2;NFATC3;HRH1
prerank,aortic valve morphogenesis (GO:0003180),-0.3763300403480617,-1.0878548203641096,0.3401015228426396,0.766906782526533,1.0,9/30,7.70%,ROBO1;ROCK2;BMP4;ELN;SLIT2;SMAD6;HEYL;EMILIN1;JAG1
prerank,regulation of cell aging (GO:0090342),-0.47959463766341004,-1.087797076307854,0.36009174311926606,0.7658497428465888,1.0,3/11,9.42%,LMNA;NEK6;NUAK1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5072695973007412,1.0876924880091368,0.38361266294227186,0.780134536045195,1.0,2/13,1.88%,PDGFB;PPARD
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.40026035050001796,-1.087594719211962,0.33712984054669703,0.7651968770082547,1.0,8/24,9.33%,PHLDB2;ARHGAP6;ARHGAP28;ARAP1;CGNL1;ARHGEF18;MET;MYOC
prerank,embryonic organ development (GO:0048568),0.38200480526927216,1.0875049442552356,0.3338235294117647,0.779895166902417,1.0,8/61,3.19%,KITLG;MFSD2A;KDR;TGFB2;TEAD4;SOX17;NES;ZFPM1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.3971665511173827,-1.0872852134588562,0.3286384976525822,0.7648749148906554,1.0,6/23,8.93%,CAMK1D;MCU;SLIT2;RIPOR2;DAPK2;DPP4
prerank,cellular protein catabolic process (GO:0044257),0.37761522391804536,1.0872178698065995,0.33663366336633666,0.7799043613762944,1.0,23/59,23.75%,DAB2IP;DENND3;CTSC;CTSW;CTSK;CTSO;UBE2G1;AP2M1;BNIP3L;MALT1;CASP8;AP2B1;AFG1L;CTSS;UBE2G2;CAPN2;RSPRY1;PISD;AP2S1;BNIP3;LGMN;RIPK1;LONP1
prerank,long-term memory (GO:0007616),-0.4199500635304412,-1.0871223316084575,0.3268765133171913,0.7641482182947034,1.0,5/19,15.20%,NFATC4;APOE;PJA2;LDLR;RASGRF1
prerank,regulation of secretion (GO:0051046),0.5073154470358202,1.0865890267699667,0.4,0.7808100902832719,1.0,4/13,14.50%,MYO6;KCNQ1;ACSL3;SGK1
prerank,lysine catabolic process (GO:0006554),-0.4628229223660043,-1.0864916904814657,0.35607675906183367,0.7634905697737404,1.0,8/12,34.92%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS;DLST;OGDH;CRYM
prerank,lysine metabolic process (GO:0006553),-0.4628229223660043,-1.0864916904814657,0.35607675906183367,0.7634905697737404,1.0,8/12,34.92%,ALDH7A1;PHYKPL;HYKK;PIPOX;AASS;DLST;OGDH;CRYM
prerank,hyaluronan catabolic process (GO:0030214),-0.414069441748536,-1.086477734184496,0.34965034965034963,0.7623286470454834,1.0,10/18,27.44%,CEMIP;CEMIP2;FGF2;SLC9A1;HEXA;CD44;LYVE1;HMMR;GUSB;HYAL3
prerank,aorta development (GO:0035904),-0.45452233278917187,-1.0861271723396693,0.35377358490566035,0.7621537589023005,1.0,7/14,10.97%,ROBO1;LRP1;PDGFRB;PKD2;JAG1;EFEMP2;ROBO2
prerank,sterol metabolic process (GO:0016125),-0.3310609224547714,-1.0860262608692255,0.2958579881656805,0.7612710769017812,1.0,15/60,18.11%,PRKAG2;CYP7B1;CYP26B1;INSIG2;CYP27A1;ABCA1;CYP1B1;APOE;OSBPL5;RXRA;TSKU;FDX1;ANGPTL3;SQLE;CLN6
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.43814703929238913,1.0859923719277074,0.38380281690140844,0.7816828095329462,1.0,5/27,4.05%,SHANK3;TJP1;WASF2;F11R;STMN1
prerank,regulation of dendrite development (GO:0050773),0.40864836256372755,1.0859700740944385,0.3443396226415094,0.7810125140871899,1.0,7/37,8.49%,MFSD2A;DAB2IP;LRP8;NEDD4L;LZTS1;CSMD3;PTN
prerank,regulation of telomerase activity (GO:0051972),0.4001821645969593,1.0859309461470354,0.3578125,0.7804069265025563,1.0,19/45,25.84%,MEN1;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;ACD;TERF1;MAPK1;NAF1;MAP2K7;NVL;ERCC4;PINX1;PTGES3;MYC;NABP2;PNKP
prerank,glycogen metabolic process (GO:0005977),-0.38302459356004215,-1.0857704650270874,0.3404761904761905,0.7608237820447916,1.0,9/27,11.69%,PRKAG2;PYGB;PHKB;PER2;PYGM;GAA;PHKA2;PPP1R3C;AGL
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.5060051386074623,1.0855712931881973,0.37662337662337664,0.7806512001786594,1.0,4/12,7.36%,PTK2;LYN;MAPK3;BST2
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.43172024314754553,-1.0839882490237038,0.3621495327102804,0.7647142187366807,1.0,3/17,11.34%,IGF1;APOE;RTN1
prerank,muscle cell development (GO:0055001),-0.377808959930842,-1.0838117418159172,0.32642487046632124,0.7640595454182161,1.0,8/30,9.11%,ANK2;IGF1;CXADR;MYOF;DMD;SLC8A1;MYH11;EFEMP2
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.4027588874799227,-1.0835930536453988,0.3659147869674185,0.7635199066509349,1.0,1/23,0.34%,IGF1
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.4693807419096624,-1.0835621930294153,0.40611353711790393,0.7624056530045673,1.0,6/12,24.32%,IRS1;IGF2;SNX5;ZBTB7B;PRKCZ;C1QTNF12
prerank,protein K48-linked deubiquitination (GO:0071108),0.45443349815539064,1.0834254341519542,0.3773913043478261,0.7855213309367216,1.0,8/23,19.25%,MINDY1;ATXN3;OTUD7A;MINDY2;TNFAIP3;OTUD4;USP25;OTUD7B
prerank,negative regulation of ion transport (GO:0043271),-0.40193702751715876,-1.0831557908828022,0.3511450381679389,0.7623269237794854,1.0,10/24,25.24%,ACTN2;WNK4;PTK2B;WNK1;HTR1B;PACSIN3;WNK3;ADRA2A;NEDD4;STC1
prerank,regulation of extracellular matrix organization (GO:1903053),-0.437805259990084,-1.0828382849376619,0.3617511520737327,0.762035658518244,1.0,5/15,9.11%,LRP1;AEBP1;DDR1;FAP;EFEMP2
prerank,regulation of cellular localization (GO:0060341),-0.3398226282076507,-1.082485677483967,0.347953216374269,0.7618044777234143,1.0,14/46,16.50%,ADCY5;GSN;PARD6G;EFNA5;CAMK2D;STXBP4;PRKN;CDK16;PARP1;LRRK2;KDM1A;BRSK1;MAP2;NR1H4
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.4709902370629079,-1.082456754320615,0.36,0.7607149157762026,1.0,4/12,6.13%,IGF1;IRS1;IRS2;IGF2
prerank,bicarbonate transport (GO:0015701),0.4397262090089171,1.0819794427050884,0.3825944170771757,0.7884982552142795,1.0,2/25,1.24%,CA4;SLC39A8
prerank,macrophage chemotaxis (GO:0048246),-0.48870395131495825,-1.0819324117677576,0.38148984198645597,0.7610931282630911,1.0,7/10,48.44%,CKLF;CCL2;CCL5;TAFA4;CXCL17;CCL3;LGALS3
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4269152280130572,-1.081838694427926,0.3490990990990991,0.7601817265015889,1.0,6/18,12.42%,HDAC4;FRS2;FZD7;CCN3;SOX6;BMP2
prerank,actin filament bundle assembly (GO:0051017),-0.36279138354342655,-1.0815786618892118,0.3359173126614987,0.7597346281712491,1.0,3/33,0.50%,CALD1;DPYSL3;PAWR
prerank,Notch signaling pathway (GO:0007219),0.3774905697754835,1.0815366370278323,0.3522561863173217,0.7888965941467152,1.0,11/59,6.71%,SORBS2;NOTCH4;JAG2;PLXND1;NOTCH1;YBX1;DLL4;SNAI2;MAML2;ADAM10;STAT1
prerank,organonitrogen compound catabolic process (GO:1901565),-0.31980324855872083,-1.0814928945565347,0.31339031339031337,0.7588386541573714,1.0,10/57,10.78%,CPQ;ANPEP;PDXDC1;ACE;ENPEP;NPEPPS;LRSAM1;RENBP;IDE;GGACT
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.444754150171019,1.0814098267717893,0.3681592039800995,0.7884712468766543,1.0,5/25,11.66%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A
prerank,regulation of biosynthetic process (GO:0009889),0.5185805071242642,1.0811337076095524,0.3892857142857143,0.7884723780717288,1.0,2/11,6.23%,PIKFYVE;SLC25A33
prerank,phagosome maturation (GO:0090382),0.41812827287872906,1.08105051325778,0.3446601941747573,0.7879447155186939,1.0,6/35,7.82%,RAB31;ATP6V0A1;MCOLN1;PIKFYVE;RAB34;RAB39A
prerank,negative regulation of cyclase activity (GO:0031280),0.4980849624303544,1.0808771977634952,0.3850574712643678,0.7876737228394455,1.0,2/14,2.58%,PALM;GNAI2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.443794431646206,-1.080866351567004,0.3413566739606127,0.7593888276722627,1.0,5/15,8.73%,PDGFRA;FGFR2;TGFBR1;SIX1;MTHFD1
prerank,second-messenger-mediated signaling (GO:0019932),0.3616653367890847,1.080805131731069,0.3338048090523338,0.7871271184954266,1.0,9/82,5.27%,NDNF;NOS3;DDAH1;PLA2G4B;PPP1R9B;PLCG1;NOS2;CCR7;CAMKK2
prerank,catecholamine metabolic process (GO:0006584),0.4925648921999288,1.0806016423348899,0.3634782608695652,0.7869352642855932,1.0,1/14,0.61%,DDC
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.5235569219642463,1.0805141342541578,0.3948339483394834,0.7864091044407201,1.0,4/10,8.10%,CALM1;NPPA;SRI;PDE4B
prerank,nuclear body organization (GO:0030575),0.5062222737086186,1.0796145399284662,0.3822975517890772,0.7880342560689251,1.0,4/12,14.13%,ETS1;ZPR1;HIPK2;SERBP1
prerank,negative regulation of lyase activity (GO:0051350),0.4855564676905301,1.0795085670537454,0.3787878787878788,0.7875782300477945,1.0,2/16,2.58%,PALM;GNAI2
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.29752449169065587,-1.0793092723711857,0.2862903225806452,0.7624819149743033,1.0,22/101,15.70%,SAMD4A;PLD1;CYFIP2;THBS1;ASPH;OGT;ATG10;DACT1;PLXNB2;AGTR1;FXR2;PERP;EZR;VGLL4;BTRC;TBC1D10A;EIF3C;FMR1;FBXW11;DDX3X;LARP6;YTHDF1
prerank,histone H2B ubiquitination (GO:0033523),-0.4958196415627289,-1.0792229612662518,0.3879310344827586,0.7615438797905234,1.0,4/10,13.80%,CTR9;UBE2E1;RNF20;PAF1
prerank,regulation of TORC1 signaling (GO:1903432),-0.35688976598545585,-1.07893864604342,0.375,0.7611504977026357,1.0,9/33,18.57%,RNF152;KLHL22;SEH1L;ATM;STK11;CLEC16A;RRAGA;SMCR8;FLCN
prerank,cellular response to light stimulus (GO:0071482),0.36921048396389644,1.0785865865139053,0.3723554301833568,0.789309610746143,1.0,18/66,21.63%,POLK;N4BP1;OPN5;RHBDD1;GPR52;COPS9;EIF2AK4;GNB1;OPN3;TRIAP1;RRH;PTPRK;NSMCE3;BAK1;NOC2L;POLD1;METTL3;ERCC4
prerank,rRNA methylation (GO:0031167),-0.39810449568236683,-1.0783487322260144,0.3597122302158273,0.7615652762848488,1.0,14/22,39.26%,NOP2;MTERF4;NSUN3;NSUN4;EMG1;FDXACB1;TRMT112;DIMT1;MRM3;MRM1;FTSJ3;BUD23;NSUN5;FBLL1
prerank,aorta morphogenesis (GO:0035909),-0.43138705524108983,-1.0778199573313285,0.35523114355231145,0.7618758374401717,1.0,7/17,9.11%,LRP1;BMPR1A;PDGFRB;MYLK;RBPJ;JAG1;EFEMP2
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.5092398904297881,1.0773618454031022,0.37891268533772654,0.7917373378585508,1.0,3/13,8.30%,STX3;HSP90AB1;ABCA7
prerank,negative regulation of viral transcription (GO:0032897),0.5040789555448802,1.0772967119287298,0.3911504424778761,0.7911541236079054,1.0,1/13,2.37%,TRIM14
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.4328363412413317,-1.0772542893566612,0.35799522673031026,0.7622882529571843,1.0,6/16,22.50%,KLHL22;SEH1L;CLEC16A;RRAGA;FLCN;LARS1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.5034580092833076,1.076580873593544,0.3800383877159309,0.7922146015756787,1.0,2/13,2.58%,PALM;GNAI2
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),-0.4097309205223091,-1.0764082449666654,0.3470319634703196,0.7634298136695777,1.0,3/20,3.85%,ACTN2;OSR1;CAMK2D
prerank,response to glucose (GO:0009749),0.39332520516589065,1.0763102559585218,0.3704866562009419,0.7921703640396864,1.0,2/46,2.00%,IGF1R;UNC13B
prerank,lipid homeostasis (GO:0055088),-0.32805500130275,-1.0763036569007756,0.3141025641025641,0.7625731356700584,1.0,10/57,9.80%,ZBTB20;PRKAA2;RBP1;NR1D2;ABCA1;THADA;IRS2;RCN3;APOE;TLCD2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.4559074169200983,-1.0762258237175044,0.38018433179723504,0.7616419301510627,1.0,4/12,13.57%,CDC14B;GOLGA2;BTRC;PTEN
prerank,positive regulation of cell cycle (GO:0045787),0.3765338488527548,1.0761762043805316,0.35787923416789397,0.7917800496534487,1.0,12/62,10.12%,PDGFB;TGFB2;APP;TBX3;CCNY;RGCC;DUSP3;TAL1;PKN2;CCND3;ADAM17;PTK6
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.37274505716771184,1.0761488930102594,0.36182336182336183,0.7911264234809019,1.0,7/62,6.64%,BCL2L1;CXCL12;PLAUR;ARHGEF2;PPIA;SNAI2;MCL1
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.38093727502432123,1.076139385422003,0.35070422535211265,0.7904294130073826,1.0,14/63,14.07%,ITGA6;CAV1;FAS;SH3RF1;TNFSF10;SP100;HYAL2;DEDD2;ZMYND11;AGTR2;CASP8;TNFSF12;CYLD;BCL10
prerank,regulation of protein autophosphorylation (GO:0031952),0.41317605349193015,1.0759215820477372,0.352,0.7902412820367472,1.0,6/36,6.61%,PDGFB;ENG;PDGFD;CALM1;MRE11;PPP2R5A
prerank,negative regulation of leukocyte migration (GO:0002686),-0.49469830308110013,-1.0754274973227838,0.391025641025641,0.7628089105195751,1.0,5/10,11.81%,BMP5;SLIT2;HOXA7;EMILIN1;CD300A
prerank,neutrophil activation involved in immune response (GO:0002283),0.3085760796022248,1.0753175445912053,0.2918502202643172,0.7910269760050324,1.0,98/428,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;SYK;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,cristae formation (GO:0042407),0.44308698973169913,1.0748204086554578,0.38397328881469117,0.7915750319277198,1.0,9/27,19.22%,ATP5F1E;ATP5MC2;LETM1;ATP5PO;SAMM50;ATP5F1A;ATP5MF;ATP5PF;CHCHD3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5259533110864256,1.0747641458559547,0.40535714285714286,0.7910078691115239,1.0,4/10,7.11%,NOTCH4;RGCC;NOTCH1;NEXMIF
prerank,inflammatory response (GO:0006954),0.32355163339905985,1.074123603165657,0.3121098626716604,0.7918480346284029,1.0,26/195,11.80%,MFHAS1;LY75;ADGRE5;AFAP1L2;F11R;NOD1;CD40;PLA2G4B;HDAC9;IL10RB;IKBKB;NOS2;CCR7;NRROS;LGALS9;PXK;TGFB1;CXCR2;SIGLEC1;AGTR2;CYBB;TAC4;CCL1;S100A8;RAC1;TNFRSF4
prerank,regulation of fatty acid metabolic process (GO:0019217),0.47671413339367447,1.0740168618454358,0.39015817223198596,0.7913740317411384,1.0,3/17,1.88%,ADIPOR2;CAV1;PPARD
prerank,regulation of cellular component movement (GO:0051270),0.39024458589769323,1.073739027986292,0.35443037974683544,0.7913946437010684,1.0,10/49,7.03%,ETS1;FES;SP100;PRAG1;LYN;PKN1;INPP5F;ACTN4;PKN2;ACTN1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.3974987811280548,-1.0734478325108732,0.3725,0.7671158638730733,1.0,5/23,10.06%,UACA;BMP7;C1QTNF3;CCN3;PPM1B
prerank,ventricular septum development (GO:0003281),-0.35099919061756124,-1.0730776713913492,0.3443526170798898,0.7669571175332992,1.0,9/37,6.34%,ROBO1;TGFBR3;BMPR1A;ZFPM2;SLIT2;SALL1;TGFBR1;MDM4;HEYL
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.3859702766846789,-1.0726286945882972,0.3611111111111111,0.76702881575262,1.0,3/26,5.14%,LGR4;APPL2;FLOT2
prerank,glial cell development (GO:0021782),0.4338604293723202,1.0726244944261023,0.40237691001697795,0.7935276528020083,1.0,6/25,12.63%,APP;NRROS;EIF2B1;EIF2B2;SOX10;SOX11
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.27244870064070426,-1.072400167088375,0.27979274611398963,0.7665277160205128,1.0,50/186,17.46%,BICC1;RBMS3;TRABD2B;LRP1;GLI3;IGFBP2;DKK3;RNF43;IGFBP6;WWOX;INVS;AMFR;DAB2;IGFBP4;SFRP4;DACT1;GLI1;PFDN5;TMEM64;CHD8;PRKN;TLE3;APOE;PSME4;GRB10;NXN;MLLT3;AXIN1;VGLL4;CUL3;STK11;FUZ;PSME3;CXXC4;BMP2;EMD;NKD2;DVL2;LMBR1L;WNT11;LRP6;LIMD1;TLE2;MDFI;TSKU;MDK;SFRP1;LATS1;HIC1;DDIT3
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.384841210735039,1.072152984814833,0.3727544910179641,0.7940068770921522,1.0,16/51,19.89%,CXCL12;IL6R;PTK2;CCR7;MAPK3;LGALS9;PTN;PGF;ADAM17;CCL1;MAPK1;GAS6;CCR2;CSF1R;MOSPD2;AKIRIN1
prerank,positive regulation of protein metabolic process (GO:0051247),0.34103573334212234,1.0719264298790045,0.35013623978201636,0.7939007878465186,1.0,24/110,15.84%,DAB2IP;APP;NFKBIA;NKD1;NEDD4L;FOXO1;KLF2;WNT7A;KLF4;NR1H2;EGLN2;OAZ1;TGFB1;SMURF1;GSK3A;TNFSF12;RANBP9;RAB1A;TNFAIP3;ASB5;BCL10;AREL1;PLK2;APC
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4390581476404251,1.0718491111681858,0.3633217993079585,0.793387532660228,1.0,3/25,5.96%,PLAUR;TNFSF10;BIK
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.3021463306952221,-1.0713645061446249,0.3142857142857143,0.768285621062966,1.0,27/84,24.25%,CELF2;DDX5;SON;RBM39;FXR2;SRRM4;NOVA1;SRSF6;DDX17;SRSF4;RBM5;FMR1;NSRP1;RBFOX1;PCBP4;SAP18;C1QBP;U2AF2;TRA2B;CIRBP;MBNL2;ZC3H10;SRSF10;RBM24;SF1;KHDRBS3;CELF6
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.5081113965629411,1.071262749623125,0.41964285714285715,0.7941751851261417,1.0,3/12,9.63%,LAMA5;ACTB;ACTG1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.41333958823215056,-1.070373889493199,0.3743961352657005,0.769831341493979,1.0,7/18,19.78%,IRS1;PRKN;CCN3;KCNB1;SFRP1;INHBB;ADRA2A
prerank,negative regulation of nervous system development (GO:0051961),0.4755901537173186,1.0700689483668206,0.36363636363636365,0.7965135413316329,1.0,3/17,4.25%,B2M;NOTCH1;WNT7A
prerank,cellular amino acid catabolic process (GO:0009063),-0.3017886259230592,-1.0699057963237517,0.33451957295373663,0.7699085720649452,1.0,30/87,21.62%,DDO;ACADSB;ASPA;ALDH7A1;IVD;HNMT;MCCC2;AUH;HIBADH;ABAT;ALDH4A1;BCKDHB;PRODH;GOT1;HIBCH;GLUL;GLS;GLS2;HMGCLL1;KYAT1;PHYKPL;HYKK;SARDH;PIPOX;BCKDK;FAH;KMO;KYNU;GOT2;AASS
prerank,inositol lipid-mediated signaling (GO:0048017),0.37952978041624486,1.0697696640673464,0.3556231003039514,0.7965422059011416,1.0,3/50,0.56%,IGF1R;PLCB1;PLCB4
prerank,neutrophil degranulation (GO:0043312),0.3071803207560895,1.0696157030534887,0.2932745314222712,0.7962318183637774,1.0,97/425,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.44888558458440264,-1.0682011373082434,0.386046511627907,0.7735995455337751,1.0,3/13,4.32%,MDFIC;APOD;SUFU
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.4682812903191645,-1.0681923517934158,0.3894736842105263,0.7724846252322143,1.0,4/11,13.29%,CAMK2D;CACNA2D1;CACNB2;CACNB1
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.4521776128266467,-1.0678810527547067,0.378021978021978,0.772243922289741,1.0,4/13,15.18%,SAR1A;SEC16B;SEC16A;CD81
prerank,protein-containing complex assembly (GO:0065003),0.3146431731390862,1.0676977465352624,0.31738623103850644,0.800486118764612,1.0,42/259,14.70%,LEF1;OCLN;SLC2A1;CXCL12;FAS;MAGI1;CD40;TIAM1;PARD3;CD2AP;MEN1;CTSC;VIL1;CTNNB1;CARD10;TCF7;DBNL;ADAM10;AIM2;CLDN14;TLE4;AP2M1;TGFA;P2RX7;CAPG;RSPH4A;AXIN2;CASP8;SAMM50;FERMT2;PEX14;TLE1;RANBP9;CSNK2B;RAB1A;CNIH3;SOX9;PDCD6;RBX1;TSPAN33;SH3BGR;NCKAP1L
prerank,regulation of blood coagulation (GO:0030193),-0.3867892367323798,-1.0676754374076745,0.36893203883495146,0.7716150158018473,1.0,8/27,8.01%,TFPI;VTN;ST3GAL4;THBS1;FAP;THBD;EPHB2;APOE
prerank,negative regulation of protein secretion (GO:0050709),0.40352220033412933,1.067533383507924,0.38485804416403785,0.8001837040342148,1.0,3/38,2.95%,RAB11FIP1;CD200;RHBDF2
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4526527301563419,1.0674766262461162,0.38879159369527144,0.799637867641776,1.0,3/20,5.09%,GATM;GCLM;MGST2
prerank,response to steroid hormone (GO:0048545),0.4134634536098121,1.0667108994133008,0.3792,0.8009991762271585,1.0,6/31,8.09%,ABHD2;TGFB2;CAV1;ATP1A1;ATP1A3;TGFB1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),-0.341771380563133,-1.0662794504487776,0.3621621621621622,0.774275063635952,1.0,8/41,11.45%,ITPR1;SLC8A3;CACNA2D1;PKD2;FGF2;SLC8A1;ITPR2;IBTK
prerank,response to UV-A (GO:0070141),-0.43584634385935017,-1.0660094120072534,0.39555555555555555,0.7739107840258638,1.0,2/14,6.54%,EGFR;MMP2
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.37197712821408896,-1.0656651498983358,0.35786802030456855,0.773701299192601,1.0,9/26,22.20%,KANK2;DAB2;HEYL;CRY2;PIAS2;SFRP1;NCOR1;BRCA1;PER1
prerank,reverse cholesterol transport (GO:0043691),0.485121335651653,1.0656252303177158,0.4172297297297297,0.8031989787282553,1.0,3/13,10.76%,SCARB1;ABCG1;LIPC
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3908399617031721,1.065044317424047,0.38354037267080743,0.8039504602050853,1.0,6/47,6.44%,CD34;RAPGEF2;CAV1;SNAI2;FYN;FBXW7
prerank,mesenchymal cell differentiation (GO:0048762),0.3865577665268027,1.064501204749727,0.3688888888888889,0.8046496049372275,1.0,8/51,5.99%,LEF1;ENG;TGFB2;NOTCH4;MEF2C;NOTCH1;CTNNB1;SNAI2
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.4928606487713623,1.0645001420172902,0.3893805309734513,0.8039302878423756,1.0,2/13,5.25%,PLCB1;CCR7
prerank,activation of GTPase activity (GO:0090630),0.348913312381629,1.0643974400726548,0.34277620396600567,0.8034794536866355,1.0,15/89,6.47%,TBC1D4;ARHGEF15;TBC1D14;TBC1D22A;SIPA1L2;SIPA1;TIAM1;ABR;RALGAPA1;TBC1D12;TBC1D2;CCR7;USP6NL;TBC1D5;ARHGAP25
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.34092106628522845,1.0643528548631858,0.3569553805774278,0.8028732522650002,1.0,37/109,21.88%,MAP3K1;LYN;PLCG1;IKBKB;CALM1;GRB2;SOS1;MAPK3;PSMB3;JUN;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;PPP3CA;RAC1;SYK;PPP3R1;PIK3CB;PSMB10;BCL10;LCP2;CARD11;PSMA8;MAPK1;LAT2;PAK2;SKP1;PSMD9;PLCG2;MAP2K7;VAV1;CUL1;PSMC3;PSMD1
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3868696990442904,-1.0641969837667917,0.35336538461538464,0.7767316508028885,1.0,8/25,11.12%,SLIT2;CAPZB;ARHGAP24;KANK1;PRKCD;YAP1;PFN2;ARHGAP44
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4638305403167341,-1.0639207600061744,0.3924050632911392,0.7763205373956859,1.0,3/11,13.15%,GRK3;ARRB1;ADM
prerank,peptidyl-proline modification (GO:0018208),-0.38195852848479894,-1.063789375874667,0.3377659574468085,0.7755309277722796,1.0,8/25,18.35%,FKBP5;PPIC;FKBP10;PPIL2;P3H2;OGFOD1;PPIH;NKTR
prerank,regulation of amyloid-beta formation (GO:1902003),-0.3649848804930942,-1.0634189696690959,0.35405405405405405,0.7754269732784428,1.0,3/34,2.04%,IGF1;ROCK2;SLC2A13
prerank,calcium ion import across plasma membrane (GO:0098703),-0.43896328290203046,-1.0631511299300889,0.4145785876993166,0.7750483770363324,1.0,3/14,7.24%,SLC8A3;CACNA2D1;SLC8A1
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.4400963425636334,-1.0631070114465186,0.39828693790149894,0.7740369964934875,1.0,9/14,28.26%,MRPS27;RMND1;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2;MPV17L2;RPUSD3
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.23495653392798813,-1.0628202746189812,0.16666666666666666,0.7737017323298894,1.0,177/807,16.32%,BMP6;FOXP2;PRDM6;FHL2;ZEB2;NR2F2;AEBP1;GLI3;RARB;GLI2;ZFHX3;GLIS3;FOXD1;WNT4;SMAD3;FOXP4;DKK3;BMP7;FGFR2;BMP4;KANK2;ZFPM2;OSR1;DDX5;FNIP1;NR6A1;MDFIC;THRB;LBH;FRK;HDAC4;CUX1;MXI1;PER3;WWOX;SALL1;SNX6;SHC1;IMPACT;NR1D2;ZHX2;FOXC2;LOXL3;DNMT3A;FOXC1;BCOR;KCNIP3;SUFU;RBPJ;ZNF423;HOXA7;DAB2;EHMT2;TBL1XR1;MIER3;MDM4;AR;DLG1;PER2;PHF21A;GLIS2;PPARA;KAT6B;RUNX2;CTR9;ZNF25;ZMYM5;IKZF4;BCL6;CBX7;IGF2;FLNA;HEYL;DACT1;SMARCC2;ZEB1;KDM2A;ZNF568;LCOR;ATF5;PHC2;RUNX1T1;PFDN5;ATN1;CHD3;CHD8;PRKN;CBX5;MITF;YAP1;ZMYND15;KDM2B;MED25;POU6F1;RBAK;ATOH8;SMURF2;SFMBT1;CREB3L1;USP2;PML;FOXO3;CXXC5;PCGF2;EZR;VGLL4;TWIST2;GCFC2;QARS1;CEBPB;BTRC;TSC22D4;MBTD1;NIBAN2;EZH1;GATA6;CBFA2T2;ZBTB38;NR2F1;URI1;PARP1;ZNF148;CRY2;PRDM11;PBXIP1;MTERF3;WWP2;KDM1A;RXRA;BCL7A;NFX1;ESR1;ATP8B1;PSEN1;BMP2;XRCC5;ZNF219;SKI;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;ZNF3;SP3;GCLC;ZBTB4;SIRT2;USP9X;PAF1;PEX2;FBXW11;GZF1;WNT11;IFI27;ZBTB1;EP300;NONO;CBX6;TSHZ3;ZBTB7B;PHF12;MAP2K5;SAP18;SPINDOC;MTA3;LIMD1;TLE2;NFIL3;CDKN1C;RUNX1;CRYAB;LDB1;LDB2;MDFI;PSPC1;ZFP37
prerank,cholesterol efflux (GO:0033344),0.44954211731084315,1.062573674125418,0.3925081433224756,0.8068521481552513,1.0,4/20,8.95%,SCARB1;ABCG1;ABCA7;NPC1
prerank,positive regulation of catabolic process (GO:0009896),0.3679146132539904,1.062374917830304,0.3717201166180758,0.8066509745805991,1.0,15/65,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;SMURF1;GSK3A;VSIR;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;APC
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.39953984709503,-1.0623192687370575,0.37254901960784315,0.7739493275427081,1.0,8/21,22.96%,SLC30A10;PPARA;PRKN;TRAP1;SIRT2;PAX2;BRCA1;AATF
prerank,zymogen activation (GO:0031638),-0.34458671075308844,-1.0621356964960376,0.35795454545454547,0.7732860155293823,1.0,8/39,13.44%,CYFIP2;MMP14;ASPH;CTSL;KLK2;PERP;TBC1D10A;CTSH
prerank,neutrophil mediated immunity (GO:0002446),0.30538747426970686,1.0621248141930262,0.3082872928176796,0.8065706007848867,1.0,98/432,17.92%,PTPRB;PECAM1;ATP8A1;ADGRE5;PGLYRP1;IMPDH1;PLAUR;RAB31;B2M;ATP11B;PTPRJ;CD93;TSPAN14;STK10;ATP6V0A1;CTSC;OSTF1;PRCP;DNAJC13;ATP11A;CFD;HSP90AB1;CAT;CMTM6;DYNLL1;PPIA;DBNL;ADAM10;LRRC7;RAP1B;ENPP4;BST2;UNC13D;SRP14;SCAMP1;PSMD11;PKM;NFASC;CXCR2;SPTAN1;IQGAP1;PDXK;TUBB;QSOX1;PDAP1;GLB1;FABP5;VAT1;ADAM17;CYFIP1;DNAJC5;NBEAL2;TOLLIP;HSPA8;CYBB;MGAM;PNP;S100A8;RAC1;KCNAB2;CEACAM1;ORMDL3;SVIP;SNAP29;SLPI;SLC27A2;CSNK2B;MANBA;LTA4H;SDCBP;DEGS1;PGAM1;PTGES2;MAN2B1;PFKL;DYNC1LI1;TMEM30A;NCKAP1L;PRDX6;TUBB4B;TMEM179B;MAPK1;CPNE3;ARMC8;CTSS;RAB24;STOM;CSTB;PRG2;DGAT1;DOCK2;TTR;ACTR2;SLCO4C1;ADGRG3;VAMP7;NEU1;CPNE1
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4060893878565804,-1.061986367007097,0.37825059101654845,0.7725589023923805,1.0,4/18,17.17%,EGFR;LCOR;ESR1;SFRP1
prerank,actin crosslink formation (GO:0051764),-0.45623314219274247,-1.0619462522157337,0.4185022026431718,0.7715342483872774,1.0,2/12,6.15%,DPYSL3;FLNA
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.4531876595480151,-1.0618503861546345,0.3825503355704698,0.7706621840759823,1.0,4/13,6.13%,IGF1;IRS1;IRS2;IGF2
prerank,ERBB signaling pathway (GO:0038127),0.36562816496575984,1.061426174245048,0.3696612665684831,0.8076810267482118,1.0,17/64,10.31%,PTK2;PTPN12;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;PTPRR;TGFB1;TGFA;IQGAP1;SHC3;ADAM17;PTK6;PIK3C2A;GRB7
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.23027572659047563,-1.06119717781623,0.25,0.7713705353646615,1.0,332/1645,16.32%,FOXP2;BNC2;PBX1;IGF1;SOX5;MAF;ZIC1;NFIA;ZEB2;EGFR;NR2F2;ZIC4;GLI3;DENND4A;COL1A1;ZBTB7C;PRRX1;ZBTB20;GLI2;ZFHX3;CREB5;ZKSCAN2;ZFHX4;EFEMP1;GLIS3;FOXD1;WNT4;HLF;SMAD3;PKNOX2;FOXP4;SSBP2;IL31RA;HOXC4;DKK3;BMP7;HOXC6;BMP4;ARNT2;ZFPM2;OSR1;HOXB3;TEAD1;DDX5;PPARGC1B;SMAD6;NR6A1;TULP3;MDFIC;HOXA3;HOXA5;NFAT5;MEOX2;RGMB;LBH;HDAC4;CUX1;TRAK1;MXI1;IKZF2;HOXB4;PRRX2;CREB3L2;TEF;SALL1;MAP3K5;FZD2;SNX6;SHC1;NR1D2;HOXB6;ZHX2;CCNT2;KIT;CDH1;FOXC2;LOXL3;FOXC1;CAMK2D;BCOR;TGFBR1;ARRB1;TBX15;HIVEP2;MLXIP;OGT;SUFU;VGLL3;PLAGL1;PPARGC1A;RBPJ;ZNF423;HOXA7;BAZ1B;FGF2;PIAS1;MKX;ZNF367;KDM7A;RORA;TBL1XR1;MDM4;AR;PER2;GLIS2;MAP3K12;ANXA4;HDGFL3;PPARA;KAT6B;PBX4;HIF3A;RUNX2;KLF3;PURG;MED23;CTR9;SIX1;TBX18;EBF4;ZNF25;SPP1;IKZF4;BCL6;TEAD3;NFXL1;IGF2;TSHZ1;CRABP2;POLR2A;CHD2;HEYL;FZD7;HOXC8;NR3C2;MEIS1;PBX3;SMARCC2;GLI1;ZEB1;SMAD9;ILF2;KDM2A;CCNL1;ZFAT;ZNF568;KDM3B;LCOR;FOXJ2;NFATC4;ATF5;EBF2;TGFB1I1;ELF4;ZSCAN29;GPBP1L1;PHC2;SOD2;KLF15;RUNX1T1;PFDN5;CHD3;CHD8;CBX5;VSX1;RFX7;SMARCD3;MITF;FBXL19;KDM5B;APOE;FOXL1;YAP1;SMARCB1;RBBP8;ZMYND15;KDM2B;TP53INP2;POU6F1;ACTR8;RBAK;CHD4;HSF2;ATOH8;SMURF2;SFMBT1;CREB3L1;MLLT3;AXIN1;STAT5A;ZNF23;PML;FOXO3;CDK16;SOX6;MGA;TGFB3;REXO4;VGLL4;BRD9;TWIST2;DDX17;GCFC2;ZNF483;ACTA2;ZKSCAN7;QARS1;ARNT;ELP3;CEBPB;CDK14;ELK1;CCNC;BTRC;SP140;TSC22D4;MBTD1;NIBAN2;ARHGEF11;NOP2;GATA6;SMARCA1;ZNF182;RNF10;CBFA2T2;ZBTB38;CCNH;NR2F1;URI1;NSD2;ARID3A;SETD5;ZNF148;CRY2;PRDM11;PBXIP1;PPP3CB;NUCKS1;CHUK;MTERF3;PRMT5;ETV1;MED14;WWP2;KDM1A;CREBRF;RNF20;TFCP2L1;SNX5;RXRA;PHF8;BCL7A;NFX1;TGFBRAP1;RFXAP;ABL1;ESR1;SBNO1;PIAS2;PGR;ATP8B1;PSEN1;BMP2;XRCC5;ZNF219;HOXB5;FOXE1;NKX6-1;SNAI1;E4F1;TWIST1;HOXC5;PCBD2;ZNF3;DVL2;SP3;GCLC;ZBTB4;SIRT2;MAFB;CAMTA2;FBXW11;SMARCA5;ACVR1B;PSIP1;MTF1;GZF1;HOXA9;MAPK14;TCIM;ATF2;WNT11;NR4A1;ZBTB1;SPTY2D1;EP300;NONO;MRGBP;TSHZ3;ZBTB7B;PHF12;E2F3;RFX5;ZSCAN20;LRP6;ELP4;SAP18;SREBF1;NFIB;MYBL2;ZSCAN2;SPINDOC;PROX2;MTA3;LIMD1;TLE2;NFIL3;CCAR1;CDKN1C;RUNX1;MAP3K2;HIVEP3;FOXJ3;CRYAB;ATMIN;LDB1;APBB3;ZSCAN21;PSPC1;MED30;ZBTB26;ZFP37
prerank,monocyte differentiation (GO:0030224),-0.4871305615575485,-1.0608726419702534,0.3758099352051836,0.7711689824681045,1.0,2/10,1.89%,IL31RA;BMP4
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.39578391656156353,-1.0606996372122937,0.36961451247165533,0.7705480833557753,1.0,9/22,25.91%,ANK2;PKD2;SLC9A1;GSTM2;STAC3;JPH2;HTT;HAP1;GSTO1
prerank,positive regulation of signal transduction (GO:0009967),0.31232342134595764,1.0598790975942254,0.35379061371841153,0.8109706916606605,1.0,27/238,6.54%,TEK;SHANK3;JCAD;DAB2IP;MACF1;LIMS2;EPN2;TGFB2;NOS3;NOTCH4;TRIM16;JAG2;TSPAN5;FAS;TPD52L1;NOD2;TSPAN14;NOTCH1;PRKD2;VWF;KLF2;WNT7A;HHEX;DLL4;MAML2;HOMER1;CRADD
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.512996971140335,1.0595312388086628,0.42018348623853213,0.8111458806010281,1.0,4/11,10.45%,ARHGEF2;PELI1;BIRC3;CASP8
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.4620975655405813,1.0590203960697986,0.4128595600676819,0.811780045650425,1.0,2/18,5.07%,BCL2L1;SLC25A5
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.41084538802159676,-1.0589964440364952,0.3799126637554585,0.7742029541804901,1.0,7/17,16.84%,WNT4;BMP4;CREB3L1;TGFB3;LARP6;RUNX1;SUCO
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.3606336738839558,1.0589426508502975,0.3891336270190896,0.8112248631022676,1.0,14/69,12.55%,IGF1R;PLCB1;PLCB4;INPP5F;PLEKHA1;PIRT;CD160;HTR2A;PLCH2;PIK3C3;PIK3C2A;PLCH1;PIK3CB;ZFP36L1
prerank,regulation of centriole replication (GO:0046599),-0.40887906554032555,-1.0587519936948984,0.3875,0.7737407318431954,1.0,9/18,23.20%,ALMS1;MDM1;SPICE1;STIL;CEP295NL;CENPJ;TRIM37;BRCA1;CEP76
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.4509684744653755,-1.0584241434717159,0.3900226757369615,0.7734987865595161,1.0,4/12,19.08%,SEH1L;CENPC;RMDN1;CENPE
prerank,cellular response to interleukin-6 (GO:0071354),0.42575973512405085,1.0581915093055887,0.3938356164383562,0.812379351666821,1.0,4/26,6.71%,ST3GAL6;IL6R;ST18;STAT1
prerank,ephrin receptor signaling pathway (GO:0048013),0.35443117609654545,1.0581797409972147,0.3712230215827338,0.8116932338286025,1.0,26/82,14.03%,ANKS1A;PTK2;KALRN;ARPC4;TIAM1;ACTB;LYN;EPHA4;FYN;YES1;EPHB4;ANKS1B;EFNA1;AP2M1;ARHGEF7;ARPC3;PAK1;ACTG1;APH1A;GRIN2B;RAC1;HRAS;AP2B1;EPHB1;SDCBP;GIT1
prerank,mononuclear cell differentiation (GO:1903131),-0.388335646160662,-1.0580683607225014,0.3793911007025761,0.7732744637126374,1.0,3/24,1.89%,IL31RA;AXL;BMP4
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.41951203271057047,-1.0578672317739972,0.4060475161987041,0.7727155650075397,1.0,10/16,23.03%,PYGB;PHKB;PYGM;GAA;PHKA2;AGL;PHKG2;PHKA1;PYGL;PHKG1
prerank,positive regulation of glucose import (GO:0046326),0.44829054675996943,1.0577386349478666,0.4079861111111111,0.8120558203066275,1.0,2/21,0.95%,OCLN;INSR
prerank,regulation of keratinocyte differentiation (GO:0045616),0.43181642195920983,1.0568049570688272,0.3823038397328882,0.8137796338726468,1.0,2/24,1.56%,PRKCH;TRIM16
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.41798213336270806,1.0567152147158079,0.39781591263650545,0.8132745039858954,1.0,6/29,8.09%,ENG;S1PR1;ZFPM1;NOTCH1;SMAD7;TGFB1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.4676053710616246,1.056524343962489,0.42077464788732394,0.813076057306024,1.0,3/18,8.93%,SHANK3;NPS;NRXN1
prerank,positive regulation of cell projection organization (GO:0031346),0.33924273608210637,1.0558669335851667,0.3860845839017735,0.8141027207812954,1.0,23/115,10.12%,ITGA6;NDNF;DAB2IP;RAPGEF2;SCARF1;FES;FZD4;PLXND1;RAPGEF1;TIAM1;PRKD1;LYN;SNX3;FUT9;RET;LRRC7;SLITRK1;TWF2;PTN;SERPINI1;ARHGDIA;METRN;PTK6
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3770281852413114,1.0557764044492823,0.39085545722713866,0.813603120868647,1.0,13/60,12.22%,PDGFB;RGCC;PRKD2;HMBOX1;CTNNB1;HSP90AB1;MAPK3;KLF4;GREM1;CCT3;CCT5;ACD;POLG2
prerank,snRNA processing (GO:0016180),-0.43126917914528623,-1.0554899586997892,0.4252136752136752,0.7781470131438767,1.0,9/16,30.01%,INTS8;INTS2;INTS4;TUT1;INTS10;INTS3;TOE1;INTS6L;INTS5
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.42579360535727806,-1.0550573427435157,0.3883495145631068,0.7782287837749708,1.0,6/15,16.13%,RIPOR2;ADAM9;EHD1;MAPK14;CAMK1;EHD2
prerank,signal transduction by p53 class mediator (GO:0072331),0.41103870161972317,1.054823793036869,0.3894736842105263,0.8152848620907727,1.0,6/30,8.89%,PPP1R13B;ACER2;MYO6;HINT1;JMY;GREM1
prerank,pulmonary valve development (GO:0003177),-0.4100943091491642,-1.0547236279527563,0.3922018348623853,0.7780200144659084,1.0,7/18,7.70%,ROBO1;NOTCH2;BMP4;SLIT2;SMAD6;HEYL;JAG1
prerank,endothelial cell migration (GO:0043542),0.39750019787216734,1.0542532914547587,0.4040066777963272,0.8160557632531595,1.0,8/37,7.20%,NOS3;PLEKHG5;ID1;PLXND1;STARD13;PXN;STAT1;SOX18
prerank,regulation of cellular senescence (GO:2000772),0.43021238853965105,1.0542231646193665,0.3888888888888889,0.8154129169759454,1.0,9/28,16.58%,B2M;YBX1;VASH1;TERF2;HMGA1;MAP3K3;ABI3;RBL1;HMGA2
prerank,regulation of response to external stimulus (GO:0032101),0.33745144350644196,1.0541858566246687,0.3888888888888889,0.8147827994628261,1.0,22/121,13.95%,SEMA7A;IL1R1;CAV1;TIRAP;LRP8;BCL6B;NOD2;TMSB4X;SAMHD1;CALM1;XIAP;HCK;N4BP1;BIRC3;NLRP6;CASP8;BRD4;USP18;CYRIB;CYLD;STK24;METAP2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.47312557903130353,1.0538184507948218,0.415061295971979,0.8149995538050037,1.0,6/16,18.32%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,metal ion export (GO:0070839),-0.35457685837361347,-1.0538160330339439,0.38095238095238093,0.7794111450734927,1.0,6/31,7.08%,ATP1A2;KCNT2;KCNK5;ATP1B3;ATP7A;ATP1B2
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.4255464488930967,1.0537649063038081,0.40894039735099336,0.8144385809595814,1.0,8/29,18.19%,HSP90AB1;MRE11;PPIA;TERF2;ACD;TERF1;NHP2;RPA1
prerank,supramolecular fiber organization (GO:0097435),0.3039881257039687,1.0534343256061625,0.3477272727272727,0.814583195339444,1.0,59/334,11.52%,ITGA6;FLII;HIP1;COLGALT2;MYO1D;MYO1E;RHOBTB1;SHROOM4;TGFB2;SHROOM1;PGM5;APP;TSPAN5;ELMO1;HIP1R;B2M;ARHGEF2;COL4A2;FGF13;TSPAN14;CD2AP;EVL;PXDN;ELMO2;PPP1R9B;MYO6;STMN1;CCDC13;NPPA;CLIP1;HSP90AB1;RHOB;TPM3;CCDC88A;NCKAP5;CCDC88B;KIF2A;ADAM10;ARHGAP25;STMN3;ACTN1;COL4A1;STMN4;KLHL24;PIN1;PLOD3;GREM1;COL9A3;TMOD1;MYO1F;ARHGAP17;CLRN1;CRIPT;HOOK1;APH1A;TPM4;RAC1;MAP10;SLK
prerank,sarcomere organization (GO:0045214),-0.3670487391505557,-1.053286313358858,0.40625,0.7796641693716406,1.0,7/27,21.24%,ACTN2;TPM1;TNNT3;SIX4;MYOM2;CSRP2;KRT19
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.5071667079520588,1.053183051621672,0.424812030075188,0.8144857839443095,1.0,2/10,8.00%,ST3GAL1;ST6GAL1
prerank,apical protein localization (GO:0045176),0.5138243343720704,1.0531216833659234,0.4308231173380035,0.8139107524460322,1.0,2/10,3.87%,MAL;ACTB
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3712063407687761,1.0525798205341543,0.39745403111739747,0.8145922711540242,1.0,13/62,5.49%,ARHGEF3;RASGRP4;NET1;F11R;ADGRG1;LPAR6;RAPGEF1;PRAG1;NOTCH1;LYN;GRB2;STK19;MAPRE2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.4499829763554386,1.052461408379097,0.4119718309859155,0.8141626581927396,1.0,5/19,7.63%,BMPR2;TGFB2;ZFPM1;NOTCH1;EFNA1
prerank,response to interleukin-1 (GO:0070555),0.360270282446033,1.0520565923124583,0.3700440528634361,0.8144778323556987,1.0,11/73,13.39%,DAB2IP;APP;IL1R1;TNFRSF11A;CD40;HYAL2;LGALS9;IRAK2;CCL1;HIF1A;SOX9
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.44417942636755253,-1.0518664644838769,0.40130151843817785,0.7824147235962086,1.0,9/13,30.69%,ABCA1;LDLR;CD9;CDH13;CD81;FCER1G;ITGB1;LPL;CD36
prerank,chromatin-mediated maintenance of transcription (GO:0048096),0.5094855897797264,1.0518195071180212,0.4144620811287478,0.8144172230787654,1.0,5/11,23.90%,ARID1A;SMARCD1;ZMIZ2;SERTAD2;PADI2
prerank,regulation of interferon-alpha production (GO:0032647),0.43620771214021764,1.0513730323537407,0.3805601317957166,0.8148810557550848,1.0,6/23,11.01%,IFIH1;TLR3;STAT1;IRF5;TLR7;TLR8
prerank,modulation of chemical synaptic transmission (GO:0050804),0.334245144493249,1.0508244296589726,0.3604806408544726,0.8155428524303535,1.0,29/107,16.74%,CACNA1A;APP;LRP8;MEF2C;CDH2;ABR;CLSTN1;TPRG1L;DGKI;BTBD9;GRID2;HOMER1;PXK;OPHN1;AKAP9;AGER;DGKZ;GRIK5;GRIK2;CPLX1;GRIK1;GRM7;DLGAP3;LRRC4C;NLGN1;RIMS2;GRM8;LGI1;CNTNAP4
prerank,regulation of T cell cytokine production (GO:0002724),0.4736555312089817,1.0507677848127994,0.42857142857142855,0.814981883361627,1.0,4/15,9.05%,B2M;SMAD7;FOXP3;MALT1
prerank,plasma membrane organization (GO:0007009),-0.3092410720612889,-1.0506173089111874,0.35,0.784764213625665,1.0,13/61,11.08%,ANK2;COL5A1;MYOF;ANO6;AHNAK2;A4GALT;ANXA6;STX2;PLSCR2;EPB41L3;SNX9;TLCD2;CLN3
prerank,positive regulation of lyase activity (GO:0051349),-0.4328968656657367,-1.0505062539532892,0.41517857142857145,0.7839558381638394,1.0,5/14,13.29%,CACNA1C;STIM1;CACNA1D;FXN;NF1
prerank,cellular response to peptide hormone stimulus (GO:0071375),-0.28370621169357724,-1.0504073478114757,0.3169811320754717,0.7830691064652001,1.0,28/102,14.43%,ADCY5;ENPP1;ADCY1;CPEB1;CPEB2;ADCY9;IRS1;SLC30A10;INSIG2;RHOQ;PRKCD;SLC39A14;ADCY2;PRKCI;ADCY7;MYO5A;IRS2;SELENOS;PDPK1;PRKACA;EPRS1;SYAP1;PARP1;GOT1;ADCY6;CYSLTR2;PIK3R1;NR4A1
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.4123389896491755,1.0503151610735175,0.409967845659164,0.8154360749798997,1.0,6/29,14.41%,DCUN1D3;SMAD7;FBXW7;PIN1;DCUN1D1;BMI1
prerank,positive regulation of bone resorption (GO:0045780),0.49609907746206455,1.0496046335355413,0.43308550185873607,0.816556492227184,1.0,4/11,11.86%,TNFRSF11A;PLEKHM1;TNFSF11;SYK
prerank,digestive tract morphogenesis (GO:0048546),-0.42786105858556556,-1.049563798559387,0.41935483870967744,0.7842565870482389,1.0,4/14,6.56%,PDGFRA;FGFR2;RBPMS2;GLI1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.44718552080857066,1.049230996593177,0.41144901610017887,0.8168597430601422,1.0,6/20,9.70%,IMPDH1;HPRT1;NT5C2;AK4;ADSS2;GART
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.40799046548707163,-1.048859976207991,0.4,0.7849983909700443,1.0,4/17,4.69%,ROBO1;EFNB2;SLIT2;FGF2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3336727557797258,1.0482184473624896,0.36435124508519,0.8187132017459479,1.0,11/122,3.59%,NAMPT;PDGFB;KDR;INSR;TGFB2;BCAR3;RGCC;NIBAN1;NOD2;PRKD2;NLRC5
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.42559613917248174,-1.0481807130339547,0.40232558139534885,0.7857768686665829,1.0,9/15,32.34%,BCL2;PRKN;KDM1A;CD44;TAF9B;TAF9;ARMC10;SIRT1;MUC1
prerank,amyloid fibril formation (GO:1990000),0.3731390545982466,1.0481130595511703,0.4158878504672897,0.8182582546100622,1.0,6/51,6.41%,APP;TSPAN5;B2M;TSPAN14;NPPA;ADAM10
prerank,nerve growth factor signaling pathway (GO:0038180),0.5253518639657542,1.0475181244514158,0.4407079646017699,0.8190492058916992,1.0,2/10,3.02%,RAPGEF2;RAPGEF1
prerank,reticulophagy (GO:0061709),-0.44337216878150226,-1.0471590946056113,0.4221218961625282,0.7875113363396851,1.0,5/12,14.77%,ULK2;ATG2B;TEX264;DDRGK1;UFC1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.4525171331466593,-1.0471377310347223,0.4370860927152318,0.7864477290818476,1.0,3/12,3.43%,APOD;CBLB;F3
prerank,regulation of JUN kinase activity (GO:0043506),0.4103659120829095,1.0471278443522503,0.3911671924290221,0.819351877471433,1.0,9/33,17.40%,DAB2IP;TNFRSF11A;NPPA;ARHGEF5;PAK1;DNAJA1;HIPK3;EDN1;MAP3K11
prerank,clathrin-dependent endocytosis (GO:0072583),0.42639786924911455,1.0471243150344574,0.41435562805872755,0.8186547536591502,1.0,9/26,14.60%,FNBP1L;ITSN2;PIP5K1C;INPP5F;FCHO2;AP2M1;SIGLEC1;AP2B1;LMBRD1
prerank,cell differentiation in spinal cord (GO:0021515),0.5087667877065742,1.0471028138601184,0.41164658634538154,0.8180008741271698,1.0,6/10,26.92%,SOX13;MDGA2;LHX1;DRAXIN;ISL1;ZC4H2
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3825404910206746,1.0467056139181699,0.391304347826087,0.818295791636635,1.0,15/46,17.12%,SHANK3;MEF2C;CDH2;TPRG1L;DGKI;HOMER1;NPS;OPHN1;NRXN1;DGKZ;GRIK1;GRM7;NLGN1;GRM8;CCR2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5146320500970113,1.0459944101812724,0.4362934362934363,0.8193359630983993,1.0,3/10,14.70%,SH3RF1;CBFB;NCKAP1L
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.4084808158082604,1.045965453409523,0.4058641975308642,0.8187006589080862,1.0,6/32,8.58%,CAV1;APLNR;PLCG1;CD19;RAMP3;P2RX7
prerank,protein monoubiquitination (GO:0006513),-0.34682273894168636,-1.0457634724239375,0.3854166666666667,0.7890643049580368,1.0,11/36,15.38%,KLHL22;CTR9;UBE2R2;MGRN1;PRKN;UBE2E1;CUL3;HUWE1;RNF20;PAF1;UBE2B
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.32257122465629967,-1.0454405474260875,0.3898305084745763,0.7888482595332257,1.0,11/51,8.50%,GAS7;DCLK1;NBL1;BMP7;NRK;DTNBP1;NGF;MAP1S;ATP7A;EPB41L3;ANKRD27
prerank,sensory perception of sound (GO:0007605),0.34443686376192234,1.0435139184672253,0.40166204986149584,0.8241348581918837,1.0,19/88,10.83%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;KCNQ1;EPS8L2;SNAI2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2
prerank,cardiac muscle cell development (GO:0055013),-0.3928211092329522,-1.0432852642755932,0.4,0.7937213503785119,1.0,6/20,7.89%,PDGFRB;PDGFRA;CXADR;OBSL1;SLC8A1;MYH11
prerank,cAMP-mediated signaling (GO:0019933),0.4274969814044599,1.0427156710632932,0.39935064935064934,0.8254856012040839,1.0,5/24,5.00%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;PDE7B
prerank,spermatid development (GO:0007286),0.40633043249575046,1.04271261680307,0.3952755905511811,0.8247856557943568,1.0,5/32,15.21%,JAM2;PIWIL1;RSPH1;YTHDC2;RNF8
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.45389094404249297,1.042500617871873,0.4241379310344828,0.8245865949387969,1.0,3/18,4.05%,RASIP1;HEG1;STMN1
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4421587041927646,1.0421406945837486,0.42857142857142855,0.8248071082799251,1.0,9/21,25.98%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4871122379479079,1.0419585206047774,0.4588910133843212,0.8245614431421935,1.0,4/13,14.68%,LCMT1;CDK5RAP2;DUSP1;DYNC1LI1
prerank,response to reactive oxygen species (GO:0000302),-0.31848779044940373,-1.0418388886681773,0.3735294117647059,0.7966229199036191,1.0,10/54,11.91%,EGFR;PDGFRA;TPM1;APOD;ADAM9;PKD2;SOD2;APOE;CHUK;MPV17
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.44472832221075714,1.0417552133953347,0.41551724137931034,0.8243960815488173,1.0,2/19,2.62%,KDR;PTPRJ
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.36874246491848534,1.041707019560649,0.38351822503961963,0.8238249944663558,1.0,7/52,8.24%,PRKCH;SPTBN1;STX3;ATP2C1;RAMP3;SORBS1;ACSL3
prerank,histone ubiquitination (GO:0016574),-0.39637243053580984,-1.0416395918526797,0.3940774487471526,0.79605444423448,1.0,7/21,15.79%,CTR9;UBE2E1;HUWE1;RNF20;PAF1;UBE2B;UBR2
prerank,negative regulation of protein ubiquitination (GO:0031397),0.37193096758962274,1.0413555573430981,0.4080370942812983,0.8240393370968381,1.0,10/50,17.70%,IVNS1ABP;CAV1;SMAD7;N4BP1;UBXN1;TNFAIP3;DNAJA1;BAG2;SIRT7;PRKCG
prerank,cellular response to cadmium ion (GO:0071276),0.43301765329883884,1.0409725371787188,0.44246353322528365,0.8243174011683213,1.0,12/24,16.69%,MAPK3;JUN;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;MAPK1;SUMO1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.4596711307112932,1.0408564902586699,0.41681901279707495,0.8238888921500366,1.0,6/17,12.53%,PDGFB;CCNY;RGCC;CCND3;ADAM17;MAPRE3
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.38123815622616586,-1.0405995801584766,0.3969631236442516,0.7979082067329603,1.0,6/23,12.31%,PRKAG2;CEMIP;BMP7;AXIN1;SPHK1;S1PR2
prerank,calcium ion import into cytosol (GO:1902656),-0.4215246652730359,-1.0401519139627295,0.4325581395348837,0.7979807581076827,1.0,3/15,7.24%,SLC8A3;CACNA2D1;SLC8A1
prerank,regulation of cholesterol transport (GO:0032374),-0.39580334268652473,-1.0397805823755892,0.42610837438423643,0.797917939492747,1.0,1/20,0.53%,LRP1
prerank,histone monoubiquitination (GO:0010390),-0.3755005716638823,-1.039735926607752,0.4094292803970223,0.7969254340667933,1.0,13/24,29.87%,BCOR;CTR9;UBE2E1;KDM2B;DDB2;RNF20;PAF1;TRIM37;CUL4B;WAC;RNF40;RNF168;UHRF1
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.40848392792550514,-1.0394385877506476,0.4194312796208531,0.7966436862444236,1.0,3/16,3.80%,SOX5;HOXB4;FOXC1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.48733647869978564,1.0393886777090229,0.4234875444839858,0.8269367142820152,1.0,3/12,11.84%,SEC62;SGTB;GET3
prerank,negative regulation of B cell proliferation (GO:0030889),0.5003091240166306,1.038879747608443,0.44190140845070425,0.8275191211907604,1.0,2/11,4.54%,LYN;TNFRSF21
prerank,regulation of cellular pH (GO:0030641),-0.35495316331369053,-1.0388518920207317,0.42896174863387976,0.7971431598130586,1.0,8/29,11.08%,SLC4A10;SLC9A2;LACC1;SLC4A7;SLC4A2;SLC9A9;SLC9A1;CLN3
prerank,regulation of mitochondrial fusion (GO:0010635),0.4982685536559938,1.038286561884741,0.42015209125475284,0.8282886914901184,1.0,1/11,0.15%,TFRC
prerank,regulation of type I interferon production (GO:0032479),0.3489776752118098,1.0375902680502311,0.40413793103448276,0.8293415320830759,1.0,15/84,15.25%,TIRAP;TRIM25;LRRFIP1;IFIH1;NLRC5;RNF125;CTNNB1;MRE11;IRF5;PIN1;NLRP4;CYLD;TNFAIP3;G3BP1;CRCP
prerank,regulation of feeding behavior (GO:0060259),-0.4591964753754154,-1.0371835128006122,0.4282560706401766,0.8007804096964951,1.0,1/11,1.10%,LEPR
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5087377809069036,1.0369830253624528,0.4429657794676806,0.8302693669885364,1.0,1/10,5.03%,HSP90AB1
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.45689064411035485,-1.0367357060273128,0.41964285714285715,0.8009324515566975,1.0,6/12,28.14%,PLK5;SDE2;WAC;RPS27L;CCND1;PLK3
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4742093421076764,1.0363448880841755,0.44064748201438847,0.8312653569255635,1.0,7/15,26.06%,SMAD7;RPS7;RPL11;BAG2;RPL23;BAG5;DTX3L
prerank,Rho protein signal transduction (GO:0007266),0.3687726623255852,1.0363314776466248,0.40610687022900765,0.8305892051233429,1.0,13/53,9.68%,ARHGEF3;NTN1;PLEKHG5;ADGRG1;RIPOR1;EPS8;GNA12;RHOB;EPS8L2;CDC42EP3;ARHGAP4;PHACTR4;ARHGDIA
prerank,organophosphate biosynthetic process (GO:0090407),0.39159379570681124,1.0363237176907825,0.41776315789473684,0.8299021691354854,1.0,4/37,7.20%,ITPKB;MBOAT1;TPK1;GPHN
prerank,generation of neurons (GO:0048699),0.3146642528002349,1.0361055486824986,0.40993788819875776,0.8297366771209861,1.0,34/190,12.71%,NDNF;TGFB2;RAPGEF2;ADGRL3;SH3RF1;FZD4;NAV1;MEF2C;FGF13;WNT7A;CTNNB1;BTG4;FUT9;INSM1;PIN1;GPM6A;ACSL3;OPHN1;SPOCK1;DNER;DISC1;DDIT4;ATOH7;DCX;CEP85L;LHX5;VXN;IER2;RAC1;LHX9;LHX6;EML1;SOX11;OLIG1
prerank,endodermal cell fate commitment (GO:0001711),0.5056502181220119,1.0347630048996244,0.44507575757575757,0.8324251160778947,1.0,1/10,2.11%,SOX17
prerank,regulation of myoblast differentiation (GO:0045661),0.40564734086353127,1.0344096852781115,0.4273927392739274,0.8326366752883316,1.0,4/32,3.41%,PLCB1;TBX3;MEF2C;NOTCH1
prerank,protein lipidation (GO:0006497),0.35927503093488783,1.0342973285354493,0.39755351681957185,0.8322303177101998,1.0,19/59,21.77%,ZDHHC14;PIGU;ZDHHC9;ZDHHC20;PIGM;PGAP4;PIGF;ZDHHC18;ZDHHC22;PIK3C3;ATG12;DPM3;ZDHHC21;WDR45;ATG7;ZDHHC17;PIGO;PIGV;PIGQ
prerank,visual perception (GO:0007601),-0.29065972662177797,-1.0341476786568982,0.3519736842105263,0.8071202828977949,1.0,9/84,5.12%,COL1A1;SLC4A10;EFEMP1;EYA4;COL18A1;ADGRV1;COL11A1;DHRS3;EML2
prerank,release of sequestered calcium ion into cytosol (GO:0051209),-0.3690837382759454,-1.0335788695507053,0.41919191919191917,0.807613367470216,1.0,6/26,11.45%,ITPR1;PKD2;FGF2;SLC8B1;ITPR2;IBTK
prerank,ATP synthesis coupled proton transport (GO:0015986),0.4608245461459522,1.0331912142345812,0.4298245614035088,0.8342782455798832,1.0,6/17,18.32%,ATP5F1E;ATP5MC2;ATP5PO;ATP5F1A;ATP5MF;ATP5PF
prerank,protein depolymerization (GO:0051261),-0.36021730951585806,-1.0328119805289073,0.38618925831202044,0.8085871462511446,1.0,3/27,1.66%,MICAL3;GSN;MICAL2
prerank,peptidyl-threonine modification (GO:0018210),-0.3009764463672001,-1.0323067154127479,0.3843843843843844,0.8088422298247616,1.0,24/66,25.37%,ROCK2;PRKCD;CAMK2D;TGFBR1;MAP3K12;PDPK1;PRKCA;LRRK2;GALNTL6;GALNT16;WNK1;ACVR1B;DYRK2;CDC42BPG;SBK1;WNK3;CSNK2A1;CDK5;MAP2K1;GALNT1;CDK10;TNKS;CIT;GALNT3
prerank,in utero embryonic development (GO:0001701),-0.36919142634036684,-1.0322201825265314,0.41578947368421054,0.8079506749750123,1.0,8/25,12.42%,FGFR2;ARNT2;PKD1;TGFBR1;IGF2;ZNF568;TGFB3;BMP2
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3563833148149284,-1.031708953872509,0.3975609756097561,0.808304097136788,1.0,6/29,8.55%,SNTA1;KCNIP3;CD63;DLG1;CACNA1D;SLMAP
prerank,regulation of cell development (GO:0060284),-0.3478266860599292,-1.0315062381974105,0.41160949868073876,0.8077796448468698,1.0,5/36,8.26%,NOTCH2;DOCK7;PER2;HEYL;YAP1
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.3419096461126639,1.0310983200983335,0.40226628895184136,0.8388905317083089,1.0,19/88,16.69%,TFRC;DAB2IP;TIRAP;RGCC;FNIP2;VIL1;TAL1;BIK;TGFB1;MMP1;SYK;SH3GLB1;HGS;SDCBP;CDH5;HAS3;MPP7;PDCD6IP;SUMO1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.43851163937063586,1.0306886802059143,0.42439862542955326,0.8392078422386193,1.0,4/21,4.54%,CAV1;CNKSR3;SMAD7;PDE4D
prerank,protein modification by small protein conjugation (GO:0032446),-0.24121925577931017,-1.0306043207507838,0.3157894736842105,0.8092212677693684,1.0,94/361,21.38%,RNF220;PDZRN3;EYA1;RNF152;FBXL7;RNF43;SPSB1;AMFR;ARRB1;ASB2;FBXL17;PIAS1;DTX4;DTX3;SEH1L;TRIM23;FBXO10;HIF3A;CTR9;FBH1;ZSWIM8;ATG10;FBXW8;DTX1;UBE2R2;MGRN1;PRKN;SELENOS;PJA2;UBE2E1;KLHL18;SMURF2;RNF135;FBXO45;UBE2M;NUP205;CUL7;CUL3;BTRC;TRIM63;TRPM4;KLHL13;HUWE1;ARRDC4;WWP2;MYLIP;RNF20;DCUN1D5;RNF181;NFX1;UBE2E3;PIAS2;TRPC4AP;UBA1;SYVN1;USP9X;PAF1;PEX2;FBXW11;DDRGK1;LZTR1;UFC1;SDE2;RRAGA;RNF144A;ATG3;UBE2B;SPSB4;DTX2;UBR2;UBR3;MKRN1;RCHY1;FBXO4;TRAIP;NUB1;CAND1;FBXO9;NSMCE2;MUL1;CDC16;HECW2;UBA6;BRCA1;TRIM17;OTULIN;RNF14;BRAP;RAE1;FBXW5;DCAF15;RNF34;UBA2;KLHL21
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4067694725053427,-1.030195637995365,0.41402714932126694,0.8092273263172212,1.0,3/17,12.09%,LPGAT1;LCLAT1;PLA2G12A
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.49799742572459105,1.0299892899632024,0.4373831775700935,0.8402041168279426,1.0,2/10,3.88%,JAK3;LYN
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.4915230353584933,1.0295763401783409,0.44083969465648853,0.8405470796082584,1.0,3/11,6.44%,CD34;CD200;LGALS9
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.445384750257893,1.0295674841942908,0.42160278745644597,0.8398659667528178,1.0,3/18,8.93%,SHANK3;WNT7A;NRXN1
prerank,negative regulation of developmental growth (GO:0048640),0.4053445158972745,1.0294244466610054,0.42327150084317033,0.839519783002243,1.0,9/30,16.96%,NKD1;FGF13;DIP2B;GDF15;WWC1;MAG;SEMA3G;DCC;WWC2
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.2909767984032324,1.0290821416013738,0.4100877192982456,0.8396574200042962,1.0,85/497,15.26%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;BMPR2;NANOS3;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;ACVRL1;SOX13;CCDC85B;NOTCH1;MEN1;YBX1;HDAC9;HMBOX1;ZBTB16;HHEX;NANOS2;CTNNB1;SOX7;GATAD2A;ENC1;MRPL13;CD38;NANOS1;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;L3MBTL4;KAT6A;JUN;TGFB1;FOXP3;ZBTB14;CIART;DEDD2;HMGA1;KDM4A;ZMYND11;YWHAQ;RPL13A;CNOT9;GRB7;HSPA8;CDC6;PEX14;CTCF;EID2;GSK3A;ZBTB7A;LHX9;TNFRSF4;TLE1;BTG2;RCOR2;TERF1;PPARG;ZBTB33;POU2F1;SOX9;PAIP2;HMGB2;NR3C1;ID3;CIC;CTBP1;RIOX1;HDAC5;YAF2;RNF139;IKZF1;LOXL2
prerank,Fc receptor signaling pathway (GO:0038093),0.32970755759407044,1.029035506650797,0.41215323645970936,0.8390697260359169,1.0,37/110,21.88%,MAP3K1;LYN;PLCG1;IKBKB;CALM1;GRB2;SOS1;MAPK3;PSMB3;JUN;PSMD11;PSMC6;MALT1;PAK1;PSME2;PSMD8;PPP3CA;RAC1;SYK;PPP3R1;PIK3CB;PSMB10;BCL10;LCP2;CARD11;PSMA8;MAPK1;LAT2;PAK2;SKP1;PSMD9;PLCG2;MAP2K7;VAV1;CUL1;PSMC3;PSMD1
prerank,regulation of organelle organization (GO:0033043),0.3460820499799254,1.0288315588246384,0.4123422159887798,0.8388541820252061,1.0,13/80,11.08%,TJP1;PDE2A;F11R;PTK2;USP6NL;MAPK3;STMN3;ARHGEF5;MSN;CLIC4;AKAP9;PDCD10;S100A8
prerank,respiratory electron transport chain (GO:0022904),0.4700039964530986,1.0287141421333723,0.4300884955752212,0.8384310841905535,1.0,3/14,9.79%,GPD2;ETFRF1;ETFB
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.41829264685652584,-1.0283930562537262,0.4205607476635514,0.812940619896467,1.0,7/15,25.22%,SELENOS;HSP90B1;SYVN1;AUP1;SEC61B;DERL1;UFD1
prerank,skeletal muscle tissue development (GO:0007519),0.4046439064460736,1.0282605845357273,0.4228187919463087,0.8388913824955186,1.0,6/32,12.12%,CAV1;MEF2C;FOXL2;MYH14;CAV2;CSRP3
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.4352214386033389,1.0280339634621976,0.42479338842975206,0.838746000310831,1.0,7/23,11.82%,PDGFB;INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.45095502966284984,1.0278120358257823,0.4297945205479452,0.838575466099903,1.0,7/18,18.54%,CCT3;CCT5;DCP2;NHP2;CCT7;NAF1;EXOSC10
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.36860852678385986,-1.0276176496230929,0.4182692307692308,0.8139686482426102,1.0,8/27,9.88%,PID1;ENPP1;IRS1;KANK1;PRKCD;GRB10;TNS2;PIP4K2C
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4425482225929837,-1.0274837076068197,0.4307692307692308,0.8131919786924233,1.0,5/12,18.64%,DAB2;HEYL;PIAS2;SFRP1;NCOR1
prerank,regulation of response to biotic stimulus (GO:0002831),0.41382789572583845,1.027403816073503,0.4175084175084175,0.8388704054427728,1.0,7/28,10.45%,TIRAP;LRP8;SAMHD1;XIAP;N4BP1;BIRC3;CASP8
prerank,acute-phase response (GO:0006953),0.4896347541855342,1.0270960952470882,0.4419889502762431,0.8389620304444817,1.0,2/12,3.44%,IL6R;SIGIRR
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.34525273044346066,-1.027063963233918,0.3882978723404255,0.8131926093257181,1.0,5/32,8.01%,PRKAG2;ZBTB20;PRKAA2;PPARA;APOE
prerank,cellular calcium ion homeostasis (GO:0006874),-0.2697110040671807,-1.0269588745521292,0.3805668016194332,0.8123685553139596,1.0,24/133,12.41%,SLC24A3;ANK2;ATP13A5;MCU;STIM1;SLC8A3;DMPK;ATP13A3;CAMK2D;TRPC3;SLC35G1;ANXA6;SLC8B1;SLC8A1;BCL2;PTH1R;TRPC6;PML;PRKACA;CLN3;SLC24A5;AFG3L2;TRPC4;PSEN1
prerank,motor neuron axon guidance (GO:0008045),0.4558234060568402,1.026912586304134,0.44525547445255476,0.8387258805908021,1.0,4/15,11.43%,NTN1;TMEFF1;EPHA4;RAC1
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),-0.2722599545555879,-1.0262097596772222,0.38288288288288286,0.8133532652349795,1.0,26/138,12.24%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;TEAD3;POLR2A;NR3C2;YAP1;CCNH;NR2F1;RXRA;TAF8;CDK7;ESR1;PGR
prerank,regulation of cytokinesis (GO:0032465),0.35000772885332077,1.0254037877276665,0.4269005847953216,0.8418378584370034,1.0,20/78,16.46%,BCL2L1;CALM1;CDC14A;CCP110;PKN2;RAB11A;PKP4;PIN1;CETN2;RAB11FIP4;PIK3C3;CDC6;KIF23;MAP10;SH3GLB1;GIT1;PLK2;RXFP3;PRPF40A;SPAST
prerank,positive regulation of organelle assembly (GO:1902117),0.38002018341634813,1.0252234361107035,0.43914473684210525,0.841542384636175,1.0,16/44,17.99%,CNOT6L;CCDC88A;CCP110;RALB;MARK4;CAPG;SH3GLB1;PIP4K2A;CNOT6;SDCBP;FSCN1;G3BP1;SPAG5;PDCD6IP;IL5;KCTD17
prerank,positive regulation of cell death (GO:0010942),0.3594038955997046,1.0252047578868821,0.43833580980683506,0.8408776419059073,1.0,8/59,11.29%,SLC6A6;ACER2;RAMP3;FYN;MARK4;DDIT4;AXIN2;GRIN2B
prerank,negative regulation of cell population proliferation (GO:0008285),0.2936571748905812,1.0251587665765765,0.40315315315315314,0.8402956374847521,1.0,43/351,9.22%,ETS1;AQP11;DAB2IP;BMPR2;TGFB2;NOS3;RAPGEF2;SH3BP4;APP;SLC16A2;DDAH1;MCC;ITGA1;CD200;TBX3;CTNNBIP1;B2M;ADGRG1;PTPRJ;RGCC;MTSS1;SMARCA2;ACVRL1;NOTCH1;MEN1;LYN;CTNNB1;GATA2;SOX7;DLL4;IGFBP7;BTG4;ST18;KLF4;CDKN2B;INSM1;TGFB1;TMEM115;FOXP3;ADAMTS8;GREM1;HMGA1;PAK1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4410736318272946,-1.0245842174264597,0.4658385093167702,0.816809295980752,1.0,6/12,22.38%,CLN3;LRRK2;GRN;CLN6;ATP6AP2;TMEM9
prerank,protein stabilization (GO:0050821),-0.2617798048985832,-1.0244935973488642,0.3867924528301887,0.8159320304022375,1.0,45/168,18.79%,ANK2;IGF1;PARVA;PLPP3;LAMP2;PER3;RASSF2;PRKCD;PPARGC1A;MDM4;FLOT2;ATP1B3;RAB21;STXBP4;AAK1;FLNA;ATP1B2;PRKN;TNIP2;PFN2;USP2;BAG1;CCNH;CDK7;SEC16A;SYVN1;P3H1;NCLN;PTEN;BAG3;OTUD3;USP9X;MORC3;PIK3R1;EP300;UBE2B;CCT2;CRYAB;GRN;TAF9B;GET1;ATF7IP;CCT6A;USP19;MUL1
prerank,regulation of lamellipodium assembly (GO:0010591),0.39106442717057555,1.0243318371851624,0.4551386623164764,0.8416873044681971,1.0,9/34,11.43%,OCLN;WASF2;NCKAP1;TWF2;CYFIP1;CLRN1;ABI3;PLXNB3;RAC1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.438076542347466,-1.0243228948456644,0.42342342342342343,0.8153561201154397,1.0,8/12,36.45%,BCL2;KDM1A;CD44;TAF9B;TAF9;SIRT1;MUC1;CD74
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.4970069746324305,1.0243136349942505,0.43253234750462105,0.8410476215362102,1.0,4/11,19.12%,STMN1;PAK1;RAC1;NRP1
prerank,protein processing (GO:0016485),-0.2831646675021635,-1.0243048754735524,0.35918367346938773,0.8143087830732083,1.0,27/102,20.74%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;CTSL;ADAM19;CPXM1;KLK2;CPXM2;FXN;CLN3;AFG3L2;PSEN1;CTSH;HTRA2;SDE2;HM13;ZMPSTE24;PRSS12;PARL;CASP4;PCSK6;PTCH1;EEF1AKMT4-ECE2;XPNPEP3
prerank,brain development (GO:0007420),0.3204615737747645,1.0240346906532238,0.4204993429697766,0.8410226633865193,1.0,23/136,13.19%,MFSD2A;SHANK3;ADGRL2;SHROOM4;RAPGEF2;ADGRL3;ADGRG1;NES;CDH2;DSCAML1;AATK;COL4A1;DHX37;CDK5RAP2;TBC1D23;DDIT4;AGTR2;GRIN2B;UFM1;UTP3;TGFBR2;EML1;CNTNAP2
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.45287391905462104,1.0240178765458092,0.44858156028368795,0.8403711704242735,1.0,2/19,1.99%,CSGALNACT1;EXTL3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.4793232969551742,1.0239504560473156,0.43622920517560076,0.8398330609150257,1.0,4/13,13.39%,TBX3;NOTCH1;TGFB1;SOX9
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4825477797040657,1.0234229732959645,0.44652908067542213,0.8404950019222672,1.0,1/12,1.71%,IL1R1
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.28320957541007336,1.0232270952715037,0.40224032586558045,0.8403132814328736,1.0,96/834,8.89%,LEF1;ETS1;ITGA6;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;BMPR2;TGFB2;LMO7;NOTCH4;MRTFB;APP;ZIC3;TBX1;PPARD;MRTFA;NFKBIA;SOX17;TBX3;KLF7;AGRN;ARHGEF2;RGCC;MEF2C;MOSPD1;NCOA1;SMARCA2;PLXND1;FOXO1;CD40;RPS6KA1;ACVRL1;ZFPM1;NOD2;PRKD1;NOTCH1;PRKD2;MEN1;YBX1;NLRC5;KLF2;MYO6;PRDM2;IRF2;ASXL3;WNT7A;IKBKB;SMAD7;HHEX;FOXF1;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;SPAG8;WWTR1;HYAL2;TAL1;ST18;TLR3;CRTC1;MAML2;MAPK3;RPS6KA5;KLF4;TOX3;NKX2-8;CDKN2B;STAT1;MAX;NR1H2;IRF5;NCOA2;SOX18;PHOX2A;NFIC;SOX12;HINFP;KAT6A;JUN;PIN1;TGFB1;ATF6B;TCF12;KLF6;FOXP3;ELK4;LRP5;NFATC2IP;GREM1
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3407629795594172,-1.0228350700376705,0.4132231404958678,0.8171696668694707,1.0,5/41,6.15%,ANK2;ACTN2;KCNMB2;KCNJ2;FLNA
prerank,positive regulation of myoblast differentiation (GO:0045663),0.4531914925403613,1.0227607362234288,0.44912280701754387,0.840799004605918,1.0,2/16,2.75%,PLCB1;MEF2C
prerank,amyloid precursor protein catabolic process (GO:0042987),0.4742822696833544,1.0226507959764775,0.4543859649122807,0.8403667342491676,1.0,5/14,11.18%,ABCG1;ADAM10;ABCA7;ADAM17;APH1A
prerank,protein transport (GO:0015031),0.2947405969361509,1.0224713673150982,0.4083710407239819,0.8401121205240489,1.0,46/332,11.61%,TFRC;TBC1D4;SPTBN1;MACF1;STX3;RAB31;TBC1D14;ARHGEF2;STX1A;TBC1D22A;RAMP2;TBC1D12;ATP6V0A1;CALCRL;SNX13;MYO6;ABCG1;MCOLN1;TBC1D2;ARF5;RAMP3;USP6NL;CMTM6;TBC1D5;REP15;LRP1B;SLC10A7;STXBP1;DNM2;ARL4A;SCAMP1;RAB34;CHMP1B;YWHAH;RAB3B;KIF3B;ARL6IP5;LRP2;TBC1D10B;ACD;AMN;PPY;STX19;PRKCB;MTTP;TBC1D30
prerank,sensory perception of mechanical stimulus (GO:0050954),0.34018119561039695,1.021988609534007,0.43447293447293445,0.8406827063077542,1.0,19/85,10.83%,CLIC5;USP53;TBX1;GRAP;HOMER2;PCDH15;CDC14A;KCNQ1;EPS8L2;SNAI2;LHFPL3;MARVELD2;POU3F4;MYH14;TIMM13;SLC52A3;TIMM10;CLRN1;LRP2
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.4003202267965695,1.0218852430361205,0.43094841930116473,0.8402774302857473,1.0,9/34,12.43%,PTPRB;PTPRJ;DUSP7;PTPN12;DUSP3;ACP4;DUSP1;PTPRQ;DUSP16
prerank,cellular protein-containing complex assembly (GO:0034622),0.314376403859272,1.021859689879068,0.424812030075188,0.8396471911409394,1.0,39/160,19.02%,HIP1;HIP1R;TIAM1;STXBP6;PXN;POMP;HSP90AB1;RPL38;EIF4H;STXBP1;FCHO2;PSMD11;DRC1;AP2M1;TGFB1;PIK3C2A;SMAD1;SAMM50;DNAAF2;EID2;EPS15;GTF2B;HIGD1A;CSNK2B;BBS10;ANLN;OMA1;DNAAF3;IMMP2L;NCK1;TESPA1;TBCEL;POGZ;TTC12;BIN1;NUP153;CHCHD4;GPX4;FKBP1A
prerank,cellular response to nutrient levels (GO:0031669),0.3591286674820349,1.0217898190623473,0.42199108469539376,0.8391361172059271,1.0,16/62,17.67%,MFSD2A;BMPR2;FOXO1;RIPOR1;FAM107A;CDKN2B;RALB;MAP1LC3B;HSPA8;RPTOR;TFEB;STK24;STK26;ATG14;MAP1LC3A;WDR45
prerank,protein insertion into membrane (GO:0051205),0.3981706085047557,1.0210638306560955,0.43450479233226835,0.8402234772637349,1.0,5/32,8.56%,APP;REEP1;STX1A;GRIN3B;RTP4
prerank,positive regulation of immune response (GO:0050778),0.35131429131917935,1.02102143826368,0.42142857142857143,0.8396413432605149,1.0,8/64,12.67%,TGFB2;NOD2;GBP5;CCR7;LGALS9;EIF2AK4;TLR8;IL15
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3748107898304263,-1.0204665958531078,0.42482100238663484,0.8229071282503945,1.0,10/22,12.11%,NTRK3;PDGFRB;PDGFRA;FGFR2;KIT;FGF2;AGTR1;PDPK1;ARL1;ESR1
prerank,cellular response to gamma radiation (GO:0071480),-0.4125534138218662,-1.020448097931016,0.4279379157427938,0.8218499255400279,1.0,7/17,23.64%,ATM;YAP1;KDM1A;XRCC5;CRYAB;WRN;ATR
prerank,monocarboxylic acid biosynthetic process (GO:0072330),-0.3105116768840801,-1.0200763771399008,0.4177215189873418,0.8218008333822783,1.0,6/59,5.81%,ALDH1A2;CYP7B1;ABCD3;CYP27A1;PER2;ACOT8
prerank,diacylglycerol metabolic process (GO:0046339),0.4175817403767986,1.0197784064468283,0.43686006825938567,0.842054270040179,1.0,7/23,16.94%,DGKH;LIPE;DGKI;DGKE;DGKZ;MOGAT2;DGAT1
prerank,response to prostaglandin E (GO:0034695),-0.45956667578467303,-1.0197050533532783,0.4391304347826087,0.8217439986981712,1.0,1/10,0.41%,TGFBR3
prerank,regulation of membrane depolarization (GO:0003254),-0.38752246978611204,-1.0195433859865666,0.42824074074074076,0.8211067321512496,1.0,5/18,11.80%,FHL1;PTPN3;CAMK2D;LRRK2;GPD1L
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.407101262089666,1.0192534838446052,0.4416,0.8426448692045158,1.0,9/29,14.07%,CAV1;TNFSF10;HYAL2;RET;DEDD2;AGTR2;TNFSF12;CYLD;BCL10
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.47910308564394305,1.018991005710495,0.4473684210526316,0.8426255587139583,1.0,4/12,12.84%,NFKBIA;ABCG1;NR1H2;PPARG
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.4698287415119272,1.018904005527433,0.4666666666666667,0.8421476694557307,1.0,6/14,17.33%,DUSP1;PPP3CA;PPP1R15B;PPP2R2C;NCK1;PPM1F
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3519257741494104,1.018458179131748,0.442090395480226,0.8425440211022641,1.0,10/74,6.64%,ITGA6;BCL2L1;NOS3;FAS;SH3RF1;TNFSF10;ARHGEF2;SNAI2;RFFL;MCL1
prerank,regulation of vacuole organization (GO:0044088),0.4279372781569651,1.0183431052763605,0.4420289855072464,0.8421314429005969,1.0,3/20,4.82%,TBC1D14;TBC1D12;PIKFYVE
prerank,water-soluble vitamin metabolic process (GO:0006767),0.344806756181278,1.0181491395029918,0.43503649635036495,0.8419325917879024,1.0,11/68,11.50%,SLC2A1;SLC19A3;ABCD4;TPK1;SLC52A2;SLC25A32;SHMT2;PDXK;SLC52A3;AMN;MMAA
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.4937048233084229,1.0180853810185668,0.4653846153846154,0.8413941162501185,1.0,1/10,0.34%,CSGALNACT1
prerank,establishment of melanosome localization (GO:0032401),-0.38866257201708043,-1.0178237549586884,0.4168618266978923,0.8247209162126662,1.0,14/19,40.56%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.34655118701612236,1.0174678258618797,0.4152046783625731,0.8422316935056168,1.0,10/70,11.35%,LMO2;GATA2;TAL1;PSMB3;PSMD11;TCF12;PSMC6;PSME2;CBFB;PSMD8
prerank,positive regulation of receptor internalization (GO:0002092),-0.3796963248167312,-1.017340696800314,0.4362745098039216,0.8250263972949167,1.0,5/22,6.33%,ANGPT1;MAGI2;ARRB1;CD63;SFRP4
prerank,neuronal action potential (GO:0019228),-0.37607872422384225,-1.0172920004571506,0.4079601990049751,0.8240857727161954,1.0,3/22,4.91%,SCN7A;KCNMB2;CACNA1G
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.37723742274711947,-1.0172251901958733,0.44933920704845814,0.8231880614556449,1.0,3/22,3.06%,CACNA1C;STIM1;ADGRV1
prerank,muscle tissue development (GO:0060537),0.4673639601293189,1.0172246638766085,0.4632352941176471,0.8421345705560801,1.0,4/13,12.12%,ENG;PGM5;STRA6;CSRP3
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.29352871171676914,-1.0167734318318764,0.40878378378378377,0.8233576647293699,1.0,19/76,20.93%,LPAR1;PLCE1;ACTN2;ADRA1B;ANO1;PTH1R;AGTR1;ESR1;LPAR4;CMKLR1;GNA14;CHRM2;GPR157;OPRK1;HTR2C;CCKBR;ADRA2A;HRH1;C3AR1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.42477597738313955,1.0165173162961199,0.4423076923076923,0.8432014765078963,1.0,4/21,10.01%,MBOAT1;PLA2G4B;OSBPL10;LPCAT3
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3417246310495783,1.0165133171666192,0.43333333333333335,0.8425255505444532,1.0,16/74,12.34%,LEF1;DAB2IP;TGFB2;RGCC;TIAM1;SMAD7;CTNNB1;WWTR1;IL17RD;EFNA1;TGFB1;GREM1;AXIN2;FERMT2;ADIPOR1;TGFBR2
prerank,stem cell differentiation (GO:0048863),-0.32923199833916394,-1.0153917054116328,0.45507246376811594,0.8260725001000545,1.0,17/39,21.50%,FGFR2;OSR1;HOXB4;KIT;FBXL17;ACE;MLLT3;LMBR1L;LRP6;SFRP1;PAX2;BATF;PTPRC;SP7;EEF1AKMT4-ECE2;SETD2;SETD6
prerank,calcium ion homeostasis (GO:0055074),0.33366336935645097,1.0153647212486363,0.4141689373297003,0.84481237787701,1.0,11/95,7.55%,TMTC2;CXCL12;CAV1;SLC30A1;CD40;ATP2C1;SLC24A2;SLC24A4;ATP2B1;SLC10A7;HTR2A
prerank,response to cadmium ion (GO:0046686),0.4211482440502613,1.0152245075834454,0.46504065040650405,0.8444696095006042,1.0,12/26,16.69%,MAPK3;JUN;MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;MAPK1;SUMO1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.3671323366905943,-1.0152224676266095,0.43552311435523117,0.8254704662633279,1.0,10/25,16.89%,AMPD3;PAICS;MTHFD1;PRPS2;GMPR2;PRPSAP1;GMPS;DGUOK;PRPSAP2;ADSL
prerank,cellular response to tumor necrosis factor (GO:0071356),0.31107779746881137,1.0152109733121988,0.4257178526841448,0.8438139896271937,1.0,27/175,12.55%,DAB2IP;NFKBIA;TNFRSF25;TNFRSF11A;ARHGEF2;CD40;TMSB4X;IKBKB;TNFRSF21;HYAL2;ST18;ACTN4;AIM2;STAT1;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;ADAM17;EIF5A;CCL1;PSMD8;TNFSF11;TNFRSF4;TNFSF12;ZFP36L1
prerank,nucleocytoplasmic transport (GO:0006913),0.38412732590049276,1.014700212141063,0.4528301886792453,0.8443907304554736,1.0,22/40,31.73%,BACH2;SNRPF;NXT1;MALT1;SNRPE;RITA1;NCBP2;SNRPB;RSRC1;SNRPD2;NCBP1;NXT2;DDX20;SNRPD1;SMN1;NUTF2;HNRNPA1;GEMIN5;ANP32A;HTATIP2;SNRPG;SNRPD3
prerank,cellular response to nerve growth factor stimulus (GO:1990090),-0.374195028352234,-1.0146316698782971,0.44221105527638194,0.8260603998179652,1.0,5/22,10.43%,NTRK3;MAGI2;NGF;ACAP2;EHD1
prerank,regulation of cilium assembly (GO:1902017),0.35281174668565624,1.0145936508283815,0.4402420574886536,0.8439606713320125,1.0,19/62,17.99%,TBC1D14;TBC1D22A;TBC1D2;USP6NL;TBC1D24;CCDC88A;LIMK2;TBC1D5;CCP110;MARK4;ODF2L;TBC1D10B;TBC1D30;CYLD;TBC1D1;TBC1D22B;TBC1D15;IFT140;KCTD17
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.3950191874232918,-1.0144901990633457,0.4447058823529412,0.8232034779643679,1.0,13/20,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.3950191874232918,-1.0144901990633457,0.4447058823529412,0.8232034779643679,1.0,13/20,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.3950191874232918,-1.0144901990633457,0.4447058823529412,0.8232034779643679,1.0,13/20,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,positive regulation of RNA splicing (GO:0033120),0.40282217453573954,1.014122828326109,0.4397993311036789,0.8444676115062341,1.0,1/29,0.46%,RBM20
prerank,cellular response to organonitrogen compound (GO:0071417),0.3310581445161513,1.0139999025650492,0.4351851851851852,0.844093794522867,1.0,27/99,18.57%,PDE2A;RAPGEF2;SH3BP4;MEF2C;RAPGEF1;RAPGEF3;ACTB;CTNNB1;KCNQ1;RAP1B;GABRB1;P2RX7;AKAP9;LAMTOR5;RPTOR;ZFP36L1;NSMF;HCN2;SOX9;AKAP6;SSH1;LAMTOR4;CRHBP;CAPN2;SLC26A3;CIB2;GABRB2
prerank,RNA metabolic process (GO:0016070),-0.2731922423724584,-1.013959773604494,0.4298245614035088,0.8235998075275137,1.0,43/127,28.91%,CELF2;RBMS1;HNRNPH1;HNRNPUL1;POLR2A;PABPN1;AGO2;RBM39;NOVA1;BICD1;DDX17;HNRNPH2;RBM5;RNASE4;ALKBH1;HNRNPR;TENT2;DDX3X;SIDT2;LAGE3;HNRNPA2B1;PABPC4;GTF2F1;DDX39B;PCBP2;FASTKD1;TP53RK;PAPOLG;FASTKD2;TBRG4;POLR2L;PARN;THOC1;DROSHA;LSM8;POLR2I;HNRNPD;RNASEH2B;ATXN1;TFIP11;SYNCRIP;POLR2K;DHX36
prerank,negative regulation of cellular component movement (GO:0051271),0.45849428168230183,1.0135615383465946,0.4547038327526132,0.844505839413317,1.0,4/15,8.04%,FRMD5;SP100;ACTN1;PIN1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3932394535094814,-1.013389838779474,0.43559718969555034,0.8240968620827975,1.0,6/18,16.02%,SMAD3;PDPN;EMILIN1;EFEMP2;BMP2;RUNX1
prerank,cellular response to hormone stimulus (GO:0032870),0.34762508208181087,1.0131997717225796,0.45269286754002913,0.8447792367224846,1.0,14/69,9.46%,LMO2;CAV1;MEF2C;NCOA1;RAMP2;SOCS2;RAMP3;CYP11B1;CYP11A1;ATP1A1;ATP1A3;NCOA2;TRIM24;NCOA4
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4216720594055549,-1.0129269384618869,0.44547563805104406,0.8242980048600396,1.0,5/14,19.35%,DMD;WNK4;SLC9A1;WNK1;WNK3
prerank,pore complex assembly (GO:0046931),-0.38836405592669515,-1.0128083211165098,0.4369158878504673,0.8235324447004626,1.0,6/19,14.42%,ANO6;PLEKHA7;AFDN;NUP205;TMEM170A;GSDMD
prerank,sprouting angiogenesis (GO:0002040),0.3597462899086461,1.01250666326681,0.43612334801762115,0.8458565815923841,1.0,7/51,3.52%,TEK;KDR;ENG;FLT4;PIK3R3;ACVRL1;RAMP2
prerank,epithelial cell development (GO:0002064),-0.38811283583224,-1.012415391396743,0.45476190476190476,0.8235618607519968,1.0,7/20,19.71%,WNT5B;SLC4A7;ACTA2;DACT2;RILPL2;PDZD7;BFSP1
prerank,mRNA methylation (GO:0080009),0.4505018648660126,1.0124140428068211,0.464471403812825,0.8453931834035038,1.0,7/15,23.95%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.35559746890743604,-1.0122698766980796,0.45036319612590797,0.8228812770810594,1.0,8/26,10.27%,ROCK2;ASAP3;ALMS1;SYNPO;PRKN;FHOD1;PFN2;SLC9A1
prerank,nuclear envelope organization (GO:0006998),-0.3806362286364092,-1.0122208635265115,0.43825665859564167,0.8219362769373421,1.0,9/20,26.03%,DMPK;TMEM170A;TOR1AIP1;EMD;SUN2;VPS4A;TMEM43;LEMD2;NUP155
prerank,cochlea morphogenesis (GO:0090103),0.5012447485328686,1.0119561439291622,0.45778611632270166,0.8457841235320445,1.0,3/10,13.39%,TBX1;POU3F4;SOX9
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.42594943727474943,1.0117403998057783,0.4540727902946274,0.8456096287112712,1.0,2/21,2.89%,CSGALNACT1;CHST11
prerank,T cell differentiation in thymus (GO:0033077),-0.42006958675533934,-1.011245787444727,0.4311111111111111,0.8234988319762979,1.0,1/14,0.65%,GLI3
prerank,female gamete generation (GO:0007292),0.395683303774978,1.0111367262360553,0.42833333333333334,0.8464567788679331,1.0,5/29,8.49%,NANOS3;NANOS2;NANOS1;PRDM9;PTN
prerank,positive regulation of protein transport (GO:0051222),0.35103653607424734,1.0111270787620121,0.4446064139941691,0.8457977529537488,1.0,12/67,8.24%,TGFB2;PRR5L;UNC13B;CD2AP;ATP2C1;RIPOR1;ABCG1;PPIA;OAZ1;ARHGEF5;TGFB1;ACSL3
prerank,regulation of microtubule nucleation (GO:0010968),0.4956401536267225,1.0109057853605214,0.44320297951582865,0.8456528948293224,1.0,6/10,19.94%,ARHGEF7;PAK1;GIT1;CKAP5;DCTN1;MECP2
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.3318729641086605,-1.0108735153047763,0.42896174863387976,0.8235409030204871,1.0,5/39,6.29%,MCU;NLGN2;RBP4;IRS2;NNAT
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.2908938973351389,-1.010694643475485,0.428125,0.8229441980663418,1.0,10/72,10.29%,FGFR2;FGF1;FRS2;KL;FGF2;HNRNPH1;POLR2A;FLRT1;SPRED1;FGFBP1
prerank,male meiosis I (GO:0007141),-0.4069168549995263,-1.0106727691163904,0.47453703703703703,0.8219340032569936,1.0,7/16,28.68%,FOXJ2;FOXJ3;ZSCAN21;HSF2BP;MYBL1;TDRD9;DDX4
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.3878668167592144,-1.0106367054740637,0.4473684210526316,0.8209633017531675,1.0,13/21,33.32%,KLHL22;ATM;ZWINT;MAD2L1;TTK;CENPF;TEX14;KNTC1;TPR;PLK1;CDC20;BUB1;TRIP13
prerank,positive regulation of T cell cytokine production (GO:0002726),0.43762407921524754,1.0102324634994164,0.4587628865979381,0.8466464296564219,1.0,4/20,10.81%,IL1R1;B2M;MALT1;DENND1B
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4044812428470408,-1.0100441539448841,0.4229828850855746,0.821494783980976,1.0,10/17,34.63%,CPEB1;CTR9;RNF20;NELFE;ZC3H3;CDK9;RNF40;ZC3H14;VIRMA;HSF1
prerank,cellular response to metal ion (GO:0071248),-0.27079657008764757,-1.0097937530898322,0.40711462450592883,0.8210864326813785,1.0,16/123,8.33%,BMP6;EGFR;PRKAA2;SLC41A1;ADCY1;ADGRV1;SLC12A2;CDH1;CAMK2D;PKD2;ADCY7;DLG4;P2RX4;PRKN;SYT9;SLC25A24
prerank,acetyl-CoA metabolic process (GO:0006084),0.45688461742215963,1.009682143534184,0.4225865209471767,0.8473425103436888,1.0,6/15,22.50%,HMGCS2;DIP2A;ACACB;ACAT1;HMGCS1;ACLY
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.40946943482433007,1.0091997894615432,0.4358108108108108,0.8478309437051348,1.0,6/26,12.23%,PLCB1;RGCC;CCND3;ADAM17;CDC6;RPTOR
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.3056500451117646,1.0090476966615138,0.4425806451612903,0.8475360144670875,1.0,48/172,21.29%,MFSD2A;PIK3R6;DGKH;INPP5D;PIK3R3;PLA2G4B;SLC44A5;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;CDS2;DGKE;CHKA;MTMR6;SELENOI;PIK3C3;LPCAT3;PIK3C2A;RAB4A;PIP4K2A;DGKZ;PIK3CB;CEPT1;CPNE6;CSNK2B;LPIN3;MTMR12;CDIPT;MTMR2;PIK3R5;PLEKHA3;SYNJ1;CPNE3;ETNPPL;INPP5E;INPPL1;CPNE1;PIP5K1B;MTMR1;PGS1;PLCG2;ETNK1;MBOAT7;PISD;INPP5K;LPCAT2
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.4065950862134288,-1.0087180632122579,0.45348837209302323,0.8228905303358204,1.0,2/16,8.01%,LRP1;APOE
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3338909331385464,1.0083048390168219,0.4476584022038568,0.8487068153877991,1.0,20/91,16.87%,HIP1;FES;HIP1R;SCARB1;DNAJC13;SYT7;INPP5F;MAPK3;HCK;RAB11A;OPHN1;RAB3B;RAB4A;SYK;LGI3;CPLX1;RNF139;MAPK1;RIMS2;RALA
prerank,axonal fasciculation (GO:0007413),-0.4486482171231325,-1.0082747988807823,0.4645030425963489,0.8229810730323022,1.0,2/12,7.23%,EPHA3;EPHB2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.4721803185958277,1.0080225368377103,0.4489051094890511,0.8486879926838136,1.0,1/13,0.77%,NAMPT
prerank,axon development (GO:0061564),0.34167968520774483,1.0077416428346853,0.44541484716157204,0.8487047234945377,1.0,21/78,20.80%,APP;KLF7;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;BAIAP2;SLITRK3;SLITRK1;ZPR1;GRM7;DCC;PLPPR4;NRCAM;ANK3;CTNNA2;CAMSAP2;RAB8A;ZDHHC17;BRSK2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.3278444431107756,-1.006912496293644,0.4463276836158192,0.825609320445344,1.0,5/41,9.42%,PRKAG2;OGT;SEH1L;LACC1;NUP205
prerank,regulation of protein localization to cell periphery (GO:1904375),0.45080610373114194,1.0068284677800394,0.47282608695652173,0.8503751807606487,1.0,2/18,3.87%,SPTBN1;ACTB
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.35812444883772204,1.0066515343689066,0.4421052631578947,0.8501366306628486,1.0,13/52,18.88%,PPP1R13B;PPP3CC;FBXW7;YWHAH;YWHAQ;CASP8;GSK3A;SH3GLB1;PPP3R1;UBE2D3;YWHAZ;YWHAB;TOMM7
prerank,negative regulation of endopeptidase activity (GO:0010951),0.37212509253076526,1.0061140253202658,0.44875776397515527,0.8507763736877427,1.0,6/47,9.50%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;SPOCK1;SERPINI1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.43294276422053657,1.0060193052611324,0.44964028776978415,0.8503318589570134,1.0,3/18,6.71%,IL6R;ST18;STAT1
prerank,negative regulation of catalytic activity (GO:0043086),0.41037365475644483,1.0059658821387447,0.4689075630252101,0.8497931611584781,1.0,2/24,3.41%,NES;NOTCH1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),0.41379602197978105,1.005918834536538,0.45797598627787306,0.8492368377607257,1.0,2/26,0.95%,OCLN;INSR
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.45907299402816937,1.0051640503271884,0.45886654478976235,0.850408370975738,1.0,4/14,7.37%,RGCC;CD40;PLCG1;CD160
prerank,negative regulation of osteoblast differentiation (GO:0045668),-0.34859356350258786,-1.004995809650871,0.4625322997416021,0.8297927358536002,1.0,10/31,13.13%,RANBP3L;CRIM1;SMAD6;SUFU;TMEM64;TWIST2;TRPM4;CHRD;SKI;TWIST1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3302004917931126,1.0048540008279012,0.4542974079126876,0.8505078671052879,1.0,21/87,11.99%,ESAM;RHOBTB1;HIP1R;F11R;CORO2B;RAPGEF3;EPS8;RHOB;CCDC88A;BAIAP2;FAM107A;BST2;ARHGEF5;TWF2;IQGAP1;PAK1;ARHGDIA;ARHGAP17;ABI3;RAC1;RND1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.42365519544933977,-1.0044494207976218,0.46258503401360546,0.830178986575459,1.0,5/13,22.65%,SLC4A10;CLN3;SYP;SHISA7;PPFIA3
prerank,response to acidic pH (GO:0010447),-0.42828255853388586,-1.0044319319890331,0.4421768707482993,0.8291573329347244,1.0,3/13,15.75%,IMPACT;SLC9A1;RAB11B
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.28663185808845926,1.0044124539113364,0.4866962305986696,0.850948686872079,1.0,69/417,15.46%,LEF1;MECOM;PLCB1;DACH1;PDGFB;ELK3;DAB2IP;ZHX3;PPARD;TBX3;ID1;SMARCA2;FOXO1;FOXL2;SOX13;CCDC85B;NOTCH1;MEN1;HDAC9;HMBOX1;ZBTB16;HHEX;CTNNB1;SOX7;GATAD2A;CD38;RPS6KA5;KLF4;PHC1;NR1H2;SOX18;YEATS2;HINFP;L3MBTL4;KAT6A;JUN;TGFB1;FOXP3;ZBTB14;CIART;DEDD2;HMGA1;KDM4A;ZMYND11;YWHAQ;HSPA8;PEX14;CTCF;EID2;ZBTB7A;LHX9;TNFRSF4;TLE1;RCOR2;PPARG;ZBTB33;POU2F1;SOX9;HMGB2;NR3C1;ID3;CIC;CTBP1;RIOX1;HDAC5;YAF2;IKZF1;LOXL2;ARID4A
prerank,pigment granule transport (GO:0051904),-0.38950690125611165,-1.00381622893805,0.4387990762124711,0.8286532143785286,1.0,14/18,40.56%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,melanosome transport (GO:0032402),-0.38950690125611165,-1.00381622893805,0.4387990762124711,0.8286532143785286,1.0,14/18,40.56%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;BLOC1S3;RAB27B
prerank,translational elongation (GO:0006414),0.3270655442407775,1.0034957450066984,0.44246575342465755,0.8525381937232521,1.0,45/101,28.71%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GTPBP1;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;EEFSEC;MRPL19;EEF1D;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;RACK1;GTPBP2;EEF1B2;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C;EEF1G;MRPL15;MRPS34;MRPS12
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.4261075610207038,1.0031119795686685,0.45595854922279794,0.8527830312707861,1.0,3/21,5.68%,CAV1;CTNNB1;FRAT2
prerank,vascular process in circulatory system (GO:0003018),-0.41630802376643616,-1.002870939555036,0.4721030042918455,0.8290643722361629,1.0,8/13,15.39%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,regulation of tube diameter (GO:0035296),-0.41630802376643616,-1.002870939555036,0.4721030042918455,0.8290643722361629,1.0,8/13,15.39%,ROCK2;SCPEP1;ACE;AGTR1;ITGB1BP1;ADCY6;GCLC;ACE2
prerank,regulation of protein sumoylation (GO:0033233),-0.3998543100613361,-1.0028416010484458,0.4518348623853211,0.828075663817654,1.0,8/17,26.67%,HDAC4;PIAS1;MUL1;UBA2;ZMIZ1;RWDD3;EGR1;GNL3L
prerank,histone H3-K9 demethylation (GO:0033169),-0.44572141072737803,-1.002802422840017,0.4723926380368098,0.8271231920215749,1.0,6/11,23.80%,KDM7A;KDM3B;KDM1A;PHF8;KDM4D;HR
prerank,peptidyl-amino acid modification (GO:0018193),-0.4478283173158961,-1.0027900033854629,0.4707112970711297,0.8260958166776312,1.0,2/10,10.72%,ATP7A;FKBP10
prerank,negative regulation of ossification (GO:0030279),-0.3663537104480304,-1.0027820412885668,0.4731182795698925,0.8250635784355724,1.0,10/23,17.17%,ENPP1;SMAD6;BCOR;RBPJ;ECM1;TRPM4;PTK2B;CHSY1;MDK;SFRP1
prerank,positive regulation of vasoconstriction (GO:0045907),0.4725651575001806,1.0025831747837768,0.46371681415929206,0.8533545591326483,1.0,2/13,5.76%,CAV1;OXTR
prerank,regulation of viral life cycle (GO:1903900),0.42666696359982337,1.002322982264861,0.45896147403685095,0.853310701263022,1.0,3/21,5.94%,TRIM25;TRIM14;PPIA
prerank,regulation of immunoglobulin production (GO:0002637),-0.3739898923210215,-1.0020624148926869,0.45161290322580644,0.825973428466465,1.0,5/23,21.01%,RBP4;EPHB2;STX4;PTPRC;VAMP3
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.31789467265115606,1.0020427914646404,0.45864661654135336,0.8533507485770512,1.0,24/136,14.63%,DAB2IP;FZD6;NFKBIA;CD200;CTNNBIP1;ID1;SP100;SIGIRR;MEN1;NLRC5;TMSB4X;SMAD7;KLF4;AIM2;FOXP3;IRAK2;EIF2AK4;PEX14;TNFRSF4;EGLN1;CYLD;TNFAIP3;FOXJ1;ID3
prerank,regulation of endopeptidase activity (GO:0052548),0.3567205558639495,1.0019066882223708,0.45701357466063347,0.8530141669376177,1.0,10/59,11.81%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;BIRC3;SPOCK1;SERPINI1;PSME2;APH1A;VSIR
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.4684928236269095,1.001341429003694,0.48582230623818523,0.8537224221710185,1.0,4/12,10.94%,LYN;CD19;ELF2;CBFB
prerank,regulation of lymphocyte activation (GO:0051249),0.47111446246366495,1.0010305684816418,0.46616541353383456,0.8537947097214068,1.0,2/12,5.26%,CD19;CD4
prerank,Notch signaling involved in heart development (GO:0061314),-0.4430493614381761,-1.0010154920120389,0.4627906976744186,0.8276686979425457,1.0,4/11,7.70%,NOTCH2;RBPJ;HEYL;JAG1
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.31379085931993406,-1.0009833416069733,0.44,0.826722769595651,1.0,18/48,18.36%,DOCK5;CARMIL1;CUX1;OBSL1;S100A10;FBXW8;FLNA;MYOC;CUL7;CAPRIN2;ABL1;DMTN;CDKL3;P4HB;TESK1;MDK;MYADM;C1QBP
prerank,ceramide catabolic process (GO:0046514),0.4570059687001814,1.0008417143718158,0.49029982363315694,0.8535620434363006,1.0,3/14,5.39%,ACER2;ACER1;NEU4
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.498016979942432,1.0005415246609568,0.46990291262135925,0.853667746089979,1.0,6/10,29.45%,PDE8A;STK26;TXN;RIPK1;NFE2L2;PARK7
prerank,secondary alcohol metabolic process (GO:1902652),0.3759630571744519,1.0003736028044212,0.4781931464174455,0.8533966055004809,1.0,6/42,6.49%,PPARD;OSBPL1A;ABCG1;CYP11B1;CYP11A1;IDH3A
prerank,telomere capping (GO:0016233),0.4454107182737531,1.000201232169091,0.4395796847635727,0.8531306545570452,1.0,4/16,12.47%,MRE11;TERF2;ACD;TERF1
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.4430708216578352,-0.9998693290265237,0.44849785407725323,0.8287672531993796,1.0,5/11,24.87%,FBH1;TIPIN;ZRANB3;DONSON;LIG3
prerank,regulation of cytoskeleton organization (GO:0051493),0.32038125101512277,0.9993509360401682,0.46862483311081443,0.8545368822826923,1.0,26/108,11.99%,TJP1;RHOBTB1;HIP1R;F11R;CORO2B;PTK2;RHOB;CCDC88A;BAIAP2;FAM107A;MAPK3;STMN3;BST2;MAP6D1;ARHGEF5;TWF2;IQGAP1;TRIM36;P2RX7;CLIC4;PFDN2;PAK1;ARHGAP17;S100A8;RAC1;RND1
prerank,icosanoid metabolic process (GO:0006690),-0.32638067767406986,-0.9990767712518379,0.4818941504178273,0.8298534961756341,1.0,6/40,6.72%,PTGIS;PTGS1;DAGLA;CYP1B1;GGT5;PON3
prerank,transcription by RNA polymerase II (GO:0006366),-0.2401897686679465,-0.9989975432024364,0.44274809160305345,0.8290406649350516,1.0,65/305,18.64%,NOTCH2;SOX5;MAF;PRRX1;RARB;GLIS3;CCN2;TEAD1;DDX5;NR6A1;THRB;NOTCH3;NR1D2;CCNT2;PHAX;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;CTR9;TEAD3;POLR2A;NR3C2;DTX1;PABPN1;PCF11;RPRD2;YAP1;MLLT3;INTS8;CPSF3;CCNH;NR2F1;PARP1;RXRA;NFX1;TAF8;CDK7;ESR1;PGR;TSC22D1;AFF4;INTS2;PAF1;NR4A1;ZBTB1;ZBTB7B;E2F3;ELP4;NELFE;GTF2F1;INTS4;NR1H4;ERCC6;RARA;INTS10;TAF9B;NRBP1;RPAP1;LSM10;HSF2BP;NCOR1
prerank,pyruvate metabolic process (GO:0006090),0.35824428507388345,0.99893076972236,0.4597875569044006,0.8549451370539805,1.0,9/52,14.42%,BSG;PDHB;PKM;HK1;PDHX;PGAM4;PGAM1;TPI1;PFKL
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.4434381830992392,-0.9987779125975288,0.4872389791183295,0.8286113866100433,1.0,6/11,33.16%,UGGT2;AUP1;DERL1;UFD1;UGGT1;POMT2
prerank,regulation of macroautophagy (GO:0016241),-0.2711633776036773,-0.9983500213019596,0.4032258064516129,0.8287245158637356,1.0,35/105,23.77%,PRKAG2;DCN;PRKAA2;SNX6;NRBP2;PRKACA;PRKAG3;CLN3;LRRK2;ATP6V1C1;SNX5;RHEB;ATP6V1G2;CLEC16A;LAMTOR3;CAPN1;CASP3;RRAGA;GNAI3;IKBKG;SMG1;ATP6V1E1;SNX32;SCOC;SMCR8;GPSM1;TSC1;ATP6V0D2;CDK5;NEDD4;PRKAB2;ATP13A2;VPS26A;WAC;SLC38A9
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.35958489571095414,-0.998233556563729,0.4419753086419753,0.8280159213936873,1.0,4/25,13.13%,IGF1;PER2;NIBAN2;TWIST1
prerank,response to purine-containing compound (GO:0014074),-0.3919083874002103,-0.9982090451362339,0.4988962472406181,0.827039735466956,1.0,3/17,7.23%,TRPC3;ABCC9;P2RX4
prerank,epiboly involved in wound healing (GO:0090505),-0.3968511970363427,-0.9981207139040016,0.4522144522144522,0.8262072686618088,1.0,5/16,11.79%,PDPN;DDR1;FLNA;CCN1;TMEFF2
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2742603581467367,0.9978039884603026,0.5096056622851365,0.8570409111058027,1.0,116/1082,8.90%,LEF1;MECOM;PLCB1;ETS1;ITGA6;FLI1;ERG;LMO2;NAMPT;EPAS1;PDGFB;ELK3;DAB2IP;ENG;BMPR2;LMO7;NOTCH4;MRTFB;TRIM16;APP;ZIC3;TBX1;PPARD;MRTFA;NFKBIA;SOX17;TBX3;AFAP1L2;FZD4;KLF7;AGRN;ARHGEF2;RGCC;MEF2C;MOSPD1;RYBP;NCOA1;SMARCA2;SP100;FOXO1;CD40;FOXL2;RPS6KA1;ACVRL1;ZFPM1;NOD2;PRKD1;NOTCH1;PRKD2;MEN1;YBX1;NLRC5;KLF2;ZBTB16;MYO6;PRDM2;IRF2;ASXL3;WNT7A;IKBKB;SMAD7;HHEX;FOXF1;RREB1;CTNNB1;GATA2;POU2AF1;CREB1;MRPL12;SPAG8;KLF1;WWTR1;HYAL2;TAL1;CD4;CAMKK2;ST18;TLR3;CD38;CRTC1;MAML2;MAPK3;RPS6KA5;KLF4;RET;TOX3;NKX2-8;CDKN2B;STAT1;MAX;NR1H2;DNM2;IRF5;NCOA2;SOX18;PHOX2A;NFIC;BRCA2;SOX12;HINFP;KAT6A;JUN;KCNH2;PIN1;TGFB1;ATF6B;YWHAH;TCF12;KLF6;FOXP3;ELK4;LRP5;CDK5RAP2;NFATC2IP;GREM1;ARID1A
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.3484789329188447,0.997758886605084,0.44610778443113774,0.856481644359706,1.0,12/66,12.05%,TFRC;WWTR1;HYAL2;CARD10;LIMK2;TGFB1;CCT3;ZPR1;CCT5;LAMTOR5;FERMT2;ORMDL3
prerank,metal ion transport (GO:0030001),0.3253775307164943,0.9976746208154164,0.46573426573426574,0.8559936462676403,1.0,15/86,11.93%,CACNA1A;SLC39A8;CAV1;SLC30A1;NIPAL3;RAMP2;ATP2C1;CALCRL;RAMP3;FYN;SLC3A2;NIPAL4;NDFIP2;LRP2;CDH23
prerank,macrophage differentiation (GO:0030225),-0.42563463505323085,-0.9974868693077832,0.4773218142548596,0.8267890698340107,1.0,2/13,1.89%,IL31RA;BMP4
prerank,negative regulation of transport (GO:0051051),0.36042804128379036,0.9973654657033277,0.4574468085106383,0.8561023229362148,1.0,10/51,10.83%,DYSF;CTTNBP2NL;PRKD1;SNX3;NR1H2;BST2;PXK;ABCA7;NDFIP2;ARL6IP5
prerank,cholesterol metabolic process (GO:0008203),0.34718115950770034,0.9973155713384698,0.4580265095729013,0.855562470869858,1.0,7/68,5.41%,SCARF1;PPARD;OSBPL1A;PLPP6;ABCG1;CYP11B1;CYP11A1
prerank,melanosome localization (GO:0032400),-0.3699960666367785,-0.997123726652105,0.4470588235294118,0.8266746227943057,1.0,15/21,40.56%,MYO5A;MKKS;RAB11B;MREG;BBS4;BLOC1S6;BLOC1S5;BBS2;ARL6;MLPH;GPR143;RAB17;VPS33A;BLOC1S3;RAB27B
prerank,microtubule-based transport (GO:0099111),-0.4204977481764473,-0.9968829740730504,0.463302752293578,0.8262887655029287,1.0,9/13,33.82%,DYNC1I1;ROPN1L;HTT;ADCY10;SPAG17;SPA17;DYNC1I2;CCDC40;DNAAF4
prerank,negative regulation of response to external stimulus (GO:0032102),0.32612250080371613,0.9967204859461807,0.48525469168900803,0.8563396847296182,1.0,9/105,6.45%,TEK;MFHAS1;PPARD;SIGIRR;DUSP3;EPHA4;INPP5F;GRID2;KLF4
prerank,regulation of macrophage activation (GO:0043030),0.3949093438282014,0.9966144359954555,0.45819935691318325,0.8559337432967107,1.0,2/30,2.13%,MFHAS1;CD200
prerank,response to organophosphorus (GO:0046683),0.4380295304028883,0.996362493143512,0.4527972027972028,0.85586800787697,1.0,3/16,8.58%,TRIM16;STAT1;P2RX7
prerank,peptide hormone secretion (GO:0030072),0.3999277428137782,0.9963191372223678,0.4512396694214876,0.8553182082440878,1.0,6/26,19.30%,LTBP4;RAB1A;EDN1;RIMS2;CAMK2G;CYB5R4
prerank,regulation of lipase activity (GO:0060191),-0.4156332248947692,-0.9960818758930394,0.46325167037861914,0.8273608876963673,1.0,4/13,18.62%,PCSK5;LMF1;ANGPTL3;PCSK6
prerank,T cell mediated immunity (GO:0002456),0.45996572518401385,0.9959378319749917,0.48717948717948717,0.8556007529062859,1.0,1/13,0.97%,CADM1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.31792740105363637,0.995441524711204,0.45564516129032256,0.8561776238554328,1.0,23/117,12.40%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.3626781743640818,0.9953105842124415,0.47217806041335453,0.8558142251586083,1.0,14/45,10.31%,PTK2;VIL1;PLCG1;GRB2;GAB1;SOS1;RPS6KA5;TGFB1;TGFA;IQGAP1;SHC3;ADAM17;PIK3C2A;GRB7
prerank,regulation of signal transduction (GO:0009966),0.29637643175428235,0.9948480016354307,0.4578616352201258,0.8562793764359796,1.0,29/190,10.19%,PLCB1;RGS12;TMEM204;RGS3;APP;RASGRP4;GIT2;SP100;PRAG1;PRKD1;PXN;MFNG;SOCS2;SNX3;KIF26A;TSPAN12;WWTR1;IGFBP7;PPIA;FYN;GNG7;HOMER1;TGFB1;FOXP3;IRAK2;LIFR;SOCS5;PTK6;SHARPIN
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3184251433286175,0.99475865997216,0.4671140939597315,0.8558388247610199,1.0,23/116,12.40%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1
prerank,regulation of establishment of protein localization (GO:0070201),0.452979566066911,0.9946968292245588,0.4658040665434381,0.8553127583401277,1.0,4/14,16.25%,CORO2B;CEP135;DNAJA1;PTP4A3
prerank,positive regulation of mitochondrion organization (GO:0010822),0.34383606053335,0.994287239373197,0.456656346749226,0.8556542871403746,1.0,6/57,5.96%,KDR;HIP1R;PLAUR;TNFSF10;CAMKK2;BIK
prerank,protein localization to lysosome (GO:0061462),0.3988543413189743,0.994093646735609,0.45084745762711864,0.8554671712095193,1.0,8/28,17.46%,SH3BP4;NCOA4;LAMTOR5;HGS;M6PR;LMBRD1;LAMTOR4;AP3M1
prerank,protein acylation (GO:0043543),0.37441699764096703,0.9935959744949376,0.4500792393026941,0.8559714476732492,1.0,8/38,12.54%,ZDHHC14;FOXO1;ZDHHC9;ZDHHC20;KAT6A;ZDHHC18;ZDHHC22;GTF2B
prerank,gonad development (GO:0008406),0.36920711858584115,0.9932207856029959,0.44724409448818897,0.8562405895455756,1.0,6/41,10.83%,KITLG;TGFB2;BIK;COL9A3;NCOA4;LRP2
prerank,intracellular lipid transport (GO:0032365),0.4103108045995126,0.9931503639193846,0.4852941176470588,0.8557607347546377,1.0,4/21,6.80%,CERT1;ABCD4;CPT1A;ACACB
prerank,membrane repolarization during action potential (GO:0086011),0.45970098094239176,0.9931384732264422,0.48044692737430167,0.8551240625153517,1.0,3/13,7.93%,KCNQ1;ATP1A1;KCNH2
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3394327507787341,0.9931336848699419,0.45977011494252873,0.8544790179199281,1.0,15/74,15.92%,EPAS1;NOTCH1;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,homotypic cell-cell adhesion (GO:0034109),-0.3262588177875342,-0.9930983399534433,0.4820936639118457,0.8342926581792576,1.0,7/39,8.95%,PLPP3;PDGFRA;MEGF11;VCL;FLNA;GNAS;MYL9
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.41137913304736806,0.992963524186674,0.4861111111111111,0.8541947640480347,1.0,2/25,1.57%,ITGA6;APP
prerank,post-transcriptional gene silencing by RNA (GO:0035194),-0.3825261993813959,-0.9925205543588208,0.46987951807228917,0.8348437146803701,1.0,9/20,31.16%,TNRC6A;AGO2;TNRC6B;LIMD1;HELZ;AJUBA;MOV10;CNOT1;AGO4
prerank,regulation of G0 to G1 transition (GO:0070316),0.3758814759465819,0.99251656179822,0.45440494590417313,0.8546377725946337,1.0,5/38,6.73%,DAB2IP;RYBP;PHC1;CDKN2B;MAX
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.33751080977943515,0.9922065389136786,0.46164978292329956,0.854724742915017,1.0,17/72,20.08%,ACER2;CNOT6L;RGCC;SP100;MYO6;CRADD;PIDD1;CNOT9;CNOT6;BTG2;HIPK2;PLK2;TRIAP1;NDRG1;CNOT11;TFAP4;E2F4
prerank,regulation of B cell apoptotic process (GO:0002902),-0.43336693172561225,-0.9919897741739971,0.4988962472406181,0.8352192603236844,1.0,3/12,6.04%,FNIP1;IRS2;BCL6
prerank,positive regulation of nervous system process (GO:0031646),0.42700708609714894,0.9918448339533831,0.4840989399293286,0.8549592080794493,1.0,6/18,19.18%,UNC13B;PARD3;CST7;RIMS2;TPPP;DICER1
prerank,regulation of chemotaxis (GO:0050920),-0.34164690885479476,-0.9914572141810637,0.5038167938931297,0.8355902253006975,1.0,6/30,7.23%,PDGFRB;PDGFRA;EFNB2;THBS1;ZSWIM8;P2RX4
prerank,glycine metabolic process (GO:0006544),0.46414922383337365,0.9906592760578683,0.4689655172413793,0.8572111652597446,1.0,5/12,23.81%,GLYAT;SHMT2;SDSL;RIDA;GCSH
prerank,positive regulation of synapse assembly (GO:0051965),0.4032774688514273,0.9905859343964126,0.473421926910299,0.8567335083711926,1.0,9/27,16.49%,AGRN;WNT7A;CLSTN1;GRID2;NRXN1;LRRC4B;EPHB1;NLGN1;IL1RAP
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.46231093142610274,0.990187039644504,0.48066298342541436,0.8570178356732199,1.0,9/12,31.80%,STK33;CDC6;ORC1;HUS1;RAD17;TOPBP1;HUS1B;CHEK2;NAE1
prerank,actin filament capping (GO:0051693),0.43425197157964546,0.9901140577551137,0.4807692307692308,0.8558800175521333,1.0,5/18,9.27%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,barbed-end actin filament capping (GO:0051016),0.43425197157964546,0.9901140577551137,0.4807692307692308,0.8558800175521333,1.0,5/18,9.27%,FLII;VIL1;EPS8;TWF2;CAPG
prerank,aortic valve development (GO:0003176),0.38141511977642245,0.9891970181576728,0.4869281045751634,0.857356973975188,1.0,9/34,8.09%,TIE1;BMPR2;NOS3;NOTCH1;NPPA;DLL4;SNAI2;EFNA1;TGFB1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3504971644377976,0.9888713753965178,0.4784,0.8574861621370821,1.0,5/52,4.91%,PRKCH;SPTBN1;STX3;EPB41;RAMP3
prerank,phospholipid dephosphorylation (GO:0046839),0.367816832246577,0.9886075781473933,0.46317512274959083,0.8574746037375526,1.0,10/37,17.06%,SGPP2;PLPP6;OCRL;INPP5F;MTMR6;MTMR12;MTMR2;PLPPR4;SYNJ1;PLPP2
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.4261628856796909,0.9883883940880216,0.4717314487632509,0.8573434554600312,1.0,4/17,10.22%,PARD3;SMAD7;CALM1;DDIT4
prerank,epithelial cell migration (GO:0010631),0.37980083231808304,0.9881835752584789,0.48625429553264604,0.8571585318018021,1.0,10/37,6.84%,NOS3;PLEKHG5;PKN3;PLXND1;STARD13;PXN;PKN1;NANOS1;STAT1;PKN2
prerank,positive regulation of lymphocyte activation (GO:0051251),0.39834255262282486,0.9881588852398651,0.4909688013136289,0.8565562857908914,1.0,7/28,17.12%,NOD2;CCDC88B;TNFSF11;CYRIB;NCKAP1L;SH3KBP1;CCR2
prerank,phosphatidylserine metabolic process (GO:0006658),0.38120997035078663,0.9881393315975899,0.47235387045813587,0.8559511062393442,1.0,5/32,10.01%,MBOAT1;PLA2G4B;SERINC5;OSBPL10;LPCAT3
prerank,negative regulation of response to wounding (GO:1903035),-0.37708495918770035,-0.9879105844494569,0.44139650872817954,0.8442910717396171,1.0,8/19,21.79%,CASK;PTPRS;FGF2;CD109;MDK;CERS2;SERPINE1;RTN4R
prerank,response to interleukin-6 (GO:0070741),0.4736071984318988,0.9878903055729428,0.4877126654064272,0.8559453741053512,1.0,1/10,0.37%,ST3GAL6
prerank,"phagocytosis, engulfment (GO:0006911)",0.3725760280419501,0.987769524965671,0.4608,0.8555745031392978,1.0,4/36,6.47%,RHOBTB1;DOCK1;ELMO1;ARHGAP25
prerank,negative regulation of histone acetylation (GO:0035067),0.4741147477738181,0.9876135189819518,0.5088652482269503,0.855327866844115,1.0,6/11,22.35%,CTBP1;SIN3A;SET;NOC2L;SNCA;SPI1
prerank,blood vessel endothelial cell migration (GO:0043534),0.40328253978302603,0.9875634761472567,0.4722689075630252,0.8547999077910932,1.0,6/22,8.89%,KDR;ID1;PIK3R3;EPHB4;SOX18;GREM1
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3596937647696644,0.9873580925701786,0.47295208655332305,0.8546455031620915,1.0,17/51,21.66%,HMBOX1;CTNNB1;MAPK3;TERF2;HNRNPC;CCT3;CCT5;ACD;DCP2;TERF1;MAPK1;CCT7;NAF1;EXOSC10;XRN1;MAP2K7;PINX1
prerank,cellular lipid catabolic process (GO:0044242),0.39862091404239464,0.9872873001650015,0.47107438016528924,0.8541824715185361,1.0,9/27,20.60%,PPARD;MGST2;ACOX1;ENPP2;LPIN3;SMPDL3B;ACBD5;AOAH;FAAH
prerank,ncRNA processing (GO:0034470),0.2954703336534462,0.9871260660618716,0.47496947496947495,0.8538993432393992,1.0,57/200,21.52%,ADAR;SARS1;RPL38;RPL13;RPL36A;RPL3;RPL27;SNU13;RPS7;DHX37;RPL9;WDR74;RPL18;RPLP2;INTS11;PDCD11;RPL13A;SMAD1;WDR36;RPL8;MPHOSPH10;RPS27;PWP2;RPL19;UTP3;RPS9;NOL9;MRM2;RPL11;RPS15;RPL37;RPS28;ESF1;UTP11;NOC4L;RPS25;MRPL44;RPL37A;RPP21;NOL8;LYAR;RPL15;RRP12;EXOSC10;RPL17;RPL23;RPL34;DICER1;WDR75;EXOSC9;XRN2;NVL;RPL21;DDX54;RPP30;METTL3;RPL18A
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3142539295183412,-0.9871098941587875,0.47953216374269003,0.8454385055759007,1.0,12/45,14.00%,IGF1;PDGFRA;S100A6;PDGFC;MED25;SPHK1;CD300A;EMD;SKI;NF1;PEX2;MORC3
prerank,necroptotic process (GO:0070266),0.4455742139749831,0.9869584315483106,0.4697986577181208,0.8536679144078869,1.0,5/16,23.35%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,establishment of vesicle localization (GO:0051650),0.43020931911220406,0.9868801180968169,0.5054945054945055,0.8532418449885809,1.0,6/18,18.50%,LIMK2;DNM2;RAB11A;F8A1;SYNJ1;CCDC186
prerank,vitamin D metabolic process (GO:0042359),0.4641963701915125,0.9860102568456047,0.4822429906542056,0.8546479430412108,1.0,4/13,22.48%,CYP11A1;LRP2;CYP24A1;LGMN
prerank,regulation of coagulation (GO:0050818),0.47494267196250634,0.985984815312562,0.46972477064220186,0.8540614392296976,1.0,1/11,1.75%,CAV1
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.33918804736304753,0.985959473341361,0.5028818443804035,0.8534834487592098,1.0,22/72,21.63%,POLK;MRE11;EDC3;GTF2H2;DNA2;PDE12;RNASE1;GTF2H4;DXO;DCP1B;FAN1;PNRC2;RBX1;RPA1;DICER1;POLD1;XRN2;GTF2H3;RFC2;DDB1;RNASE6;ERCC4
prerank,toxin transport (GO:1901998),-0.4398278978120801,-0.9857271465621047,0.47019867549668876,0.8481814056108823,1.0,3/10,13.98%,ANTXR2;RAB29;SLC22A2
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.4661299514437167,0.9852097123512311,0.5091911764705882,0.8546132620891117,1.0,2/12,6.45%,TIRAP;KLF4
prerank,regulation of cell death (GO:0010941),-0.27370513952395026,-0.9851202222118257,0.46863468634686345,0.8487523823656009,1.0,22/94,16.16%,LRP1;CCN2;BMP7;BMP4;ACER3;IMPACT;FGF2;CCN5;CCN1;PRKN;CCN3;PRODH;SLC25A24;SRSF6;CCN4;LRRK2;RAB29;DUS2;WNT11;CTSZ;SARM1;CRYAB
prerank,myeloid cell development (GO:0061515),0.434544813033098,0.9849845102531786,0.49464285714285716,0.8545293664670435,1.0,3/18,5.46%,APP;ALAS1;NRROS
prerank,primary alcohol metabolic process (GO:0034308),-0.3555419004604756,-0.9845599692928018,0.49764150943396224,0.8492409637705738,1.0,6/25,10.14%,IGF1;RBP4;DHRS3;CYP1B1;NAAA;PECR
prerank,purine-containing compound catabolic process (GO:0072523),0.4522183453383419,0.9845591912180833,0.4817391304347826,0.8548772074613501,1.0,3/13,11.08%,XDH;NT5C2;PNP
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.4213232517815092,-0.9842241936683126,0.4945770065075922,0.8490945215678386,1.0,3/11,8.15%,NBL1;SLIT2;CCN3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.28520141645214253,0.9841788360562015,0.5194508009153318,0.8551081469684066,1.0,56/348,13.45%,LEF1;TFRC;ETS1;OCLN;CLDN5;PDGFB;INSR;CD34;NOS3;PDE2A;APP;RGCC;MEF2C;PIK3R3;NOTCH1;RAMP2;KLF2;GATA2;TCF23;FGF16;RAMP3;DLL4;TLR3;INPP5F;TBC1D5;MAPK3;LGALS9;KLF4;HINFP;TGFB1;TERF2;RPS7;P2RX7;MSN;GREM1;ZPR1;ACTG1;PDCD10;SMAD1;PRKAB1;CNTF;LAMTOR5;TASOR;CTCF;GSK3A;VSIR;HIF1A;TLE1;PIK3CB;HGS;SOX11;DNAJA4;SETDB1;RPL11;SOX9;CDH5
prerank,regulation of mononuclear cell migration (GO:0071675),-0.36562508434001983,-0.9840785938470623,0.4780600461893764,0.8484468303041226,1.0,4/23,3.29%,IL34;BMP5;SLIT2;THBS1
prerank,axonemal dynein complex assembly (GO:0070286),0.39120481853832095,0.9839465028249623,0.47761194029850745,0.8550255889147848,1.0,9/28,17.66%,ZMYND10;LRRC49;CFAP100;DRC1;DNAAF2;DNAH8;DNAAF3;DNAH5;TTC12
prerank,protein heterotetramerization (GO:0051290),-0.415190286268709,-0.9835858929088023,0.46205357142857145,0.8487111890061341,1.0,2/13,4.66%,PKD1;PKD2
prerank,regulation of cellular protein catabolic process (GO:1903362),0.42601327068215206,0.9834969652236624,0.47586206896551725,0.8554725294144802,1.0,6/18,20.96%,DAB2IP;MSN;RGP1;PTTG1IP;NELL1;RDX
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3165204388229087,0.9834751215755015,0.48053691275167787,0.8548836121899057,1.0,21/108,14.18%,HIP1;ACER2;XDH;FAS;HIP1R;TNFSF10;NOD1;FOXL2;SOX7;ST18;LGALS9;CRADD;PIDD1;MALT1;CASP8;ARL6IP5;S100A8;SYK;PPARG;BCL10;PDCD6
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.42168652971509984,0.9830672918960038,0.46099290780141844,0.8552048589540828,1.0,1/18,0.20%,TEK
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.44156962372316194,-0.9827184314102173,0.5144628099173554,0.850064665327513,1.0,4/10,9.92%,VTN;ITGA5;GRB10;ARNT
prerank,regulation of presynapse assembly (GO:1905606),-0.381095228722813,-0.982667445322133,0.498812351543943,0.8481349095759104,1.0,2/18,4.60%,GPC6;GPC4
prerank,regulation of presynapse organization (GO:0099174),-0.381095228722813,-0.982667445322133,0.498812351543943,0.8481349095759104,1.0,2/18,4.60%,GPC6;GPC4
prerank,phosphatidylinositol metabolic process (GO:0046488),0.31136561216270203,0.9825510804292117,0.4745308310991957,0.8557628159268649,1.0,25/109,17.30%,PLCB1;PIK3R6;INPP5D;PIK3R3;PLCG1;PIKFYVE;PIP5K1C;OCRL;INPP5F;PLEKHA1;MTMR6;PIK3C3;PIK3C2A;RAB4A;PIP4K2A;PIK3CB;MTMR12;CDIPT;MTMR2;PIK3R5;PLEKHA3;SYNJ1;INPP5E;INPPL1;CSF1R
prerank,nucleotide biosynthetic process (GO:0009165),-0.38483712387961416,-0.9821860298149052,0.4882075471698113,0.8484103411040357,1.0,8/18,18.63%,NMNAT2;ME1;MTHFD1;PRPS2;PRPSAP1;PRPSAP2;ADSL;NMNAT1
prerank,protein insertion into mitochondrial membrane (GO:0051204),0.4019782571816822,0.9821489115526378,0.47237076648841353,0.8560942830325613,1.0,4/23,10.56%,TOMM22;TIMM13;TIMM10;SAMM50
prerank,central nervous system development (GO:0007417),0.28792933539655763,0.9816865031289694,0.5070588235294118,0.856537997959605,1.0,45/250,14.06%,SLC2A1;MFSD2A;ADGRL2;SHROOM4;ZIC3;ADGRL3;MAL;TBX3;SEMA6B;ADGRG1;NES;CDH2;DSCAML1;ZBTB16;LSR;MOG;AATK;NCKAP1;COL4A1;SOX12;DHX37;CDK5RAP2;SPOCK1;CAPG;DNER;SERPINI1;ZPR1;TBC1D23;DDIT4;AGTR2;DCX;THOC6;EIF2B2;GRIN2B;UFM1;UTP3;SOX10;TGFBR2;EML1;SOX11;CNTNAP2;SOX9;GRIK1;FOXJ1;HAPLN2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4226987944560398,0.9810037758455746,0.4991624790619765,0.8574838574711698,1.0,6/21,17.45%,JAK3;DUSP3;SOX11;TNFAIP3;FOXJ1;SAMSN1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),-0.4404696776787676,-0.980852567175076,0.4989010989010989,0.8509449566904174,1.0,9/12,42.14%,TIPIN;WDR18;NBN;METTL4;GMNN;TICRR;NUGGC;CDT1;KAT7
prerank,inorganic anion transmembrane transport (GO:0098661),-0.2904028998158801,-0.9799260716317988,0.46984126984126984,0.8523735318761422,1.0,12/63,9.09%,SLC1A3;SLC26A2;GABRA3;SLC12A2;ANO6;SLC5A5;SLC6A1;SLC12A7;SLC5A6;ANO1;SLC20A2;GLRB
prerank,cellular response to oxygen-containing compound (GO:1901701),0.2869886619798021,0.9793134739049344,0.5214368482039398,0.8608445126062143,1.0,50/291,14.07%,PDGFB;DAB2IP;PDE2A;RAPGEF2;SH3BP4;FES;TBX1;TIRAP;FZD4;MEF2C;FOXO1;RAPGEF1;DEFA6;NOD2;PRKD1;PXN;RAPGEF3;ACTB;LYN;TGM2;CREB1;RAMP3;KCNQ1;KCNC2;CAMKK2;MAPK3;RET;RAP1B;JUN;PDE4B;TWF2;IRGM;P2RX7;BRINP3;AKAP9;PTK6;LAMTOR5;BRINP2;RPTOR;GNB1;ZFP36L1;NSMF;HCN2;SOX9;AKAP6;HMGB2;TNFAIP3;SSH1;GIT1;BCL10
prerank,extracellular matrix assembly (GO:0085029),-0.3554479250838787,-0.9792395302935331,0.49643705463182897,0.8531717548608675,1.0,8/23,11.26%,TNXB;FBLN5;ATP7A;EMILIN1;MYH11;LAMB1;EFEMP2;MFAP4
prerank,glycerol metabolic process (GO:0006071),-0.43943941500998485,-0.9788484053522454,0.5011086474501109,0.8531856969731664,1.0,4/10,17.85%,GK;GOT1;COQ2;ANGPTL3
prerank,regulation of store-operated calcium entry (GO:2001256),-0.44473785621587925,-0.978753030412962,0.5033112582781457,0.8523872474225533,1.0,4/10,8.87%,STIM1;EFHB;SLC8B1;SARAF
prerank,response to peptide hormone (GO:0043434),-0.3191964966286728,-0.9787310903055985,0.4918032786885246,0.8514075228442107,1.0,6/43,5.24%,TGFBR3;ROCK2;IGFBP5;IRS1;OGT;ANXA1
prerank,T cell migration (GO:0072678),0.4589373048030963,0.9787255728772847,0.4891696750902527,0.8616279605380999,1.0,3/13,8.79%,S1PR1;ZAP70;MSN
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.4683532973103327,0.9783268373006682,0.5027932960893855,0.8619266634221543,1.0,4/11,17.88%,CCT3;CCT5;TERF1;CCT7
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.4540814397768608,0.9778785330530287,0.48811700182815354,0.8623312142262919,1.0,2/14,5.76%,NOS3;OXTR
prerank,cellular response to topologically incorrect protein (GO:0035967),0.3780869850109603,0.9778775839460905,0.4742268041237113,0.8616933651814501,1.0,4/31,10.71%,DAB2IP;ATXN3;RHBDD1;HSPA8
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.45202548962214584,0.977305298848821,0.49635036496350365,0.8624068592189339,1.0,1/12,0.76%,LMO2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.31158317264976126,0.9769606810552521,0.516297262059974,0.8625604314549605,1.0,26/129,15.94%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;DNM2;LCMT1;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP135;CEP72;FBXL8;TUBB4B;TUBA1A;FBXL15;CKAP5;CEP70;PPME1
prerank,indolalkylamine catabolic process (GO:0046218),-0.43596142760633655,-0.9769267406551326,0.5176991150442478,0.855190314189547,1.0,5/10,30.36%,KYAT1;KMO;KYNU;IL4I1;HAAO
prerank,apoptotic nuclear changes (GO:0030262),0.40825104119690436,0.9768980928679881,0.5,0.8620516066569688,1.0,9/24,19.18%,FOXL2;CECR2;DFFB;DEDD2;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,cellular protein localization (GO:0034613),0.28399031446218526,0.9766528439578759,0.53125,0.8619814007548218,1.0,40/285,11.15%,OCLN;ESAM;TBC1D4;REEP1;STX3;RAB31;ID1;TBC1D14;ARHGEF2;STX1A;TBC1D22A;AMOT;TBC1D12;SNX13;MYO6;TBC1D2;HHEX;CTNNB1;ARF5;CEP68;PIGU;USP6NL;MESD;TBC1D5;GRID2;ABHD17A;STXBP1;CNTN2;COG3;GRIN3B;ARL4A;YWHAH;RTP4;PIGK;SMURF1;AXIN2;FERMT2;TBC1D10B;ACD;STX19
prerank,nucleoside phosphate catabolic process (GO:1901292),0.46013396562257103,0.9764863712934624,0.47697974217311234,0.8617394352717175,1.0,2/13,6.20%,ENTPD1;ENTPD5
prerank,regulation of astrocyte differentiation (GO:0048710),0.453590888835407,0.9764461636071439,0.5009140767824497,0.861194102378464,1.0,2/12,5.52%,NOTCH1;EPHA4
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.43852848033525565,-0.976356964811944,0.5,0.855639679473459,1.0,2/10,7.89%,OGT;SELENOS
prerank,pinocytosis (GO:0006907),-0.43479371095012287,-0.9758088656010871,0.5120350109409191,0.8560784749880354,1.0,7/10,29.49%,CARMIL1;MAPKAPK3;SNX5;SNX33;PYCARD;AHSG;MAPKAPK2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.3897566044807101,0.9756537996414099,0.49504950495049505,0.8624211237270573,1.0,7/30,5.48%,RASGRP4;RAPGEF1;NOTCH1;LYN;TGM2;GRB2;STK19
prerank,negative regulation of defense response (GO:0031348),0.3327549353098996,0.975527768123651,0.49646393210749645,0.8620812730419966,1.0,3/77,1.88%,TEK;MFHAS1;PPARD
prerank,positive regulation of protein acetylation (GO:1901985),0.47171137533716245,0.9751336255965357,0.52,0.8623188467520772,1.0,3/12,5.82%,DIP2B;RAPGEF3;DIP2A
prerank,negative regulation of cellular protein localization (GO:1903828),0.3726514881485975,0.974995152541307,0.49417637271214643,0.8619930326482551,1.0,3/34,3.12%,MFHAS1;NEDD4L;ANKRD13A
prerank,response to thyroid hormone (GO:0097066),0.44463804328290174,0.9749919166418145,0.4920071047957371,0.861367335852415,1.0,1/13,0.76%,LMO2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.4409410878411021,-0.9746994029562883,0.4911242603550296,0.8579985129618579,1.0,6/10,38.03%,PTPRS;PPM1B;PYCARD;LILRB1;NLRC3;REL
prerank,positive regulation of cell development (GO:0010720),-0.33568998268572237,-0.9745047537551105,0.4931129476584022,0.8574814763477095,1.0,7/31,15.19%,PDE3A;BMP4;SERPINF1;NUMBL;NIBAN2;NKX6-1;NAP1L1
prerank,androgen receptor signaling pathway (GO:0030521),-0.43404859135878643,-0.974351573853109,0.5136986301369864,0.8568416706635597,1.0,5/11,21.52%,DDX5;AR;DDX17;RNF14;ZMIZ1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3351640665305782,-0.9743044277459423,0.5064599483204134,0.8559415173328385,1.0,6/29,14.96%,SMAD3;TUT4;ZC3H7B;AGO2;PUS10;HNRNPA2B1
prerank,regulation of necroptotic process (GO:0060544),0.40384367432574936,0.9742371205716155,0.4856661045531197,0.8624373941206701,1.0,7/23,16.44%,ARHGEF2;PELI1;BIRC3;CASP8;CYLD;SDCBP;PDCD6IP
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.426239729520922,-0.9741041082635553,0.5052410901467506,0.8554841953928776,1.0,5/11,12.42%,EFNB2;FRS2;FZD7;SOX6;BMP2
prerank,protein palmitoylation (GO:0018345),0.3844010318052612,0.973854072497709,0.49755301794453505,0.8626926569050878,1.0,6/30,9.79%,ZDHHC14;ZDHHC9;ZDHHC20;ZDHHC19;ZDHHC18;ZDHHC22
prerank,cytoskeleton organization (GO:0007010),0.3103376820123781,0.9738161190744983,0.5321944809461235,0.8621602719616116,1.0,24/114,13.84%,FGD5;SEMA6A;ARAP3;RHOBTB1;FMNL3;NEDD9;SIPA1;MAST4;RHOB;PAK5;CECR2;DPYSL2;ARHGAP4;RANBP10;FGD6;STRIP1;KLHL20;PDZD8;RAC1;RND1;RANBP9;FGD2;TNFAIP3;CFL1
prerank,cellular response to organic cyclic compound (GO:0071407),0.30677971715411356,0.9737195153115821,0.505851755526658,0.8617523361882026,1.0,30/141,13.85%,SLC1A1;PDGFB;PDE2A;RAPGEF2;FES;MEF2C;RAPGEF1;RAPGEF3;ACTB;TGM2;CTNNB1;RAMP3;KCNQ1;ATP1A1;ATP1A3;CASP7;RAP1B;GABRB1;TGFB1;P2RX7;MSN;NCOA4;AKAP9;PDE12;ARL6IP5;GNB1;ZFP36L1;HCN2;AKAP6;SSH1
prerank,sensory perception of light stimulus (GO:0050953),-0.2702818654251067,-0.9731186793961157,0.4896551724137931,0.8570780285518008,1.0,9/87,5.12%,COL1A1;SLC4A10;EFEMP1;EYA4;COL18A1;ADGRV1;COL11A1;DHRS3;EML2
prerank,sterol homeostasis (GO:0055092),0.3398957635418359,0.9730777382919549,0.5051698670605613,0.862637324152192,1.0,11/65,11.60%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LRP5;NPC1;LIPC;ABCD1;MTTP
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.47470465198845246,0.9726371781686671,0.5168539325842697,0.8630590626360801,1.0,3/11,12.03%,SMAD7;FOXP3;CEACAM1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.4145648436418261,-0.9725835126164559,0.47737556561085975,0.8574620484330292,1.0,2/14,5.27%,ENPP1;ENPP3
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.47320346763180937,0.9723114139751295,0.5091240875912408,0.8631843352796651,1.0,4/11,22.85%,SP100;HIPK2;TFAP4;ING4
prerank,histone H3-K4 trimethylation (GO:0080182),-0.4236582241368648,-0.9719702194900117,0.4904051172707889,0.8580729088239002,1.0,2/11,5.56%,OGT;CTR9
prerank,regulation of protein kinase C signaling (GO:0090036),0.443528225575236,0.971565941242224,0.5144404332129964,0.8642557355935582,1.0,2/14,3.06%,FLT4;CD40
prerank,mesenchymal cell development (GO:0014031),0.4130795350282047,0.9713185014728128,0.49917898193760263,0.8642381787941277,1.0,6/18,17.63%,CDH2;NOTCH1;SNAI2;SOX11;PDCD6;KBTBD8
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.35153972462945515,0.9708410455757897,0.4815950920245399,0.8646990437897827,1.0,7/44,12.55%,NANOS3;PRR5L;NANOS2;NANOS1;GTPBP1;BTG2;ZFP36L1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.45135072864461456,0.9708370931903695,0.4962121212121212,0.8640726987916393,1.0,3/14,10.97%,MFSD2A;ABCB11;ABCD1
prerank,positive regulation of positive chemotaxis (GO:0050927),0.43681318955432413,0.9707689985356256,0.48211243611584326,0.8636027991514098,1.0,2/15,1.41%,KDR;CXCL12
prerank,negative regulation of peptidase activity (GO:0010466),0.35386929724550836,0.9707218580362436,0.509090909090909,0.8630958427861073,1.0,8/47,9.86%,SPOCK2;SERPINB5;SERPINA9;SERPINA11;CST7;SPOCK1;SERPINI1;UBXN1
prerank,endomembrane system organization (GO:0010256),-0.24697127270628277,-0.9704434818812049,0.5815217391304348,0.8610674126827906,1.0,68/178,26.35%,RAB30;MYOF;GBF1;DMPK;OBSL1;TANGO2;ARHGAP21;GOLGB1;A4GALT;FBXW8;FAM174B;DYNC2H1;GOLGA2;HOOK2;SEC31A;SEC16B;PI4K2B;COG4;CUL7;TLCD2;PLEKHF1;TMEM170A;ARL1;ARFGEF2;HUWE1;LRRK2;GORASP2;AKTIP;ATP8B2;RAB29;ATP8B1;SPTSSB;BCAS3;PLEKHM2;SEC16A;LMAN1;SNX33;WASHC5;SURF4;OPTN;SNX10;USP50;SYP;SUN2;BLZF1;GOLGA5;GOLGA8B;RAB22A;VPS4A;ATL3;TMED4;DNM1;LMAN2L;SEC23IP;TMED9;MYO18A;UBXN2A;ALS2;HTT;LEMD2;TJAP1;OTOF;WASHC4;NUP155;ANXA8L1;ANXA8;EIF2AK3;PHETA2
prerank,negative regulation of organelle assembly (GO:1902116),-0.33035797755988616,-0.9702726638641084,0.5226130653266332,0.8604989465667403,1.0,14/35,19.92%,NUPR1;TMEM39A;YAP1;LRRK2;SCFD1;MDM1;TESK1;PHF23;FEZ1;SMCR8;TCHP;TRIM37;TBC1D7;BRCA1
prerank,skeletal muscle organ development (GO:0060538),0.3949591081343855,0.9699586613847433,0.5073891625615764,0.8642210350929588,1.0,6/26,12.12%,CAV1;MEF2C;FOXL2;MYH14;STRA6;CSRP3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",0.47772755460490335,0.9698281155425152,0.5202952029520295,0.8639131564991713,1.0,4/10,22.85%,SP100;HIPK2;TFAP4;ING4
prerank,regulation of filopodium assembly (GO:0051489),0.36588965636858223,0.9696333312449666,0.5095238095238095,0.8637438178184758,1.0,6/38,5.25%,MYO10;PPP1R16B;FNBP1L;PALM;AGRN;CCR7
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.4723142497015418,0.9695461278060842,0.5239852398523985,0.8633223590043805,1.0,4/12,12.26%,STX3;STX1A;STX19;SNAP29
prerank,nucleotide-excision repair (GO:0006289),0.3179538541694226,0.969326348526183,0.4966078697421981,0.8631949904416711,1.0,35/101,26.34%,POLK;ATXN3;GTF2H2;BRCA2;CETN2;GTF2H4;POLB;FAN1;RBX1;AQR;COPS5;RAD23A;GPS1;ISY1;HUS1;POLR2J;RPA1;TCEA1;POLL;POLD1;ERCC8;GTF2H3;POLA1;COPS6;RFC2;DDB1;ERCC4;RAD23B;PPIE;XPC;RFC4;COPS2;PNKP;POLD4;USP45
prerank,regulation of protein localization to plasma membrane (GO:1903076),0.3252755427808469,0.9692742523384501,0.5022156573116692,0.8626868604584231,1.0,10/78,8.09%,PRKCH;SPTBN1;BCL2L1;STX3;ACTB;RAMP3;PPP2R5A;SORBS1;AP2M1;TGFB1
prerank,cellular response to acid chemical (GO:0071229),0.38767463031508903,0.968725362059101,0.5114754098360655,0.8633163247367472,1.0,8/27,19.26%,SH3BP4;KLF2;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2
prerank,carboxylic acid transmembrane transport (GO:1905039),0.3588465797709035,0.9686824258209304,0.49606299212598426,0.8627801501034935,1.0,2/40,1.98%,SLC7A5;SLC38A5
prerank,immunoglobulin mediated immune response (GO:0016064),0.4688344726679214,0.9686365012270156,0.5384615384615384,0.8622594589423546,1.0,2/10,11.01%,CD19;TLR8
prerank,regulation of mitotic nuclear division (GO:0007088),0.34188873431580946,0.9685319843680033,0.48406676783004554,0.8618871986377239,1.0,9/55,8.63%,PDGFB;INSR;RGCC;LCMT1;PIN1;TGFA;CAV2;LRP5;CDK5RAP2
prerank,copper ion transport (GO:0006825),0.46584416518155736,0.9680555825373409,0.508411214953271,0.862365646388119,1.0,2/11,4.15%,ATOX1;SLC31A1
prerank,regulation of wound healing (GO:0061041),0.3617373392151524,0.9679579248629936,0.5077399380804953,0.8619534985875579,1.0,5/42,6.30%,OCLN;CAV1;PTK2;VIL1;INSL3
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.3205827663217553,0.9678898613722985,0.509090909090909,0.8614979613011857,1.0,19/88,12.42%,EXOC6B;APP;EXOC6;STXBP6;AP1S2;SORT1;SORCS1;DNM2;SCAMP1;CLINT1;AP1S3;KLHL20;CLVS2;HSPA8;EXOC4;EXOC2;AP4S1;EPS15;HGS
prerank,T cell differentiation (GO:0030217),0.36004148335776004,0.9677290867427211,0.4894308943089431,0.8612460067221169,1.0,10/40,12.55%,JAG2;SOX13;ZAP70;DLL4;CD4;TCF7;ADAM17;GPR89A;GPR89B;ZFP36L1
prerank,stress granule assembly (GO:0034063),-0.37113938587942974,-0.9675817369405998,0.5202863961813843,0.866675845509796,1.0,8/20,24.23%,UBAP2L;BICD1;OGFOD1;DDX3X;YTHDF1;ATXN2L;CIRBP;CSDE1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3369334626691252,0.9673971836717897,0.4970501474926254,0.8614116827117162,1.0,1/60,0.03%,LEF1
prerank,regulation of neuron death (GO:1901214),0.32238647124978487,0.9671812709646671,0.5188811188811189,0.8613071894951431,1.0,16/82,15.22%,CD34;CD200;MEF2C;GRID2;FYN;EGLN2;CD200R1;DDIT4;KIR3DL2;GRIN2B;EPHB1;NSMF;GPR75;TRIM2;BTBD10;DCC
prerank,actin-myosin filament sliding (GO:0033275),-0.3239900671336089,-0.9669600548462522,0.5290858725761773,0.8662391770278993,1.0,5/38,10.36%,ACTN2;TPM1;DMD;TPM2;DES
prerank,muscle filament sliding (GO:0030049),-0.3239900671336089,-0.9669600548462522,0.5290858725761773,0.8662391770278993,1.0,5/38,10.36%,ACTN2;TPM1;DMD;TPM2;DES
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.30342893421481604,-0.9669185943541391,0.5221238938053098,0.865326896397656,1.0,17/47,18.36%,DOCK5;FBLN1;PDPN;CARMIL1;EFNA5;KANK1;S100A10;FLNA;MYOC;ITGB1BP1;ABL1;DMTN;P4HB;TESK1;MDK;MYADM;C1QBP
prerank,iron-sulfur cluster assembly (GO:0016226),0.39994413309930016,0.9668651977920011,0.519327731092437,0.8614184888894042,1.0,15/24,29.82%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;BOLA2;NUBPL;GLRX3;LYRM4;NFU1;ISCA1;ISCA2;NUBP2;NUBP1;ISCU
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.48160331166207815,0.966785259832173,0.4990403071017274,0.8609759378873079,1.0,3/10,17.12%,ADAM10;ADAM17;CCR2
prerank,basement membrane organization (GO:0071711),0.4422715412803335,0.9665619692118234,0.4990825688073395,0.8608478969980208,1.0,4/14,7.04%,NTNG2;RAMP2;PXDN;COL4A1
prerank,mRNA destabilization (GO:0061157),-0.31977942931496095,-0.966350824167903,0.5155807365439093,0.865831361006052,1.0,2/38,2.79%,ROCK2;TUT4
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.33780868112584295,-0.96621664517663,0.4960835509138381,0.8651601190911367,1.0,2/28,1.34%,PRKAG2;PRKAA2
prerank,regulation of tumor necrosis factor production (GO:0032680),0.3082465560047628,0.9656246721672179,0.5152317880794702,0.8623765282807017,1.0,16/112,13.79%,CD34;APP;TIRAP;PTPRJ;ARHGEF2;NOD2;IFIH1;TLR3;LGALS9;AGER;HSPB1;VSIR;SYK;C1QTNF4;DDT;TNFAIP3
prerank,response to muscle stretch (GO:0035994),0.4284768286364323,0.9656173982445824,0.5116696588868941,0.8617753467117291,1.0,4/15,4.86%,PTK2;CDH2;CTNNB1;NPPA
prerank,morphogenesis of an epithelium (GO:0002009),-0.3482795326169794,-0.9652057692472586,0.5076142131979695,0.8668448345029837,1.0,8/25,15.26%,FGFR2;VCL;DAG1;TBX18;KDM2B;ARHGAP12;AHI1;LRP6
prerank,inner dynein arm assembly (GO:0036159),0.46145743599655165,0.9650814748440655,0.50293542074364,0.8623535156914072,1.0,2/11,7.43%,ZMYND10;CFAP100
prerank,DNA modification (GO:0006304),0.407409511062046,0.9646674146670638,0.5094339622641509,0.8627037686030825,1.0,6/22,12.47%,NTHL1;TERF2;SMUG1;ACD;MPG;TERF1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.45586705469099786,0.9645593807004024,0.5105633802816901,0.8623334784819435,1.0,1/11,1.17%,ITPKB
prerank,mRNA stabilization (GO:0048255),0.3641590065859109,0.9643324993776703,0.5053110773899848,0.862199200225827,1.0,7/40,14.77%,TIRAP;YBX1;NOCT;HNRNPC;AXIN2;PAIP1;ELAVL1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),-0.36485788822111526,-0.9641900889138865,0.5096618357487923,0.8684953990816825,1.0,2/20,1.57%,WNT4;BMP5
prerank,cellular protein metabolic process (GO:0044267),0.27516733134603366,0.964078360502582,0.5638766519823789,0.8621595296479333,1.0,98/396,19.60%,ST8SIA4;ST3GAL6;DAB2IP;DENND3;APP;ST3GAL1;STK38;SPARCL1;VWA1;CDH2;MEN1;SARS1;NOTUM;ZAR1L;RPL38;IGFBP7;MRPL13;RPL13;RPS29;ABCA3;MRPL10;ADAM10;RPL36A;YES1;RPL3;GOLM1;UBE2G1;MSRB2;YARS2;LCMT1;MSRB3;RPL27;RPSA;PDIA6;RPS7;QSOX1;RPL9;RPL18;RPLP2;PLAT;SCG3;ADAM17;RPL13A;MMP1;FBXL2;CHRM3;RPS11;DUSP12;APH1A;RPL8;RPS27;RPL19;UBA3;RPS9;MRPL28;SPCS2;EVA1A;MANBA;RPL11;LTA4H;FBXW2;RPS15;SRBD1;RPL37;RPS28;MAN2B1;SERPINC1;RPS10;OMA1;UBE2D3;LOXL2;MMP15;RPS25;MCRS1;PROC;RPL37A;MRPL9;COPS5;GAS6;SEPHS1;TMEM132A;UBE2G2;SCG2;FBXO2;RPL15;SFTPC;TNIP1;SPPL3;ERO1A;CPE;MRPL23;RPL17;RPL23;RPL34;USP25;LMCD1;FARSB;RPS18
prerank,serine family amino acid metabolic process (GO:0009069),0.4415345143548558,0.9639997515400565,0.4956063268892794,0.8617287373361263,1.0,4/16,9.59%,SARS1;GLYAT;SHMT2;CBS
prerank,snRNA 3'-end processing (GO:0034472),-0.37310838999129503,-0.9636963656071218,0.5292740046838408,0.8687990620313961,1.0,7/19,30.01%,INTS8;INTS2;TUT1;EXOSC2;TOE1;INTS6L;INTS5
prerank,lysosome organization (GO:0007040),-0.32584077221328916,-0.9633830567383705,0.5118733509234829,0.868592756736835,1.0,12/36,18.25%,ABCA1;HOOK2;ARSB;GAA;CLN3;LRRK2;AKTIP;ACP2;GNPTAB;GRN;CLN6;MBTPS1
prerank,limb morphogenesis (GO:0035108),-0.36686828728892074,-0.9633601449746053,0.5269320843091335,0.8676459264519264,1.0,3/20,2.40%,GLI3;CYP26B1;PCSK5
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3445042793732337,-0.9632911637428407,0.5138539042821159,0.8668433501321686,1.0,6/24,12.29%,PID1;RHOQ;DAB2;ITGB1BP1;LZTFL1;DMTN
prerank,steroid biosynthetic process (GO:0006694),-0.2944442419295042,-0.9631856319307033,0.5072886297376094,0.8660726481369123,1.0,5/56,5.81%,PRKAG2;CYP7B1;INSIG2;CYP27A1;ACOT8
prerank,cell cycle G2/M phase transition (GO:0044839),0.3057769536965771,0.9625645479037921,0.5520833333333334,0.8644018168135844,1.0,26/130,15.94%,PLCB1;CCNY;TPD52L1;NES;DYNLL1;CDKN2B;CCP110;DNM2;LCMT1;PRKAR2B;CETN2;TUBB;CDK5RAP2;PPP1CB;AKAP9;HAUS6;CEP78;CEP135;CEP72;FBXL8;TUBB4B;TUBA1A;FBXL15;CKAP5;CEP70;PPME1
prerank,regulation of phospholipase C activity (GO:1900274),0.4345810606386507,0.9622268041221346,0.5311942959001783,0.8645592252358992,1.0,2/15,4.11%,FLT1;PLCG1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.4255423253246309,0.9621239274148841,0.52,0.8641870245463187,1.0,1/17,0.99%,BCL2L1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.46286139102845225,0.962004101319445,0.5206766917293233,0.8638363424911489,1.0,3/12,12.50%,B4GALT5;HSP90AB1;EPHB1
prerank,nuclear export (GO:0051168),-0.2718950826210234,-0.9617037098849275,0.5369774919614148,0.8690072734058754,1.0,26/80,26.87%,RANBP3L;PKD1;PHAX;RANBP17;SRSF5;SRSF11;XPO5;SRSF6;XPO6;SRSF4;STRADA;DDX39B;XPO1;THOC2;THOC7;U2AF2;U2AF1;RAE1;DDX39A;EIF4A3;POLDIP3;THOC1;WASHC4;NUP155;TPR;ATXN1
prerank,ribosomal small subunit biogenesis (GO:0042274),0.3577686332436004,0.9614590610912415,0.5053272450532724,0.8645108746685868,1.0,20/39,31.34%,RPSA;SNU13;RPS7;RPS27;PWP2;RIOK1;RPS15;RPS28;RPS25;SURF6;RIOK3;ERAL1;RPS19;UTP4;RPS6;LSM6;RPS14;RPS24;WDR3;RPS16
prerank,anterior/posterior axis specification (GO:0009948),-0.38523175522351694,-0.9613268943345128,0.5213675213675214,0.8689492108505893,1.0,1/15,0.25%,WLS
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.31504306945298466,0.9612394982844626,0.5236111111111111,0.8644394013760236,1.0,21/88,17.97%,DAB2IP;NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PLAT;RPL13A;CNOT9;GRB7;BTG2;PAIP2;CLN8;RNF139;EDN1;CSTB;RGP1;BAG6;TRIM71;NELL1
prerank,regulation of cellular component size (GO:0032535),0.37787846249677903,0.9610976551506952,0.5182119205298014,0.8641268402110875,1.0,9/30,15.55%,RIN3;EPS8;AP2M1;MSN;RAB3B;LAMTOR5;RAC1;RPTOR;LAMTOR4
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.41331921848985537,-0.9608194312643438,0.5367483296213809,0.8692590438076365,1.0,4/12,17.87%,SMO;SIX1;SIX4;PAX2
prerank,proteoglycan metabolic process (GO:0006029),0.39548187588277095,0.9607271962539532,0.5270935960591133,0.8643386138615159,1.0,3/26,2.89%,CSGALNACT1;BMPR2;CHST11
prerank,regulation of cartilage development (GO:0061035),-0.3793388251213822,-0.9606486302117743,0.5,0.8687141118320383,1.0,7/18,17.09%,SOX5;BMP4;SOX6;PTHLH;BMP2;WNT11;MDK
prerank,peptide cross-linking (GO:0018149),0.3912416067545399,0.9599993504918763,0.5058043117744611,0.8653995376058232,1.0,3/25,8.30%,NDNF;TGM2;ABCA7
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.30146051627097464,0.9596175052399065,0.5445026178010471,0.8656072216312958,1.0,18/121,10.58%,PECAM1;PDGFB;IL6R;LRP8;NEDD9;ARL2BP;PTPRJ;ARHGEF2;CD40;LYN;EPHA4;STAP2;EFNA1;TGFB1;ENPP2;GREM1;PTK6;CNTF
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.3241679326307001,-0.9593707568231495,0.5105820105820106,0.8712076913221878,1.0,12/33,21.83%,DDX5;AR;KLK2;AXIN1;KDM1A;ESR1;EP300;DDRGK1;RUNX1;LATS1;RNF14;SAFB2
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.4509524645055984,0.9590484404895616,0.5056390977443609,0.8663251404522985,1.0,1/12,0.22%,PLCB1
prerank,Golgi inheritance (GO:0048313),-0.4245107826367026,-0.9586962782155651,0.5463917525773195,0.8720245682619022,1.0,4/11,14.52%,GBF1;GOLGA2;STX5;PLK5
prerank,negative regulation of kinase activity (GO:0033673),-0.28775478543874505,-0.9585457699654012,0.5278592375366569,0.8713879500474812,1.0,16/62,20.58%,PRKAG2;PPM1E;DEPTOR;DTNBP1;IRS2;PDPK1;SPRED1;QARS1;ITGB1BP1;NF1;LRP6;CDKN1C;PTPRC;SMCR8;THY1;TARBP2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.224838264893352,-0.9584610574590441,0.5981308411214953,0.8705905735783837,1.0,72/327,16.51%,BNC2;NFIA;DENND4A;ZFHX3;EFEMP1;SSBP2;ARNT2;PPARGC1B;TULP3;PRRX2;NR1D2;FOXC1;TGFBR1;SUFU;PPARGC1A;ZNF423;RORA;KAT6B;MED23;CTR9;SIX1;NFXL1;IGF2;CRABP2;POLR2A;FZD7;ZFAT;ATF5;GPBP1L1;PFDN5;CHD3;VSX1;MITF;ACTR8;RBAK;PML;SOX6;REXO4;GCFC2;CEBPB;ZBTB38;NSD2;PRMT5;RNF20;NFX1;TGFBRAP1;ABL1;ESR1;SBNO1;BMP2;ZNF219;DVL2;SP3;ZBTB4;MAFB;ACVR1B;GZF1;ATF2;SPTY2D1;EP300;NONO;PHF12;MYBL2;LIMD1;NFIL3;CCAR1;LDB1;APBB3;ZSCAN21;PSPC1;ZFP37;NFATC2
prerank,regulation of cell cycle (GO:0051726),0.2806319683004956,0.9574399727669645,0.5690672963400236,0.8693647754101858,1.0,28/271,8.39%,MECOM;DAB2IP;APBB2;PPP1R13B;TGFB2;NANOS3;TBX3;AFAP1L2;DCUN1D3;RGCC;SIPA1;NOTCH1;MEN1;PPP1R9B;HSP90AB1;CDC14A;XIAP;BTG4;RHOB;TTC28;ADAM10;CDKN2B;INSM1;JMY;JUN;BIRC3;TGFB1;IQGAP1
prerank,positive regulation of protein ubiquitination (GO:0031398),0.3230834766781275,0.9569054612703202,0.5374823196605375,0.8700164485664832,1.0,22/80,19.21%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;PIN1;MALT1;NDFIP2;UBQLN1;GSK3A;DCUN1D1;BCL10;PDCD6;RBX1;BMI1;INAVA;PTTG1IP;UBE2D1;FKBP1A;NSMCE3
prerank,positive regulation of macroautophagy (GO:0016239),0.35089805315694117,0.9565649796222774,0.5319148936170213,0.870197273064632,1.0,13/48,14.19%,KDR;SLC25A5;SESN3;SPTLC2;RALB;IRGM;FYCO1;BNIP3L;VPS13D;SH3GLB1;PIP4K2A;SPTLC1;EPM2A
prerank,muscle tissue morphogenesis (GO:0060415),-0.38912780148484083,-0.9563635839262785,0.5251141552511416,0.8751747680270447,1.0,3/16,2.08%,TGFBR3;BMP4;MYLK
prerank,microglial cell activation (GO:0001774),0.40334721761915954,0.9558110125421122,0.5147313691507799,0.8713414347565124,1.0,8/21,30.79%,APP;AGER;IFNGR1;SNCA;ITGB2;CX3CR1;CLU;AIF1
prerank,plasma membrane repair (GO:0001778),-0.40064059847735045,-0.9555929347258446,0.5152838427947598,0.8761701752264424,1.0,3/13,5.39%,MYOF;AHNAK2;ANXA6
prerank,carbohydrate catabolic process (GO:0016052),0.36408208031881856,0.9555911137192102,0.5351882160392799,0.8711938751518731,1.0,12/38,18.47%,NEU4;PKM;HK1;MANBA;NEU2;PGAM4;PGAM1;TPI1;MAN2B1;PFKL;NEU1;LDHA
prerank,pharyngeal system development (GO:0060037),0.43217361527826914,0.9555687458861647,0.5282331511839709,0.8706335261947895,1.0,3/15,1.88%,BMPR2;TGFB2;TBX1
prerank,detection of mechanical stimulus (GO:0050982),0.4144869161626217,0.9549024395118364,0.5137457044673539,0.8715413697514091,1.0,4/19,4.52%,PTK2;CDH2;PIEZO1;CTNNB1
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.46543009753768083,0.9543419059351964,0.5414258188824663,0.8722374261460102,1.0,2/10,12.03%,LGALS9;CEACAM1
prerank,regulation of protein kinase A signaling (GO:0010738),-0.3572044062526891,-0.9539509678485434,0.5171568627450981,0.8794813982943828,1.0,6/20,14.29%,ADGRV1;AKAP12;AKAP7;PJA2;LRRK2;TCIM
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.39612295520331614,-0.9537494112242121,0.5271493212669683,0.8789876645080034,1.0,2/15,5.34%,OSBPL8;PPARA
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3577077100608605,0.953500637787427,0.5142405063291139,0.8734955900359717,1.0,4/40,5.96%,BCL2L1;PLAUR;TNFSF10;BIK
prerank,amyloid precursor protein metabolic process (GO:0042982),0.41409548054975653,0.9532817440252334,0.5197255574614065,0.8733856394007528,1.0,5/18,11.18%,ABCG1;ADAM10;TMCC2;ADAM17;APH1A
prerank,protein methylation (GO:0006479),-0.3032915690455904,-0.9531483621174517,0.5299145299145299,0.879451528978147,1.0,13/40,23.32%,PCMT1;EHMT2;EEF2KMT;PRMT5;RAB6A;PRMT8;METTL22;FAM98B;EZH2;TRMT112;GSPT1;NSD1;EEF1AKMT2
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.2994877027896534,-0.9530745552760304,0.5446927374301676,0.8786526262324894,1.0,9/48,12.15%,ANK2;CEMIP;DMD;CAMK2D;DIAPH1;PDPK1;PRKACA;PTK2B;JPH1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3601466458023978,0.9527512048508208,0.5240384615384616,0.8739831801537656,1.0,11/38,19.25%,DAB2IP;STAT1;ZMYND11;OTUD7A;CASP8;TLE1;TRIM39;TNFAIP3;TRIM59;TNIP1;OTUD7B
prerank,positive regulation of myelination (GO:0031643),0.4523878685535536,0.9526926100888435,0.5499021526418787,0.8734967747839127,1.0,4/11,19.18%,PARD3;CST7;TPPP;DICER1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.3485581606240322,0.9524309571874059,0.5336322869955157,0.8734626840104878,1.0,9/50,12.10%,APP;NOD1;NOD2;TLR3;ACTN4;LGALS9;TLR7;AGER;C1QTNF4
prerank,determination of left/right symmetry (GO:0007368),0.36333990100863434,0.9517987822404441,0.5308641975308642,0.874297040592221,1.0,7/37,15.28%,ZIC3;TBX1;NOTCH1;KIF3B;FOXJ1;DAND5;DNAH5
prerank,telomere maintenance via telomerase (GO:0007004),0.38494475064591205,0.9513777053522309,0.5174129353233831,0.8746770920553545,1.0,9/28,24.06%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1;PTGES3
prerank,detection of calcium ion (GO:0005513),-0.39641612231856094,-0.951260132935085,0.5389344262295082,0.882376323194855,1.0,2/13,4.49%,STIM1;KCNMB2
prerank,pentose-phosphate shunt (GO:0006098),-0.42538319645035194,-0.9510669825008286,0.5291576673866091,0.8818803950685922,1.0,4/11,14.58%,PGLS;H6PD;PGD;DERA
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.4388336714528477,0.9510363151735038,0.5082568807339449,0.8748522739504397,1.0,2/12,5.09%,GCLM;MGST2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.4098772859263629,-0.950677185238594,0.5411255411255411,0.8798365429729477,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),-0.4098772859263629,-0.950677185238594,0.5411255411255411,0.8798365429729477,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.4098772859263629,-0.950677185238594,0.5411255411255411,0.8798365429729477,1.0,7/12,32.28%,ANAPC5;CUL3;NSMCE2;CDC16;ANAPC4;DLGAP5;ESPL1
prerank,cellular response to calcium ion (GO:0071277),0.326519996808879,0.9506518339616922,0.5431547619047619,0.8750947991325438,1.0,17/67,17.95%,ITPKB;MEF2C;MCOLN1;ACER1;SYT7;CPNE8;RASGRP2;IQGAP1;CLIC4;CPNE5;SYT4;CPNE6;NLGN1;CPNE3;CRHBP;CPNE1;NEUROD2
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.39068784829972136,-0.9505066317671663,0.5182648401826484,0.8792770799835783,1.0,3/16,9.76%,DDX5;SRSF6;DDX17
prerank,ganglion development (GO:0061548),0.4551156682752832,0.9505006963974232,0.5284403669724771,0.8748549468331979,1.0,4/11,19.12%,CTNNB1;INSM1;NRP2;NRP1
prerank,positive regulation of nervous system development (GO:0051962),0.35365530151724617,0.9503088132787422,0.5192307692307693,0.8746800839285533,1.0,12/42,16.49%,TGM2;WNT7A;CLSTN1;GRID2;FAIM;NRXN1;LRRC4B;LRP2;EPHB1;SOX11;NLGN1;IL1RAP
prerank,response to ATP (GO:0033198),-0.36273527768527286,-0.950300695836158,0.5157384987893463,0.8788269494282521,1.0,4/18,12.78%,TRPC3;ABCC9;P2RX4;HSP90B1
prerank,fatty acid transmembrane transport (GO:1902001),0.4028317062976621,0.950280976680644,0.5123674911660777,0.8741320211785636,1.0,4/19,6.80%,SLC2A1;ABCD4;CPT1A;ACACB
prerank,regulation of actin nucleation (GO:0051125),-0.4129932221529834,-0.9499058392050429,0.5146726862302483,0.8788466456397579,1.0,5/12,21.03%,GSN;ARFIP2;WASHC5;ARF1;CORO1B
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.3504208230553886,-0.9492555722499167,0.5311720698254364,0.8795097295102129,1.0,7/24,13.61%,KIT;CYP1B1;OCIAD1;PTK2B;PRLR;PIBF1;GHR
prerank,regulation of exit from mitosis (GO:0007096),0.3550047778226649,0.9491345210283142,0.5264797507788161,0.875983458614474,1.0,15/38,23.32%,RGCC;PPP1R9B;CDC14A;NPM2;BUB3;ANLN;ANAPC16;ANAPC7;ANAPC10;UBE2D1;ZW10;ANAPC2;CDC23;CDC26;CDC27
prerank,regulation of sensory perception of pain (GO:0051930),-0.4121042808224671,-0.9491002508996301,0.5543710021321961,0.8789094571737501,1.0,2/11,8.15%,TMEM100;CCN3
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.4257319254433782,0.9488238871547403,0.507168458781362,0.8760797111023935,1.0,7/14,24.01%,PRKD2;BCL10;CARD11;TESPA1;KCNN4;TRAT1;NECTIN2
prerank,dendritic cell migration (GO:0036336),0.4252477369576377,0.9487208944856111,0.516245487364621,0.8757025634557578,1.0,3/16,8.20%,EPS8;CCR7;CXCR2
prerank,cellular response to unfolded protein (GO:0034620),0.37680089342118095,0.9485540289185648,0.5201401050788091,0.8754859480629917,1.0,3/26,10.71%,DAB2IP;RHBDD1;HSPA8
prerank,synaptic vesicle membrane organization (GO:0048499),0.4256721022378924,0.9484560183920941,0.5334507042253521,0.8751026675459262,1.0,4/17,12.26%,STX3;STX1A;STX19;SNAP29
prerank,actin filament network formation (GO:0051639),-0.4219164816563188,-0.947980155147323,0.5456521739130434,0.8809142564876944,1.0,3/11,7.91%,CARMIL1;COBL;FHOD1
prerank,inner mitochondrial membrane organization (GO:0007007),0.35338815720175526,0.9479473515686407,0.5355450236966824,0.8756609352395327,1.0,15/47,22.97%,ATP5F1E;TIMM13;ATP5MC2;LETM1;ATP5PO;GHITM;TIMM10;SAMM50;ATP5F1A;HSPA9;ATP5MF;ATP5PF;CHCHD3;TMEM11;MTX1
prerank,regulation of intracellular pH (GO:0051453),-0.3171342962501888,-0.9478832017892086,0.556786703601108,0.880150366530704,1.0,8/34,11.10%,SLC4A10;SLC9A2;SLC4A7;SLC4A2;SLC9A9;SLC9A1;CLN3;LRRK2
prerank,sphingolipid catabolic process (GO:0030149),0.4197241137083782,0.9477255585759362,0.5160714285714286,0.8755557234408369,1.0,3/15,8.63%,ACER2;ACER1;ENPP2
prerank,genitalia development (GO:0048806),0.4483774200435181,0.9473688349524478,0.5380530973451327,0.8757478889585518,1.0,4/12,16.49%,TBX3;STRA6;DNAJC19;FOXF2
prerank,positive regulation of sodium ion transport (GO:0010765),0.44098154022420294,0.9466540839181622,0.5105263157894737,0.8767871148237808,1.0,1/12,2.01%,CNKSR3
prerank,endochondral bone morphogenesis (GO:0060350),0.44645072035469113,0.9460182491380302,0.5203703703703704,0.8776084498349677,1.0,2/11,2.75%,BMPR2;MEF2C
prerank,sulfur compound biosynthetic process (GO:0044272),0.3081760508637458,0.9459556539927793,0.5612104539202201,0.877135816425192,1.0,16/104,10.19%,CSGALNACT1;ST3GAL6;ST3GAL1;B4GALT5;B4GALT4;CHST11;GCLM;B3GNT2;TPK1;MGST2;GSTA4;SLC10A7;MAT2A;CBS;HPGDS;GSTK1
prerank,regulation of receptor binding (GO:1900120),0.4559261449225994,0.9456273277113924,0.5414364640883977,0.8772848098212312,1.0,2/10,3.06%,B2M;ADAM15
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.40508161969430845,-0.9456200036876956,0.526431718061674,0.8850118588616134,1.0,11/12,53.57%,CDC45;MCM3;MCM4;MCM5;CDC7;MUS81;MCMDC2;MCM2;MCM7;GINS4;GINS2
prerank,positive regulation of cell aging (GO:0090343),0.4560137404194713,0.9451700119812543,0.524822695035461,0.8776763235594313,1.0,4/11,16.58%,B2M;HMGA1;ABI3;HMGA2
prerank,intrinsic apoptotic signaling pathway (GO:0097193),-0.26707176333927773,-0.9445274340601659,0.5789473684210527,0.8868889722129072,1.0,17/94,10.31%,ITPR1;FHIT;PDK1;DDX5;MAP3K5;PRKCD;IKBKE;CYP1B1;TMEM117;BCL2;ATM;PRODH;PML;CUL3;CEBPB;STK11;CRIP1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.4266405940733854,-0.9444004749046228,0.5503080082135524,0.8862078820553536,1.0,3/10,11.81%,APPL2;ANO6;CD300A
prerank,actin nucleation (GO:0045010),0.39983489610601913,0.9443353664635896,0.519298245614035,0.8789855018527544,1.0,8/21,26.08%,ARPC4;JMY;ARPC3;ACTR2;ARPC1B;ARPC2;ARPC5;WHAMM
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.36370854051653956,0.9442442388613262,0.5405844155844156,0.878561000305478,1.0,5/38,6.22%,XDH;PHLPP1;PTPRJ;HYAL2;PLEKHA1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.40850031594141684,-0.9439889638952494,0.5288683602771362,0.8862401775404716,1.0,3/12,10.60%,CACNA1C;DLG1;TRPM4
prerank,primary miRNA processing (GO:0031053),-0.4280192125788991,-0.9439444285099187,0.5294117647058824,0.8853588544801743,1.0,3/10,14.96%,SMAD3;PUS10;HNRNPA2B1
prerank,positive regulation of gene expression (GO:0010628),0.26786318946351134,0.943711444150454,0.6252723311546841,0.8791832076311799,1.0,31/442,6.45%,LEF1;TFRC;ETS1;OCLN;TENT4A;RBM20;CLDN5;PDGFB;CADM1;CD34;NOS3;PDE2A;APP;RGCC;MEF2C;NIBAN1;PIK3R3;NOTCH1;RAMP2;ACTB;GATA2;TCF23;FGF16;RAMP3;DLL4;TLR3;TAF1B;MAPK3;CCDC88B;LGALS9;KLF4
prerank,positive regulation of filopodium assembly (GO:0051491),-0.3508163448074399,-0.9436035955364439,0.5350467289719626,0.8851975336777509,1.0,5/24,4.23%,DPYSL3;DOCK11;ARAP1;RHOQ;RIPOR2
prerank,neuron differentiation (GO:0030182),-0.2393599418792485,-0.9433923373253378,0.6502463054187192,0.884720170627466,1.0,19/165,8.81%,PBX1;GLI2;WNT4;WNT5B;WNT6;FZD2;TGFBR1;WNT9A;PBX4;RUNX2;NRBP2;FZD7;TDP2;PBX3;HS6ST1;FZD3;VSX1;MET;ATOH8
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.31737884467603733,0.9429926337667373,0.5412587412587413,0.8801820174002092,1.0,33/87,27.05%,NDUFAF3;NDUFA2;NDUFA8;SLC25A33;SCO2;NDUFAF7;DMAC2;SAMM50;TMEM126B;SCO1;OMA1;IMMP2L;NDUFA12;NDUFB3;NDUFAF8;SDHAF4;CHCHD4;COA3;SDHAF1;NDUFC1;SMIM20;NUBPL;SDHAF2;NDUFA10;COX20;COX17;ECSIT;DMAC1;PET100;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.42509657595835154,0.9428432096386075,0.5113636363636364,0.8799083103136847,1.0,1/13,0.30%,ABHD2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.4378665875528552,0.9425550101371899,0.528695652173913,0.8799656824392632,1.0,4/14,19.78%,TIRAP;HNRNPC;ELAVL1;DAZL
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3638814339056654,0.9424259627393604,0.5522620904836193,0.8796175872841454,1.0,3/33,3.70%,SLC39A8;DDAH1;GCLM
prerank,cardiac ventricle morphogenesis (GO:0003208),0.35666538071311343,0.9421555339215285,0.5328125,0.8796254045982262,1.0,12/41,12.63%,ENG;TGFB2;MEF2C;NOTCH1;SMAD7;FOXF1;DLL4;TGFB1;NPY5R;GSK3A;TGFBR2;SOX11
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.36793089770577225,0.9418113781509637,0.5460420032310178,0.8798352755223856,1.0,5/34,8.59%,PDGFB;INSR;RGCC;TGFA;LRP5
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.34998882814189525,-0.9417615718927582,0.5714285714285714,0.8881096746023511,1.0,9/22,19.83%,DMD;CACNB4;CACNB2;GNB5;FMR1;CACNB1;STAC3;AHNAK;CACNB3
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.31187892381683663,0.9413988648758624,0.5614525139664804,0.8801929816512429,1.0,20/87,12.34%,CLDN5;ENG;TGFB2;F11R;ID1;PTK2;ACVRL1;PARD3;PXN;SMAD7;NRROS;JUN;TGFB1;SMURF1;SMAD5;SMAD1;FERMT2;EID2;GDF15;TGFBR2
prerank,cellular response to misfolded protein (GO:0071218),-0.3569605531145999,-0.9408456075827342,0.5208845208845209,0.889414593714948,1.0,8/20,25.22%,UGGT2;CUL3;KLHL15;AUP1;DNAJC18;DNAJB14;DERL1;UFD1
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.3399492746515067,-0.9406106068854571,0.56,0.8889761321943577,1.0,10/23,19.74%,ERRFI1;CBLB;SNX6;TSG101;ZFYVE28;SRCIN1;GPRC5A;MVP;PTPRC;THY1
prerank,regulation of mast cell activation (GO:0033003),0.4537839472217031,0.9405413547462149,0.5411089866156787,0.8815284011841099,1.0,3/10,16.98%,LYN;MILR1;CRLF2
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.4185802797096357,0.9405226031198873,0.5244360902255639,0.8809641293808749,1.0,7/15,23.12%,HOMER2;HOMER1;GRM7;GRM8;GRM2;GRM3;GRIK3
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.38312809922070307,0.9402821538947805,0.5414462081128748,0.8808887158819416,1.0,6/23,12.63%,ENG;LTBP4;SMAD7;TGFB1;EID2;SOX11
prerank,mitotic cell cycle phase transition (GO:0044772),0.28410739033588955,0.9402397583408911,0.6036363636363636,0.8803751323236648,1.0,54/204,22.50%,PLCB1;CCNY;TPD52L1;NES;EPS8;DYNLL1;CDKN2B;CCP110;MAX;DNM2;LCMT1;CCNI;PRKAR2B;HINFP;CETN2;TUBB;CDK5RAP2;PPP1CB;CCND3;AKAP9;HAUS6;CEP78;EIF4E;CEP135;CEP72;PIM2;FBXL8;TUBB4B;TUBA1A;FBXL15;PLK2;CKAP5;CEP70;PPME1;ACVR1;ANAPC7;SPAST;TRIM71;SKP1;USP29;CDK6;DCTN1;SFI1;BRSK2;TAF2;CLASP1;NDE1;HAUS2;CDK4;NASP;CUL1;CCNJL;CDC23;ENSA
prerank,cellular response to chemokine (GO:1990869),0.3390102040141374,0.9402081328951929,0.5467289719626168,0.879843455118991,1.0,2/46,1.41%,LRCH1;CXCL12
prerank,positive regulation of monooxygenase activity (GO:0032770),0.38205428180301026,0.9401086330742461,0.5388272583201268,0.8794621102625233,1.0,7/26,14.67%,GCH1;SCARB1;TERF2;AGTR2;HIF1A;PIK3CB;NUS1
prerank,cellular response to superoxide (GO:0071451),0.4592453849856545,0.9398872671553373,0.5437616387337058,0.8793635985406519,1.0,1/10,1.35%,NOS3
prerank,negative regulation of viral life cycle (GO:1903901),0.43068178471990276,0.9396287366508803,0.5504587155963303,0.8792714758371538,1.0,4/15,7.36%,LY6E;SNX3;PPIA;BST2
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),-0.34341962806576964,-0.9395635132498837,0.5567010309278351,0.8906551090746466,1.0,7/22,19.74%,BMP7;FLOT2;WNK1;MAP2K5;CD44;MYADM;THY1
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.40616171008697455,-0.9387967125477875,0.5573394495412844,0.891619359961786,1.0,7/13,18.28%,PKD1;SUFU;PKD2;FLNA;MDFI;LATS1;DBN1
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.42893851377977643,0.9386261667906264,0.5258467023172906,0.8809244797999994,1.0,1/14,0.99%,BCL2L1
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3264662815450428,0.9384470731328252,0.5606060606060606,0.88071691784462,1.0,21/72,23.22%,TIRAP;CARD10;TLR3;PSMB3;PSMD11;BIRC3;PSMC6;MALT1;PSME2;PSMD8;PSMB10;PSMA8;RELB;SKP1;PSMD9;DICER1;CUL1;PSMC3;PSMD1;PSMD10;TRAF6
prerank,negative regulation of cell cycle (GO:0045786),-0.27314616443796613,-0.9381540748984568,0.5850746268656717,0.8922792992023384,1.0,8/73,3.80%,NR2F2;SMAD3;BMP7;BMP4;NUPR1;PTPN3;GAS1;FOXC1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.3454028076156413,-0.9381034769800815,0.5772357723577236,0.8914089146303035,1.0,3/23,2.73%,IGF1;EFNB2;MMP14
prerank,substantia nigra development (GO:0021762),0.35558305471623053,0.9375993333037768,0.5395569620253164,0.8820560071314064,1.0,16/37,24.35%,ACTB;CALM1;INA;DYNLL1;YWHAH;YWHAQ;MAOB;SYPL2;GNB4;MBP;ATP5PF;BASP1;SUDS3;RAD1;PADI2;TTBK1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.3658020853625567,0.9373572648857963,0.5544871794871795,0.8820066434532996,1.0,13/32,25.98%,ARHGEF2;FGF13;STMN1;ATXN7;CDH5;APC;CAMSAP2;DYRK1A;CLASP1;SNCA;CAMSAP1;NAV3;CLASP2
prerank,response to tumor necrosis factor (GO:0034612),0.30967666719640913,0.937323906029849,0.592087312414734,0.881471219702643,1.0,10/91,6.41%,DAB2IP;MAP4K3;GCH1;TNFRSF11A;ARHGEF2;CD40;IKBKB;TNFRSF21;HYAL2;ADAM10
prerank,cell differentiation in hindbrain (GO:0021533),0.44497307353575866,0.9367476200094453,0.5464895635673624,0.8821378678992298,1.0,4/11,17.33%,GRID2;OPHN1;LHX1;PROX1
prerank,mitochondrial translational elongation (GO:0070125),0.310767408513084,0.936387185832722,0.5552447552447553,0.8822801069924258,1.0,35/88,26.76%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C
prerank,mitochondrial membrane organization (GO:0007006),0.37653401781870155,0.9362692265041683,0.5698412698412698,0.8819570608545987,1.0,11/32,24.74%,BCL2L1;SLC25A5;GHITM;SAMM50;HSPA9;CHCHD3;BAK1;BNIP3;TMEM11;MTX1;PMAIP1
prerank,protein K11-linked ubiquitination (GO:0070979),-0.3347413673865883,-0.9357554274034909,0.5574572127139364,0.8965488622096469,1.0,9/27,26.17%,UBE2E2;ANAPC5;PRKN;UBE2E3;UBE2B;CDC16;UBE2S;ANAPC4;ANAPC13
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.3447670493127659,-0.9357462241784354,0.5594405594405595,0.8955712376047059,1.0,8/23,18.36%,AXL;TLR4;NR1H4;RARA;DDIT3;INHA;LAPTM5;C1QBP
prerank,GPI anchor biosynthetic process (GO:0006506),0.3608105042831471,0.9357307303294502,0.5385878489326765,0.882598533026723,1.0,10/30,21.77%,PIGU;PIGM;PGAP4;PIGK;PIGF;DPM3;PIGS;PIGO;PIGV;PIGQ
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.37189833231204505,0.9352678415664896,0.5343137254901961,0.8830383030546416,1.0,11/32,24.87%,CDK17;HINFP;ZPR1;BRD4;CDC6;ORC1;CDK18;POLA1;DHFR;KLF11;TYMS
prerank,embryonic heart tube development (GO:0035050),0.42983165769238785,0.9352374791902462,0.559931506849315,0.882511261510266,1.0,2/14,7.20%,SOX17;SOX18
prerank,negative regulation of chemokine production (GO:0032682),0.42110176224665113,0.9352060072441641,0.5211267605633803,0.8819704645347548,1.0,3/14,6.45%,SIGIRR;LGALS9;KLF4
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.34676813051953415,0.934937324645946,0.5497630331753555,0.8819435003414345,1.0,8/39,9.03%,ACER2;FZD4;CORO2B;ADAM15;NOTCH1;ACTN4;NEXMIF;SPOCK1
prerank,cholesterol homeostasis (GO:0042632),0.32653039731880146,0.9349262580381323,0.5638766519823789,0.8813790475194351,1.0,10/64,11.60%,CAV1;SCARB1;HDAC9;ABCG1;ABCB11;NR1H2;LRP5;NPC1;LIPC;MTTP
prerank,protein localization to centrosome (GO:0071539),-0.3699581755991565,-0.9349152494764909,0.5218390804597701,0.8967166941125068,1.0,11/17,29.48%,GOLGB1;CCDC14;PIBF1;PCM1;SNX10;STIL;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.3804150619732606,0.9348402662431918,0.5471380471380471,0.8809811178137814,1.0,3/27,8.88%,TIRAP;MAP3K1;IRAK2
prerank,protein K63-linked deubiquitination (GO:0070536),0.36427427379847555,0.93475427655535,0.5144230769230769,0.8805562356816109,1.0,10/31,19.25%,ATXN3;SHMT2;OTUD7A;BABAM1;CYLD;TNFAIP3;BRCC3;OTUD4;USP25;OTUD7B
prerank,positive regulation of viral transcription (GO:0050434),-0.3357379325915576,-0.9344177820975148,0.5544794188861986,0.8969406858479523,1.0,8/25,28.83%,MDFIC;POLR2A;NELFE;GTF2F1;POLR2L;CDK9;POLR2I;POLR2K
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3695994289699729,0.9341707411543947,0.5641025641025641,0.8812027320486506,1.0,2/28,1.41%,ESAM;CXCL12
prerank,protein autoprocessing (GO:0016540),-0.3683943888066001,-0.933921485500455,0.5650224215246636,0.8971422707061318,1.0,5/17,17.70%,CTSL;FXN;AFG3L2;HTRA2;CASP4
prerank,central nervous system neuron differentiation (GO:0021953),0.3627359906460053,0.9338194883449069,0.5394736842105263,0.881416614913346,1.0,10/33,19.35%,CTNNB1;MDGA2;GRID2;OPHN1;SPOCK1;TOX;LHX1;PROX1;SIN3A;DRAXIN
prerank,establishment of skin barrier (GO:0061436),0.4223874028242658,0.9335877398576764,0.5496323529411765,0.8807440391922353,1.0,6/15,24.27%,LSR;STMN1;FA2H;HRNR;TMEM79;SFN
prerank,regulation of water loss via skin (GO:0033561),0.4223874028242658,0.9335877398576764,0.5496323529411765,0.8807440391922353,1.0,6/15,24.27%,LSR;STMN1;FA2H;HRNR;TMEM79;SFN
prerank,triglyceride metabolic process (GO:0006641),-0.29462675968579344,-0.9335531959293363,0.6034985422740525,0.8970655056200301,1.0,8/48,15.28%,AGMO;MOGAT3;GK;APOE;LPGAT1;LMF1;GPAT3;PNPLA3
prerank,negative regulation of telomere maintenance (GO:0032205),-0.39183509029294283,-0.9335185341515967,0.5707762557077626,0.8961539554413138,1.0,8/15,25.26%,TNKS2;ATM;RTEL1;PARP1;ERCC1;RAD50;NBN;TNKS
prerank,peptidyl-serine modification (GO:0018209),0.2833048599404463,0.9334472690503341,0.5908529048207664,0.8804721382637616,1.0,33/166,18.02%,PRKCH;NDNF;PDGFB;STK38;PKN3;RPS6KA1;PRKD1;PRKD2;IKBKB;MAST4;PKN1;RPS6KA5;PKN2;MARK3;HPF1;STK32C;PRKCB;TGFBR2;HIPK2;NAA11;VRK1;SGK1;HIPK3;PLK2;SGK3;SGK2;MAPK1;GAS6;POGLUT1;PRKCG;PRKCE;TBK1;PAK2
prerank,regulation of spindle organization (GO:0090224),-0.36503961492277315,-0.9330423294068726,0.5501165501165501,0.8964223340628138,1.0,9/18,38.05%,PARP3;GPSM2;SENP6;RAE1;TPX2;NUMA1;PSRC1;TACC3;NUP62
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2539016339495394,-0.9327047154666107,0.6439393939393939,0.8962604809386233,1.0,20/96,11.13%,EPHA7;NUPR1;SLC30A10;SNX6;PRKCI;PPARGC1A;NGF;SIX1;NRBP2;EGLN3;NFATC4;BCL2;SOD2;PRKN;APOE;KDM2B;FOXO3;TGFB3;CLN3;PTK2B
prerank,regulation of muscle cell differentiation (GO:0051147),0.36578464528256105,0.9323949803256557,0.543613707165109,0.8821528840408925,1.0,6/31,7.40%,MEF2C;CDH2;HDAC9;CTNNB1;TCF23;SPAG9
prerank,response to endoplasmic reticulum stress (GO:0034976),-0.25683909852658027,-0.9323714585910149,0.648854961832061,0.8961262182820446,1.0,29/107,19.11%,ITPR1;CREB3L2;THBS1;MAP3K5;ATG10;TMEM117;RCN3;BCL2;TMEM259;PRKN;SELENOS;CREB3L1;CEBPB;GORASP2;HSP90B1;SCAMP5;SEC16A;SYVN1;PIK3R1;P4HB;DDRGK1;UFC1;RASGRF1;ATP2A3;DDIT3;CASP4;MBTPS1;USP19;ATP2A2
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.3911247470932921,-0.9321033102209222,0.5513392857142857,0.8958301382517516,1.0,3/13,10.04%,RNF152;ATM;STK11
prerank,chromatin organization (GO:0006325),0.29360943448856064,0.9318400443632172,0.578005115089514,0.8827491640844176,1.0,24/132,16.58%,MECOM;SMARCA2;NPM3;BAZ2B;NPM2;PWWP3A;FOXP3;ARID1A;CHD1;HCFC2;PAK1;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;SETDB1;SOX9;HMGB2;HDAC5;LOXL2;SMARCAD1;HCFC1;HMGA2
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.30752694710371,-0.9317896173738391,0.5591939546599496,0.8955477565175447,1.0,10/37,13.66%,PRKAG2;CEMIP;BMP7;AXIN1;SPRED1;PPEF2;SPHK1;DMTN;S1PR2;SIRT2
prerank,negative regulation of cellular catabolic process (GO:0031330),0.3270734204351943,0.9303544091188366,0.5720720720720721,0.8854665500379844,1.0,4/63,2.62%,MFSD2A;DAB2IP;RASIP1;TBC1D14
prerank,respiratory chain complex IV assembly (GO:0008535),0.3918906033316576,0.9301639589214985,0.5405405405405406,0.8852926185918714,1.0,14/21,31.35%,SCO2;SCO1;COA6;COA3;SMIM20;COX10;COX20;COX17;COX15;PET100;TIMM21;COA5;BCS1L;COA8
prerank,regulation of leukocyte migration (GO:0002685),-0.3721980858240851,-0.9299749971480972,0.5657894736842105,0.8991970050673586,1.0,4/16,19.97%,HOXA7;ANXA1;CD81;RHOH
prerank,positive regulation of actin filament polymerization (GO:0030838),-0.29327135013519096,-0.9298931544970949,0.5862068965517241,0.8983899214168948,1.0,9/44,11.13%,GSN;FCHSD2;CARMIL1;CDC42EP4;CDC42EP5;SNX9;PFN2;LMOD1;PTK2B
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.37735272185190305,0.9297350358147084,0.5575079872204473,0.8856432226207231,1.0,5/28,10.45%,DAB2IP;SORT1;CRADD;DEDD2;CASP8
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.32303153177471056,0.9295141487073215,0.5514705882352942,0.8855280777481962,1.0,1/59,0.03%,LEF1
prerank,chemical homeostasis (GO:0048878),-0.27233579921041046,-0.9293701785462898,0.6442307692307693,0.8987761566722916,1.0,14/61,15.36%,ZBTB20;SLC4A10;RBP1;NR1D2;WNK4;THADA;IRS2;SLC4A7;SLC4A2;TLCD2;WNK1;DDX3X;PNPLA3;SLC4A3
prerank,regulation of response to interferon-gamma (GO:0060330),0.42217711765884913,0.9293421776833426,0.5262206148282098,0.8852890068985936,1.0,7/14,24.58%,HSP90AB1;STAT1;SUMO1;IFNGR1;PARP9;SOCS1;IFNGR2
prerank,negative regulation of autophagy (GO:0010507),-0.2817523129019254,-0.9291705800866329,0.5804597701149425,0.8982894325576108,1.0,18/54,20.39%,LEPR;NUPR1;KLHL22;NRBP2;SNRNP70;DAPL1;BCL2;GOLGA2;MET;PTPN22;LRRK2;SIRT2;RRAGA;SMG1;CTSA;SMCR8;EIF4G1;TSC1
prerank,cation transport (GO:0006812),0.2849280393470574,0.9289679727286367,0.585,0.8855053697158837,1.0,19/167,10.87%,SLC6A6;SLC7A1;SLC1A1;SLC38A5;NEDD4L;FGF13;PIEZO1;MCOLN1;ATP1A4;KCNK6;KCNG2;CHRNB1;SCN1A;KCNN2;SLC3A2;NDFIP2;KCNV1;LRP2;KCNA4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.32983717158205733,0.9287755788900475,0.5521739130434783,0.8853578691924605,1.0,6/50,6.48%,SH3RF1;PLAUR;RPS6KA1;XIAP;KLF4;RFFL
prerank,CENP-A containing chromatin organization (GO:0061641),-0.32115816839544525,-0.9286613678057392,0.5808219178082191,0.8975869500480109,1.0,8/29,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.32115816839544525,-0.9286613678057392,0.5808219178082191,0.8975869500480109,1.0,8/29,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,regulation of lipid kinase activity (GO:0043550),0.4462149475010918,0.9285004479170315,0.5422794117647058,0.8853684172888882,1.0,3/11,15.45%,PIK3R3;PPP2R5A;RBL1
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3735594738126125,0.9284793790226857,0.5501672240802675,0.8848207265800523,1.0,15/28,30.47%,STMN1;MAPRE2;STMN3;STMN4;MAPRE3;CAMSAP2;CLASP1;GAS2L1;CAMSAP1;ARL2;CLASP2;PRUNE1;STMN2;SKA3;FKBP4
prerank,cellular response to interferon-beta (GO:0035458),0.4277174822805816,0.9283307717536285,0.5406360424028268,0.8845605099981596,1.0,3/14,8.17%,AIM2;STAT1;IRGM
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4467426743057018,0.928280841418868,0.5559633027522936,0.8840718125515697,1.0,1/11,1.47%,NOVA2
prerank,icosanoid biosynthetic process (GO:0046456),0.4436361007791537,0.9280716829798661,0.5517241379310345,0.8839325528161487,1.0,2/10,13.41%,MGST2;LTA4H
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.31831838615010594,0.9280483745856513,0.596045197740113,0.8833940723037133,1.0,6/77,6.64%,ITGA6;BCL2L1;SH3RF1;PLAUR;SLC25A5;MCL1
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3742784217267661,0.9279170058716664,0.5771812080536913,0.8830955255777038,1.0,10/29,25.85%,PLA2G4B;NR1H2;LPCAT3;PNPLA8;MBOAT7;LPCAT2;MBOAT2;LPCAT4;TMEM86B;LPCAT1
prerank,T cell activation (GO:0042110),0.31489297503358443,0.9277979956614621,0.6125730994152047,0.8827669040769934,1.0,14/69,11.80%,JAG2;ZAP70;DLL4;CCR7;CD4;FOXP3;CD8B;MSN;EIF2AK4;CASP8;PPP3CA;GPR89A;GPR89B;TNFRSF4
prerank,regulation of fat cell differentiation (GO:0045598),0.31367430989675715,0.9276752709179814,0.5922190201729106,0.8824569941885686,1.0,16/74,12.84%,PPARD;FOXO1;ZFPM1;CCDC85B;ZBTB16;GATA2;NOCT;CREB1;WWTR1;TGFB1;LRP5;TRIB2;FERMT2;PTPRQ;ZFP36L1;PPARG
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.34657140697531064,-0.9276425506110412,0.5651105651105651,0.8992514075378214,1.0,9/21,28.91%,MITF;MED14;TWIST1;MED30;BCLAF1;MED4;MED24;MED16;DHX36
prerank,female gonad development (GO:0008585),-0.35621335959540734,-0.9275005771109616,0.5763888888888888,0.8986057885512324,1.0,5/19,17.72%,NR2F2;KIT;CEBPB;INHBB;INHA
prerank,positive regulation of phosphatase activity (GO:0010922),0.3875025655759605,0.9272504519285688,0.5609756097560976,0.8827554911356678,1.0,4/21,5.03%,ITGA1;MEF2C;CALM1;HSP90AB1
prerank,DNA conformation change (GO:0071103),-0.36862337502275433,-0.9271335182605764,0.5714285714285714,0.8985523546915811,1.0,4/17,11.95%,TOP2B;TOP1;HAT1;ABL1
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.4636079104481185,0.927052726689277,0.562152133580705,0.8826007717140213,1.0,2/10,1.75%,ENG;CAV1
prerank,regulation of intracellular transport (GO:0032386),-0.30566770446359093,-0.926990305056555,0.5702005730659025,0.8979089180414168,1.0,9/38,16.16%,ATP9A;GAS1;GRIPAP1;LRRK2;SCFD1;NEFH;MAP2;RAB11B;CRYAB
prerank,neuron projection morphogenesis (GO:0048812),0.29030848539222204,0.9269760560825977,0.6153846153846154,0.8821855556122009,1.0,23/137,9.61%,SHANK3;SRGAP2;DAB2IP;APP;KLF7;PARD3;NTNG2;DSCAML1;ACTB;WNT7A;CTNNB1;BAIAP2;DIP2A;DBNL;NCKAP1;SLITRK3;DNM2;SLITRK1;GPM6A;IQGAP1;PAK1;SLC9A6;EIF2AK4
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.34464215056505676,0.9269613093065657,0.5584,0.8816338790137631,1.0,13/40,20.02%,PTK2;GNA12;FBXW7;RPS7;SMURF1;HIPK2;RPL11;TRIM39;RNF139;RAD23A;FOXF2;RPL23;DESI1
prerank,negative regulation of phosphate metabolic process (GO:0045936),-0.34377017544321253,-0.9266868584431037,0.5395033860045146,0.8976598733026199,1.0,2/22,1.89%,BMP7;BMP4
prerank,striated muscle tissue development (GO:0014706),0.3663395410561271,0.9263479101591784,0.5607779578606159,0.8824184410195257,1.0,4/29,2.75%,BMPR2;PGM5;CAV1;MEF2C
prerank,positive regulation of cilium assembly (GO:0045724),0.407103257260658,0.9260347598595692,0.5575539568345323,0.8825440878151815,1.0,6/18,17.99%,ZMYND10;CCDC88A;CCP110;MARK4;CEP135;KCTD17
prerank,intestinal lipid absorption (GO:0098856),-0.3987003346806671,-0.9259772195966217,0.5567685589519651,0.8984603251554214,1.0,7/11,49.30%,LDLR;CD36;SOAT2;AKR1C1;ABCG5;UGCG;NPC1L1
prerank,Wnt signaling pathway (GO:0016055),0.3099113280134838,0.9259571996338738,0.5767045454545454,0.8821401184480135,1.0,7/92,5.83%,LEF1;FZD6;FZD4;WNT7A;SNX3;CTNNB1;TCF7
prerank,neurotransmitter transport (GO:0006836),0.31175215222616076,0.9257944751194793,0.60056258790436,0.8819366122174751,1.0,9/73,10.71%,SLC1A1;SLC6A2;UNC13B;STX1A;SLC1A2;STXBP1;NRXN1;DNAJC5;HSPA8
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.41330523300342076,-0.9254710647140457,0.5711111111111111,0.8987704801578927,1.0,2/12,4.68%,BMP4;PTPN14
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.37091647176717196,0.9253392369062176,0.5524590163934426,0.8823724452724143,1.0,8/28,13.14%,EGFL7;GATA2;DLL4;FBXW7;RITA1;DLK2;ZBTB7A;ARRDC1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.419793434215367,0.9250966121578904,0.5602189781021898,0.8823270355157822,1.0,4/15,10.22%,GRB2;SORT1;SOS1;DDIT4
prerank,nuclear membrane organization (GO:0071763),-0.3564753300291901,-0.9249177003765445,0.5654205607476636,0.8991505915539725,1.0,7/19,23.93%,AKAP8L;TOR1AIP1;EMD;VPS4A;GPER1;UBXN2A;TMEM43
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.3113997511367639,-0.9246800086579978,0.5984848484848485,0.8987751325213037,1.0,7/33,11.95%,MAP3K5;IMPACT;PRKCD;ANXA1;CYP1B1;FXN;ABL1
prerank,response to growth factor (GO:0070848),0.34549390119250045,0.924607459823814,0.5621019108280255,0.8827459076154389,1.0,8/41,12.34%,PDGFB;BMPR2;ACVRL1;CTNNB1;KLF4;TWF2;LRP2;TGFBR2
prerank,secretion (GO:0046903),-0.39422949501065524,-0.9243635609938968,0.5627906976744186,0.898586301605953,1.0,4/14,4.51%,FBLN5;SLC22A4;PRKCI;SLC22A6
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2855290954527645,0.9237595840573543,0.610062893081761,0.8840054455004343,1.0,34/161,14.80%,DAB2IP;FZD6;CAV1;ANKRD6;MCC;SOX17;NKD1;FZD4;SOX13;ZNRF3;CTNND1;NOTUM;WWTR1;SNAI2;PSMB3;TLE4;PSMD11;TMEM88;PSMC6;GREM1;PSME2;AMER2;AXIN2;PSMD8;GSK3A;SHISA6;TLE1;CYLD;STK3;SOX9;PSMB10;RBX1;TPBG;TMEM131L
prerank,negative regulation by host of viral transcription (GO:0043922),0.4268693784472294,0.9232140777511372,0.5577617328519856,0.8846614979980278,1.0,5/12,21.71%,JUN;HMGA2;TFAP4;INPP5K;PSMC3
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.2998837277600677,-0.9232086549078214,0.5872576177285319,0.9005291727720486,1.0,11/38,18.52%,PRKN;NPEPPS;RNF31;HUWE1;LRRK2;LMAN1;ATP5IF1;HTRA2;SREBF1;PARL;ABLIM3
prerank,positive regulation of organelle organization (GO:0010638),-0.31041998637746404,-0.9230625963093415,0.5745192307692307,0.8999094280112522,1.0,11/32,20.22%,ANXA2;PPARGC1A;ANXA1;STX18;LMAN1;HTRA2;SURF4;RAB3GAP2;SMCR8;C2CD5;ATL3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.34791774461182307,-0.9230517265514371,0.5795724465558195,0.8989557443639546,1.0,2/21,2.79%,SAMD4A;TUT4
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.40970273131636514,0.9230269446172464,0.5602968460111317,0.8845027230191939,1.0,4/15,10.43%,TJP1;KLF4;PKM;SMAD1
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.36971076674405123,0.9229205500278238,0.5687789799072643,0.8841424783201972,1.0,11/29,23.35%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3;TICAM2;RIPK1
prerank,cilium organization (GO:0044782),-0.2283005121535743,-0.9228636783677079,0.7175141242937854,0.898418793596365,1.0,52/210,18.96%,PARVA;GSN;CYS1;CC2D2A;DCDC2;PKD1;WDR35;IFT80;GBF1;DYNC2I1;IFT81;WDPCP;ARL3;PKD2;CDC14B;DZIP1;DZIP1L;IFT74;CCDC57;TTC39C;FLNA;PTPDC1;DYNC2H1;CFAP44;TTC8;IFT122;CEP164;FUZ;ARMC9;EHD1;BBS9;LZTFL1;TRAPPC14;CLUAP1;MKKS;PIBF1;PCM1;RILPL2;WDR19;AHI1;DYNC2I2;RP2;EHD2;SNX10;TMEM231;SCLT1;INTU;ABLIM3;CFAP70;CEP20;RPGR;CENPJ
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.36385693065485236,-0.9227908372208173,0.5829383886255924,0.897625980666462,1.0,2/18,2.04%,ROCK2;SLC2A13
prerank,signal peptide processing (GO:0006465),-0.4065366163014408,-0.9226201443973034,0.5815899581589958,0.8970884484480939,1.0,3/11,17.16%,PCSK5;HM13;PARL
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.38820200149948614,0.9225605487487324,0.5680672268907563,0.8843458350537916,1.0,8/23,19.18%,FOXL2;CECR2;DFFB;HMGB2;DNASE2;EXOG;ENDOG;DICER1
prerank,positive regulation of cell communication (GO:0010647),-0.3203290446534741,-0.9225349163881758,0.5919395465994962,0.8963221033666862,1.0,3/28,7.03%,WLS;CLSTN2;DLG4
prerank,positive regulation of neuron death (GO:1901216),-0.285839280453278,-0.9222974402600523,0.5702005730659025,0.8959734623497618,1.0,10/46,17.46%,EPHA7;EFNB2;NUPR1;MAP3K5;FOXO3;NF1;TLR4;SARM1;GRN;DDIT3
prerank,presynaptic endocytosis (GO:0140238),0.3816286379629755,0.922175891205894,0.5592920353982301,0.8846339046589579,1.0,7/24,15.89%,STX1A;PIP5K1C;FCHO2;OPHN1;AMPH;NLGN1;SYNJ1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4560399380676149,0.9216015167754845,0.5566037735849056,0.8852546088859812,1.0,3/10,14.70%,FOXP3;VSIR;NCKAP1L
prerank,proteasome assembly (GO:0043248),0.44449813683691886,0.9215757367275857,0.5656370656370656,0.8847317626771081,1.0,5/11,27.30%,POMP;PSMD11;PSMD9;PSMD10;ADRM1
prerank,regulation of monocyte differentiation (GO:0045655),0.4208564517202766,0.9214257421806875,0.5743494423791822,0.8844560329074045,1.0,3/14,5.26%,FES;CTNNBIP1;CD4
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),-0.3281288823592717,-0.9210520802924549,0.5558375634517766,0.898106483922176,1.0,5/25,13.43%,UGGT2;FBXL17;CUL3;KLHL15;AUP1
prerank,regulation of nervous system process (GO:0031644),0.39544019286589743,0.9210163292295396,0.5822784810126582,0.8847572853307335,1.0,2/18,1.57%,NOS3;APP
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.32730286482439325,0.9209861220655923,0.5739910313901345,0.884236466975466,1.0,14/56,17.09%,SPTBN1;EFHC2;STMN1;RHOB;CECR2;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;ANK3;SPAST;MYH10
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.4099385059816589,-0.9202563587518259,0.572354211663067,0.8992324161740628,1.0,4/12,16.49%,GLI2;EPHB2;NFIB;TSKU
prerank,negative regulation of hemostasis (GO:1900047),-0.40092248391548635,-0.9196747528291476,0.5492341356673961,0.8996288710535664,1.0,4/12,8.01%,TFPI;VTN;THBD;APOE
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2841836596929676,-0.9191740750719279,0.6109510086455331,0.8989882490241092,1.0,17/50,29.31%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2841836596929676,-0.9191740750719279,0.6109510086455331,0.8989882490241092,1.0,17/50,29.31%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;EIF4G1;RAE1;POLR2L;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.4077465762646809,-0.9188043756048637,0.5491990846681922,0.8989545417793652,1.0,5/10,30.70%,GALNT16;POGLUT2;GALNT1;GALNT3;MGAT5B
prerank,regulation of protein ubiquitination (GO:0031396),0.29858429999128483,0.9187039401375297,0.6260623229461756,0.8885978097306961,1.0,28/108,19.64%,IVNS1ABP;CAV1;SMAD7;HSP90AB1;XIAP;FAM107A;FBXW7;N4BP1;BIRC3;MALT1;NDFIP2;UBXN1;UBQLN1;GSK3A;DCUN1D1;TNFAIP3;BCL10;DNAJA1;INAVA;BAG2;SIRT7;FOXF2;PTTG1IP;PRKCG;UBE2D1;FKBP1A;NSMCE3;PRR7
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.3846507658174918,0.9185559524332901,0.5803722504230119,0.8883109371963482,1.0,8/22,14.25%,LYN;ABCG1;EPHA4;EFNA1;AGER;GSK3A;RANBP9;SP1
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.318823071380578,0.9181761472957547,0.5859598853868195,0.8885655971229991,1.0,28/72,25.37%,IFNAR2;SIGIRR;IKBKB;PALM3;HSP90AB1;STAT1;BIRC3;IRAK2;LIFR;SHARPIN;CASP8;CBFB;USP18;SYK;CYLD;TNFAIP3;GAS6;SUMO1;SPPL2A;RBCK1;IFNGR1;RACK1;SOCS1;ABCE1;RIPK1;IFNGR2;TRAF1;TRADD
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.405922112623558,0.9176010125628222,0.5716723549488054,0.8891432048825985,1.0,5/17,6.71%,NOTCH4;PLXND1;NOTCH1;MAML2;STAT1
prerank,negative regulation of immune system process (GO:0002683),-0.3646173218750648,-0.9173814383208777,0.580952380952381,0.9016138659553297,1.0,3/16,7.33%,COL3A1;HOXA7;IL17D
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3764554255457866,0.917292859397943,0.5774410774410774,0.8892759987861094,1.0,9/24,21.66%,TERF2;HNRNPC;ACD;DCP2;TERF1;EXOSC10;XRN1;ERCC4;PINX1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.2652512804630461,0.9172835655443647,0.6712485681557846,0.888710420918781,1.0,104/306,26.51%,B4GALT5;ALAS1;PTMA;SARS1;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;RPS29;MRE11;FUT9;MRPL10;RPL36A;NKX2-8;RPL3;RNPS1;YARS2;RPL27;RPSA;RPS7;PWP1;RPL9;RPL18;RPLP2;GTPBP1;MCM10;DNA2;RPL13A;CDC6;RPS11;RECQL4;RPL8;RPS27;RPL19;RPS9;MRPL28;ORC1;RPL11;EEFSEC;RPS15;SRBD1;RPL37;RPS28;RPS10;POLE3;EEF1D;RPS25;RPL37A;MRPL9;COPS5;HUS1;RPL15;POLR2J;TNIP1;RPA1;SET;MRPL23;RPL17;RPL23;RPL34;FARSB;RPS18;RAD9B;POLL;POLD1;GRWD1;RPL21;POLA1;RPS4X;MRPS18A;RFC2;RPL18A;RAD1;DHPS;RPS21;RPL10A;GTPBP2;EEF1B2;ING4;RAD17;RSL24D1;RPL24;RPL7A;ING5;TOPBP1;MRPL41;MRPL27;MRPL51;TYMS;HARS1;RFC4;RPL32;RMI1;RPL4;UPF1;RPS2;MRPS33;BLM;MEF2A;MRPL37;RPS20;RPL6;RPS13
prerank,meiosis I (GO:0007127),-0.33847914843941246,-0.9172426855931202,0.5626535626535627,0.9009728611229202,1.0,10/23,30.21%,FOXJ2;FOXJ3;ZSCAN21;HSF2BP;MYBL1;ZCWPW1;SGO1;TDRD9;DDX4;MEIOB
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.3002911744719453,-0.9172156564657812,0.5940298507462687,0.9000669189956498,1.0,9/38,21.32%,BMP6;PRKCA;CYBA;SLC15A4;POLR3G;GRN;PLSCR1;ADAM8;USP15
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.43777344324096046,0.916918759761955,0.5680147058823529,0.8889050654571717,1.0,2/12,3.96%,TRIM16;KLF2
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.3633405386205385,-0.9168986487019032,0.5710900473933649,0.8999159488301505,1.0,2/18,3.76%,UGGT2;AMFR
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.3463301332826295,-0.9161660006222074,0.5714285714285714,0.9007016682303873,1.0,6/21,15.68%,DAG1;ADAM9;BACE2;ADAM19;PSEN1;HM13
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3808111200357745,-0.9149351584577626,0.5874439461883408,0.902757605229815,1.0,4/13,10.71%,ACSL1;ANO6;CLIP3;AZIN1
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3118551183782817,0.9147497613099344,0.590782122905028,0.8929666854289569,1.0,9/76,8.88%,DAB2IP;NFKBIA;CD200;NLRC5;TMSB4X;KLF4;AIM2;FOXP3;IRAK2
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.2724280905138609,-0.9146127626221235,0.6285714285714286,0.9025833720745184,1.0,10/66,6.43%,EGFR;APPL2;KANK2;FHL1;UBE2E2;PKD1;PKD2;DLG1;ANXA1;DACT1
prerank,response to sterol (GO:0036314),-0.40233480946701916,-0.9145507902351562,0.5822222222222222,0.9017639659966229,1.0,2/11,4.86%,TGFBR1;RORA
prerank,embryonic appendage morphogenesis (GO:0035113),0.4250733961710193,0.9144277486400298,0.5669724770642202,0.8931039206941895,1.0,1/12,1.32%,TGFB2
prerank,positive regulation of vacuole organization (GO:0044090),-0.3999440397012189,-0.9143865969852731,0.5688259109311741,0.9011994523715333,1.0,5/10,16.97%,ANXA2;LRSAM1;PIP4K2C;RAB3GAP2;GRN
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.41339776796071076,-0.9140941838834656,0.5726315789473684,0.900933768133175,1.0,2/10,2.82%,LRP1;APOD
prerank,cell projection assembly (GO:0030031),0.38305985325961084,0.9140196610746532,0.5508771929824562,0.8933834306594879,1.0,8/22,14.70%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.33917728334728015,0.9136129848362141,0.573170731707317,0.8936850879408033,1.0,10/43,12.42%,DAB2IP;ITGA1;PTPRJ;DUSP3;GRB2;TGFA;ARHGEF7;SOCS5;EPS15;HGS
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.3347168914993953,-0.9135637437653279,0.5623529411764706,0.9012934251753225,1.0,4/22,11.14%,ROCK2;PPP4R4;PTPA;CRY2
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3530127260608302,0.9133636107459134,0.5872274143302181,0.8936667439297078,1.0,7/34,11.43%,LIMS2;DOCK1;NEDD9;RREB1;ARHGEF7;FERMT2;RAC1
prerank,response to retinoic acid (GO:0032526),0.31768415490609053,0.9133274308353999,0.5958395245170877,0.8931610605645212,1.0,11/59,11.20%,ACER2;TRIM16;TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,regulation of actin filament-based process (GO:0032970),0.30912714889439574,0.9129344892087854,0.6031294452347084,0.8934246039303796,1.0,16/70,11.99%,RHOBTB1;HIP1R;F11R;CORO2B;RHOB;CCDC88A;BAIAP2;FAM107A;BST2;ARHGEF5;TWF2;IQGAP1;PAK1;ARHGAP17;RAC1;RND1
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.416390844641538,0.9127521133499595,0.5789473684210527,0.8932288135043182,1.0,1/15,1.82%,REEP1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3962551719331325,0.9122661879251411,0.5448028673835126,0.893709104722863,1.0,5/17,15.44%,HDAC9;SORT1;NR1H2;LIPC;ANGPTL4
prerank,cellular response to chemical stress (GO:0062197),-0.2537758139773617,-0.9121540417864424,0.6553030303030303,0.9038704760962191,1.0,22/96,14.30%,PRKAA2;MGAT3;CPEB2;PPARGC1A;PKD2;STX2;SOD3;GPX8;SOD2;NOX4;SELENOS;ATM;SLC25A24;FOXO3;CYBA;PARP1;LRRK2;TMEM161A;ABL1;SIRT2;HTRA2;DDX3X
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2739272283340257,-0.9120497062155948,0.6209912536443148,0.9031619292978086,1.0,20/59,25.33%,ROCK2;PRKCD;CAMK2D;TGFBR1;MAP3K12;PDPK1;PRKCA;LRRK2;WNK1;ACVR1B;DYRK2;CDC42BPG;SBK1;WNK3;CSNK2A1;CDK5;MAP2K1;CDK10;TNKS;CIT
prerank,mitochondrial translation (GO:0032543),0.29491381855062215,0.9120448501263512,0.5994659546061415,0.8936136366798693,1.0,45/104,28.71%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MTIF3;GFM1;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;GATC;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;IARS2;MRPL51;HARS1;MRPL49;MRPS33;MRPL37;MRPL2;NDUFA7;MRPS18C;QRSL1;MRPL15;LARS2;MRPS34;MRPS12
prerank,regulation of ion transmembrane transporter activity (GO:0032412),-0.2963277260909359,-0.9120126370145762,0.628808864265928,0.9022890777638187,1.0,8/39,13.20%,ANK2;FHL1;PTPN3;CACNA1D;TRPC6;WWP2;GPD1L;FXYD1
prerank,toll-like receptor signaling pathway (GO:0002224),0.3060878005263202,0.9118375452177366,0.6133518776077886,0.8934695175211821,1.0,24/84,20.16%,TIRAP;MAP3K1;IKBKB;TLR3;TRIL;LGALS9;CTSK;TLR7;BIRC3;IRAK2;PIK3C3;CASP8;TLR8;S100A8;BCL10;RFTN1;UBE2D3;CTSS;TNIP1;UBE2D1;TRAF3;NMI;PLCG2;RPS6KA3
prerank,regulation of Golgi organization (GO:1903358),0.40999906371108574,0.9113056045617589,0.5753424657534246,0.8940060214442238,1.0,6/17,17.98%,USP6NL;MAPK3;AKAP9;PDCD10;MAPK1;CAMSAP2
prerank,regulation of inclusion body assembly (GO:0090083),-0.4032308108741346,-0.9112886969750555,0.5726315789473684,0.9030888384344696,1.0,1/11,0.93%,SNCAIP
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.35881362817336493,-0.9109865470703348,0.5933806146572104,0.9028693763539712,1.0,3/17,7.70%,CD55;IL18;JAG1
prerank,"DNA-templated transcription, initiation (GO:0006352)",-0.23386729521595584,-0.9107690360346393,0.714975845410628,0.9023972939584659,1.0,36/166,17.91%,NOTCH2;RARB;CCN2;TEAD1;NR6A1;THRB;NOTCH3;NR1D2;PPARGC1A;RBPJ;RORA;TBL1XR1;AR;PPARA;MED23;TEAD3;POLR2A;NR3C2;YAP1;CCNH;NR2F1;RXRA;TAF8;CDK7;ESR1;PGR;SMARCA5;TAF1D;NR4A1;E2F3;GTF2F1;NR1H4;POLR1C;RARA;TAF9B;NRBP1
prerank,regulation of oxidative phosphorylation (GO:0002082),0.40089764351438195,0.9099223484882079,0.5754884547069272,0.8963527290663018,1.0,5/16,10.97%,AK4;SLC25A33;SHMT2;PDE12;ABCD1
prerank,positive regulation of viral life cycle (GO:1903902),-0.3310133761486838,-0.9099188680923357,0.6,0.9035689962268214,1.0,6/22,18.69%,AXL;LGALS1;TSG101;FMR1;P4HB;VPS4A
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.30529928795748035,0.9099108632487434,0.6159029649595688,0.8957913546009805,1.0,28/85,25.04%,RNF144B;DAB2IP;SMAD7;ATXN3;FBXW7;PSMC6;HECTD1;SOCS5;TRIB2;GSK3A;RBX1;BAG2;ELOB;RAD23A;SUMO1;BAG6;RNF19A;CBFA2T3;GABARAP;PSMC3;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;OSBPL7;KEAP1
prerank,positive regulation of phospholipid transport (GO:2001140),0.4556177179629112,0.909553264564602,0.5708812260536399,0.895980162657445,1.0,4/10,17.31%,ABCA3;ABCA7;TMEM30A;TRIAP1
prerank,melanosome organization (GO:0032438),-0.32785709844908684,-0.9093026680931982,0.5897435897435898,0.904130051314155,1.0,16/26,38.31%,DTNBP1;AP3B1;RAB29;BLOC1S2;LYST;BLOC1S6;BLOC1S5;HPS4;HPS1;BLOC1S4;KIF13A;RAB38;PMEL;GPR143;AP1M1;RAB32
prerank,B cell activation involved in immune response (GO:0002312),0.42595569115339144,0.9085800519352385,0.5900178253119429,0.8974813890969379,1.0,3/13,15.56%,CD19;RNF8;MSH2
prerank,mammary gland epithelium development (GO:0061180),-0.37996169674378255,-0.9085586804226765,0.5751173708920188,0.9048979343676776,1.0,6/14,32.42%,WNT4;LATS1;ID2;WNT2;WNT3;IRF6
prerank,regulation of aerobic respiration (GO:1903715),0.4055059440433989,0.9085116436977487,0.5806451612903226,0.8970516873824074,1.0,4/15,10.97%,AK4;SLC25A33;SHMT2;ABCD1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.32221828441129313,-0.9085089717870771,0.5957446808510638,0.90407287603012,1.0,6/27,11.14%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.3462584937074638,0.9084228256195928,0.5872274143302181,0.8966638792762442,1.0,4/36,6.73%,DAB2IP;RYBP;PHC1;MAX
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.3629841457589307,0.9083003544213518,0.6031007751937985,0.8963388661684168,1.0,9/30,19.03%,CD40;IKBKB;TLR3;BIRC3;CASP8;UBE2D3;TBK1;UBE2D1;TRAF3
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.30611406104632083,0.9081010527367401,0.615606936416185,0.8961925120607046,1.0,13/78,12.53%,PDGFB;CCNY;RGCC;MEN1;ACTB;HHEX;CDKN2B;CCNI;CCND3;ADAM17;CDC6;CCNK;MAPRE3
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.41619512217058985,0.9080911378098764,0.5499124343257443,0.8956311635720299,1.0,5/15,18.10%,CCT3;CCT5;NHP2;CCT7;NAF1
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.4134899611109746,-0.9076365785013438,0.5883668903803132,0.9053098395246195,1.0,4/10,26.10%,DDIT3;QRICH1;CCL2;EIF2AK3
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.37941324076844746,-0.9075924644964918,0.5478260869565217,0.9044901837481663,1.0,5/13,21.90%,SAR1A;SEC16B;SEC16A;CD81;EDEM2
prerank,negative regulation of coagulation (GO:0050819),-0.38275496857788227,-0.9073733552494804,0.5507900677200903,0.9040608797132655,1.0,4/14,8.01%,TFPI;VTN;THBD;APOE
prerank,cellular respiration (GO:0045333),-0.29527364256446875,-0.907372944062699,0.6176470588235294,0.9031182462100835,1.0,17/41,25.63%,PPARGC1A;SIRT3;SDHC;MDH2;SDHB;COQ10A;UQCRFS1;MTFR1;SLC25A14;NDUFS1;SURF1;MTFR2;COQ10B;UQCRC2;NR4A3;LYRM7;NDUFS8
prerank,"phototransduction, visible light (GO:0007603)",0.41956467186403595,0.9073653959604425,0.5870736086175943,0.8965803352483159,1.0,3/14,12.40%,GNAQ;RP1;GNB1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.41890227165868216,0.907244716662626,0.5594149908592322,0.8962575239722993,1.0,3/13,4.51%,NOS3;TMSB4X;NOS2
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.40053477006842186,0.9072072123843605,0.5985915492957746,0.8957553907045557,1.0,7/16,28.81%,SNRPC;NCBP2;DCPS;WBP11;SRSF12;SFSWAP;SRSF1
prerank,negative regulation of bone mineralization (GO:0030502),-0.3827092773573353,-0.9071629718486639,0.5957943925233645,0.9026851307911573,1.0,5/13,11.13%,ENPP1;BCOR;ECM1;TRPM4;PTK2B
prerank,apoptotic cell clearance (GO:0043277),-0.3120023989744226,-0.9068824124458764,0.600997506234414,0.9024256737471521,1.0,7/30,10.36%,LRP1;THBS1;XKR4;ANXA1;RHOBTB2;TXNDC5;ITGAV
prerank,mitochondrion distribution (GO:0048311),-0.3951805144030891,-0.9068190599870404,0.5799086757990868,0.901627587517404,1.0,2/12,11.10%,TRAK1;LRRK2
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.4032099687933751,-0.9064463736258653,0.582392776523702,0.9015686888826185,1.0,3/10,10.12%,ABCA1;APOE;PRKACA
prerank,actin filament bundle organization (GO:0061572),0.3483622129204605,0.9063060626075565,0.5633116883116883,0.8970351106582936,1.0,7/33,6.17%,SHROOM1;NEDD9;PLS3;RFLNB;EPS8;BAIAP2;FAM107A
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3737554810786471,-0.906272609797283,0.6132478632478633,0.9010238345333393,1.0,7/14,26.81%,IL18;ANXA1;RARA;CD80;PRKCZ;CCL19;CD86
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.3573729886635847,-0.9061394312226452,0.5833333333333334,0.9003895121100353,1.0,8/17,25.22%,SELENOS;HSP90B1;SYVN1;AUP1;HM13;SEC61B;DERL1;UFD1
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.3701829373379003,0.9061186332416433,0.5921052631578947,0.8968614581993898,1.0,4/24,7.40%,MEF2C;CDH2;CTNNB1;SPAG9
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.32954965794395447,-0.9059858483671352,0.5909090909090909,0.8998002331659457,1.0,2/25,1.47%,ANK2;CEMIP
prerank,positive regulation of cyclase activity (GO:0031281),-0.38168496428300236,-0.9059255887697024,0.5908096280087527,0.8990191614000017,1.0,5/14,14.21%,CACNA1C;STIM1;CACNA1D;NF1;MAPK14
prerank,central nervous system myelination (GO:0022010),0.4363031990639296,0.9059121750888229,0.5778611632270169,0.8967389114319008,1.0,2/11,12.11%,B4GALT5;SOX10
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.35108340605282173,-0.9057613995555803,0.583732057416268,0.8984720987534048,1.0,4/19,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3285001488323801,-0.9057603307965155,0.6052631578947368,0.8975449927745162,1.0,5/26,6.49%,ERRFI1;CBLB;SNX6;SHC1;TSG101
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.38985580697858646,0.905171344184471,0.5795246800731262,0.8977182540421511,1.0,4/18,7.93%,CAV1;NEDD4L;SLC43A2;KCNH2
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.44064798058866217,0.9049299301254298,0.6,0.8970812360790476,1.0,1/11,1.39%,NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.44064798058866217,0.9049299301254298,0.6,0.8970812360790476,1.0,1/11,1.39%,NOTCH4
prerank,long-chain fatty acid transport (GO:0015909),0.35308895210022867,0.9047521110142116,0.5854063018242123,0.8968807844646292,1.0,9/30,12.91%,MFSD2A;ABCD4;CPT1A;ACACB;ACSL3;FABP5;ABCD1;PPARG;SLC27A2
prerank,cortical cytoskeleton organization (GO:0030865),0.33355061129001584,0.9045938412867549,0.5964912280701754,0.8966227192083105,1.0,11/41,16.62%,RHOBTB1;FMNL3;IKBKB;RHOB;NCKAP1;STRIP1;RAC1;RND1;NCKAP1L;NLGN1;TRPV4
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.36691017117492625,-0.9040554369237029,0.6004319654427646,0.9007638340456979,1.0,5/15,13.15%,IRS1;PPARA;IRS2;SLC45A3;ADM
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.44418672467917497,0.9040505392326627,0.5773381294964028,0.8971870075553957,1.0,3/10,11.99%,ATP5MC2;ATP5PO;ATP5F1A
prerank,leukocyte tethering or rolling (GO:0050901),0.3936632189222892,0.9038926263392532,0.5827702702702703,0.8969297263446279,1.0,1/17,1.49%,JAM2
prerank,response to insulin (GO:0032868),0.30310406861828715,0.9038773128409935,0.6317280453257791,0.8963807308685549,1.0,17/80,14.97%,TBC1D4;INSR;RAB31;FOXO1;HDAC9;SORT1;DENND4C;SLC25A33;SORBS1;PKM;GSK3A;CEACAM1;ZFP36L1;PPARG;LPIN3;PDE3B;HDAC5
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.29213978283206293,-0.9036404445560275,0.6278409090909091,0.9008287251748189,1.0,10/38,19.99%,CENPC;HAT1;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4;UBN1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),0.42057473272794454,0.9032343088378678,0.5764925373134329,0.8971931410904248,1.0,2/11,10.44%,TIMM13;TIMM10
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.34871905465753755,0.9030491450142507,0.5832012678288431,0.8970212585202583,1.0,13/34,25.86%,MEF2C;GRID2;INSYN2A;GRIN2B;GSK3A;GABRG1;GABRG3;GABRA1;RAB3GAP1;GABRA2;GRIN1;GLRA1;GABRG2
prerank,activation of protein kinase B activity (GO:0032148),0.3676940481641052,0.9029217394625046,0.5979899497487438,0.8967161611895259,1.0,5/29,6.32%,PDGFB;INSR;CCDC88A;PPIA;ADRA2B
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),0.4135380421832472,0.9025275777569548,0.5586592178770949,0.8969655660104672,1.0,7/14,20.67%,CHKA;SELENOI;CEPT1;LPIN3;ETNPPL;ETNK1;PISD
prerank,regulation of hormone secretion (GO:0046883),-0.3750411034628077,-0.90231566953081,0.6032482598607889,0.9031006927631169,1.0,7/15,33.59%,SNX6;ANXA1;VAMP2;VAMP3;SCG5;IL11;LIF
prerank,positive regulation of macrophage migration (GO:1905523),-0.3570266535837389,-0.9022142885973149,0.6,0.9023977769429912,1.0,6/19,17.09%,IL34;THBS1;P2RX4;CMKLR1;RARRES2;MDK
prerank,antibacterial humoral response (GO:0019731),0.40816730226864045,0.901879657374225,0.5711743772241993,0.8977936396652701,1.0,4/16,21.62%,DEFA6;SLPI;JCHAIN;RNASE6
prerank,positive regulation of cell cycle process (GO:0090068),0.29745576659468925,0.9018430870304287,0.6210670314637483,0.8973011484834734,1.0,21/91,18.30%,PDGFB;INSR;RGCC;CDC14A;PKN2;PKP4;NPM2;TGFA;LRP5;CDC6;KIF23;MAP10;DYNC1LI1;SPAG5;RXFP3;RCC2;EDN1;SPAST;RAD21;PRKCE;DDX11
prerank,smooth muscle tissue development (GO:0048745),-0.40262611573603696,-0.9018065026896626,0.5745140388768899,0.902410359383337,1.0,5/10,13.29%,BMP4;MYLK;SMO;EFEMP2;NF1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.3622592702184188,0.9012464417846181,0.5915966386554622,0.8979858117745417,1.0,2/26,2.10%,ST8SIA6;B4GALT5
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.4035973630744434,-0.9012368648292406,0.5730088495575221,0.9028208829602051,1.0,4/10,18.39%,IMPACT;BAG3;SIRT2;CITED2
prerank,positive regulation of heart contraction (GO:0045823),-0.3480360523455676,-0.9010595199114475,0.6121951219512195,0.9023317796245999,1.0,1/19,0.02%,ATP1A2
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.23182450618214193,-0.9010543987295668,0.7402597402597403,0.9014153601349919,1.0,22/170,11.18%,PRDM6;IGF1;ROCK2;AFF3;AFF2;ZNF462;CDH1;SLC8A1;YBX3;AFF1;APOE;KDM6B;FUBP1;LDLR;NOVA1;MTMR3;CRIP1;ZNF507;STX1B;IGF2BP2;PRDM11;PTHLH
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.3668204720048292,-0.9007958790854893,0.61875,0.9010733348379172,1.0,4/14,15.18%,CD55;IL18;PTPN22;CD81
prerank,UV protection (GO:0009650),-0.41078563504563986,-0.9007824168875861,0.6008771929824561,0.9001801471348474,1.0,2/10,11.26%,SCARA3;MFAP4
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.40508987903904115,-0.900622014629358,0.5516483516483517,0.8996746947899393,1.0,2/10,13.80%,CPEB1;PAF1
prerank,ERBB2 signaling pathway (GO:0038128),0.35169723824239835,0.9005222303049655,0.5922165820642978,0.8989730693778234,1.0,7/31,10.31%,PTPN12;GRB2;GAB1;SOS1;PTPRR;PTK6;GRB7
prerank,intracellular sterol transport (GO:0032366),0.41479977160042125,0.8998609387000935,0.5667870036101083,0.8998229177720098,1.0,4/13,14.49%,OSBP;ABCG1;NPC1;STARD4
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.29319190391834704,-0.8997819721063549,0.6398891966759003,0.9007413722439405,1.0,4/41,9.42%,PRKAG2;OGT;SEH1L;NUP205
prerank,renal absorption (GO:0070293),-0.41282888889016406,-0.8997691831538257,0.6008146639511202,0.8998672625643898,1.0,2/10,3.67%,GSN;WNK4
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.2969514652367405,0.8996004057237207,0.6086350974930362,0.8998101596239064,1.0,7/86,2.67%,PECAM1;PDGFB;APP;IL6R;LRP8;PTPRJ;ARHGEF2
prerank,regulation of vasoconstriction (GO:0019229),0.3644297259569821,0.8995059629520542,0.605,0.8994358853238693,1.0,4/27,6.35%,BMPR2;CAV1;OXTR;ATP2B1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.3573117548528544,-0.8994271821968778,0.5931818181818181,0.89976139437654,1.0,4/17,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,neutrophil activation (GO:0042119),0.4188459666096004,0.899391571988799,0.5817223198594025,0.8990930007751078,1.0,4/12,12.67%,CXCR2;PREX1;SYK;IL15
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.4225642259740384,0.8987942989275989,0.5597826086956522,0.8997636154040614,1.0,3/11,19.40%,ABCG1;LIPC;AGT
prerank,superoxide metabolic process (GO:0006801),0.36338593859540635,0.8985808292498845,0.6185064935064936,0.8996447969651815,1.0,7/29,12.57%,NOS3;NOS2;NRROS;PREX1;CYBB;NCF4;NOX3
prerank,homocysteine metabolic process (GO:0050667),-0.39270684844934756,-0.8982624835718754,0.5819327731092437,0.9014785966682529,1.0,2/11,8.66%,NOX4;MTHFR
prerank,signal release from synapse (GO:0099643),0.3337721970411086,0.8976165441642242,0.6209048361934477,0.9011331446318933,1.0,7/43,13.19%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.34859637380238506,0.8972931215188916,0.5889261744966443,0.9012532225225698,1.0,7/29,12.67%,IFNAR1;IFNAR2;JAK3;SOCS2;STAT1;PTK6;IL15
prerank,sterol biosynthetic process (GO:0016126),-0.3045499758182245,-0.896887840593306,0.610705596107056,0.9037966459562803,1.0,2/33,2.95%,PRKAG2;INSIG2
prerank,protein localization to synapse (GO:0035418),-0.380397595082025,-0.8968125987691953,0.6017130620985011,0.9030305794597456,1.0,2/12,7.03%,NLGN2;DLG4
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.3600896681333621,0.896725034872594,0.5942275042444821,0.9018636291464942,1.0,2/27,2.89%,CSGALNACT1;CHST11
prerank,keratinocyte differentiation (GO:0030216),-0.3105996536287295,-0.8966294372715531,0.6347150259067358,0.9025785728905191,1.0,9/29,19.51%,ADAM9;ANXA1;TXNIP;JAG1;SCEL;BCR;CASP3;DSP;WNT16
prerank,negative regulation of cation channel activity (GO:2001258),-0.3209430276363318,-0.8963323828242781,0.6074766355140186,0.902352178646996,1.0,7/26,15.68%,SLC6A9;PKD2;EPHB2;GNB5;FMR1;GSTM2;KCNAB1
prerank,regulation of axon guidance (GO:1902667),-0.40354598664885377,-0.89627598014158,0.6157112526539278,0.9015541481765725,1.0,3/10,16.69%,ZSWIM8;YTHDF1;TUBB2B
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.26032750688763456,-0.8961144178268233,0.6452702702702703,0.901018685741126,1.0,16/69,11.13%,SLC30A10;SNX6;PRKCI;PPARGC1A;NGF;SIX1;NRBP2;NFATC4;BCL2;SOD2;PRKN;APOE;KDM2B;TGFB3;CLN3;PTK2B
prerank,mitotic cytokinesis (GO:0000281),0.3327980356551855,0.896079250979388,0.5990491283676703,0.9026554719876656,1.0,13/47,17.09%,SPTBN1;EFHC2;STMN1;RHOB;TRIM36;KIF23;MITD1;ANLN;APC;PDCD6IP;ANK3;SPAST;MYH10
prerank,regulation of protein localization to cell surface (GO:2000008),0.3538007461166219,0.8958208382130541,0.6040372670807453,0.9026217573363093,1.0,6/33,11.56%,STX3;NEDD4L;CTNNB1;HSP90AB1;ABCA7;KCNAB2
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.3628378826175195,-0.8957536994799334,0.6325581395348837,0.900990815430394,1.0,1/16,1.30%,APPL2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.33800587206850374,0.8955871750615594,0.6058732612055642,0.9025111927345041,1.0,5/37,11.08%,BCL2L1;CAV1;RPS7;EIF5A;S100A8
prerank,negative regulation of protein localization to cell periphery (GO:1904376),0.37414693444886615,0.8954212133331435,0.573051948051948,0.9022848616450914,1.0,7/20,14.85%,BCL2L1;PPP2R5A;AP2M1;TGFB1;ABI3;MRAP;TMEM59
prerank,regulation of cardiac muscle contraction (GO:0055117),0.3459874564348328,0.8953555305463641,0.605475040257649,0.9018572287167221,1.0,7/34,8.10%,SMAD7;CALM1;PDE4D;NPPA;KCNQ1;SRI;PDE4B
prerank,positive regulation of protein localization to membrane (GO:1905477),0.28811209049861564,0.8951567678968915,0.6284074605451937,0.9016929942204912,1.0,13/98,11.94%,PRKCH;SPTBN1;PPP1R13B;STX3;PPP3CC;RAMP3;FYN;SORBS1;YWHAH;YWHAQ;CASP8;HRAS;PPP3R1
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.3842638394521628,-0.895063554562392,0.6022222222222222,0.9016809041742978,1.0,4/12,19.86%,AR;SELENOS;TMEFF2;AP2A1
prerank,chloride transport (GO:0006821),0.3032437489020745,0.8949744204773136,0.628005657708628,0.9014950919405663,1.0,18/74,19.47%,CLIC5;SLC1A1;SLC12A6;GABRB1;SLC12A9;CLCN3;CLIC4;TTYH3;GABRQ;GABRG1;CLIC1;GABRG3;PACC1;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.38805402403803024,-0.8947250163015696,0.6141078838174274,0.9015594359980599,1.0,2/11,10.12%,IL34;PRKCA
prerank,mitochondrial transport (GO:0006839),0.32092543635362486,0.8946908209890306,0.6288343558282209,0.9015382483298261,1.0,11/53,21.97%,BCL2L1;TOMM22;SLC25A5;TIMM13;TIMM10;DNAJC19;MFF;TOMM7;BAK1;TOMM5;BNIP3
prerank,fatty acid catabolic process (GO:0009062),0.3073359602754465,0.8946040157657775,0.6290076335877862,0.9011428053670519,1.0,12/67,15.66%,ABHD2;PPARD;ABCD4;ACOX1;AIG1;ABCD1;MMAA;SLC27A2;LPIN3;HACL1;ECI2;ACAT1
prerank,ERK1 and ERK2 cascade (GO:0070371),0.37470535883508366,0.8945823391911158,0.5958549222797928,0.9006177198643939,1.0,6/21,15.98%,KDR;MAPK3;LGALS9;ZFP36L1;SOX9;MAPK1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.34321609017758686,-0.8941349047301386,0.5981735159817352,0.901991612724488,1.0,7/17,24.38%,EMC8;EMC7;GET1;EMC1;EMC2;EMC3;EMC4
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.2408192279472492,-0.893964509568802,0.7653846153846153,0.9015048052246726,1.0,19/117,9.79%,IGF1;ALDH1A2;CYP26B1;ACADSB;ME1;PER2;PPARA;CPT1C;GGT5;ME2;MCCC2;SLC5A6;SCPEP1;ACOT11;ABAT;CKB;ALDH4A1;NAAA;AMACR
prerank,regulation of gene expression (GO:0010468),0.24633899446660945,0.89378320698409,0.8137154554759468,0.9016999061137947,1.0,122/903,13.45%,LEF1;SLC7A5;TFRC;ETS1;OCLN;RBM20;CLDN5;PDGFB;KDR;INSR;CD34;APBB2;SLC39A8;ENG;TGFB2;NOS3;PDE2A;NOVA2;APP;XDH;SOX17;TRIM14;BCL6B;RGCC;MEF2C;RYBP;SMARCA2;PIK3R3;ACVRL1;SOX13;APLNR;NOTCH1;YBX1;RAMP2;LYN;PRDM2;IRF2;RREB1;NOS2;GATA2;SOX7;NOCT;MOG;HINT1;TCF23;FGF16;RAMP3;DLL4;KLF1;WWTR1;SORT1;TLR3;DIP2A;TCF7;NANOS1;CAVIN4;SNAI2;MAPK3;RPS6KA5;ADAM10;FBXW7;LGALS9;KLF4;PTBP3;DNM2;INSM1;NCOA2;SOX18;YBX2;BRCA2;SOX12;HINFP;CRNN;TDRD7;PIN1;TGFB1;TERF2;FOXP3;RPS7;PRDM9;P2RX7;MSN;HCFC2;HMGA1;NDFIP2;KDM4A;ZPR1;ACTG1;UBE2V1;BTG1;PTRH2;PDCD10;SMAD1;CASP8;PRKAB1;CNTF;ZNF205;NR5A2;LAMTOR5;ADNP;CTCF;HRAS;GSK3A;ONECUT1;VSIR;HIF1A;TLE1;PIK3CB;RNF187;HGS;TFEB;ZFP36L1;SOX11;WWC1;RO60;EDF1;DNAJA4;SETDB1;RPL11;TRIM39;SOX9;CDH5
prerank,electron transport chain (GO:0022900),0.40341493486509733,0.8936917658148363,0.5763636363636364,0.9013248594244312,1.0,4/15,9.79%,ETFRF1;ENOX2;CYB561;ETFB
prerank,mitochondrial translational termination (GO:0070126),0.2967293381407033,0.8934630208105496,0.6336088154269972,0.9012126221471359,1.0,34/88,26.76%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;MRPL21;MRPS18A;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2;MRPS18C
prerank,motile cilium assembly (GO:0044458),0.4239103030908478,0.8929571963237134,0.5907407407407408,0.901668779068462,1.0,3/12,20.08%,ZMYND10;DNAAF3;E2F4
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.421739071928682,0.8926700570367851,0.5984555984555985,0.901718631961275,1.0,3/11,11.66%,FOXO1;NOTCH1;GSK3A
prerank,photoperiodism (GO:0009648),-0.314697389234055,-0.8925983718375607,0.6459459459459459,0.903794217011214,1.0,6/28,11.14%,PER3;FBXL17;PER2;USP2;PML;CRY2
prerank,defense response to Gram-negative bacterium (GO:0050829),0.33389979043546336,0.8924864791579769,0.5957120980091883,0.901527551564027,1.0,4/42,8.17%,IL6R;DEFA6;NOS2;IRGM
prerank,regulation of T cell chemotaxis (GO:0010819),0.42791574872861854,0.8923974731168209,0.5825602968460112,0.9011525191461897,1.0,3/11,17.12%,ADAM10;ADAM17;CCR2
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.40546484876567324,0.8918740309153013,0.601063829787234,0.9016983384355027,1.0,3/14,9.47%,LIMS2;PRKD1;PHACTR4
prerank,regulation of glycogen metabolic process (GO:0070873),-0.3865266094539448,-0.8917686952952485,0.5847107438016529,0.904813985535897,1.0,3/12,19.11%,PPP1R3B;PPP1R3C;PPP1R3F
prerank,negative regulation of cellular senescence (GO:2000773),0.41499875457954644,0.8915426116296292,0.6116504854368932,0.9018089452818694,1.0,7/13,23.00%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,sympathetic nervous system development (GO:0048485),0.40277686324188106,0.8908826623460674,0.6095406360424028,0.9026712793806773,1.0,5/15,19.12%,CTNNB1;INSM1;SOX11;NRP2;NRP1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.3455483143272353,0.8908727240826194,0.5919003115264797,0.9021273110246997,1.0,9/33,24.06%,HSP90AB1;MRE11;TERF2;ACD;TERF1;NHP2;RPA1;PINX1;PTGES3
prerank,polyol biosynthetic process (GO:0046173),-0.3540609514513706,-0.8907586776588453,0.6329411764705882,0.9061909559643397,1.0,5/16,11.05%,CYP27A1;ACER3;FGF2;ISYNA1;PPIP5K2
prerank,negative regulation of RNA splicing (GO:0033119),-0.345464173601166,-0.8906997134101159,0.6221719457013575,0.9053970794832712,1.0,8/19,21.28%,SRSF6;SRSF4;PCBP4;SAP18;C1QBP;U2AF2;PTBP2;SRSF10
prerank,positive regulation of interferon-beta production (GO:0032728),0.3484104172396336,0.8901902462372273,0.5996884735202492,0.9029624079520233,1.0,14/33,27.41%,IFIH1;TLR3;IRF5;TLR7;TLR8;TBK1;POLR3F;FLOT1;RIOK3;POLR3B;ISG15;POLR3C;IRF7;TOMM70
prerank,negative regulation of stem cell differentiation (GO:2000737),0.4175545882958367,0.8901102440229729,0.588021778584392,0.9025619418684713,1.0,1/12,3.41%,NOTCH1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.37449126180627373,0.8900939739885964,0.603648424543947,0.9020266495135439,1.0,6/20,12.14%,DIP2B;DIP2A;MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,snRNA metabolic process (GO:0016073),-0.3554676998613185,-0.8897898119737256,0.5958904109589042,0.9065045101711394,1.0,5/17,17.37%,INTS8;INTS2;INTS4;TUT1;INTS10
prerank,regulation of translation (GO:0006417),0.27269781343648397,0.8896766063538646,0.6797468354430379,0.9023597233784745,1.0,30/173,13.59%,NANOS3;APP;NIBAN1;RPS6KA1;YBX1;MTG1;NANOS2;EIF4H;ENC1;MRPL13;NANOS1;KLHL25;YBX2;SHMT2;EIF3E;EIF2AK4;RPL13A;CNOT9;EIF3D;CYFIP1;GRB7;HSPB1;EIF2B2;NCBP2;BTG2;EIF4E;PUM3;PAIP2;PAIP1;EIF3B
prerank,nuclear pore organization (GO:0006999),-0.37042535440072794,-0.8894941831216926,0.6216814159292036,0.9062594689139741,1.0,7/14,31.05%,SEH1L;NUP205;TMEM170A;NUP35;NDC1;TPR;RTN4
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.3694254649016141,0.8894270960081464,0.5950819672131148,0.9023077506563064,1.0,4/24,6.64%,TGFB2;CTNNB1;FBXW7;MCL1
prerank,C-terminal protein amino acid modification (GO:0018410),0.42143393046183747,0.8892358658251146,0.6139705882352942,0.902150434962579,1.0,7/11,31.35%,LCMT1;ATG12;TTL;ATG7;AGBL4;FOLH1;AGTPBP1
prerank,positive regulation of stem cell proliferation (GO:2000648),-0.3427384846404306,-0.8888909282441876,0.6244541484716157,0.9067001534396044,1.0,5/17,19.65%,GJA1;KDM1A;PTPRC;PDCD2;LTBP3
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.33658290106320105,-0.8888585341615225,0.6153846153846154,0.905860953469853,1.0,5/20,12.41%,CAMK2D;THADA;BCL2;PML;PSEN1
prerank,protein kinase B signaling (GO:0043491),0.365048715138287,0.8884621833121434,0.5889464594127807,0.9032202038404298,1.0,3/23,8.09%,KDR;PIK3R3;TGFB1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.3034560035757074,-0.8883362876443582,0.631578947368421,0.9061387496935206,1.0,5/31,6.43%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,regulation of response to stress (GO:0080134),0.4262947352158349,0.8883143499662849,0.6003683241252302,0.9029515658117405,1.0,1/10,2.60%,CORO2B
prerank,cellular response to purine-containing compound (GO:0071415),-0.40058422163416346,-0.887874720703523,0.6112224448897795,0.9063035936942391,1.0,5/10,33.71%,SLC8A1;GSTM2;RYR3;P2RY1;CASQ2
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.3901854454752031,-0.8878090299376727,0.5954825462012321,0.905527833258221,1.0,7/10,32.89%,GAR1;RPUSD4;RPUSD1;TSR3;RPUSD2;RPUSD3;NOP10
prerank,oxoacid metabolic process (GO:0043436),-0.32206961919373794,-0.887803103075833,0.6422764227642277,0.9046414420099654,1.0,2/27,1.67%,DDO;ENPP1
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.2938363936322772,0.8874793093205685,0.6460055096418733,0.9041209357385462,1.0,15/86,15.92%,EPAS1;KLF2;PSMB3;EGLN2;PSMD11;PSMC6;PSME2;PSMD8;HIF1A;HIGD1A;EGLN1;PSMB10;RBX1;ELOB;PSMA8
prerank,purine nucleotide metabolic process (GO:0006163),0.36596708795836713,0.8873288873889001,0.6059602649006622,0.9038816635462827,1.0,5/24,11.08%,XDH;HPRT1;NT5C2;GART;PNP
prerank,positive regulation of transporter activity (GO:0032411),-0.36428070323618916,-0.8869036032969001,0.5986842105263158,0.9057515363026005,1.0,7/13,31.29%,TRPC6;RXRA;KCTD7;WNK3;SYNGR3;KMT2A;PDZK1
prerank,GPI anchor metabolic process (GO:0006505),0.34987334015931676,0.8868691758469428,0.575503355704698,0.904271911637522,1.0,8/26,21.77%,PIGU;PIGM;PGAP4;PIGF;DPM3;PIGO;PIGV;PIGQ
prerank,regulation of phosphatase activity (GO:0010921),-0.32616987613789483,-0.8865178093275743,0.6056701030927835,0.905718490725183,1.0,10/24,28.67%,SH3RF2;PTPA;URI1;BMP2;HSP90B1;SH2D4A;TSC1;HTT;ZCCHC9;MTMR9
prerank,positive regulation of neutrophil migration (GO:1902624),-0.34467383492191217,-0.886024502194568,0.6353211009174312,0.9059733791081289,1.0,4/18,6.81%,CAMK1D;MCU;RIPOR2;DAPK2
prerank,alcohol catabolic process (GO:0046164),0.42608781511743354,0.8859674391186431,0.5951940850277264,0.9056005211910797,1.0,1/10,1.76%,SCARF1
prerank,proteasomal protein catabolic process (GO:0010498),0.2664926862001287,0.8857292563054867,0.7090464547677262,0.9055040608535948,1.0,65/201,24.82%,ZNRF1;NEDD4L;PELI1;CTNNB1;ENC1;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;RHBDD1;PSMC6;FEM1C;PSME2;SMURF1;UBXN1;KCTD10;SHARPIN;KLHL20;UBE3D;PSMD8;GSK3A;RNF187;MAEA;PSMB10;NHLRC1;RBX1;TRIM2;UBE2D3;AREL1;RNF139;PSMA8;ATE1;ARMC8;RAD23A;BAG6;GID8;BFAR;TRIM71;TRIM3;KCTD17;PSMD9;SIAH1;RNF4;RBCK1;NSFL1C;PLAA;ANKRD9;BRSK2;ERCC8;DDB1;PSMC3;PSMD1;RAD23B;RNF126;PSMD10;HECW1;CRBN;RNF216;PMAIP1;UBXN2B;ZFAND2B;MTA1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.28417736479238576,-0.8856602367645083,0.673469387755102,0.9058731412175766,1.0,9/41,12.70%,RNF152;UBE2E2;TRAF3IP2;PRKN;RNF135;WWP2;UBE2E3;PRPF19;PELI3
prerank,neuromuscular junction development (GO:0007528),-0.31876895668517613,-0.8854767678634324,0.6286407766990292,0.9053974786277537,1.0,7/24,13.29%,PDZRN3;UNC13C;PPFIBP2;CACNB4;LRRK2;CACNB2;CACNB1
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.38765088287728,0.8850340085121962,0.5879120879120879,0.906344145511151,1.0,4/16,18.19%,HMGA1;RECQL4;TWNK;RPA1
prerank,regulation of T cell activation (GO:0050863),0.33079207383529086,0.8848206179273588,0.6273584905660378,0.906217843620995,1.0,6/42,12.52%,JAK3;DUSP3;CD4;CCDC88B;TNFSF11;CYRIB
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.32996775953468965,-0.8843390615236758,0.6208651399491094,0.9069803384322196,1.0,6/22,17.82%,DDX5;PLA2R1;ATM;SPRED1;HIC1;CHD5
prerank,GTP metabolic process (GO:0046039),0.408810179087746,0.8842913008501458,0.625886524822695,0.9068130628797346,1.0,3/15,9.07%,IMPDH1;AK4;GTPBP1
prerank,protein destabilization (GO:0031648),-0.29657741829350553,-0.8835223064942991,0.6948228882833788,0.9078723041513936,1.0,8/32,14.57%,GSN;PRKN;CUL3;BTRC;CTSH;PEX2;FBXW11;EP300
prerank,programmed necrotic cell death (GO:0097300),0.3878816376144843,0.8828924892611323,0.5973154362416108,0.9091565547220813,1.0,5/18,23.35%,TLR3;IPMK;CYLD;TICAM2;RIPK1
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.33065967883352254,0.8827286845919827,0.6122754491017964,0.9089191099283978,1.0,3/40,2.47%,HIP1;INSR;B2M
prerank,regulation of autophagy (GO:0010506),-0.215220641003762,-0.8821933170239699,0.8313253012048193,0.909935395312308,1.0,49/216,18.57%,PRKAG2;DCN;ITPR1;LEPR;PRKAA2;RNF152;NUPR1;SNX6;KLHL22;DAPK2;DAPL1;BCL2;GOLGA2;PRKN;MET;ATM;FOXO3;PTPN22;PLEKHF1;PIP4K2C;MTMR3;STK11;PRKACA;PRKAG3;LRRK2;ATP6V1C1;SNX5;ABL1;RHEB;ATP6V1G2;TPCN1;SIRT2;HTRA2;LAMTOR3;EP300;CAPN1;CASP3;RRAGA;WDR41;SREBF1;OPTN;CISD2;ATP6V1E1;SNX32;DDIT3;CTSA;PSAP;SMCR8;FLCN
prerank,negative regulation of endocytosis (GO:0045806),0.36160832292313855,0.882026168084752,0.6126878130217028,0.9097663810422811,1.0,5/24,11.43%,CAV1;PRKD1;NR1H2;ABCA7;RAC1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3928602727537622,0.8820117934352104,0.6256684491978609,0.909232885937324,1.0,5/17,16.69%,NPPA;AKAP6;ANK3;KCNRG;SUMO1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.33651845265010316,-0.8816908933049835,0.6048192771084338,0.9101179094080873,1.0,1/18,0.45%,FBN1
prerank,regulation of microtubule depolymerization (GO:0031114),0.3649331591807466,0.8815213507939585,0.6335078534031413,0.9096449331383438,1.0,10/25,25.98%,ARHGEF2;FGF13;ATXN7;APC;TRPV4;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,regulation of hemopoiesis (GO:1903706),0.43537132605769924,0.8813983068162796,0.6133333333333333,0.9093277795131859,1.0,4/10,11.53%,PTN;MYSM1;CBFB;PRKCB
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.29906175268448537,0.881171519883896,0.6570644718792867,0.9092358605334866,1.0,25/76,25.04%,RNF144B;PTK2;SMAD7;FBXW7;HECTD1;SOCS5;SMURF1;TRIB2;GSK3A;RBX1;RNF139;BAG2;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1
prerank,B cell homeostasis (GO:0001782),0.43098894600669746,0.8811411788844377,0.5847299813780261,0.9087377138618735,1.0,4/10,14.70%,MEF2C;LYN;TNFAIP3;NCKAP1L
prerank,autophagosome maturation (GO:0097352),0.34286740017216377,0.8808280990951278,0.6295081967213115,0.9088184391895924,1.0,15/32,23.67%,CALM1;TECPR1;MAP1LC3B;UBQLN1;SNAP29;ATG14;VPS16;MAP1LC3A;VAMP7;UVRAG;GABARAP;VMP1;RUBCNL;VAMP8;GABARAPL2
prerank,AMP metabolic process (GO:0046033),0.4155320435419895,0.8804049397576724,0.6010928961748634,0.9091191292126559,1.0,3/13,7.35%,XDH;AK4;ADSS2
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.4211197044399213,0.8800456772172236,0.5844402277039848,0.9093185187102345,1.0,3/10,9.62%,CTNNB1;DCT;DISC1
prerank,negative regulation of inclusion body assembly (GO:0090084),0.43100568209900375,0.8799547239362815,0.5911708253358925,0.9089398490687237,1.0,3/10,17.78%,SACS;DNAJA4;DNAJB6
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2876051942371598,0.8799202331355583,0.6697736351531292,0.908452126871055,1.0,36/100,25.71%,RNF144B;RYBP;SMAD7;GNA12;HSP90AB1;N4BP1;HECTD1;SOCS5;UBXN1;TRIB2;GSK3A;RPL11;TRIM39;SDCBP;RBX1;BAG2;ELOB;RAD23A;FOXF2;SUMO1;BAG6;RNF19A;CBFA2T3;DESI1;GABARAP;EIF3H;RACK1;RAD23B;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1;BAG5;CAMLG
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.2780689089523582,-0.8785966589198012,0.6840579710144927,0.9161809495534757,1.0,10/47,15.39%,PID1;PDGFRB;THBS1;PRKCD;AGTR1;SLC5A3;CYBA;MAPK14;TLR4;ACE2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.4185258357946705,0.8785485311987851,0.59251968503937,0.9106944323347383,1.0,1/11,0.99%,BCL2L1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.38072632419872016,-0.8783560215100252,0.6073903002309469,0.9158195242164077,1.0,3/12,14.16%,PRCC;ZWINT;ZWILCH
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.3600399811752669,0.8782271672280968,0.631762652705061,0.9107755236467028,1.0,4/26,10.75%,PDE8A;PPIA;FYN;HSPB1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3881276692357414,0.8776512921572893,0.6170212765957447,0.911336638370824,1.0,5/17,18.27%,STX1A;UNC13D;SYT4;NLGN1;CACNA1I
prerank,polyamine metabolic process (GO:0006595),0.40857895226007857,0.8775727789104865,0.6057142857142858,0.9109374079580187,1.0,8/13,29.43%,SMOX;AMD1;SMS;OAZ2;DHPS;AOC1;SRM;HDAC6
prerank,cardiocyte differentiation (GO:0035051),0.4162998788640839,0.8772587571673766,0.5874769797421732,0.9110188216780915,1.0,1/10,1.32%,TGFB2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.36977551177367557,0.8769602917164582,0.6148760330578512,0.9110970358112693,1.0,7/20,14.85%,BCL2L1;PPP2R5A;AP2M1;TGFB1;ABI3;MRAP;TMEM59
prerank,nuclear pore complex assembly (GO:0051292),-0.3957979189501691,-0.8767741239064409,0.6213389121338913,0.9184826326836416,1.0,8/10,44.99%,NUP205;TMEM170A;NDC1;TPR;RTN4;NUP98;NUP107;AHCTF1
prerank,positive regulation of dendrite development (GO:1900006),0.42749928041144897,0.8766080507469145,0.6224677716390423,0.9112389725819541,1.0,3/10,8.49%,DAB2IP;LRP8;PTN
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.3990817958767537,0.8765348718155661,0.592057761732852,0.9108457323490718,1.0,1/13,2.06%,PDE8A
prerank,atrial septum development (GO:0003283),0.412028296428931,0.8763612902851979,0.6013986013986014,0.910640480879498,1.0,3/13,3.19%,BMPR2;TGFB2;ZFPM1
prerank,negative regulation of translation (GO:0017148),-0.24709661477185496,-0.8758999214848542,0.7517482517482518,0.919552563280439,1.0,5/87,2.18%,SAMD4A;ROCK2;IGFBP5;CPEB1;CPEB2
prerank,proton transmembrane transport (GO:1902600),-0.286309629787047,-0.8758132469256008,0.675,0.91884256244976,1.0,2/36,5.04%,ATP1A2;ATP6V0A4
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.32287307414301125,-0.8749195984529219,0.6497584541062802,0.919931186181744,1.0,5/20,18.35%,FKBP5;PPIC;PPIL2;PPIH;NKTR
prerank,heterotypic cell-cell adhesion (GO:0034113),-0.31625922496284825,-0.874284184303499,0.6186868686868687,0.9204617531873283,1.0,4/25,10.36%,PARVA;CXADR;ITGA5;ITGAV
prerank,positive regulation of keratinocyte migration (GO:0051549),0.42248245169286924,0.8740909446276067,0.6082289803220036,0.9147065673474404,1.0,3/10,12.23%,MAPRE2;IQSEC1;MAP4K4
prerank,cellular response to lipopolysaccharide (GO:0071222),0.28679524648999144,0.8740095195066713,0.6767123287671233,0.9143236739388417,1.0,10/101,8.17%,DAB2IP;MEF2C;DEFA6;NOD2;LYN;CD6;HCK;TGFB1;PDE4B;IRGM
prerank,mitotic DNA replication (GO:1902969),-0.39517921964990743,-0.8739005832643679,0.6102783725910065,0.920424391125192,1.0,6/10,34.70%,CDC45;LIG1;MCM3;MCM4;GINS1;GINS3
prerank,negative regulation of type I interferon production (GO:0032480),0.3335603522187585,0.8737831182428138,0.6472491909385113,0.9142068611960633,1.0,9/40,17.96%,TRIM25;IFIH1;NLRC5;RNF125;PIN1;CYLD;TNFAIP3;RELB;TBK1
prerank,dendrite morphogenesis (GO:0048813),0.3343154216697543,0.8736772052395464,0.6398176291793313,0.9138617791706812,1.0,5/35,8.49%,SHANK3;KLF7;WNT7A;DIP2A;PTN
prerank,maturation of 5.8S rRNA (GO:0000460),-0.3453926052756776,-0.8736386315131192,0.6370192307692307,0.9201417853940396,1.0,3/17,12.48%,NSA2;WDR12;LAS1L
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.3761825512239588,0.8732090640276333,0.6254416961130742,0.9142432711998792,1.0,2/18,3.74%,JAK3;DUSP3
prerank,neurotransmitter secretion (GO:0007269),0.32310376749938263,0.8730136583609652,0.664576802507837,0.9140564310560687,1.0,12/44,24.10%,STX1A;PIP5K1C;STXBP1;NRXN1;DNAJC5;HSPA8;CPLX1;RIMS2;UNC13A;SNCA;PTPRN2;SYN1
prerank,positive regulation of signaling (GO:0023056),-0.29050932812761804,-0.8728785610238003,0.6416666666666667,0.9208601441959339,1.0,4/37,7.03%,WLS;ANXA2;CLSTN2;DLG4
prerank,mitotic recombination (GO:0006312),-0.35339877283967025,-0.8723984607179369,0.6385809312638581,0.9210376925012111,1.0,7/15,19.24%,SMC6;TEP1;ERCC1;RAD50;NSMCE2;DMC1;TPRKB
prerank,regulation of hippo signaling (GO:0035330),0.3899228526163517,0.8723306089476563,0.6083032490974729,0.9148600546762657,1.0,6/17,16.96%,MOB3B;MARK3;SCHIP1;SOX11;WWC1;WWC2
prerank,regulation of neuroblast proliferation (GO:1902692),0.38559994712757584,0.871947867347772,0.6319569120287253,0.9150715067299537,1.0,4/15,9.62%,CTNNB1;DCT;PTN;DISC1
prerank,regulation of amyloid fibril formation (GO:1905906),0.39523425413965985,0.8718478478275437,0.6179577464788732,0.9147078689339019,1.0,3/15,9.20%,APP;PFDN4;PFDN2
prerank,regulation of ion transmembrane transport (GO:0034765),0.340529754114984,0.8715859561980293,0.6505823627287853,0.9147198710081857,1.0,10/33,18.39%,NEDD4L;KCNQ1;KCNH2;P2RX7;AKAP9;CHRM3;AKAP6;KCNJ3;KCNJ5;KCNJ6
prerank,regulation of mitochondrion organization (GO:0010821),-0.2681559331742972,-0.8712515550831337,0.7283236994219653,0.9227665722333471,1.0,12/47,18.93%,PID1;PPARGC1A;PRKN;LRRK2;HTRA2;MIEF2;EP300;SREBF1;PARL;FLCN;MUL1;RHOT1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.3817152180623494,0.8711534338122531,0.615916955017301,0.9150306052727868,1.0,1/18,0.69%,MFHAS1
prerank,gene expression (GO:0010467),0.2508012464979448,0.8709990193469038,0.7861990950226244,0.9147800770641982,1.0,112/348,26.77%,TSPAN5;AGFG1;TSPAN14;ADAR;PTMA;HHEX;SARS1;ZAR1L;RPL38;TAF1B;MRPL13;RPL13;RPS29;MRPL10;RPL36A;NKX2-8;RPL3;RNPS1;YARS2;RPL27;RPSA;RPS7;PWP1;RPL9;RPL18;RPLP2;NXT1;DEDD2;CPSF1;MAGOHB;RPL13A;THOC6;RPS11;RPL8;NUP54;MPHOSPH10;RBPMS;NCBP2;RPS27;RPL19;RPS9;MRPL28;EIF4E;NOL9;ADAD1;ZC3H11A;RPL11;RPS15;SRBD1;RPL37;RPS28;TSPAN33;RPS10;NUP160;RPS25;MRPL44;RPL37A;MRPL9;COPS5;PRPF4;RPL15;POLR2J;TNIP1;NUP153;NUP50;MRPL23;RPL17;RPL23;RPL34;RBM8A;RBMS2;FARSB;RPS18;UPF2;XRN2;RPL21;RPS4X;MRPS18A;DDX54;RPL18A;NCBP1;DHPS;RPS21;NUP42;DUSP11;RPL10A;ADARB2;RSL24D1;RPL24;RPL7A;NUP85;MRPL41;MRPL27;NUP210;MRPL51;HARS1;RPL32;DHX38;RPL4;UPF3B;UPF1;RPS2;MRPS33;MEF2A;NUP188;MRPL37;CHTOP;RPS20;RPL6;RPS13;MRPS18C;DNAJB11
prerank,protein-containing complex disassembly (GO:0032984),0.30740444018911434,0.8703579328427483,0.661608497723824,0.9154919276043805,1.0,20/54,24.72%,CAV1;CTNNB1;TECPR1;FRAT2;MAP1LC3B;HSPA8;UBQLN1;SNAP29;APC;VPS16;MAP1LC3A;VAMP7;RPL23;UVRAG;GABARAP;RUBCNL;VAMP8;CSNK1A1;GABARAPL2;MYC
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.3600825383529961,0.8702338930089006,0.6471600688468159,0.9151702473118161,1.0,3/25,5.93%,CSGALNACT1;B3GNT2;FUT9
prerank,monocarboxylic acid catabolic process (GO:0072329),0.3715185377774304,0.8698897594246818,0.6119929453262787,0.91529476471992,1.0,7/21,20.60%,PPARD;ACOX1;LDHD;LPIN3;AGXT;ACBD5;FAAH
prerank,negative regulation by host of viral process (GO:0044793),0.409152608443386,0.8696282473412973,0.6296296296296297,0.9152622431145189,1.0,5/10,25.68%,EIF2AK4;CCNK;PSMC3;PTX3;ZC3H12A
prerank,response to estrogen (GO:0043627),0.3400525601746742,0.8694433346069766,0.6468699839486356,0.9150913417241636,1.0,4/31,9.46%,CAV1;TRIM25;TRIM24;NCOA4
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3457784538541827,-0.869027827340434,0.6378504672897196,0.9266331096039031,1.0,6/18,14.16%,DCN;MCU;PRKN;MIEF1;DDHD1;MIEF2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.36727715331445576,-0.8689095966264055,0.6450892857142857,0.9259920503955895,1.0,2/13,6.78%,PLXNA2;PLXNB2
prerank,cellular glucan metabolic process (GO:0006073),-0.38304279688631704,-0.8687229577102535,0.6288888888888889,0.9255037134256505,1.0,4/11,10.73%,PRKAG2;PHKB;PYGM;PPP1R3C
prerank,histone H2A acetylation (GO:0043968),-0.3487100125659229,-0.868679593414901,0.6275862068965518,0.9246774995799861,1.0,6/16,30.24%,MORF4L2;BRD8;NAA40;EPC1;MSL3;SPHK2
prerank,regulation of myotube differentiation (GO:0010830),0.35421460829593326,0.8684697858574185,0.6356073211314476,0.916498650436812,1.0,4/24,4.77%,NOTCH1;HDAC9;PIEZO1;ATP11A
prerank,regulation of establishment of planar polarity (GO:0090175),0.29075981208389956,0.8684527417093008,0.6857142857142857,0.9159748497779359,1.0,13/88,12.31%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;RAC1;AP2B1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.3007807846140831,0.8683649570759144,0.6623188405797101,0.915605134214985,1.0,18/72,21.63%,POLK;GTF2H2;GTF2H4;RBX1;AQR;COPS5;GPS1;ISY1;POLR2J;RPA1;TCEA1;POLD1;ERCC8;GTF2H3;COPS6;RFC2;DDB1;ERCC4
prerank,establishment of mitotic spindle localization (GO:0040001),-0.3024636365979911,-0.8681433937734544,0.649746192893401,0.9249206736757649,1.0,14/28,32.61%,GJA1;GPSM2;FBXW11;NUSAP1;MAD2L1;MISP;HTT;KPNB1;SPDL1;NUMA1;ITGB1;PLK1;ESPL1;PKHD1
prerank,positive regulation of cartilage development (GO:0061036),0.3817610550941631,0.8680051643774158,0.6243386243386243,0.9157289382909514,1.0,3/17,3.97%,BMPR2;ACVRL1;ZBTB16
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.35594811629581863,0.8672519528152799,0.6239460370994941,0.9166818245125594,1.0,9/23,27.37%,CYP2E1;ELOVL6;LTA4H;GPX4;HPGD;GSTM1;LTC4S;ACSBG1;ASAH2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.418128134845552,0.8663872585023377,0.6144144144144145,0.9178154191524343,1.0,4/11,8.63%,VIL1;RREB1;ARHGEF7;ENPP2
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),-0.38441431421018196,-0.8663660211347403,0.6244979919678715,0.9279399675807624,1.0,2/10,3.85%,OSR1;CAMK2D
prerank,negative regulation of bone remodeling (GO:0046851),0.4089255832238558,0.8658109274597201,0.6,0.918397526044684,1.0,4/11,21.75%,P2RX7;GREM1;TNFAIP3;GPR137
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.28714239891604876,0.865580222635845,0.6866295264623955,0.9183060173781736,1.0,8/87,7.78%,NDNF;TBX1;GRB2;FGF16;DLL4;HYAL2;MAPK3;TIAL1
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.3362316074629222,0.8652625381692304,0.6544585987261147,0.9183669081793385,1.0,8/30,13.42%,RYBP;HSP90AB1;N4BP1;UBXN1;SVIP;RPL11;TRIM39;SDCBP
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.40072630605892584,0.8646094601959007,0.6357142857142857,0.9191071366129836,1.0,5/13,18.61%,STAT1;EBI3;OASL;IL27RA;IL27
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.3891398171248549,-0.8645932378069416,0.6299559471365639,0.930768362394077,1.0,3/11,11.84%,SLC30A10;PPARA;TRAP1
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.2775793266377068,-0.8643555916247649,0.6813186813186813,0.9303659384523507,1.0,5/41,5.81%,ACSL1;PTGS1;DAGLA;CYP1B1;ACOT8
prerank,response to organic cyclic compound (GO:0014070),0.3126252547525148,0.8642148915220047,0.6722306525037937,0.9193487835064024,1.0,7/52,11.91%,SLC1A1;SOCS2;CTNNB1;TLR3;TGFB1;ARL6IP5;PAQR7
prerank,pseudouridine synthesis (GO:0001522),-0.35983372219466414,-0.864035255241693,0.627906976744186,0.9301243618522622,1.0,3/13,15.09%,PUS7;PUS10;GAR1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.38800521804991656,-0.8640319990345727,0.6277056277056277,0.9292360208522513,1.0,2/10,6.13%,DNMT3A;IGF2
prerank,adrenergic receptor signaling pathway (GO:0071875),0.3728834064799105,0.8636587467865134,0.6268656716417911,0.9199148440744274,1.0,3/20,6.32%,RAPGEF2;PDE4D;ADRA2B
prerank,macrophage migration (GO:1905517),-0.3578833013324304,-0.8636556085109767,0.6490825688073395,0.929156706094107,1.0,8/13,44.81%,P2RX4;CKLF;CCL2;CCL5;P2RY12;TAFA4;CXCL17;CCL3
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.28742797170443424,0.8636131256114788,0.7024456521739131,0.9194513977456905,1.0,13/85,12.31%,FZD6;FZD4;TIAM1;WNT7A;PSMB3;PSMD11;AP2M1;PSMC6;PSME2;SMURF1;PSMD8;RAC1;AP2B1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3028228574158373,0.8633070866772494,0.6591591591591591,0.9195241727562458,1.0,9/57,12.67%,IL6R;ARL2BP;CD40;LYN;INPP5F;STAP2;PTK6;CNTF;IL15
prerank,response to UV (GO:0009411),0.2844861998477244,0.8632556159364521,0.6962552011095701,0.9190803322856147,1.0,10/95,9.61%,POLK;MAP4K3;DCUN1D3;MEN1;CAT;GTF2H2;N4BP1;RHBDD1;COPS9;EIF2AK4
prerank,metallo-sulfur cluster assembly (GO:0031163),0.36762551439021496,0.863134035468446,0.6287215411558669,0.9187553111686904,1.0,13/22,29.82%,CIAO2B;CIAPIN1;HSCB;HSPA9;CIAO3;NUBPL;LYRM4;NFU1;ISCA1;ISCA2;NUBP2;NUBP1;ISCU
prerank,response to laminar fluid shear stress (GO:0034616),0.4152408135145171,0.8629915595391869,0.6148282097649186,0.9184870595513281,1.0,3/10,6.45%,KLF2;SMAD7;KLF4
prerank,positive regulation of fat cell differentiation (GO:0045600),0.3151123921950528,0.8629902255383805,0.6762048192771084,0.9179392140691164,1.0,6/47,4.72%,PPARD;SOX13;ZBTB16;RREB1;NOCT;CREB1
prerank,receptor signaling pathway via STAT (GO:0097696),-0.3149420853874517,-0.862796400092015,0.6410256410256411,0.9300691857895413,1.0,6/25,9.17%,IL31RA;PKD1;PKD2;PIAS1;CTR9;STAT5A
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.3319919661617892,0.862786986458306,0.6367924528301887,0.9177650205961723,1.0,6/35,5.00%,PDE2A;RAPGEF2;RAPGEF3;PDE4D;NPPA;PDE7B
prerank,response to estradiol (GO:0032355),-0.2987470334990236,-0.86260321230217,0.6747311827956989,0.9295618110467818,1.0,4/31,6.99%,EGFR;ANXA1;GGT5;LCOR
prerank,negative regulation of protein depolymerization (GO:1901880),0.35796193639043977,0.8625458320929323,0.6464471403812825,0.9176945163863118,1.0,9/24,25.98%,ARHGEF2;FGF13;ATXN7;APC;CAMSAP2;CLASP1;CAMSAP1;NAV3;CLASP2
prerank,glycolipid biosynthetic process (GO:0009247),-0.280123173452618,-0.8621046880152039,0.6735751295336787,0.9296615066588854,1.0,10/38,15.65%,LARGE1;ST3GAL4;A4GALT;ST3GAL5;PIGN;GBGT1;B4GALT6;ST6GALNAC5;PIGA;PIGP
prerank,translational termination (GO:0006415),0.2820757560352072,0.8616678264884678,0.6875834445927904,0.9189002047374176,1.0,35/95,26.04%,MRPL12;MRPL13;MRPL10;MRPL50;MRPL14;MRPL54;MRPL57;MRPL30;MRPL28;MRPL20;MRPL19;MRPL40;MRPL44;MRPS2;MRPS9;MRPL9;MRPL58;MRPL16;MRPL23;MRPL39;APEH;MRPL21;MRPS18A;ABCE1;ERAL1;MRPL1;PTCD3;MRPL41;MRPL27;MRPL22;MRPL51;MRPL49;MRPS33;MRPL37;MRPL2
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.3365994957222435,0.861148202207168,0.6551181102362205,0.9193362234301093,1.0,6/33,12.23%,PLCB1;RGCC;CRNN;CCND3;ADAM17;RPTOR
prerank,negative regulation of T cell activation (GO:0050868),0.32940867258255413,0.8606240833441636,0.6546644844517185,0.9198121944350106,1.0,6/35,14.70%,JAK3;DUSP3;TNFRSF21;FOXP3;CEACAM1;NCKAP1L
prerank,positive regulation of exosomal secretion (GO:1903543),-0.3538718773463831,-0.8603492871067638,0.6427015250544662,0.9324928793230839,1.0,3/15,7.96%,SMPD3;TSG101;SDC4
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.41534827491716836,0.8602961403833885,0.6224299065420561,0.9199120909449257,1.0,1/10,2.03%,TIRAP
prerank,manganese ion transport (GO:0006828),0.3933360385239829,0.8596847364785106,0.6433691756272402,0.9205645360561775,1.0,2/14,3.60%,SLC39A8;ATP2C1
prerank,regulation of phosphorylation (GO:0042325),0.2758892065015732,0.8594872228565678,0.7256515775034293,0.9204088008674862,1.0,23/120,15.38%,ITGA6;APP;PTK2;NLRC5;LYN;FNIP2;IKBKB;CCDC88A;DYNLL1;CDKN2B;PIN1;HSPB1;NUP54;ZBTB7A;HIF1A;KCTD20;SDCBP;CDH5;PGAM1;BCL10;NCKAP1L;BTBD10;NUP160
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.27734778201294863,-0.8593719522107626,0.6920980926430518,0.9336630179629707,1.0,9/41,18.90%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;NR1H4;RARA;PTPN6
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.3994833085283992,0.8593701529109882,0.6289752650176679,0.9200796934335251,1.0,3/12,9.70%,IMPDH1;ADSS2;GART
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.38721560398666577,0.8591925028868661,0.647912885662432,0.9198858865369971,1.0,4/15,4.06%,PRKD1;NOTCH1;PRKD2;TMSB4X
prerank,regulation of microglial cell activation (GO:1903978),-0.3543343790690363,-0.8589895624845127,0.6504424778761062,0.9335620570191508,1.0,4/15,17.98%,LDLR;SPHK1;GRN;PTPRC
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.30870841191776976,-0.8587787503283701,0.6940874035989717,0.9331166790940335,1.0,2/26,1.34%,PRKAG2;PRKAA2
prerank,nucleosome organization (GO:0034728),0.3031859690329443,0.8587530507125327,0.6706586826347305,0.9202310232483341,1.0,24/55,25.82%,PRDM9;ARID1A;HMGA1;CTCF;CHAF1A;NAA60;SMARCD1;SOX9;HMGB2;VPS72;POLE3;RNF8;CHAF1B;SET;SRCAP;GRWD1;NASP;DAXX;LIN54;INO80;NAP1L4;ARID2;SMARCA4;SART3
prerank,response to calcium ion (GO:0051592),0.277402637461314,0.8586622761243312,0.7295423023578363,0.9198659131434419,1.0,23/102,17.95%,ITPKB;CAV1;MEF2C;MCOLN1;CALM1;ACER1;SYT7;CPNE8;RASGRP2;HOMER1;IQGAP1;CLIC4;CPNE5;PPP3CA;SYT4;CPNE6;PDCD6;NLGN1;CPNE3;CRHBP;TTN;CPNE1;NEUROD2
prerank,"transcription, DNA-templated (GO:0006351)",0.25627703455917616,0.8585986904742938,0.7542997542997543,0.9194513371205526,1.0,50/207,19.85%,IVNS1ABP;PTMA;RREB1;NOCT;MRPL12;PIR;TAF1B;IRF9;SLC25A33;NKX2-8;GTF2H2;ABT1;RNPS1;YBX2;NFIC;PWP1;KLF13;TRIM24;CEBPD;PKNOX1;CBFB;NCBP2;GTF2H4;NELFCD;CCNK;GTF2B;GTF3A;MLLT1;GTF3C5;RO60;NAT14;HIPK3;ELOB;CRCP;TWNK;UBTF;TAF4B;LHX1;TAF4;MNT;POLR2J;DEK;TAF5;TCEA1;CCNT1;TBPL1;EAF1;THRA;GTF2E2;BRF2
prerank,cellular amide metabolic process (GO:0043603),-0.23755113535656608,-0.8579227802671625,0.8378378378378378,0.9340286379808294,1.0,22/102,18.30%,AEBP1;PLPP3;ACOT8;SMPD3;MCCC2;SLC5A6;ACOT11;CPXM1;MTHFR;MTHFD1;NNMT;NAAA;CPXM2;ACSF2;NSMAF;PCCB;NIT1;BTD;DBI;MTHFD1L;OXSM;MTHFD2
prerank,regulation of protein targeting to membrane (GO:0090313),-0.30191714437850947,-0.8576965397752253,0.6755447941888619,0.9336473950065792,1.0,7/28,18.24%,CEMIP;MIEF1;ITGB1BP1;DMTN;MIEF2;KCNB1;C2CD5
prerank,regulation of mitochondrial fission (GO:0090140),-0.3094963004825503,-0.85746391382525,0.6840909090909091,0.9332734344067674,1.0,7/24,14.16%,DCN;MCU;PRKN;MIEF1;LRRK2;DDHD1;MIEF2
prerank,NLS-bearing protein import into nucleus (GO:0006607),-0.3645080920244883,-0.8572145365455063,0.6730310262529833,0.9328917687916338,1.0,6/13,26.84%,CBLB;KPNA3;KPNB1;KPNA6;NUP35;KPNA1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.3205977140212943,-0.8569844388243677,0.6814814814814815,0.9324556943345258,1.0,9/23,28.14%,PRCC;ZWINT;ZWILCH;PLK5;CHMP4C;VPS4A;INTS3;SETMAR;PLK3
prerank,positive regulation of calcium ion transport (GO:0051928),0.33509541647174723,0.8569708350595269,0.6557120500782473,0.9221532223172322,1.0,3/36,1.75%,PDGFB;CXCL12;CAV1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.37278048687479204,0.8568459474530157,0.6535714285714286,0.9218374621277392,1.0,1/18,1.02%,DAB2IP
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.31172959383238513,0.8568024406547718,0.6645569620253164,0.9213870469958813,1.0,20/46,30.86%,TOMM22;TIMM13;TIMM10;HK1;DNAJC19;MFF;TOMM20L;RALA;CHCHD4;TOMM7;TOMM5;TIMM21;TIMM50;TOMM70;BCAP31;TIMM9;AIFM1;FIS1;GRPEL2;AKT1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.36575579552435805,0.8564763149746946,0.6302083333333334,0.9214925568475805,1.0,3/21,6.19%,MTUS1;PTK2;MAPK3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.3573575619292913,0.8560463480193237,0.6444444444444445,0.9217903554318168,1.0,4/24,12.55%,PLA2G4B;ABCA3;CDS2;PNPLA8
prerank,regulation of interferon-beta production (GO:0032648),0.31815734004484675,0.8546991654296816,0.6739469578783152,0.9238226933891902,1.0,18/46,27.41%,TIRAP;IFIH1;TLR3;IRF5;TLR7;TLR8;RELB;TBK1;TRAF3;POLR3F;FLOT1;RIOK3;POLR3B;RNF216;ISG15;POLR3C;IRF7;TOMM70
prerank,peptidyl-serine phosphorylation (GO:0018105),0.26246329055802453,0.8546518708549964,0.7573435504469987,0.9233643864622839,1.0,13/153,6.84%,PRKCH;PDGFB;STK38;PKN3;RPS6KA1;PRKD1;PRKD2;IKBKB;PIKFYVE;MAST4;PKN1;RPS6KA5;PKN2
prerank,protein homotetramerization (GO:0051289),0.3014813891624547,0.8544433267269996,0.6681481481481482,0.9232213569107472,1.0,7/49,8.05%,B2M;HPRT1;GBP5;SAMHD1;MCOLN1;ACACB;SHMT2
prerank,positive regulation of TOR signaling (GO:0032008),-0.278877195681891,-0.8542796704508523,0.7302052785923754,0.9373169177312046,1.0,9/40,18.57%,FNIP1;KLHL22;SEH1L;RHEB;CLEC16A;LAMTOR3;RRAGA;SMCR8;FLCN
prerank,positive regulation of synaptic transmission (GO:0050806),0.29188909173604627,0.854114640163043,0.7144927536231884,0.9233517838344278,1.0,15/72,17.12%,SHANK3;APP;SLC24A2;CLSTN1;NPS;NRXN1;EIF2AK4;AGER;GRIN2B;GRIK2;PLK2;NLGN1;RIMS2;LGI1;CCR2
prerank,DNA methylation (GO:0006306),-0.3184159073233382,-0.8538083586285988,0.6719160104986877,0.9374361732853683,1.0,10/23,30.13%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15;PICK1;ZFP57;METTL4;FOS;BAZ2A
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.2923251416785778,0.8531796870842551,0.7113259668508287,0.9247209858229816,1.0,23/78,25.04%,RNF144B;CAV1;SMAD7;HECTD1;SOCS5;TRIB2;UBQLN1;GSK3A;RBX1;BAG2;ELOB;RAD23A;SUMO1;RNF19A;CBFA2T3;GABARAP;RACK1;PSMD10;CSNK1A1;PABIR1;ZYG11B;ANKIB1;KEAP1
prerank,protein deubiquitination (GO:0016579),0.2518017359988975,0.8529385956967767,0.783175355450237,0.9246580442562136,1.0,86/242,27.39%,MINDY1;NFKBIA;IFIH1;ACTB;SMAD7;SNX3;ATXN3;CCP110;EIF3F;PSMB3;PSMD11;BIRC3;SHMT2;PSMC6;PSME2;OTUD7A;MYSM1;BABAM1;SMAD1;MINDY2;PSMD8;USP18;HIF1A;TADA2B;POLB;HGS;ATXN7;WDR48;CYLD;TNFAIP3;PSMB10;WDR20;TRRAP;MCRS1;APC;PSMA8;COPS5;HCFC1;RAD23A;USP49;RCE1;TNIP1;PSMD9;JOSD2;USP32;USP29;UBE2D1;BRCC3;TRAF3;OTUD4;ASXL1;USP25;USP21;OTUD7B;DESI2;JOSD1;SUDS3;KAT2B;MBD5;PSMC3;PSMD1;STAMBP;RAD23B;INO80;PSMD10;TRAF6;ENY2;RIPK1;USP30;VCPIP1;FOXO4;MYC;KEAP1;KDM1B;ZC3H12A;USP38;PSME1;USP45;TAB1;ACTR5;ADRB2;UBB;PSMD2;PSMA1;ADRM1;NFRKB
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.28420547696200377,0.8529008630149992,0.7006896551724138,0.9241862692358904,1.0,12/95,14.07%,DAB2IP;TIRAP;MEF2C;DEFA6;NOD2;PDE4B;IRGM;CYRIB;HMGB2;TNFAIP3;GIT1;BCL10
prerank,oligodendrocyte differentiation (GO:0048709),0.371931001282002,0.8519774111968947,0.6506469500924215,0.9254063935041429,1.0,7/19,18.49%,SOX13;EIF2B1;EIF2B2;SOX10;SOX9;PTPRZ1;TPPP
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.2884205185406611,0.8519521709398304,0.7118155619596542,0.9249174424135201,1.0,20/76,19.21%,CAV1;DCUN1D3;SMAD7;XIAP;FAM107A;FBXW7;BIRC3;MALT1;NDFIP2;UBQLN1;GSK3A;WDR48;DCUN1D1;BCL10;INAVA;PTTG1IP;TNIP1;UBE2D1;FKBP1A;NSMCE3
prerank,membrane raft organization (GO:0031579),-0.34466065370477494,-0.8519132237507563,0.6566820276497696,0.940497991574759,1.0,4/15,11.08%,ANXA2;S100A10;FLOT2;CLN3
prerank,epidermal cell differentiation (GO:0009913),-0.2780390877495721,-0.8516759944171194,0.7097701149425287,0.9401038295704849,1.0,11/41,19.51%,ADAM9;ANXA1;GLI1;TXNIP;JAG1;GATA6;SCEL;BCR;CASP3;DSP;WNT16
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.27288809501151345,-0.8507702440955864,0.726775956284153,0.9411278635872421,1.0,9/43,18.90%,IGF1;LBP;SELENOS;PTPN22;IRAK3;TLR4;NR1H4;RARA;PTPN6
prerank,protein maturation (GO:0051604),-0.23305851237937109,-0.8506451070887084,0.782608695652174,0.9404811087082026,1.0,15/95,12.41%,AEBP1;PCSK5;MMP14;MMP16;F3;OGT;NAA35;NNAT;ADAM19;CPXM1;CPXM2;CLN3;AFG3L2;LMF1;PSEN1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.26279419803390835,-0.8503501570374904,0.7463556851311953,0.9402384707186088,1.0,11/52,13.05%,LMNA;SHC1;KDELR3;ARFGAP1;GFPT1;TSPYL2;SEC31A;CUL7;FKBP14;TLN1;SYVN1
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.32424884098157297,-0.8499293956688508,0.6484560570071259,0.9401734336897919,1.0,6/19,13.52%,CUX1;OBSL1;FBXW8;CUL7;CAPRIN2;CDKL3
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.3275889767651191,-0.8496984674028499,0.6697459584295612,0.9397517910552865,1.0,15/19,46.11%,APOE;SLC5A7;NQO1;CHRNA4;CHRNB2;ACHE;COLQ;CHRFAM7A;CHRNA7;CHRNA5;CHRNA3;CHRNE;CHRNB4;CHRNB3;RAPSN
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.32522160365929903,-0.8490114307878308,0.671264367816092,0.940363092100227,1.0,4/20,7.91%,ROCK2;RHOQ;DLG1;FHOD1
prerank,positive regulation of immune effector process (GO:0002699),-0.30044222555888656,-0.8489008847949133,0.6878048780487804,0.9397210342537029,1.0,2/27,2.68%,APPL2;LBP
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.3570218279196944,0.848767384104578,0.6509598603839442,0.930591776384865,1.0,1/21,0.99%,BCL2L1
prerank,protein complex oligomerization (GO:0051259),0.2827480310694679,0.8486383389773976,0.7146814404432132,0.9303081940923768,1.0,17/85,16.56%,AQP11;LRRC8C;KCNC2;HOMER1;SHMT2;MAT2A;LETM1;EHD4;LRRC8D;BCL10;ELAVL1;TRMT61B;CARD11;TWNK;PDCD6IP;SPAST;NLRC4
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.36410207164412794,0.8477731268838096,0.6609880749574105,0.931487924275585,1.0,3/19,6.44%,TIRAP;TRIL;LGALS9
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.36493424869519553,-0.8470736273291435,0.6702819956616052,0.9425921121695088,1.0,1/13,0.65%,GLI3
prerank,positive regulation of cell division (GO:0051781),-0.28404394456881854,-0.8466102643918478,0.7166212534059946,0.9427014729591995,1.0,9/38,16.08%,FGFR2;FGF1;SVIL;CDC14B;CUL3;CDC25B;GIPC1;SIRT2;RACGAP1
prerank,acyl-CoA metabolic process (GO:0006637),0.32424266213502934,0.8463598314433652,0.6687306501547987,0.9337108091842834,1.0,5/35,7.77%,HMGCS2;ACBD6;GLYAT;ACACB;ACSL6
prerank,positive regulation of type I interferon production (GO:0032481),0.29046625660585335,0.8462961262601114,0.7286713286713287,0.9332826224246555,1.0,8/73,7.62%,LRRFIP1;IFIH1;CTNNB1;TLR3;MRE11;STAT1;IRF5;TLR7
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.3699800044685385,-0.846163646704824,0.6318082788671024,0.9427516065890017,1.0,5/11,37.05%,SIRT1;CIITA;TMEM106A;PF4;IL4
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.271478993569669,0.8459381055921202,0.75,0.9334318510389298,1.0,16/104,12.42%,DAB2IP;ACTB;CALM1;FGF16;CDKN2B;RALB;CCNI;IRGM;LRP5;CCND3;TRIB2;PDCD10;CDC6;CCNK;RPTOR;HGS
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.31570876909542606,0.8458152379815802,0.6855828220858896,0.9331195262924797,1.0,9/37,13.42%,RYBP;HSP90AB1;N4BP1;RPS7;UBXN1;HIPK2;RPL11;TRIM39;SDCBP
prerank,myotube differentiation (GO:0014902),0.3727620155627105,0.845657899499046,0.6608996539792388,0.932874627140029,1.0,3/17,5.10%,JAM2;MEF2C;SORT1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3337010580195078,-0.8453204847876451,0.6296296296296297,0.9435967646932522,1.0,4/18,15.46%,FCHSD2;DTNA;SLC5A7;STAC3
prerank,positive regulation of neuron differentiation (GO:0045666),0.31144204631686245,0.8452562709534996,0.6841294298921418,0.9330724666013843,1.0,12/40,17.95%,ARHGEF2;MEF2C;MMD;ADRA2B;BRINP3;BRINP2;SOX11;NRCAM;PROX1;SIN3A;CPNE1;NEUROD2
prerank,regulation of receptor internalization (GO:0002090),0.3259039075464309,0.8444648743033815,0.6937394247038917,0.9340768092158298,1.0,6/35,8.89%,INSR;ANKRD13A;RIN3;TBC1D5;MKLN1;GREM1
prerank,negative regulation of biosynthetic process (GO:0009890),-0.3361852859252308,-0.8442264882659745,0.672093023255814,0.944948439250283,1.0,4/16,11.84%,SLC30A10;PPARA;EMILIN1;TRAP1
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.370984413377978,0.8439770215844653,0.6447602131438721,0.934480462940807,1.0,5/15,23.39%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,protein localization to nucleus (GO:0034504),-0.2328636679489042,-0.8435011086491389,0.8392156862745098,0.9455315393235766,1.0,29/102,27.07%,COL1A1;APPL2;BMP7;BMP4;LMNA;RANBP17;SIX1;PML;TOR1AIP1;TAF8;PAF1;MORC3;E2F3;FAM53B;SIX4;CNEP1R1;IPO7;BBS4;WRN;GBP2;BCL3;STAT3;KPNB1;MSX1;HIKESHI;NUP155;IPO8;TPR;NOP53
prerank,plasma membrane tubulation (GO:0097320),0.3957962591399754,0.8434420380012458,0.6468531468531469,0.9349458106714483,1.0,2/13,9.17%,FNBP1L;CAVIN2
prerank,negative regulation of cell aging (GO:0090344),0.3794441497206632,0.8432756355157619,0.6497175141242938,0.934727186850975,1.0,7/16,23.00%,YBX1;TERF2;MAP3K3;RBL1;HMGA2;CDK6;AKT3
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.32731128804592186,0.8430389835913236,0.6703821656050956,0.9346294572152928,1.0,10/32,20.09%,HMBOX1;CTNNB1;MAPK3;CCT3;CCT5;ACD;MAPK1;CCT7;NAF1;MAP2K7
prerank,cellular response to amino acid stimulus (GO:0071230),0.3286909721386266,0.8430266114433796,0.6677631578947368,0.9341098524311845,1.0,9/33,19.26%,SH3BP4;SESN3;FYN;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.33902326675985306,-0.8426368079688837,0.6629464285714286,0.9463616095164192,1.0,3/16,11.39%,SLC39A14;PRKCA;PRMT5
prerank,fatty acid metabolic process (GO:0006631),0.2682858346625317,0.8425855358573973,0.7638326585695007,0.9344532417039928,1.0,19/115,15.01%,ADIPOR2;FASN;PPARD;ACSL5;CPT1A;CRAT;ACOX1;ABCB11;ACSL6;ACSL3;LIPC;ADIPOR1;PNPLA8;PPARG;SLC27A2;LPIN3;HACL1;HSD17B8;FA2H
prerank,cellular senescence (GO:0090398),0.3393496435897625,0.8425346472549705,0.6720257234726688,0.9340122694628545,1.0,6/27,11.49%,TBX3;CDKN2B;KAT6A;TERF2;HMGA1;HRAS
prerank,positive regulation of actin nucleation (GO:0051127),-0.3706145133905184,-0.8425175800530537,0.6659340659340659,0.9457389381251442,1.0,3/11,7.33%,GSN;FCHSD2;ABI2
prerank,nucleoside salvage (GO:0043174),0.4145766410533021,0.8424585387326889,0.6395563770794824,0.9336308099860864,1.0,1/10,3.05%,HPRT1
prerank,long-term synaptic potentiation (GO:0060291),-0.3153993495171281,-0.842089492735132,0.6968973747016707,0.9456859923324853,1.0,9/21,27.36%,SLC8A3;NFATC4;PTK2B;TSHZ3;STX4;VAMP2;PRKCZ;GRIN2D;SLC8A2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.3773236597684439,-0.8419768113852942,0.6720647773279352,0.9450568706446775,1.0,4/10,31.50%,TLR4;TLR6;CD36;CD68
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.3519856197554295,-0.841700592170296,0.6869747899159664,0.9447273183703055,1.0,5/14,17.09%,IL34;THBS1;CMKLR1;RARRES2;MDK
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.302426984628199,0.8416181180195222,0.7192716236722306,0.93410734523463,1.0,18/56,27.05%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;ECSIT;DMAC1;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.302426984628199,0.8416181180195222,0.7192716236722306,0.93410734523463,1.0,18/56,27.05%,NDUFAF3;NDUFA2;NDUFA8;NDUFAF7;DMAC2;TMEM126B;NDUFA12;NDUFB3;NDUFAF8;NDUFC1;NUBPL;NDUFA10;ECSIT;DMAC1;TIMMDC1;NDUFA7;TIMM21;NDUFS5
prerank,positive regulation of cellular catabolic process (GO:0031331),0.263249777409089,0.8413935767455261,0.7582278481012659,0.9339826931022944,1.0,23/132,12.45%,INSR;SH3BP4;APP;PRR5L;TRIM14;FOXO1;PRKD1;ENTPD5;IRGM;P2RX7;MSN;GTPBP1;PFKFB3;PIK3C2A;ABCD1;GSK3A;HIF1A;SH3GLB1;ORMDL3;PIK3CB;SVIP;DXO;TFEB
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4119423450107038,0.8412289674712017,0.6465201465201466,0.933768716275956,1.0,6/10,31.01%,INPP5F;SH2B3;SOCS1;PARP14;PPP2R1A;NF2
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.39218130423581377,0.8405348216067084,0.6229508196721312,0.934538582280004,1.0,6/13,25.56%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3167535142244858,-0.8403388613506891,0.6615776081424937,0.9465501216956731,1.0,4/20,11.61%,MCU;SLC8A3;SLC8B1;AFG3L2
prerank,methylguanosine-cap decapping (GO:0110156),0.4148931799630704,0.8397420562894848,0.6842105263157895,0.9355062752817352,1.0,4/10,13.62%,EDC3;DCP2;DCP1B;PNRC2
prerank,regulation of TOR signaling (GO:0032006),0.28871786447432785,0.8389995348398459,0.7283406754772394,0.9364052720332882,1.0,16/67,16.47%,SH3BP4;TNFAIP8L1;GNA12;WDR59;RFFL;DEPDC5;DDIT4;LAMTOR5;GSK3A;RPTOR;TMEM127;PDCD6;EPM2A;TBCK;LAMTOR4;GAS6
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.30745571244864534,-0.8388185030496018,0.700507614213198,0.9487742587545939,1.0,9/24,17.50%,PKD1;APOE;PRKACA;PSME3;PTK2B;ATP5IF1;RHBDF1;LATS1;NUB1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.3886066753068595,0.8387079346977961,0.6401446654611211,0.9364241121013231,1.0,6/14,25.56%,CSTF2;CPSF1;NCBP2;NCBP1;CPSF4L;CSTF2T
prerank,zinc ion transport (GO:0006829),0.3615647982834705,0.8386990137051986,0.6666666666666666,0.9358935826516569,1.0,2/21,3.02%,SLC39A8;SLC30A1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.3511794002379071,-0.8382975435357829,0.6858316221765913,0.9489031116046917,1.0,5/13,21.27%,ATG10;SENP6;UBA1;UBA6;UBA2
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.38482385246068107,0.8380724957952117,0.6706484641638225,0.9366025035129532,1.0,4/15,12.84%,PPARD;NR1H2;ELOVL5;PPARG
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.37813470657037707,0.8377483571878478,0.6516464471403813,0.9366645776852771,1.0,3/14,9.70%,IMPDH1;ADSS2;GART
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.3385085454290714,-0.8374972330761341,0.693717277486911,0.9496709771168818,1.0,6/18,15.18%,DACT1;APOE;EZR;VGLL4;ATP5IF1;CD81
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.37310960187805675,0.8372737438459477,0.6546762589928058,0.9370201113871919,1.0,4/16,18.03%,VPS36;TMEM50A;VPS25;LEPROTL1
prerank,myofibril assembly (GO:0030239),0.31324508545160024,0.836429911106094,0.694136291600634,0.9381019039936671,1.0,2/42,1.54%,FLII;PGM5
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2875518031450688,0.8362467126955608,0.7291666666666666,0.9379242366535977,1.0,11/65,12.89%,NDNF;EPAS1;RGCC;AK4;EGLN2;BNIP3L;UBQLN1;HIF1A;ZFP36L1;EGLN1;HIPK2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.30033753682736497,-0.835091302736798,0.7150127226463104,0.9536890151249874,1.0,8/28,17.70%,ITPR1;MAP3K5;TMEM117;BCL2;CEBPB;ATP2A3;DDIT3;CASP4
prerank,glycoprotein catabolic process (GO:0006516),0.3709390400625262,0.834993094149878,0.6672473867595818,0.9398774762502725,1.0,7/17,13.93%,OGA;NEU4;STT3B;FBXO6;MANBA;EDEM1;NEU2
prerank,rRNA 3'-end processing (GO:0031125),-0.3852271542965269,-0.8342803750036727,0.6598639455782312,0.9543827443527284,1.0,4/10,25.05%,ERI3;ERI2;EXOSC2;ERI1
prerank,cell junction maintenance (GO:0034331),-0.34537941295300045,-0.8340354197200516,0.6935866983372921,0.953983933915008,1.0,5/14,25.83%,NLGN2;CLDN1;MYADM;CBLN2;PRTN3
prerank,macrophage activation involved in immune response (GO:0002281),0.3876797716576804,0.8338063123821506,0.649090909090909,0.9416367319524356,1.0,5/13,20.06%,DYSF;SYK;NMI;SBNO2;PLCG2
prerank,cellular response to nitrogen compound (GO:1901699),-0.3183794656087565,-0.8337024451169435,0.7244655581947743,0.9538120877574678,1.0,1/20,0.65%,ROCK2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.24025059467305293,0.8334847675611543,0.8547297297297297,0.9416968546912396,1.0,95/341,23.32%,RNF144B;ZNRF1;TRIM25;NEDD4L;PELI1;RNF125;ZNRF3;CTNNB1;KLHL25;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;RNF215;PSMD11;PSMC6;FEM1C;KLHL3;NDFIP2;PSME2;PPP1R11;SMURF1;UBXN1;KCTD10;OTUD7A;SHARPIN;KLHL20;RNF130;TOLLIP;UBE3D;UBQLN1;PSMD8;GSK3A;RNF187;ARRDC1;MAEA;BUB3;TNFAIP3;PSMB10;FBXO21;NHLRC1;RBX1;PTTG1;ANAPC16;TRIM2;UBE2D3;AREL1;RNF8;PSMA8;ATE1;ARMC8;RAD23A;ANAPC7;UBE2G2;BAG6;GID8;BFAR;RNF19A;TRIM71;TRIM3;KCTD17;ANAPC10;PSMD9;SIAH1;CBL;RNF4;UBE2D1;VPS37A;OTUD7B;RBCK1;RNF166;FBXO8;ANAPC2;NSFL1C;PLAA;ANKRD9;VPS37B;ERCC8;MIB1;RLIM;DDB1;PSMC3;UBL7;PSMD1;CDC23;RAD23B;RNF126;VPS37C;CNOT4;PSMD10;CDC26;FBXL14;CDC27
prerank,positive regulation of chondrocyte differentiation (GO:0032332),-0.37840081799277253,-0.8334450994938917,0.692144373673036,0.953411821163931,1.0,3/10,12.27%,SOX5;SOX6;PKDCC
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.3286949965504853,0.833408848078695,0.6817472698907956,0.9412927364721799,1.0,2/31,7.20%,GCH1;GPHN
prerank,microtubule anchoring (GO:0034453),-0.34610099096166486,-0.833332669283373,0.672093023255814,0.952756562445022,1.0,3/12,13.56%,DAG1;BICD1;PCM1
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.33552910134296055,0.8332632201103047,0.6930860033726813,0.9410221282838765,1.0,2/27,2.59%,UTRN;NEDD4L
prerank,positive regulation of glycolytic process (GO:0045821),0.35998229793531566,0.8330437927195202,0.6825657894736842,0.94037576699272,1.0,6/20,11.82%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.35998229793531566,0.8330437927195202,0.6825657894736842,0.94037576699272,1.0,6/20,11.82%,INSR;APP;ENTPD5;P2RX7;PFKFB3;HIF1A
prerank,regulation of urine volume (GO:0035809),-0.3806830451862223,-0.8325684104712994,0.7021276595744681,0.953331071708986,1.0,3/10,13.15%,NPR3;ADCY6;ADM
prerank,regulation of tissue remodeling (GO:0034103),0.36691221042152355,0.8325260330066082,0.6813186813186813,0.9407976046326542,1.0,5/18,12.67%,FLT4;SYT7;TGFB1;CEACAM1;IL15
prerank,regulation of cation channel activity (GO:2001257),-0.2325862994527871,-0.8322389456986947,0.8515901060070671,0.9530690400296017,1.0,22/89,18.42%,ANK2;ACTN2;NLGN2;DMD;CAMK2D;DLG1;DLG4;SLMAP;CACNB4;PRKACA;PRRT1;PTK2B;GRIA3;CACNB2;JPH1;CACNB1;CAPN1;FGF11;KCNAB1;VAMP2;AHNAK;JPH2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.3036554632815317,0.8321473123002592,0.7125382262996942,0.940936015247355,1.0,18/50,28.17%,PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2733362805537223,-0.8319253127890647,0.752112676056338,0.9528463785831277,1.0,7/40,13.91%,PID1;SLC25A36;BCL2;PPA2;LRRK2;ABL1;ATP5IF1
prerank,negative regulation of transposition (GO:0010529),-0.3331948281356561,-0.831773912442263,0.6772727272727272,0.9522807936905131,1.0,8/16,28.68%,TUT4;UBR2;TEX15;PIWIL2;MYBL1;TDRD9;MOV10;DDX4
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.3160346700517979,-0.8317224768402498,0.7206572769953051,0.9515068290357215,1.0,6/20,17.34%,NR2F2;CDK5RAP1;PTEN;CDKN1C;LATS1;MYOCD
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.29961129373275663,0.8316940444998343,0.7129629629629629,0.9412377667149631,1.0,8/49,12.67%,IL6R;ARL2BP;CD40;LYN;STAP2;PTK6;CNTF;IL15
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.301570580104795,-0.8316754629355798,0.7307692307692307,0.9507387976580504,1.0,8/26,18.79%,TRAFD1;PPM1B;IRAK3;SIRT2;MAPKBP1;PCBP2;C1QBP;MUL1
prerank,ubiquinone metabolic process (GO:0006743),-0.33689983764702547,-0.8315433805773356,0.7295454545454545,0.9501514808676859,1.0,5/15,19.93%,COQ10A;AIFM2;COQ2;COQ8B;COQ10B
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.2845687996947659,-0.8313590353544417,0.7289972899728997,0.9496453597591995,1.0,5/33,6.43%,KANK2;FHL1;PKD2;DLG1;DACT1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),0.32509000811311867,0.8286800844606614,0.7022653721682848,0.94643495588515,1.0,9/32,22.58%,TAF1B;MAPK3;GTF2H2;GTF2H4;RRN3;UBTF;POLR1A;GTF2H3;TAF1C
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.28519531331896325,0.8285518521083056,0.7375366568914956,0.9461363299909196,1.0,20/70,23.03%,B2M;IKBKB;PSMB3;PSMD11;MFSD6;TAP2;PSMC6;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;PSMC3;PSMD1;VAMP8;PSMD10;CALR
prerank,peroxisome organization (GO:0007031),-0.3045143808169853,-0.8277264677209507,0.7255369928400954,0.9557675929611731,1.0,7/25,18.06%,ABCD3;ACOT8;SEC16B;PEX7;PEX2;TMEM135;PEX11A
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.3080222488346555,-0.8276514099559164,0.6985645933014354,0.955032616659378,1.0,6/22,17.34%,NR2F2;CDK5RAP1;PTEN;CDKN1C;LATS1;MYOCD
prerank,regulation of protein polymerization (GO:0032271),-0.2755922398950549,-0.8271284049795216,0.7694524495677233,0.9551527167459313,1.0,10/35,18.28%,ARHGAP28;FCHSD2;PLEKHG2;ARHGAP18;PFN2;ABL1;MAP2;CTTN;LATS1;DBN1
prerank,negative regulation of cell communication (GO:0010648),0.35536068541310717,0.8270640501281911,0.7135593220338983,0.9483885541708473,1.0,5/21,16.32%,KIF26A;SOCS5;PTK6;SRMS;ACVR1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.29529994880981275,-0.8267848299588494,0.697560975609756,0.9549228071820092,1.0,6/25,16.98%,CCNT2;WDR43;SETD5;DDX39B;LDB1;ERCC6
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.3308020073966866,-0.8266535852423654,0.7129629629629629,0.9542936674449812,1.0,8/16,40.91%,TOP2B;TOP2A;HFM1;MEIOB;EME1;SHOC1;CENPS;MUS81
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.2926990643445109,0.8265828670045534,0.7444279346210996,0.9487462944643397,1.0,18/57,19.90%,TNFSF10;NOD1;FOXL2;SOX7;FYN;AIM2;MALT1;CASP8;ARL6IP5;GRIN2B;SYK;BCL10;PDCD6;NLRC4;PPM1F;BAK1;CYCS;F2R
prerank,negative regulation of signaling (GO:0023057),0.34098076593912274,0.8261579632569441,0.697452229299363,0.9490131161693486,1.0,9/25,24.90%,KIF26A;SOCS5;PTK6;SRMS;AP1AR;ACVR1;TRAT1;OPRM1;GLRA1
prerank,mesoderm formation (GO:0001707),0.3695842293620917,0.8261055261450773,0.6861063464837049,0.9485704746417419,1.0,1/17,1.29%,BMPR2
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.37718769075178704,-0.8259474114712574,0.673036093418259,0.9547802742528578,1.0,4/10,17.48%,ALDH7A1;HNMT;COMT;SARDH
prerank,bone morphogenesis (GO:0060349),-0.34354531018664514,-0.8257906592648757,0.7052154195011338,0.9542186013476054,1.0,5/14,15.26%,FGFR2;CYP26B1;SFRP4;SKI;LRP6
prerank,cell projection organization (GO:0030030),0.3304441128884841,0.825776838776246,0.7043478260869566,0.9486162948080833,1.0,8/30,14.70%,PARVB;PARVG;NCKAP1;CAPG;CYFIP1;RAC1;RHOV;NCKAP1L
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.34713706910137554,-0.8256462343078301,0.6863636363636364,0.953643654430015,1.0,2/14,4.11%,NMNAT2;ME1
prerank,regulation of mitotic cell cycle (GO:0007346),0.2507952249963938,0.8250925987963046,0.8235294117647058,0.9493298656317356,1.0,53/171,23.54%,APP;AFAP1L2;DUSP3;TAL1;BTG4;TTC28;PSMB3;PKN2;PSMD11;HECA;PIN1;TGFB1;IQGAP1;CAV2;PSMC6;PSME2;BRINP3;BTG1;BRINP2;PSMD8;BTG2;EIF4E;CYLD;SDCBP;MAEA;BUB3;PSMB10;PIM2;TTL;ANAPC16;PSMA8;ANAPC7;SKP1;ANAPC10;CDK11B;PSMD9;UBE2D1;PIM3;TFAP4;ANAPC2;BTG3;ASNS;DDB1;CUL1;PSMC3;PSMD1;CDC23;SCRIB;LGMN;PSMD10;CDC26;CDC27;CDKN1B
prerank,regulation of lipid storage (GO:0010883),0.34240247790083156,0.824919221718922,0.6857142857142857,0.9490961905010177,1.0,2/22,6.44%,NFKBIA;FBXW7
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.3533087246810639,-0.8248893372165769,0.7012987012987013,0.9542161265614328,1.0,2/12,5.81%,ACSL1;ACOT8
prerank,tRNA modification (GO:0006400),-0.24460154607605736,-0.8244985169667011,0.7802547770700637,0.9540784164648095,1.0,18/62,20.25%,THADA;TRMT9B;THUMPD3;NSUN2;OSGEP;ALKBH1;METTL6;PUS7;ELP5;DUS2;PUS10;TRIT1;TPRKB;DTWD1;TRMT112;ANKRD16;TYW5;BCDIN3D
prerank,detection of visible light (GO:0009584),0.36243141158389114,0.8243407128190353,0.6789915966386555,0.9495674264634651,1.0,2/16,5.50%,GNAQ;RP1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.33395405895603364,-0.8240530642788548,0.7,0.9540229461953953,1.0,5/16,14.96%,TNKS2;ATM;RTEL1;PARP1;HNRNPA2B1
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.2857728744013101,0.8239155269938077,0.7395833333333334,0.9498155190708257,1.0,20/57,24.02%,APP;MEF2C;LRRC7;GRIA4;AKAP9;GRIN2B;SHISA6;CNIH3;MINK1;CAMK2B;DLGAP3;NLGN1;CRHBP;NPTX1;GRIA2;NPTXR;CACNG2;OPRM1;GSG1L;GRIN1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.4018394569303252,0.8237856334573574,0.6760299625468165,0.9494935535145438,1.0,3/10,17.88%,CCT3;CCT5;CCT7
prerank,regulation of cell killing (GO:0031341),-0.3270487818282979,-0.8235203499749516,0.6908665105386417,0.954123393221853,1.0,5/16,13.37%,CD55;CFH;FZD7;CYBA;DVL2
prerank,cGMP biosynthetic process (GO:0006182),0.39438047295617606,0.8233299553959675,0.6810810810810811,0.9497777899450736,1.0,3/10,13.27%,NPPA;NPR1;NPR2
prerank,cytoplasmic microtubule organization (GO:0031122),0.2958632693279917,0.8233001661750283,0.725705329153605,0.9492859372055908,1.0,18/54,21.14%,CCDC13;CLIP1;CCDC88A;LIMK2;CCDC88B;STMN3;RAB11A;CRIPT;HOOK1;MAP10;SLK;SPAST;TRPV4;CLIP2;CAMSAP2;TPPP;DCTN1;CLASP1
prerank,regulation of DNA replication (GO:0006275),-0.25757612227671833,-0.8230851789769487,0.7982708933717579,0.9540635349495907,1.0,7/49,11.31%,EGFR;GLI2;EHMT2;GLI1;TSPYL2;ZBTB38;NUCKS1
prerank,cellular response to heat (GO:0034605),-0.2750423637677463,-0.822943916235936,0.736986301369863,0.9534918561624658,1.0,14/35,26.77%,FGF1;THBS1;ANO1;PRKACA;BAG3;HTRA2;TCIM;HSBP1;CLPB;RBBP7;HIKESHI;HSPA1A;HMOX1;TPR
prerank,positive regulation of translational initiation (GO:0045948),-0.32950618458315983,-0.8229239203268486,0.687793427230047,0.9526681442332282,1.0,7/18,32.92%,HABP4;DDX3X;YTHDF1;RPS6KB1;CDC123;BOLL;CCL5
prerank,cellular response to retinoic acid (GO:0071300),0.3037634260902969,0.8225413029125057,0.7220496894409938,0.9501012719765592,1.0,9/42,11.20%,TBX1;FZD4;LYN;CREB1;RET;TWF2;BRINP3;PTK6;BRINP2
prerank,NAD biosynthetic process (GO:0009435),0.35487986910735586,0.8219336510554486,0.6557093425605537,0.9506890944644363,1.0,1/20,0.77%,NAMPT
prerank,regulation of platelet aggregation (GO:0090330),0.3665986358344693,0.8218149020307771,0.7126050420168067,0.9503617857416605,1.0,5/17,12.03%,F11R;LYN;PRKG1;SYK;CEACAM1
prerank,response to hexose (GO:0009746),-0.3023663967445278,-0.8213400930923422,0.7357142857142858,0.9547611213819902,1.0,3/25,7.89%,THBS1;IRS2;SELENOS
prerank,phosphatidic acid biosynthetic process (GO:0006654),-0.26624130941493596,-0.8213265429946113,0.7617728531855956,0.9539164788493356,1.0,10/46,15.56%,PLD1;AGPAT4;LCLAT1;GPD1L;PLA2G12A;ACP6;GPAT3;DDHD1;PNPLA3;SLC27A1
prerank,transport along microtubule (GO:0010970),-0.3477310320754269,-0.8211926632975746,0.7057569296375267,0.9533133475283834,1.0,8/13,23.27%,ARHGAP21;CLIP3;DYNC1I1;SPG11;BAG3;APBA1;BORCS5;COPG1
prerank,mRNA polyadenylation (GO:0006378),0.33118298147824576,0.8211004546303321,0.6824104234527687,0.9505503369800761,1.0,4/26,10.84%,APP;MTPAP;CPSF1;SSU72
prerank,RNA polyadenylation (GO:0043631),0.33118298147824576,0.8211004546303321,0.6824104234527687,0.9505503369800761,1.0,4/26,10.84%,APP;MTPAP;CPSF1;SSU72
prerank,regulation of stem cell differentiation (GO:2000736),0.2713742839289216,0.8202909443847254,0.7819444444444444,0.9514771094925975,1.0,12/89,11.35%,LMO2;NOTCH1;GATA2;TAL1;PSMB3;PSMD11;TCF12;PTN;PSMC6;PSME2;CBFB;PSMD8
prerank,DNA alkylation (GO:0006305),-0.3159544008198216,-0.8202758003537731,0.707196029776675,0.9533470041805029,1.0,5/19,19.69%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,DNA methylation or demethylation (GO:0044728),-0.3159544008198216,-0.8202758003537731,0.707196029776675,0.9533470041805029,1.0,5/19,19.69%,DNMT3A;EHMT2;PPM1D;ATF7IP;TEX15
prerank,DNA packaging (GO:0006323),0.3600437923740051,0.820209291881782,0.6919014084507042,0.9510862815450494,1.0,5/16,20.07%,KAT6A;BANF1;CHAF1A;CHAF1B;NOC2L
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.38761824501516084,0.8198116486716216,0.6653771760154739,0.9512762285371067,1.0,5/11,16.32%,TGFB2;SMAD7;TGFB1;TGFBR2;ACVR1
prerank,tRNA wobble base modification (GO:0002097),-0.34196451730624244,-0.8196504561449902,0.6993318485523385,0.9536777507197761,1.0,4/14,15.33%,TRMT9B;ELP3;ALKBH1;ELP4
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.30196768452344475,-0.8195733844017891,0.706601466992665,0.9529561216287004,1.0,11/23,32.61%,GJA1;GPSM2;FBXW11;MAD2L1;MISP;HTT;SPDL1;NUMA1;ITGB1;PLK1;PKHD1
prerank,nuclear membrane disassembly (GO:0051081),-0.33391295112634467,-0.8192520248586184,0.7046413502109705,0.9526880371076083,1.0,5/14,22.46%,NEK6;AKAP8L;PRKCA;CNEP1R1;CCNB2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2374615113501719,-0.8192162797456957,0.8158844765342961,0.9519007738842944,1.0,27/80,26.63%,DENND2A;SGSM2;SNX6;GBF1;SNX12;STX5;ARL1;TBC1D10A;SNX5;SNX8;RAB29;RAB6A;LMAN1;STX16;TRAPPC10;SURF4;SNX32;VPS54;BET1L;VAMP3;TMED9;VPS26A;RAB9A;BAIAP3;PHETA2;VPS26B;RHOBTB3
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.33547358750519357,0.8190178122781044,0.6753022452504318,0.9521809131909743,1.0,4/26,6.84%,APP;DUSP3;TAL1;PKN2
prerank,positive regulation of cation channel activity (GO:2001259),0.3058790074412271,0.8188341606610651,0.7086614173228346,0.9519694183459075,1.0,4/40,6.96%,SHANK3;TMSB4X;CALM1;PIRT
prerank,chromatin remodeling at centromere (GO:0031055),-0.2787372962373328,-0.8183935003704348,0.7859154929577464,0.9526179465569214,1.0,8/31,18.14%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,plasma membrane invagination (GO:0099024),0.32620149475202964,0.8182008192365944,0.6960132890365448,0.9525709668726429,1.0,3/29,6.47%,DOCK1;ELMO1;ARHGAP25
prerank,regulation of proteolysis (GO:0030162),0.29958019041835743,0.8181179385956175,0.732612055641422,0.9521789062091166,1.0,3/48,2.28%,LTBP4;CAV1;PLAUR
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.3680450443909948,-0.817899367619202,0.7094017094017094,0.9526797076314224,1.0,2/10,6.79%,ZEB2;ATP7A
prerank,chloride transmembrane transport (GO:1902476),0.29376868415631185,0.8177191358293678,0.7078986587183308,0.9523579570536445,1.0,13/48,19.47%,SLC1A1;SLC12A6;GABRB1;SLC12A9;CLCN3;GABRQ;GABRG1;GABRG3;GABRA1;ANO3;GABRB2;GLRA2;ANO5
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.3676132035238469,-0.817301553776687,0.7258426966292135,0.9529372440572706,1.0,5/10,18.57%,PRKAA2;KLF15;SETD5;MYOCD;FLCN
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.36721748172505325,-0.8171350963487463,0.6973684210526315,0.9524088438173935,1.0,5/10,36.75%,KDM1A;BRCA1;SIRT1;JARID2;MYB
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.3330848677388891,-0.816871984965978,0.7053364269141531,0.9520225602881774,1.0,7/16,17.11%,AMPD3;PAICS;LHPP;IMPDH2;GMPS;ADSL;ATIC
prerank,multivesicular body organization (GO:0036257),0.32382779315632226,0.816496150443642,0.6848184818481848,0.9540708958985497,1.0,13/31,28.32%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C;CHMP2B;VPS4B;RAB27A;VPS28
prerank,positive regulation of lipid metabolic process (GO:0045834),0.3438987823915443,0.816193426881838,0.6855241264559068,0.9540741196843614,1.0,5/22,14.02%,PPARD;CREB1;SORBS1;PPARG;DISP3
prerank,kinetochore organization (GO:0051383),-0.34487300805244936,-0.8161382348064695,0.7312072892938497,0.952521785460474,1.0,8/13,41.12%,CENPC;CENPE;CENPF;DLGAP5;NUF2;CENPW;CENPH;CDT1
prerank,heart process (GO:0003015),-0.3408424527120537,-0.815748623560513,0.6936542669584245,0.9523767916509371,1.0,3/14,7.82%,SGCD;ACE;NOX4
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.34925458528945236,0.8156910746670722,0.6938405797101449,0.9544314006903625,1.0,10/17,31.47%,NDUFA4;AFG1L;COX6C;CYCS;COX10;COX15;COX7A2L;COX5B;COX4I1;COX8A
prerank,RNA 3'-end processing (GO:0031123),0.27833371221909714,0.8153979221025964,0.7628111273792094,0.9544515672403694,1.0,9/69,13.09%,TENT4A;MTPAP;RNPS1;CSTF2;CPSF1;MAGOHB;THOC6;NCBP2;ZC3H11A
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.2790251807875863,0.8152979998222313,0.7742857142857142,0.9540843405531747,1.0,14/76,13.09%,APP;NFKBIA;NOD1;NOD2;HDAC7;TMSB4X;TLR3;ACTN4;LGALS9;TLR7;AGER;ADIPOR1;C1QTNF4;CYLD
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.31003322888923074,-0.8149564635418795,0.7180094786729858,0.9529115389274482,1.0,7/20,18.66%,RBPJ;RUNX2;SMAD9;BMP2;EP300;CHD6;CREB3
prerank,lipoprotein catabolic process (GO:0042159),0.3923021583928994,0.8130250110035766,0.6884057971014492,0.9576792692980647,1.0,3/11,8.87%,NOTUM;ABHD17A;LYPLA1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.3648499484306885,-0.812955206037134,0.7040169133192389,0.9556593276099662,1.0,6/10,27.78%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;MTHFS;SHMT1
prerank,protein import into peroxisome membrane (GO:0045046),-0.3003400120234955,-0.8127505069590178,0.7655860349127181,0.9551723546375325,1.0,6/22,23.79%,ABCD3;PXMP2;PEX2;ALDH3A2;ATAD1;PEX13
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.2913632077708618,-0.8127313972706257,0.7396313364055299,0.954354827113488,1.0,6/24,18.24%,CEMIP;MIEF1;ITGB1BP1;MIEF2;KCNB1;C2CD5
prerank,cellular response to UV (GO:0034644),0.27634340378221683,0.8127018681257596,0.7689015691868759,0.9577683375736195,1.0,19/76,21.63%,POLK;HYAL2;N4BP1;OPN5;RHBDD1;COPS9;EIF2AK4;MMP1;OPN3;TRIAP1;PTPRK;NSMCE3;BAK1;NOC2L;POLD1;HYAL1;METTL3;DDB1;ERCC4
prerank,cellular response to inorganic substance (GO:0071241),0.35226038530908066,0.8122013850497845,0.7205387205387206,0.958115116000684,1.0,2/21,5.21%,FOXO1;KCNC2
prerank,regulation of lipid metabolic process (GO:0019216),0.26788205974070783,0.8121437342867713,0.7836338418862691,0.9576902180400676,1.0,18/88,14.25%,CAV1;FASN;PPARD;NCOA1;ACACB;NCOA2;ZFP69;ABCA7;OPA3;HELZ2;LACTB;ADIPOR1;HMGCR;ELOVL6;PPARG;EDF1;DISP3;SP1
prerank,regulation of protein catabolic process (GO:0042176),0.26608807209963914,0.8121095766257425,0.7902777777777777,0.9572116734473202,1.0,19/99,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;SNX3;EGLN2;OAZ1;PIN1;SMURF1;GSK3A;HMGCR;HGS;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;GFAP;APC
prerank,regulation of nervous system development (GO:0051960),-0.2695448535567296,-0.8120451753252301,0.7675070028011205,0.9547290654391497,1.0,6/37,13.98%,DOCK7;PER2;HEYL;YAP1;SIRT2;LGI4
prerank,positive regulation of viral genome replication (GO:0045070),0.32868355669014476,0.8118738284463135,0.7057851239669422,0.9571242857326046,1.0,6/29,10.78%,FKBP6;ADAR;PPIA;PKN2;PDE12;NR5A2
prerank,triglyceride homeostasis (GO:0070328),-0.28477986539304545,-0.81142203101972,0.7582938388625592,0.9550112248323241,1.0,4/26,8.01%,IL18;RORA;C1QTNF3;APOE
prerank,morphogenesis of an epithelial sheet (GO:0002011),-0.36388627830169024,-0.8111761640912106,0.7092050209205021,0.9546248471257909,1.0,2/10,1.67%,BMP5;BMP7
prerank,macromolecule catabolic process (GO:0009057),0.3307574006366109,0.810974429537317,0.6964586846543002,0.9582372171266444,1.0,13/26,27.66%,TGFB1;TRIM24;SMURF1;SH3GLB1;CLN8;USE1;SIAH1;UVRAG;LGMN;SNX25;MTOR;PPT1;BECN1
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.3239537878853502,-0.81091121410535,0.7004830917874396,0.9542556667760937,1.0,2/19,2.73%,AXL;MMP14
prerank,mitotic nuclear division (GO:0140014),-0.23822130767118263,-0.8107893507433793,0.8259493670886076,0.9536362022633286,1.0,31/71,32.28%,KLHL22;FLNA;GOLGA2;ZWINT;SMC4;PIBF1;CENPK;TUBG1;KLHDC8B;STAG2;SPICE1;KIF18A;NUSAP1;CCDC61;MISP;TPX2;KNSTRN;KIFC1;NSL1;UBE2S;KPNB1;KIF11;SGO1;CDCA8;CEP192;ABRAXAS2;BCCIP;PLK1;ABRAXAS1;TOGARAM2;ESPL1
prerank,positive regulation of protein catabolic process (GO:0045732),0.2688364824474108,0.8105500311750097,0.7667597765363129,0.9584542148798725,1.0,15/84,15.84%,DAB2IP;NKD1;NEDD4L;FOXO1;EGLN2;OAZ1;MSN;SMURF1;GSK3A;TNFSF12;TNFAIP3;ASB5;AREL1;PLK2;APC
prerank,positive regulation of secretion by cell (GO:1903532),0.2780646868938387,0.8102079088304828,0.776824034334764,0.9585476140666094,1.0,9/70,8.09%,TGFB2;UNC13B;RGCC;STX1A;CD2AP;ABCG1;PPIA;UNC13D;TGFB1
prerank,axonal transport of mitochondrion (GO:0019896),-0.3566931563215612,-0.8098103138705068,0.71875,0.954539481277577,1.0,1/11,2.97%,TRAK1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.37351691420190725,0.8095357243393868,0.6709558823529411,0.9592363156853345,1.0,4/13,26.57%,PVR;CYRIB;NECTIN2;IL12A
prerank,engulfment of apoptotic cell (GO:0043652),0.35906587611833474,0.8091535776211682,0.717948717948718,0.9593956061749644,1.0,1/15,1.07%,RHOBTB1
prerank,extracellular transport (GO:0006858),-0.3388018135850357,-0.8088253407682747,0.7238307349665924,0.9554472303201722,1.0,8/13,33.82%,TSG101;WWP2;ROPN1L;ADCY10;SPAG17;SPA17;CCDC40;DNAAF4
prerank,negative regulation of transferase activity (GO:0051348),0.3184939621339578,0.808728139374946,0.7210526315789474,0.9596455180511999,1.0,14/28,31.42%,MEN1;SMAD7;GSK3A;TERF1;INPP5K;ERCC4;PINX1;CDKN1B;BAG5;DTX3L;PARK7;TP53;GSK3B;SRC
prerank,regulation of protein kinase activity (GO:0045859),-0.22161763758612085,-0.8075060703524172,0.9316546762589928,0.9569569754626156,1.0,18/106,13.29%,PRKAG2;PLCE1;PPM1E;DEPTOR;RASSF2;DTNBP1;CCN1;TSPYL2;SNX9;PDPK1;SPRED1;QARS1;ITGB1BP1;PTK2B;JTB;XRCC5;ANKRD54;NF1
prerank,positive regulation of catalytic activity (GO:0043085),0.3091323503906582,0.8074018605755967,0.7707692307692308,0.961505379169613,1.0,9/37,17.11%,CAV1;NOD2;MAPK3;PHACTR4;APH1A;B3GAT3;MSH3;MSH2;YWHAB
prerank,response to unfolded protein (GO:0006986),0.2929375985874654,0.8070662698667628,0.7246835443037974,0.961578101980789,1.0,6/48,10.75%,DAB2IP;HSP90AB1;STT3B;RHBDD1;HSPA8;HSPB1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.30369354223763945,-0.8069722837182494,0.7493540051679587,0.9570753571736776,1.0,8/22,25.47%,ERI3;ERI2;WDR12;NOP14;EXOSC2;NOP9;ERI1;UTP20
prerank,transcription by RNA polymerase I (GO:0006360),0.31306663996794293,0.8068184763058351,0.7388535031847133,0.9615142055601577,1.0,9/34,22.58%,TAF1B;MAPK3;GTF2H2;GTF2H4;RRN3;UBTF;POLR1A;GTF2H3;TAF1C
prerank,fatty acid oxidation (GO:0019395),0.28425298024437273,0.8067197868397392,0.7703703703703704,0.9611655668230725,1.0,14/57,19.06%,ADIPOR2;PPARD;ABCD4;ACOX1;ABCD1;ADIPOR1;SLC27A2;HACL1;ADH5;ECI2;ACAT1;CYP24A1;ACAD11;ABCD2
prerank,negative regulation of axonogenesis (GO:0050771),0.3256429459761296,0.8064614257579945,0.714765100671141,0.9610968792071776,1.0,6/27,15.22%,FGF13;DIP2B;ARHGDIA;MAG;SEMA3G;DCC
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.34842193514084124,0.8064042721069594,0.7044247787610619,0.960671376291184,1.0,9/22,26.99%,GTF2H2;CETN2;GTF2H4;RBX1;GTF2H3;DDB1;RAD23B;XPC;UBB
prerank,spliceosomal snRNP assembly (GO:0000387),0.30839411900165953,0.8061348687693264,0.7475728155339806,0.9606069982804851,1.0,21/38,31.73%,SNRPF;SNRPC;SNRPE;SNRPB;AAR2;PRMT7;LSM4;SNRPD2;WDR77;PRPF8;SART3;DDX20;SNRPD1;SRSF12;SMN1;PRPF31;COIL;GEMIN5;PRPF6;SNRPG;SNRPD3
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.28036329591173176,0.8060948942830254,0.7899408284023669,0.960151170481239,1.0,19/67,23.03%,B2M;IKBKB;PSMB3;PSMD11;TAP2;PSMC6;PSME2;CYBB;PSMD8;NCF4;PSMB10;PSMA8;PSMD9;TAP1;PSMC3;PSMD1;VAMP8;PSMD10;CALR
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.3937670537003559,0.8058866273719218,0.6853526220614828,0.959974224173539,1.0,3/10,10.97%,NR1H2;ELOVL5;ABCD1
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),0.36777246629677557,0.8058270938787733,0.6942003514938488,0.9595502957651808,1.0,3/15,12.18%,HIP1R;PIK3CB;TNK2
prerank,protein localization to microtubule organizing center (GO:1905508),-0.32622670846300655,-0.8054004070339673,0.7352941176470589,0.9590331215157175,1.0,10/15,29.48%,CCDC14;PIBF1;PCM1;SNX10;STIL;BBS4;CEP131;C2CD3;CEP192;NEDD1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.39031899402442183,0.8053326700601909,0.680373831775701,0.9599085742710355,1.0,1/10,0.90%,KDR
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.3841143804062327,0.8053027384969895,0.6848249027237354,0.9594293474033977,1.0,3/11,11.81%,LGALS9;CBFB;VSIR
prerank,regulation of cellular response to stress (GO:0080135),-0.21626382492016985,-0.805261718994947,0.9250936329588015,0.9584179047420199,1.0,35/115,26.77%,ROCK2;NUPR1;AMFR;CAMK2D;NEK6;SEH1L;PRKN;ATM;NUAK1;NUP205;BAG1;CEBPB;CLN3;AIFM2;ABL1;ARMT1;BAG3;EP300;CRYAB;SMG1;SLC38A2;HSBP1;USP19;EIF4G1;RAE1;AJUBA;CASP9;ATR;HIKESHI;HSPA1A;NUP155;CREBBP;NUP35;NDC1;TPR
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.27622414430994524,0.8051576586538075,0.7931547619047619,0.9591653071346472,1.0,24/69,27.64%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COA6;COX6C;NDUFA12;NDUFB3;CYCS;NDUFC1;UQCRQ;COX10;UQCR11;SDHAF2;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.3580545353465633,-0.8046466546838507,0.7326086956521739,0.9586460080489758,1.0,3/11,24.32%,C1QTNF3;EP300;C1QTNF12
prerank,neurogenesis (GO:0022008),-0.2624021154839842,-0.8045941255844543,0.7905027932960894,0.957890814968526,1.0,5/43,5.68%,LPAR1;TRAK1;DAGLA;ANXA1;SIX1
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.2894369189038383,-0.804520806990556,0.756544502617801,0.9571524548763667,1.0,6/26,17.72%,FBN1;HOXA7;MAFB;TLR4;RARA;INHA
prerank,cellular response to hypoxia (GO:0071456),0.2540470271084267,0.8037792200200908,0.8448275862068966,0.9610981394510125,1.0,22/126,16.11%,NDNF;EPAS1;RGCC;AK4;PSMB3;EGLN2;PSMD11;PSMC6;BNIP3L;PSME2;UBQLN1;PSMD8;HIF1A;ZFP36L1;HIGD1A;EGLN1;HIPK2;PSMB10;RBX1;ELOB;PSMA8;OPRD1
prerank,RNA splicing (GO:0008380),0.2664157342200318,0.803322777912121,0.781292984869326,0.9613630297683359,1.0,34/95,29.87%,IVNS1ABP;PPP1R9B;RNPS1;SNRPF;HNRNPC;MAGOHB;SNRPN;ZCRB1;MPHOSPH10;NCBP2;SNRPB;PRPF4;RSRC1;SCNM1;SMU1;LSM4;SNRPD2;RBM8A;SF3B3;NCBP1;PRPF8;SMNDC1;USB1;SCAF11;SNRNP48;PPP2R1A;NOL3;SNRPD1;SRSF7;LSM6;PPIG;BCAS2;PRPF6;ZRSR2
prerank,piRNA metabolic process (GO:0034587),0.3444632111165973,0.803095399606123,0.7046263345195729,0.9612164709177594,1.0,2/19,4.89%,FKBP6;PIWIL1
prerank,negative regulation of fat cell differentiation (GO:0045599),0.31004668694898335,0.8029634435668431,0.7389078498293515,0.960915485487485,1.0,8/34,10.91%,FOXO1;ZFPM1;CCDC85B;GATA2;WWTR1;TGFB1;TRIB2;FERMT2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2706492284417715,0.8027693986108042,0.782608695652174,0.9607260766665507,1.0,21/80,20.16%,SH3RF1;TNFSF10;NOD1;FOXL2;RPS6KA1;SOX7;XIAP;KLF4;MALT1;ARL6IP5;LAMTOR5;SYK;BCL10;PDCD6;GAS6;TRIAP1;PPM1F;DNAJB6;CYCS;F2R;RPS6KA3
prerank,protein import into peroxisome matrix (GO:0016558),0.3821114546458171,0.8025358890241115,0.7130281690140845,0.9605941529349139,1.0,5/12,23.89%,PEX5L;PEX14;PEX16;PEX6;PEX1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.36806761004364974,0.8023202572425114,0.6828828828828829,0.9604489064633992,1.0,5/14,16.18%,CRAT;ACOX1;ABCD1;ECI2;DECR2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.33760723189391184,0.8019252306829269,0.7266775777414075,0.9606235323798362,1.0,8/21,16.47%,NOS3;SRGN;NOTCH1;TGFB1;GREM1;SOX9;HEY1;GAS6
prerank,regulation of centrosome duplication (GO:0010824),-0.2817222235738802,-0.8017116422277903,0.7708333333333334,0.9611723408460763,1.0,9/30,23.20%,ALMS1;SPICE1;STIL;CHMP4C;CEP295NL;CENPJ;FBXW5;CEP131;CEP76
prerank,mitochondrion organization (GO:0007005),0.24823097292172477,0.8015094687841245,0.8485607008760951,0.9608181460335217,1.0,24/165,15.54%,DNM3;BCL2L1;NOS3;ALAS1;TOMM22;BIK;SLC25A33;DNM2;MYH14;TIMM13;CAV2;BNIP3L;FANCG;TIMM10;SAMM50;VPS13D;DNAJC19;POLG2;HIGD1A;AFG1L;OMA1;MFF;IMMP2L;TWNK
prerank,protein K48-linked ubiquitination (GO:0070936),0.2857705761112814,0.8013136309992455,0.7812018489984591,0.9606455631958306,1.0,16/54,18.63%,ZNRF1;NEDD4L;PELI1;RFFL;UBE2G1;KLHL3;RNF187;TNFAIP3;RBX1;UBE2D3;RNF8;UBE2Q2;UBE2G2;BFAR;RNF4;UBE2D1
prerank,regulation of NMDA receptor activity (GO:2000310),0.30765960380425716,0.8011228105447816,0.7424749163879598,0.9604322937074071,1.0,9/32,17.12%,APP;MEF2C;LRRC7;GRIA4;GRIN2B;CAMK2B;NLGN1;CRHBP;CCR2
prerank,negative regulation of neuron death (GO:1901215),0.2664510839130798,0.8007245782141573,0.8189300411522634,0.9605852757126242,1.0,18/93,18.75%,NDNF;CD34;CD200;MEF2C;TOX3;RETREG1;CD200R1;FOXQ1;CNTF;KIR3DL2;MAG;BTBD10;UNC5B;MSH2;PTPRZ1;PRKCG;PM20D1;SET
prerank,protein targeting to mitochondrion (GO:0006626),0.2856740433853565,0.8007213283982489,0.7739403453689168,0.9600595997461121,1.0,20/52,30.77%,TOMM22;TIMM13;PMPCA;TIMM10;SAMM50;DNAJC19;MFF;IMMP2L;TOMM20L;CHCHD4;TOMM7;TOMM5;TIMM21;TIMM50;TOMM70;BCAP31;TIMM9;AIFM1;FIS1;GRPEL2
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.3439652465145541,0.7998319713519545,0.7557522123893805,0.9610595626522042,1.0,4/18,17.36%,LYN;CD19;SH2B2;BAG6
prerank,positive regulation of protein maturation (GO:1903319),-0.35182542970744785,-0.7997885664557179,0.716566866267465,0.9635960425742559,1.0,1/11,1.62%,CCBE1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.311373521516195,0.7996745436411499,0.7405582922824302,0.9608213926101757,1.0,4/32,4.79%,APLNR;PLCG1;CALM1;CD19
prerank,mitotic metaphase plate congression (GO:0007080),-0.24778026466215,-0.7990785399532377,0.8372093023255814,0.9639766946324005,1.0,11/51,19.08%,EML4;SEH1L;CENPC;CUL3;PIBF1;RMDN1;CHMP4C;KIF18A;EML3;VPS4A;CENPE
prerank,global genome nucleotide-excision repair (GO:0070911),0.33304302396376145,0.7990628298878641,0.7120689655172414,0.9613742112510114,1.0,11/26,26.99%,GTF2H2;CETN2;GTF2H4;RBX1;GTF2H3;DDB1;ERCC4;RAD23B;XPC;USP45;UBB
prerank,cGMP-mediated signaling (GO:0019934),0.37480721368247244,0.7986611033919714,0.6863117870722434,0.9615703433776067,1.0,3/13,5.21%,PDE2A;NPPA;KCNC2
prerank,negative regulation of immune response (GO:0050777),0.24689328326008936,0.7983891865737349,0.8633461047254151,0.9614806622285874,1.0,32/154,17.45%,RHBDF2;RAMP2;CALCRL;LYN;PLCG1;CREB1;RAMP3;PRKACB;FYN;INSL3;ADCY4;YES1;HCK;PRKAR2B;NPS;FOXP3;CALCB;ADAM17;PRKAR2A;CYSLTR1;ADCYAP1R1;CD163;SYK;GNB1;TNFAIP3;HTR4;PLK2;RXFP2;GLP1R;CCR2;LYAR;SAMSN1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3384456666574575,0.7982400487851163,0.712280701754386,0.9611998574244583,1.0,6/19,14.21%,PARD3;LRRC7;CLIC4;FSCN1;FOXJ1;SYNJ2BP
prerank,protein polyubiquitination (GO:0000209),0.23235831558239856,0.7978766299899775,0.9140893470790378,0.9613054964214883,1.0,84/297,23.32%,RNF144B;LMO7;ZNRF1;TRIM14;NEDD4L;PELI1;RNF125;CTNNB1;UBE2V2;FBXW7;RFFL;PSMB3;UBE2G1;FBXO41;PSMD11;TRIM36;PSMC6;KLHL3;PSME2;HECTD1;UBE2V1;SMURF1;SHARPIN;KLHL20;UBOX5;HERC6;CBFB;UBE3D;PSMD8;ZNRF2;WSB1;FBXO6;RNF187;TRIM69;FBXW2;TNFAIP3;PSMB10;FBXO21;NHLRC1;RBX1;FBXL8;TRIM2;UBE2D3;AREL1;FBXL15;RNF8;UBE2Q2;PSMA8;ANAPC7;UBE2G2;BFAR;TRIM68;FBXO2;RNF19A;TRIM71;TRIM3;SKP1;ANAPC10;PSMD9;SIAH1;FBXW9;RNF4;UBE2D1;FBXO28;TRAF3;TMEM129;RBCK1;RNF166;ANAPC2;ERCC8;RLIM;CUL1;PSMC3;PSMD1;CDC23;UBE2J1;RNF126;UNKL;PSMD10;FBXO32;CDC26;TRAF6;FBXL14;CDC27
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.35845065091033596,-0.7974089894898081,0.6975169300225733,0.9660683572094296,1.0,6/10,41.12%,DBF4;E2F7;E2F8;WIZ;CDC7;CDT1
prerank,calcineurin-mediated signaling (GO:0097720),-0.3556752549077587,-0.7973554497797634,0.6995708154506438,0.9644745438688838,1.0,5/10,19.55%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.3556752549077587,-0.7973554497797634,0.6995708154506438,0.9644745438688838,1.0,5/10,19.55%,NFAT5;NFATC4;PPP3CB;NFATC2;NFATC3
prerank,multivesicular body assembly (GO:0036258),0.3160399972747944,0.7971480489392652,0.7173553719008264,0.9620035464018245,1.0,12/30,28.32%,RAB11A;CHMP1B;VPS36;HGS;VPS25;PDCD6IP;VPS37A;VPS37B;VPS37C;CHMP2B;VPS4B;VPS28
prerank,intracellular protein transport (GO:0006886),-0.1883809436736656,-0.7970351451764556,0.9833333333333333,0.9641416260205578,1.0,72/304,21.27%,RANBP3L;WLS;APPL2;SGSM2;PKD1;LAMP2;TRAK1;SNX6;USO1;KIF13B;SIL1;RANBP17;COPA;TRIM23;RAB21;STX2;COPZ2;ARFGAP3;GRTP1;GGA2;AP3B1;SAR1A;XPO5;SNX9;SEC31A;CLIP3;STX5;SNX15;AP4M1;XPO6;EHD1;ARL1;STX1B;TBC1D10A;SNX8;RAB29;RAB6A;SCFD1;SEC16A;ARFIP2;GIPC1;BAG3;STRADA;LMAN1;STX16;RABGAP1;COPB2;E2F3;SURF4;RAB3GAP2;CTTN;HOMER3;STX4;XPO1;TBC1D2B;FAM53B;LAPTM5;CTSA;C2CD5;RAB22A;VPS26C;RPGR;LTBP2;AP2A1;TBC1D9B;ARL5C;COX18;ARF1;RAB14;SNX17;COPZ1;IPO7
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.342128453399344,-0.7970307168868904,0.7397849462365591,0.9633071590420691,1.0,4/12,16.16%,PFDN5;APOE;LDLR;CRYAB
prerank,organelle organization (GO:0006996),0.229274897072631,0.7969796311789608,0.9223946784922394,0.9617596515610248,1.0,53/388,13.84%,FGD5;SEMA6A;ARAP3;SYNE1;NOS3;CAV1;FNBP1L;FMNL3;RAB31;NEDD9;ALAS1;SIPA1;PRKD1;MCOLN1;ABCD4;PIKFYVE;SORT1;MAST4;USP6NL;PPIA;ABCA3;PAK5;SLC25A33;CECR2;COG3;MARK4;RAB34;CHMP1B;DPYSL2;CAV2;ARHGEF7;ARHGAP4;FANCG;RANBP10;FGD6;STRIP1;REEP5;KLHL20;ABCD1;PEX14;CEP78;VPS13D;PDZD8;EPS15;POLG2;ATXN7;RANBP9;RAB1A;FGD2;TSGA10IP;AFG1L;TNFAIP3;CFL1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.340248216066418,-0.7969742411526897,0.7222222222222222,0.9625596142888346,1.0,1/12,1.67%,BMP7
prerank,regulation of primary metabolic process (GO:0080090),0.2513995213781425,0.7968875397312983,0.7992021276595744,0.9613886378758106,1.0,30/126,18.73%,FASN;PPARD;NCOA1;PSMB3;ACACB;NCOA2;OAZ1;PSMD11;ZFP69;ABCA7;PSMC6;OPA3;PSME2;PRKAB1;HELZ2;LACTB;PSMD8;ADIPOR1;HMGCR;ELOVL6;PPARG;EDF1;PSMB10;SP1;PSMA8;IDI1;SIN3A;DHCR7;PSMD9;HMGCS1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.3615783128533361,0.7962262425089447,0.6900369003690037,0.9620271154516817,1.0,3/14,11.01%,JAK3;CCR7;TLR8
prerank,regulation of interleukin-1 production (GO:0032652),0.3500261019493275,0.7960197424480889,0.7058823529411765,0.9618486219323472,1.0,5/15,20.10%,CCR7;CEACAM1;GAS6;F2R;FOXP1
prerank,mitochondrial protein processing (GO:0034982),0.38026068199533414,0.7960085875201913,0.6898496240601504,0.9613365534335196,1.0,3/11,15.12%,PMPCA;OMA1;IMMP2L
prerank,glial cell differentiation (GO:0010001),0.31846505741127534,0.7958098549864177,0.7161936560934892,0.9611580791737603,1.0,8/28,18.49%,CDH2;MMP24;METRN;SOX10;SOX11;SOX9;PTPRZ1;TPPP
prerank,mitochondrial genome maintenance (GO:0000002),-0.35112841119467014,-0.7958097215927011,0.7168949771689498,0.9636202821257118,1.0,3/11,11.91%,SLC25A36;PARP1;MPV17
prerank,ether lipid metabolic process (GO:0046485),-0.337752642153714,-0.7955804251918897,0.7307692307692307,0.9631928569345954,1.0,5/14,23.05%,AGMO;PEX7;PLA2G6;AGPS;GNPAT
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.3267291003447764,0.7955107793963897,0.7408695652173913,0.9611739631636665,1.0,5/23,9.42%,SLC12A6;SLC12A9;KCNH2;CLCN3;SLC9A7
prerank,regulation of osteoclast differentiation (GO:0045670),-0.2738583537296617,-0.7952881363095923,0.7627118644067796,0.9628531242008355,1.0,22/33,44.91%,FBN1;CEBPB;MAFB;TLR4;FSTL3;CAMK4;LILRB3;CARTPT;LRRC17;POU4F1;BGLAP;CCR1;IL4;UBASH3B;OCSTAMP;IL23A;TNF;IL23R;PRXL2A;TCTA;CCL3;IL12B
prerank,placenta development (GO:0001890),0.37422665620932327,0.7948493793655566,0.7162872154115587,0.9617620187038075,1.0,2/12,12.84%,PTK2;PPARG
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.35004792822291236,0.7945693428856988,0.7106227106227107,0.9617005288399828,1.0,5/17,22.48%,CXCL12;CCL1;CCR2;MOSPD2;LGMN
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.36905397957853586,0.7944767762750413,0.7234782608695652,0.961338371110401,1.0,2/12,5.41%,CYP11B1;CYP11A1
prerank,protein N-linked glycosylation (GO:0006487),0.2756570934206103,0.7939744240033563,0.7886904761904762,0.9616414076100028,1.0,7/66,8.00%,SLC39A8;ST3GAL1;FUT8;STT3B;ENTPD5;GAL3ST1;ST6GAL1
prerank,mRNA catabolic process (GO:0006402),0.29038169927058155,0.793470065487549,0.7537764350453172,0.9619645826079087,1.0,18/44,27.44%,NANOS2;PDE12;DCP2;DXO;EXOSC10;NBAS;XRN1;NUDT16;ZFP36L2;EXOSC9;XRN2;METTL3;RIDA;NUDT12;UPF1;NUDT16L1;AGO1;NBDY
prerank,chromatin assembly or disassembly (GO:0006333),0.3843948143580881,0.7932561165204596,0.7106299212598425,0.9617947416548237,1.0,4/11,20.07%,CHAF1A;CHAF1B;HIRIP3;NOC2L
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.31203180840312006,0.7931484156414912,0.7576736672051696,0.9614714547603594,1.0,4/29,7.63%,DAB2IP;SMAD7;IL17RD;EFNA1
prerank,negative regulation of extracellular matrix organization (GO:1903054),-0.3618400480150381,-0.7930050873022098,0.7573839662447257,0.9657972916036069,1.0,3/10,8.93%,FAP;EMILIN1;DPP4
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.2061760547486231,-0.7929037405773944,0.9563106796116505,0.965118906813855,1.0,52/148,29.18%,PRKAG2;PRKAA2;EHMT2;MDM4;CHD3;ATM;RBBP8;CHD4;PDPK1;USP2;PML;NUAK1;STK11;PRKAG3;NOP2;PRMT5;DYRK2;MAPK14;EP300;RAD50;ATRIP;TAF9B;CHD5;RBBP4;BOP1;TP53RK;RFC3;CSNK2A1;BRCA1;KMT5A;RNF34;CDK5;TBP;WRN;PRKAB2;TPX2;PIP4K2B;NBN;RBBP7;ATR;MAPK11;TAF9;PPP1R13L;SMYD2;EXO1;RFC5;NOP53;PRR5;PLK3;TTC5;PRDM1;HDAC1
prerank,mitochondrial gene expression (GO:0140053),0.2954769825430625,0.7919746885261703,0.7335473515248796,0.9629397244997766,1.0,21/42,30.68%,MRPL12;SLC25A33;MRPL57;GATC;TWNK;MRPS2;MRPL16;MRPL23;MRPS18A;PTCD3;IARS2;MRPL51;HARS1;MRPL2;NDUFA7;QRSL1;LARS2;MRPS34;MRPS12;MRPS28;MRPS24
prerank,negative regulation of cell division (GO:0051782),-0.3494701571261277,-0.7919050253031724,0.7096774193548387,0.9659636001985237,1.0,7/11,39.88%,TXNIP;CHMP4C;VPS4A;E2F7;E2F8;ORC6;AURKB
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3128387110169451,-0.7913360710539484,0.7425968109339408,0.966100905524136,1.0,8/18,28.83%,FLNA;WDR43;PHF8;POLR2L;RASL11A;ERBB2;EIF2AK3;POLR2K
prerank,regulation of organelle assembly (GO:1902115),0.2684458946933193,0.7912486248952063,0.8078034682080925,0.9636092644518452,1.0,19/73,18.51%,TBC1D14;TBC1D22A;TBC1D12;TBC1D2;PIKFYVE;USP6NL;TBC1D24;TBC1D5;HCK;MSN;TBC1D10B;CYLD;PLK2;TBC1D1;PDCD6IP;TBC1D22B;TBC1D15;IFT140;RNF4
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.2855475154467548,0.7910655544069694,0.7737556561085973,0.9633771039825151,1.0,18/53,28.17%,PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,aggrephagy (GO:0035973),0.3143795148866174,0.791062130347021,0.7430441898527005,0.9628601087593681,1.0,12/27,29.53%,DYNLL1;WDFY3;UBE2V1;UBQLN1;DYNC1LI1;ACBD5;ARL13B;UBB;PCNT;HDAC6;PARK7;DYNC1H1
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.34115897389470223,0.7909878332077508,0.7216312056737588,0.962464373133959,1.0,10/20,25.99%,ADAM10;TGFB1;RHBDD1;ADAM17;APH1A;SPPL2A;APH1B;TRAF6;MBTPS2;NCSTN
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.2856842948045266,0.7908759390449845,0.794074074074074,0.9621390231230253,1.0,14/56,20.16%,NOD1;NOD2;TLR3;CTSK;TLR7;IRAK2;TLR8;S100A8;BCL10;INAVA;CTSS;TRAF3;PLCG2;RPS6KA3
prerank,lipoprotein biosynthetic process (GO:0042158),-0.34169397258664835,-0.7908382587067094,0.7262931034482759,0.9661344253450638,1.0,2/11,8.01%,ATG10;APOE
prerank,phosphatidic acid metabolic process (GO:0046473),-0.2534036712500316,-0.7904720186399772,0.8189415041782729,0.9659134818313291,1.0,10/48,15.56%,PLD1;AGPAT4;LCLAT1;GPD1L;PLA2G12A;ACP6;GPAT3;DDHD1;PNPLA3;SLC27A1
prerank,myoblast fusion (GO:0007520),0.3778063799895707,0.7902623733888952,0.7282229965156795,0.9626199988230082,1.0,3/12,13.82%,JAM2;PTGFRN;ADAM12
prerank,nucleus organization (GO:0006997),0.28993572871388207,0.7902367703072878,0.7602523659305994,0.962133701058783,1.0,10/47,18.00%,SYNE1;CHMP1B;LEMD3;NUP54;ATXN7;SUN1;REEP3;PDCD6IP;PITPNB;BIN1
prerank,bile acid biosynthetic process (GO:0006699),-0.28985656364556933,-0.7901800714315393,0.7654320987654321,0.9655446453917613,1.0,4/24,9.79%,CYP7B1;CYP27A1;ACOT8;AMACR
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.34910381177715943,0.7893052010162019,0.7202797202797203,0.9632014814815666,1.0,6/18,15.98%,SNX3;DNAJC13;MAPK3;MSN;MTMR2;MAPK1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2667763060923676,0.789166455566749,0.8,0.9629292023569013,1.0,14/79,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;MFSD6;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.26184468426612034,0.7890796355741714,0.8044692737430168,0.9625583388761482,1.0,25/87,21.88%,DCUN1D3;RGCC;FAM107A;KLF4;CDKN2B;PSMB3;PSMD11;PSMC6;PSME2;PSMD8;ZFP36L1;PSMB10;RBX1;RBL1;APC;PSMA8;SKP1;PSMD9;CDK6;ZFP36L2;CDK4;PINX1;CUL1;PSMC3;PSMD1
prerank,regulation of cellular catabolic process (GO:0031329),-0.2355198373815075,-0.7882500769449369,0.8722741433021807,0.9678955747941514,1.0,27/62,29.24%,ITPR1;NUPR1;DAPK2;PRKN;ATM;PIP4K2C;MTMR3;LRRK2;ABL1;EP300;RRAGA;WDR41;CISD2;DDIT3;PSAP;SMCR8;USP13;RAB39B;PIP4K2B;TYSND1;USP10;KAT8;WDR91;MTMR4;WDR24;USP33;PIK3R2
prerank,organelle assembly (GO:0070925),0.2252991852301803,0.7882193221582698,0.9229050279329609,0.9635094036407073,1.0,41/385,11.25%,ABCC4;FLII;ABLIM1;CD34;PGM5;FNBP1L;EXOC6;STARD9;NOTCH1;CNGA2;CEP83;POC1B;CDC14A;MAPRE2;CFAP52;OCRL;DYNLL1;ABCA3;DBNL;EDC3;CDS2;RAB11A;SAC3D1;TTLL3;CHMP1B;IRGM;MAP1LC3B;DHX37;TMOD1;DISC1;PIK3C3;ATG12;GRB7;VPS36;HAUS6;KIF3B;EHD4;CFAP54;EXOC4;EXOC2;UBQLN1
prerank,microtubule nucleation (GO:0007020),-0.29906598420213293,-0.7879640511236442,0.7745803357314148,0.9675248188302801,1.0,7/20,22.19%,CCDC57;GOLGA2;TUBGCP2;TUBGCP4;TUBG1;CENPJ;TPX2
prerank,nucleic acid-templated transcription (GO:0097659),0.2866707773497896,0.7875367216126293,0.7779503105590062,0.9640857476076916,1.0,5/42,8.48%,PTMA;TAF1B;NKX2-8;RNPS1;PWP1
prerank,protein targeting to peroxisome (GO:0006625),-0.2743303019949152,-0.7871140236553915,0.8103896103896104,0.9680428954817621,1.0,5/29,13.81%,ABCD3;ZFAND6;PXMP2;PEX7;PEX2
prerank,positive regulation of leukocyte degranulation (GO:0043302),-0.33031717279177186,-0.7870437421884782,0.7390350877192983,0.9673070409600336,1.0,1/13,1.94%,GAB2
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.31195205236280066,0.7867497583102826,0.7576736672051696,0.964886327406037,1.0,11/29,29.65%,RNF212B;PRDM9;SIRT7;RAD21;BAG6;SYCP2;REC8;TEX12;IHO1;TERB1;P3H4
prerank,thymus development (GO:0048538),0.36066724620648133,0.7865492652931226,0.7116788321167883,0.9646769095714378,1.0,1/13,1.88%,TBX1
prerank,ncRNA catabolic process (GO:0034661),0.3155168759864879,0.785584125005958,0.7592891760904685,0.9657299557926348,1.0,9/28,22.45%,DEDD2;TRIR;SND1;DIS3L;EXOSC10;XRN1;NUDT16;EXOSC9;EXOSC8
prerank,regulation of protein transport (GO:0051223),0.31677983195846315,0.7855278775814395,0.7329931972789115,0.9653144294890128,1.0,6/27,17.33%,RHBDF2;SNX3;NDFIP2;HSPA8;DNAJA1;PPM1F
prerank,maturation of SSU-rRNA (GO:0030490),0.3016032204861906,0.7848597423600423,0.7395498392282959,0.9659369456711238,1.0,7/34,14.11%,SNU13;DHX37;PWP2;NOL10;UTP3;RIOK1;RPS28
prerank,purine ribonucleotide metabolic process (GO:0009150),0.27525954202943215,0.7846568832839607,0.7988826815642458,0.9657312414995262,1.0,10/68,9.07%,HPRT1;HINT1;NT5C2;ACBD6;GLYAT;AK4;TPST2;ADSS2;ACSL6;GTPBP1
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.3679436396019552,0.7845406245566535,0.7093235831809872,0.9653945603874956,1.0,3/12,15.03%,NOD2;SOX9;INAVA
prerank,cellular response to UV-A (GO:0071492),0.3710469483967063,0.78449785391805,0.7255985267034991,0.9649369490071706,1.0,3/11,15.23%,OPN5;MMP1;OPN3
prerank,regulation of cell cycle phase transition (GO:1901987),0.2595742632753793,0.7844238020324628,0.8392101551480959,0.9645519129282882,1.0,29/91,24.43%,FBXW7;PSMB3;PSMD11;PSMC6;PSME2;PSMD8;TRIM39;BUB3;PSMB10;ANAPC16;PSMA8;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;TFAP4;ANAPC2;ATP2B4;DDB1;CUL1;PSMC3;PSMD1;CDC23;PSMD10;CDC26;CDC27;CDKN1B;XPC
prerank,regulation of protein acetylation (GO:1901983),0.37858844932506275,0.7843408931479369,0.7059925093632958,0.9641727497702014,1.0,1/12,3.85%,RAPGEF3
prerank,ncRNA metabolic process (GO:0034660),-0.26188121266171227,-0.784208145070666,0.8113207547169812,0.9710327726630428,1.0,14/37,28.68%,TUT4;AGO2;XPO5;DDX17;EXD1;DTD1;BCDIN3D;TARBP2;PIWIL2;PARN;DROSHA;TDRD9;DTD2;DDX4
prerank,regulation of synapse assembly (GO:0051963),0.28601638206767294,0.7833831939087231,0.7622699386503068,0.9652128008817881,1.0,9/46,9.94%,APP;MEF2C;WNT7A;CLSTN1;GRID2;SLITRK3;SLITRK1;NRXN1;LRRC4B
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.3724033242815695,0.7823421216159775,0.7225225225225225,0.9663831228708081,1.0,3/11,12.20%,STAT1;EBI3;IL27RA
prerank,protein alkylation (GO:0008213),-0.2897076577822742,-0.7817394555127356,0.7603911980440098,0.9741477281681148,1.0,9/22,28.73%,PCMT1;EEF2KMT;PRMT8;METTL22;FAM98B;GSPT1;EEF1AKMT2;PRMT2;METTL21C
prerank,ether lipid biosynthetic process (GO:0008611),-0.3576840174426091,-0.7814539398427831,0.741869918699187,0.9737782466698363,1.0,4/10,30.33%,PEX7;AGPS;GNPAT;FAR1
prerank,ribosome assembly (GO:0042255),0.2830463218890648,0.7809208614690191,0.7856093979441997,0.9681962539628938,1.0,19/47,28.37%,RPL3;RPSA;DHX37;RPS27;PWP2;MRPL20;RPL11;RPS15;RPS28;MRPS2;RSL24D1;RPL24;ERAL1;MRPL22;RPL6;RPS19;TRAF7;SBDS;DHX29
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.33535581284377014,0.7802856211851594,0.7309027777777778,0.9687145435417734,1.0,5/18,23.39%,FAM107A;ZFP36L1;NR3C1;ZFP36L2;ISL1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.29360212801247654,0.7798587745923531,0.7595541401273885,0.9689154864638957,1.0,3/39,3.22%,UTRN;NEDD4L;FGF13
prerank,DNA metabolic process (GO:0006259),0.22969008037070268,0.778874402783314,0.9158878504672897,0.9700421339853468,1.0,61/270,21.64%,POLK;SP100;MEN1;SAMHD1;NTHL1;MRE11;UBE2V2;HINFP;TERF2;PWWP3A;DFFB;FANCG;CBS;MCM10;DNA2;AXIN2;PARG;SMUG1;MGMT;CDC6;ACD;RECQL4;GTF2H4;MPG;FBXO6;BTG2;POLB;TERF1;HELLS;ORC1;FAN1;HMGB2;NSMCE4A;POLE3;MSH3;SMARCAD1;MSH2;TSN;TRRAP;DNASE2;SIRT7;SUMO1;RAD21;UHRF2;HUS1;NUDT1;ENDOG;RPA1;ADPRS;NSMCE3;RAD9B;POLL;POLD1;UVRAG;GTF2H3;POLA1;PARP2;RFC2;DDB1;ERCC4;RAD1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.29745476925858444,0.7788677641774219,0.7669902912621359,0.9695314969489657,1.0,7/33,13.02%,CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;SNRPB
prerank,striated muscle cell differentiation (GO:0051146),0.3406142902102903,0.7786708924605301,0.748653500897666,0.9693436651149427,1.0,2/16,5.10%,MEF2C;SORT1
prerank,chromatin remodeling (GO:0006338),0.25357756911792884,0.778495003124592,0.8471074380165289,0.9691114970454813,1.0,22/100,16.58%,SMARCA2;NPM3;ACTB;BAZ2B;CECR2;NPM2;FOXP3;ARID1A;HNRNPC;HCFC2;PAK1;KDM4A;MYSM1;ZBTB7A;TADA2B;SMARCD1;SOX9;POLE3;HDAC5;SMARCAD1;HCFC1;HMGA2
prerank,cilium assembly (GO:0060271),0.2267550384469584,0.7784863093505877,0.9303135888501742,0.9686032661148549,1.0,49/297,15.76%,ABCC4;ABLIM1;FNBP1L;EXOC6;NOTCH1;CNGA2;CEP83;POC1B;CCDC13;ZMYND10;CDC14A;RP1;CFAP52;OCRL;DYNLL1;CCP110;RAB11A;PRKAR2B;MARK4;TTLL3;CETN2;TUBB;CDK5RAP2;DISC1;AKAP9;RSPH4A;DCX;HAUS6;KIF3B;EHD4;TBC1D32;CFAP54;CEP78;EXOC4;EXOC2;SNAP29;RAB1A;RSPH1;BBIP1;BBS10;CEP135;FOXJ1;CEP72;DNAAF3;TUBB4B;TUBA1A;DNAH5;CKAP5;CEP70
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.3299039000489891,0.7779007882729706,0.7433628318584071,0.9690211896780248,1.0,4/20,8.09%,LYN;CD6;HCK;TGFB1
prerank,platelet aggregation (GO:0070527),0.30362904053094514,0.7771004195063792,0.7576243980738363,0.9698415727535458,1.0,8/33,12.38%,ACTB;PPIA;STXBP1;ACTN1;ACTG1;HSPB1;PIK3CB;MYL12A
prerank,post-translational protein modification (GO:0043687),0.22444438390274307,0.7769445126005647,0.9503945885005637,0.9695760324945498,1.0,67/332,18.43%,EPAS1;LMO7;KLHL5;KLHL2;APP;DCUN1D3;SPARCL1;VWA1;CDH2;MEN1;ZBTB16;SOCS2;NOTUM;IGFBP7;STT3B;KLHL25;ADAM10;FBXW7;PSMB3;GOLM1;RAB11A;FBXO41;PDIA6;PSMD11;RHBDD1;QSOX1;PSMC6;FEM1C;KLHL3;PSME2;SCG3;SOCS5;KLHL20;PSMD8;WSB1;UBA3;HIF1A;FBXO6;ASB13;RAB1A;EVA1A;DCUN1D1;FBXW2;ASB5;PSMB10;FBXO21;RBX1;SERPINC1;FBXL8;FBXL15;ELOB;ASB15;PROC;DCAF5;PSMA8;ASB7;COPS5;GAS6;TMEM132A;GPS1;FN3K;SCG2;KBTBD8;FBXO2;SKP1;PSMD9;FBXW9
prerank,leukotriene metabolic process (GO:0006691),-0.2998149780164905,-0.776880394146628,0.7588652482269503,0.9801461810404405,1.0,10/19,33.56%,GGT5;ABCC10;MGST3;PTGR1;ABCC1;PLA2G5;MAPKAPK2;ALOX12;DPEP1;GGT1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),-0.29909838625221785,-0.7765433641947233,0.7788235294117647,0.9798066593724125,1.0,8/19,24.68%,CDIP1;PML;DYRK2;EP300;PHLDA3;PYCARD;BCL3;RPS27L
prerank,establishment of spindle localization (GO:0051293),0.34932801042299266,0.7758076913712938,0.722735674676525,0.9708643448143227,1.0,2/14,13.84%,MAP4;CFL1
prerank,prostanoid metabolic process (GO:0006692),-0.33619590440946456,-0.7756911626237808,0.7256637168141593,0.980290943579061,1.0,5/13,20.54%,PTGS1;PTGES;PTGR2;CYP2S1;PTGR1
prerank,glycolytic process (GO:0006096),0.304509476217874,0.7754245838058074,0.7611940298507462,0.9709558661804746,1.0,7/28,18.47%,PKM;HK1;PGAM4;PGAM1;TPI1;PFKL;LDHA
prerank,centromere complex assembly (GO:0034508),-0.25941812496190086,-0.7748786181798971,0.8431952662721893,0.980740826320147,1.0,11/36,23.98%,CENPC;CENPP;CENPK;SMARCA5;CENPQ;MIS18BP1;CENPL;RBBP4;CENPE;RBBP7;CENPF
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.36378947466791534,0.7746603521675829,0.7241379310344828,0.9716695679249294,1.0,7/12,33.00%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;TRIM28;PPHLN1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.27624793318537766,0.7743377237576755,0.8301587301587302,0.9716583459317398,1.0,15/54,19.16%,CAV1;NEDD4L;KCNQ1;KCNH2;KCNN2;KCNN3;KCNAB2;GNB1;AKAP6;KCNJ3;KCNJ5;BIN1;KCNJ6;KCNIP2;KCNN4
prerank,neuron cell-cell adhesion (GO:0007158),0.34534037667654627,0.7739198174324255,0.7390542907180385,0.9718163229648238,1.0,4/14,15.74%,RET;NCAM2;NRXN1;NLGN1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.27470641536704066,-0.7732470647050173,0.8040201005025126,0.9824369187268145,1.0,6/27,15.78%,GBF1;OBSL1;VPS13A;ARL1;RAB6A;OPTN
prerank,early endosome to late endosome transport (GO:0045022),-0.2905012109410029,-0.7729800614461255,0.7709923664122137,0.9820019205450967,1.0,12/20,35.74%,EEA1;ANKRD27;HOOK2;AKTIP;WDR81;WDR91;EMP2;SNF8;PTPN23;SNX16;RILP;RAB5A
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.308921499725845,0.7726476387271146,0.7648,0.9733333884391198,1.0,8/29,23.49%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1;NBAS;TENT5C;PABPC1
prerank,aerobic electron transport chain (GO:0019646),0.2651010091753916,0.7726386084932543,0.8474074074074074,0.9728277762265092,1.0,24/68,28.51%,NDUFA2;UQCRB;NDUFA8;CYC1;NDUFA4;UQCRC1;AFG1L;COX6C;NDUFA12;NDUFB3;CYCS;NDUFC1;UQCRQ;COX10;UQCR11;SDHAF2;NDUFA10;COX15;NDUFA7;COX7A2L;UQCR10;NDUFS5;COX5B;NDUFAB1
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.3564465787965423,0.7725261328474305,0.7437722419928826,0.9725067302746765,1.0,2/14,4.06%,NFKBIA;TMSB4X
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.2438578342692962,-0.7721090400787689,0.8688046647230321,0.9825370908832285,1.0,13/42,18.14%,SMARCC2;CHD3;CHD8;SMARCB1;ACTR8;CHD4;SMARCA1;SMARCA5;SPTY2D1;ERCC6;MBD2;SMARCC1;RBBP4
prerank,regulation of gene silencing by miRNA (GO:0060964),-0.23288148857682978,-0.7720735502685815,0.9044585987261147,0.9817556266279683,1.0,20/62,29.31%,TNRC6A;SEH1L;POLR2A;AGO2;NUP205;FMR1;LIMD1;EIF4G1;RAE1;AJUBA;POLR2L;STAT3;NUP155;POLR2I;NUP35;NDC1;IPO8;TPR;POLR2K;NUP43
prerank,lipid biosynthetic process (GO:0008610),-0.2217056196754815,-0.7720642581832817,0.8954703832752613,0.9809337084079219,1.0,4/77,3.79%,ABCD3;PRKAA2;ACSL1;PAM
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.27989340161457094,-0.772042199633207,0.7974358974358975,0.9801440859749726,1.0,6/26,14.74%,SLC30A10;PPARA;SLC5A3;CYBA;TRAP1;TLR4
prerank,dendritic cell differentiation (GO:0097028),0.32041125732056486,0.771574378566414,0.7555555555555555,0.9735156024824713,1.0,5/22,16.47%,LYN;CCR7;LGALS9;TGFBR2;GAS6
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.22335980977824707,0.771159555302571,0.9426605504587156,0.9736409024771958,1.0,93/314,24.82%,ZNRF1;TRIM25;NEDD4L;PELI1;CTNNB1;STT3B;ATXN3;FBXW7;RFFL;ZFAND2A;PSMB3;UBE2G1;PSMD11;SGTB;PSMC6;FEM1C;DMAC2;PSME2;SMURF1;UBXN1;KCTD10;SHARPIN;KLHL20;FBXL2;UBE3D;UBQLN1;PSMD8;GSK3A;FBXO6;RNF187;DERL2;MAN1B1;MAEA;EDEM1;BUB3;PSMB10;NHLRC1;RBX1;PTTG1;FBXL8;ANAPC16;TRIM2;UBE2D3;AREL1;FBXL15;DNAJB9;TMUB2;PSMA8;ARMC8;RAD23A;ANAPC7;UBE2G2;BAG6;GID8;BFAR;FBXO2;TRIM71;TRIM3;KCTD17;SKP1;ANAPC10;PSMD9;SIAH1;RNF4;UBE2D1;TMEM129;RBCK1;ANAPC2;NSFL1C;PLAA;ANKRD9;ERCC8;ANKZF1;DDB1;CUL1;PSMC3;TMUB1;PSMD1;CDC23;RAD23B;UBE2J1;RNF126;PSMD10;CDC26;FBXL14;CDC27;HECW1;CRBN;FBXL3;RNF216;UBXN2B;ZFAND2B;MTA1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.30317118296839496,-0.7711537035109717,0.7676537585421412,0.980615608398914,1.0,5/18,17.09%,IL34;DAAM2;SLC45A3;NF1;MDK
prerank,regulation of endocytosis (GO:0030100),0.2685573951624953,0.7709295333921085,0.8052147239263804,0.9734842726973137,1.0,4/61,3.37%,HIP1;HIP1R;NEDD4L;PRKD1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.3119732814268066,-0.7700279919389451,0.7777777777777778,0.9815314690363403,1.0,5/15,17.73%,EGFR;RBPJ;CDH13;RHBDF1;MVB12A
prerank,serine family amino acid catabolic process (GO:0009071),0.3693732969812126,0.7697134407633103,0.7043795620437956,0.9748927517436274,1.0,2/10,9.59%,SHMT2;CBS
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.22003802902679392,0.7692620115879455,0.9516853932584269,0.9750946255671505,1.0,47/366,13.22%,INSR;APBB2;SLC39A8;ENG;NANOS3;APP;SOX17;MEF2C;RYBP;SMARCA2;ACVRL1;SOX13;NOTCH1;YBX1;PRDM2;IRF2;RREB1;SOX7;HINT1;KLF1;WWTR1;CCDC88A;TCF7;SNAI2;RPS6KA5;DNM2;NCOA2;SOX18;BRCA2;SOX12;HINFP;FOXP3;HCFC2;HMGA1;UBE2V1;CYFIP1;BTG1;ZNF205;NR5A2;ONECUT1;HIF1A;TFEB;SOX11;WWC1;EIF4E;EDF1;PUM3
prerank,regulation of defense response to virus (GO:0050688),-0.3227675200691152,-0.7685929500147418,0.7806004618937644,0.9829230179468426,1.0,4/14,18.36%,PPM1B;ZMPSTE24;PCBP2;C1QBP
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.37779882453252966,0.7685612648723449,0.7577981651376147,0.9756922151568248,1.0,1/10,4.52%,CTNNB1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.334487125427685,0.7684422114965085,0.7401709401709402,0.9753697661479284,1.0,11/18,31.35%,SCO2;SCO1;COA3;SMIM20;COX20;COX17;PET100;TIMM21;COA5;BCS1L;COA8
prerank,mitochondrial transcription (GO:0006390),0.3785942015910867,0.7683827235751785,0.7214953271028037,0.9749353475017376,1.0,3/10,15.54%,MRPL12;SLC25A33;TWNK
prerank,positive regulation of telomere maintenance (GO:0032206),-0.26706358154138826,-0.7680812764812763,0.8289473684210527,0.9828292587124591,1.0,13/31,26.59%,TNKS2;ATM;PML;RTEL1;HNRNPA2B1;ERCC1;RAD50;NBN;SIRT6;TNKS;PKIB;HNRNPD;MAP3K4
prerank,histone H2A ubiquitination (GO:0033522),-0.30276776039202946,-0.7680181154775417,0.7476190476190476,0.9820979174886516,1.0,7/17,21.71%,BCOR;KDM2B;DDB2;UBE2B;UBR2;TRIM37;CUL4B
prerank,regulation of myeloid cell differentiation (GO:0045637),0.26885195021257247,0.7679252746109988,0.8460388639760837,0.9751389187190617,1.0,5/62,3.97%,FES;MEF2C;ZFPM1;LYN;ZBTB16
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.2894359987310355,0.7678146163864508,0.7910685805422647,0.9748033189859225,1.0,7/37,11.82%,NOD2;GBP5;NOS2;CD6;PLD4;ABCD1;HIF1A
prerank,regulation of histone acetylation (GO:0035065),0.2933234645445949,0.7675447429188943,0.7762345679012346,0.9746987799967836,1.0,11/33,22.35%,RAPGEF3;MAPK3;RPS6KA5;FOXP3;TADA2B;CTBP1;HDAC5;SET;NOC2L;SNCA;SPI1
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.3420118475418217,-0.767454509158491,0.7627811860940695,0.9821013857243374,1.0,3/10,15.18%,CD55;ZBTB7B;CD81
prerank,negative regulation of insulin secretion (GO:0046676),-0.30322846826591165,-0.7674168621195026,0.7679425837320574,0.9813362064703182,1.0,7/17,19.78%,IRS1;PRKN;CCN3;KCNB1;SFRP1;INHBB;ADRA2A
prerank,negative regulation of transmembrane transport (GO:0034763),0.36614818132164906,0.7673750494928075,0.7344961240310077,0.9744340162301226,1.0,2/10,11.53%,CTTNBP2NL;PRKCB
prerank,body fluid secretion (GO:0007589),-0.31127606071907216,-0.7673013596753367,0.7726218097447796,0.9806768218356761,1.0,4/15,14.82%,SLC22A4;PRLR;SLC22A2;ZBTB7B
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.28088755865023246,-0.7672559623060032,0.7852193995381063,0.9799232556981585,1.0,4/22,11.97%,PPM1E;PPM1D;PPM1B;DUSP10
prerank,positive regulation of transport (GO:0051050),-0.21803168118882735,-0.7671679436810922,0.8927335640138409,0.9792098767529783,1.0,13/85,12.85%,LRP1;GPC3;CAMK1D;ANXA2;DAB2;ANXA1;IL15RA;APOE;CLIP3;BID;CYBA;RXRA;FMR1
prerank,DNA replication checkpoint signaling (GO:0000076),0.34584592069068515,0.766980037288166,0.7431693989071039,0.9745237992489006,1.0,9/16,29.23%,DNA2;CDC6;ORC1;HUS1;RAD9B;RAD17;TOPBP1;TIMELESS;HUS1B
prerank,positive regulation of cell killing (GO:0031343),0.35837740288064557,0.7663229334444377,0.7219152854511971,0.9750805930179366,1.0,3/13,11.86%,NOS2;RAC1;SYK
prerank,DNA catabolic process (GO:0006308),-0.3415778862150387,-0.7662927192699907,0.7758241758241758,0.9796740721238077,1.0,2/11,9.55%,FBH1;REXO4
prerank,negative regulation of cell cycle process (GO:0010948),0.2669758750733067,0.7658654669415007,0.8257016248153619,0.975242216598356,1.0,7/61,8.29%,DAB2IP;RYBP;NANOS2;PHC1;CCP110;MAX;TERF2
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.27761790778896767,-0.7658005600138951,0.7965686274509803,0.9795572345968501,1.0,8/26,19.68%,ANAPC5;NEK6;RIOK2;CUL3;NSMCE2;CENPE;CDC16;HECW2
prerank,glutathione derivative metabolic process (GO:1901685),0.33128084177462186,0.7655186186465279,0.7694974003466204,0.9747509511547792,1.0,4/20,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.33128084177462186,0.7655186186465279,0.7694974003466204,0.9747509511547792,1.0,4/20,10.19%,MGST2;GSTA4;HPGDS;GSTK1
prerank,protein insertion into ER membrane (GO:0045048),0.28776779770257443,0.7655183531169657,0.7753164556962026,0.974237902742752,1.0,2/37,2.69%,APP;STX1A
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.31592506640903945,-0.7652864039827805,0.8133640552995391,0.979535569068397,1.0,7/15,38.22%,CPEB2;DDX3X;GSTO1;DHX36;ZFAND1;HSF1;VCP
prerank,sensory perception of smell (GO:0007608),0.3707776713258967,0.7651129479344476,0.7609942638623327,0.9743734511970272,1.0,1/11,4.01%,SLC24A4
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.2284588982977968,-0.7649046317669056,0.9060773480662984,0.9792960936618765,1.0,22/64,28.83%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;ELP4;NELFE;GTF2F1;SETD2;GTF2H1;POLR2L;CDK12;EAF2;CDK9;POLR2I;ELOA;TCEA2;ERCC2;POLR2K
prerank,tyrosine metabolic process (GO:0006570),0.36891518986772665,0.7645162090012748,0.7321100917431193,0.974821766942373,1.0,3/11,23.83%,DCT;HGD;THAP4
prerank,glutathione metabolic process (GO:0006749),0.28611623447094453,0.7641019564464621,0.7946287519747235,0.9749702070828296,1.0,5/38,10.19%,GCLM;MGST2;GSTA4;HPGDS;GSTK1
prerank,regulation of intracellular protein transport (GO:0033157),0.29598739278164005,0.7640000372534789,0.7909967845659164,0.974613347837781,1.0,9/32,19.69%,PRR5L;RIPOR1;OAZ1;TGFB1;PDCD10;B3GAT3;SIRT7;TENM1;OAZ2
prerank,negative regulation of T cell proliferation (GO:0042130),0.3033776988160583,0.7639528232747265,0.7495682210708118,0.9741774276129096,1.0,3/28,8.41%,TNFRSF21;LGALS9;FOXP3
prerank,osteoclast differentiation (GO:0030316),-0.2877274478003543,-0.7639279051834573,0.7995049504950495,0.9799120084593242,1.0,2/22,2.21%,GAB2;ANXA2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.28318469084690157,0.7630522565797423,0.7941176470588235,0.9750192134943151,1.0,6/44,10.86%,SH3RF1;RPS6KA1;XIAP;KLF4;CST7;LAMTOR5
prerank,toll-like receptor 3 signaling pathway (GO:0034138),-0.33921666765298275,-0.7630490106064952,0.7510638297872341,0.9803769585576965,1.0,2/11,8.17%,SCARA3;TNIP2
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.369742623979912,0.763020323142892,0.7482142857142857,0.974557442356659,1.0,11/11,63.05%,MALT1;NFKBID;PRKCQ;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.2685439753790689,-0.7629491382305069,0.8369829683698297,0.9796945536956664,1.0,6/27,20.93%,LPAR1;AGTR1;LPAR4;GPR157;HTR2C;C3AR1
prerank,insulin secretion (GO:0030073),-0.2943942095963546,-0.7629234156597591,0.7925407925407926,0.9789170722441944,1.0,2/19,5.24%,RAB11FIP2;ANXA1
prerank,regulation of keratinocyte migration (GO:0051547),0.3561301147563886,0.7628294657245909,0.7361853832442068,0.9743367528161406,1.0,3/12,12.23%,MAPRE2;IQSEC1;MAP4K4
prerank,outer dynein arm assembly (GO:0036158),0.34270518852155984,0.7625112024204224,0.7779751332149201,0.9743024995531847,1.0,4/15,15.28%,ZMYND10;LRRC49;DNAH8;DNAH5
prerank,cellular response to catecholamine stimulus (GO:0071870),0.3153052020531692,0.7622439931885272,0.7834710743801653,0.9742039425801035,1.0,9/23,22.85%,TGM2;KCNQ1;MAPK3;PDE4B;GNB1;MAPK1;ATP2B4;SNCA;RYR2
prerank,cellular response to starvation (GO:0009267),0.2354380103407487,0.7616985787752126,0.9129886506935687,0.9745465957776871,1.0,20/147,12.45%,MFSD2A;BMPR2;FAS;FOXO1;PRKD1;RIPOR1;WDR59;XPR1;SESN3;MAPK3;RALB;MAP1LC3B;EIF2AK4;PIK3C3;DEPDC5;HSPA8;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.24135974486523248,-0.7615598318950572,0.8922155688622755,0.9800801467201016,1.0,3/48,5.18%,PRKAG2;OGT;SEH1L
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3266496212390274,-0.7610563650200429,0.7705627705627706,0.9799916669129755,1.0,1/13,1.61%,AXL
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.2655903220571424,-0.7601887644842752,0.8333333333333334,0.9804267133286657,1.0,8/29,19.92%,KANK2;YAP1;AXIN1;ESR1;DDRGK1;RUNX1;LATS1;BRCA1
prerank,regulation of autophagosome assembly (GO:2000785),0.2954341673561262,0.7600572757192848,0.7914614121510674,0.9765535919418066,1.0,7/33,12.79%,TBC1D14;TBC1D12;PIKFYVE;RALB;SH3GLB1;PIP4K2A;FEZ2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.3329774680217227,-0.759956224051752,0.7687074829931972,0.9799503944184704,1.0,2/11,9.99%,P2RX4;CDH13
prerank,regulation of response to oxidative stress (GO:1902882),-0.33586921549895643,-0.7595046876658776,0.740174672489083,0.9797508646734046,1.0,9/11,43.53%,PRKN;AIFM2;ACOX2;HEBP2;STOX1;MCTP1;SELENON;ALOX5;PINK1
prerank,regulation of cellular response to heat (GO:1900034),0.25939056360085405,0.7593873131487286,0.8464849354375896,0.9770464900515506,1.0,25/77,26.37%,CD34;HSP90AB1;MAPK3;HSPA8;NUP54;RPTOR;CAMK2B;BAG2;NUP160;DNAJC7;MAPK1;DNAJB6;RPA1;NUP153;NUP50;CAMK2G;IER5;NUP42;PTGES3;NUP85;MTOR;NUP210;BAG5;NUP188;BAG4
prerank,negative regulation of neuron differentiation (GO:0045665),0.32133392106948055,0.7591834295544866,0.7586206896551724,0.9768352717174222,1.0,5/22,16.14%,B2M;EIF2AK4;SOX9;DISP3;HEY1
prerank,synaptic vesicle localization (GO:0097479),0.34422054906427135,0.758933621110236,0.72875226039783,0.9767324640870076,1.0,3/13,15.89%,DNM2;NLGN1;SYNJ1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3519410895143753,0.7588359486521631,0.7641843971631206,0.9763753340540854,1.0,3/13,9.98%,TLR7;IRAK2;PIK3C3
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.27547244993513353,0.7581773582870616,0.837037037037037,0.9768614660989101,1.0,6/48,6.88%,SIGIRR;NLRC5;SAMHD1;PALM3;RFFL;NR1H2
prerank,ruffle organization (GO:0031529),-0.3082993936683883,-0.7581431925577419,0.7832957110609481,0.9808912048879808,1.0,2/16,2.33%,TPM1;CARMIL1
prerank,regulation of cell division (GO:0051302),0.25916206478549125,0.7579648120491577,0.8616071428571429,0.9766650831341682,1.0,13/72,16.22%,BCL2L1;CALM1;TAL1;CCP110;RAB11A;PIN1;CETN2;RAB11FIP4;PIK3C3;SH3GLB1;GIT1;PLK2;PRPF40A
prerank,histone H4-K8 acetylation (GO:0043982),0.34349806101304614,0.7579610152954933,0.7726465364120781,0.9756487660967941,1.0,4/15,16.34%,PHF20;JADE2;MCRS1;HCFC1
prerank,histone H4-K5 acetylation (GO:0043981),0.34349806101304614,0.7579610152954933,0.7726465364120781,0.9756487660967941,1.0,4/15,16.34%,PHF20;JADE2;MCRS1;HCFC1
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.3688697567690825,0.75792349612759,0.7282809611829945,0.9746895246886963,1.0,3/11,17.88%,CCT3;CCT5;CCT7
prerank,regulation of protein localization to Cajal body (GO:1904869),0.3688697567690825,0.75792349612759,0.7282809611829945,0.9746895246886963,1.0,3/11,17.88%,CCT3;CCT5;CCT7
prerank,response to metal ion (GO:0010038),0.2629151134495836,0.7578899205776792,0.8502906976744186,0.9742280827580646,1.0,13/67,17.65%,CAV1;NEDD4L;CALM1;HOMER1;GPHN;PPP3CA;HIF1A;MT1X;MT1A;PDCD6;LOXL2;TTN;NDRG1
prerank,regulation of monocyte chemotaxis (GO:0090025),0.3110491828377435,0.7578162284553188,0.7743055555555556,0.9738283527964146,1.0,5/24,11.06%,CXCL12;LYN;GREM1;CCL1;DUSP1
prerank,regulation of dopamine secretion (GO:0014059),-0.2722025614565401,-0.7570508623665547,0.8120481927710843,0.9816470037365979,1.0,5/25,16.88%,DTNBP1;PRKN;SYT9;SYT13;SYT3
prerank,response to zinc ion (GO:0010043),0.31287682071478384,0.7567364919204608,0.7804878048780488,0.9749189158973419,1.0,10/25,20.32%,MT1F;MT1X;MT1M;MT1H;MT1A;MT1E;MT1G;MT1B;GLRA2;SLC30A4
prerank,histone exchange (GO:0043486),-0.25181881440426623,-0.7566496434593221,0.8700564971751412,0.9814114312505328,1.0,9/37,18.14%,CENPC;CENPP;CENPK;SMARCA5;SPTY2D1;CENPQ;MIS18BP1;CENPL;RBBP4
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.2964323298615379,-0.7564413843715192,0.8117913832199547,0.9809256642679278,1.0,3/20,5.14%,NUPR1;OGT;FLOT2
prerank,response to light stimulus (GO:0009416),0.26916539538402917,0.755183470246408,0.849624060150376,0.9767370741803666,1.0,6/55,8.66%,MAP4K3;MEN1;DCT;GTF2H2;OPN5;GPR52
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3407846197004274,0.7548997725762182,0.7631133671742809,0.9766238923061594,1.0,2/17,6.32%,RAPGEF2;ADRA2B
prerank,positive regulation of cytokinesis (GO:0032467),0.3012605608732587,0.7548063566336544,0.7860696517412935,0.976256406426189,1.0,9/32,17.83%,CDC14A;PKN2;PKP4;CDC6;KIF23;MAP10;RXFP3;SPAST;PRKCE
prerank,rRNA modification (GO:0000154),-0.2814668663836849,-0.7544391232204675,0.8287153652392947,0.9829444887055657,1.0,7/21,22.12%,MTERF4;GAR1;NSUN3;NSUN4;TRMT112;DIMT1;TSR3
prerank,regulation of smooth muscle contraction (GO:0006940),-0.2830966138282629,-0.7542520938034454,0.8192771084337349,0.9824085468708248,1.0,6/20,17.34%,PLCE1;KCNB2;SPHK1;CHRM2;CTTN;MYOCD
prerank,regulation of neuron differentiation (GO:0045664),0.25722926239309934,0.7539362629501914,0.8563134978229318,0.9770559807579327,1.0,20/76,18.00%,ARHGEF2;MEF2C;TIAM1;MMD;ADRA2B;YWHAH;CDK5RAP2;EIF2AK4;BRINP3;BRINP2;SOX11;DISP3;NLGN1;HEY1;NRCAM;ALK;SIN3A;CPNE1;NEUROD2;BIN1
prerank,protein import (GO:0017038),-0.21347504252347757,-0.753235739687235,0.942652329749104,0.9829840774549983,1.0,21/84,26.77%,ABCD3;APPL2;LAMP2;RANBP17;HSPA4;APOE;PXMP2;PEX2;SNX33;E2F3;FAM53B;ALDH3A2;IPO7;ATAD1;PEX13;STAT3;KPNB1;HIKESHI;NUP155;IPO8;TPR
prerank,positive regulation of ATPase activity (GO:0032781),-0.24248857768638502,-0.7524953708551934,0.8476454293628809,0.9832015113341216,1.0,8/41,17.80%,TPM1;ATP1B3;ATP1B2;PFN2;TOR1AIP1;TNNT3;DNAJB2;PLSCR1
prerank,membrane assembly (GO:0071709),-0.2569985007942583,-0.7514188548086014,0.8263157894736842,0.9838428972971078,1.0,5/34,5.95%,ANXA2;NLGN2;S100A10;FLOT2;STX2
prerank,C21-steroid hormone metabolic process (GO:0008207),0.3215974182522151,0.7509857502738021,0.7931623931623931,0.9809467080899809,1.0,2/20,5.41%,CYP11B1;CYP11A1
prerank,regulation of RNA metabolic process (GO:0051252),0.26338048571648687,0.7505935953720454,0.8611111111111112,0.9809961913720396,1.0,2/59,1.47%,RBM20;NOVA2
prerank,modification-dependent protein catabolic process (GO:0019941),0.2266341524842033,0.7501852438467623,0.9325153374233128,0.981068752273763,1.0,51/193,23.32%,RNF144B;TRIM25;NEDD4L;RNF125;ZNRF3;KLHL25;ATXN3;RFFL;UBE2G1;RNF215;PSMD11;FEM1C;KLHL3;NDFIP2;PPP1R11;SMURF1;KCTD10;RNF130;TOLLIP;UBQLN1;ARRDC1;BUB3;FBXO21;RBX1;PTTG1;ANAPC16;AREL1;RNF8;ANAPC7;UBE2G2;BAG6;BFAR;RNF19A;ANAPC10;PSMD9;SIAH1;CBL;UBE2D1;RNF166;FBXO8;ANAPC2;MIB1;RLIM;DDB1;UBL7;CDC23;RNF126;CNOT4;CDC26;FBXL14;CDC27
prerank,regulation of chromatin organization (GO:1902275),-0.31152388201601133,-0.74952353582229,0.8141592920353983,0.9857088092596558,1.0,3/14,10.98%,IGF2;MLLT3;SETD5
prerank,positive regulation of heart rate (GO:0010460),0.3284253009513112,0.7493910529187322,0.7580372250423012,0.9817091805636035,1.0,3/17,5.16%,PDE4D;NPPA;KCNQ1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.3129041544010293,-0.7484420259213429,0.8058690744920993,0.986314597198457,1.0,1/13,1.74%,MOGAT3
prerank,negative regulation of protein transport (GO:0051224),0.30819127705144933,0.7484025485260817,0.8121911037891268,0.9826403827211064,1.0,4/25,12.09%,RHBDF2;SNX3;NDFIP2;HMGCR
prerank,regulation of autophagosome maturation (GO:1901096),-0.320928372164699,-0.7479355544506565,0.7620087336244541,0.9861880030704843,1.0,5/13,18.21%,TMEM39A;CLN3;CLEC16A;PHF23;SMCR8
prerank,regulation of stem cell population maintenance (GO:2000036),0.3309239992301083,0.7478672677358497,0.7806215722120659,0.9829282131913916,1.0,7/18,25.12%,PTN;ELAVL1;LOXL2;ZC3H13;HMGA2;MYC;TAF5L
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.31942224848956535,0.7477971173792729,0.7737104825291181,0.9825096745262025,1.0,5/21,11.20%,MCUB;TGM2;RAP1GDS1;LETM1;PDZD8
prerank,regulation of synapse organization (GO:0050807),0.2989760226268884,0.7469180178660789,0.8066115702479338,0.9833006007268632,1.0,6/26,17.93%,MEF2C;EPHA4;ABHD17A;CAMK2B;YWHAZ;CTNNA2
prerank,covalent chromatin modification (GO:0016569),0.34263287804676323,0.7467939028546274,0.7797513321492007,0.9829504260558382,1.0,5/14,21.07%,CHD1;HELLS;SIRT7;HLCS;PARP2
prerank,positive regulation of rRNA processing (GO:2000234),-0.3338301757290576,-0.746163075644503,0.756701030927835,0.9877670310563732,1.0,4/10,21.58%,RIOK2;WDR43;TRMT112;DIMT1
prerank,"base-excision repair, gap-filling (GO:0006287)",0.2900283771287199,0.7456312953746372,0.8385502471169687,0.9841519778101467,1.0,13/35,25.97%,NTHL1;PARG;SMUG1;MPG;POLB;RPA1;ADPRS;POLL;POLD1;RFC2;RFC4;PNKP;POLD4
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2700663575372845,0.745553717199339,0.833587786259542,0.9837598462647253,1.0,12/53,17.70%,DAB2IP;GNA12;HSP90AB1;FBXW7;OPHN1;PSMC6;PSME2;F8A1;BAG2;RAD23A;FOXF2;PRKCG
prerank,intracellular cholesterol transport (GO:0032367),0.3370387476072012,0.7452346207176489,0.781651376146789,0.9837029771491874,1.0,4/15,14.49%,OSBP;ABCG1;NPC1;STARD4
prerank,Golgi to endosome transport (GO:0006895),-0.2982597974931726,-0.7451418371975337,0.8060344827586207,0.9883704281801217,1.0,7/16,23.44%,GBF1;VPS13A;AP4M1;MON2;AP2A1;RAB14;CORO7
prerank,histone mRNA catabolic process (GO:0071044),-0.303690335173984,-0.745085472455144,0.8126582278481013,0.9876285450555115,1.0,4/15,16.23%,TUT4;ATM;TENT2;TUT1
prerank,mRNA modification (GO:0016556),0.3114454006553586,0.744800462779214,0.7941176470588235,0.9838271054081248,1.0,7/22,23.95%,CBLL1;TRMT10C;TRMT61B;ZC3H13;CMTR1;METTL3;PCIF1
prerank,protein tetramerization (GO:0051262),0.25519393285504427,0.7443026213489712,0.8751814223512336,0.9840185304511719,1.0,8/67,8.05%,B2M;HPRT1;GBP5;SAMHD1;MCOLN1;HOMER1;ACACB;SHMT2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.2672286598918484,0.744239900033038,0.8606060606060606,0.983606380943867,1.0,7/56,12.23%,PLCB1;RGCC;RAB11A;CCND3;ADAM17;BRD4;RPTOR
prerank,response to gamma radiation (GO:0010332),0.3077919943731111,0.7436933763342585,0.7980132450331126,0.9838875295785401,1.0,2/24,3.46%,DCUN1D3;MEN1
prerank,autophagosome assembly (GO:0000045),0.2615954020589669,0.743532442037337,0.8474320241691843,0.9836183418487819,1.0,23/52,27.66%,IRGM;MAP1LC3B;SMURF1;PIK3C3;ATG12;UBQLN1;RAB1A;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;NSFL1C;GABARAP;VMP1;ATG2A;GABARAPL2;UBXN2B;ULK1;RAB1B;UBQLN2;RAB7A;BECN1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2518399662696989,0.7435237598661317,0.8656509695290858,0.9826162945407129,1.0,13/78,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2518399662696989,0.7435237598661317,0.8656509695290858,0.9826162945407129,1.0,13/78,12.31%,OSBPL1A;AP1S2;KIF26A;PIKFYVE;DYNLL1;KIF2A;DNM2;AP2M1;AP1S3;KIF3B;KIF23;DCTN4;AP2B1
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.3610719378133396,0.7434704802667075,0.7703703703703704,0.9821866481000839,1.0,4/10,16.07%,TBX1;ACTN4;PPARG;RXRB
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.22533654899583583,0.7424916707862956,0.9533742331288344,0.9830885879606123,1.0,54/185,23.32%,RGCC;PPP1R9B;CDC14A;DYNLL1;CCP110;PSMB3;NPM2;PRKAR2B;PSMD11;CETN2;TUBB;CDK5RAP2;PSMC6;PSME2;AKAP9;HAUS6;CDC6;CEP78;PSMD8;ZFP36L1;BUB3;CEP135;PSMB10;CEP72;ANLN;ANAPC16;TUBB4B;TUBA1A;CKAP5;CEP70;PSMA8;ANAPC7;SKP1;ANAPC10;PSMD9;UBE2D1;ZW10;ZFP36L2;TFAP4;DCTN1;ANAPC2;SFI1;CLASP1;NDE1;HAUS2;DDB1;CUL1;PSMC3;PSMD1;CDC23;INO80;PSMD10;CDC26;CDC27
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.32172984446352865,-0.7423159902127122,0.8162291169451074,0.9905133297581825,1.0,1/13,1.67%,ENPP1
prerank,regulation of adaptive immune response (GO:0002819),-0.28552119756736083,-0.7422591574129509,0.8114942528735632,0.989776556209157,1.0,8/18,30.76%,ADCY7;PYCARD;IL6ST;AHR;IRF1;FADD;IL4I1;SIRT1
prerank,protein modification by small protein removal (GO:0070646),0.2186182836779386,0.7417975729963285,0.964622641509434,0.9835934814514441,1.0,86/252,27.39%,NFKBIA;IFIH1;ACTB;SMAD7;SNX3;ATXN3;CCP110;EIF3F;PSMB3;PSMD11;BIRC3;PSMC6;PSME2;OTUD7A;MYSM1;BABAM1;SMAD1;PSMD8;USP18;HIF1A;TADA2B;POLB;HGS;ATXN7;WDR48;CYLD;TNFAIP3;PSMB10;WDR20;TRRAP;MCRS1;APC;PSMA8;COPS5;HCFC1;RAD23A;GPS1;USP49;RCE1;TNIP1;PSMD9;JOSD2;USP32;USP29;UBE2D1;BRCC3;TRAF3;OTUD4;ASXL1;USP25;USP21;OTUD7B;DESI2;DESI1;JOSD1;SUDS3;COPS6;KAT2B;MBD5;PSMC3;PSMD1;STAMBP;RAD23B;INO80;PSMD10;TRAF6;RIPK1;USP30;VCPIP1;FOXO4;MYC;KEAP1;COPS2;KDM1B;ZC3H12A;USP38;PSME1;USP45;TAB1;ACTR5;ADRB2;UBB;PSMD2;PSMA1;ADRM1;NFRKB
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.26691055220569826,0.7417303890087851,0.8535825545171339,0.9831796029142912,1.0,7/50,12.11%,ACTB;HSP90AB1;CDKN2B;CCNI;CCND3;CDC6;CCNK
prerank,regulation of protein localization to centrosome (GO:1904779),0.3649438985071408,0.7414111152318852,0.7578558225508318,0.9831509417654203,1.0,5/10,24.75%,MARK4;CEP72;APC;NSFL1C;UBXN2B
prerank,regulation of neurotransmitter transport (GO:0051588),-0.3001174367839479,-0.741137069345519,0.8238993710691824,0.9904223026955767,1.0,1/16,0.93%,SNCAIP
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.32204296016998535,-0.7411177802361154,0.7632183908045977,0.9896384453135866,1.0,5/11,30.73%,STX4;TYROBP;MAVS;CAMK4;ITGAM
prerank,snRNA transcription (GO:0009301),-0.21178433835130955,-0.7410482815395466,0.9485714285714286,0.9889154840285455,1.0,23/70,30.57%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;USPL1;TBP;POLR2L;TAF9;SNAPC2;CDK9;POLR2I;INTS3;POLR2K;ZC3H8;INTS5;SNAPC4
prerank,regulation of lipid catabolic process (GO:0050994),0.32402911563597114,0.7408801212174423,0.7908163265306123,0.9833977630117942,1.0,6/19,22.21%,ABCB11;ABCD1;PDE3B;ALK;LONP2;PRKAA1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.30474348393919376,-0.740502393645783,0.8014184397163121,0.9880264031923157,1.0,6/15,21.85%,DTNBP1;AP3B1;BLOC1S2;AP3S2;BLOC1S6;BLOC1S5
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.30474348393919376,-0.740502393645783,0.8014184397163121,0.9880264031923157,1.0,6/15,21.85%,DTNBP1;AP3B1;BLOC1S2;AP3S2;BLOC1S6;BLOC1S5
prerank,phospholipid homeostasis (GO:0055091),-0.3260258460944621,-0.7394181634506747,0.7822014051522248,0.988665313007011,1.0,3/11,9.80%,ABCA1;RCN3;TLCD2
prerank,protein-DNA complex assembly (GO:0065004),0.2377955737281247,0.7393324360845341,0.8998646820027063,0.985075432043103,1.0,37/116,28.17%,GTF2H2;PSMB3;PSMD11;CETN2;PSMC6;PSME2;CDC6;PSMD8;GTF2H4;CHAF1A;NAA60;ORC1;SOX9;HMGB2;PSMB10;RBX1;PSMA8;CHAF1B;RPA1;PSMD9;GRWD1;GTF2H3;DDB1;PSMC3;DAXX;PSMD1;RAD23B;PSMD10;NAP1L4;XPC;SART3;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.3325113402836215,-0.7390187726578364,0.77079107505071,0.9883758573554839,1.0,6/10,37.05%,IL18;RARA;PRKCZ;SPHK2;GATA3;IL4
prerank,negative regulation of viral entry into host cell (GO:0046597),0.35239546483176665,0.738896478903519,0.7731568998109641,0.9852078299029248,1.0,2/12,4.37%,LY6E;SNX3
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.3143312264718847,0.738512753090852,0.8160136286201022,0.985224891040505,1.0,12/22,33.79%,ENC1;PSMB3;PSMB10;PSMA8;PSMA1;NFE2L2;PSMB8;PSMA7;PSMB9;PSMB1;PSMA4;PSMB7
prerank,negative regulation of microtubule polymerization (GO:0031115),0.34030337939044486,0.7382947312556493,0.7622377622377622,0.9850432888451328,1.0,5/12,22.16%,STMN1;ARHGEF7;CDH5;DYRK1A;SNCA
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.3275674842986453,0.7380766102746866,0.7809694793536804,0.98482973231781,1.0,5/17,14.34%,ITGA1;CALM1;HSP90AB1;AGTR2;PPP1R15B
prerank,negative regulation of ATPase activity (GO:0032780),-0.2943033268823835,-0.7378098646911304,0.8181818181818182,0.9890511396985425,1.0,3/16,20.39%,THADA;ATP5IF1;TSC1
prerank,negative regulation of TOR signaling (GO:0032007),0.27927400988035,0.7377392141131806,0.8214285714285714,0.9847759774011937,1.0,9/36,14.19%,SH3BP4;TNFAIP8L1;SESN3;DEPDC5;DDIT4;GSK3A;TMEM127;PDCD6;EPM2A
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.22348786864160552,-0.7376909116176186,0.9393939393939394,0.9884147661955838,1.0,21/62,28.83%,CCNT2;CTR9;POLR2A;MLLT3;CCNH;CDK7;AFF4;PAF1;ELP4;NELFE;GTF2F1;SETD2;GTF2H1;POLR2L;CDK12;EAF2;CDK9;POLR2I;ELOA;ERCC2;POLR2K
prerank,regulation of transferase activity (GO:0051338),0.3195760517738342,0.73759451039846,0.7891891891891892,0.9844809539321824,1.0,2/17,3.77%,NLRC5;HMBOX1
prerank,endoplasmic reticulum organization (GO:0007029),0.24947874324442612,0.7370957680317702,0.877906976744186,0.9846686324603433,1.0,6/72,10.33%,APP;REEP1;STX1A;CAV2;LPCAT3;REEP5
prerank,carnitine metabolic process (GO:0009437),0.34181540000362653,0.7368330510594594,0.7815442561205274,0.9845410637281848,1.0,2/12,5.58%,CPT1A;CRAT
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.2853743945309249,0.7368292525474587,0.8421052631578947,0.9840454727223404,1.0,6/31,14.41%,DCUN1D3;FBXW7;PIN1;RAB1A;DCUN1D1;BMI1
prerank,vacuolar acidification (GO:0007035),-0.27840868560860255,-0.7367456762894145,0.8102678571428571,0.9888830805814214,1.0,8/21,22.38%,ATP6V0A4;CLN3;GRN;CLN6;ATP6AP2;TCIRG1;ATP6V0D2;TMEM9
prerank,cellular response to pH (GO:0071467),-0.2900504166826573,-0.7364665098912707,0.8091954022988506,0.9884287401773428,1.0,3/17,15.75%,IMPACT;SLC9A1;RAB11B
prerank,hexose metabolic process (GO:0019318),0.28091125373451437,0.7364152878893088,0.8301886792452831,0.9841209396089551,1.0,6/39,14.74%,SORD;PPARD;HK1;BRAT1;HECTD4;OMA1
prerank,import into nucleus (GO:0051170),0.25412518628882463,0.7362717040578516,0.8721590909090909,0.9838223540883169,1.0,30/73,31.73%,BACH2;IPO11;SNRPF;NXT1;SNRPE;RANBP6;SYK;SNRPB;PTTG1IP;SNRPD2;NUP153;NUP50;IPO4;CSE1L;NXT2;NUP85;FAM53A;NUP188;DDX20;RAN;SNRPD1;SMN1;NUTF2;HNRNPA1;GEMIN5;HTATIP2;AKT1;RPAIN;SNRPG;SNRPD3
prerank,folic acid-containing compound metabolic process (GO:0006760),-0.2810566499455791,-0.7362210342307034,0.8188235294117647,0.9879359605890778,1.0,7/19,22.68%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;GGH;FPGS;MTHFS
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.26529147700586403,0.7359889893655003,0.8666666666666667,0.9837269700315275,1.0,5/55,6.23%,PDGFB;XDH;GRB2;PIKFYVE;SLC25A33
prerank,protein deacylation (GO:0035601),0.3089218138730928,0.735874480228526,0.7972508591065293,0.9833968968074891,1.0,7/23,17.62%,HDAC7;NOTUM;ABHD17A;LYPLA1;HDAC5;SIRT7;SIN3A
prerank,internal peptidyl-lysine acetylation (GO:0018393),-0.26404281381581357,-0.7357219390664455,0.8663366336633663,0.9877931242855932,1.0,13/27,33.07%,KAT6B;SGF29;MORF4L2;BRD8;EP300;MRGBP;TAF6L;NAA50;CREBBP;KAT8;MSL3;KAT5;TAF6
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.24254831344615876,0.735680632715207,0.8919667590027701,0.983161542346437,1.0,24/95,21.27%,CEP83;DYNLL1;CCP110;RAB11A;PRKAR2B;MARK4;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP135;CEP72;TUBB4B;TUBA1A;CKAP5;CEP70;CEP97;DCTN1;SFI1;CLASP1;NDE1;HAUS2
prerank,regulation of chromatin binding (GO:0035561),0.3570711988604775,0.7354195859954804,0.7685009487666035,0.9830254013632579,1.0,5/10,26.06%,HMBOX1;DDX11;WAPL;PARP9;DTX3L
prerank,regulation of pH (GO:0006885),0.3471277748039723,0.7350996165968113,0.7695099818511797,0.9829367997614575,1.0,3/11,9.42%,ATP1A4;CLCN3;SLC9A7
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.24365667294430088,0.7348660130184702,0.8987517337031901,0.9827731035222232,1.0,15/84,13.44%,NANOS3;YBX1;NANOS2;ENC1;MRPL13;NANOS1;PIN1;ABCA7;RPL13A;CNOT9;GRB7;ORMDL1;ORMDL3;BTG2;PAIP2
prerank,regulation of protein export from nucleus (GO:0046825),0.30972125464406086,0.7347364429507682,0.803448275862069,0.9824721481886705,1.0,2/23,3.85%,SP100;RAPGEF3
prerank,response to hydrogen peroxide (GO:0042542),0.27342103923977085,0.73468635132899,0.849445324881141,0.9820588361579982,1.0,9/45,14.59%,NET1;RHOB;CAT;FYN;PLEKHA1;PDCD10;STK24;TNFAIP3;STK26
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.3433737318612357,0.7344619259015034,0.7769652650822669,0.9818737255002139,1.0,3/12,17.88%,CCT3;CCT5;CCT7
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),0.3263281613750822,0.7338869871059616,0.7621527777777778,0.982169316639192,1.0,1/15,0.99%,BCL2L1
prerank,pre-miRNA processing (GO:0031054),-0.3100758999775468,-0.733853769939245,0.8314855875831486,0.9893692538242586,1.0,2/14,7.30%,TUT4;AGO2
prerank,receptor catabolic process (GO:0032801),0.30655351283180554,0.7336328114332143,0.8127147766323024,0.9820279986785843,1.0,6/24,12.31%,ZNRF3;AP2M1;TGFB1;SMURF1;SH3GLB1;AP2B1
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.331109192845164,0.7334823002616142,0.7992766726943942,0.981715349324604,1.0,3/16,12.52%,AGER;CEACAM1;CYRIB
prerank,negative regulation of macrophage activation (GO:0043031),0.3272113617210672,0.7329307263779619,0.7918871252204586,0.9819495079604589,1.0,2/16,8.24%,CD200;CST7
prerank,protein homooligomerization (GO:0051260),0.23320754106179747,0.7328995126421086,0.9158878504672897,0.9814910451342249,1.0,19/114,16.56%,AQP11;B2M;HPRT1;GBP5;SAMHD1;MCOLN1;SLC1A2;KCNC2;ACACB;SHMT2;LETM1;EHD4;BCL10;ELAVL1;TRMT61B;CARD11;PDCD6IP;SPAST;NLRC4
prerank,protein ubiquitination (GO:0016567),0.20839848859688562,0.7325950661062156,0.9914438502673797,0.9814016185673007,1.0,95/471,18.63%,RNF144B;EPAS1;LMO7;ZNRF1;KLHL2;SH3RF1;TRIM25;TRIM14;NEDD4L;KLHL7;PELI1;RNF125;ZNRF3;CTNNB1;ENC1;KLHL25;UBE2V2;ABCB11;FBXW7;PHC1;PSMB3;UBE2G1;FBXO41;PSMD11;KLHL24;TRIM36;TRIM24;PSMC6;KLHL3;PSME2;UBE2V1;SMURF1;KCTD10;CBLL1;KLHL20;FBXL2;UBOX5;HERC6;CBFB;PEX14;UBE3D;PSMD8;ZNRF2;WSB1;HIF1A;FBXO6;RNF187;TRIM69;ARRDC1;TRIM39;FBXW2;RNF38;RNF208;ASB5;PSMB10;BCL10;FBXO21;NHLRC1;RBX1;FBXL8;ANAPC16;TRIM2;UBE2D3;AREL1;FBXL15;RNF139;ELOB;RNF8;UBE2Q2;PSMA8;MSL2;ANAPC7;HERC2;UBE2G2;TRIM26;TRIM47;UHRF2;UBE2Z;BFAR;KBTBD8;TRIM68;FBXO2;RNF19A;TRIM71;TRIM3;NEUROD2;SKP1;HLTF;PSMD9;SIAH1;CBL;FBXW9;TRIM11;RNF4;UBE2D1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.31713934879136757,-0.732339662033785,0.7964989059080962,0.9904562535863785,1.0,4/12,18.25%,CLCN2;H6PD;SREBF1;MBTPS1
prerank,positive regulation of phagocytosis (GO:0050766),0.26456698166590004,0.7322658783922483,0.852017937219731,0.981367104829047,1.0,10/47,17.30%,RAB31;PTPRJ;MERTK;GATA2;ABCA7;IL15;NCKAP1L;GAS6;DOCK2;LYAR
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.2619269687493915,0.7320594873201253,0.8541374474053296,0.9811334195208778,1.0,15/57,20.83%,RPL38;NOP16;RPS7;DHX37;WDR74;GTF3A;RIOK1;RPL11;RPS15;RPS28;RPS25;NAF1;NOC2L;PAK1IP1;NVL
prerank,DNA repair (GO:0006281),0.21415264856564864,0.7319003337681705,0.9756380510440835,0.980828312892066,1.0,63/284,22.36%,TENT4A;POLK;MEN1;MRE11;UBE2V2;ATXN3;GTF2H2;ALKBH2;BRCA2;HINFP;CETN2;PWWP3A;FANCG;KDM4A;HPF1;UBE2V1;UBXN1;DNA2;BABAM1;SMUG1;MGMT;RECQL4;GTF2H4;MPG;FBXO6;BTG2;POLB;ASCC3;WDR48;FAN1;NSMCE4A;FANCF;MSH3;RNF8;MSH2;TRRAP;RAD23A;HERC2;HMGA2;SUMO1;RAD21;FANCB;HUS1;NUDT1;RPA1;ADPRS;BRCC3;NSMCE3;RAD9B;POLL;POLD1;UVRAG;ERCC8;GTF2H3;POLA1;PARP2;RFC2;DDB1;ERCC4;RAD1;DCLRE1C;PARP9;RAD23B
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.28950813698694217,0.7316866401384519,0.8044871794871795,0.9806181571666068,1.0,5/29,11.86%,ABT1;DHX37;PWP2;NOL10;UTP3
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.280054614644601,0.7312345110084942,0.8264331210191083,0.980757958669543,1.0,10/35,20.09%,HMBOX1;CTNNB1;MAPK3;CCT3;CCT5;ACD;MAPK1;CCT7;NAF1;MAP2K7
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.3098116845972674,-0.7307659115654399,0.8014018691588785,0.9916020577817236,1.0,6/12,30.07%,ESR1;NCOR1;BCDIN3D;ZC3H10;STAT3;TERT
prerank,nuclear transport (GO:0051169),0.31805839571450756,0.7306482790459502,0.7795414462081128,0.9810550270231909,1.0,4/16,17.07%,NXT1;HMGA1;BANF1;RSRC1
prerank,response to ionizing radiation (GO:0010212),0.2513448453341396,0.7305088272146555,0.8877980364656382,0.980739848753403,1.0,26/70,27.79%,NET1;DCUN1D3;MEN1;GRB2;RHOB;BABAM1;BRAT1;RNF8;MSH2;EEF1D;HUS1;BRCC3;RAD9B;RAD1;PRKAA1;INO80;TOPBP1;MYC;MTA1;SMPD1;NABP2;BLM;CLOCK;XRRA1;GADD45A;RFWD3
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.29650007411347384,-0.7304782030767327,0.8023529411764706,0.9911461304142462,1.0,5/15,19.68%,NEK6;RIOK2;CENPE;CDC16;HECW2
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22773500778594916,0.7304086532384332,0.9377431906614786,0.98038261275816,1.0,39/146,21.88%,DYNLL1;CCP110;PSMB3;RAB11A;PRKAR2B;PSMD11;CETN2;TUBB;CDK5RAP2;PSMC6;PSME2;AKAP9;HAUS6;BRD4;CEP78;PSMD8;CEP135;PSMB10;CEP72;RBX1;TUBB4B;TUBA1A;RCC2;CKAP5;CEP70;PSMA8;SKP1;PSMD9;DCTN1;MECP2;SFI1;CLASP1;NDE1;HAUS2;CDK4;PINX1;CUL1;PSMC3;PSMD1
prerank,regulation of oxidoreductase activity (GO:0051341),0.3341644265396932,0.7303537633012587,0.7718360071301248,0.9799624606553621,1.0,1/13,3.20%,NOD2
prerank,protein deacetylation (GO:0006476),-0.23363392631297566,-0.7295267379917638,0.910761154855643,0.9915630358900328,1.0,6/41,9.15%,HDAC4;TBL1XR1;MIER3;FLNA;SIRT3;MORF4L2
prerank,regulation of nuclear division (GO:0051783),-0.2775734316656586,-0.7295097075166537,0.8392434988179669,0.9907827003033602,1.0,3/20,11.39%,OBSL1;CUL7;PRMT5
prerank,regulation of exocytosis (GO:0017157),0.267101793348872,0.7287628545759051,0.841079460269865,0.9816369358311633,1.0,13/46,22.16%,STXBP6;UNC13D;RAB3B;LGI3;CPLX1;CADPS;RIMS2;RALA;CADPS2;RAB8A;CLASP1;ATP6AP1;SNCA
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.23502204058007992,-0.7286442203351449,0.9226190476190477,0.9910069760723468,1.0,16/45,25.07%,EGFR;BMP4;DDX5;POLR2A;RIOK2;WDR43;HABP4;PIK3R1;SLC38A2;U2AF2;TRMT112;DIMT1;MAP2K1;ZC3H18;GRSF1;HSPA1A
prerank,embryonic axis specification (GO:0000578),0.33278731645611603,0.7278788036437409,0.8070175438596491,0.9823493025169098,1.0,3/15,10.97%,TBX3;WNT7A;TASOR
prerank,response to amino acid (GO:0043200),0.2839619894372186,0.7277165832604521,0.8405103668261563,0.9820541373220762,1.0,10/31,24.90%,SH3BP4;LAMTOR5;RPTOR;NSMF;LAMTOR4;CAPN2;GLRA2;GRIN1;MTOR;GLRA1
prerank,neuron projection regeneration (GO:0031102),0.3591311107109343,0.7274879497526314,0.7810760667903525,0.9818753815826319,1.0,2/10,23.20%,PTN;DHFR
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.29730646675977956,0.7274234752717232,0.8374384236453202,0.9814621522784173,1.0,4/24,11.82%,NOTCH1;KLF2;ATF6B;HIF1A
prerank,regulation of ion transport (GO:0043269),0.24370603271344105,0.727244189234956,0.8806179775280899,0.981204508116966,1.0,16/76,18.53%,B2M;NEDD4L;NKAIN2;SYT7;ATP1A1;PXK;YWHAH;P2RX7;NKAIN1;SYT4;ANK3;KCNJ3;KCNJ5;CA2;KCNJ6;KCNA5
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.290668297870215,-0.7269087909783671,0.8299319727891157,0.9923056561096124,1.0,7/16,24.25%,PIGN;PIGA;PIGP;PIGX;PIGB;PIGH;PIGL
prerank,acylglycerol homeostasis (GO:0055090),-0.2726097212271402,-0.7261783504177564,0.8600917431192661,0.9923768489927526,1.0,3/20,8.01%,IL18;RORA;APOE
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.35459772481240437,0.7258020582897108,0.7804878048780488,0.982624657788552,1.0,4/10,20.44%,AKAP9;DLGAP3;NPTX1;NPTXR
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3394987906348818,0.7255312753971211,0.8056537102473498,0.9824815515842056,1.0,7/13,29.62%,CIAO2B;BOLA2;GLRX3;YAE1;NFU1;ISCA1;ISCA2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.26132024796059405,0.7251600009070713,0.8670605612998523,0.9825026690329204,1.0,23/54,27.88%,MAK16;RPL3;SNU13;NOP16;WDR74;MRPL20;GTF3A;RPL11;RRP15;NHP2;NOC2L;PAK1IP1;NVL;RPL10A;SURF6;RSL24D1;RPL24;MRPL1;RPL7A;RPL6;TRAF7;RPL14;RPL26
prerank,dopaminergic neuron differentiation (GO:0071542),0.3057548567644677,0.725033588104722,0.8071672354948806,0.9821830764610856,1.0,2/19,7.32%,CTNNB1;PHOX2A
prerank,telomere organization (GO:0032200),0.2649581404381653,0.7249926310979161,0.8429878048780488,0.9817430244016827,1.0,14/43,25.97%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1;HUS1;RPA1;POLD1;ERCC4;PTGES3;BLM;POLD4
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.2868044741868946,0.7242224216066273,0.8460236886632826,0.9822717043587182,1.0,6/30,16.02%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,triglyceride catabolic process (GO:0019433),0.3103929708140651,0.7225568026765427,0.787719298245614,0.9839658864194897,1.0,2/19,10.76%,FABP5;LIPC
prerank,DNA duplex unwinding (GO:0032508),0.261880609229413,0.7218728709314338,0.889739663093415,0.9843444566856737,1.0,14/50,22.36%,MRE11;GTF2H2;CETN2;HMGA1;RECQL4;GTF2H4;ASCC3;RBX1;TWNK;RPA1;DDX11;GTF2H3;DDB1;RAD23B
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.32960198295027165,0.7215172276367872,0.7566607460035524,0.9842891158407578,1.0,3/14,17.12%,ADAM10;ADAM17;CCR2
prerank,regulation of peptidase activity (GO:0052547),0.3143878895623462,0.7213575099681859,0.8162544169611308,0.9839954055228246,1.0,2/19,8.24%,CAV1;CST7
prerank,regulation of cytoplasmic transport (GO:1903649),0.3475072506082282,0.720587692589677,0.776536312849162,0.9845191090286532,1.0,2/11,6.19%,DNAJC13;MAPK3
prerank,peptidyl-asparagine modification (GO:0018196),0.28253731674766713,0.7204836607597257,0.8488372093023255,0.98414415888713,1.0,6/31,16.02%,FUT8;STT3B;ST6GAL1;DAD1;DPM3;MGAT2
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),-0.2590225667979962,-0.7199503730039324,0.8496420047732697,0.9989661467412139,1.0,6/24,14.96%,DMD;CAMK2D;PKD2;PRKACA;JPH1;GSTM2
prerank,regulation of RNA export from nucleus (GO:0046831),-0.32558791368385026,-0.7199296280372455,0.8073593073593074,0.9981821910079324,1.0,4/11,26.77%,AKAP8L;NSUN2;SETD2;TPR
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.27636452662361854,0.7194732606378331,0.8512,0.9849250455339608,1.0,13/36,26.64%,NLRC5;IRGM;ADAM17;HIF1A;C1QTNF4;EDN1;GAS6;CPNE1;PARP9;TICAM2;RIPK1;PARP14;AGPAT2
prerank,negative regulation of lipid metabolic process (GO:0045833),0.30699019058751054,0.7193454804447648,0.8315972222222222,0.984598260973773,1.0,5/22,16.57%,ASXL3;PPP2R5A;CEACAM1;PDE3B;ALK
prerank,regulation of neurogenesis (GO:0050767),0.2562387650391729,0.7192106994546635,0.8931750741839762,0.9842844260689041,1.0,9/55,13.76%,B2M;NOTCH1;TGM2;WNT7A;CTNNB1;FAIM;LRP2;SOX11;HMGB2
prerank,response to nutrient levels (GO:0031667),-0.28010178400536195,-0.7186895806965863,0.828978622327791,0.9988141833455352,1.0,4/17,19.94%,PRKAA2;KCNB1;RPS6KB1;EIF4G1
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.31911028815505293,-0.7184533273721996,0.7873303167420814,0.9982814351827664,1.0,1/12,1.07%,B3GALT1
prerank,positive chemotaxis (GO:0050918),-0.285524398848851,-0.7183509343198027,0.8380281690140845,0.9976073574077403,1.0,2/17,8.05%,ANGPT1;MET
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.27573059364867375,-0.7182121192915654,0.8564705882352941,0.9969761979181466,1.0,8/18,34.70%,POLD2;RFC3;LIG1;MCM3;MCM4;LIG3;GINS1;GINS3
prerank,N-terminal protein amino acid modification (GO:0031365),0.3235815809021506,0.7172799679371439,0.7864768683274022,0.9862253797912803,1.0,4/14,13.95%,NAA60;NAA16;NAA11;METAP2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.2927906068273228,0.7170752115505401,0.829225352112676,0.9859983157585435,1.0,8/23,21.28%,OCRL;INPP5F;MTMR6;MTMR12;MTMR2;SYNJ1;MTMR1;INPP5K
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.29471313386339787,0.7169275684833463,0.8401360544217688,0.9856973615107045,1.0,3/25,10.72%,SORT1;CHMP1B;TMEM50A
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.27939677468583607,0.7164691105689066,0.8590831918505942,0.9857958289777382,1.0,4/31,11.78%,STX1A;SYT7;STXBP1;SYT4
prerank,membrane protein proteolysis (GO:0033619),-0.24069131495499768,-0.7164595108428272,0.8903743315508021,0.9982443667317645,1.0,10/37,18.25%,DAG1;ADAM9;BACE2;ADAM19;AFG3L2;PSEN1;CTSH;HM13;PARL;MBTPS1
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.3476980546618433,0.7158572063339118,0.7747747747747747,0.9861037340642954,1.0,1/10,4.35%,CALM1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.3423388314069615,0.7155115275505918,0.8,0.9860528830297615,1.0,4/13,17.62%,TMSB4X;SOX11;HEY1;SIN3A
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.3065206022602368,-0.7154497271017866,0.8311965811965812,0.9986271157219131,1.0,4/12,22.46%,NEK6;PRKCA;CNEP1R1;CCNB2
prerank,DNA replication (GO:0006260),-0.19548213696630234,-0.7150013260106907,0.9818840579710145,0.9983313015081381,1.0,40/105,32.26%,TOP1;RBMS1;REV1;ATM;RBBP8;TIPIN;HELB;IGHMBP2;NAP1L1;RAD50;BAZ1A;CLSPN;DUT;ATRIP;POLD2;RFC3;BRCA1;PCLAF;DONSON;CDC45;DBF4;WRN;NBN;MCM3;ATR;MCM4;POLE2;MCM5;MCM9;EXO1;RFC5;ORC2;ORC5;TOP1MT;TBRG1;PIF1;FEN1;KAT5;TICRR;MCMBP
prerank,cardiolipin metabolic process (GO:0032048),0.33120053432521246,0.7142505749430942,0.7681159420289855,0.9871272168407895,1.0,2/13,12.55%,PTPMT1;PNPLA8
prerank,mRNA 3'-end processing (GO:0031124),-0.20434965770678237,-0.7142145193348296,0.9533333333333334,0.9984175429056897,1.0,27/78,25.41%,SRSF5;PABPN1;SRSF11;PCF11;RPRD2;SRSF6;CPSF3;SRSF4;TENT2;PAF1;DDX39B;PAPOLB;TUT1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;CSTF3;PAPOLG;FIP1L1;DDX39A;EIF4A3;GRSF1;POLDIP3;THOC1;SYMPK
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.2766179147350309,0.7135122531014401,0.864516129032258,0.9875708015228953,1.0,9/35,15.75%,ITGA1;CALM1;HSP90AB1;PPP1R2;PPP1R11;AGTR2;CSNK2B;PPP1R15B;BOD1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.31075882682174977,0.7134420254296795,0.8364888123924269,0.9871659060557048,1.0,5/17,19.17%,CTCF;BUB3;BOD1;ZW10;IK
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.34483981342287656,0.7132251342926315,0.8109090909090909,0.9869402816384423,1.0,1/11,4.52%,CTNNB1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.30867511729904307,0.7130943221094838,0.7964912280701755,0.9866079141040108,1.0,6/18,20.06%,DYSF;SYK;DOCK2;NMI;SBNO2;PLCG2
prerank,selective autophagy (GO:0061912),-0.21159190772883987,-0.7128900472781756,0.9356913183279743,0.9990924600423678,1.0,11/56,14.77%,LGALS8;ULK2;ATG2B;PRKN;ATM;TEX264;DYNC1I1;AUP1;AMBRA1;DDRGK1;UFC1
prerank,histone H3-K4 methylation (GO:0051568),-0.25005938764159374,-0.7128077142574519,0.8784119106699751,0.9983728120648993,1.0,3/26,6.37%,OGT;CTR9;SETD4
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3173351311868448,-0.7124166484197312,0.8034557235421166,0.9979996613436005,1.0,6/10,40.94%,DDX39B;THOC1;FEM1B;ETAA1;CCAR2;THOC5
prerank,sensory perception (GO:0007600),-0.2235344524496032,-0.7122778933835867,0.9171270718232044,0.9973432102975023,1.0,6/45,8.63%,ADGRV1;PTGES;GNAS;P2RX4;TTC8;ADORA2A
prerank,chromatin assembly (GO:0031497),0.267896328623227,0.710672063509798,0.8543371522094927,0.9891264120116913,1.0,14/38,24.04%,PRDM9;CTCF;CHAF1A;NAA60;SOX9;HMGB2;POLE3;CHAF1B;HMGA2;NOC2L;GRWD1;DAXX;LIN54;NAP1L4
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.25346289934419886,0.7105724036903694,0.8917682926829268,0.9887631888921206,1.0,7/54,12.16%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.3085076176640885,-0.7104415669437036,0.8096330275229358,0.9985669294246642,1.0,1/13,1.07%,B3GALT1
prerank,signal transduction in response to DNA damage (GO:0042770),0.25585831888333527,0.7100548853938949,0.8833592534992224,0.988912302003079,1.0,10/49,19.37%,ACER2;MYO6;GRB2;HINFP;STK33;FBXO6;TRIAP1;HUS1;NDRG1;CDC5L
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.30732589561309365,0.709826861557922,0.8057040998217468,0.988224216282753,1.0,7/21,21.63%,GTF2H2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;ERCC4
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.30732589561309365,0.709826861557922,0.8057040998217468,0.988224216282753,1.0,7/21,21.63%,GTF2H2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;ERCC4
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3420222577640909,0.7094681726874597,0.8103448275862069,0.9881735945846906,1.0,4/11,22.42%,NCBP2;ZFP36L1;NCBP1;PAPOLA
prerank,pre-replicative complex assembly (GO:0036388),0.24803619677083846,0.7091933524125641,0.8982300884955752,0.9880254342919668,1.0,19/64,28.17%,PSMB3;PSMD11;PSMC6;PSME2;CDC6;PSMD8;ORC1;PSMB10;PSMA8;PSMD9;PSMC3;PSMD1;PSMD10;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,myelination in peripheral nervous system (GO:0022011),-0.29915887373231687,-0.7090167082786305,0.841304347826087,0.999416771542482,1.0,8/13,27.75%,MYOC;SKI;NF1;SIRT2;LGI4;NCMAP;PRX;CNTNAP1
prerank,regulation of pseudopodium assembly (GO:0031272),0.34336873611918406,0.7086216136426492,0.7939508506616257,0.9877460513896231,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.34336873611918406,0.7086216136426492,0.7939508506616257,0.9877460513896231,1.0,2/10,5.77%,CCR7;CDC42EP3
prerank,DNA-dependent DNA replication (GO:0006261),0.22688575391880128,0.7085466200530984,0.9325236167341431,0.9873519627480987,1.0,39/128,28.65%,PSMB3;PSMD11;PSMC6;HMGA1;PSME2;MCM10;DNA2;CDC6;RECQL4;PSMD8;POLB;POLG2;ORC1;PSMB10;POLE3;TWNK;PSMA8;SIRT7;RPA1;PSMD9;REV3L;POLD1;POLA1;RFC2;PSMC3;PSMD1;PSMD10;TOPBP1;RFC4;PNKP;BLM;POLD4;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7;WRNIP1
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.22600194425943793,-0.7084342436528009,0.9164420485175202,0.9992591304014172,1.0,11/42,27.38%,FBH1;RTEL1;PARP1;KDM1A;KLHL15;HELB;ERCC6;SETD2;SIRT6;SPIDR;RAD51AP1
prerank,action potential (GO:0001508),0.2599752859063158,0.7081241383241414,0.9001560062402496,0.9873773157517541,1.0,7/44,8.33%,GNAQ;KCNQ1;SRI;SCN1A;MYH14;KCNH2;YWHAH
prerank,regulation of histone deacetylation (GO:0031063),0.3236116824348848,0.7077802720718115,0.8074766355140187,0.9872963097420691,1.0,3/13,14.86%,APLNR;FOXP3;CTBP1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2735160217932649,0.7077623716126592,0.8509933774834437,0.986831672064541,1.0,3/32,4.12%,RAPGEF2;NEDD4L;LZTS1
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3306699077624577,0.7076835420939129,0.8040293040293041,0.9864343218257582,1.0,3/14,8.24%,CD200;CD200R1;CST7
prerank,negative regulation of interleukin-6 production (GO:0032715),0.28601912967500853,0.7076219155663833,0.842809364548495,0.986033873489159,1.0,6/27,16.47%,CD200;CD200R1;TNFAIP3;FOXJ1;NCKAP1L;GAS6
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.3238036152468411,0.7074764836814014,0.8129370629370629,0.9857254950844296,1.0,2/13,4.45%,SOX13;RREB1
prerank,autophagosome organization (GO:1905037),0.25274144796532827,0.7067243466482627,0.8932496075353218,0.9861798472019883,1.0,22/50,27.66%,IRGM;MAP1LC3B;PIK3C3;ATG12;UBQLN1;RAB1A;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;NSFL1C;GABARAP;VMP1;ATG2A;GABARAPL2;UBXN2B;ULK1;RAB1B;UBQLN2;RAB7A;BECN1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.31017975828223804,0.7058868030159187,0.8297101449275363,0.9867377819107197,1.0,3/17,10.23%,WASF2;NCKAP1;CYFIP1
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.33653047479720133,0.7058656170251935,0.8115384615384615,0.9857868899466107,1.0,2/11,7.16%,CALM1;SRI
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.33653047479720133,0.7058656170251935,0.8115384615384615,0.9857868899466107,1.0,2/11,7.16%,CALM1;SRI
prerank,cellular response to estrogen stimulus (GO:0071391),-0.29363636377542157,-0.7058298292313818,0.8371559633027523,1.0,1.0,6/14,21.79%,AR;BCAS3;SFRP1;RARA;PELP1;SRA1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.3241245057133795,0.7054460558720737,0.8160291438979964,0.985793006209517,1.0,3/13,18.27%,STX1A;SYT4;CACNA1I
prerank,bile acid metabolic process (GO:0008206),0.2847618124867869,0.7050504210241891,0.8314238952536824,0.9857708005149862,1.0,5/27,12.91%,OSBPL1A;OSBP;ABCB11;NPC1;SLC27A2
prerank,sensory perception of chemical stimulus (GO:0007606),-0.2941250261821382,-0.7048617862580606,0.8592750533049041,1.0,1.0,5/15,22.34%,GNAS;MKKS;UBR3;BBS4;GNAL
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.27282596718505414,-0.7046989346626348,0.8703703703703703,1.0,1.0,5/18,14.61%,SOD2;PRKN;TRAP1;HTRA2;NONO
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.26503740376931406,-0.7044719518653808,0.8627002288329519,1.0,1.0,2/21,5.31%,EPHA7;NGF
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2409955635248906,-0.7043885318004951,0.8798955613577023,0.9995921422984959,1.0,7/30,16.98%,FBH1;UBR5;KLHL15;TWIST1;HELB;TRIP12;ERCC6
prerank,non-motile cilium assembly (GO:1905515),-0.2458777798842746,-0.703647098414549,0.912718204488778,0.9995721538872889,1.0,11/30,24.38%,TTC8;IFT122;FUZ;RPGRIP1L;IFT57;PIBF1;PCM1;CEP250;BBS4;TMEM17;C2CD3
prerank,lysosome localization (GO:0032418),0.26684494068859416,0.7034695997779274,0.8672,0.9871249908576206,1.0,7/37,14.10%,SPAG9;RAB34;MILR1;PLEKHM1;TFEB;KXD1;FAM98A
prerank,magnesium ion transport (GO:0015693),-0.29950623586926833,-0.7033626374237062,0.8438177874186551,0.9990620429116721,1.0,4/12,19.77%,SLC41A1;NIPAL2;MAGT1;TUSC3
prerank,glucose metabolic process (GO:0006006),0.2471458763490104,0.7030132918310364,0.9208523592085236,0.9871949591289734,1.0,10/58,14.74%,SORD;PPARD;LRP5;BRAT1;SLC25A1;G6PC3;HECTD4;PGAM1;TPI1;OMA1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.28245971392962876,-0.7028275835307948,0.8530805687203792,0.9988372714790602,1.0,4/15,13.94%,MAGI2;DACT1;SKI;ACVR1B
prerank,leukotriene biosynthetic process (GO:0019370),-0.2901717397652014,-0.7022085766901254,0.839622641509434,0.9986975263368856,1.0,3/14,15.63%,GGT5;GGTA1;MGST3
prerank,nucleic acid metabolic process (GO:0090304),-0.20664049087382746,-0.7018098357569221,0.9775641025641025,0.9983290309634967,1.0,11/69,17.09%,ENPP1;NT5E;HNRNPH1;POLR2A;DDX1;HNRNPH2;HNRNPR;HNRNPA2B1;GTF2F1;RAD50;PCBP2
prerank,regulation of mitotic spindle organization (GO:0060236),-0.23740099026400477,-0.7015533817859834,0.9074074074074074,0.997796699807607,1.0,12/35,31.68%,PARP3;GPSM2;CHMP4C;EML3;RAE1;TPX2;HSPA1A;CCSAP;TPR;NUMA1;PLK1;PSRC1
prerank,protein sumoylation (GO:0016925),-0.2197688572788202,-0.7015308611988192,0.9375,0.9970296262428221,1.0,6/49,12.16%,EYA1;PIAS1;SEH1L;NUP205;TRPM4;PIAS2
prerank,secretory granule organization (GO:0033363),-0.31430851445873004,-0.7012354730303396,0.8254310344827587,0.9965525915792981,1.0,2/10,5.16%,ABCA1;DTNBP1
prerank,positive regulation of intracellular protein transport (GO:0090316),0.21711912308768438,0.7002954882359541,0.9607843137254902,0.98990528484788,1.0,27/144,17.11%,PPP1R13B;PRR5L;RAPGEF3;RIPOR1;PPP3CC;HYAL2;FYN;FBXW7;OAZ1;TGFB1;YWHAH;ZPR1;YWHAQ;PDCD10;CASP8;HRAS;GSK3A;SH3GLB1;PPP3R1;B3GAT3;TMEM30A;MFF;UBE2D3;ANK3;GAS6;YWHAZ;YWHAB
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.20196262129027426,-0.7001964287442004,0.9738372093023255,0.9968299173184845,1.0,22/69,30.57%,CCNT2;PHAX;POLR2A;RPRD2;INTS8;TAF8;CDK7;INTS2;GTF2F1;INTS4;INTS10;TBP;POLR2L;TAF9;SNAPC2;CDK9;POLR2I;INTS3;POLR2K;ZC3H8;INTS5;SNAPC4
prerank,steroid hormone biosynthetic process (GO:0120178),0.28232826156495555,0.6996516398071189,0.8553259141494436,0.9901949489602696,1.0,6/29,19.63%,CYP11B1;CYP11A1;HSD17B7;HSD17B8;DHCR7;STARD3NL
prerank,steroid metabolic process (GO:0008202),-0.20009458480624742,-0.6995342446487832,0.9753521126760564,0.9966854584915752,1.0,4/72,5.39%,CYP7B1;CYP26B1;CYP27A1;CYP1B1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2880854181482337,-0.6991578774619608,0.8478260869565217,0.9962994333375048,1.0,4/13,20.90%,RHOQ;LRRK2;GNAI3;ENTPD7
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.282608744062672,-0.6990892261619536,0.8501228501228502,0.9955944509365791,1.0,3/16,14.02%,FBH1;KLHL15;HELB
prerank,negative regulation of phosphatase activity (GO:0010923),0.284271138479396,0.6981550974028463,0.8336106489184693,0.9914417424525308,1.0,6/25,19.97%,TGFB2;PPP1R11;PPP1R35;BOD1;FKBP1A;SEMA4D
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.28016500378444614,0.6979399033369943,0.8529886914378029,0.9911974147515272,1.0,4/30,10.12%,CAV1;HYAL2;INPP5F;PTK6
prerank,Golgi localization (GO:0051645),0.33784156935442033,0.6973068113261615,0.8026315789473685,0.9914152269696066,1.0,6/11,27.11%,RIPOR1;PDCD10;YWHAZ;UVRAG;CDC42;HOOK3
prerank,regulation of ATP metabolic process (GO:1903578),-0.21588290614512506,-0.6970038705917034,0.9510703363914373,0.9969314091165447,1.0,5/54,9.42%,PRKAG2;OGT;SEH1L;ATP7A;NUP205
prerank,regulation of T cell differentiation (GO:0045580),0.26880242032901674,0.6959992319250261,0.8733552631578947,0.9924072332427625,1.0,4/33,10.94%,ZAP70;TCF7;FOXP3;CBFB
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2924949189764056,0.695780695708005,0.8228279386712095,0.992177629567194,1.0,10/23,26.99%,CETN2;RBX1;COPS5;GPS1;COPS6;DDB1;RAD23B;XPC;COPS2;UBB
prerank,histone H4 deacetylation (GO:0070933),0.33623113272740446,0.6955540664782175,0.8025830258302583,0.9919660465521015,1.0,3/10,16.91%,HDAC9;SMARCAD1;RCOR1
prerank,regulation of protein localization (GO:0032880),0.24271291429409286,0.695122280185263,0.9219440353460973,0.9919730641351514,1.0,5/58,6.44%,TRIM25;TRIM14;MMD;HSP90AB1;FBXW7
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.33687406702125905,0.6945427398558277,0.8166023166023166,0.992160828808651,1.0,4/11,20.98%,NEDD4L;GOPC;LEPROTL1;GPM6B
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23721172531642143,0.6937722252181828,0.9147058823529411,0.9925424039990786,1.0,17/71,17.36%,CTSC;ATXN3;CTSW;CTSK;CTSO;RHBDD1;MALT1;OTUD7A;CASP8;TNFAIP3;OMA1;PSMA8;ATE1;PDCD6IP;CTSS;CAPN2;BAG6
prerank,synaptonemal complex organization (GO:0070193),0.3101102240995748,0.6923056257670397,0.8497316636851521,0.9932008794820211,1.0,6/15,29.65%,RAD21;BAG6;SYCP2;REC8;TEX12;P3H4
prerank,synaptonemal complex assembly (GO:0007130),0.3101102240995748,0.6923056257670397,0.8497316636851521,0.9932008794820211,1.0,6/15,29.65%,RAD21;BAG6;SYCP2;REC8;TEX12;P3H4
prerank,tRNA methylation (GO:0030488),-0.23061037684739444,-0.6916549473807141,0.9059139784946236,1.0,1.0,7/34,12.54%,THADA;PRORP;DALRD3;THUMPD3;TRMT1L;NSUN2;METTL6
prerank,ubiquinone biosynthetic process (GO:0006744),-0.278670397756574,-0.6915723276816771,0.8764044943820225,1.0,1.0,6/15,28.71%,COQ10A;COQ2;COQ8B;COQ10B;NDUFA9;COQ6
prerank,lipid catabolic process (GO:0016042),0.30319194235585173,0.6908469715694275,0.8191489361702128,0.9943646114178627,1.0,2/18,10.76%,LIPE;LIPC
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.28654923605698435,0.6903285798637977,0.8484320557491289,0.9944586277534978,1.0,2/23,3.56%,NOTCH1;IL10RB
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.23381463468711305,0.6901939582448959,0.9328571428571428,0.9941221758226545,1.0,24/83,24.87%,CDK17;MAX;HINFP;BRD4;CDC6;EIF4E;ORC1;PIM2;PLK2;ACVR1;TRIM71;USP29;CDK18;CDK6;POLA1;CDK4;NASP;CUL1;DHFR;CDKN1B;KLF11;MYC;CDKN2C;TYMS
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.27450718866420115,0.68992735766818,0.8694942903752039,0.9939273074244802,1.0,4/31,12.63%,LYN;TNFRSF21;FOXP3;SOX11
prerank,integrated stress response signaling (GO:0140467),-0.28724638692829085,-0.6892742334931885,0.8355555555555556,1.0,1.0,5/14,26.10%,IMPACT;DDIT3;QRICH1;CCL2;EIF2AK3
prerank,midbody abscission (GO:0061952),0.3077774208092874,0.6885828953414272,0.8416370106761566,0.9949280509528372,1.0,6/17,28.96%,CHMP1B;MITD1;PDCD6IP;CHMP2B;VPS4B;CEP55
prerank,maturation of LSU-rRNA (GO:0000470),-0.24836325087329517,-0.6884774925295567,0.8852040816326531,1.0,1.0,4/26,12.48%,NSA2;WDR12;NOP2;LAS1L
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.2828708122895471,0.6882918076657738,0.8772802653399668,0.9947560905597526,1.0,8/27,21.67%,MAP3K8;IKBKB;MAPK3;CCM2;MAPK1;SKP1;MAP2K7;CUL1
prerank,spindle assembly (GO:0051225),0.23492937470915187,0.6882290135381465,0.9429386590584878,0.9943488849901279,1.0,9/67,12.53%,STARD9;MAPRE2;KIF2A;RAB11A;SAC3D1;MZT1;HAUS6;KIF3B;MAPRE3
prerank,regulation of mitochondrial translation (GO:0070129),-0.25855990791459543,-0.6879661907079001,0.8747044917257684,1.0,1.0,9/21,21.99%,MRPS27;RMND1;ALKBH1;NSUN3;RPUSD4;C1QBP;RCC1L;FASTKD3;FASTKD2
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.19825292804569197,-0.6878775043866336,0.959866220735786,1.0,1.0,15/73,19.26%,HDAC4;DNMT3A;BAZ1B;IGF2;TDG;PPM1D;SMARCA5;TAF1D;EP300;POLR1C;ERCC6;RBBP4;EED;PHF2;EZH2
prerank,cellular response to amino acid starvation (GO:0034198),0.2347923978534127,0.6877125363012022,0.936231884057971,0.9944229861606698,1.0,11/71,12.45%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;DEPDC5;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,response to amino acid starvation (GO:1990928),0.23406289505786657,0.6874442522215011,0.9343794579172611,0.9942583947395813,1.0,11/72,12.45%,FAS;PRKD1;WDR59;SESN3;MAPK3;EIF2AK4;DEPDC5;LAMTOR5;SH3GLB1;RPTOR;TFEB
prerank,glycerolipid metabolic process (GO:0046486),0.3355534243224,0.6874033892941781,0.8246628131021194,0.9938186514968053,1.0,3/11,18.95%,GAL3ST1;DGKZ;PGP
prerank,regulation of RNA splicing (GO:0043484),0.23849165364594016,0.6873186640219792,0.938622754491018,0.9934278951852649,1.0,2/69,1.59%,RBM20;QKI
prerank,cellular response to virus (GO:0098586),0.27390310269366197,0.6871004349254961,0.8518518518518519,0.9931757751146462,1.0,6/30,11.82%,IFIH1;POU2AF1;LGALS9;IRGM;EIF5A;HIF1A
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3350467454926003,0.6868411419552298,0.8355387523629489,0.9929929945418884,1.0,2/10,10.96%,TERF2;ACD
prerank,sulfur amino acid catabolic process (GO:0000098),0.33424893126598093,0.6867154441350959,0.8145315487571702,0.9926355317083096,1.0,2/10,18.90%,CBS;TXN2
prerank,dendritic cell chemotaxis (GO:0002407),0.316801239997584,0.6864101589777427,0.8355140186915888,0.9924786465046641,1.0,2/14,8.20%,CCR7;CXCR2
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.2744056517749491,-0.6857131613675356,0.8768115942028986,1.0,1.0,4/16,21.77%,PARP3;KMT5C;KMT5B;KDM4D
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.23680213091274377,-0.6840277957716753,0.9203980099502488,1.0,1.0,5/31,9.52%,PRKCI;PARD3B;DLG1;MYO9A;EZR
prerank,histone H2A monoubiquitination (GO:0035518),-0.2669708214452839,-0.6839218858258507,0.8923444976076556,1.0,1.0,4/17,9.81%,BCOR;KDM2B;PCGF2;DDB2
prerank,protein-DNA complex disassembly (GO:0032986),0.3055597891691857,0.6838863422529858,0.8336314847942755,0.9946471995177927,1.0,9/16,25.09%,ARID1A;HMGA1;SMARCD1;SET;RPL23;GRWD1;ARID2;MYC;SMARCA4
prerank,linoleic acid metabolic process (GO:0043651),-0.2676718629998148,-0.6828633881936443,0.8558352402745996,1.0,1.0,1/17,1.89%,ACSL1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.2765203851732675,-0.6826898212214031,0.8708240534521158,1.0,1.0,6/15,30.36%,KYAT1;FAH;KMO;KYNU;IL4I1;HAAO
prerank,negative regulation of DNA recombination (GO:0045910),-0.21908038903408555,-0.6826129365454701,0.9268929503916449,1.0,1.0,7/43,14.02%,FBH1;PARP3;POLR2A;RTEL1;KLHL15;ZRANB3;HELB
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.32311873256691304,0.6820692401745314,0.8481973434535104,0.9961460472899579,1.0,3/11,14.59%,FYN;UBQLN1;STK26
prerank,cellular response to DNA damage stimulus (GO:0006974),0.19591703059768958,0.6811742094415002,0.9977272727272727,0.996646182525784,1.0,71/336,21.64%,POLK;BCL2L1;ACER2;FOXO1;MEN1;LYN;FNIP2;SAMHD1;GRB2;CCDC13;RNF169;XIAP;MRE11;MAPK3;MCL1;HINFP;PIDD1;PWWP3A;FANCG;PAK1;HPF1;MCM10;STK33;MGMT;RECQL4;GTF2H4;BRAT1;CCNK;FBXO6;BTG2;POLB;WDR48;FAN1;NSMCE4A;FANCF;POLE3;MSH3;RNF8;MSH2;TRRAP;APC;SIRT7;HERC2;CDKN2AIP;SUMO1;GNL1;ALKBH8;HUS1;NUDT1;CBX1;SLF1;RPA1;DDX11;ADPRS;NSMCE3;BAK1;RAD9B;FOXP1;POLD1;UVRAG;TIGAR;ERCC8;GTF2H3;POLA1;PARP2;RBBP5;RFC2;METTL3;DDB1;ERCC4;RAD1
prerank,regulation of sodium ion transport (GO:0002028),0.26085886815625403,0.679925873075255,0.8747993579454254,0.9974947093243769,1.0,6/34,11.34%,CNKSR3;NKAIN2;ATP1A1;YWHAH;P2RX7;NKAIN1
prerank,mismatch repair (GO:0006298),-0.23774095611668916,-0.6798817976493543,0.9047619047619048,1.0,1.0,9/27,25.95%,TDG;ABL1;ERCC1;MLH3;POLD2;SETD2;LIG1;MCM9;EXO1
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",0.3189181934455386,0.679363256311826,0.8901098901098901,0.9975947018978858,1.0,3/14,10.96%,BRCA2;TERF2;ACD
prerank,mRNA processing (GO:0006397),-0.16345839477310348,-0.6792554125416396,1.0,1.0,1.0,80/287,27.74%,DDX5;SRRM2;PPARGC1A;HNRNPH1;HNRNPUL1;SON;SRSF5;POLR2A;RNPC3;PABPN1;SNRNP70;SRSF11;PRCC;RAVER2;PCF11;RPRD2;AKAP8L;SRRM4;NOVA1;SRSF6;CPSF3;GCFC2;PRKACA;SUGP1;CCNH;HNRNPH2;SRSF4;PNN;CDK7;RBM5;PRPF19;HNRNPR;RBM41;NONO;HNRNPA2B1;PRMT9;GTF2F1;PPIH;DDX39B;CCAR1;PSPC1;RAMAC;PCBP2;THOC2;PRPF18;PRPF3;THOC7;U2AF2;U2AF1;TRA2B;LSM3;TCERG1;CPSF2;CSTF3;FIP1L1;SRSF10;DDX39A;RBMX2;AURKAIP1;SF1;TBRG4;RBM10;EIF4A3;GTF2H1;DBR1;PPIL1;POLR2L;POLDIP3;CWF19L1;THOC1;RNMT;SYMPK;LSM8;POLR2I;HNRNPD;SNRPA1;SF3B5;DHX35;CRNKL1;TFIP11
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.297938082223542,-0.6789462676649818,0.8728070175438597,1.0,1.0,3/12,14.74%,SLC5A3;CYBA;TLR4
prerank,regulation of neurotransmitter secretion (GO:0046928),0.2604957959188416,0.6779594620427241,0.8773424190800682,0.9985342131371131,1.0,7/32,18.11%,MEF2C;SLC30A1;PNKD;CPLX1;RIMS4;RIMS2;PREPL
prerank,DNA geometric change (GO:0032392),-0.24944455913464775,-0.6779116078471261,0.8974358974358975,1.0,1.0,14/24,32.81%,ANXA1;DDX1;RTEL1;ZRANB3;HNRNPA2B1;RAD50;WRN;NBN;MCM9;HMGB1;RECQL;DHX36;PIF1;SUPV3L1
prerank,negative regulation of hippo signaling (GO:0035331),-0.29141952570901264,-0.6763928251941448,0.8580508474576272,1.0,1.0,6/12,25.33%,VGLL4;MAPK14;LIMD1;MAP2K3;AJUBA;CIT
prerank,histone mRNA metabolic process (GO:0008334),0.2726271412530096,0.6759368438529247,0.8842281879194631,1.0,1.0,9/27,21.57%,MTPAP;SNRPF;SNRPE;DCP2;NCBP2;SNRPB;EXOSC10;XRN1;NCBP1
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.28447935868926705,0.6755193522013412,0.8460236886632826,1.0,1.0,3/22,12.52%,B2M;MALT1;CYRIB
prerank,positive regulation of acute inflammatory response (GO:0002675),0.3134192132765705,0.6748803041297284,0.8734622144112478,1.0,1.0,1/14,4.60%,OSMR
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.2701974199786683,0.6747062339281082,0.8830508474576271,0.9999728721801797,1.0,8/27,20.67%,CHKA;SELENOI;CEPT1;PNPLA8;LPIN3;ETNPPL;ETNK1;PISD
prerank,heterochromatin assembly (GO:0031507),0.2899530716618607,0.6744654006748374,0.866785079928952,0.99972611939108,1.0,5/20,16.58%,ZNFX1;HMGA1;HELLS;POLE3;HMGA2
prerank,membrane lipid catabolic process (GO:0046466),-0.3012768009195354,-0.6740488968513817,0.8789144050104384,1.0,1.0,3/10,13.88%,CYP1B1;PDXDC1;NAGA
prerank,peptidyl-arginine modification (GO:0018195),-0.269697942538444,-0.674003032103196,0.8717948717948718,1.0,1.0,10/15,44.76%,PRMT5;PRMT8;ART3;KRTCAP2;PRMT1;ART1;PADI1;PADI4;ART4;ART5
prerank,regulation of DNA recombination at telomere (GO:0072695),0.2869741983448611,0.6730876506680421,0.8756660746003553,1.0,1.0,5/19,21.77%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.2869741983448611,0.6730876506680421,0.8756660746003553,1.0,1.0,5/19,21.77%,TERF2;ACD;TERF1;POLR2J;DAXX
prerank,gastrulation (GO:0007369),-0.27393972612029055,-0.6726608875028465,0.8758465011286681,1.0,1.0,1/15,1.79%,GPC3
prerank,mitotic sister chromatid segregation (GO:0000070),0.21981745099091055,0.6720832770090076,0.9679572763684913,1.0,1.0,17/98,19.15%,TENT4A;NCAPH;RAB11A;MCPH1;CHMP1B;NCAPG;KIF23;CSNK2B;SPAG5;BOD1;PDCD6IP;TTN;RAD21;POGZ;NCAPH2;SET;ZW10
prerank,purine nucleotide biosynthetic process (GO:0006164),0.3157950302210528,0.6718198967111079,0.8605947955390335,1.0,1.0,2/12,9.70%,HPRT1;GART
prerank,histone H4-K16 acetylation (GO:0043984),0.2893283130256599,0.6705760808702088,0.8730703259005146,1.0,1.0,5/19,16.39%,PHF20;JADE2;MCRS1;HCFC1;MSL2
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.25879407263401605,-0.6701582861083241,0.8972602739726028,1.0,1.0,4/18,17.76%,PABPN1;DDX19B;MCM3AP;THOC2
prerank,positive regulation of peptidase activity (GO:0010952),-0.2605085302731686,-0.6701261186155518,0.8873239436619719,1.0,1.0,5/20,16.97%,RCN3;PSME3;CTSH;DDRGK1;GRN
prerank,endocytic recycling (GO:0032456),-0.2086175471072314,-0.6692335940170158,0.9728915662650602,1.0,1.0,16/50,24.67%,SNX12;ENTR1;ACAP2;ANKRD27;VPS35L;EHD1;RAB11B;EHD2;VPS26C;RAB13;ANKRD50;RAB14;SNX17;CCDC22;VPS26A;VPS39
prerank,negative regulation of myotube differentiation (GO:0010832),-0.2880231857438664,-0.6690729908373432,0.8693790149892934,1.0,1.0,2/12,8.15%,HDAC4;CCN3
prerank,DNA double-strand break processing (GO:0000729),0.2972482969232139,0.6686651100636467,0.8756567425569177,1.0,1.0,4/18,15.43%,MRE11;UBE2V2;DNA2;SMARCAD1
prerank,regulation of cellular metabolic process (GO:0031323),0.24591969836157282,0.6684979637187004,0.921996879875195,1.0,1.0,5/45,8.23%,FASN;ABCG1;ABCB11;ACACB;MKLN1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.26083107570697184,0.6672765505489421,0.8853503184713376,1.0,1.0,16/31,32.22%,PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;TIMM21;TIMM50;TOMM70;PEX12;AIFM1;PEX5;GRPEL2;GRPEL1;PEX10
prerank,regulation of brown fat cell differentiation (GO:0090335),0.2952149895238624,0.6668623974839571,0.8485915492957746,1.0,1.0,2/16,4.45%,SOX13;RREB1
prerank,anterograde axonal transport (GO:0008089),-0.2215167264167051,-0.6663603198043988,0.9368421052631579,1.0,1.0,4/37,7.83%,TRAK1;DTNBP1;RAB21;AP3B1
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3209335856901864,0.6662041142357744,0.8519924098671727,1.0,1.0,3/10,15.14%,NPPA;DNAJA1;HIPK3
prerank,protein acetylation (GO:0006473),0.26038413866168575,0.6661559634293831,0.886326194398682,1.0,1.0,6/30,13.41%,FOXO1;KAT6A;NAA60;GTF2B;NAA16;NAA11
prerank,intracellular pH reduction (GO:0051452),0.2592210765935876,0.6654353123199648,0.9162640901771336,1.0,1.0,5/33,11.71%,ATP6V0A1;RAB39A;CLCN3;GPR89A;GPR89B
prerank,receptor clustering (GO:0043113),0.2654962694296788,0.664965820266823,0.8900169204737732,1.0,1.0,7/27,16.54%,AGRN;LRRC7;PTN;NRXN1;SYNJ2BP;NLGN1;ITGA4
prerank,regulation of double-strand break repair (GO:2000779),-0.21729777355582822,-0.6639584523678891,0.9554973821989529,1.0,1.0,13/39,27.38%,UBR5;PML;RTEL1;KDM1A;TWIST1;TRIP12;SETD2;SLF2;OTUB1;SIRT6;ZCWPW1;SPIDR;RAD51AP1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.2408827875643605,-0.6638894407820474,0.9004739336492891,1.0,1.0,7/22,28.91%,MED14;ESR1;MED30;MED4;MED24;MED16;DHX36
prerank,positive regulation of defense response to virus by host (GO:0002230),0.2690071942596116,0.6631473148526871,0.8915254237288136,1.0,1.0,9/24,27.41%,AIM2;STAT1;EIF2AK4;SIN3A;PARP9;ZC3H12A;CGAS;DTX3L;TOMM70
prerank,apoptotic mitochondrial changes (GO:0008637),0.2580600309126847,0.6631174065668586,0.9229508196721311,1.0,1.0,2/32,5.96%,BCL2L1;BIK
prerank,regulation of cholesterol esterification (GO:0010872),0.3218731970158724,0.6624790385426118,0.8412408759124088,1.0,1.0,3/10,19.40%,ABCG1;STARD4;AGT
prerank,quinone biosynthetic process (GO:1901663),-0.2721899474617809,-0.6622737255650173,0.8997772828507795,1.0,1.0,4/14,19.93%,COQ10A;COQ2;COQ8B;COQ10B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.23892350279975622,0.6618853951356874,0.9251908396946565,1.0,1.0,13/48,23.90%,ACTB;TAF1B;ARID1A;HMGA1;SMARCD1;DEK;POLR1A;MYO1C;KAT2B;TAF1C;ZMIZ2;SERTAD2;PADI2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.2875210934225864,0.6616715311852449,0.8896672504378283,1.0,1.0,8/17,25.09%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;IL2RG;SMARCA4
prerank,cellular response to interleukin-7 (GO:0098761),0.2875210934225864,0.6616715311852449,0.8896672504378283,1.0,1.0,8/17,25.09%,JAK3;SOCS2;IL7R;CRLF2;CISH;SOCS1;IL2RG;SMARCA4
prerank,cytoplasmic translational initiation (GO:0002183),0.29741857407439937,0.6615965745847636,0.8665511265164645,1.0,1.0,6/17,23.52%,EIF4H;EIF3D;EIF3M;EIF4A1;EIF4B;EIF2S2
prerank,positive regulation of hormone secretion (GO:0046887),-0.2618748401735837,-0.661588547085905,0.91725768321513,1.0,1.0,2/17,7.57%,SPP1;C1QTNF3
prerank,regulation of telomere maintenance (GO:0032204),-0.2381996357290442,-0.6609629685414903,0.9379474940334129,1.0,1.0,11/26,31.27%,PML;RTEL1;XRCC5;ERCC1;RAD50;SMG1;NBN;SIRT6;HNRNPD;DHX36;PIF1
prerank,cellular response to interleukin-2 (GO:0071352),-0.29012257790821716,-0.6609268703728698,0.8587443946188341,1.0,1.0,5/11,21.37%,SHC1;STAT5A;PTK2B;STAT5B;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.29012257790821716,-0.6609268703728698,0.8587443946188341,1.0,1.0,5/11,21.37%,SHC1;STAT5A;PTK2B;STAT5B;JAK1
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.2930215166396809,0.658789028199056,0.872072072072072,1.0,1.0,1/17,3.45%,PLA2G4B
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.21146694394011348,-0.6583443636371045,0.9558011049723757,1.0,1.0,19/42,29.67%,PPA2;QARS1;EPRS1;YARS1;HARS2;VARS2;WARS2;RARS2;DARS2;DARS1;FARS2;EARS2;FARSA;LARS1;TARS1;AIMP1;PPA1;RARS1;KARS1
prerank,presynapse organization (GO:0099172),-0.29193106398933644,-0.6570589170962763,0.879746835443038,1.0,1.0,1/10,2.74%,NLGN2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.23951245147641217,0.6559082850706343,0.9291338582677166,1.0,1.0,7/42,20.92%,CXCL12;CCL1;GPR75;CCR2;SH2B3;CCL25;RBM15
prerank,cytosolic transport (GO:0016482),-0.17937972591961207,-0.6555496519535114,0.9885496183206107,1.0,1.0,17/108,12.32%,DENND2A;SNX6;GBF1;VPS13A;EEA1;ANKRD27;HOOK2;STX5;AP4M1;ARL1;CLN3;AKTIP;TBC1D10A;MON2;SNX5;RAB29;RAB6A
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.29235870423727905,0.6554142332194751,0.8754266211604096,1.0,1.0,2/17,3.95%,MEF2C;PRKG1
prerank,secondary alcohol biosynthetic process (GO:1902653),0.26166067978886554,0.6553861869669458,0.8911222780569514,1.0,1.0,7/30,18.73%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.26736331245376777,0.6550037386239744,0.9027303754266212,1.0,1.0,9/29,24.43%,GTF2H2;CETN2;GTF2H4;RBX1;RPA1;GTF2H3;DDB1;RAD23B;XPC
prerank,nucleosome disassembly (GO:0006337),-0.2708387875574876,-0.6544060415668832,0.8948545861297539,1.0,1.0,3/14,8.30%,SMARCC2;SMARCD3;SMARCB1
prerank,chromatin disassembly (GO:0031498),-0.2708387875574876,-0.6544060415668832,0.8948545861297539,1.0,1.0,3/14,8.30%,SMARCC2;SMARCD3;SMARCB1
prerank,ncRNA transcription (GO:0098781),0.30728597761143894,0.6542618820683047,0.8571428571428571,1.0,1.0,5/13,27.65%,GTF3A;SIRT7;SPIN1;GTF3C1;SNAPC3
prerank,positive regulation of glial cell differentiation (GO:0045687),0.2858335858610182,0.65351845566779,0.8556338028169014,1.0,1.0,6/17,19.18%,NOTCH1;TGFB1;PTN;PTPRZ1;BIN1;DICER1
prerank,negative regulation of leukocyte activation (GO:0002695),0.2934107250388047,0.6530924576296003,0.8785211267605634,1.0,1.0,1/15,2.13%,CD200
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),-0.2919291151286991,-0.6518757773783058,0.874439461883408,1.0,1.0,3/10,13.65%,PRKCD;CD9;SERPINE2
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.21750292786472203,-0.6515935696712948,0.9564032697547684,1.0,1.0,15/32,35.56%,CDC14B;ATM;BRSK1;CLSPN;BRCA1;DONSON;NBN;DTL;TAOK3;NOP53;PLK1;ABRAXAS1;TICRR;TAOK2;UIMC1
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.24261737248825202,-0.6512112656324687,0.9197994987468672,1.0,1.0,5/21,18.49%,CDC14B;GOLGA2;BTRC;PTEN;MAD2L1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.27747837871225817,0.6510493619166937,0.8875219683655536,1.0,1.0,3/19,11.66%,CAMKK2;FBXW7;GSK3A
prerank,mitochondrial RNA metabolic process (GO:0000959),0.304948872115133,0.6508972598385415,0.8609022556390977,1.0,1.0,2/14,6.23%,MRPL12;SLC25A33
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.2559446488579137,0.6506491109859425,0.9037800687285223,1.0,1.0,6/29,14.55%,APP;ACP4;SHISA6;NSMF;GRIK2;CAMK2B
prerank,regulation of mRNA stability (GO:0043488),-0.17426245190982959,-0.6506352098161192,1.0,1.0,1.0,31/145,25.39%,SAMD4A;ROCK2;PRKCD;TENT5A;DCP1A;CSDC2;PSME4;FXR2;PRKCA;PSME3;IGF2BP2;FMR1;PCBP4;YTHDF1;XPO1;FASTKD1;EXOSC2;FASTKD3;EIF4G1;PSMD7;CIRBP;PSMA3;EXOSC1;PSMD14;SAMD4B;RBM24;TBRG4;PARN;MEX3D;HSPA1A;TNFSF13
prerank,regulation of steroid metabolic process (GO:0019218),0.2727277186329585,0.6502035661806322,0.8890814558058926,1.0,1.0,2/23,6.18%,ABCG1;ABCB11
prerank,macroautophagy (GO:0016236),0.20327742168018542,0.6497086058513531,0.9839142091152815,1.0,1.0,36/118,22.48%,TOMM22;TECPR1;DYNLL1;TBC1D5;TOMM6;MAP1LC3B;KLHL3;PIK3C3;ATG12;VPS36;PRKAB1;UBQLN1;PLEKHM1;PIP4K2A;SNAP29;HGS;CSNK2B;VPS25;TMEM74;ATG14;VPS16;MAP1LC3A;VAMP7;TOMM7;VPS37A;ATG7;ACBD5;PLAA;UVRAG;VPS37B;TOMM5;GABARAP;RUBCNL;VAMP8;PRKAA1;VPS37C
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.29035184131185754,0.6494496301731805,0.875219683655536,1.0,1.0,6/15,23.21%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,regulation of neutrophil migration (GO:1902622),0.3142882216671096,0.6489465209782276,0.8392523364485981,1.0,1.0,2/10,14.70%,RAC1;NCKAP1L
prerank,cholesterol biosynthetic process (GO:0006695),0.25827693058327933,0.6486115722907609,0.9093959731543624,1.0,1.0,7/31,18.73%,PLPP6;HMGCR;HSD17B7;LBR;IDI1;DHCR7;HMGCS1
prerank,modulation by host of viral genome replication (GO:0044827),0.294988540230812,0.6482201151474256,0.8506375227686703,1.0,1.0,4/13,14.87%,EIF2AK4;FBXL2;CCNK;YTHDC2
prerank,ERAD pathway (GO:0036503),0.2186135937082572,0.6477821066925795,0.9682320441988951,1.0,1.0,23/83,22.40%,TRIM25;STT3B;ATXN3;SGTB;RHBDD1;PSMC6;UBQLN1;FBXO6;DERL2;MAN1B1;EDEM1;RNF139;DNAJB9;TMUB2;UBE2G2;BAG6;GET4;FBXO2;TMEM129;BRSK2;ANKZF1;TMUB1;UBE2J1
prerank,positive regulation of histone modification (GO:0031058),0.24446402064254644,0.6471486192972459,0.9184,1.0,1.0,6/33,14.86%,APLNR;MAPK3;RPS6KA5;FOXP3;TADA2B;CTBP1
prerank,response to UV-B (GO:0010224),-0.28500689241869387,-0.6468514934929598,0.8777777777777778,1.0,1.0,3/12,11.26%,STK11;CRIP1;MFAP4
prerank,fatty acid beta-oxidation (GO:0006635),0.23278345554637955,0.6466247602894302,0.9531013615733737,1.0,1.0,13/51,19.06%,PPARD;ABCD4;CRAT;ACOX1;ETFB;ABCD1;SLC27A2;ECI2;ACAT1;DECR2;ACAD11;ETFDH;ABCD2
prerank,positive regulation of innate immune response (GO:0045089),0.25695317584933874,0.6466101579728144,0.9186602870813397,1.0,1.0,11/30,27.29%,GBP5;NLRC5;TLR8;NMI;POLR3F;SPI1;RIOK3;POLR3B;POLR3C;IFI35;RPS19
prerank,vesicle transport along microtubule (GO:0047496),0.2683714112049748,0.6464728955523883,0.8934707903780069,1.0,1.0,5/23,13.02%,KIF1A;FYCO1;BICDL1;KIF3B;RAB1A
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.21789667465198218,0.6463300283463218,0.9683908045977011,1.0,1.0,20/83,21.27%,DYNLL1;CCP110;PRKAR2B;CETN2;TUBB;CDK5RAP2;AKAP9;HAUS6;CEP78;CEP135;CEP72;TUBB4B;TUBA1A;CKAP5;CEP70;DCTN1;SFI1;CLASP1;NDE1;HAUS2
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.31271628744619606,0.646326365433027,0.8598484848484849,1.0,1.0,7/11,33.00%,TASOR;SETDB1;SETDB2;DNMT1;MPHOSPH8;TRIM28;PPHLN1
prerank,folic acid metabolic process (GO:0046655),-0.248256140162799,-0.6459374828030023,0.925754060324826,1.0,1.0,9/18,32.79%,MTHFR;MTHFD1;MTHFD1L;MTHFD2;FPGS;MTHFS;SHMT1;ALDH1L1;PM20D2
prerank,TOR signaling (GO:0031929),0.26842757495488967,0.6456117362414366,0.9158249158249159,1.0,1.0,4/26,15.35%,PRR5L;CCDC88A;RPTOR;CARD11
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.2251992151636118,0.6449106767182794,0.961038961038961,1.0,1.0,18/69,22.40%,TRIM25;STT3B;SGTB;PSMC6;UBQLN1;FBXO6;DERL2;MAN1B1;EDEM1;DNAJB9;TMUB2;UBE2G2;BAG6;FBXO2;TMEM129;ANKZF1;TMUB1;UBE2J1
prerank,histone deacetylation (GO:0016575),-0.20757021522789618,-0.6440484974532037,0.967391304347826,1.0,1.0,16/43,30.76%,HDAC4;TBL1XR1;MIER3;PER2;MORF4L2;SIRT2;MTA3;RCOR3;PER1;SIRT6;MIER2;HDAC1;MSL3;BAZ2A;RBM14;SIRT1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.23055874504715973,0.6440475846218066,0.9487179487179487,1.0,1.0,9/52,13.07%,CNOT6L;EDC3;PAN3;CNOT9;PDE12;PAN2;DCP2;CNOT6;DCP1B
prerank,RNA modification (GO:0009451),-0.19651771280915503,-0.6437702050114944,0.9810126582278481,1.0,1.0,16/54,23.94%,TRMT9B;NOP2;NSUN2;ALKBH1;PUS7;ELP5;NSUN3;TRIT1;NSUN4;DTWD1;ANKRD16;TYW5;BCDIN3D;TSR3;LCMT2;PARN
prerank,regulation of lymphocyte differentiation (GO:0045619),0.2803415143874472,0.6435147362468276,0.8717047451669596,1.0,1.0,5/18,21.50%,ZFP36L1;NCKAP1L;CCR2;ZFP36L2;METTL3
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.3038207938332762,0.643322146071479,0.8870056497175142,1.0,1.0,5/11,25.09%,PWP1;SIRT7;DDX11;MTOR;SMARCA4
prerank,regulation of regulated secretory pathway (GO:1903305),0.246989110379138,0.6429882892651055,0.9299674267100977,1.0,1.0,11/34,26.32%,SYT7;UNC13D;SYT4;RIMS4;RIMS2;PREPL;DOC2A;SYN1;SYT17;RIMS1;SYT15
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.2781690496902008,0.6429641063947257,0.8981324278438031,1.0,1.0,10/19,26.52%,RPTOR;PRDX5;TENM1;BRF2;POLR3F;ZNF76;MAF1;ICE1;MTOR;POLR3C
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.29262540701521267,0.6428483951757181,0.8830935251798561,1.0,1.0,6/14,23.21%,CSTF2;CPSF1;RTRAF;TSEN15;RTCB;TSEN34
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.28318132887945646,-0.6425503233857466,0.8846153846153846,1.0,1.0,3/11,19.99%,HAT1;RBBP4;UBN1
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.2716598926933135,-0.6424517393167616,0.9184149184149184,1.0,1.0,5/14,23.16%,PELI3;NLRP2B;TRAIP;GPS2;CCDC3
prerank,peroxisomal membrane transport (GO:0015919),-0.2264759544957604,-0.6414592256310403,0.9565217391304348,1.0,1.0,7/27,23.79%,ABCD3;PXMP2;PEX7;PEX2;ALDH3A2;ATAD1;PEX13
prerank,regulation of catabolic process (GO:0009894),0.27867960545753506,0.6411985393056269,0.8874538745387454,1.0,1.0,1/18,2.59%,NEDD4L
prerank,skeletal muscle contraction (GO:0003009),0.2751857544032155,0.6403692450203871,0.9094017094017094,1.0,1.0,2/19,8.31%,MYH14;RCSD1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.2655085475007195,-0.6401170462488823,0.9030172413793104,1.0,1.0,3/13,9.06%,FGF2;IGF2;PDPK1
prerank,cellular response to osmotic stress (GO:0071470),0.27638724265012476,0.6401080961927444,0.8943781942078365,1.0,1.0,5/21,16.62%,ARHGEF2;RCSD1;ZFP36L1;LRRC8D;TRPV4
prerank,regulation of B cell differentiation (GO:0045577),-0.2575964156721068,-0.6400830030025799,0.9172413793103448,1.0,1.0,4/17,18.73%,MMP14;SFRP1;INHA;ID2
prerank,superoxide anion generation (GO:0042554),0.29566253331607073,0.6396839893257175,0.8747731397459165,1.0,1.0,3/13,12.57%,CYBB;NCF4;NOX3
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.2912672636113723,-0.6395401052011594,0.9082969432314411,1.0,1.0,5/10,28.94%,GATA6;TSKU;CDH3;TYROBP;LILRB1
prerank,positive regulation of protein deacetylation (GO:0090312),0.284672253606716,0.6394034691059535,0.8765880217785844,1.0,1.0,3/14,19.42%,APLNR;CTBP1;DYRK1A
prerank,protein heterooligomerization (GO:0051291),-0.252781006145969,-0.6392794187256967,0.905829596412556,1.0,1.0,2/17,4.66%,PKD1;PKD2
prerank,aminoglycan metabolic process (GO:0006022),0.30872798257439465,0.6388075738892869,0.8537477148080439,1.0,1.0,6/10,29.60%,XYLT2;B3GAT3;CHST9;B3GAT2;GAL3ST3;XYLT1
prerank,cellular response to ionizing radiation (GO:0071479),0.2307599112965661,0.6387318838436532,0.9492537313432836,1.0,1.0,3/47,5.30%,NET1;GRB2;RHOB
prerank,tRNA transport (GO:0051031),0.245711442753825,0.6383271463878042,0.9266770670826833,1.0,1.0,11/35,26.01%,YBX1;NUP54;NUP160;TOMM20L;NUP153;NUP50;XPOT;NUP42;NUP85;NUP210;NUP188
prerank,regulation of defense response to virus by host (GO:0050691),0.24747622611845146,0.6382526677901602,0.9340836012861736,1.0,1.0,11/30,27.41%,AIM2;STAT1;EIF2AK4;TNFAIP3;SIN3A;PARP9;RNF216;ZC3H12A;CGAS;DTX3L;TOMM70
prerank,inositol phosphate catabolic process (GO:0071545),0.3042736336806405,0.6373793569757782,0.8876190476190476,1.0,1.0,6/12,25.08%,OCRL;NUDT3;INPP1;SYNJ1;INPP5K;IMPA1
prerank,protein targeting to lysosome (GO:0006622),-0.24384630739763707,-0.637183548856088,0.9367945823927766,1.0,1.0,6/20,22.11%,LAMP2;AP4M1;GNPTAB;LAPTM5;VPS4A;NEDD4
prerank,RNA transport (GO:0050658),-0.1849121209337091,-0.6366870650162753,0.99375,1.0,1.0,22/71,26.77%,SIDT1;SRSF5;SRSF11;XPO5;SRSF6;SRSF4;FMR1;RBFOX1;SIDT2;HNRNPA2B1;DDX39B;THOC2;THOC7;U2AF2;U2AF1;RAE1;DDX39A;EIF4A3;POLDIP3;THOC1;NUP155;TPR
prerank,regulation of viral release from host cell (GO:1902186),0.2758616381098785,0.6363788908242309,0.9030612244897959,1.0,1.0,6/21,23.50%,TRIM25;TRIM26;TRIM11;VPS37B;DDB1;MID2
prerank,tRNA metabolic process (GO:0006399),0.28070157591751965,0.635891505732019,0.8836805555555556,1.0,1.0,2/17,7.22%,SARS1;YARS2
prerank,mitotic nuclear membrane reassembly (GO:0007084),-0.197496923203029,-0.6354097055198342,0.9807162534435262,1.0,1.0,15/51,29.31%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1;NUP43
prerank,mitotic nuclear membrane organization (GO:0101024),-0.197496923203029,-0.6354097055198342,0.9807162534435262,1.0,1.0,15/51,29.31%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1;NUP43
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.30268617609268983,0.634913680277233,0.8860103626943006,1.0,1.0,3/12,14.77%,TGFB1;PPARG;ELAVL1
prerank,lipid droplet organization (GO:0034389),0.2654036699283847,0.63449690424754,0.9051724137931034,1.0,1.0,2/22,6.74%,PPIA;CDS2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.2203603515605145,0.6344114270301943,0.9576642335766423,1.0,1.0,7/63,12.16%,CNOT6L;RGCC;CRADD;PIDD1;CNOT9;CNOT6;BTG2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.281631152969511,0.633500381872871,0.912739965095986,1.0,1.0,1/15,3.49%,GBP5
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.2806630042079508,-0.6319568366327136,0.9267782426778243,1.0,1.0,3/12,17.09%,PPARA;WNK1;MDK
prerank,endosome organization (GO:0007032),0.23978612030185628,0.631792055988941,0.9318181818181818,1.0,1.0,5/41,10.88%,ALS2CL;SNX3;DNAJC13;CLCN3;HOOK1
prerank,DNA strand elongation (GO:0022616),-0.244998238860963,-0.6316911333949452,0.9219512195121952,1.0,1.0,8/18,30.26%,RAD50;POLD2;RFC3;NBN;MCM3;MCM4;TERT;GINS1
prerank,calcium import into the mitochondrion (GO:0036444),0.3123751664117431,0.6313096611070356,0.8809523809523809,1.0,1.0,1/10,2.82%,MCUB
prerank,gene silencing by miRNA (GO:0035195),0.24889011281176734,0.6312342993420919,0.9357495881383855,1.0,1.0,2/32,4.27%,NOTCH4;ADAR
prerank,calcium-ion regulated exocytosis (GO:0017156),0.2496848012885292,0.6302229777559936,0.9103214890016921,1.0,1.0,8/27,26.32%,SYT7;ARHGAP17;SYT4;RIMS2;VAMP7;SYT17;RIMS1;SYT15
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.26601701942021205,-0.6291748362113718,0.9119638826185101,1.0,1.0,2/13,12.68%,ALG1;MPDU1
prerank,negative regulation of B cell activation (GO:0050869),0.26979624624793275,0.6290648834314061,0.9077181208053692,1.0,1.0,5/21,17.45%,LYN;TNFRSF21;TNFAIP3;FOXJ1;SAMSN1
prerank,DNA biosynthetic process (GO:0071897),0.28176303875820957,0.6284173664395366,0.8980322003577818,1.0,1.0,7/16,28.65%,PPIA;POLL;POLD1;POLA1;TYMS;POLD4;WRNIP1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.3055139694129304,0.6281829488646101,0.8703007518796992,1.0,1.0,4/10,19.18%,TSNAX;TSN;MRPL44;DICER1
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.2791817118622522,0.6279222348440607,0.9084380610412927,1.0,1.0,3/17,11.25%,PPIA;HSPB1;UBQLN1
prerank,homologous chromosome segregation (GO:0045143),0.2672704440003727,0.6277187027495572,0.9057239057239057,1.0,1.0,4/20,16.41%,RNF212B;PRDM9;PTTG1;SIRT7
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.20847968785028087,0.627547348087632,0.9828326180257511,1.0,1.0,27/84,28.17%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;BUB3;PSMB10;PTTG1;ANAPC16;PSMA8;ANAPC7;ANAPC10;PSMD9;UBE2D1;ANAPC2;PSMC3;PSMD1;CDC23;PSMD10;CDC26;CDC27;PSME1;UBB;PSMD2;PSMA1;PSMB8;PSMA7
prerank,negative regulation of histone modification (GO:0031057),0.2890512882218198,0.6266799785112541,0.8920353982300885,1.0,1.0,5/14,22.16%,FOXP3;CTBP1;SET;NOC2L;SNCA
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),-0.2757039622313816,-0.6263017241369175,0.9085106382978724,1.0,1.0,4/11,15.58%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,inositol phosphate dephosphorylation (GO:0046855),-0.2757039622313816,-0.6263017241369175,0.9085106382978724,1.0,1.0,4/11,15.58%,SYNJ2;PTEN;INPP5A;INPP5B
prerank,maintenance of protein localization in organelle (GO:0072595),0.26532576108721373,0.62555193477392,0.9124087591240876,1.0,1.0,2/19,10.89%,ARL2BP;HK1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.24254030623081554,0.6252415840410482,0.9325463743676222,1.0,1.0,7/32,17.36%,PPP1R13B;HINT1;JMY;DDIT4;HIPK2;MSH2;BAG6
prerank,regulation of cell size (GO:0008361),0.26084672044902646,0.6241954935431455,0.9095744680851063,1.0,1.0,10/23,24.53%,MSN;LAMTOR5;RAC1;RPTOR;LAMTOR4;EDN1;RDX;VAV1;RAP1GAP2;MTOR
prerank,RNA processing (GO:0006396),0.19064048518610885,0.6241059826370482,0.9951159951159951,1.0,1.0,18/176,13.02%,TENT4A;IVNS1ABP;PPP1R9B;ADAR;MTPAP;RNPS1;SNRPF;HNRNPC;DEDD2;MAGOHB;SNRPN;ZCRB1;MPHOSPH10;RBPMS;NCBP2;NOL9;ADAD1;SNRPB
prerank,'de novo' posttranslational protein folding (GO:0051084),0.2419995397223833,0.6238512445186909,0.9209225700164745,1.0,1.0,7/30,18.69%,ENTPD5;HSPA8;DNAJC7;HSPA9;HSPE1;CHCHD4;ERO1A
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.18357929022916283,-0.6225767795237088,0.993421052631579,1.0,1.0,17/57,27.07%,CDC14B;ATM;TIPIN;BRSK1;ATF2;SDE2;CLSPN;FANCD2;BRCA1;DONSON;NBN;WAC;DTL;RPS27L;CCND1;TAOK3;NOP53
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2580210225577742,0.622442875938392,0.9301919720767888,1.0,1.0,4/22,11.81%,SOX12;FOXP3;CBFB;VSIR
prerank,protein deneddylation (GO:0000338),0.30578299527988706,0.6222140013947303,0.8943396226415095,1.0,1.0,4/10,25.22%,COPS5;GPS1;COPS6;COPS2
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.26530580185090435,0.6220393065300804,0.9070567986230637,1.0,1.0,4/21,13.44%,PGM2L1;TALDO1;HK1;G6PC3
prerank,regulation of receptor recycling (GO:0001919),0.2767401017834661,0.6218220897163816,0.8926654740608229,1.0,1.0,8/16,27.01%,RAMP3;INPP5F;AP1AR;SNCA;SCRIB;TRAT1;NSF;ECE1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.23303294535198033,-0.6212636927123995,0.9519230769230769,1.0,1.0,6/22,25.18%,CCNT2;DDX39B;ERCC6;TCERG1;CDK12;THOC1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.2748425899731565,0.6211106619092893,0.8952042628774423,1.0,1.0,8/18,25.81%,RAP1B;RIMS4;NLGN1;RIMS2;PREPL;RAB3GAP1;SYN1;RIMS1
prerank,purine-containing compound salvage (GO:0043101),-0.2670035057581437,-0.6205698901768186,0.9127659574468086,1.0,1.0,3/12,16.14%,AMPD3;GMPR2;DGUOK
prerank,regulation of DNA metabolic process (GO:0051052),0.22338294815843696,0.6205445085303483,0.9474497681607419,1.0,1.0,14/44,25.57%,UBE2V2;TERF2;UBE2V1;PARG;IL7R;SMARCAD1;YLPM1;SIRT7;RADX;SUB1;WDR70;MYC;UPF1;KDM1B
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.248826248173329,-0.6203117289670967,0.9249448123620309,1.0,1.0,5/16,20.95%,PLEKHM2;VAMP2;RAET1E;LYST;ULBP1
prerank,positive regulation of type 2 immune response (GO:0002830),0.28440383169401684,0.6194528231963706,0.8839285714285714,1.0,1.0,2/14,10.81%,NOD2;DENND1B
prerank,DNA recombination (GO:0006310),0.2342092035154145,0.6194497962923091,0.9424920127795527,1.0,1.0,9/37,18.19%,RAD54B;MRE11;RECQL4;MSH3;MSH2;TSN;RAD21;ENDOG;RPA1
prerank,sensory perception of taste (GO:0050909),0.30694871633921283,0.6183636479758777,0.8945386064030132,1.0,1.0,10/10,69.32%,TAS1R1;PKD2L1;ASIC2;ASIC1;PKD1L3;TAS1R3;GNAT3;TAS1R2;ASIC3;CD36
prerank,microtubule polymerization (GO:0046785),0.24818567468344138,0.6180937359274526,0.9319286871961102,1.0,1.0,10/29,21.22%,FGF13;PIN1;AKAP9;RANBP9;CKAP5;TRPV4;TPPP;CLASP1;TUBG2;NDE1
prerank,nuclear membrane reassembly (GO:0031468),-0.19007219365189187,-0.6179728268486856,0.9861495844875346,1.0,1.0,15/54,27.61%,LMNA;SEH1L;NUP205;EMD;SIRT2;CHMP4C;VPS4A;CCNB2;UBXN2A;LEMD2;KPNB1;NUP155;NUP35;NDC1;IST1
prerank,canonical glycolysis (GO:0061621),0.24906460819555543,0.6169385525993707,0.9078726968174204,1.0,1.0,5/24,14.42%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,glucose catabolic process to pyruvate (GO:0061718),0.24906460819555543,0.6169385525993707,0.9078726968174204,1.0,1.0,5/24,14.42%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.2855232702463213,0.6169306195851415,0.8799249530956847,1.0,1.0,2/13,10.50%,NTHL1;SMUG1
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.21684388306079025,0.6159816209453916,0.9633967789165446,1.0,1.0,20/61,28.17%,CAV1;PSMB3;OAZ1;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;PSMA8;PSMD9;OAZ2;PSMC3;PSMD1;PSMD10;SIRT5;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,regulation of DNA recombination (GO:0000018),-0.2062723294424275,-0.6150591998104624,0.9653465346534653,1.0,1.0,11/32,27.38%,RTEL1;KDM1A;ZRANB3;RAD50;SETD2;SIRT6;ZCWPW1;THOC1;SPIDR;KPNA1;RAD51AP1
prerank,termination of RNA polymerase I transcription (GO:0006363),0.24292816612540571,0.6146621405877689,0.937799043062201,1.0,1.0,7/30,22.58%,TAF1B;GTF2H2;GTF2H4;UBTF;POLR1A;GTF2H3;TAF1C
prerank,protein kinase A signaling (GO:0010737),-0.27037526326190714,-0.6145657916548681,0.9222222222222223,1.0,1.0,4/12,19.00%,EZR;PRKACA;MYOM1;RAB13
prerank,lipoxygenase pathway (GO:0019372),-0.25013583640743753,-0.6138260848369617,0.9432314410480349,1.0,1.0,7/14,42.29%,PON3;PTGS2;ALOXE3;ALOX12;GPX1;PON1;ALOX5
prerank,establishment of apical/basal cell polarity (GO:0035089),0.2814879082295181,0.6127942823509587,0.8998144712430427,1.0,1.0,4/14,14.05%,OPHN1;MSN;FSCN1;FOXJ1
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.1703429295967824,-0.6119740324820352,1.0,1.0,1.0,30/95,27.38%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;CDC45;PSMD14;WRN;KDM4D;SEM1;NBN;MCM3;AP5Z1;MCM4;ZSWIM7;LIG3;SPIDR;RAD54L;MCM5;MCM9;RECQL;ZFYVE26;RAD51AP1
prerank,base-excision repair (GO:0006284),0.22272209148976718,0.6105886166250938,0.9659969088098919,1.0,1.0,12/48,21.33%,NTHL1;DNA2;PARG;SMUG1;MPG;POLB;HMGA2;RPA1;ADPRS;POLL;POLD1;RFC2
prerank,Golgi to lysosome transport (GO:0090160),0.29373422834705437,0.6105343736433846,0.9085923217550275,1.0,1.0,3/11,20.91%,SORT1;AP1G1;ANKFY1
prerank,myelin assembly (GO:0032288),-0.27733112383963204,-0.6100257478296908,0.9155555555555556,1.0,1.0,2/10,9.73%,EPB41L3;CD9
prerank,positive regulation of viral process (GO:0048524),-0.18576498871915004,-0.6099352119916145,1.0,1.0,1.0,9/60,15.81%,AXL;MDFIC;PPARA;POLR2A;TMEM39A;DDX3X;NELFE;GTF2F1;PPIH
prerank,histone deubiquitination (GO:0016578),0.26401478822544006,0.6088975530676753,0.921875,1.0,1.0,6/18,23.26%,ATXN7;TRRAP;USP49;BRCC3;USP21;ENY2
prerank,regulation of mRNA processing (GO:0050684),0.23735242369718845,0.6084333679175177,0.9467741935483871,1.0,1.0,1/32,1.59%,QKI
prerank,intracellular protein transmembrane transport (GO:0065002),0.2270631239157744,0.6079176360582788,0.9708141321044547,1.0,1.0,20/42,32.22%,SEC62;PEX14;DNAJC19;TOMM20L;PEX16;CHCHD4;PEX6;PEX1;ZFAND2B;TIMM21;TIMM50;TOMM70;SEC63;AKT2;PEX12;AIFM1;PEX5;GRPEL2;GRPEL1;PEX10
prerank,chaperone-mediated protein complex assembly (GO:0051131),-0.2310383094062943,-0.6076607718250335,0.9479905437352246,1.0,1.0,9/20,31.82%,HSPA4;MKKS;CCT2;PSMG1;PTGES3L;HSPA1A;HOPX;TMEM35A;PSMG2
prerank,telomere maintenance via telomere trimming (GO:0090737),0.2914704969996612,0.6075879903004227,0.8798449612403101,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,t-circle formation (GO:0090656),0.2914704969996612,0.6075879903004227,0.8798449612403101,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.2914704969996612,0.6075879903004227,0.8798449612403101,1.0,1.0,2/10,12.47%,DNA2;TERF1
prerank,sulfur amino acid metabolic process (GO:0000096),-0.22020266370103264,-0.6067951005616091,0.9662650602409638,1.0,1.0,4/24,13.47%,NOX4;MTHFR;MTHFD1;GCLC
prerank,regulation of catecholamine secretion (GO:0050433),0.2411054812950448,0.605854057343374,0.9448160535117057,1.0,1.0,3/29,11.78%,STX1A;SYT7;SYT4
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.24096003292135118,-0.6034790476232264,0.945054945054945,1.0,1.0,6/16,26.33%,NAA35;NAA80;EP300;NAA40;NAA50;CREBBP
prerank,RNA export from nucleus (GO:0006405),-0.1656197583361209,-0.6032295551164826,1.0,1.0,1.0,30/100,26.77%,SEH1L;SRSF5;SRSF11;DDX19B;XPO5;SRSF6;CPSF3;NUP205;SRSF4;MCM3AP;HNRNPA2B1;DDX39B;SMG1;FYTTD1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;RAE1;FIP1L1;DDX39A;EIF4A3;POLDIP3;THOC1;SYMPK;NUP155;NUP35;NDC1;TPR
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2700093500225682,-0.6032186278633116,0.9502164502164502,1.0,1.0,3/11,17.46%,CREB3L1;CEBPB;DDIT3
prerank,cranial nerve development (GO:0021545),-0.2656317659333932,-0.6031434331101154,0.9191489361702128,1.0,1.0,1/11,3.34%,SALL1
prerank,synaptic vesicle transport (GO:0048489),0.2867114536229889,0.6030292844807882,0.8800738007380073,1.0,1.0,2/11,15.89%,DNM2;SYNJ1
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.29697655615896823,0.6026367248599133,0.8858195211786372,1.0,1.0,2/10,12.31%,AP2M1;AP2B1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.29697655615896823,0.6026367248599133,0.8858195211786372,1.0,1.0,2/10,12.31%,AP2M1;AP2B1
prerank,cellular response to leucine starvation (GO:1990253),0.293567617171284,0.6025744049831897,0.8808193668528864,1.0,1.0,2/10,9.61%,SESN3;EIF2AK4
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.2888705274172214,0.6024480514064626,0.8878504672897196,1.0,1.0,6/10,25.86%,GABRG1;GABRG3;GABRA1;GABRB2;GABRA2;GABRG2
prerank,cilium movement (GO:0003341),0.21660218789144745,0.6011824038268108,0.9736434108527132,1.0,1.0,6/48,11.10%,DNHD1;CFAP100;CFAP91;RSPH4A;CFAP54;DNAAF2
prerank,phosphate ion transport (GO:0006817),0.2642808732262242,0.6011092188452904,0.9101899827288429,1.0,1.0,5/16,23.80%,XPR1;SLC37A3;SLC37A2;SLC34A3;SLC37A1
prerank,recombinational repair (GO:0000725),-0.17305146484303488,-0.6005959690457102,0.9965986394557823,1.0,1.0,25/77,27.38%,FBH1;RAD51B;RBBP8;SMC6;PARP1;NUCKS1;XRCC1;NSMCE1;RAD50;SWI5;NSMCE2;BRCA1;PSMD14;WRN;KDM4D;SEM1;NBN;AP5Z1;ZSWIM7;LIG3;SPIDR;MCM9;RECQL;ZFYVE26;RAD51AP1
prerank,negative regulation of DNA replication (GO:0008156),-0.2594204529851359,-0.6002417455566778,0.9427966101694916,1.0,1.0,7/13,31.03%,TSPYL2;CDAN1;S100A11;ATR;GMNC;PDS5A;GMNN
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.26015771432136053,-0.5994176571335184,0.93058568329718,1.0,1.0,3/11,23.43%,PRKN;NONO;NR4A3
prerank,mRNA export from nucleus (GO:0006406),-0.16447758482459296,-0.598908278084826,1.0,1.0,1.0,30/102,26.77%,SEH1L;SRSF5;PABPN1;SRSF11;DDX19B;SRSF6;CPSF3;NUP205;SRSF4;MCM3AP;HNRNPA2B1;DDX39B;SMG1;FYTTD1;THOC2;THOC7;U2AF2;U2AF1;CPSF2;RAE1;FIP1L1;DDX39A;EIF4A3;POLDIP3;THOC1;SYMPK;NUP155;NUP35;NDC1;TPR
prerank,tRNA 5'-end processing (GO:0099116),0.26721275941014844,0.5987820430072069,0.8964285714285715,1.0,1.0,5/15,21.47%,TRMT10C;RPP38;RPP21;HSD17B10;RPP30
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.234031957177826,-0.5987567708922658,0.9551886792452831,1.0,1.0,8/17,26.78%,PRKN;KDM1A;SNAI1;TWIST1;CD44;RNF34;YJU2;ARMC10
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.1752893096359119,0.5979008300420037,1.0,1.0,1.0,81/241,29.87%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;HNRNPC;SNRPC;SNRPE;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;PPWD1;NCBP2;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;FRG1;AQR;PRPF40A;PRPF4;RSRC1;ISY1;USP49;SMU1;SNRPB2;POLR2J;SF3A2;LSM4;SNRPD2;IK;PUF60;CDC5L;RBM8A;HNRNPM;ELAVL2;SF3B3;RBM15;METTL3;NCBP1;PAPOLA;WBP11;PABPC1;PRPF8;PPIE;SNRPA;SMNDC1;DHX38;UPF3B;CSTF2T;SART3;SNW1;PHF5A;CWC27;SNRNP48;HNRNPF;HNRNPA3;CSTF1;CWF19L2;HNRNPL;SNRPD1;SRSF12;SRSF7;SRSF1;LSM6;PRPF31;XAB2;DDX41;HNRNPA1;BCAS2;GEMIN5;PRPF6;ZRSR2
prerank,histone H3 deacetylation (GO:0070932),0.2723569371325885,0.5977456254498454,0.9262589928057554,1.0,1.0,4/15,16.41%,HDAC9;ELK4;SMARCAD1;SIRT7
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.21578918474500533,0.5977289010754936,0.9720062208398134,1.0,1.0,3/48,6.64%,BCL2L1;FNIP2;MCL1
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.2367359344879079,0.5970512795002011,0.9499165275459098,1.0,1.0,8/29,22.45%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;DCPS;EXOSC8
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.21270334807114274,0.5958905470703185,0.96759941089838,1.0,1.0,8/53,16.40%,CALCRL;HTR2A;AGTR2;CHRM3;MTNR1A;HTR4;OPRD1;SSTR1
prerank,retrograde axonal transport (GO:0008090),0.2650212358131716,0.5951300065003026,0.9223484848484849,1.0,1.0,1/16,6.88%,KIF1A
prerank,axonal transport (GO:0098930),0.22825473789302078,0.5937414397209184,0.9584664536741214,1.0,1.0,8/36,19.90%,AP3M2;KIF1A;AP3S1;KIF3B;HIF1A;SPAST;AP3M1;DCTN1
prerank,protein localization to chromosome (GO:0034502),0.23197583592202714,0.5927788443074867,0.9614740368509213,1.0,1.0,10/34,21.73%,TERF2;ACD;CTCF;MSH2;BOD1;RAD21;SLF1;RPA1;PINX1;WAPL
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.2144497368029973,0.5925164773645698,0.9806259314456036,1.0,1.0,13/54,19.38%,IKBKB;RFFL;BIRC3;ADAM17;SHARPIN;CASP8;SYK;CYLD;TNFAIP3;GAS6;CPNE1;SPPL2A;RBCK1
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.24916444943913038,-0.5907772397903646,0.9340659340659341,1.0,1.0,1/13,3.61%,PRKCD
prerank,cellular response to alkaloid (GO:0071312),0.2564418245844662,0.5906198403153455,0.9236234458259325,1.0,1.0,2/17,6.72%,TGM2;CASP7
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2558636838467996,-0.5903096218922594,0.9463519313304721,1.0,1.0,3/11,19.92%,MDM1;TRIM37;BRCA1
prerank,double-strand break repair (GO:0006302),0.18195018881747965,0.5890038442624823,0.9987373737373737,1.0,1.0,25/158,18.81%,TENT4A;SAMHD1;RAD54B;MRE11;UBE2V2;PALB2;BRCA2;KDM4A;HPF1;UBXN1;DNA2;BABAM1;RECQL4;POLB;FAN1;HMGB2;RNF8;SMARCAD1;HERC2;SUMO1;RAD21;HUS1;RPA1;REV3L;BRCC3
prerank,tRNA wobble uridine modification (GO:0002098),-0.2505289056542619,-0.588863419598054,0.9331797235023042,1.0,1.0,3/14,15.33%,TRMT9B;ELP3;ELP4
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.22984876090421968,0.5881446463873969,0.9584717607973422,1.0,1.0,8/31,22.45%,EDC3;DCP2;CNOT6;DCP1B;LSM4;EXOSC9;DCPS;EXOSC8
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.21398999615351336,-0.5872629324098665,0.9694656488549618,1.0,1.0,6/24,23.17%,DNMT3A;PPM1D;RBBP4;EED;EZH2;RBBP7
prerank,protein localization to mitochondrion (GO:0070585),-0.25939355052712343,-0.5870378038423969,0.936734693877551,1.0,1.0,4/11,22.64%,HK2;LRRK2;COX18;MTCH2
prerank,positive regulation of intracellular transport (GO:0032388),0.2236837082232599,0.5869011940367075,0.9691558441558441,1.0,1.0,6/38,15.24%,PRR5L;RIPOR1;OAZ1;PDCD10;B3GAT3;SPAG5
prerank,regulation of mRNA metabolic process (GO:1903311),-0.256838291671427,-0.5868742714900486,0.9405286343612335,1.0,1.0,5/11,34.72%,SAFB2;SLTM;SRPK1;PTCD2;SRPK2
prerank,replication fork processing (GO:0031297),0.22162068879035823,0.5868728245521864,0.9811616954474097,1.0,1.0,4/38,9.90%,SAMHD1;MRE11;BRCA2;DNA2
prerank,positive regulation of histone acetylation (GO:0035066),0.23877161052906407,0.5863616274537403,0.932258064516129,1.0,1.0,4/23,12.14%,MAPK3;RPS6KA5;FOXP3;TADA2B
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.2829596543049946,0.5861193041150914,0.9077490774907749,1.0,1.0,2/10,14.97%,RAPGEF3;HDAC5
prerank,autophagy of peroxisome (GO:0030242),0.2708150750441685,0.5858873648867832,0.9163701067615658,1.0,1.0,4/12,23.46%,MAP1LC3B;PIK3C3;ACBD5;USP30
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.28969859241222556,0.5852469634664408,0.9137931034482759,1.0,1.0,2/10,8.79%,OPHN1;MSN
prerank,regulation of cilium movement (GO:0003352),0.28698660675677723,0.5850025942509501,0.9053030303030303,1.0,1.0,1/10,7.92%,DRC1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.2185203223847818,-0.5845696153920638,0.9694117647058823,1.0,1.0,6/20,24.85%,APOE;SREBF1;NR1H4;MBTPS1;EPHX2;KPNB1
prerank,negative regulation of translational initiation (GO:0045947),0.2747811417205437,0.5839814356175927,0.9312267657992565,1.0,1.0,3/13,13.44%,EIF3E;EIF2AK4;PAIP2
prerank,telomere maintenance (GO:0000723),0.2101371046778116,0.583829057839744,0.9739263803680982,1.0,1.0,7/50,12.47%,SP100;MRE11;TERF2;DNA2;ACD;RECQL4;TERF1
prerank,ovarian follicle development (GO:0001541),0.2732790833784106,0.5833698690771126,0.9150090415913201,1.0,1.0,2/13,10.81%,FOXL2;EIF2B2
prerank,regulation of telomere capping (GO:1904353),-0.21531357488831415,-0.5832299505570477,0.9778869778869779,1.0,1.0,9/23,26.59%,TNKS2;ATM;RTEL1;RAD50;NBN;TNKS;PKIB;HNRNPD;MAP3K4
prerank,tRNA aminoacylation (GO:0043039),-0.19253549339116743,-0.5823802009782052,0.9893899204244032,1.0,1.0,17/37,29.67%,PPA2;QARS1;EPRS1;YARS1;HARS2;WARS2;RARS2;DARS2;DARS1;FARS2;FARSA;LARS1;TARS1;AIMP1;PPA1;RARS1;KARS1
prerank,ESCRT III complex disassembly (GO:1904903),0.2947885906377382,0.5819691280338195,0.9029126213592233,1.0,1.0,1/10,7.84%,CHMP1B
prerank,ESCRT complex disassembly (GO:1904896),0.2947885906377382,0.5819691280338195,0.9029126213592233,1.0,1.0,1/10,7.84%,CHMP1B
prerank,neuron projection fasciculation (GO:0106030),0.28835045060088027,0.5817001851398157,0.9229249011857708,1.0,1.0,2/10,16.29%,EPHA4;NRCAM
prerank,regulation of translational initiation (GO:0006446),0.20448923190561955,0.5793739858601183,0.9880597014925373,1.0,1.0,17/63,21.57%,EIF4H;KLHL25;EIF3E;EIF2AK4;HSPB1;EIF2B2;NCBP2;PAIP2;PAIP1;EIF3B;PPP1R15B;EIF1B;NCK1;DAZL;EIF4EBP3;EIF3H;NCBP1
prerank,chromosome organization (GO:0051276),-0.15552401665980145,-0.5791907081156462,1.0,1.0,1.0,35/99,33.84%,TOP2B;SETD7;HMGN3;MTHFR;DDB2;EZH1;PARP1;NUCKS1;ABL1;COPS4;LDB1;CDAN1;LATS1;TOP2A;EZH2;RAE1;CUL4B;COPS8;NUP155;FAM50A;BAHD1;CDCA8;BRWD1;COPS7B;HMGN2;HDAC1;SIRT1;NUF2;GEM;MTF2;LIG4;SOX2;LRWD1;CENPW;DOT1L
prerank,presynapse assembly (GO:0099054),-0.23277335188749917,-0.5790200036931669,0.9477272727272728,1.0,1.0,6/16,31.51%,NLGN2;PTEN;LRRTM3;DVL1;NLGN3;BSN
prerank,"DNA-templated transcription, termination (GO:0006353)",0.1983137242485819,0.5784697229440781,0.9883551673944687,1.0,1.0,10/68,13.02%,TAF1B;GTF2H2;CSTF2;SNRPF;SNRPE;CPSF1;SSU72;NCBP2;GTF2H4;SNRPB
prerank,protein import into nucleus (GO:0006606),-0.16877807219917773,-0.5781403058360777,0.9967320261437909,1.0,1.0,16/66,26.84%,APPL2;CBLB;RANBP17;E2F3;FAM53B;KPNA3;IPO7;STAT3;KPNB1;HIKESHI;KPNA6;NUP155;NUP35;IPO8;TPR;KPNA1
prerank,negative regulation of RNA metabolic process (GO:0051253),0.25058984099742004,0.5778633421603613,0.9339130434782609,1.0,1.0,6/18,26.51%,PTBP3;TGFB1;NUDT16;KAT2B;ZC3H12A;RPS13
prerank,regulation of acute inflammatory response (GO:0002673),0.2463068396352045,0.5777901142607286,0.9361702127659575,1.0,1.0,1/18,4.60%,OSMR
prerank,positive regulation of protein export from nucleus (GO:0046827),0.2627740909730916,0.5776786595861426,0.9339449541284404,1.0,1.0,1/15,3.85%,RAPGEF3
prerank,autophagy of nucleus (GO:0044804),-0.23136306547792954,-0.57413194511294,0.9625292740046838,1.0,1.0,2/16,6.27%,ULK2;ATG2B
prerank,pyroptosis (GO:0070269),0.2583791694676557,0.5734634584038423,0.927689594356261,1.0,1.0,3/15,16.56%,AIM2;CASP8;NLRC4
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.24174200424047945,-0.5721338079822387,0.9567307692307693,1.0,1.0,3/13,24.35%,SDAD1;XPO1;NOP9
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.2510123663613376,0.5719419203786983,0.9181818181818182,1.0,1.0,4/18,19.50%,ATXN3;NCK1;BAG6;BAK1
prerank,autophagy of mitochondrion (GO:0000422),0.21747684873240108,0.5706255221571791,0.9808612440191388,1.0,1.0,14/38,25.02%,CTSK;MAP1LC3B;ATG12;ATG14;ATG9B;MAP1LC3A;WDR45;ATG7;GABARAP;ATG2A;BNIP3;USP30;GABARAPL2;ULK1
prerank,DNA damage checkpoint signaling (GO:0000077),-0.19902910205287683,-0.5697145347258373,0.9829268292682927,1.0,1.0,9/28,23.64%,ATM;PRPF19;CLSPN;ERCC6;ATRIP;DONSON;NBN;CEP63;ATR
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.2037943889206473,-0.5692612465242278,0.9798994974874372,1.0,1.0,10/27,27.49%,ZC3H12B;PCF11;CPSF3;RNASE4;LACTB2;CSTF3;PARN;ZC3H12C;TOE1;POP7
prerank,natural killer cell mediated immunity (GO:0002228),-0.23174826914928254,-0.5691809198351987,0.9685393258426966,1.0,1.0,4/15,20.95%,PLEKHM2;RAET1E;LYST;ULBP1
prerank,error-free translesion synthesis (GO:0070987),-0.21582297426187186,-0.5688227557664327,0.9673659673659674,1.0,1.0,6/22,29.34%,REV1;RCHY1;RFC3;UFD1;RFC5;SPRTN
prerank,regulation of actin filament depolymerization (GO:0030834),0.27746252050965287,0.5686756634631279,0.9288321167883211,1.0,1.0,1/12,3.93%,VIL1
prerank,regulation of rRNA processing (GO:2000232),-0.22417815523610618,-0.566921989905313,0.9607390300230947,1.0,1.0,5/16,25.71%,RIOK2;WDR43;TRMT112;DIMT1;USP36
prerank,protein localization to kinetochore (GO:0034501),0.2575280108051988,0.5663430297364235,0.9293286219081273,1.0,1.0,4/14,19.17%,BUB3;RCC2;ZW10;IK
prerank,RNA biosynthetic process (GO:0032774),-0.1949946497050832,-0.5662204017318814,0.9818652849740933,1.0,1.0,7/31,21.69%,POLR2A;PRMT5;SMARCA5;HELB;PRIM2;BRF1;TBP
prerank,phagosome acidification (GO:0090383),-0.20006410119460283,-0.5653636049223743,0.9722222222222222,1.0,1.0,7/26,21.49%,ATP6V0A4;ATP6V1C1;ATP6V1G2;ATP6V1E1;TCIRG1;ATP6V1F;ATP6V0D2
prerank,protein localization to chromatin (GO:0071168),-0.2245672807260537,-0.5649682927036587,0.9697674418604652,1.0,1.0,8/18,33.05%,SGF29;ESR1;LEMD2;MCM9;PIH1D1;PLK1;MCM8;LRWD1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.19668329798150488,0.5634467719628631,0.986627043090639,1.0,1.0,23/65,28.17%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;ZFYVE19;PINX1;CUL1;PSMC3;PSMD1;PSMD10;PABIR1;NABP2;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.22412336374308048,-0.5631054857849346,0.9566265060240964,1.0,1.0,4/17,18.25%,FGF1;APOE;SREBF1;MBTPS1
prerank,receptor recycling (GO:0001881),-0.25212282721220297,-0.5616883033957982,0.9234234234234234,1.0,1.0,5/10,31.00%,ARFGEF2;RAB11B;NSG1;PHETA2;PLEKHJ1
prerank,nucleosome assembly (GO:0006334),0.21850832558707614,0.5588927842975128,0.9679595278246206,1.0,1.0,12/31,25.82%,CHAF1A;NAA60;SOX9;HMGB2;CHAF1B;IPO4;GRWD1;NASP;DAXX;HIRA;NAP1L4;SART3
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.16307083491778843,0.5587124070420095,1.0,1.0,1.0,89/264,29.87%,NOVA2;YBX1;EFTUD2;GPATCH1;RNPS1;BUD31;SNU13;CSTF2;SNRPF;HNRNPC;SNRPC;SNRPE;RBM19;CPSF1;MAGOHB;SNRPN;ZCRB1;HSPA8;PPWD1;NCBP2;GPKOW;CTNNBL1;SNRPB;SNRNP27;ELAVL1;FRG1;AQR;PRMT7;PRPF40A;PRPF4;RSRC1;ISY1;SCNM1;USP49;SMU1;SNRPB2;POLR2J;SF3A2;LSM4;SNRPD2;IK;PUF60;CDC5L;RBM8A;WDR77;HNRNPM;ELAVL2;SF3B3;RBM15;METTL3;NCBP1;DCPS;PAPOLA;WBP11;PABPC1;PRPF8;PPIE;SNRPA;SMNDC1;DHX38;UPF3B;CSTF2T;SART3;SNW1;PHF5A;CWC27;SCAF11;SNRNP48;HNRNPF;HNRNPA3;CSTF1;CWF19L2;HNRNPL;DDX20;SNRPD1;SRSF12;SRSF7;SRSF1;LSM6;SMN1;PRPF31;XAB2;DDX41;COIL;HNRNPA1;BCAS2;GEMIN5;PRPF6;ZRSR2
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.17739689442604084,-0.5583053339687275,0.9912280701754386,1.0,1.0,5/49,8.95%,TNRC6A;THBS1;MTURN;TNRC6B;MYL9
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.20870361095087972,0.5577884223437892,0.9793977812995246,1.0,1.0,8/40,16.58%,UBE2V2;MCL1;UBE2V1;PARG;IER3;NSMCE4A;SIRT7;HMGA2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.22479673841917966,0.556907812657273,0.957983193277311,1.0,1.0,5/25,14.42%,PKM;HK1;PGAM1;TPI1;PFKL
prerank,ncRNA export from nucleus (GO:0097064),-0.18677998218203323,-0.5564552809653963,0.9887323943661972,1.0,1.0,16/36,38.05%,PHAX;SEH1L;NUP205;TSC1;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.26909639861054696,0.5562111816277412,0.9306569343065694,1.0,1.0,3/10,21.71%,PSMC6;THRA;PSMC3
prerank,positive regulation of chromosome organization (GO:2001252),0.25464990848708036,0.5552010196055708,0.9510869565217391,1.0,1.0,4/15,18.30%,MRE11;SHCBP1L;RAD21;DDX11
prerank,negative regulation of cellular metabolic process (GO:0031324),0.21279839600873698,0.555045520272154,0.9813664596273292,1.0,1.0,8/37,19.35%,ANKRD13A;RIN3;SDCBP;MTMR2;EDN1;AP1AR;TFAP2A;LRPAP1
prerank,aromatic amino acid family metabolic process (GO:0009072),-0.2534883253935835,-0.5540602581798347,0.9483870967741935,1.0,1.0,3/10,20.05%,ATP7A;KYAT1;KYNU
prerank,RNA stabilization (GO:0043489),0.21509641872039273,0.5528724846220112,0.9698412698412698,1.0,1.0,5/33,14.77%,YBX1;NOCT;AXIN2;PAIP1;ELAVL1
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.22305447769652792,0.5525673115497437,0.9705400981996727,1.0,1.0,3/29,7.77%,ACBD6;GLYAT;ACSL6
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.22305447769652792,0.5525673115497437,0.9705400981996727,1.0,1.0,3/29,7.77%,ACBD6;GLYAT;ACSL6
prerank,establishment of protein localization to organelle (GO:0072594),-0.1610476361378856,-0.5519595803857869,1.0,1.0,1.0,5/72,9.55%,APPL2;LAMP2;RANBP17;HK2;LRSAM1
prerank,response to histamine (GO:0034776),0.2722737324651083,0.5518317168256606,0.9118773946360154,1.0,1.0,4/10,25.86%,GABRB1;GABRB2;AOC1;GABRG2
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.23917318833984325,0.5514504433083968,0.9578207381370826,1.0,1.0,5/18,21.32%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,mRNA transport (GO:0051028),0.17707912137582651,0.5505649352559165,0.9973190348525469,1.0,1.0,12/101,13.09%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NUP54;NCBP2;ZFP36L1;EIF4E;ZC3H11A
prerank,regulation of mRNA catabolic process (GO:0061013),0.1760811331613996,0.5505306029525441,0.9973684210526316,1.0,1.0,28/121,23.49%,PRR5L;PSMB3;PSMD11;PSMC6;GTPBP1;PSME2;HSPA8;HSPB1;PSMD8;DCP2;ZFP36L1;PSMB10;SERBP1;ELAVL1;ZC3HAV1;PSMA8;YWHAZ;YWHAB;PSMD9;SET;XRN1;ZFP36L2;EXOSC9;PSMC3;PSMD1;EXOSC8;PSMD10;PABPC1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.18239086170479993,0.5495831049150609,0.9959016393442623,1.0,1.0,22/88,23.25%,FBXW7;PSMB3;PSMD11;PSMC6;DMAC2;PSME2;FBXL2;PSMD8;FBXO6;PSMB10;RBX1;FBXL8;FBXL15;PSMA8;FBXO2;SKP1;PSMD9;CUL1;PSMC3;PSMD1;PSMD10;FBXL14
prerank,defense response to fungus (GO:0050832),0.24093870578658094,0.5495411867554634,0.9430147058823529,1.0,1.0,3/17,20.06%,S100A8;BCL10;PLCG2
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.27702219055854144,0.5488464234267869,0.940952380952381,1.0,1.0,3/10,15.84%,SPAG5;RCC2;APC
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.204558868860638,0.5482094145724775,0.9819548872180451,1.0,1.0,13/43,25.86%,MRE11;BABAM1;CDC6;ORC1;TRIM39;HMGA2;HUS1;BRCC3;RAD17;PABIR1;TOPBP1;NABP2;BLM
prerank,regulation of superoxide anion generation (GO:0032928),-0.22785776364697988,-0.5470104208325933,0.9581497797356828,1.0,1.0,1/14,3.61%,PRKCD
prerank,mitochondrion disassembly (GO:0061726),0.21036130883251067,0.546560828198488,0.9870550161812298,1.0,1.0,13/34,25.02%,CTSK;MAP1LC3B;ATG12;ATG9B;MAP1LC3A;WDR45;ATG7;GABARAP;ATG2A;BNIP3;USP30;GABARAPL2;ULK1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.20928835154903802,0.5463431373055756,0.9699367088607594,1.0,1.0,7/38,21.84%,NDUFA2;NDUFA8;NDUFA4;NDUFA12;NDUFB3;NDUFC1;NDUFA10
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.22955498306294375,-0.5455886380604409,0.9546485260770975,1.0,1.0,4/13,17.01%,KDM1A;SNAI1;TWIST1;CD44
prerank,mitotic spindle assembly (GO:0090307),0.20162885466388372,0.5453821511598819,0.983358547655068,1.0,1.0,6/42,11.51%,KIF2A;RAB11A;MZT1;KIF3B;KIF23;MAP10
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.24811913114235584,-0.5442151725773153,0.9379157427937915,1.0,1.0,2/10,22.06%,PRKN;AOC3
prerank,positive regulation of lipid storage (GO:0010884),0.23162558758140164,0.5434451392239013,0.9655765920826161,1.0,1.0,1/21,2.93%,SCARB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.17232411924810784,0.5410215768688369,1.0,1.0,1.0,17/125,16.09%,EFHC2;MAP4;STMN1;CLIP1;DYNLL1;KIF2A;KIF3B;RPS27;EML1;BUB3;CENPU;DYNC1LI1;PLK2;NUP160;RCC2;CKAP5;CENPN
prerank,establishment of spindle orientation (GO:0051294),0.21243507330139916,0.5403877956454173,0.9768595041322314,1.0,1.0,7/28,21.22%,MAP4;CDK5RAP2;ZW10;DCTN1;NSFL1C;CLASP1;NDE1
prerank,regulation of secretion by cell (GO:1903530),-0.16900283154079526,-0.539497089481688,0.9941520467836257,1.0,1.0,9/54,19.00%,SNCAIP;ANXA1;RAB21;FMR1;P3H1;STX4;RHBDF1;VAMP2;RAB13
prerank,protein localization to phagophore assembly site (GO:0034497),-0.24127470903468315,-0.5388097682337449,0.9492273730684326,1.0,1.0,5/11,34.83%,MFN2;ATG9A;WIPI1;STX17;WIPI2
prerank,phosphate ion transmembrane transport (GO:0035435),0.2520919816798805,0.5388069842267065,0.9477477477477477,1.0,1.0,4/12,23.80%,XPR1;SLC37A3;SLC37A2;SLC37A1
prerank,positive regulation of exocytosis (GO:0045921),0.20670763840118117,0.5385486010396933,0.9854368932038835,1.0,1.0,13/35,28.29%,UNC13D;HGS;SDCBP;CADPS;PDCD6IP;CADPS2;CLASP1;ATP6AP1;SNCA;CLASP2;RAB7A;VPS4B;RAB27A
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.17497614906812167,0.5384824672920868,0.9972714870395635,1.0,1.0,25/96,26.17%,AGFG1;HHEX;RNPS1;NXT1;CPSF1;MAGOHB;THOC6;NUP54;NCBP2;EIF4E;ZC3H11A;NUP160;NUP153;NUP50;RBM8A;UPF2;NCBP1;NUP42;NUP85;NUP210;DHX38;UPF3B;UPF1;NUP188;CHTOP
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.24971301498484394,0.5382448264239749,0.9427083333333334,1.0,1.0,8/15,31.61%,MRE11;HUS1;RAD9B;RAD17;HUS1B;CHEK2;MDC1;EME2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.2296193945484235,0.5378220858018872,0.9607508532423208,1.0,1.0,19/19,77.07%,DNAAF2;AQP4;RFX3;CFAP53;ODAD4;CABYR;NPHP3;SPEF2;CCDC39;CCDC103;NEK10;OFD1;DNAAF1;DNAAF4;CCDC40;SPA17;SPAG17;ADCY10;ROPN1L
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.19135784712512283,0.5377950658680504,0.9969924812030075,1.0,1.0,20/55,28.17%,PSMB3;PSMD11;PSMC6;PSME2;PSMD8;PSMB10;RBX1;PSMA8;SKP1;PSMD9;PINX1;CUL1;PSMC3;PSMD1;PSMD10;PSME1;PSMD2;PSMA1;PSMB8;PSMA7
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.2354663293629034,0.5350156444514564,0.9456140350877194,1.0,1.0,4/15,16.74%,STXBP1;NPS;NLGN1;CNTNAP4
prerank,regulation of phosphate metabolic process (GO:0019220),0.24246655985942253,0.5345708566323689,0.968421052631579,1.0,1.0,4/16,23.44%,IKBKB;PGAM1;TIGAR;RAD17
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.2263972306527388,0.5335747509020262,0.966044142614601,1.0,1.0,6/20,19.18%,TSNAX;ZC3H7A;TSN;MRPL44;TRIM71;DICER1
prerank,lipid droplet formation (GO:0140042),0.2585473117896364,0.5329435571055092,0.9485714285714286,1.0,1.0,1/10,6.74%,CDS2
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.19714891965887327,-0.5301174437433761,0.9858490566037735,1.0,1.0,7/22,26.10%,SMARCB1;WDR43;PHF8;RASL11A;ERBB2;NCL;EIF2AK3
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.2535744878776798,0.529968268033082,0.9496124031007752,1.0,1.0,5/11,25.54%,LPCAT3;ATL1;BNIP1;VCPIP1;VAPB
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.20463999163039398,-0.5280019281250202,0.9748858447488584,1.0,1.0,4/19,18.27%,AMPD3;GMPR2;DGUOK;POLD2
prerank,steroid catabolic process (GO:0006706),-0.23684781296120128,-0.5278138491623025,0.9651162790697675,1.0,1.0,1/10,5.86%,SPP1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.18655793951866012,0.5266737351084179,0.9970760233918129,1.0,1.0,16/58,21.81%,MRE11;UBE2V2;BABAM1;ZBTB7A;POLB;HMGB2;RNF8;HERC2;SUMO1;BRCC3;POLL;UVRAG;ERCC8;POLA1;ERCC4;DCLRE1C
prerank,7-methylguanosine RNA capping (GO:0009452),0.20605723182299132,0.5265452728056293,0.984251968503937,1.0,1.0,8/31,21.57%,GTF2H2;NCBP2;GTF2H4;CMTR2;CMTR1;POLR2J;GTF2H3;NCBP1
prerank,7-methylguanosine mRNA capping (GO:0006370),0.20605723182299132,0.5265452728056293,0.984251968503937,1.0,1.0,8/31,21.57%,GTF2H2;NCBP2;GTF2H4;CMTR2;CMTR1;POLR2J;GTF2H3;NCBP1
prerank,isotype switching (GO:0045190),0.260310810420552,0.5258706882069543,0.9450757575757576,1.0,1.0,2/10,15.56%,RNF8;MSH2
prerank,phasic smooth muscle contraction (GO:0014821),0.26143995982675305,0.5250283799766048,0.9630931458699473,1.0,1.0,10/10,73.87%,EDN1;TIFAB;EDN3;EDNRB;EDN2;DRD2;GDNF;HTR1D;HTR2B;PTGER3
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.21083533503491309,-0.5247843591001411,0.9724770642201835,1.0,1.0,7/16,37.58%,TRA2B;CIRBP;NCL;CELF4;CELF3;SF3B4;NUP98
prerank,eye photoreceptor cell development (GO:0042462),-0.2206086619194417,-0.5237415285925027,0.9866369710467706,1.0,1.0,7/15,35.21%,RPGRIP1L;TULP1;THY1;BBS4;MYO7A;CRB2;NRL
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.21421430350629805,0.5223110092471552,0.9797979797979798,1.0,1.0,5/25,19.14%,ZMYND11;BRD4;NELFCD;RNF8;EAF1
prerank,mitotic spindle organization (GO:0007052),0.1620107344560132,0.521342494810321,1.0,1.0,1.0,21/153,16.46%,EFHC2;MAP4;STMN1;CLIP1;DYNLL1;KIF2A;RAB11A;MZT1;KIF3B;KIF23;RPS27;EML1;BUB3;CENPU;DYNC1LI1;PLK2;NUP160;RCC2;CKAP5;CENPN;SPAST
prerank,cellular response to ATP (GO:0071318),-0.21119693034619413,-0.5203472165629868,0.9636803874092009,1.0,1.0,8/14,38.08%,P2RX4;HSP90B1;RYR3;P2RY1;P2RX3;P2RY12;P2RY2;PDXP
prerank,peripheral nervous system development (GO:0007422),0.216164070788973,0.5201084431048311,0.9780405405405406,1.0,1.0,6/23,24.48%,NFASC;SERPINI1;SOX10;PMP22;BDNF;ADGRG6
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.21788891887478168,0.5200707248848858,0.9717607973421927,1.0,1.0,2/23,13.95%,CALM1;METAP2
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.24172405734505398,0.5172661252878619,0.9517625231910947,1.0,1.0,7/13,29.83%,AAR2;PRPF8;SART3;DDX20;SRSF12;PRPF31;PRPF6
prerank,RNA methylation (GO:0001510),0.1826954484156898,0.5172640636370446,0.9956395348837209,1.0,1.0,21/60,26.67%,CBLL1;GTPBP3;TRMT10C;MRM2;TRMT12;TRMT61B;METTL2B;METTL2A;ZC3H13;ALKBH8;CMTR1;TRMT5;NSUN6;RBM15;METTL3;ZCCHC4;TRMO;PCIF1;TARBP1;TRMT10A;TYW3
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.25052804393324074,0.5170407746350597,0.9516728624535316,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.25052804393324074,0.5170407746350597,0.9516728624535316,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.25052804393324074,0.5170407746350597,0.9516728624535316,1.0,1.0,2/11,15.66%,PANK3;ACAT1
prerank,RNA interference (GO:0016246),0.2255061553947863,0.5154232116988601,0.9699646643109541,1.0,1.0,4/17,19.18%,TSNAX;TSN;MRPL44;DICER1
prerank,myelin maintenance (GO:0043217),0.2468043720175362,0.5149251490618116,0.9580952380952381,1.0,1.0,3/10,19.06%,ABCD1;DEGS1;ABCD2
prerank,ribonucleoprotein complex assembly (GO:0022618),0.16301652892363755,0.5148864002498434,0.9987277353689568,1.0,1.0,50/132,29.87%,HSP90AB1;RPL38;EIF4H;RPL3;ABT1;RPSA;SNRPF;SNRPC;SNRPE;RPS27;PWP2;MRPL20;SNRPB;RPL11;RPS15;RPS28;PRMT7;ISY1;NAF1;SF3A2;LSM4;SNRPD2;DICER1;PUF60;WDR77;NCBP1;EIF4B;EIF2S2;RSL24D1;RPL24;ERAL1;PTGES3;SART3;SCAF11;RPL6;RPS19;TRAF7;NOL3;DDX20;DHX29;SNRPD1;SRSF1;SETX;SMN1;XAB2;COIL;GEMIN5;PRPF6;RPS14;ZRSR2
prerank,response to leucine (GO:0043201),0.2498173789416819,0.5148544403399535,0.939622641509434,1.0,1.0,2/10,12.23%,SESN3;RPTOR
prerank,cellular response to leucine (GO:0071233),0.2498173789416819,0.5148544403399535,0.939622641509434,1.0,1.0,2/10,12.23%,SESN3;RPTOR
prerank,positive regulation of mRNA processing (GO:0050685),-0.19367529954278148,-0.5142662410808193,0.9858156028368794,1.0,1.0,10/21,38.34%,PAF1;TRA2B;CIRBP;NCL;CELF4;DHX36;CELF3;SF3B4;NUP98;CDC73
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.17492437208089934,-0.5141915642936736,1.0,1.0,1.0,6/30,18.52%,NPEPPS;RNF31;HUWE1;HTRA2;PDCD5;ABLIM3
prerank,V(D)J recombination (GO:0033151),-0.22377270594129267,-0.5117460666012569,0.9757709251101322,1.0,1.0,4/11,31.43%,LIG1;LIG3;HMGB1;LIG4
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.21349927464812823,-0.510801910884957,0.9817351598173516,1.0,1.0,5/13,25.47%,RCL1;NOP14;NOP9;BMS1;UTP20
prerank,regulation of spindle assembly (GO:0090169),-0.18734889797184948,-0.5106415607048785,0.9907192575406032,1.0,1.0,9/25,30.36%,GPSM2;SENP6;CHMP4C;EML3;HSPA1A;CCSAP;TPR;NUMA1;PLK1
prerank,tRNA processing (GO:0008033),0.17909235474436985,0.510620053663163,0.9985207100591716,1.0,1.0,16/61,23.21%,SARS1;CDKAL1;CSTF2;CPSF1;TRMT10C;DTWD2;RTRAF;RPP21;TSEN15;RTCB;THUMPD1;NSUN6;QTRT2;RPP30;CTU2;TSEN34
prerank,UV-damage excision repair (GO:0070914),-0.22067260940469147,-0.5095317287541578,0.9645232815964523,1.0,1.0,3/12,21.71%,DDB2;ERCC1;CUL4B
prerank,polarized epithelial cell differentiation (GO:0030859),0.2375553746469528,0.5088013653081305,0.9575645756457565,1.0,1.0,2/13,8.79%,OPHN1;MSN
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.24829813166458803,0.5086782929435764,0.9711191335740073,1.0,1.0,4/10,22.16%,CTBP1;SET;NOC2L;SNCA
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2257759224081526,0.5078266365480834,0.9733570159857904,1.0,1.0,5/16,25.68%,ZFP36L1;TRIM71;ZFP36L2;UPF1;ZC3H12A
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.2510827945515035,0.5073825969837361,0.9529190207156308,1.0,1.0,10/10,74.91%,GNB1;PDE6G;PDE6B;PDE6A;CNGA1;GRK1;GNAT1;RHO;SAG;CNGB1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.24883458776766004,0.5047938650993652,0.9544592030360531,1.0,1.0,3/10,18.83%,ETFB;ACAD11;ETFDH
prerank,negative regulation of innate immune response (GO:0045824),0.1940184801184035,0.5047746882893654,0.987220447284345,1.0,1.0,11/34,27.29%,NLRC5;SAMHD1;USP18;TNFAIP3;LYAR;NMI;METTL3;STAT2;ISG15;ACOD1;RPS19
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.20224253581684726,-0.503187365691848,0.9776785714285714,1.0,1.0,7/15,37.66%,ZC3H12B;LACTB2;ZC3H12C;POP7;ZC3H12D;RPP40;NYNRIN
prerank,regulation of chromosome organization (GO:0033044),0.21155872810357568,0.5027151458144081,0.9814502529510961,1.0,1.0,6/22,25.51%,TERF2;SHCBP1L;YLPM1;WAPL;MYC;UPF1
prerank,peptidyl-lysine acetylation (GO:0018394),-0.22940613451323,-0.5007287856071366,0.9812108559498957,1.0,1.0,5/10,34.55%,EP300;CREBBP;SIRT1;KAT5;ESCO1
prerank,response to organonitrogen compound (GO:0010243),-0.16791370618708262,-0.5004150587726031,0.9970501474926253,1.0,1.0,8/38,22.30%,RCN3;PRKN;GLRB;IRAK3;SYVN1;NR1H4;KYNU;DERL1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2005110021442549,0.4993452518157569,0.9773462783171522,1.0,1.0,11/27,32.77%,AK4;CMPK1;GSR;DTYMK;NME2;TYMS;AK2;AK1;GUK1;AK8;AK7
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.20923049837769853,0.4981880098534222,0.9880341880341881,1.0,1.0,5/21,21.32%,RAB11A;BRD4;RCC2;MECP2;CDK4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.24577287551563265,0.496517419584588,0.9670932358318098,1.0,1.0,2/10,16.84%,KLF4;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.24577287551563265,0.496517419584588,0.9670932358318098,1.0,1.0,2/10,16.84%,KLF4;MBP
prerank,tricarboxylic acid metabolic process (GO:0072350),0.23429146336863893,0.495875296326254,0.9669117647058824,0.9998896332484778,1.0,5/12,22.50%,IDH3A;IREB2;ASS1;IDH3B;ACLY
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.20576896463422578,0.4914537562823003,0.9897084048027445,1.0,1.0,12/22,30.56%,VPS36;VPS25;VPS37A;PLAA;VPS37B;RNF126;VPS37C;RNF115;VPS4B;VPS28;MVB12B;UBAP1
prerank,response to ethanol (GO:0045471),-0.20744302964243289,-0.4893238889134864,0.9758771929824561,1.0,1.0,1/14,4.82%,ADCY7
prerank,cellular response to hydroxyurea (GO:0072711),0.2433774873150935,0.4869767089332727,0.9577205882352942,1.0,1.0,6/10,32.69%,DDX11;NSMCE3;BLM;TIMELESS;DDI2;RTF2
prerank,interstrand cross-link repair (GO:0036297),-0.14986407935032925,-0.4855629627807241,1.0,1.0,1.0,17/53,32.96%,FANCE;FANCI;FAAP100;NUCKS1;ERCC1;ATRIP;FANCD2;ATR;MCM9;RAD51AP1;RNF168;USP1;NEIL3;FAAP24;FANCL;UBE2T;MCM8
prerank,regulation of T cell mediated immunity (GO:0002709),-0.2187652906243627,-0.4850189098176578,0.9874213836477987,1.0,1.0,2/10,14.46%,TRPM4;ZBTB1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.18601871780638657,0.48348785215600437,0.9935379644588045,1.0,1.0,15/36,29.95%,HINFP;DNA2;CDC6;FBXO6;HUS1;CDC5L;RAD9B;RAD1;RAD17;TIPRL;CLOCK;TIMELESS;HUS1B;CHEK2;MAP3K20
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.2237709549821058,0.48310548692039396,0.9872727272727273,1.0,1.0,14/14,77.64%,TNFSF11;ATP6AP1;TRAF6;CSF1;IFNG;POU4F2;IL12B;IL23R;TNF;IL23A;OCSTAMP;CCR1;POU4F1;TYROBP
prerank,regulation of transposition (GO:0010528),0.22427116479219134,0.48270078791618254,0.9762340036563071,1.0,1.0,1/13,4.89%,PIWIL1
prerank,protein prenylation (GO:0018342),0.23653893480127686,0.48253169431592213,0.9709618874773139,1.0,1.0,2/10,17.85%,PGGT1B;RCE1
prerank,negative regulation of secretion (GO:0051048),-0.22024691677435965,-0.4810246461651552,0.9870410367170627,1.0,1.0,4/10,36.45%,VAMP3;PTGER3;SPX;CD74
prerank,regulation of centrosome cycle (GO:0046605),0.2051157831265366,0.47723028410107005,0.9819819819819819,1.0,1.0,2/21,7.84%,MARK4;CHMP1B
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.2346996422070179,0.47704876753059167,0.9706959706959707,1.0,1.0,10/10,76.54%,NAF1;ZNHIT3;ZNHIT6;RUVBL1;RUVBL2;NUFIP1;SHQ1;PIH1D1;TAF9;PIH1D2
prerank,sensory perception of pain (GO:0019233),-0.1736396734756301,-0.4749994667392406,0.9886363636363636,1.0,1.0,2/21,7.23%,PTGES;P2RX4
prerank,cellular response to oxygen levels (GO:0071453),0.22697884627455917,0.474707121329986,0.9728155339805825,1.0,1.0,10/10,77.32%,CCDC115;ATP6AP1;ATP6V1A;ATP6V0D1;NDUFS2;ATP6V1G1;ATP6V0A2;TMEM199;PICK1;CPEB4
prerank,androgen metabolic process (GO:0008209),-0.1890572150620379,-0.47459426083419237,0.987146529562982,1.0,1.0,1/18,5.86%,SPP1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.18643025162795235,-0.47339793434515626,0.9837587006960556,1.0,1.0,5/17,26.05%,ALG1;MPDU1;MVD;DHDDS;SRD5A3
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.20834235135301743,-0.4726985297384363,0.987012987012987,1.0,1.0,5/12,37.07%,PIBF1;BRCA1;APOC1;SIRT1;ERLIN1
prerank,DNA replication initiation (GO:0006270),-0.1567267377928372,-0.47085066758991106,0.9974619289340102,1.0,1.0,14/37,33.05%,POLE4;PRIM2;CDC45;DBF4;MCM3;MCM4;POLE2;MCM5;ORC2;ORC5;GMNN;CDC34;MCM8;LRWD1
prerank,mitotic cytokinetic process (GO:1902410),0.20118954989589652,0.4691644611532927,0.9858906525573192,1.0,1.0,3/20,16.44%,CHMP1B;MITD1;PDCD6IP
prerank,regulation of lymphocyte proliferation (GO:0050670),-0.18647304289765987,-0.469070881918478,0.9953379953379954,1.0,1.0,8/16,39.90%,PTPN22;TNFSF8;AHR;LST1;IKZF3;FGF10;CD22;TNFSF9
prerank,regulation of microtubule-based movement (GO:0060632),0.2210268339875713,0.4649954850617726,0.97131931166348,1.0,1.0,1/11,7.92%,DRC1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.21660325701041333,0.4649294897464856,0.9801084990958409,1.0,1.0,2/13,15.21%,NELFCD;RNF8
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.22130534481008862,0.46392429664658,0.9760147601476015,1.0,1.0,2/12,15.21%,NELFCD;RNF8
prerank,protein import into mitochondrial matrix (GO:0030150),0.20178358349557252,0.4620009734592299,0.9880341880341881,1.0,1.0,18/18,79.84%,DNAJC19;TOMM20L;TIMM21;TIMM50;TOMM70;GRPEL2;GRPEL1;PAM16;TOMM20;DNLZ;ROMO1;TIMM17A;DNAJC15;TOMM40;TIMM17B;TIMM23;TIMM44;TOMM40L
prerank,neuron fate commitment (GO:0048663),-0.18917548122180197,-0.45938790099641796,0.9869281045751634,1.0,1.0,7/14,34.53%,TGFBR1;ID2;POU3F2;SHH;POU4F1;PAX6;ASCL1
prerank,coenzyme A metabolic process (GO:0015936),-0.1928798363780389,-0.4580844898724497,0.9842342342342343,1.0,1.0,2/14,13.42%,DCAKD;CROT
prerank,mitochondrion transport along microtubule (GO:0047497),0.21524246353113416,0.45783468182249876,0.9810017271157168,1.0,1.0,5/13,30.69%,HIF1A;SPAST;LRPPRC;UBB;SYBU
prerank,estrogen metabolic process (GO:0008210),-0.18652933203919744,-0.4572818400935175,0.9977272727272727,1.0,1.0,7/15,40.15%,CYP1B1;HSD17B2;SULT1A1;HSD17B14;HSD17B1;HSD17B11;CYP1A1
prerank,organophosphate catabolic process (GO:0046434),0.22265817157371498,0.4571595156342335,0.9851301115241635,1.0,1.0,1/11,8.63%,ENPP2
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.21250974664044447,0.45523544740766464,0.9858156028368794,1.0,1.0,5/14,28.37%,NOL9;DDX18;ZNHIT3;RPL7L1;ZNHIT6
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.2092469084974006,0.45297273993576503,0.9823008849557522,0.9999655636297551,1.0,7/13,34.25%,BNIP3L;BNIP3;PMAIP1;BCL2L11;BAX;BAD;BMF
prerank,positive regulation of double-strand break repair (GO:2000781),0.16928489624216084,0.45290495623303034,0.9924242424242424,0.9995450912079107,1.0,12/39,26.06%,SHLD1;MGMT;WDR48;ACTR2;FANCB;SLF1;DDX11;PARP9;FMN2;ARID2;PNKP;DTX3L
prerank,ribosomal large subunit assembly (GO:0000027),0.1870877888212303,0.4521392612731535,0.9903225806451613,0.9992101137257985,1.0,7/24,27.56%,RPL3;MRPL20;RPL11;RSL24D1;RPL24;RPL6;TRAF7
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.15133846267558432,-0.44934715346784915,0.9919786096256684,1.0,1.0,14/32,38.05%,SEH1L;NUP205;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,tRNA export from nucleus (GO:0006409),-0.15133846267558432,-0.44934715346784915,0.9919786096256684,1.0,1.0,14/32,38.05%,SEH1L;NUP205;RAE1;NUP155;NUP35;NDC1;TPR;NUP43;AAAS;NOL6;NUP37;SSB;NUP98;NUP62
prerank,cell cycle G1/S phase transition (GO:0044843),0.15562228694457625,0.44083618906893784,1.0,1.0,1.0,16/61,24.77%,MAX;HINFP;EIF4E;PIM2;PLK2;ACVR1;MAP3K11;TRIM71;USP29;CDK6;CDK4;NASP;CUL1;CDKN1B;MYC;CDKN2C
prerank,tRNA 5'-leader removal (GO:0001682),-0.18292515747419058,-0.4400280481578515,0.9910112359550561,1.0,1.0,6/13,36.32%,PRORP;POP4;RPP25L;POP7;RPP40;SSB
prerank,eosinophil chemotaxis (GO:0048245),0.20141897406919082,0.43984215134324123,0.9911816578483245,0.999513204029993,1.0,14/14,79.88%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL3;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2;CCL13
prerank,eosinophil migration (GO:0072677),0.20141897406919082,0.43984215134324123,0.9911816578483245,0.999513204029993,1.0,14/14,79.88%,CCL1;SCG2;CCL4;CCL26;CCL24;LGALS3;CCL3;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2;CCL13
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.17712740855276382,-0.43726160982164136,0.9933920704845814,1.0,1.0,5/16,29.90%,PDS5B;NAA50;SGO1;DSCC1;PDS5A
prerank,response to hydroxyurea (GO:0072710),0.2139353589296977,0.43614328516709755,0.9816176470588235,0.9994917388440488,1.0,6/11,32.69%,DDX11;NSMCE3;BLM;TIMELESS;DDI2;RTF2
prerank,P-body assembly (GO:0033962),0.2047543457215713,0.4331371441752969,0.9944649446494465,0.9994014615388586,1.0,3/12,24.18%,EDC3;LSM4;LSM14A
prerank,regulation of chromosome segregation (GO:0051983),-0.1729136405172346,-0.4328703062450427,0.9976415094339622,1.0,1.0,9/16,44.55%,SMC6;CSNK2A1;NUMA1;RAD18;BUB1;KIF2C;AURKB;MKI67;HORMAD1
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.19504206901674115,0.4311733641228433,0.9890909090909091,0.9991897715405527,1.0,3/14,17.43%,WDR48;ACTR2;FANCB
prerank,intermediate filament organization (GO:0045109),0.1891391664337938,0.42738459446263594,0.9910394265232975,0.9991488862971785,1.0,3/17,17.78%,KLHL24;GFAP;DNAJB6
prerank,protein localization to condensed chromosome (GO:1903083),0.1999186762634164,0.4269095392318836,0.9855072463768116,0.9987625866208949,1.0,3/12,19.17%,BUB3;ZW10;IK
prerank,gas transport (GO:0015669),-0.19403838015708683,-0.426641323027842,0.9891774891774892,1.0,1.0,1/10,8.90%,CYGB
prerank,regulation of viral transcription (GO:0046782),0.16143740420970118,0.4255384350598018,0.9984276729559748,0.9984596824520774,1.0,1/39,2.37%,TRIM14
prerank,phospholipid metabolic process (GO:0006644),0.1410465028632894,0.42308868687490403,1.0,0.9982865794196641,1.0,10/71,20.26%,MBOAT1;PLA2G4B;ENPP2;PIP4K2A;CLN8;PLPPR4;PLPP2;GPX4;PGP;PLAA
prerank,positive regulation of telomere capping (GO:1904355),-0.16709761550550922,-0.4226851345102095,0.997624703087886,1.0,1.0,6/17,26.59%,TNKS2;RTEL1;TNKS;PKIB;HNRNPD;MAP3K4
prerank,T cell activation involved in immune response (GO:0002286),-0.1803560395841314,-0.42248844301275296,0.9935344827586207,0.9995186367058277,1.0,9/12,46.95%,MDK;FCER1G;ICAM1;LILRB1;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,histone lysine methylation (GO:0034968),0.16203372992956683,0.4202322720367762,1.0,0.9981266604189324,1.0,8/33,26.12%,MEN1;PRDM9;SETDB1;SMYD1;RBBP5;SETDB2;WDR82;SUV39H1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.16856499994180504,0.4190572977204424,1.0,0.9977922785962828,1.0,5/25,18.69%,HSPA8;DNAJC7;HSPA9;HSPE1;ERO1A
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.1813197373208461,-0.4170368051600572,0.9935483870967742,0.9991581833497916,1.0,8/12,48.96%,ZBTB1;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,sno(s)RNA 3'-end processing (GO:0031126),-0.18557655414352964,-0.41300110609556784,1.0,0.998691605836687,1.0,4/11,40.57%,EXOSC2;PARN;FBLL1;LARP7
prerank,regulation of mitotic spindle assembly (GO:1901673),0.17912322572541123,0.4086512011342514,0.9964349376114082,0.9982122885380211,1.0,19/19,82.11%,CHMP1B;PDCD6IP;CEP97;CHMP2B;VPS4B;DRG1;CHMP3;CHMP4B;HNRNPU;CHMP5;HSPA1B;CHMP2A;CHMP1A;PLK1;TPR;CCSAP;HSPA1A;EML3;CHMP4C
prerank,negative regulation of viral release from host cell (GO:1902187),-0.17177297840281266,-0.3998820955268582,0.9976580796252927,0.9986209684293889,1.0,13/13,82.84%,PML;TRIM8;TRIM5;TRIM21;TRIM35;TRIM13;TRIM15;CHMP3;TRIM28;TRIM32;MID2;TRIM11;TRIM26
prerank,myeloid dendritic cell activation (GO:0001773),0.17967229581266872,0.3863072167785679,0.994413407821229,0.9991531197012914,1.0,12/12,82.05%,TGFBR2;DOCK2;BATF2;DHRS2;DCSTAMP;SLAMF1;BATF3;IL4;CAMK4;HMGB1;PYCARD;BATF
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.14721967914745612,0.370743966863925,0.9983416252072969,0.9993917382929159,1.0,9/28,27.61%,SHLD1;SIRT7;HMGA2;ACTR2;PARP9;PNKP;DTX3L;NUDT16L1;CYREN
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.13758304263609528,0.334356225911709,1.0,0.9997532904720694,1.0,8/25,29.83%,MPHOSPH10;PRPF4;SF3B3;PRPF8;SMNDC1;SCAF11;BCAS2;PRPF6
